<SEC-DOCUMENT>0001510964-21-000012.txt : 20210319
<SEC-HEADER>0001510964-21-000012.hdr.sgml : 20210319
<ACCEPTANCE-DATETIME>20210319172336
ACCESSION NUMBER:		0001510964-21-000012
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		81
CONFORMED PERIOD OF REPORT:	20201231
FILED AS OF DATE:		20210319
DATE AS OF CHANGE:		20210319

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CV Sciences, Inc.
		CENTRAL INDEX KEY:			0001510964
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				800944970
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-54677
		FILM NUMBER:		21759159

	BUSINESS ADDRESS:	
		STREET 1:		10070 BARNES CANYON ROAD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		866-290-2157

	MAIL ADDRESS:	
		STREET 1:		10070 BARNES CANYON ROAD
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CannaVEST Corp.
		DATE OF NAME CHANGE:	20130205

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Foreclosure Solutions, Inc.
		DATE OF NAME CHANGE:	20110124
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>cvsi-20201231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:eca8e0c2-d550-4e97-a9fa-88ee2e9b3168,g:095536f4-fd9c-45bc-aa88-ebcfe4d45a75,d:ca64940eaba8432cb3e8a74baaac4713--><html xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:cvsi="http://cvsciences.com/20201231" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>cvsi-20201231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM180L2ZyYWc6ZmJiMDgwYWIyZjRlNGFlZjgyYzVlMjE3ZTY3MDY4NmYvdGFibGU6ZWZkYjNjNGRlZDZlNDE3OWEwNDU2NGVjOWVhMzMzNWUvdGFibGVyYW5nZTplZmRiM2M0ZGVkNmU0MTc5YTA0NTY0ZWM5ZWEzMzM1ZV8zLTEtMS0xLTA_6d585226-024c-4b4d-9fb1-291929947a7d">0001510964</ix:nonNumeric><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM180L2ZyYWc6ZmJiMDgwYWIyZjRlNGFlZjgyYzVlMjE3ZTY3MDY4NmYvdGFibGU6ZWZkYjNjNGRlZDZlNDE3OWEwNDU2NGVjOWVhMzMzNWUvdGFibGVyYW5nZTplZmRiM2M0ZGVkNmU0MTc5YTA0NTY0ZWM5ZWEzMzM1ZV83LTEtMS0xLTA_b90fe62e-a723-470d-80d0-584342c56222">false</ix:nonNumeric><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM180L2ZyYWc6ZmJiMDgwYWIyZjRlNGFlZjgyYzVlMjE3ZTY3MDY4NmYvdGFibGU6ZWZkYjNjNGRlZDZlNDE3OWEwNDU2NGVjOWVhMzMzNWUvdGFibGVyYW5nZTplZmRiM2M0ZGVkNmU0MTc5YTA0NTY0ZWM5ZWEzMzM1ZV8xOS0xLTEtMS0w_fe158ad1-40fd-4e3c-8ca8-97c8c8edd701">FY</ix:nonNumeric><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM180L2ZyYWc6ZmJiMDgwYWIyZjRlNGFlZjgyYzVlMjE3ZTY3MDY4NmYvdGFibGU6ZWZkYjNjNGRlZDZlNDE3OWEwNDU2NGVjOWVhMzMzNWUvdGFibGVyYW5nZTplZmRiM2M0ZGVkNmU0MTc5YTA0NTY0ZWM5ZWEzMzM1ZV8yMC0xLTEtMS0w_b3534acf-86a4-4cfa-bfe3-593a14a2be92">2020</ix:nonNumeric><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:TypeOfRevenueExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzItMC0xLTEtMA_21e27cb9-2ecc-40f1-a3e5-fb173f0ff2f4">us-gaap:ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" name="us-gaap:TypeOfRevenueExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzItMC0xLTEtMA_85a5bcce-34c7-4688-b42a-3948caec6542">us-gaap:ProductMember</ix:nonNumeric><ix:nonNumeric contextRef="i85b38ef36bb04db7be1a75cdedabb16e_D20200101-20201231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzY1OTcwNjk4MDk1ODc_f5674a51-c511-43ac-a681-83d953908b76">P2Y</ix:nonNumeric><ix:nonNumeric contextRef="i18b1bfee52e244df92d350109e304526_D20200101-20201231" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzIxOTkwMjMzMTk0MDU_d0b87cf7-bf22-4fdd-a58e-c194e22353b3">P10Y</ix:nonNumeric><ix:nonNumeric contextRef="i32add06262af4753ba901af35fd023f3_D20200101-20201231" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzE4NzE_8bd9e890-25d8-4554-b080-b96de69f559a">P2Y</ix:nonNumeric><ix:nonNumeric contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" format="ixt-sec:durwordsen" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMTE2L2ZyYWc6YTQ3MDFlOGM2NDA3NDQxMmFkNTgxOGYyNjhiZmY0ZTkvdGFibGU6M2Y5OWE1ZTVmYzhhNDE3MmI2ZWMyYWRiOWE2ZDc0NDcvdGFibGVyYW5nZTozZjk5YTVlNWZjOGE0MTcyYjZlYzJhZGI5YTZkNzQ0N181LTEtMS0xLTYyMTE_c49e0f7f-d87e-420e-bcef-9bc93e278c98">5 years, 19 days</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="cvsi-20201231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="ieb170334852144ef80f82c113af94f9a_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i1aa88da6c8d9457692e0febdb65cb1cf_I20210316"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-16</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i95335529356f4afbb8b76a88b727d1d2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib68a40c3668644fc87db08988f699fec_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i131f52df83994257bc0a0cfa19c3a287_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7937d2f589d84d8fb67618c8a842735b_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6e7fe9b796a34c8bb8a1612cb22866da_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifc2c804db67543dd84291701c746b6fa_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8ff8bfc5f83647a4892aab327120d79e_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7cbd69ac9b3b4f10a86a91c48e412fad_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id718b729adc144caa3a6bf9c95dc04de_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i162f6e60104546399b0dd90dbead19b3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i37c881596124431c92dfe85bd94a4cea_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0027a2179d842fe82581b40a11ca56d_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4789842d4b954973b49e7fed17e8c8eb_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05bf25010f5e4bfc8fdea3b99d63f2ba_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i421a1d1328f941c893389dbf40b7b314_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3c2ab9e7b8f8470ca661e005ae40f9cb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if96d39e36198411b85070b25ac1ee3f6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i598932caa7504ab8a4125324d9bbd23d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>cvsi:segment</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="ia430bcca043b4606a1c759ed7eaa8883_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:OwnershipAxis">cvsi:CannaVestEuropeGmbHMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="supplier"><xbrli:measure>cvsi:supplier</xbrli:measure></xbrli:unit><xbrli:context id="i1eb2e25e3bc14d80a5c0329eebbc85a5_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="company"><xbrli:measure>cvsi:company</xbrli:measure></xbrli:unit><xbrli:context id="if5456eaf29c94cbf9434311c42b7d007_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3019b5e0eea94dff87d9cf02a903f261_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3100b80a9d7c4d53bf9d8e711e804a24_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i796f849901b445a9a1017431e7f0feb3_D20200417-20200417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-17</xbrli:startDate><xbrli:endDate>2020-04-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5ce71eb8f7d045f680a63998d5ebc762_D20201208-20201208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cvsi:CommonStockPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-08</xbrli:startDate><xbrli:endDate>2020-12-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if01f3c8b8a7e46bfb048274a7d4ddc6a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f6446e2781145b58aadd810c3831360_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if8aa597259fe4304b7b63ce40ce227b4_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvsi:RetailFDMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7864245a6d34e58aacbabaa8179f74f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvsi:RetailFDMMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70f9d718799644699f10f809156bd286_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvsi:RetailNaturalProductsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if54d7cb037ac4f8e8327ff809a2b2c0f_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvsi:RetailNaturalProductsAndOtherMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if3d15c156ba349c48d60f8791891481a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvsi:ECommMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icf894d15f551418abe1ae2f318b3c813_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvsi:ECommMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iafc1a3c97c0d4080885871840e0654af_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvsi:ConsumerProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4ab148dfa19a48ec9bfc7253afd2d8e0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvsi:ConsumerProductsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8c7e853cfb97488bafd77f77828becba_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvsi:SpecialtyPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic13b530da3e44e4384e40cfb677c6d60_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvsi:SpecialtyPharmaceuticalSegmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i85b38ef36bb04db7be1a75cdedabb16e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7a9055c1eb65417caab586e37cae413e_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i18b1bfee52e244df92d350109e304526_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if25ec98df6e64c53939bb7efcbfb124b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d8eb0e4462f4dccb7cee6c898b097bf_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i80b463299c26463ca972ff8dfaeefa07_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id4f11b83791e4d0b89e930d959aa4d4c_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i052975c55e0d4a6d81b116eed98ad8ad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifeda5edcf0e343769d5a4ca6eb1ca2ad_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i28b6a29ef2f34583975d18a2fb7b09a4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i934d7b1779574fc9bec6c9c0df80e88e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia86834c02416429a998a484d9434a8e1_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sic:Z3821</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9518c9e514be4d70877b504c26d8c59d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sic:Z3821</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iba1ca127b1714615af145434271838ed_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sic:Z3821</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id25e838c282448c79258da27d6aefa6d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic1d3e49783f149a084f798c4590d9931_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i24523ddf355143439c1af05532a3151a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i78a46d9043e74a11aadbd6f65daf06f0_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie07b37afc2754e398a196bfcb6c55c30_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i46bcdf3737e4410c9206873ea3b39599_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f8eb91898874f04aea260438b7f2aa9_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i86dca6f99d5c4d1297b510610a68e59e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99b603840d5c471597402724690a24b2_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4f83a0e15d4f46709af062728537490d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id6886463cfa747f2937d6827839da75e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9d576fcf864e471bb409eafe4c6155e0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5dfcb74883a1467d82e99d0d2ce81499_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cvsi:TaxLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i051b211947594052beb7406aed759748_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cvsi:TaxLiabilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9869509e2682490b9a206064b3920d90_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvsi:PayrollProtectionProgramLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2f85a3238c7b4681b71554667cce5b1e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvsi:FirstInsuranceFundingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27feea483e57465a9526919db75d6d01_D20200417-20200417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvsi:PayrollProtectionProgramLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-04-17</xbrli:startDate><xbrli:endDate>2020-04-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0461202b2e27451b9b8caee714491a29_I20200417"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvsi:PayrollProtectionProgramLoanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-04-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie007d6f497f642ab81bc374925609676_I20181031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvsi:PremiumFinanceAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibcfcb94673094dfa87f562c52cfef25e_D20181001-20181031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvsi:PremiumFinanceAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3a704f978fb548eca2e891c2407e5390_I20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvsi:FirstInsuranceFundingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i794dcec76c204870a043fce5338d2a6f_D20201001-20201031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvsi:FirstInsuranceFundingMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="tradingday"><xbrli:measure>cvsi:tradingDay</xbrli:measure></xbrli:unit><xbrli:context id="ia5dcf374512b4bb6ad637f627f49d3ca_I20201208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cvsi:CommonStockPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-08</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="businessday"><xbrli:measure>cvsi:businessDay</xbrli:measure></xbrli:unit><xbrli:context id="i7e602472f0d2419187a53398197f884a_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cvsi:CommonStockPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if6de0662d6994f7eb059488a08f7185c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvsi:Amended2013PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if9290810e4b94539b8af15efd7d0d1e5_I20190611"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvsi:Amended2013PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-11</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74658c74a8c3444fa9b7905dcc912472_D20210101-20210101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvsi:Amended2013PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i32add06262af4753ba901af35fd023f3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvsi:Amended2013PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i57a9d80096aa464eac00c8580957daf0_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvsi:Amended2013PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i265c122e61ad44b2ba1101201ca25d44_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvsi:Amended2013PlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9ff3f55fc97e475b8bb8bc843ae1b0d2_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i910e3383f6764b46b22f1e9d7e5e1aa0_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2b8102c1b9274b8d837c6a3a9496441b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cvsi:FormerFoundersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idfba81407b1f4dc7bb6ac7356bcb5b8f_D20200601-20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvsi:StockOptionModificationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-01</xbrli:startDate><xbrli:endDate>2020-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i632c0a45a9a741cfa8a17f0f306a9fe4_I20200630"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvsi:StockOptionModificationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibfbe4fc0a05542b79480de4c56feef6f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29ae30a4315946c0b52f15f8e6c4ed26_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icffd0f08944b4303b75cda5726a991c1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifec0d5d2e64345b7942f20ab0f15368e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvsi:OptionsOutsidePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i141553cffe3a4f4bbd6b47ebbf217e1b_D20190101-20190930"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i928a711d627049609b68b71da873a14b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic23cca2bec294144b5380b314f6c1bef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iea15e228d81c4928a6f435953afcbf22_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2f9d57085cfb485a90040682008ea5ab_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib7c5476be195460facee7c724fb5e3c7_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iabb6a4dc10ab4561a4bd6c32f75acae6_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibbef676a29a64d80a42a8bffab80309b_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvsi:UnvestedStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i70dd93c7ed5b49f6acea67a36d5704e8_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvsi:UnvestedStockOptionsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5b538a137f6741c3b99ad8296d75054d_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifd0eb69ed84344f29547d2b900088211_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c8f78232aff43cb8627c3ae776e97a9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i60d2bb9447ef4e4897ab3d30bf70ebab_D20160701-20160731"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-07-01</xbrli:startDate><xbrli:endDate>2016-07-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib232e5ef4b084e428542b0fef60816ab_D20170301-20170331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-03-01</xbrli:startDate><xbrli:endDate>2017-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dd1ee59fde04743b61fc6fe09e084f1_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8b7ec1006fa44a45bcff5a676228a041_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iad05935855d347f29bdc066d4323531c_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7d7c3395910943ff95580815849b5296_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0bbd982c5f7748b69d855640a70331d5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0d1f25384b814879a0628fe92c2764bc_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if9b34d8b19d8479caf351bc959791056_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaafe986d776f4e188381ad93b70a5c59_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0c9d5f9107d5452b85e1137ecfedf90f_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i93952393aa0f490bbfec7462592c6301_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerChiefOperatingOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib47971077b1a4742984a8c6a25cbc462_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerChiefOperatingOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8d06315f2bbc4bcf8bad96452ea47672_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerChiefOperatingOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8e03e73784db49a2b0712b19d7179af8_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerChiefOperatingOfficerMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e10759d7520413498f7340ef1cbc70c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerChiefOperatingOfficerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="lawsuit"><xbrli:measure>cvsi:lawsuit</xbrli:measure></xbrli:unit><xbrli:context id="i5c0ab77805bb4407a83db8bc568155ac_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvsi:SmithComplaintMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="leaseterminationagreement"><xbrli:measure>cvsi:leaseTerminationAgreement</xbrli:measure></xbrli:unit><xbrli:context id="i62d68f33d7fa4992b1f81cb57f0893fb_I20200727"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">cvsi:SanDiegoFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-07-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i791cd87ec1804ff590fd70ba4350941f_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">cvsi:SanDiegoFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9aebc800dcb4be88f9cb52dea0fefae_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">cvsi:SanDiegoFacilityMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i864c15d843724344970a49378789e8a3_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvsi:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6a040ed995bb443b9e3e752576188250_D20190101-20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvsi:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id25294b42e17449aacccb4d1a2701113_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvsi:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i33313851bb654bc197ef8021968d854a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvsi:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib7a85037629e4eada1ad14bd2d8d91a8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i125b29ebd2174a6781154a863a9cf67c_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i839a4daa37e5474fbf72320ba3f3488e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">cvsi:StatesOtherThanCaliforniaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic6419ee2e046444089e8042fa93ef87d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">cvsi:After2017Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iaf5bdfbc65224887baa9c61a983f16cc_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">cvsi:Before2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie5001f6661f94fcb9a78097ff24a3842_D20210101-20210319"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001510964</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cvsi:CommonStockPurchaseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-19</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ica64940eaba8432cb3e8a74baaac4713_1"></div><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:1pt solid #000000;border-top:3pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">FORM <ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGV4dHJlZ2lvbjpmZmJmOGY2Nzk0Y2U0NzliODEyZTkzZTZmZDJjZTcwM18yMTk5MDIzMjU4NTg1_cedcc301-0ede-44fa-870e-224184282c79">10-K</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.069%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.815%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.816%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentAnnualReport" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M18wLTAtMS0xLTM4_9035939f-465e-4f61-8d27-a25a4f61dc91">&#9746;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Annual Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For the fiscal year ended <ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M18xLTEtMS0xLTA_96ebae99-38a4-4d04-937e-3f69fa68968a"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M18xLTEtMS0xLTA_4134b48b-615e-415c-bf7c-e7077919747c">December 31</ix:nonNumeric>, 2020</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M18zLTAtMS0xLTM1_1c97393f-1e56-4f7a-9711-4ab88c3b57be">&#9744;</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Transition Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934<br/>For the transition period from _________ to _________</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commission File Number:&#160;&#160; <ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M181LTAtMS0xLTE0Ni90ZXh0cmVnaW9uOjdkZGE4NWUyMDM1YTQ5YmFiYmI1ZTgwNjQ2YWFhOTU0XzIxOTkwMjMyNTU2MDE_a1cff8fd-5984-451f-b496-bc5ad7ac1fcd">000-54677</ix:nonNumeric></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M183LTAtMS0xLTE1MS90ZXh0cmVnaW9uOmNmOTM0Mjc3ZDI3ZTRhZDNiZmJmMjlhM2IzMTllNjc3XzIxOTkwMjMyNTU2NDY_ae71a10e-c606-429a-bb34-ed07df7c5ba5">CV Sciences, Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Exact name of registrant as specified in its charter)</span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" format="ixt-sec:stateprovnameen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M185LTAtMS0xLTE3OS90ZXh0cmVnaW9uOjliM2E5MzljOTYyMTQwYjY4NzMwYWVhMmQzNThlZmIwXzIxOTkwMjMyNTU2MzY_f6f56b51-0e6d-4b35-9ff3-3b96b247ed46">Delaware</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation or organization)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M185LTItMS0xLTE5Mi90ZXh0cmVnaW9uOjNlYTQ0OGU2OTBmMDQ0MWRhOTUwOWQyMzI5MjBlODE3XzIxOTkwMjMyNTU2MTQ_c30b9dab-88f9-48c1-a5df-a0faac67e87d">80-0944974</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M18xMS0wLTEtMS0yMDIvdGV4dHJlZ2lvbjoyMzYyMWUyZjVjNDE0NWQ1OWQ4MGI3OWE2NTg3OGM1ZV8yMTk5MDIzMjU1OTAx_b1d54156-a3f6-453b-a968-eebacbf5963d">10070 Barnes Canyon Road</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M18xMS0wLTEtMS0yMDIvdGV4dHJlZ2lvbjoyMzYyMWUyZjVjNDE0NWQ1OWQ4MGI3OWE2NTg3OGM1ZV8yMTk5MDIzMjU1OTEz_d53a5f53-0097-4a3f-bb98-b0f41b136227">San Diego</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="dei:EntityAddressStateOrProvince" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M18xMS0wLTEtMS0yMDIvdGV4dHJlZ2lvbjoyMzYyMWUyZjVjNDE0NWQ1OWQ4MGI3OWE2NTg3OGM1ZV8yMTk5MDIzMjU1OTE4_a2817d03-3c2c-4994-9b3d-a2693f9c1667">CA</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M18xMS0wLTEtMS0yMDIvdGV4dHJlZ2lvbjoyMzYyMWUyZjVjNDE0NWQ1OWQ4MGI3OWE2NTg3OGM1ZV8yMTk5MDIzMjU1OTI2_a1cc6509-54cc-4c35-831e-1f8c091610a0">92121</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Address of principal executive offices) (Zip Code)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Registrants telephone number, including area code </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M18xMS0wLTEtMS0yMDIvdGV4dHJlZ2lvbjoyMzYyMWUyZjVjNDE0NWQ1OWQ4MGI3OWE2NTg3OGM1ZV8yMTk5MDIzMjU1OTMy_7972e091-155d-4519-a7fc-deda6a76ae7b">866</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">-</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M18xMS0wLTEtMS0yMDIvdGV4dHJlZ2lvbjoyMzYyMWUyZjVjNDE0NWQ1OWQ4MGI3OWE2NTg3OGM1ZV8yMTk5MDIzMjU1ODU0_f8651d7e-5223-4b0e-81de-64011b554504">290-2157</ix:nonNumeric></span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Securities registered pursuant to Section 12(b) of the Act:&#160;&#160;&#160; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">None</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:33.526%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.667%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.503%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.649%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(g) of the Act:</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock, $0.0001 par value per share</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.&#160;&#160;Yes&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="dei:EntityWellKnownSeasonedIssuer" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGV4dHJlZ2lvbjpmZmJmOGY2Nzk0Y2U0NzliODEyZTkzZTZmZDJjZTcwM18yMTk5MDIzMjU4NTg3_c0216340-c360-4ab3-842f-5b52e5bc3d40">No</ix:nonNumeric>&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#253;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.&#160;&#160;Yes&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> <ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="dei:EntityVoluntaryFilers" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGV4dHJlZ2lvbjpmZmJmOGY2Nzk0Y2U0NzliODEyZTkzZTZmZDJjZTcwM18yMTk5MDIzMjU4NTg4_9b46c1e1-35a7-4cc7-afad-ed7874f87124">No</ix:nonNumeric>&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#253;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. <ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGV4dHJlZ2lvbjpmZmJmOGY2Nzk0Y2U0NzliODEyZTkzZTZmZDJjZTcwM18yMTk5MDIzMjU4NTg5_84d73307-7e5f-4999-a2c2-5f6a6b3b311b">Yes</ix:nonNumeric>&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#253;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#167; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). <ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGV4dHJlZ2lvbjpmZmJmOGY2Nzk0Y2U0NzliODEyZTkzZTZmZDJjZTcwM18yMTk5MDIzMjU4NTkw_d87f9449-7c48-4345-928c-b2d731d28011">Yes</ix:nonNumeric> &#160;&#160; </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#253;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221;, &#8220;smaller reporting company&#8221;, and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:28.210%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.279%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.468%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.643%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#9744;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6YTQ4OGFhY2Q0MTFhNDgwN2E4ZDViMDQyNmRlNjdkMTAvdGFibGVyYW5nZTphNDg4YWFjZDQxMWE0ODA3YThkNWIwNDI2ZGU2N2QxMF8xLTAtMS0xLTY4MjM_3bb2dc63-662d-423d-bc5a-2c9d6ea1cc9a">Non-accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#9745;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6YTQ4OGFhY2Q0MTFhNDgwN2E4ZDViMDQyNmRlNjdkMTAvdGFibGVyYW5nZTphNDg4YWFjZDQxMWE0ODA3YThkNWIwNDI2ZGU2N2QxMF8xLTMtMS0xLTMyMA_71a30c04-d6c5-43a1-840c-af0801698100">&#9745;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6YTQ4OGFhY2Q0MTFhNDgwN2E4ZDViMDQyNmRlNjdkMTAvdGFibGVyYW5nZTphNDg4YWFjZDQxMWE0ODA3YThkNWIwNDI2ZGU2N2QxMF8yLTMtMS0xLTMyOQ_911ba741-2a40-42eb-a241-54661bccf898">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9744;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:IcfrAuditorAttestationFlag" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGV4dHJlZ2lvbjpmZmJmOGY2Nzk0Y2U0NzliODEyZTkzZTZmZDJjZTcwM18yMTk5MDIzMjU5ODE2_d58bcb2f-35c7-4c32-bdf6-6f513184f04c">&#9744;</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).  Yes </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGV4dHJlZ2lvbjpmZmJmOGY2Nzk0Y2U0NzliODEyZTkzZTZmZDJjZTcwM18yMTk5MDIzMjU4NTk4_7a5b87c6-0902-43b7-a1aa-67b1bff416ab">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No </span><span style="color:#000000;font-family:'Arial Narrow',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#9746;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The aggregate market value of the registrant's common stock held by non-affiliates as of June 30, 2020, the last day of the registrant's most recently completed second fiscal quarter, based upon the closing price of the registrant's common stock as reported by the OTC:QB Marketplace on such date, was approximately $<ix:nonFraction unitRef="usd" contextRef="ieb170334852144ef80f82c113af94f9a_I20200630" decimals="-6" name="dei:EntityPublicFloat" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGV4dHJlZ2lvbjpmZmJmOGY2Nzk0Y2U0NzliODEyZTkzZTZmZDJjZTcwM18zMjk4NTM0ODg3MjUz_84f74634-bf6d-4ed6-a485-1845fc8e38c1">60</ix:nonFraction> million. This calculation does not reflect a determination that persons are affiliates for any other purposes.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the registrant's classes of common stock, as of the latest practicable date.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As of March&#160;16, 2021, the issuer had <ix:nonFraction unitRef="shares" contextRef="i1aa88da6c8d9457692e0febdb65cb1cf_I20210316" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGV4dHJlZ2lvbjpmZmJmOGY2Nzk0Y2U0NzliODEyZTkzZTZmZDJjZTcwM18zMjk4NTM0ODg2Mzk0_67bdcd98-243b-4346-a4f9-e91c80aa7d49">106,605,784</ix:nonFraction> shares of issued and outstanding common stock, par value $0.0001.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. <ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGV4dHJlZ2lvbjpmZmJmOGY2Nzk0Y2U0NzliODEyZTkzZTZmZDJjZTcwM18yMTk5MDIzMjU4NTg2_6f0d87b8-148c-4aeb-a4c9-eebe593140b6" escape="true">Certain sections of the registrant&#8217;s definitive proxy statement for its 2021 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the end of the registrant&#8217;s fiscal year ended December&#160;31, 2020, are incorporated by reference into Part III of this Form 10-K.</ix:nonNumeric>&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.842%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:19.132%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="15" style="border-bottom:3pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ica64940eaba8432cb3e8a74baaac4713_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CV SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORM 10-K</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:10.043%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:76.465%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.192%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">PAGE</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_13">PART I</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_16">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_16">BUSINESS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_16">1</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_19">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_19">RISK FACTORS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_19">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_22">Item 1B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_22">UNRESOLVED STAFF COMMENTS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_22">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_25">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_25">PROPERTIES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_25">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_28">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_28">LEGAL PROCEEDINGS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_28">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_31">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_31">MINE SAFETY DISCLOSURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_31">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_34">PART II</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_37">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_37">MARKET FOR REGISTRANTS COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_37">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_40">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_40">SELECTED FINANCIAL DATA</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_40">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_43">Item 7.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_43">MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_43">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_64">Item 7A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_64">QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_64">17</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_67">Item 8.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_67">FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_67">17</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_70">Item 9.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_70">CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_70">17</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_73">Item 9A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_73">CONTROLS AND PROCEDURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_73">17</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_76">Item 9B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_76">OTHER INFORMATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_76">18</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_79">PART III</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_82">Item 10.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_82">DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_82">19</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_85">Item 11.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_85">EXECUTIVE COMPENSATION</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_85">19</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_88">Item 12.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_88">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_88">19</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_91">Item 13.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_91">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_91">19</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_94">Item 14.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_94">PRINCIPAL ACCOUNTING FEES AND SERVICES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_94">19</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_97">PART IV</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_100">Item 15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_100">EXHIBITS, FINANCIAL STATEMENT SCHEDULES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_100">20</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_103">Item 16.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_103">FORM 10-K SUMMARY</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_103">20</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_109">SIGNATURES</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_109">24</a></span></div></td></tr></table></div><div style="text-align:justify"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="ica64940eaba8432cb3e8a74baaac4713_10"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">WHERE YOU CAN FIND MORE INFORMATION</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file annual, quarterly and current reports, proxy statements and other information required by the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), with the Securities and Exchange Commission (the &#8220;SEC&#8221;). You may read and copy any document we file with the SEC at the SEC&#8217;s public reference room located at 100&#160;F&#160;Street, N.E., Washington, D.C. 20549, U.S.A. Please call the SEC at 1-800-SEC-0330 for further information on the public reference room. Our SEC filings are also available to the public from the SEC&#8217;s internet site at http://www.sec.gov.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On our Internet website, http://www.cvsciences.com, we post the following recent filings as soon as reasonably practicable after they are electronically filed with or furnished to the SEC: our annual reports on Form 10-K, our quarterly reports on Form 10-Q, our current reports on Form&#160;8-K, and any amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">When we use the terms &#8220;CV Sciences&#8221;, &#8220;Company&#8221;, &#8220;we&#8221;, &#8220;our&#8221; and &#8220;us&#8221; we mean CV Sciences, Inc., a Delaware corporation, and its consolidated subsidiaries, taken as a whole, as well as any predecessor entities, unless the context otherwise indicates.</span></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FORWARD LOOKING STATEMENTS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Annual Report on Form 10-K, the other reports, statements, and information that the Company has previously filed with or furnished to, or that we may subsequently file with or furnish to, the SEC and public announcements that we have previously made or may subsequently make include, may include, or may incorporate by reference certain statements that may be deemed to be &#8220;forward-looking statements&#8221; within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, and that are intended to enjoy the protection of the safe harbor for forward-looking statements provided by that Act. To the extent that any statements made in this report contain information that is not historical, these statements are essentially forward-looking. Forward-looking statements can be identified by the use of words such as &#8220;anticipate&#8221;, &#8220;estimate&#8221;, &#8220;plan&#8221;, &#8220;project&#8221;, &#8220;continuing&#8221;, &#8220;ongoing&#8221;, &#8220;expect&#8221;, &#8220;believe&#8221;, &#8220;intend&#8221;, &#8220;may&#8221;, &#8220;will&#8221;, &#8220;should&#8221;, &#8220;could&#8221;, and other words of similar meaning. These statements are subject to risks and uncertainties that cannot be predicted or quantified and, consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. Such risks and uncertainties include, without limitation, marketability of our products; legal and regulatory risks associated with OTC Markets; our ability to raise additional capital to finance our activities; the future trading of our common stock; our ability to operate as a public company; our ability to protect our proprietary information; general economic and business conditions; the volatility of our operating results and financial condition; our ability to attract or retain qualified senior management personnel and research and development staff; the risk that our results could be adversely affected by natural disaster, public health crises (including, without limitation, the recent spread and continuing outbreak of Coronavirus, or COVID-19), political crises, negative global climate patterns, or other catastrophic events; and other risks detailed from time to time in our filings with the SEC, or otherwise.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information regarding market and industry statistics contained in this report is included based on information available to us that we believe is accurate. It is generally based on industry and other publications that are not produced for purposes of securities offerings or economic analysis. Forecasts and other forward-looking information obtained from these sources are subject to the same qualifications and the additional uncertainties accompanying any estimates of future market size, revenue and market acceptance of products and services. We do not undertake any obligation to publicly update any forward-looking statements. As a result, investors should not place undue reliance on these forward-looking statements.</span></div><div style="margin-top:10pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ii</span></div></div></div><div id="ica64940eaba8432cb3e8a74baaac4713_13"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I</span></div><div id="ica64940eaba8432cb3e8a74baaac4713_16"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. BUSINESS</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CV Sciences, Inc. ("CV Sciences," "we," "our" or "us") is a life science company that operates two distinct business segments: (i) a consumer product division focused on developing, manufacturing, marketing and selling plant-based dietary supplements and hemp-based cannabidiol ("CBD") products to a range of market sectors; and (ii) a specialty pharmaceutical segment focused on developing and commercializing CBD-based novel therapeutics utilizing CBD. The Company&#8217;s consumer products are marketed and sold at more than 7,300 retail locations throughout the United States. According to SPINS, the leading provider of syndicated data and insights for the natural, organic, and specialty products industry, the Company's </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PlusCBD&#8482; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">product is the top-selling brand of hemp-derived CBD in the natural product retail market. CV Sciences&#8217; state-of-the-art facility follows all guidelines for Good Manufacturing Practices ("GMP") and our hemp extracts are processed, produced, and tested throughout the manufacturing process to confirm that the cannabinoid content meets strict company standards. With a commitment to science, our products' benefits in healthy people are supported by human clinical research data, in addition to three published clinical case studies available on PubMed.gov. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PlusCBD&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> was the first hemp CBD supplement brand to invest in the scientific evidence necessary to achieve self-affirmed Generally Recognized as Safe ("GRAS") status. We have primary offices and facilities in San Diego, California. </span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Current Operations</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consumer Products</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture and distribute more than 50 products and expect to continue to add new products to our portfolio to enhance our line of CBD and plant-based dietary supplements. We also expect to develop and launch new product lines and brands to more effectively market and sell specific products. Our mission and core values inform our product development and market positioning.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Mission:</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our mission is to improve quality of life through nature and science.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our Core Values:</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Provide the best products.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We look to nature and lean into science to create extraordinary products that transform health, so people can best navigate the course of their lives.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Make positive impacts.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We strive to ensure the impact of our actions is net positive for our customers, our employees, and our planet.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Be bold and brave.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are committed to positively impacting people's lives - even if it means taking a bold or unconventional approach.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We develop, manufacture, market and sell plant-based dietary supplements and CBD products under the following brands: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PlusCBD&#8482;, PlusCBD&#8482; Pet, ProCBD&#8482;, HappyLane&#8482;, ProCBD&#8482;, CV&#8482;Acute, CV&#8482;Defense, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PlusCBD&#8482; Pet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the Health Care market sector including nutraceutical, beauty care, specialty foods, and pet products. </span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">PlusCBD&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our award-winning line of products available in softgel, tinctures, topicals, and gummies. It is our first brand to market in 2014 and the top-selling brand of hemp-derived CBD in the natural product retail market. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PlusCBD&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is backed by published research, third party safety testing, and rigorous quality standards. </span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">PlusCBD&#8482; Pet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products under our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PlusCBD&#8482; Pet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand offer all the hemp extract benefits offered by </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PlusCBD&#8482; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">formulated just for cats and dogs. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PlusCBD&#8482; Pet </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provides physical and emotional support to help address the stress and physical discomfort keeping pets from being their best. Available in easy to use liquids and flavors: beef, chicken, salmon, and peanut butter.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">ProCBD&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products under our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ProCBD&#8482; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">brand are available exclusively through health practitioners. These clinical strength formulas were designed to fit seamlessly with patient care plans. Available in softgels, liquids, and roll-ons.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">HappyLane&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our worry-free CBD for those looking to avoid even trace amount of THC. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HappyLane&#8482; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">features different softgels, roll-ons, liquids, chews, and gummies in unique flavors, and easy to use form factors, all with less than 0.00% THC.</span></div><div style="margin-top:3pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.5pt">CV&#8482;Immunity</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our award-winning line of non-CBD daily and intensive immune support products. </span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.46pt">CV&#8482;Acute</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> -</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A clinically supported immunity product for intense support. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CV&#8482;Acute </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">features formulas and ingredients backed by clinical research and cited by the World Health Organization for immune support. </span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%;padding-left:14.46pt">CV&#8482;Defense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> - </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A clinically supported immunity product for daily support. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CV&#8482;Defense </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">features formulas and ingredients (PEA) backed by six double-blind placebo-controlled clinical trials. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Hemp-based CBD is one of more than 100 cannabinoids found in hemp and is non-psychoactive. Our U.S. based operations oversee our raw material supply chain, raw material processing, product development and manufacturing, and sales and marketing. We will continue to scale operations to accommodate market conditions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Specialty Pharmaceuticals</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our specialty pharmaceutical segment is developing cannabinoids to treat medical indications. Cannabinoids are compounds derived from the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cannabis sativa</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> plant, which contains two primary cannabinoids, CBD, and tetrahydrocannabinol (&#8220;THC&#8221;). Clinical and preclinical data suggest that CBD has promising results in treating a range of medical indications. We acquired drug development assets in the CanX acquisition, utilizing CBD as the active pharmaceutical ingredient.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our first product candidate, CVSI-007, combines CBD and nicotine in treatment of smokeless tobacco use and addiction. There are currently no drugs approved by the U.S. Food and Drug Administration (&#8220;FDA&#8221;) for treatment of smokeless tobacco use and addiction. The worldwide smokeless tobacco addiction treatment market is estimated at greater than $2 billion. We believe this product candidate will provide treatment options for this significant unmet medical need. CVSI-007 is based on proprietary formulations, processes and technology. In May 2016, we filed a patent application for these formulation and processes with the U.S. Patent and Trademark Office ("USPTO"). On May 19, 2020, we received a formal notice of issuance from the USPTO for our patent application 15/426,617. The patent covers methods of treating smokeless tobacco addiction by administering pharmaceutical formulations containing CBD and nicotine. The communication between the USPTO and CV Sciences concluded substantive examination of the patent application, resulting in formal issuance of the patent. We are pursuing similar patent protection in other key markets throughout the world. During the year ended December 31, 2020, we received a notice of allowance from the Japan Patent Office. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will continue our development efforts as we seek approval from the FDA to commercialize the world's first and only FDA-approved treatment for smokeless tobacco addiction. We currently contract with qualified parties and contract research organizations for our preclinical research and Investigational New Drug application (&#8220;IND&#8221;) preparation and development. Commercialization of future specialty pharmaceutical products in the United States and other territories may rely on licensing and co-promotion agreements with strategic partners. If we choose to build a commercial infrastructure to support marketing in the United States, such commercial infrastructure could include a sales organization, internal sales support, an internal marketing group and distribution support. However, we anticipate that building such a commercial infrastructure will require significant investment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of our Subsidiaries</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CV Sciences was incorporated under the name Foreclosure Solutions, Inc. in the State of Texas on December 9, 2010. On July 25, 2013, CannaVest Corp., a Texas corporation (&#8220;CannaVest Texas&#8221;), merged with CV Sciences, a wholly-owned Delaware subsidiary of CannaVest Texas, to effectuate a change in the Company&#8217;s state of incorporation from Texas to Delaware. On January 4, 2016, we filed a Certificate of Amendment of Certificate of Incorporation reflecting our corporate name change to &#8220;CV Sciences, Inc.&#8221;, effective on January 5, 2016. In addition, on January 4, 2016, we amended our Bylaws to reflect our corporate name change to &#8220;CV Sciences, Inc.&#8221; </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 30, 2015, we completed the acquisition of CanX, Inc., a Florida-based specialty pharmaceutical corporation ("CanX").  Acquired assets included in-process research and development, trade names and non-compete agreements associated with pharmaceutical product development programs and a line of consumer products.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 7, 2019, we filed a Certificate of Cancellation for Plus CBD, LLC (formerly, &#8220;Global Hemp Source, LLC&#8221;) with the Secretary of State of California. CANNAVEST Acquisition, LLC, a Delaware limited liability company formed in connection with the CanX Acquisition was dissolved in 2018,&#160;with administrative approval in Florida carrying over into January 2019 before final resolution.&#160;We previously owned a 70% interest in CannaVest Europe, GmbH. On January 20, 2017, we filed for dissolution </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of CannaVest Europe, GmbH, with the District Court, Dusseldorf Germany, effective December 31, 2016. CannaVest Europe GmbH did not have any assets or liabilities at the time of its dissolution. As of December 31, 2020, we no longer own interest in any subsidiaries. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Government Regulation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to local and federal laws and regulations pertaining to the sale of hemp derived CBD products in our operating jurisdictions. We maintain required licenses for sourcing, manufacturing, and distribution; as well as monitor changes in laws, regulations, treaties, and agreements.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Agriculture Improvement Act of 2018, known as the "2018 Farm Bill", is United States federal legislation signed into law on December 20, 2018, that provides the legal framework for hemp-based products. The 2018 Farm Bill permanently removed &#8220;hemp&#8221; from the purview of the Controlled Substances Act, and accordingly, the U.S. Drug Enforcement Administration (&#8220;DEA&#8221;) no longer has any claim to interfere with the interstate commerce of hemp products. Some of the immediate impact from this legislation includes the ability for hemp farmers to access crop insurance and U.S. Department of Agriculture (&#8220;USDA&#8221;) programs for competitive grants. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2018 Farm Bill officially removes the DEA from enforcement of hemp regulations; however, the U.S. Food and Drug Administration (&#8220;FDA&#8221;) retains its authority to regulate ingestible and topical hemp products, including hemp extracts that contain CBD. Although no longer a controlled substance under federal law, cannabinoids derived from industrial hemp are still subject to a patchwork of state regulations. We have dedicated staff that actively monitors state regulations and proposed regulations to ensure compliance.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A range of federal laws and regulations govern sourcing, manufacturing, distribution, sales, and marketing of hemp derived CBD products in the U.S. Products sold for oral consumption as liquids, tablets, capsules, softgels, or gummies are under the purview of The Dietary Supplement Health and Education Act of 1994 (&#8220;DSHEA&#8221;). Under DSHEA, supplement manufacturing is regulated by the FDA for current Good Manufacturing Practices (&#8220;cGMP&#8221;) under 21 CFR Part 111. Furthermore, DSHEA defines a &#8220;dietary supplement&#8221; as a product intended to supplement the diet that contains one or more of the following: (a) a vitamin; (b) a mineral; (c) an herb or other botanical; (d) an amino acid; (e) a dietary substance for use by man to supplement the diet by increasing the total dietary intake; or (f) a concentrate, metabolite, constituent, extract, or combination of any ingredient described in clause (a) through (e). Thus, the law permits a wide range of dietary ingredients in dietary supplements, including CBD, which is an extract of hemp (Cannabis sativa L.), which is a legal botanical. CBD also falls under clause (e) as it is a dietary substance for use by man to supplement the diet by increasing the total dietary intake.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In conjunction with the enactment of the 2018 Farm Bill, the FDA released a statement about the regulatory status of CBD. The statement noted that the 2018 Farm Bill explicitly preserved the FDA&#8217;s authority to regulate products containing cannabis or cannabis-derived compounds under the U.S. Federal Food, Drug, and Cosmetic Act (&#8220;FDCA&#8221;) and Section 351 of the Public Health Service Act. This authority allows the FDA to continue enforcing the law to protect the public while also providing potential regulatory pathways for products containing cannabis and cannabis-derived compounds. The statement also noted the growing public interest in cannabis and cannabis-derived products, including CBD, and informed the public that the FDA will treat products containing cannabis or cannabis-derived compounds as it does any other FDA-regulated products &#8212; meaning the products will be subject to the same authorities and requirements as FDA-regulated products containing any other substance, regardless of the source of the substance, including whether the substance is derived from a plant that is classified as hemp under the 2018 Farm Bill. The FDA&#8217;s CBD enforcement discretion and regulatory actions with regards to CBD provide regulatory guidance to the CBD industry.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of the date of this report, and based upon publicly available information, to our knowledge the FDA has not taken any enforcement actions against CBD companies that are compliant with the FDCA. The FDA, however, has sent Warning Letters to companies demanding they cease and desist from the production, distribution, or advertising of CBD products when these companies have made prohibited, misleading, and unapproved drug claims. We continue to monitor the FDA&#8217;s position on CBD.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to federal and state consumer protection laws, including laws protecting the privacy of customer non-public information; the handling of customer complaints; the requirement to provide warnings about exposures to chemicals with adverse health effects; and regulations prohibiting unfair and deceptive trade practices. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The growth and demand for online commerce has resulted in more stringent consumer protection laws that impose additional compliance burdens on online companies. These laws cover issues such as user privacy, spyware and the tracking of consumer activities, marketing e-mails and communications, other advertising and promotional practices, money transfers, pricing, product safety, content and quality of products and services, taxation, electronic contracts and other communications and information security.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is uncertainty over whether or how existing laws governing issues such as sales and other taxes, auctions, libel, and personal privacy apply to the internet and commercial online services. These issues are predicted to take years to resolve. For example, tax authorities in some states, as well as a Congressional advisory commission, are currently reviewing the appropriate tax treatment of companies engaged in online commerce. Furthermore, new state tax regulations may subject CV Sciences to additional state sales and income taxes. Other areas that may result in significant additional taxes or regulatory restrictions include, without limitation, new legislation or regulation; the application of laws and regulations from jurisdictions whose laws do not currently apply; or the application of existing laws and regulations to the internet and commercial online services. These taxes or restrictions could have an adverse effect on our cash flow, output, and overall financial condition. Furthermore, there is a possibility that we may be financially responsible for past failures to comply with requirements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Sales and Distribution</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are currently sold online through our websites (www.pluscbdoil.com and www.cvsciences.com), select distributors, brick and mortar retailers, and select e-tailers. We have relationships with wholesalers, distributors and retailers across the food, drug and mass ("FDM"), natural product, specialty, professional market, and convenience industries. We utilize our knowledgeable partners to display and present our products to customers in their brick and mortar stores. These relationships are important to ensure consumers across a variety of sales channels have access to our products. These partnerships and our expansive distribution allow us to build consumer trust in our brand and products. We have additional partners in the natural product channel to service our retail customers by stocking and displaying products and explaining product attributes and health benefits. We also utilize e-commerce platforms to reach consumers and guide them through the CBD buying process as we believe consumers rely heavily on digital research. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Markets, Geography, Seasonality, and Major Customers</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our products are predominantly sold in North America and primarily in the retail space. Based on our current and historical balance sheets and statement of operations, it does not appear that our business or operations experience any seasonality with respect to our sales as any such seasonality appears to be unpredictable. Although we believe our customers&#8217; historical buying patterns and budgetary cycles may be a factor that impacts our quarterly sales results, we are not able to reliably predict our sales based on seasonality because outside factors (timing of orders, introduction of new products, and other economic factors impacting our industry) can also substantially impact our sales patterns during the year.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, because the majority of our sales are spread amongst various retailers, distributors, and direct consumers, our largest customer only accounted for approximately 3% of our sales. As a result, we do not believe our financial condition and results of operations is dependent on any one particular major customer. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Working Capital Items</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our inventory levels are currently adequate for our short-term needs based upon present level of demand. We consider our products to be generally available and current suppliers to be reliable and capable of satisfying anticipated needs.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Competition</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CBD-based consumer product industry is highly competitive and fragmented with numerous companies, consisting of publicly- and privately-owned companies, such as Charlotte's Web Holdings Inc., cbdMD, Inc., Medterra CBD, Inc., and many others. There are also large, well-funded companies that have indicated their intention to compete in the hemp-based product category in the U.S. We routinely evaluate internal and external opportunities to optimize value for shareholders through new product development or by asset acquisitions or sales and believe we are well-positioned to capitalize in the growing CBD product category. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are several companies developing cannabinoid therapeutics for a range of medical indications. The cannabinoid therapeutic area currently includes formulated extracts of the </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cannabis</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> plant and synthetic formulations. These formulations include CBD or THC, or a combination of CBD and THC as the active pharmaceutical ingredient. Certain companies such as GW Pharmaceuticals plc have focused on plant-based CBD formulations, while other companies such as Zynerba Pharmaceuticals, Inc. and Insys Therapeutics, Inc. have focused on synthetic CBD formulations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Intellectual Property</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have filed trademark applications on our brands, logos and marks in the U.S. and internationally. On January 30, 2016, we received a Notice of Allowance from the U.S. Patent and Trademark Office for our utility patent application number 14/791,184, Novel Process for Generating Hemp Oil with a High CBD Content. This patent covers our solvent-free and highly repeatable process for producing hemp oil with higher concentrations of CBD and expires in 2033.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2016, we filed a patent application for our product candidate CVSI-007 with the USPTO. On May 19, 2020, we received formal notice of issuance from the USPTO for our patent application 15/426,617. The patent covers methods of treating smokeless tobacco addiction by administering pharmaceutical formulations containing CBD and nicotine. The communication between the USPTO and us concluded substantive examination of the patent application, resulting in formal issuance of the patent. We are pursuing similar patent protection in other key markets throughout the world. During the year ended December 31, 2020, we received a notice of allowance from the Japan Patent Office.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review our intellectual property portfolio on a periodic basis, and we will continue to broaden our portfolio in a fiscally prudent manner. We rely on a combination of trade secret laws and restrictions on disclosure to protect our intellectual property rights. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development costs have consisted primarily of salaries and related personnel expense, facilities and equipment expense and other costs related to both our consumer product and drug development business segments. We charge all research and development expenses to operations as incurred in the ongoing development of new consumer products and in development of our drug candidate CVSI-007. We established a cross-functional innovation process for our consumer products development using a modified stage gate process. Our new product development activities include ideation and feasibility, product development, scaleup and validation, and product launch. We incurred research and development expenses of $2.9 million and $5.9 million, respectively, for the years ended December&#160;31, 2020 and 2019.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Raw Materials and Product Manufacturing</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have invested significant capital to develop and maintain relationships with growers on a global scale to ensure access to raw materials to support anticipated revenue growth. We have historically sourced our raw materials from well-established and well-recognized hemp growers in Europe. In addition, we have developed relationships with hemp growers in the United States and have started to purchase raw materials domestically as well. We have maintained access to these growers for their raw material supply and continue to explore and develop other relationships to ensure that we can meet the expected demand for hemp-based consumer products well into the future. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are committed to producing a quality product and testing transparency. Our goals include the optimization of our product manufacturing processes and the sourcing of reliable, high-quality raw materials. Our testing procedures are robust and comprehensive, starting with a supply chain built through our supplier verification program. All incoming cannabinoid ingredients are required to be first tested by the supplier at an independent, ISO accredited, third-party laboratory before they reach our production facilities and a Certificate of Analysis provided with each delivery. We then have the cannabinoid ingredients re-tested by an independent, ISO accredited, third-party laboratory to verify the supplier results before they are released into our production process. We test in-house throughout the production process before sending the finished goods off for final verification by an independent ISO accredited third-party laboratory to ensure the finished products meet our high standards. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are dedicated to providing the highest quality CBD consumer products on the market. We strive to meet or exceed the FDAs GMP guidelines. These guidelines provide a system of processes, procedures and documentation to assure a product has the identity, strength, composition, quality and purity that appear on its label. Our third party manufacturers use FDA-registered facilities which are independently GMP certified and subject to continuing independent audit and certification. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Environmental Matters</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No significant pollution or other types of hazardous emission result from the Company's operations, and it is not anticipated that our operations will be materially affected by federal, state or local provisions concerning environmental controls. Our costs of complying with environmental health and safety requirements have not been material. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, compliance with federal, state and local requirements regulating the discharge of materials into the environment, or otherwise relating to the protection of the environment, have not had, nor are they expected to have, any material effect on the capital expenditures, earnings or competitive position of the Company. However, we will continue to monitor emerging developments in this area.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Employees</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our future success will depend, in part, on our ability to continue to attract, hire, and retain qualified personnel. As of December&#160;31, 2020, we had a total of 96 employees, which included 91 full-time and 5 part-time employees. In addition to our full-time employees, we contract with third-parties for the conduct of certain marketing, sales and manufacturing efforts as well as certain preclinical, clinical and manufacturing activities related to drug development efforts. Employee health and safety in the workplace is one of our core values. The COVID-19 pandemic has underscored for us the importance of keeping our employees safe and healthy. In response to the pandemic, we have taken actions aligned with the World Health Organization and the Centers for Disease Control and Prevention in an effort to protect our employees, so they can more safely and effectively perform their work. We have no collective bargaining agreements with our employees, and none are represented by labor unions. Management believes the Company has good relationships with its employees.&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Company Websites</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a corporate Internet website at: www.cvsciences.com. In addition, we sell our products online at: www.pluscbdoil.com. The contents of these websites are not incorporated in or otherwise to be regarded as part of this Annual Report on Form 10-K. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file reports with the SEC, which are available on our website free of charge. These reports include annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, &#8220;Section 16&#8221; filings on Form 3, Form 4, and Form 5, and other related filings, each of which is provided on our website as soon as reasonably practical after we electronically file such materials with or furnish them to the SEC. In addition, the SEC maintains a website (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including the Company.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_19"></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A. RISK FACTORS</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable to a &#8220;smaller reporting company&#8221; as defined in Item 10(f)(1) of Regulation S-K.</span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_22"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1B. UNRESOLVED STAFF COMMENTS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.&#160;</span></div><div id="ica64940eaba8432cb3e8a74baaac4713_25"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. PROPERTIES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, our primary facility consists of approximately 30,000 square feet of leased office, laboratory and warehouse space located in San Diego, California, which is leased through January 2026 and used by both of our business segments. We lease an additional facility in San Diego related to our distribution activities that covers an aggregate of approximately 2,500 square feet, which is leased through March 2021, after which we agreed with the landlord to continue to lease the space on a month to month basis, with a 90 days notice period for termination. On July 27, 2020, we entered into a lease termination agreement for a 45,500 square foot production and warehouse facility in San Diego, which was effective August 31, 2020. We believe that our existing facilities are sufficient to accommodate our current and future operations.</span></div><div><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_28"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. LEGAL PROCEEDINGS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of our material pending legal proceedings, please see Note 12, Commitments and Contingencies, to our consolidated financial statements included in Part IV in this Annual Report on Form 10-K.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="text-align:justify"><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_31"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. MINE SAFETY DISCLOSURES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="ica64940eaba8432cb3e8a74baaac4713_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II</span></div><div id="ica64940eaba8432cb3e8a74baaac4713_37"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5. MARKET FOR REGISTRANT'S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is traded on the OTC:QB under the symbol "CVSI." Trading of securities on the OTC:QB is often sporadic and investors may have difficulty buying and selling or obtaining market quotations. Any OTC:QB market quotations reflect inter-dealer quotations, without adjustment for retail mark-up, mark-down, or commission and may not necessarily represent actual transactions.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Holders of Common Stock</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of February 18, 2021, there were 37 registered shareholders of our common stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Dividend Policy</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No cash dividends have been paid on our common stock for the 2020 and 2019 fiscal years and the Board of Directors has not considered any change in this practice, and has no intentions of considering any such change in the foreseeable future.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The payment of cash dividends in the future, if ever, will be determined by our Board of Directors, in light of conditions then existing, including our earnings, financial requirements, and opportunities for reinvesting earnings, business conditions, and other factors. There are otherwise no restrictions on the payment of dividends.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Compensation Plan Information</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Part III, Item 12. "Securities Ownership of Certain Owners and Management and Related Stockholder Matters" for information regarding securities authorized for issuance under equity compensation plans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unregistered Sales of Equity Securities </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Issuer Repurchases of Equity Securities</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not repurchase any shares of our common stock during the fourth quarter of the fiscal year covered by this Annual Report on Form 10-K. </span></div><div><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_40"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. SELECTED FINANCIAL DATA</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable to a &#8220;smaller reporting company&#8221; as defined in Item 10(f)(1) of SEC Regulation S-K.</span></div><div style="text-align:justify"><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_43"></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following discussion of our financial condition and results of operations for the years ended December&#160;31, 2020 and 2019 should be read in conjunction with our consolidated financial statements and the notes to those statements that are included elsewhere in this Annual Report on Form 10-K. Our discussion includes forward-looking statements based upon current expectations that involve risks and uncertainties, such as our plans, objectives, expectations and intentions. Actual results and the timing of events could differ materially from those anticipated in these forward-looking statements as a result of a number of factors. We use words such as &#8220;anticipate&#8221;, &#8220;estimate&#8221;, &#8220;plan&#8221;, &#8220;project&#8221;, &#8220;continuing&#8221;, &#8220;ongoing&#8221;, &#8220;expect&#8221;, &#8220;believe&#8221;, &#8220;intend&#8221;, &#8220;may&#8221;, &#8220;will&#8221;, &#8220;should&#8221;, &#8220;could&#8221;, and similar expressions to identify forward-looking statements.</span></div><div id="ica64940eaba8432cb3e8a74baaac4713_46"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">OVERVIEW</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a life science company with two distinct business segments. Our consumer product segment is focused on manufacturing, marketing and selling hemp-based CBD products to a range of market sectors. Our specialty pharmaceutical segment is focused on developing and commercializing novel therapeutics utilizing CBD. We are traded on the OTC:QB, and our trading symbol is CVSI.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our consumer product business segment manufactures, markets and sells a variety of consumer products containing hemp-based CBD under our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PlusCBD&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> brand in a range of market sectors including nutraceutical, beauty care and specialty foods.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our specialty pharmaceutical business segment is developing cannabinoids to treat a range of medical indications. Our product candidates are based on proprietary formulations, processes and technology that we believe are patent-protectable, and we plan to vigorously pursue patent protection on our drug candidates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to realize revenue from our consumer products business segment to fund our working capital needs. However, in order to fund our pharmaceutical product development efforts, we will need to raise additional capital either through the issuance of equity and/or the issuance of debt. In the event we are unable to fund our drug development efforts, we may need to curtail, partner or delay such activity.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_49"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comparison of the Years ended December&#160;31, 2020 vs. December&#160;31, 2019 </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenues and gross profit</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales, net</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,429&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,696&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29,267)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(55)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,420&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,188)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,009&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,088&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(24,079)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(69)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45.1&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65.3&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;text-decoration:underline">Revenue by channel</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of product sales, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of product sales, net</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail - FDM</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,651&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail - Natural products and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-Comm</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,429&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,696&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had product sales of $24.4 million and gross profit of $11.0 million, representing a gross margin of 45.1% in 2020 compared with product sales of $53.7 million and gross profit of $35.1 million, representing a gross margin of 65.3% in 2019. Our product sales decreased by $29.3 million or 55% in 2020 when compared to 2019 results. The decline is primarily due to lower retail sales as a result of COVID-19 and increased market competition, which is largely due to the lack of a clear regulatory framework. As of December&#160;31, 2020, our products were in 7,346 retail stores, of which 4,332 were with retailers in the FDM channel. The store count increased from 5,567 stores as of December&#160;31, 2019. For the years ended December&#160;31, 2020 and 2019, e-commerce sales accounted for 31.5% and 18.5% of revenue, respectively.  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second half of 2020, we launched the following new products:</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Refresh of our PlusCBD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> branded product line</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">30+new PlusCBD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> products</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Happy Lane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a new THC-free CBD brand</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">CV Acute</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to support immune system and respiratory health</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">CV Defense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, to provide daily immune support</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">PlusCBD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pet, a full line of hemp extracts formulated for dogs and cats</span></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">ProCBD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">TM</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a full product line exclusively through health care practitioners </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of goods sold consists primarily of raw materials, packaging, manufacturing overhead (including payroll, employee benefits, stock-based compensation, facilities, depreciation, supplies and quality assurance costs), merchant card fees and shipping. Cost of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">goods sold in 2020 increased as a percentage of revenue due to higher overhead and production cost compared to 2019. The gross profit decrease of $24.1million or 69% to $11.0 million in 2020 is mostly driven by the decline in product sales. Gross margins decreased from 65.3% in 2019 to 45.1% in 2020. The decrease is primarily due to higher overhead cost and associated volume deleverage, increased production cost, and reduced sales pricing as a result of increased market competition. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development expense</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,943&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,877&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,934)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(50)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development (&#8220;R&amp;D&#8221;) expense decreased to $2.9 million in 2020 compared to $5.9 million in 2019. The decrease is related to reductions in R&amp;D expenses for our specialty pharmaceutical segment of $1.5 million and for our consumer products segment of $1.4 million. We incurred $0.7 million and $2.1 million of R&amp;D expense related to our consumer products segment in 2020 and 2019, respectively. The reduction in R&amp;D expense in our consumer products segment is mostly related to lower personnel cost and cost for outside services for new consumer product developments. We incurred $2.2 million and $3.8 million of R&amp;D expenses related to our specialty pharmaceutical segment in 2020 and 2019, respectively. The reduction in R&amp;D expense in our specialty pharmaceutical segment is mostly related to reduced activities related to preclinical work, development cost associated with our active pharmaceutical ingredient ("API"), and expenses paid to outside consultants.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, general and administrative expense</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">%</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,658&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,451&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,793)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Percentage of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.296%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.262%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.264%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of product sales, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">% of product sales, net</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales expense</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,543&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.6&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,439&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.8&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marketing expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,759&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">27.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">General &amp; administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19,356&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">79.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,947&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50.2&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,658&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">125.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,451&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative (&#8220;SG&amp;A&#8221;) expenses decreased to $30.7 million in 2020 compared to $46.5 million in 2019. </span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Sales expense decreased due to a decrease in sales commissions resulting from lower retail sales primarily due to COVID-19.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Marketing expense decreased due to lower marketing activity and third party consultant spending.</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">General and administrative expense decreased primarily due to decreased share-based compensation and payroll expense, partially offset by impairment charge in 2020 for the founder RSU settlement. During 2019, we had stock-based compensation expense of $9.5 million and payroll expense of $1.6 million related to the settlement of our former founders' employment agreements. During 2020, we derecognized the tax receivable for founder RSU settlement of $6.2 million. For more information regarding the founder RSU settlement, please see Note 11, Related Parties, to our consolidated financial statements included in Part IV in this Annual Report on Form 10-K. </span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="ica64940eaba8432cb3e8a74baaac4713_52"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Non-GAAP Financial Measures</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use Adjusted EBITDA internally to evaluate our performance and make financial and operational decisions that are presented in a manner that adjusts from their equivalent GAAP measures or that supplement the information provided by our GAAP measures. Adjusted EBITDA is defined by us as EBITDA (net income (loss) plus depreciation expense, amortization expense, and interest expense, minus income tax benefit), further adjusted to exclude certain non-cash expenses and other adjustments as set forth below. We use Adjusted EBITDA because we believe it helps to provide insights in trends in our business in addition to GAAP financial measures, since Adjusted EBITDA eliminates from our results specific financial items that have less bearing on our core operating performance. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use Adjusted EBITDA in communicating certain aspects of our results and performance, including in this Annual Report, and believe that Adjusted EBITDA, when viewed in conjunction with our GAAP results and the accompanying reconciliation, can provide investors with additional understanding of factors affecting our financial condition and results of operations than GAAP measures alone. In addition, we believe the presentation of Adjusted EBITDA is useful to investors in making period-to-period comparison of results because the adjustments to GAAP are not reflective of our core business performance. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Adjusted EBITDA is not presented in accordance with, or as an alternative to, GAAP financial measures and may be different from non-GAAP measures used by other companies. We encourage investors to review the GAAP financial measures included in this Annual Report, including our consolidated financial statements, to aid in their analysis and understanding of our performance and in making comparisons. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation from our net income (loss) to Adjusted EBITDA, a non-GAAP measure, for the years ended December&#160;31, 2020 and 2019 is detailed below:</span></div><div style="margin-bottom:5pt;margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:34.007%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.115%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.540%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.691%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.828%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31, 2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31, 2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consumer Products</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Specialty Pharma</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consumer Products</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Specialty Pharma</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,908)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,376)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,284)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,793)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,817)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,610)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">836&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">681&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense (income)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(615)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(615)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EBITDA</span></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(19,380)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,340)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21,720)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12,742)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3782)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(16,524)</span></td><td style="border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation (1)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,426&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">163&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,589&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation associated with founder employment settlements (2)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,531&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,531&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll expense associated with founder employment settlements (3)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,585&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Derecognition of tax receivable for founder RSU settlement (4)</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,229&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,229&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjusted EBITDA</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,407)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,203)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(11,610)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,800&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,619)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">181&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents stock-based compensation expense related to stock options and warrants awarded to employees, consultants and non-executive directors based on the grant date fair value using the Black-Scholes valuation model.</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents stock-based compensation expense related to accelerated vesting of RSU's, accelerated vesting of certain performance stock options and the modification of certain stock options associated with the separation of our founders. </span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents accrued payroll and related benefits associated with the separation of our founders.</span></div><div style="padding-left:54pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Represents the derecognition of the tax receivable related to founder RSU settlement. For more information, please see Note 11, Related Parties, to our consolidated financial statements included in Part IV in this Annual Report on Form 10-K. </span></div><div style="padding-left:54pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><div id="ica64940eaba8432cb3e8a74baaac4713_55"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, our primary sources of capital came from (i) cash flows from our operations, predominantly from the sale of our CBD products, (ii) existing cash, (iii) government loans, and (iii) proceeds from third-party financings.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19 has spread (and continues to spread) worldwide, resulting in shutdowns of manufacturing and commerce. COVID-19 has resulted in government authorities implementing numerous measures to try to contain it, such as travel bans and restrictions, quarantines, shelter-in-place orders, and shutdowns. These measures have impacted, and may further impact, our workforce and operations, the operations of our customers and our partners, and those of our respective vendors and suppliers. Our critical business operations, including our headquarters, and many of our key suppliers, are located in regions which have been impacted by COVID-19. Our customers and suppliers worldwide have also been affected and may continue to be affected by COVID-19 related restrictions and closures. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19, along with the resulting government-imposed restrictions on businesses, shelter-in place orders and temporary retail and grocery store closures had a significant impact on our results of operations for the year ended December 31, 2020, and we expect that it will continue to negatively impact our operations due to decreased consumer demand as well as potential production and warehouse limitations which results in an event or condition, before consideration of management&#8217;s plans, that could impact our ability to meet future obligations. In response to the continuing uncertainty resulting from COVID-19, we have implemented, and as necessary will continue to make, strategic cost reductions, including reductions in employee headcount, vendor spending, and the delay of expenses related to our drug development activities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, while the extent and duration of the COVID-19 pandemic on the global economy and our business in particular is difficult to assess or predict, the pandemic has resulted in, and may continue to result in, significant disruption of global financial markets, which may reduce our ability to access capital or our customers&#8217; ability to pay us for past or future purchases, which could negatively affect our liquidity. A recession or financial market correction resulting from the lack of containment and spread of COVID-19 could impact overall spending, adversely affecting demand for our products, our business, and the value of our common stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 15, 2020, we applied for a loan from JPMorgan Chase Bank, N.A., as lender, pursuant to the Paycheck Protection Program (the "PPP") of the CARES Act as administered by the U.S. Small Business Administration (the "SBA"). On April 17, 2020, the loan was approved, and we received proceeds in the amount of $2.9 million (the &#8220;PPP Loan&#8221;).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PPP Loan, which took the form of a promissory note, matures on April 15, 2022 and bears interest at a rate of 0.98% per annum (the &#8220;Promissory Note&#8221;). We did not provide any collateral or guarantees for the PPP Loan, nor did we pay any facility charge to obtain the PPP Loan. The Promissory Note provides for customary events of default, including, among others, those relating to failure to make payment, bankruptcy, breaches of representations and material adverse effects. We may prepay the principal of the PPP Loan at any time without incurring any prepayment charges.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the original rules, all or a portion of the PPP Loan may be forgiven by the SBA and lender upon application by the Company beginning 60 days but not later than 120 days after loan approval and upon documentation of expenditures in accordance with the SBA's requirements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the CARES Act, loan forgiveness is available for the sum of documented payroll costs, covered rent payments, and covered utilities during the covered period of 8 weeks beginning on the date of loan approval. For purposes of the CARES Act, payroll costs exclude compensation of an individual employee in excess of $100,000, prorated annually. Not more than 25% of the forgiven amount may be for non-payroll costs. Forgiveness is reduced if full-time headcount declines, or if salaries and wages for employees with salaries of $100,000 or less annually are reduced by more than 25%. In the event the PPP Loan, or any portion thereof, is forgiven pursuant to the PPP, the amount forgiven is applied to outstanding principal.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Paycheck Protection Program Flexibility Act of 2020 (the &#8220;PPP Flexibility Act&#8221;), enacted on June 5, 2020, amended the Paycheck Protection Program, among others, as follows: (i) extended the covered period from 8 weeks to 24 weeks from the date the PPP Loan is originated, during which PPP funds needed to be expended in order to be forgiven. A borrower may submit a loan forgiveness application any time on or before the maturity date of the loan &#8211; including before the end of the covered period &#8211; if the borrower has used all of the loan proceeds for which the borrower is requesting forgiveness; (ii) at least 60% of PPP funds must be spent on payroll costs, with the remaining 40% available to spend on other eligible expenses; and (iii) payments are deferred until the date on which the amount of forgiveness determined is remitted to the lender. If a borrower fails to seek forgiveness within 10 months after the last day of its covered period, then payments will begin on the date that is 10 months after the last day of the covered period. In addition, the PPP Flexibility Act modified the CARES Act by increasing the maturity date for loans made after the effective date from two years to a minimum maturity of five years from the date on which the borrower </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applies for loan forgiveness. Existing PPP loans made before the new legislation retain their original two-year term, but may be renegotiated between a lender and a borrower to match the 5-year term permitted under the PPP Flexibility Act.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March 16, 2021, the balance due on the Promissory Note was $2.9 million. We intend to apply for loan forgiveness within the required timeframe. No assurance is provided that we will obtain forgiveness of the PPP Loan in whole or in part.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company entered into a finance agreement with First Insurance Funding in order to fund a portion of its insurance policies. The amount financed is $0.7 million and incurs interest at a rate of 3.60%. The Company is required to make monthly payments of $0.1 million through July 2021. The outstanding balance as of December 31, 2020 was $0.7 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 8, 2020, we entered into a common stock purchase agreement ("SPA") with Tumim Stone Capital, LLC ("Tumim"), pursuant to which Tumim committed to purchase up to $10.0 million in shares of our common stock, from time to time. The SPA provides, among other things, that we may direct, every three trading days, Tumim to purchase a number of shares of our common stock not to exceed an amount determined based upon the trading volume and stock price of our shares. During the year ended December&#160;31, 2020, we sold 450,000 shares of common stock pursuant to the SPA and recognized proceeds of $0.2 million. As of March 16, 2021, we have sold 5,941,816 additional shares of common stock and recognized proceeds of $3.1 million under the SPA during 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2019, we issued 2,950,000 Restricted Stock Units ("RSU") to our founder, former President and Chief Executive Officer, Michael Mona Jr. ("Mona Jr."). The vesting of the RSU is treated as a taxable compensation and thus subject to income tax withholdings. No amounts were withheld (either in cash or the equivalent of shares of common stock from the vesting of the RSU's) or included in our payroll tax filing at the time of vesting. During the year ended December 31, 2020, we reported the taxable compensation associated with the RSU release to the taxing authorities and included the amount in Mona Jr's W-2 for 2019. In addition, the Company paid the employer and employee portion of the FICA taxes of $0.2 million, respectively. Although the primary tax liability is the responsibility of Mona Jr., we are secondarily liable and thus have recorded the liability on our consolidated balance sheet as of December 31, 2020. The liability may be relieved once the tax amount is paid by Mona Jr. and the Company has received the required taxing authority documentation from Mona Jr.. The deadline to file and pay personal income taxes for 2019 was on October 15, 2020. We initiated legal action against Mona Jr. in July 2020, in connection with which we requested that Mona Jr. provides to us, among other things, appropriate taxing authority documentation. As of March 16, 2021, Mona Jr. has not provided us with proof that he filed and paid his taxes for 2019. Therefore, we wrote off the previously recorded income tax receivable during the fourth quarter of 2020. Refer to Note 11. Related Parties to our consolidated financial statements included in Part IV in this Annual Report on Form 10-K for additional information. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our sources of liquidity and cash flows are used to fund ongoing operations and for research and development projects for new products. Over the next two fiscal years, we anticipate that we will use our liquidity and cash flows from our operations to help fund our growth. In addition, as part of our business strategy, we occasionally evaluate potential acquisitions of businesses, products, and/or the development of new products. Accordingly, a portion of our available cash may be used at any time for the acquisition of complementary products, businesses, and/or the research and development of new products. Such potential uses of funds may require substantial capital resources, which may require us to seek additional debt or equity financing. We cannot assure you that we will be able to successfully identify suitable acquisition or investment candidates, complete acquisitions or investments, integrate acquired businesses and/or products into our current operations, expand into new markets, and/or development new products. Furthermore, we cannot provide assurances that additional financing will be available to us in any required time frame and on commercially reasonable terms, if at all.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are dependent on cash flow from operations to satisfy our working capital requirements. No assurance can be given that cash flow from operations will be sufficient to provide for our liquidity for the next 12 months. However, we believe that our cash and cash equivalents on hand together with our equity commitment with Tumim and cost reduction measures described above, will provide sufficient liquidity to fund our operations for the next 12 months from the issuance of the consolidated financial statements and cover our ongoing operations and obligations. However, we shall continue to evaluate our capital expenditure needs based upon factors including but not limited to our cash from operations, growth rate, the timing and extent of spending to support development efforts, the expansion of our sales and marketing, the timing of new product introductions, and the continuing market acceptance of our products. Should we be unable to generate sufficient revenue in the future to achieve positive cash flow from operations or satisfy our capital requirements, additional working capital will be required, and we may open a revolving line of credit with a bank, or we may have to sell additional equity or debt securities or obtain expanded credit facilities to fund our operating expenses, pay our obligations, diversify our geographical reach, and grow our company. In the event such financing is needed in the future, there can be no assurance that such financing will be available to us, or, if available, that it will be in amounts and on terms acceptable to us. If we cannot raise additional funds when we need or want them, our prospects, financial condition and results of operations could be negatively affected. However, if cash flows from operations become insufficient to continue operations at the current level, and if no additional financing were obtained, then management would restructure the Company in a way to preserve its business while maintaining expenses within operating cash flows.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of our changes in cash flows for the years ended December&#160;31, 2020 and 2019 is provided below:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.267%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.270%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash flows provided by (used in):</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,300)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,227)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,057)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,147)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,274&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net decrease in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,083)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,327)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, beginning of year</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, end of year</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,525&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,608&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Activities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities includes our net loss adjusted for non-cash expenses such as stock-based compensation, depreciation and amortization, bad debt expense and other non-cash items. Operating assets and liabilities primarily include balances related to funding of inventory purchases and customer accounts receivable. Operating assets and liabilities that arise from the funding of inventory purchases and customer accounts receivable can fluctuate significantly from day to day and period to period depending on the timing of inventory purchases and customer behavior.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities was $7.3 million in 2020 compared to $2.2 million in 2019, an increase of $5.1 million. The primary reason for this increase is our net loss of $22.3 million in 2020 due to lower sales as a result of COVID-19 and increased market competition. Our net loss was partially offset by non-cash items and changes in operating assets and liabilities.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Activities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities was $1.1 million in both 2020 and 2019. During 2020, we invested in additional technology to support our e-commerce activities and tenant improvements to our main facility. During 2019, we purchased additional manufacturing equipment for our planned expansion and tenant improvements to our main facility. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Activities</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities increased by $3.2 million from 2019 to $3.3 million in 2020. Our financing activity for 2020 consisted of proceeds from the PPP Loan of $2.9 million and stock option exercises of $0.2 million. In addition, we sold 450,000 shares of common stock for proceeds of $0.2 million under our new SPA with Tumim. Our financing activities in 2019 consisted of proceeds from stock option exercises of $0.5 million, offset by repayment of our insurance financing of $0.5 million. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inflation</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not been affected materially by inflation during the periods presented, and no material effect is expected in the near future.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Known Trends or Uncertainties</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have seen some consolidation in our industry during economic downturns. These consolidations have not had a negative effect on our total sales; however, should consolidations and downsizing in the industry continue to occur, those events could adversely impact our revenues and earnings going forward.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As discussed in this Annual Report on Form 10-K, the world has been affected due to the COVID-19 pandemic. Until the pandemic has passed, there remains uncertainty as to the effect of COVID-19 on our business in both the short and long-term.</span></div><div><span><br/></span></div><div style="text-align:justify"><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_58"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of these financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. On an ongoing basis management evaluates its critical accounting policies and estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A &#8220;critical accounting policy&#8221; is one which is both important to the understanding of the financial condition and results of operations of the Company and requires management&#8217;s most difficult, subjective, or complex judgments, and often requires management to make estimates about the effect of matters that are inherently uncertain. Management believes the following accounting policies fit this definition:</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We evaluate the carrying value of goodwill and intangible assets annually during the fourth quarter in accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 350, Intangibles Goodwill and Other and between annual evaluations if events occur or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Such circumstances could include, but are not limited to (1) a significant adverse change in legal factors or in business climate, (2) unanticipated competition, or (3) an adverse action or assessment by a regulator. All of the goodwill and intangible assets are assigned to our specialty pharmaceutical segment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is evaluated for impairment by first performing a qualitative assessment to determine whether a quantitative goodwill test is necessary. If it is determined, based on qualitative factors, that the fair value of the reporting unit may be more likely than not less than carrying amount, or if significant adverse changes in our future financial performance occur that could materially impact fair value, a quantitative goodwill impairment test would be required. Additionally, we can elect to forgo the qualitative assessment and perform the quantitative test. If the qualitative assessment indicates that the quantitative analysis should be performed, or if management elects to bypass a qualitative assessment, we then evaluate goodwill for impairment by comparing the fair value of the reporting unit to its carrying amount, including goodwill. The quantitative assessment for goodwill requires us to estimate the fair value of our reporting units using either an income or market approach or a combination thereof. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management makes critical assumptions and estimates in completing impairment assessments of goodwill and other intangible assets. Our cash flow projections look several years into the future and include assumptions on variables such as future sales and operating margin growth rates, economic conditions, probability of success, market competition, inflation and discount rates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, we performed our annual goodwill impairment test and determined, after performing a qualitative test of the reporting unit, that it is more likely than not that the fair value of the reporting unit exceeds its carrying amount. Accordingly, there was no indication of impairment and the quantitative impairment test was not performed. We did not record any goodwill impairment charges for the years ended December 31, 2020 or 2019.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We classify intangible assets into three categories: (1) intangible assets with definite lives subject to amortization; (2) intangible assets with indefinite lives not subject to amortization; and (3) goodwill. We determine the useful lives of our identifiable intangible assets after considering the specific facts and circumstances related to each intangible asset. Factors we consider when determining useful lives include the contractual term of any agreement related to the asset, the historical performance of the asset, our long-term strategy for using the asset, any laws or regulations which could impact the useful life of the asset and other economic factors, including competition and specific market conditions. Intangible assets that are deemed to have definite lives are amortized, primarily on a straight-line basis, over their useful lives to their estimated residual values, generally five years. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In-process research &amp; development ("</span><span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D") has an indefinite life and is not amortized until completion and development of the project, at which time the IPR&amp;D becomes an amortizable asset. Until such time as the projects are either completed or abandoned, we test those assets for impairment at least annually at year end, or more frequently at interim periods, by evaluating qualitative factors which could be indicative of impairment. Qualitative factors being considered include, but are not limited to, macro-economic conditions, progress on drug development activities, and overall financial performance. If impairment indicators </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are present as a result of our qualitative assessment, we will test those assets for impairment by comparing the fair value of the assets to their carrying value. Quantitative factors being considered include, but are not limited to, the current project status, forecasted changes in the timing or amounts required to complete the project, forecasted changes in timing or changes in the future cash flows to be generated by the completed products, a probability of success of the ultimate project and changes to other market-based assumptions, such as discount rates. Upon completion or abandonment, the value of the IPR&amp;D assets will be amortized to expense over the anticipated useful life of the developed products, if completed, or charged to expense when abandoned if no alternative future use exists. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our intangible assets are included in our specialty pharmaceutical segment.  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No impairments were identified during the years ended December&#160;31, 2020 and 2019.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The majority of our revenue contracts represent a single performance obligation related to the fulfillment of customer orders for the purchase of our products, which is primarily related to our </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Plus CBD&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">line of products. Net sales reflect the transaction prices for these contracts based on our selling list price, which is then reduced by estimated costs for trade promotional programs, consumer incentives, and allowances and discounts used to incentivize sales growth and build brand awareness. We recognize revenue at the point in time that control of the ordered product is transferred to the customer, which is typically upon shipment to the customer or other customer-designated delivery point. We accrue for estimated sales returns by customers based on historical sales return results. The computation of the sales return and discount allowances require that management makes certain estimates and assumptions that effect the timing and amounts of revenue and liabilities recorded. Shipping and handling fees charged to customers are included in product sales and totaled $0.2 million and $0.3 million for the years ended December&#160;31, 2020 and 2019, respectively. Taxes collected from customers that are remitted to governmental agencies are accounted for on a net basis and not included as revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Certain employees, officers, directors, and consultants participate in various long-term incentive plans that provide for granting stock options, restricted stock awards, restricted stock units, stock bonus awards and performance-based awards. Stock options generally vest in equal increments over a two- to four-year period and expire on the tenth anniversary following the date of grant. Performance-based stock options vest once the applicable performance condition is satisfied. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risk-free interest rates are based on the implied yield available on U.S.&#160;Treasury constant maturities with remaining terms equivalent to the respective expected terms of the options. The Company estimates the expected term for stock options awarded to employees, non-employees, officers and directors using the simplified method in accordance with ASC Topic 718, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Compensation, because the Company does not have sufficient relevant historical information to develop reasonable expectations about future exercise patterns. Through September 30, 2019, the Company determined expected volatility based on the Company&#8217;s peer group, consisting of five companies in the industry in which the Company does business because the Company did not have sufficient historical volatility data. Starting on October 1, 2019, the Company had sufficient historical volatility data, and used its own volatility. In the future, as the Company gains historical data for the actual term over which stock options are held, the expected term may change, which could substantially change the grant-date fair value of future stock option awards, and, consequently, compensation of future grants.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize stock-based compensation for equity awards granted to employees, officers and directors as compensation and benefits expense in the consolidated statements of operations. The fair value of stock options is estimated using a Black-Scholes valuation model on the date of grant. The fair value of restricted stock awards is equal to the closing price of our stock on the date of grant. Stock-based compensation is recognized over the requisite service period of the individual awards, which generally equals the vesting period. For performance-based stock options, compensation is recognized once the applicable performance condition is satisfied. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize stock-based compensation for equity awards granted to consultants as selling, general and administrative expense in the consolidated statements of operations. The fair value of stock options is estimated using a Black-Scholes valuation model on the date of grant and unvested awards are revalued at each reporting period. The fair value of restricted stock awards is equal to our stock closing price on the date of grant multiplied by the number of shares awarded. Stock-based compensation is recognized over the requisite service period of the individual awards, which generally equals the vesting period. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Refer to Note 2 of our consolidated financial statements for a discussion of recent accounting standards and pronouncements.</span></div><div><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_61"></div><div style="margin-top:10pt;text-align:justify;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-top:10pt;text-align:justify;text-indent:-4.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_64"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable to a &#8220;smaller reporting company&#8221; as defined in Item 10(f)(1) of Regulation S-K.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_67"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements required by this item are set forth at the pages indicated in Part IV, Item 15(a)(1) of this Annual Report.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_70"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_73"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9A. CONTROLS AND PROCEDURES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EVALUATION OF DISCLOSURE CONTROLS AND PROCEDURES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our disclosure controls and procedures (as defined in Rules 13a-15(e) or 15d-15(e) under the Securities Exchange Act of 1934, as amended) are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission and to ensure that information required to be disclosed is accumulated and communicated to management, including our principal executive and financial officers, to allow timely decisions regarding disclosure. Our Chief Executive Officer (CEO) and our Chief Financial Officer (CFO), with assistance from other members of management, have reviewed the effectiveness of our disclosure controls and procedures as of December 31, 2020 and, based on their evaluation, have concluded that the disclosure controls and procedures were effective as of such date.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MANAGEMENT&#8217;S ANNUAL REPORT ON INTERNAL CONTROL OVER FINANCIAL REPORTING</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) under the Exchange Act. Our internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP and includes those policies and procedures that: (1) pertain to the maintenance of records that in reasonable detail accurately and fairly reflect our transactions and the dispositions of our assets; (2) provide reasonable assurance that our transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles and that our receipts and expenditures are being made only in accordance with appropriate authorizations; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on our financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Projections of any evaluation of effectiveness for future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the supervision of and with the participation of our management, we assessed the effectiveness of our internal control over financial reporting as of December 31, 2020, using the criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control-Integrated Framework (2013). A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We previously identified and disclosed in our Annual Report on Form 10-K for the year ended December 31, 2019, a material weakness in internal control related to insufficient time to test the effectiveness of the implemented remediation action for the material weakness for the year ended December 31, 2018. The original material weakness was related to management&#8217;s lack of maintaining appropriate staffing in its accounting department with the appropriate level of technical expertise and experience, resulting in insufficient oversight of the financial reporting function. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December 31, 2020, management implemented our previously disclosed remediation plan that included: </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Engaging external consultants, as necessary, to assist in the continued development of our risk assessment process and identification of internal controls responsive to such risks; </span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Performing educational sessions throughout the organization regarding the requirements for appropriate documentation and evidence to demonstrate the operating effectiveness of our internal controls; and</span></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Continued hiring of additional finance and accounting individuals.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, we completed our testing of the operating effectiveness of the implemented controls and found them to be effective. As a result, we have concluded the material weakness has been remediated as of December 31, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CHANGES IN INTERNAL CONTROL OVER FINANCIAL REPORTING</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for the changes in connection with our implementation of the remediation plan discussed above, there has been no other changes in our internal control over financial reporting during the quarter ended December&#160;31, 2020 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ATTESTATION REPORT OF THE REGISTERED PUBLIC ACCOUNTING FIRM </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">This Annual Report on Form 10-K does not include an attestation report of our independent registered public accounting firm on the Company&#8217;s internal controls as the Company is a non-accelerated filer and is thus not required to provide such a report.</span></div><div><span><br/></span></div><div><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_76"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 9B. OTHER INFORMATION</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="ica64940eaba8432cb3e8a74baaac4713_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART III</span></div><div id="ica64940eaba8432cb3e8a74baaac4713_82"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 10. DIRECTORS, EXECUTIVE OFFICERS, AND CORPORATE GOVERNANCE</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by this item will be contained in our definitive proxy statement to be filed with the Securities and Exchange Commission in connection with our 2021 Annual Meeting of Stockholders, or the Definitive Proxy Statement, which is expected to be filed not later than 120 days after the end of our fiscal year ended December&#160;31, 2020, under the headings "Election of Directors," "Corporate Governance," "Our Executive Officers," and "Section 16(a) Beneficial Ownership Reporting Compliance," and is incorporated herein by reference.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the procedures by which security holders may recommend nominees to our board of directors since we last described such procedures.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a Code of Ethics which is posted on our website at: www.cvsciences.com.</span></div><div id="ica64940eaba8432cb3e8a74baaac4713_85"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 11. EXECUTIVE COMPENSATION</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by this item will be contained in our Definitive Proxy Statement under the heading "Executive Compensation and Other Information," and is incorporated herein by reference.</span></div><div id="ica64940eaba8432cb3e8a74baaac4713_88"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by this item will be contained in our Definitive Proxy Statement under the heading "Security Ownership of Certain Beneficial Owners and Management," and is incorporated herein by reference.</span></div><div id="ica64940eaba8432cb3e8a74baaac4713_91"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by this item will be contained in our Definitive Proxy Statement under the headings "Certain Relationships and Related Person Transactions," "Board Independence" and "Committees of the Board of Directors" and is incorporated herein by reference.</span></div><div id="ica64940eaba8432cb3e8a74baaac4713_94"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information required by this item will be contained in our Definitive Proxy Statement under the heading "Independent Registered Public Accountants' Fee" and is incorporated herein by reference.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="ica64940eaba8432cb3e8a74baaac4713_97"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART IV</span></div><div id="ica64940eaba8432cb3e8a74baaac4713_100"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Financial Statements</span></div><div><span><br/></span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following consolidated financial statements of the Company are submitted herewith:</span></div><div style="text-indent:72pt"><span><br/></span></div><div style="text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Report of Independent Registered Public Accounting Firm</span></div><div style="text-indent:117pt"><span><br/></span></div><div style="padding-left:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Balance Sheets as of December&#160;31, 2020 and&#160;2019 </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Operations for the years ended&#160;December&#160;31, 2020 and 2019 </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Stockholders&#8217; Equity for the years ended&#160;December&#160;31, 2020 and 2019 </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consolidated Statements of Cash Flows for the years ended&#160;December&#160;31, 2020 and 2019 </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notes to Consolidated Financial Statements</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Financial Statement Schedules</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Schedules are not submitted because they are not applicable or not required under Regulation S-X or because the required information is included in the financial statements or notes thereto.</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">Exhibits required to be filed by Item 601 of Regulations S-K</span></div><div><span><br/></span></div><div style="padding-left:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information called for by this Item is incorporated by reference from the Index to Exhibits included in this Annual Report on Form 10-K.</span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_103"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 16. FORM 10-K SUMMARY</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="ica64940eaba8432cb3e8a74baaac4713_106"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT INDEX</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Exhibit</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.1 (1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agreement and Plan of Merger, dated as of July 25, 2013, by and between CannaVest Corp., a Texas corporation, and CannaVest Corp., a Delaware corporation.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.2 (2)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Agreement and Plan of Reorganization, dated December 30, 2015, by and among CannaVEST Corp., CANNAVEST Merger Sub, Inc., CANNAVEST Acquisition LLC, CanX, Inc., and The Starwood Trust, as the Shareholder Representative</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.3 (3)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 1 to the Agreement and Plan of Reorganization, dated as of March 16, 2017, by and among the Company, CANNAVEST Acquisition LLC, and the Starwood Trust, as the Shareholder Representative</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.1 (1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of Incorporation of CannaVest Corp., as filed on July 26, 2013.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.2 (1)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bylaws of CannaVest Corp., dated as of June 26, 2013.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3 (3)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bylaws of the Company, as amended.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.4 (4)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of Amendment to Certificate of Incorporation of CannaVest Corp., as filed on January 4, 2016</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.5 (5)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of Incorporation of the Company, as amended.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6 (6)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of Amendment to the Bylaws of the Company, as amended.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.7 (7)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Certificate of Amendment to the Bylaws of the Company, as amended.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1 (8)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CannaVest Corp. Specimen Stock Certificate</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.1 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8224; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Stock Option Award Grant Notice and Form of Stock Award Agreement.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.3 (10)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Promissory Note, dated January 29, 2016, issued by the Company to Wiltshire, LLC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.4 (10)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock Purchase Warrant, dated January 29, 2016, issued by the Company to Wiltshire, LLC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5 (11)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Common Stock Purchase Warrant, issued by the Company to Bart Mackay, dated July 6, 2016.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.6 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8224; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(12)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amended and Restated 2013 Equity Incentive Plan, as amended.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8224; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment Agreement, dated July 6, 2016, by and between the Company and Michael J. Mona, Jr.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.8 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8224; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment Agreement, dated July 6, 2016, by and between the Company and Joseph Dowling</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.9 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8224; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment Agreement, dated July 6, 2016, by and between the Company and Michael Mona, III.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.10 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8224; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Qualified Stock Option Agreement, by and between the Company and Michael J. Mona, Jr., dated July 6, 2016.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.11 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8224;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (13)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Qualified Stock Option Agreement, by and between the Company and Joseph Dowling, dated July 6, 2016.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.12 </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#8224;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> (13)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Qualified Stock Option Agreement, by and between the Company and Michael Mona, III, dated July 6, 2016.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.13 (14)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Securities Purchase Agreement, dated March 1, 2017, by and between the Company and Iliad Research and Trading, L.P.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.14 (14)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Form of Secured Convertible Promissory Note, issued by the Company on March 1, 2017, to Iliad Research and Trading, L.P.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.15 (14)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Security Agreement, dated March 1, 2017, by and between the Company and Iliad Research and Trading, L.P.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.17 &#8224; (13)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to Employment Agreement, dated March 16, 2017, by and between the Company and Michael Mona, Jr.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.18 &#8224; (13)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to Employment Agreement, dated March 16, 2017, by and between the Company and Michael Mona, III.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.19 &#8224; (13)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to Stock Option Agreement, dated March 16, 2017, to that certain Non-Qualified Stock Option Agreement, dated July 6, 2016, by and between the Company and Michael Mona, Jr.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.20 &#8224; (13)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to Stock Option Agreement, dated March 16, 2017, to that certain Non-Qualified Stock Option Agreement, dated July 6, 2016, by and between the Company and Joseph Dowling.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.21 &#8224; (13)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment to Stock Option Agreement, dated March 16, 2017, to that certain Non-Qualified Stock Option Agreement, dated July 6, 2016, by and between the Company and Michael Mona, III.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.22 &#8224; (13)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Qualified Stock Option Agreement, dated March 15, 2017, by and between the Company and Michael Mona, Jr.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.23 &#8224; (15)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Qualified Stock Option Agreement, dated April 7, 2017, by and between the Company and Joseph Dowling.</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:12.223%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:84.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description of Exhibit</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.24 &#8224; (15)</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-Qualified Stock Option Agreement, dated April 7, 2017, by and between the Company and Michael Mona, III.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.25 (16)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amendment No. 4 to the Secured Convertible Promissory Note, dated August 2, 2017, by and between the Company and Iliad Research and Trading, L.P., dated May 25, 2016.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.26 &#8224; (17)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment Agreement, dated June 8, 2018, by and between the Company and Mr. Mona, Jr. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.27 &#8224; (17)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted Stock Unit Award Agreement, dated June 8, 2018, by and between the Company and Mr. Michael Mona, Jr. </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.28 &#8224; (17)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment Agreement, dated June 14, 2018, by and between the Company and Mr. Joseph Dowling.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.29 &#8224; (17)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment Agreement, dated June 14, 2018, by and between the Company and Mr. Michael Mona, III.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.30 (17)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent to Judgment.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.31 (17)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Consent to Judgment.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.32 &#8224; (18)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Employment Agreement, dated December 26, 2018, by and between the Company and Mr. Joerg Grasser.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.33 (19)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common Stock Purchase Agreement, dated December 4, 2020, by and between the Company and Tumim Stone Capital, LLC.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.34 (20)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Promissory Note, dated April 15, 2020, by and between the Company and JP Morgan Chase Bank, N.A.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="consentex231202010kng.htm">Consent of Deloitte LLP</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a302certificationceoex3112.htm">Certification of the Principal Executive Officer pursuant to Section 302(a) of the Sarbanes-O</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a302certificationceoex3112.htm">xley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a302certificationcfoex3122.htm">Certification of the Principal Financial Officer pursuant to Section 302(a) of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a906certificationceoex3212.htm">Certification of the Principal Executive Officer pursuant to 18 U.S.C.Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32.2*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="a906certificationcfoex3222.htm">Certification of the Principal Financial Officer pursuant to 18 U.S.C.Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101 INS*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Instance Document**</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101 SCH*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document**</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101 CAL*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document**</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101 LAB*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document**</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101 PRE*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document**</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">101 DEF*</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document**</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101 attachments)</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">* Filed herewith.</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8224; Indicates a management contract or compensatory plan or arrangement.</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;** The XBRL related information in Exhibit 101 shall not be deemed filed for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to liability of that section and shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.</span></div><div style="margin-top:10pt;padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Incorporated by reference from an exhibit to our Quarterly Report on Form 10-Q filed on August 13, 2013.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Incorporated by reference from an exhibit to our Current Report on Form 8-K filed on January 4, 2016.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Incorporated by reference from an exhibit to our Quarterly Report on Form 10-Q filed on May 9, 2017.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Incorporated by reference from an exhibit to our Annual Report on Form 10-K filed on April 14, 2016.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Incorporated by reference from an exhibit to our Quarterly Report on Form 10-Q filed on May 16, 2016.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Incorporated by reference from an exhibit to our Current Report on Form 8-K filed on May 26, 2016.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Incorporated by reference from an exhibit to our Current Report on Form 8-K filed on March 22, 2017.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Incorporated by reference from an exhibit to our Current Report on Form 8-K filed on July 31, 2013.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.34pt">Incorporated by reference from an exhibit to our Form S-8 filed on October 6, 2014.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.34pt">Incorporated by reference from an exhibit to our Current Report on Form 8-K filed on February 3, 2016.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.34pt">Incorporated by reference from an exhibit to our Current Report on Form 8-K filed on July 11, 2016.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.34pt">Incorporated by reference from an exhibit to our Current Report on Form 8-K filed on June 17, 2019.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(13)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.34pt">Incorporated by reference from an exhibit to our Quarterly Report on Form 10-Q filed on November 1, 2016.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.34pt">Incorporated by reference from an exhibit to our Current Report on Form 8-K filed on March 7, 2017.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.34pt">Incorporated by reference from an exhibit to our Annual Report on Form 10-K filed on March 30, 2018.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.34pt">Incorporated by reference from an exhibit to our Quarterly Report on Form 10-Q filed on August 11, 2017.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.34pt">Incorporated by reference from an exhibit to our Quarterly Report on Form 10-Q filed on August 1, 2018.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(18)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.34pt">Incorporated by reference from an exhibit to our Annual Report on Form 10-K filed on March 12, 2019.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.34pt">Incorporated by reference from an exhibit to our Current Report on Form 8-K filed on December 8, 2020.</span></div><div style="padding-left:27pt;text-align:justify;text-indent:-27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.34pt">Incorporated by reference from an exhibit to our Current Report on Form 8-K filed on April 21, 2020.</span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><div id="ica64940eaba8432cb3e8a74baaac4713_109"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:47.948%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.342%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:43.410%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CV Sciences, Inc.<br/>(Registrant)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Joseph D. Dowling</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joseph D. Dowling<br/>Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated March 19, 2021</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:28.914%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.577%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.209%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Signature</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Title</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Date</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Joseph D. Dowling</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Director<br/>(Principal Executive Officer)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 19, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joseph D. Dowling</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Joerg Grasser</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer<br/>(Principal Financial and Accounting Officer)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 19, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joerg Grasser</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Terri Funk Graham</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 19, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Terri Funk Graham</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Dr. Joseph C. Maroon</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 19, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Joseph C. Maroon</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Dr. Paul Blake</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 19, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Paul Blake</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Beth Altman</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Director</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 19, 2021</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Beth Altman</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><div id="ica64940eaba8432cb3e8a74baaac4713_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CV Sciences, Inc.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Index to Financial Statements</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:86.162%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.638%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual Financial Statements</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_115">Report</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_115"> of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_115">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_115">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Consolidated Balance Sheets as of December 31, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118"> and 201</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_124">Consolidated Statements of Operations for the years ended December 31, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_124">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_124"> and 201</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_124">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_124">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_124">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_127">Consolidated Statements of Stockholders Equity for the years ended December 31, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_127">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_127"> and 201</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_127">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_127">F-8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_130">Consolidated Statements of Cash Flows for the years ended December 31, 20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_130">20</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_130"> and 201</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_130">9</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_130">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_130">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:justify"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_133">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_133">F-</a><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_133">9</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-1</span></div></div></div><div id="ica64940eaba8432cb3e8a74baaac4713_115"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:center;text-indent:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="padding-left:9pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the stockholders and the Board of Directors of CV Sciences, Inc.</span></div><div style="margin-bottom:8pt;text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of CV Sciences, Inc. and subsidiaries (the "Company") as of December 31, 2020 and 2019, the related consolidated statements of operations, stockholders' equity, and cash flows, for each of the two years ended December 31, 2020, and the related notes (collectively referred to as the "financial statements"). In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2020 and 2019, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2020, in conformity with accounting principles generally accepted in the United States of America.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company's management. Our responsibility is to express an opinion on the Company's financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#8217;s internal control over financial reporting. Accordingly, we express no such opinion.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matter</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current-period audit of the financial statements that was communicated or required to be communicated to the audit committee and that (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the accounts or disclosures to which it relates.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Impairment evaluation of indefinite-lived intangible assets &#8211; Note 2</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Critical Audit Matter Description</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December 31, 2020, the Company&#8217;s indefinite-lived intangible asset balance, consisting of in-process research and development (IPR&amp;D), was $3.7 million. IPR&amp;D is evaluated for impairment annually during the fourth quarter in accordance with ASC Topic 350, Intangibles Goodwill and Other, and between annual evaluations if events occur or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management evaluates qualitative factors to determine whether it is more likely than not that the fair value of the IPR&amp;D asset is less than its carrying amount. During 2020, management performed a quantitative impairment test for the IPR&amp;D asset and compared the fair value of the IPR&amp;D asset with its carrying amount. The qualitative and quantitative factors management considers include, but are not limited to, the current project status, forecasted changes in the timing or amounts required to complete the project, forecasted changes in timing or changes in the future cash flows to be generated by the completed products, a probability of success of the ultimate project and changes to other market-based assumptions, such as discount rates.   </span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified the impairment evaluation of the IPR&amp;D asset as a critical audit matter because of the significant judgments made by management to estimate the fair value of the IPR&amp;D asset. This required a high degree of auditor judgment and an increased </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">extent of effort, including the need to involve our fair value specialists, when performing audit procedures to evaluate the reasonableness of management&#8217;s estimates and assumptions, including projected revenue and expenses.</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How the Critical Audit Matter Was Addressed in the Audit</span></div><div style="margin-bottom:8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures related to the impairment evaluation of IPR&amp;D included in the following, among others:</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">With the assistance of our fair value specialists, we evaluated the reasonableness of the Company&#8217;s impairment evaluation by:</span></div><div style="margin-bottom:8pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Testing the appropriateness of the Company&#8217;s valuation methodology.</span></div><div style="margin-bottom:8pt;padding-left:72pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Testing the mathematical accuracy of the fair value model.</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Evaluated the key assumptions, including projected revenue and expenses, used in the discounted cash flow analysis and reviewed the projections relative to internal and external documents relating to the progress of the IPR&amp;D asset and the expected commercialization timeline.</span></div><div style="margin-bottom:8pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Compared historical assumptions to current market information.</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:8pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ DELOITTE &amp; TOUCHE LLP</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Diego, California</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;19, 2021 </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">We have served as the Company&#8217;s auditor since 2019.</span></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="margin-bottom:8pt"><span><br/></span></div><div style="padding-left:9pt;text-align:justify"><span><br/></span></div><div><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-3</span></div></div></div><div id="ica64940eaba8432cb3e8a74baaac4713_118"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CV SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(in thousands, except per share data)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzQtMS0xLTEtMA_ee6cea2b-cb1a-42d7-8e8c-c0263d6d229e">4,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzQtMy0xLTEtMA_cbda31ff-ea79-401f-b30e-4402ada7e92e">9,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzUtMS0xLTEtMA_0899c172-36cf-48ae-8a11-5f005e064b15">501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" name="us-gaap:RestrictedCashAndCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzUtMy0xLTEtMA_8b82f8e4-c167-48da-b44b-96afcfe5cb11">501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzYtMS0xLTEtMA_348c49db-554d-4e88-8722-3dc0062c000b">1,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzYtMy0xLTEtMA_9ae92218-c7e4-4b60-ab40-afaa04be1edb">2,177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzctMS0xLTEtMA_a8dc78cc-725d-4855-ad6a-ac43038e2dc1">8,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzctMy0xLTEtMA_32dfd111-e1f2-47c2-871a-2085541dbd78">9,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzgtMS0xLTEtMA_e5d3c8d5-5989-4984-813d-48d3f96a19a4">2,372</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzgtMy0xLTEtMA_0d44c90d-9bbe-4e6a-b91f-44fee03530e7">10,611</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzktMS0xLTEtMA_94a241fc-1bb8-40ec-b865-e104f0d6fa08">16,863</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzktMy0xLTEtMA_2cc9e392-d510-4554-a06e-eeff80e0483e">32,367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property &amp; equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzEyLTEtMS0xLTA_5acbdc80-264a-4df9-a8ae-3f80c16c66b6">2,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzEyLTMtMS0xLTA_9202dccc-ce7c-48bb-9719-74c98853b22e">3,615</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzEzLTEtMS0xLTA_8ea0caa2-5474-4937-9d2a-902620d1e0a2">3,057</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzEzLTMtMS0xLTA_1e97fbeb-de1d-4d06-a5a1-f377fa57e7d1">8,709</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangibles, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzE0LTEtMS0xLTA_59968d18-ca41-4f56-b335-924dd52714ec">3,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzE0LTMtMS0xLTA_7162db35-e27a-46e7-bb47-d5dc7a503922">3,766</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzE1LTEtMS0xLTA_a9fdafdd-4295-4205-9b12-df44ddcf9e04">2,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzE1LTMtMS0xLTA_f27888b8-bcc5-4f7b-99e7-2ca886188993">2,788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzE2LTEtMS0xLTA_21198a94-2437-4d83-af1a-b6a672559094">1,310</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzE2LTMtMS0xLTA_e44a6db4-8783-4d83-b95d-9805cf00ab2a">1,442</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total assets</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzE3LTEtMS0xLTA_c09de08e-dc47-4b85-be7d-8b9fcfdfa0b7">30,625</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzE3LTMtMS0xLTA_ac42ecd2-feae-4498-89d1-fa4a033ef838">52,687</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities and stockholders' equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzIxLTEtMS0xLTA_e818d041-5ada-4bd2-9dd3-e3ce0d0dafe8">1,677</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzIxLTMtMS0xLTA_e468244f-bde4-44d6-a4ae-16453f6e62d4">1,617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzIyLTEtMS0xLTA_65c048eb-e206-4403-92ed-a7fedf4ef579">9,805</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzIyLTMtMS0xLTA_9cf2fd53-2564-4d4a-8354-ef892a3d7208">10,856</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzIzLTEtMS0xLTA_74b95ddc-0bf2-40d5-83c9-daa7ad491ab6">680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzIzLTMtMS0xLTA_ce3a8ebc-128b-4103-943d-ceb28c2b2e88">723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current portion of long-term debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NotesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzI0LTEtMS0xLTA_481d20b9-de12-49c9-b4dd-cbdc72c92517">2,174</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:NotesPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzI0LTMtMS0xLTA_4dfc1b51-a607-48b1-bf97-d491a601359d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzI1LTEtMS0xLTA_e689abc5-3149-4df2-9829-c6f12fdcbc68">14,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzI1LTMtMS0xLTA_79b2bf9d-ed32-4b91-a070-3c40102ea143">13,196</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzI3LTEtMS0xLTA_122b8cfd-dfc1-438e-9283-16dfe0776f0e">3,467</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzI3LTMtMS0xLTA_2f2ff8af-2f71-45df-acfe-1db0d702277c">9,517</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzI4LTEtMS0xLTA_8239bdbf-f188-4ce4-a592-6af15a497b59">1,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzI4LTMtMS0xLTA_586fb0fb-8ffd-4f93-84b2-9b31b4fe3d27">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liability</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzI5LTEtMS0xLTA_06adca67-ab45-402a-852e-d452841a602d">157</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzI5LTMtMS0xLTA_32188e88-a88c-4ec0-bf7a-8cf5d1e956ad">421</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzMwLTEtMS0xLTA_11825c59-4584-4573-bfea-96f6f3edae44">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzMwLTMtMS0xLTA_b4eb04c5-ea40-49da-a68c-64742800d409">406</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzMxLTEtMS0xLTA_cb93c949-5e5d-419c-a2d0-ae58b62dc240">19,413</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzMxLTMtMS0xLTA_0376f815-a386-47b3-8344-baefa4c98101">23,540</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 12)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzMzLTEtMS0xLTA_0df3d5ab-18aa-4948-9152-360cf90e05b6"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzMzLTMtMS0xLTA_f7f9eefd-5433-4076-a22e-b88d86e914d6"></ix:nonFraction></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Stockholders' equity</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjozMGNhNGQ1MzkzMzY0MjY4YTVkMDYzNWFhM2M2MjgwOF8yMTk5MDIzMjU1NjU4_7e411abe-9c95-4cc5-8370-81845ebc936c"><ix:nonFraction unitRef="usdPerShare" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjozMGNhNGQ1MzkzMzY0MjY4YTVkMDYzNWFhM2M2MjgwOF8yMTk5MDIzMjU1NjU4_a55c3f72-9cbd-422f-8ac5-1cfb074777c3">0.0001</ix:nonFraction></ix:nonFraction>; <ix:nonFraction unitRef="shares" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjozMGNhNGQ1MzkzMzY0MjY4YTVkMDYzNWFhM2M2MjgwOF8yMTk5MDIzMjU1NjY4_10b2b179-fe3f-4cde-abd3-ae8e54e47e65"><ix:nonFraction unitRef="shares" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjozMGNhNGQ1MzkzMzY0MjY4YTVkMDYzNWFhM2M2MjgwOF8yMTk5MDIzMjU1NjY4_154b9330-2f83-4a03-ad1e-a310b7091314">10,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjozMGNhNGQ1MzkzMzY0MjY4YTVkMDYzNWFhM2M2MjgwOF8yMTk5MDIzMjU1Njcz_3e8f3838-8817-4179-ab63-2a3799bfa77b"><ix:nonFraction unitRef="shares" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjozMGNhNGQ1MzkzMzY0MjY4YTVkMDYzNWFhM2M2MjgwOF8yMTk5MDIzMjU1Njcz_8697929c-09a6-4260-9528-c1d762226c10"><ix:nonFraction unitRef="shares" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjozMGNhNGQ1MzkzMzY0MjY4YTVkMDYzNWFhM2M2MjgwOF8yMTk5MDIzMjU1Njcz_8fc4c8ea-44d3-4afc-8f80-4fb0758dbd53"><ix:nonFraction unitRef="shares" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjozMGNhNGQ1MzkzMzY0MjY4YTVkMDYzNWFhM2M2MjgwOF8yMTk5MDIzMjU1Njcz_95b84fe4-d8f4-415e-a69d-d119fe20c81f">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM2LTEtMS0xLTA_16d42fe6-e791-4bbc-8bd0-b18dd8b533aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:PreferredStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM2LTMtMS0xLTA_c2e2d3a7-a233-4970-9c35-3c411f676c67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:15.75pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock, par value $<ix:nonFraction unitRef="usdPerShare" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjpkZDZhNmM4NGE5M2I0YTY1OGQzMjI5MDE1YzRiOTQ4M18yMTk5MDIzMjU1NzA3_2f3f6ea5-5feb-4d00-be83-989b318cd727"><ix:nonFraction unitRef="usdPerShare" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjpkZDZhNmM4NGE5M2I0YTY1OGQzMjI5MDE1YzRiOTQ4M18yMTk5MDIzMjU1NzA3_d22c52e4-135e-4078-83fe-0210f809283c">0.0001</ix:nonFraction></ix:nonFraction>; <ix:nonFraction unitRef="shares" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjpkZDZhNmM4NGE5M2I0YTY1OGQzMjI5MDE1YzRiOTQ4M18yMTk5MDIzMjU1NzE3_15279fff-a477-4e85-8b55-8912066983f3"><ix:nonFraction unitRef="shares" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjpkZDZhNmM4NGE5M2I0YTY1OGQzMjI5MDE1YzRiOTQ4M18yMTk5MDIzMjU1NzE3_83fbbde6-b4a7-4167-a30f-a1f4fcb2ee2e">190,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjpkZDZhNmM4NGE5M2I0YTY1OGQzMjI5MDE1YzRiOTQ4M18yMTk5MDIzMjU1NzM4_066fe133-d0b3-4abc-97ec-c09d5275b169"><ix:nonFraction unitRef="shares" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjpkZDZhNmM4NGE5M2I0YTY1OGQzMjI5MDE1YzRiOTQ4M18yMTk5MDIzMjU1NzM4_4aba45e0-84ec-4fd2-beac-27edb97ecce6">100,664</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjpkZDZhNmM4NGE5M2I0YTY1OGQzMjI5MDE1YzRiOTQ4M18yMTk5MDIzMjU1NzQ3_0043ae6f-bfb0-4c92-9694-3c8119b4b84a"><ix:nonFraction unitRef="shares" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjpkZDZhNmM4NGE5M2I0YTY1OGQzMjI5MDE1YzRiOTQ4M18yMTk5MDIzMjU1NzQ3_4b660435-808e-432a-94d8-a2171e778644">99,416</ix:nonFraction></ix:nonFraction> shares issued and outstanding as of December 31, 2020 and 2019, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM3LTEtMS0xLTA_8b04324f-5703-4ac2-96ef-87b7c62883c6">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM3LTMtMS0xLTA_35f73949-c5d7-47fd-ab85-0d11338885de">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM4LTEtMS0xLTA_ec1daa07-c445-4167-8fe9-f84df33b3a8b">75,123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM4LTMtMS0xLTA_aaee47cb-9d0d-48d8-9c40-bb6849dcb846">70,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM5LTEtMS0xLTA_f2f458cb-9a94-4bea-8f0a-290befd46c92">63,921</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM5LTMtMS0xLTA_1bdb8784-5a46-42ed-bdd3-6b3cca0b01d8">41,637</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total stockholders' equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzQwLTEtMS0xLTA_e5e99d6b-f53a-40c7-bf2d-b0ea18f18712">11,212</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzQwLTMtMS0xLTA_4648e775-b90b-4ab9-8338-2519a78eb56b">29,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Total liabilities and stockholders' equity</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzQyLTEtMS0xLTA_f9adfd82-f6f2-4227-8cd5-7fe41ab8663c">30,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzQyLTMtMS0xLTA_6ad4800a-276e-45bf-88ff-67512054f6f4">52,687</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-4</span></div></div></div><div id="ica64940eaba8432cb3e8a74baaac4713_124"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CV SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF OPERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(in thousands, except per share data)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.434%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the Years Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzItMC0xLTEtMA_21e27cb9-2ecc-40f1-a3e5-fb173f0ff2f4"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzItMC0xLTEtMA_85a5bcce-34c7-4688-b42a-3948caec6542">Product sales, net</span></span></span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzItMS0xLTEtMA_bb106bf1-104a-4c9e-ac47-7e33e4039189">24,429</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzItMy0xLTEtMA_c8ddacf7-d2d1-48bd-9973-e5a9156664fd">53,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of goods sold</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzMtMS0xLTEtMA_e6983bd9-18e0-42c7-abd8-dcfc27d2278b">13,420</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzMtMy0xLTEtMA_393f96ea-15b5-45ea-8875-9b6313cdfc1c">18,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Gross profit</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzQtMS0xLTEtMA_31c6df44-c584-4f12-9be5-23641068a0e3">11,009</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzQtMy0xLTEtMA_8e8ed87e-82b9-4296-9c79-f5e5c3bd84ba">35,088</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzctMS0xLTEtMA_24adf661-9db2-4063-b931-c15d7dbbcb2e">2,943</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzctMy0xLTEtMA_326bfc39-77f1-491d-86f2-c25821591eaa">5,877</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzgtMS0xLTEtMA_617877ac-1ac0-4899-b9d1-f74636ce98a0">30,658</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzgtMy0xLTEtMA_d8dbedf4-83fd-4666-90f2-bbabfaae419e">46,451</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzktMS0xLTEtMA_26f10d44-946e-451a-ade9-4fa70d0a91f6">33,601</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzktMy0xLTEtMA_d399ea89-023b-4aaa-a953-002725bab20c">52,328</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Operating loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzExLTEtMS0xLTA_7e443833-2938-472d-9be5-dfe531e01aeb">22,592</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzExLTMtMS0xLTA_f5ac2449-f287-491c-9c3b-22dab9175e35">17,240</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest (income) expense, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzEzLTEtMS0xLTA_12a8a896-eb97-477e-aff6-60cc72589173">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" name="us-gaap:InterestIncomeExpenseNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzEzLTMtMS0xLTA_219e9235-d965-4f45-a194-305394004535">15</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzE1LTEtMS0xLTA_369afa57-dfd7-4915-9a7f-27f767567793">22,601</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzE1LTMtMS0xLTA_8e531a5e-d919-4188-a1c3-afab05201fee">17,225</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzE2LTEtMS0xLTA_659b9714-cd18-450f-9d4b-c60fd1b02ea7">317</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzE2LTMtMS0xLTA_47de3c89-c209-4589-adbe-665b8a7b0f7b">615</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzE3LTEtMS0xLTA_afb50103-94aa-4fae-b9a8-82ef71e1d6ab">22,284</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzE3LTMtMS0xLTA_7f94c0bf-90db-41be-a2b5-2dbbe7228161">16,610</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares outstanding, basic and diluted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzIwLTEtMS0xLTA_db51ad84-18d5-4d32-9bc0-5698645ead0a">99,913</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzIwLTMtMS0xLTA_4c39737d-13ac-4599-8434-7c8ab9afe266">97,861</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per common share, basic and diluted</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzI0LTEtMS0xLTA_e73a7dea-70b7-42cd-a4e0-0d9accbaaf44">0.22</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzI0LTMtMS0xLTA_544265de-6d40-4b46-ab9d-2b92b2b89e72">0.17</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-5</span></div></div></div><div id="ica64940eaba8432cb3e8a74baaac4713_127"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">V SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(in thousands)</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.152%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.949%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.388%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.393%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance - December 31, 2018</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i131f52df83994257bc0a0cfa19c3a287_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzItMS0xLTEtMA_492c409c-f9db-4f5e-ae1a-9ea0632090f1">94,940</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i131f52df83994257bc0a0cfa19c3a287_I20181231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzItMy0xLTEtMA_72c42df7-9471-4da0-b48c-23bd4b8a73d7">9</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7937d2f589d84d8fb67618c8a842735b_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzItNS0xLTEtMA_af017d89-6717-427a-ae67-8fc56fd098fa">55,134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6e7fe9b796a34c8bb8a1612cb22866da_I20181231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzItNy0xLTEtMA_a477a70b-7fd1-42a4-bab4-2bea26387ce3">25,027</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc2c804db67543dd84291701c746b6fa_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzItOS0xLTEtMA_7b3fd08e-7c8b-4f34-9c15-4d53e667a034">30,116</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock from exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8ff8bfc5f83647a4892aab327120d79e_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzQtMS0xLTEtMA_61df70ad-0949-4aa9-9090-81615c5720e4">4,476</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8ff8bfc5f83647a4892aab327120d79e_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzQtMy0xLTEtMA_031ff7d8-517e-4d1a-b8cf-4a08b23b523e">1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cbd69ac9b3b4f10a86a91c48e412fad_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzQtNS0xLTEtMA_5ad8e43c-27e8-4d4e-9662-d134dc82f577">520</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzQtOS0xLTEtMA_4854dc3c-360d-4350-96f3-ab06d8d7191a">521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cbd69ac9b3b4f10a86a91c48e412fad_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzYtNS0xLTEtMA_9d9f7de8-1152-4de8-875c-57ed8257618e">5,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzYtOS0xLTEtMA_12cfab22-20ca-46e3-86d0-62a670efe52f">5,589</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation associated with founders employment settlements (Note 11)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7cbd69ac9b3b4f10a86a91c48e412fad_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cvsi:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzUtNS0xLTEtNDgx_78772dca-70c2-42a7-9d58-b5798d46473d">9,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cvsi:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzUtOS0xLTEtNDg5_70c84614-0e7b-4586-866c-5f1ed3ef70ac">9,531</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id718b729adc144caa3a6bf9c95dc04de_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzctNy0xLTEtMA_514133e8-35a7-417c-8ffa-5bd5a2c5090b">16,610</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzctOS0xLTEtMA_868b9f44-1ce4-4d52-813c-3d4382f4d471">16,610</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance - December 31, 2019</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i162f6e60104546399b0dd90dbead19b3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzgtMS0xLTEtMA_5d6a1105-6884-4dc7-b148-97101a097310">99,416</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i162f6e60104546399b0dd90dbead19b3_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzgtMy0xLTEtMA_ab55bb7d-7346-4c29-8d21-37944de6592b">10</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i37c881596124431c92dfe85bd94a4cea_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzgtNS0xLTEtMA_e1e0d00b-11e1-42b7-b0f5-e5934c6616c7">70,774</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib0027a2179d842fe82581b40a11ca56d_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzgtNy0xLTEtMA_cd6d9a6a-27b9-4f50-bf9a-fe392fa5a5c3">41,637</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzgtOS0xLTEtMA_1d085f90-a1c9-4d07-b1bb-993d989641e1">29,147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock from exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4789842d4b954973b49e7fed17e8c8eb_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzktMS0xLTEtMA_c4e223ab-5b1d-4c85-b1fd-e212e277bb29">613</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05bf25010f5e4bfc8fdea3b99d63f2ba_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzktNS0xLTEtMA_226c2231-027d-4472-9fc4-0ea86ae41916">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzktOS0xLTEtMA_013fa5eb-1ac6-4841-9b85-5626338a10df">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock under equity commitment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4789842d4b954973b49e7fed17e8c8eb_D20200101-20201231" decimals="-3" name="cvsi:StockIssuedDuringPeriodSharesEquityCommitment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzktMS0xLTEtNDk2_510b0d2e-8fcc-4c2c-89ed-46d6b8350d7a">635</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05bf25010f5e4bfc8fdea3b99d63f2ba_D20200101-20201231" decimals="-3" name="cvsi:StockIssuedDuringPeriodValueEquityCommitment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzktNS0xLTEtNTA0_5ee5680e-3c1b-4839-b247-7caf04fdf6ba">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" name="cvsi:StockIssuedDuringPeriodValueEquityCommitment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzktOS0xLTEtNTEy_fcec9635-c266-45e5-88f7-2c3123b6d3a4">293</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i05bf25010f5e4bfc8fdea3b99d63f2ba_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzEwLTUtMS0xLTA_718763ce-926d-40ac-9ddb-3cf4578fe271">3,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzEwLTktMS0xLTA_8564d279-683e-4496-ab99-6412213a379b">3,881</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i421a1d1328f941c893389dbf40b7b314_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzEyLTctMS0xLTA_2b740d06-649a-4b55-9ebc-8d33d48bce8a">22,284</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzEyLTktMS0xLTA_d53086d4-ec89-4964-a631-f65539a26c89">22,284</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Balance - December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3c2ab9e7b8f8470ca661e005ae40f9cb_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharesOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzEzLTEtMS0xLTA_07373907-15b3-4fdf-b5df-41b2e23fda32">100,664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3c2ab9e7b8f8470ca661e005ae40f9cb_I20201231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzEzLTMtMS0xLTA_fef98096-752b-48a2-92d9-540a3c193163">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if96d39e36198411b85070b25ac1ee3f6_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzEzLTUtMS0xLTA_1367e6ce-90a7-44cb-b32d-984401ddf81f">75,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i598932caa7504ab8a4125324d9bbd23d_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzEzLTctMS0xLTA_8f030db3-9be4-40ed-b722-037c13d3db14">63,921</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzEzLTktMS0xLTA_4556f56f-eb09-48d5-855e-0d0c41a1d3a9">11,212</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-6</span></div></div></div><div id="ica64940eaba8432cb3e8a74baaac4713_130"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CV SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONSOLIDATED STATEMENTS OF CASH FLOW</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(in thousands)</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.267%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.270%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the years ended  December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">OPERATING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzMtMS0xLTEtMA_b825cba8-14cb-41c3-9613-72db59d9a9ea">22,284</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzMtMy0xLTEtMA_1c05c9ff-06d1-4cf8-a987-9a14352cf9ce">16,610</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash flows used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzUtMS0xLTEtMA_1a884d9b-267e-4f1b-9529-a73a5be6ca67">872</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzUtMy0xLTEtMA_9407dcf4-d86a-4a20-b074-5baddd46931e">716</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common stock issued for commitment fee</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzctMS0xLTEtMA_f9a7f047-2169-4ce2-8ddf-6094e76962e2">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzctMy0xLTEtMA_2e7ee567-d0eb-4406-a323-e3eef75e7d57">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzgtMS0xLTEtMA_4a8056ee-e07e-4233-85a0-1528575bfb87">3,881</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzgtMy0xLTEtMA_9abf6f55-9e3c-41fc-b123-04b16c0b82ba">5,589</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Stock-based compensation associated with founders employment settlements (Note 11)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RoyaltyExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzktMS0xLTEtMA_6d570efe-ef5e-41f4-8319-f59a5c1ac44f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RoyaltyExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzktMy0xLTEtMA_70f933c4-7474-4c3e-8706-9bf54d02722c">9,531</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derecognition of tax receivable for founder RSU settlement (Note 11)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="cvsi:ImpairmentOfTaxReceivableForRSUSettlement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzktMS0xLTEtMzAyMw_09bf4343-ca7d-4af4-8fd0-ca0fb767e85e">6,229</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="cvsi:ImpairmentOfTaxReceivableForRSUSettlement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzktMy0xLTEtMzAxOQ_b2f2e0d4-d6d9-4654-9804-d144b9b42fba">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss on disposal of fixed assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzEwLTEtMS0xLTUzNzA_028199fa-788e-4623-b616-707ab8cb67d9">191</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzEwLTMtMS0xLTUzNzQ_7f107168-98a2-4e43-b84b-16471fc1aa64">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Bad debt expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzEwLTEtMS0xLTA_625202e1-1ea9-419f-8059-4c24d96ae016">133</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzEwLTMtMS0xLTA_9d316e42-3b8a-48f4-8940-750202159b34">236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Non-cash lease expense </span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" name="cvsi:NoncashLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzEyLTEtMS0xLTA_489a5270-6a11-471d-81a0-50efa192103a">598</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" name="cvsi:NoncashLeaseExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzEyLTMtMS0xLTA_238391e8-b7ee-4f50-aa41-891408c4988e">817</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Deferred taxes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzEzLTEtMS0xLTA_67632a80-c18a-40a8-a831-6c4ab200041a">264</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzEzLTMtMS0xLTA_2d0e138f-664b-4e18-a43e-c2ed7303167a">644</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzE0LTEtMS0xLTQzNzA_88067de6-dfb2-4d12-85fe-75367d47018f">134</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzE0LTMtMS0xLTQzNjY_c0ec155d-f02b-4dbf-9912-35d6e87d919c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzE1LTEtMS0xLTA_81941a6d-2ebb-461f-9017-28bf39b1aee9">918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzE1LTMtMS0xLTA_55a6382b-8f8a-42e4-b0be-9d27f0e400a3">927</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzE2LTEtMS0xLTA_45468723-1e48-4f9c-b78f-1a2d880ac8b5">1,703</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzE2LTMtMS0xLTA_1e1b1924-5d4b-4306-8788-c1f5aa6fe8e8">1,421</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzE3LTEtMS0xLTA_0ebc78b7-025f-4119-9929-1bd990668d41">2,959</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzE3LTMtMS0xLTA_3ec178de-6b57-4db9-9bf9-faecb9a7815e">3,016</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable and accrued expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzE4LTEtMS0xLTA_fd4501c1-cc25-4986-9762-a7c183f955a4">2,470</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzE4LTMtMS0xLTA_004523fa-01e2-4c01-93ab-ea685b2d240e">1,648</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzIwLTEtMS0xLTA_a2859109-cd6b-4c19-89fd-21a81e81a468">7,300</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzIwLTMtMS0xLTA_e7e29cb3-f6a0-49f7-b22c-586b62d2df09">2,227</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">INVESTING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzIzLTEtMS0xLTA_7a97735f-5732-4c1d-8510-3b4dc38e9d01">1,057</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzIzLTMtMS0xLTA_f2bc3f9c-01b9-4e3f-9e0c-fce223d7822f">1,147</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzI1LTEtMS0xLTA_c5ee1703-79ca-4771-a1fe-14e1db8395d0">1,057</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzI1LTMtMS0xLTA_3dc86498-a536-4859-9c4a-472f3001cbfd">1,147</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">FINANCING ACTIVITIES</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromUnsecuredNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzI4LTEtMS0xLTA_1e1538eb-3967-4843-9db4-d2b15166a610">2,906</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromUnsecuredNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzI4LTMtMS0xLTA_2805c56a-7dae-47f6-92f5-659f445653d1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Repayment of unsecured debt</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RepaymentsOfNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzI5LTEtMS0xLTA_7eb62f2e-c745-43bf-bbf5-1e9b584c27f3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" name="us-gaap:RepaymentsOfNotesPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzI5LTMtMS0xLTA_c51f0a6a-4b1e-47ae-93e1-406c42366973">474</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from issuance of common stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzI4LTEtMS0xLTQxMTE_7eeb380f-9252-4385-be61-f0c986987a81">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzI4LTMtMS0xLTQxMTU_4f8fa55c-f6c4-49dc-848f-5334a486c869">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzMwLTEtMS0xLTA_ef96446a-1ffd-4df7-932e-ccf16d732431">175</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzMwLTMtMS0xLTA_70e64826-2ab7-40d1-b48e-9b9f79ba4ba7">521</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzMxLTEtMS0xLTA_45e6c9c8-f425-43f6-a2be-729795f122be">3,274</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzMxLTMtMS0xLTA_40668825-3d1b-42c2-8d15-660204643bea">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net decrease in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzMzLTEtMS0xLTA_7d9fa045-150c-45a0-8bed-98e79189347e">5,083</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzMzLTMtMS0xLTA_db215836-37e4-484c-a71f-b1848d0c718f">3,327</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">beginning of year</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzM0LTEtMS0xLTA_e78bd6af-01cb-444f-b1a2-86ba817f4491">9,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc2c804db67543dd84291701c746b6fa_I20181231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzM0LTMtMS0xLTA_1247c99b-e001-4980-a078-7665af8ef93a">12,935</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash, cash equivalents and restricted cash, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">end of year</span></div></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzM1LTEtMS0xLTA_02f82811-fcd6-48d2-80f4-382f22cdf65f">4,525</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzM1LTMtMS0xLTA_bcac5a4a-ecc7-4087-95fa-5dd75af8b74c">9,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#ica64940eaba8432cb3e8a74baaac4713_118">Table of Contents</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.020%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.836%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.126%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">For the years ended  December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental cash flow disclosures:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest paid</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzMtMS0xLTEtMA_f9e681e2-3a5b-4a65-b5b8-c8698cdf9b71">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzMtMy0xLTEtMA_94c5a0f2-14e3-4256-b7b4-3c9ea1274e9b">9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Income taxes paid</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzQtMS0xLTEtMA_7d33d108-f30f-4590-ad1f-26d3c014801c">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxesPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzQtMy0xLTEtMA_05afa28d-a5bb-4980-95f3-7132372573d6">99</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Supplemental disclosure of non-cash transactions:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of property and equipment in accounts payable and accrued expenses</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzctMS0xLTEtMA_900b72b6-b1cc-459d-b9ef-6c01b979f6c2">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzctMy0xLTEtMA_02a9654c-190d-496f-b078-2bd0a5a282cd">89</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Derecognition of operating ROU asset related to operating lease termination</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="cvsi:RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzgtMS0xLTEtNDM5Ng_9d9e8cbf-123f-4b08-ac24-c84b6e668fc3">4,704</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="cvsi:RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzgtMy0xLTEtNDQxNw_8569c3c9-b92b-42cb-b58d-e7f7b597ad4b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sale of property and equipment in exchange for note receivable (recorded in prepaid expense and other) and inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" name="cvsi:SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzktMS0xLTEtNDM4OA_6f553385-940b-4c81-ba63-48aad145b2a5">675</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="cvsi:SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzktMy0xLTEtNDM5Mg_53c25c2a-6f51-4cea-a91a-5e795e2894b1">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Purchase of insurance through issuance of note payable (Note 7)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" name="cvsi:PurchaseOfInsuranceThroughIssuanceOfNotePayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzEwLTEtMS0xLTQ0MDY_231aebb6-0500-482b-a418-36acaac7eb1a">721</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="cvsi:PurchaseOfInsuranceThroughIssuanceOfNotePayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzEwLTMtMS0xLTQ0MDk_ae918815-301c-4491-ba49-d9544d46b7b9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating ROU lease assets obtained in exchange for operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzgtMS0xLTEtMA_42a9e29f-9baa-4685-a914-260bceb7fadc">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzgtMy0xLTEtMA_8869c7a4-340b-4794-9ce2-52222063ef1b">5,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Recognition of founder RSU tax withholding obligation and receivable (Note 11)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="cvsi:RecognitionofEquityAwardandWithholdingObligationandReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzktMS0xLTEtMA_27d67c6e-6e1e-4024-95d1-40c344491475">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cvsi:RecognitionofEquityAwardandWithholdingObligationandReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzktMy0xLTEtMA_c7660c01-1178-4eae-9da5-55c5a9951c11">6,409</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cashless exercise of options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" name="cvsi:CashlessExerciseOfStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzEzLTEtMS0xLTY5ODU_85ba5a2c-4dfd-4116-91ae-2341085f7681">108</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" name="cvsi:CashlessExerciseOfStockOptions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzEzLTMtMS0xLTY5OTA_effcac8c-5460-476e-b3ad-d9c1ddcee4bd">39</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-8</span></div></div></div><div id="ica64940eaba8432cb3e8a74baaac4713_133"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CV SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_136"></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzYvZnJhZzoyYjIzYmE0ODRlYzQ0NGI5OGFhOGU0NmNkMTE0NGNlNi90ZXh0cmVnaW9uOjJiMjNiYTQ4NGVjNDQ0Yjk4YWE4ZTQ2Y2QxMTQ0Y2U2XzExNTU_4a9725ff-22b2-42e9-847e-1802b45ba1d2" continuedAt="i4fd0f4c908754015ab724d2d16687eb5" escape="true">ORGANIZATION AND BUSINESS</ix:nonNumeric></span></div><ix:continuation id="i4fd0f4c908754015ab724d2d16687eb5"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CV Sciences, Inc. (the &#8220;Company&#8221;) was incorporated under the name Foreclosure Solutions, Inc. in the State of Texas on December 9, 2010. On July 25, 2013, CannaVest Corp., a Texas corporation (&#8220;CannaVest Texas&#8221;), merged with the Company, a wholly-owned Delaware subsidiary of CannaVest Texas, to effectuate a change in the Company&#8217;s state of incorporation from Texas to Delaware. On January 4, 2016, the Company filed a Certificate of Amendment of Certificate of Incorporation reflecting its corporate name change to &#8220;CV Sciences, Inc.&#8221;, effective on January 5, 2016. In addition, on January 4, 2016, the Company amended its Bylaws to reflect its corporate name change to &#8220;CV Sciences, Inc.&#8221; </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has <ix:nonFraction unitRef="segment" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzYvZnJhZzoyYjIzYmE0ODRlYzQ0NGI5OGFhOGU0NmNkMTE0NGNlNi90ZXh0cmVnaW9uOjJiMjNiYTQ4NGVjNDQ0Yjk4YWE4ZTQ2Y2QxMTQ0Y2U2Xzc0Mw_7ff25deb-cfec-4c22-bd41-4dc4df6973d3">two</ix:nonFraction> operating segments; consumer products and specialty pharmaceutical. The consumer products segment develops, manufactures, markets and sells plant-based dietary supplements and hemp-based cannabidiol ("CBD"). The Company sells its products under tradenames, such as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PlusCBD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8482;, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HappyLane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8482;, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ProCBD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8482;, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acute</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defenese. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's products are sold in a variety of market sectors including nutraceutical, beauty care and specialty foods. The specialty pharmaceutical segment is developing drug candidates which use CBD as a primary active ingredient.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_139"></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzE5_6ed18314-06f9-4f05-aff2-3794075c30b7" continuedAt="i5abf752a24a043529fa0ae38e6b205b2" escape="true">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ix:nonNumeric></span></div><ix:continuation id="i5abf752a24a043529fa0ae38e6b205b2" continuedAt="i519c14bd4bb145779329faf648b5dbf8"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzA1_1be76080-b3dd-4cea-9cdc-71189232c17d" continuedAt="i00294c52346b4c8e8771e724ee7f81ec" escape="true">Basis of Presentation</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i00294c52346b4c8e8771e724ee7f81ec"> - The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"). The consolidated financial statements include the accounts of CV Sciences, Inc., the accounts of its wholly-owned subsidiaries of Plus CBD, LLC and CANNAVEST Acquisition, LLC, and the accounts of a <ix:nonFraction unitRef="number" contextRef="ia430bcca043b4606a1c759ed7eaa8883_I20201231" decimals="2" name="us-gaap:MinorityInterestOwnershipPercentageByParent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzQyNg_d612bea4-901a-484f-a6b7-82e1f4ee4884">70</ix:nonFraction>% interest in CannaVest Europe, GmbH. On January 20, 2017, the Company filed for dissolution of CannaVest Europe, GmbH, with the District Court, Dusseldorf Germany, effective December&#160;31, 2017. CANNAVEST Acquisition, LLC, a Delaware limited liability company formed in connection with the CanX Acquisition, was dissolved in 2018, with administrative approval in Florida carrying over into January 2019 before final resolution. On August 7, 2019, the Company filed for dissolution of Plus CBD, LLC (formerly, &#8220;Global Hemp Source, LLC&#8221;) with the Secretary of State of California. As a result, the Company no longer owns interests in any subsidiaries as of December&#160;31, 2020. All intercompany accounts and transactions have been eliminated in consolidation.</ix:continuation> </span></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzM1_eaade5ec-a515-4669-b377-30554a6ebe84" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results may differ from these estimates. Significant estimates include the valuation of intangible assets, inputs for valuing equity awards, and assumptions related to revenue recognition.</span></ix:nonNumeric></div><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4Njkx_48afaa88-2990-438f-9b58-34ec129d9a42" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; As of December&#160;31, 2020, the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) provided insurance coverage of up to $0.3 million per depositor per bank. The Company has not experienced any losses in such accounts and does not believe that the Company is exposed to significant risks from excess deposits. The Company&#8217;s cash balance in excess of FDIC limits totaled $<ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CashUninsuredAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzIwNDY_b3af6cb7-b8c9-4a93-8c05-9db0ecc78d29">3.3</ix:nonFraction> million as of December&#160;31, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company's raw materials purchases for the year ended December&#160;31, 2019 were sourced from <ix:nonFraction unitRef="supplier" contextRef="i1eb2e25e3bc14d80a5c0329eebbc85a5_D20190101-20191231" decimals="INF" format="ixt-sec:numwordsen" name="cvsi:NumberofSuppliers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzIxNTE_1735745a-4359-423e-95cd-7026a58307e5">one</ix:nonFraction> supplier in Europe. During the year ended December&#160;31, 2020 the Company added <ix:nonFraction unitRef="company" contextRef="if5456eaf29c94cbf9434311c42b7d007_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="cvsi:NumberOfAdditionalSuppliers" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzIxOTkwMjMzMDAwNjY_e1557afb-81ec-48be-b342-affd1b75ac9e">one</ix:nonFraction> additional domestic supplier. There was no concentration of accounts receivable or revenue as of and for the years ended December&#160;31, 2020 and 2019.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:FairValueOfFinancialInstrumentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4Njkz_180afb31-2e87-4d21-b134-5463e37df192" continuedAt="ic45f18eaffa5415d90fec8b4d0bdf7cb" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Fair value is defined as the price that would be received from the sale of an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The carrying values of accounts receivable, other current assets, accounts payable, and certain accrued expenses as of December&#160;31, 2020 and 2019, approximate their fair value due to the short-term nature of these items. The Company's notes payable balance also approximates fair value as of December&#160;31, 2020, as the interest rate on the notes payable approximates the rates available to the Company as of this date. The accounting guidance establishes a three-level hierarchy for disclosure that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 - uses unadjusted quoted prices that are available in active markets for identical assets or liabilities. The Company's Level 1 assets are comprised of $<ix:nonFraction unitRef="usd" contextRef="i3019b5e0eea94dff87d9cf02a903f261_I20201231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzMyOTg1MzQ5MjM4MDI_3943222e-3c53-4642-9047-d0554c2207e2">2.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i3100b80a9d7c4d53bf9d8e711e804a24_I20191231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzMyOTg1MzQ5MjM4MTE_c3449dfd-c011-4f79-8505-8c302168a447">4.0</ix:nonFraction> million in money market funds which are classified as cash equivalents as of December&#160;31, 2020 and 2019, respectively. In addition, the Company's restricted cash of $<ix:nonFraction unitRef="usd" contextRef="i3019b5e0eea94dff87d9cf02a903f261_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzMwNDU_0d60105e-6f6d-44d4-95a7-c2370ba121c1"><ix:nonFraction unitRef="usd" contextRef="i3100b80a9d7c4d53bf9d8e711e804a24_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RestrictedCashAndCashEquivalents" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzMwNDU_a75574f6-36b8-46e8-908e-c8963b83d327">0.5</ix:nonFraction></ix:nonFraction> million as of December&#160;31, 2020 and 2019 is comprised of certificates of deposits. The carrying value of the cash </span></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CV SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i519c14bd4bb145779329faf648b5dbf8" continuedAt="iff4b9314e7f3479e8f107d3205305ffe"><ix:continuation id="ic45f18eaffa5415d90fec8b4d0bdf7cb"><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">equivalents and restricted cash equals the fair value as of December&#160;31, 2020 and 2019. The Company does not have any liabilities that are valued using inputs identified under a Level 1 hierarchy as of December&#160;31, 2020 and 2019. </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 - uses inputs other than quoted prices included in Level 1 that are either directly or indirectly observable through correlation with market data. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data. The Company did not have any assets or liabilities that are valued using inputs identified under a Level 2 hierarchy as of December&#160;31, 2020 and 2019. </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 - uses one or more significant inputs that are unobservable and supported by little or no market activity, and that reflect the use of significant management judgment. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques, and significant management judgment or estimation. The Company did not have any assets or liabilities that are valued using inputs identified under a Level 3 hierarchy as of December&#160;31, 2020 and 2019.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity Considerations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; COVID-19 has spread (and continues to spread) worldwide, resulting in shutdowns of manufacturing and commerce. COVID-19 has resulted in government authorities implementing numerous measures to try to contain it, such as travel bans and restrictions, quarantines, shelter-in-place orders, and shutdowns. These measures have impacted, and may further impact, the Company's workforce and operations, the operations of our customers and our partners, and those of our respective vendors and suppliers. The Company's critical business operations, including its headquarters, and many of its key suppliers, are located in regions which have been impacted by COVID-19. The Company's customers and suppliers worldwide have also been affected and may continue to be affected by COVID-19 related restrictions and closures. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19, along with the resulting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> government-imposed restrictions on businesses, shelter-in place orders, and temporary retail and grocery store closures had a significant impact on the Company's results of operations for the year ended December 31, 2020, and the Company's management expects that it will continue </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to negatively impact its operations due to decreased consumer demand as well as potential production and warehouse limitations which results in an event or condition, before consideration of management&#8217;s plans, that could impact its ability to meet future obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, while the extent and duration of the COVID-19 pandemic on the global economy and the Company's business in particular is difficult to assess or predict, the pandemic has resulted in, and may continue to result in, significant disruption of global financial markets, which may reduce the Company's ability to access capital or its customers&#8217; ability to pay for past or future purchases, which could negatively affect the Company's liquidity. A recession or financial market correction resulting from the lack of containment and spread of COVID-19 could impact overall spending, adversely affecting demand for the Company's products, its business, and the value of its common stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 17, 2020, the Company received $<ix:nonFraction unitRef="usd" contextRef="i796f849901b445a9a1017431e7f0feb3_D20200417-20200417" decimals="-5" name="us-gaap:ProceedsFromUnsecuredNotesPayable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzMyOTg1MzQ5MTI3NTY_301dfafe-f64e-4ed9-a083-3df1157e5301">2.9</ix:nonFraction> million pursuant to the Paycheck Protection Program ("PPP") under the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") as administered by the U.S. Small Business Administration (the "SBA"), as further discussed in Note 7. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 8, 2020, the Company entered into a common stock purchase agreement with Tumim Stone Capital, LLC to issue and sell up to $<ix:nonFraction unitRef="usd" contextRef="i5ce71eb8f7d045f680a63998d5ebc762_D20201208-20201208" decimals="-5" name="cvsi:SaleOfStockMaximumValueOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzMyOTg1MzQ5MTMxNzU_ead9d3fc-3414-4665-8464-ccc9b1c049d2">10.0</ix:nonFraction> million in shares of the Company's common stock, from time to time, as further discussed in Note 8. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the continuing uncertainty resulting from COVID-19, management has implemented, and as necessary will continue to make strategic cost reductions, including reductions in employee headcount, vendor spending, and the delay of expenses related to its drug development activities. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that its cash and cash equivalents on hand </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">together with the equity commitment with Tumim and </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">these cost reduction measures, as needed, will provide sufficient liquidity to fund its operations for the next 12 months from the issuance of the consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzAx_7df4b331-a7ad-43d3-ad5d-d7a3bd78f071" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; For purposes of the consolidated statements of cash flows, the Company considers amounts held by financial institutions and short-term investments with an original maturity of three months or less when purchased to be cash and cash equivalents. As of December&#160;31, 2020, the Company had cash of $<ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-5" name="us-gaap:Cash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzMyOTg1MzQ5MjM4MTk_d2d7f11b-f8c6-497d-a561-de9b306dda28">1.6</ix:nonFraction> million and cash equivalents of $<ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzMyOTg1MzQ5MjM4Mjk_1a8ba94b-7eb6-426d-aa5f-a2a7298b9727">2.4</ix:nonFraction> million. As of December&#160;31, 2019, the Company had cash of $<ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-5" name="us-gaap:Cash" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzMyOTg1MzQ5MjM4NDA_b1110c4d-4189-4213-934e-beced08b5861">5.1</ix:nonFraction> million and cash equivalents of $<ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzMyOTg1MzQ5MjM4NTE_fa3d9aa6-bd0e-43ff-8883-69c318fbf8f3">4.0</ix:nonFraction> million.</span></ix:nonNumeric></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzEw_6820e282-810a-460d-aac7-c7ff5d13463d" continuedAt="ia9e73d48afd04e9e83525e64748e7d2c" escape="true">Restricted Cash</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ia9e73d48afd04e9e83525e64748e7d2c"> &#8211; The Company&#8217;s restricted cash as of  December&#160;31, 2020 and 2019 consists of certificates of deposits related to the Company's corporate credit card program.</ix:continuation> </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CV SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="iff4b9314e7f3479e8f107d3205305ffe" continuedAt="i3b8ed2d724d94b32acea63a0d2a6facf"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4Njky_90536c11-2b01-4859-93c9-071485083ca0" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets to the total of the same amounts shown in the statement of cash flows as of December&#160;31, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZToyYjQ3YTM0MTI3N2E0MDcwODA0MTU4MmQ3ZmExMDA3YS90YWJsZXJhbmdlOjJiNDdhMzQxMjc3YTQwNzA4MDQxNTgyZDdmYTEwMDdhXzItMS0xLTEtMA_0262dde6-aa1e-459e-9946-bdc66abba562">4,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZToyYjQ3YTM0MTI3N2E0MDcwODA0MTU4MmQ3ZmExMDA3YS90YWJsZXJhbmdlOjJiNDdhMzQxMjc3YTQwNzA4MDQxNTgyZDdmYTEwMDdhXzItMy0xLTEtMA_c5a82fbc-bb7e-401b-ab88-3304d999b133">9,107</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" name="us-gaap:RestrictedCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZToyYjQ3YTM0MTI3N2E0MDcwODA0MTU4MmQ3ZmExMDA3YS90YWJsZXJhbmdlOjJiNDdhMzQxMjc3YTQwNzA4MDQxNTgyZDdmYTEwMDdhXzMtMS0xLTEtMA_30cb85d3-6cff-4cc5-9eea-1fdfe1655479">501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" name="us-gaap:RestrictedCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZToyYjQ3YTM0MTI3N2E0MDcwODA0MTU4MmQ3ZmExMDA3YS90YWJsZXJhbmdlOjJiNDdhMzQxMjc3YTQwNzA4MDQxNTgyZDdmYTEwMDdhXzMtMy0xLTEtMA_b7edb322-d60a-4fc9-810c-e8f8d5e55577">501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and restricted cash shown in the statements of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZToyYjQ3YTM0MTI3N2E0MDcwODA0MTU4MmQ3ZmExMDA3YS90YWJsZXJhbmdlOjJiNDdhMzQxMjc3YTQwNzA4MDQxNTgyZDdmYTEwMDdhXzQtMS0xLTEtMA_61ef057f-377b-43e9-80cc-c45910065d80">4,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZToyYjQ3YTM0MTI3N2E0MDcwODA0MTU4MmQ3ZmExMDA3YS90YWJsZXJhbmdlOjJiNDdhMzQxMjc3YTQwNzA4MDQxNTgyZDdmYTEwMDdhXzQtMy0xLTEtMA_5169d32e-a3a6-40d1-a549-bbaf0cc539a1">9,608</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:ReceivablesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzI4_1b8828d0-20f3-40af-939f-444f7097c84f" continuedAt="i27dc133ac14e4ff7a0e1c2ff908aa5b4" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Generally, the Company requires payment prior to shipment. However, in certain circumstances, the Company extends credit to companies located throughout the U.S. Accounts receivable consists of trade accounts arising in the normal course of business. Accounts for which no payments have been received after <ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" format="ixt-sec:durday" name="cvsi:AccountsReceivableThresholdforDeterminingDelinquentAccount" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzc4OTA_eac00255-86d7-492c-9b0c-17a67595511b">30</ix:nonNumeric> days are considered delinquent and customary collection efforts are initiated. Accounts receivable are carried at original invoice amount less a reserve made for doubtful receivables based on a review of all outstanding amounts on a quarterly basis.</span></ix:nonNumeric></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i27dc133ac14e4ff7a0e1c2ff908aa5b4">Management has determined the allowance for doubtful accounts by regularly evaluating individual customer receivables and considering a customer&#8217;s financial condition and credit history, and current economic conditions.</ix:continuation> As of each December&#160;31, 2020 and 2019, the Company maintained an allowance for doubtful accounts related to accounts receivable in the amount of $<ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzg0OTE_f0103152-f125-4fc7-8b9e-ba15c6c74ce0">0.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzg0OTg_1ea41d66-71ae-4786-8cd7-ffe7306240ec">0.4</ix:nonFraction> million, respectively.</span></div><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzMx_176f6d6d-36ca-4dda-838a-a4198155aa6a" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Inventory is stated at lower of cost or net realizable value, with cost being determined on an average cost basis. Cost includes costs directly related to manufacturing and distribution of the products. Primary costs include raw materials, packaging, manufacturing overhead, shipping and depreciation of manufacturing equipment and production facilities. Manufacturing overhead includes payroll, employee benefits, utilities, maintenance and property taxes. Total shipping and handling costs were $<ix:nonFraction unitRef="usd" contextRef="if01f3c8b8a7e46bfb048274a7d4ddc6a_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzkwMjU_40f14a45-53f8-4601-8bfe-09a79e0e2677">1.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2f6446e2781145b58aadd810c3831360_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:CostOfGoodsAndServicesSold" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzkwMzI_520bb358-eb04-44c3-8dbf-e071714253cf">2.7</ix:nonFraction> million for the years ended December&#160;31, 2020 and 2019, respectively, and are recorded in cost of goods sold.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs an assessment of inventory obsolescence to measure inventory at the lower of cost or net realizable value. Factors considered in the determination of obsolescence include slow-moving or non-marketable items. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's inventory production process includes the cultivation of botanical raw material. Because of the duration of the cultivation process, a portion of our inventory will not be sold within one year. Starting April 1, 2019, consistent with the practice in other industries that cultivate botanical raw materials, all inventory is classified as a current asset.</span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzEy_bad6e669-63b1-4799-ade3-710a0d769ef2" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property &amp; Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Equipment is stated at cost less accumulated depreciation. Cost represents the purchase price of the asset and other costs incurred to bring the asset into its existing use. Depreciation is provided on a straight-line basis over the assets estimated useful lives. Tenant improvements are amortized on a straight-line basis over the shorter of the useful life or the remaining life of the related lease. Maintenance or repairs are charged to expense as incurred. Upon sale or disposition, the historically-recorded asset cost and accumulated depreciation are removed from the respective accounts and any related gain or loss is recognized.</span></ix:nonNumeric></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzIw_613cf900-416a-4768-939e-b9775282b30a" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; In accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 360, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for the Impairment or Disposal of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of property and equipment is measured by comparing its carrying value to the undiscounted projected future cash flows that the assets are expected to generate. If the carrying amount of an asset is not recoverable, the Company recognizes an impairment loss based on the excess of the carrying amount of the long-lived asset over its respective fair value, which is generally determined as the present value of estimated future cash flows or at the appraised value. The impairment analysis is based on significant assumptions of future results made by management, including revenue and cash flow projections. Circumstances that may lead to impairment of property and equipment include a significant decrease in the market price of a long-lived asset, a significant adverse change in the extent or manner in which a long-lived asset is being used or in its physical condition and a significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset including an adverse action or assessment by a regulator. As of December&#160;31, 2020 and 2019, the Company determined that long-lived assets were not impaired.</span></ix:nonNumeric></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzE2_fcfebff1-cd07-4687-a0a4-f870fbadeb5c" continuedAt="icf7a80b26e104dc4bdcb58749bcc65d0" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company evaluates the carrying value of goodwill and intangible assets annually during the fourth quarter in accordance with ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and between annual evaluations if events </span></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CV SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i3b8ed2d724d94b32acea63a0d2a6facf" continuedAt="i1e552459c6ef438381406d0f3dfed6f1"><ix:continuation id="icf7a80b26e104dc4bdcb58749bcc65d0" continuedAt="ie3bae2030f294017ab55f241dd69d15a"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">occur or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Such circumstances could include, but are not limited to (1) a significant adverse change in legal factors or in business climate, (2) unanticipated competition, or (3) an adverse action or assessment by a regulator. All of the Company's goodwill and intangible assets are assigned to the Company's specialty pharmaceutical segment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is evaluated for impairment by first performing a qualitative assessment to determine whether a quantitative goodwill test is necessary. If it is determined, based on qualitative factors, that the fair value of the reporting unit may be more likely than not less than carrying amount, or if significant adverse changes in the Company's future financial performance occur that could materially impact fair value, a quantitative goodwill impairment test would be required. Additionally, management can elect to forgo the qualitative assessment and perform the quantitative test. If the qualitative assessment indicates that the quantitative analysis should be performed, or if management elects to bypass a qualitative assessment, the Company then evaluates goodwill for impairment by comparing the fair value of the reporting unit to its carrying amount, including goodwill. The quantitative assessment for goodwill requires management to estimate the fair value of the Company's reporting units using either an income or market approach or a combination thereof. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management makes critical assumptions and estimates in completing impairment assessments of goodwill and other intangible assets. The Company's cash flow projections look several years into the future and include assumptions on variables such as future sales and operating margin growth rates, economic conditions, probability of success, market competition, inflation and discount rates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company performed its annual goodwill impairment test and determined, after performing a qualitative test of the reporting unit, that it is more likely than not that the fair value of the reporting unit exceeds its carrying amount. Accordingly, there was no indication of impairment and the quantitative impairment test was not performed. The Company did <ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzIxOTkwMjMzMTg0MTU_6472f81a-0f9c-4c2f-9b1b-637eceeece43"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-6" format="ixt-sec:numwordsen" name="us-gaap:GoodwillImpairmentLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzIxOTkwMjMzMTg0MTU_e2552cf6-ec7d-48da-b1a7-b3f5e7b6b60a">no</ix:nonFraction></ix:nonFraction>t record any goodwill impairment charges for the years ended December&#160;31, 2020 or 2019.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie3bae2030f294017ab55f241dd69d15a" continuedAt="i662ca1616ff5419885d711bb511c9188">The Company classifies intangible assets into three categories: (1) intangible assets with definite lives subject to amortization; (2) intangible assets with indefinite lives not subject to amortization; and (3) goodwill. The Company determines the useful lives of its identifiable intangible assets after considering the specific facts and circumstances related to each intangible asset. Factors considered when determining useful lives include the contractual term of any agreement related to the asset, the historical performance of the asset, the Company's long-term strategy for using the asset, any laws or regulations which could impact the useful life of the asset and other economic factors, including competition and specific market conditions. Intangible assets that are deemed to have definite lives are amortized, primarily on a straight-line basis, over their useful lives to their estimated residual values, generally five years. In-process research &amp; development ("</ix:continuation></span><span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i662ca1616ff5419885d711bb511c9188">IPR&amp;D") has an indefinite life and is not amortized until completion and development of the project, at which time the IPR&amp;D becomes an amortizable asset. Until such time as the projects are either completed or abandoned, the Company test those assets for impairment at least annually at year end, or more frequently at interim periods, by evaluating qualitative factors which could be indicative of impairment. Qualitative factors being considered include, but are not limited to, macro-economic conditions, progress on drug development activities, and overall financial performance. If impairment indicators are present as a result of the Company's qualitative assessment, the Company will test those assets for impairment by comparing the fair value of the assets to their carrying value. Quantitative factors being considered include, but are not limited to, the current project status, forecasted changes in the timing or amounts required to complete the project, forecasted changes in timing or changes in the future cash flows to be generated by the completed products, a probability of success of the ultimate project and changes to other market-based assumptions, such as discount rates. Upon completion or abandonment, the value of the IPR&amp;D assets will be amortized to expense over the anticipated useful life of the developed products, if completed, or charged to expense when abandoned if no alternative future use exists.</ix:continuation> </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company completed its annual impairment assessment during the fourth quarter of 2020 and 2019. No impairments were identified during the years ended December&#160;31, 2020 and 2019.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:10pt;text-align:justify"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzMy_29aef42f-a77d-465a-8866-e92db7a4331d" continuedAt="id5498ec1fec141aaae067e31c19bafc2" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The majority of the Company's revenue contracts represent a single performance obligation related to the fulfillment of customer orders for the purchase of its products. Net sales reflect the transaction prices for these contracts based on the Company's selling list price, which is then reduced by estimated costs for trade promotional programs, consumer incentives, and allowances and discounts used to incentivize sales growth and build brand awareness. The Company recognizes revenue at the point in time that control of the ordered product is transferred to the customer, which is typically upon shipment to the customer or other customer-designated delivery point. The Company accrues for estimated sales returns by customers based on historical sales return results. The computation of the sales return and discount allowances require that management makes certain estimates and assumptions that effect the timing and amounts of revenue and liabilities recorded. Shipping and handling fees charged to customers are included in product sales and totaled $<ix:nonFraction unitRef="usd" contextRef="if01f3c8b8a7e46bfb048274a7d4ddc6a_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzE2NTE1_40e26413-b749-4c34-9458-c3509d649c22">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2f6446e2781145b58aadd810c3831360_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzE2NTIy_0e46f8a5-a8c2-4d10-9971-e65aecf94482">0.3</ix:nonFraction> million for the years ended December&#160;31, </span></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CV SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i1e552459c6ef438381406d0f3dfed6f1" continuedAt="iaa11696a04c54edaa6dea9461a1d0e82"><ix:continuation id="id5498ec1fec141aaae067e31c19bafc2"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020 and 2019, respectively. Taxes collected from customers that are remitted to governmental agencies are accounted for on a net basis and not included as revenue.</span></div><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzY1OTcwNjk4MDk1Nzk_b0e435c7-95f6-4144-9793-8521f97292bf" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents product sales by channel for food, drug and mass ("FDM"), natural product and other, and e-commerce for the years ended December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.767%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.394%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.397%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of product sales, net</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of prodct sales, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail - FDM</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if8aa597259fe4304b7b63ce40ce227b4_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzMtMS0xLTEtMTAwNw_02b0d6fa-90d9-47ef-bd0f-49fa40deb0a3">1,651</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if8aa597259fe4304b7b63ce40ce227b4_D20200101-20201231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzMtMy0xLTEtMTAyMw_7568c199-c270-4ba2-8c8f-1a7b9664efb8">6.8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7864245a6d34e58aacbabaa8179f74f_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzMtNS0xLTEtMTAyNw_02b66014-4f5f-47fa-ac50-5b19b10d7207">2,229</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ie7864245a6d34e58aacbabaa8179f74f_D20190101-20191231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzMtNy0xLTEtMTAzMQ_ed821161-d28e-440e-bee2-409d3648d247">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail - Natural products and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i70f9d718799644699f10f809156bd286_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzQtMS0xLTEtMTAxMQ_2aa5ab25-8604-4894-871e-5d18efe2bfc9">15,073</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i70f9d718799644699f10f809156bd286_D20200101-20201231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzQtMy0xLTEtMTAyMw_bcdd185d-c2ac-4f1e-a0e5-3cc7d694cc61">61.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if54d7cb037ac4f8e8327ff809a2b2c0f_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzQtNS0xLTEtMTAyNw_edb11d1c-fa16-4108-bd39-f6a565090a76">41,534</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if54d7cb037ac4f8e8327ff809a2b2c0f_D20190101-20191231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzQtNy0xLTEtMTAzMQ_ca60c138-e112-4192-a2e2-76dc8f5a3551">77.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-Comm</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if3d15c156ba349c48d60f8791891481a_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzUtMS0xLTEtMTAxNQ_bd176256-ce1e-4812-b743-0033bada40a6">7,705</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if3d15c156ba349c48d60f8791891481a_D20200101-20201231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzUtMy0xLTEtMTAyMw_41beca9c-9e9e-4478-8c27-494a23b2eaef">31.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icf894d15f551418abe1ae2f318b3c813_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzUtNS0xLTEtMTAyNw_1daaadcc-0746-4830-9e93-dcc393ef169c">9,933</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="icf894d15f551418abe1ae2f318b3c813_D20190101-20191231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzUtNy0xLTEtMTAzMQ_2fd77bfd-7959-4a39-8057-8df47413f207">18.5</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzYtMS0xLTEtMTAxOQ_8331a620-c18a-4e17-8153-603761ffb4eb">24,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzYtMy0xLTEtMTAyMw_95b17c73-510d-45da-85dc-785251845788">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzYtNS0xLTEtMTAyNw_a9fe349d-c43f-4629-8bf3-b9d41659e01d">53,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="INF" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzYtNy0xLTEtMTAzMQ_854f2ada-fd65-47e4-9baf-b2cc20d8c8b6">100.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4Njg4_33875a09-7434-43d7-99ed-d8f86fe5a683" continuedAt="ie5cea3eb43be4e8facd7df3e8265105d" escape="true">Compensation and Benefits</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie5cea3eb43be4e8facd7df3e8265105d"> &#8211; The Company records compensation and benefits expense for all cash and deferred compensation, benefits, and related taxes as earned by its employees. Compensation and benefits expense also includes compensation earned by temporary employees and contractors who perform similar services to those performed by the Company&#8217;s employees, primarily information technology and project management activities. The Company maintains a defined contribution 401(k) plan available to eligible employees. Employee contributions are voluntary and are determined on an individual basis, limited to the maximum amount allowable under federal tax regulations. The Company, at its discretion, may make certain matching contributions to the 401(k) plan.</ix:continuation> The Company suspended its matching contributions in April 2020. The Company made matching contributions of $<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzE3NTY5_bc84275c-0445-4e4a-9f43-feb843592574">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzE3NTc2_7c005d74-6f83-48ef-9d62-df5863cbb8ab">0.2</ix:nonFraction> million for the years ended December&#160;31, 2020 and 2019, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4Njgz_37c6217e-4b29-465c-91ec-0b99e62322a8" continuedAt="idcdf76b1c9e74269a5fc684fafc63ed1" escape="true">Research and Development Expense</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idcdf76b1c9e74269a5fc684fafc63ed1"> &#8211; Research and development costs are charged to expense as incurred and include, but are not limited to, employee salaries and benefits, cost of inventory used in product development, consulting service fees, the cost of renting and maintaining our laboratory facility and depreciation of laboratory equipment.</ix:continuation> Research and development expense for the consumer products segment was $<ix:nonFraction unitRef="usd" contextRef="iafc1a3c97c0d4080885871840e0654af_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzE4MDM5_6f5dbc19-44c9-453c-b020-df7eec5e6542">0.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i4ab148dfa19a48ec9bfc7253afd2d8e0_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzE4MDQ2_86a1512f-12a7-4a18-af3d-c0f72bcb2182">2.1</ix:nonFraction> million for the years ended December&#160;31, 2020 and 2019, respectively. Research and development expense for the specialty pharmaceutical segment was $<ix:nonFraction unitRef="usd" contextRef="i8c7e853cfb97488bafd77f77828becba_D20200101-20201231" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzMyOTg1MzQ5MjYyMDc_05d62228-3c45-46e0-ac30-ecb01f51e502">2.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic13b530da3e44e4384e40cfb677c6d60_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzE4MTc5_ad07c7ec-59e1-468b-9506-8371d1a8ac62">3.8</ix:nonFraction> million for the years ended December&#160;31, 2020 and 2019, respectively.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzA4_7ae3ab5a-8d56-4ed5-aa4d-89271614c190" continuedAt="i34f520371e23465cb57052b5e6c55906" escape="true">Advertising</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i34f520371e23465cb57052b5e6c55906"> &#8211; The Company supports its products with advertising to build brand awareness of the Company&#8217;s various products in addition to other marketing programs executed by the Company&#8217;s marketing team. The Company believes the continual investment in advertising is critical to the development and sale of its products.</ix:continuation> Advertising costs of $<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzE4NTg5_623f0ca3-ac7f-430a-8a80-7aa21c5efa49">1.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AdvertisingExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzE4NTk2_3f4913fe-89b6-4d4f-8626-dce6202ef1dd">2.5</ix:nonFraction> million were expensed as incurred during the years ending December&#160;31, 2020 and 2019, respectively.</span></div><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzI5_a77448f6-6754-470a-8760-65b6f2a36228" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Certain employees, officers, directors, and consultants of the Company participate in various long-term incentive plans that provide for granting stock options, restricted stock awards, restricted stock units, stock bonus awards and performance-based awards. Stock options generally vest in equal increments over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzY1OTcwNjk4MDk1ODc_f5674a51-c511-43ac-a681-83d953908b76">two</span>- to <ix:nonNumeric contextRef="i7a9055c1eb65417caab586e37cae413e_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzY1OTcwNjk4MDk2MDU_21203a6f-20c7-4b05-8985-165c0e6463a3">four-year</ix:nonNumeric> period and expire on the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzIxOTkwMjMzMTk0MDU_d0b87cf7-bf22-4fdd-a58e-c194e22353b3">ten</span>th anniversary following the date of grant. Performance-based stock options vest once the applicable performance condition is satisfied. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes stock-based compensation for equity awards granted to employees, officers and directors as compensation and benefits expense in the consolidated statements of operations. The fair value of stock options is estimated using a Black-Scholes valuation model on the date of grant. The fair value of restricted stock awards is equal to the closing price of the Company&#8217;s stock on the date of grant. Stock-based compensation is recognized over the requisite service period of the individual awards, which generally equals the vesting period. For performance-based stock options, compensation is recognized once the applicable performance condition is satisfied.</span></div></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzA5_21586e54-12fa-4e85-9996-81f67d32e4f5" continuedAt="ifcfb20b475ea4a74bfb8d9c7da53922a" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the related temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized when the rate change is enacted. Valuation allowances are recorded to reduce deferred tax assets to the amount that will more likely than not be realized. In accordance with ASC Topic 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recognizes the effect of uncertain income tax positions only if the positions are more likely than not of being sustained in an audit, based on the technical merits of the position. Recognized uncertain income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in </span></ix:nonNumeric></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CV SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="iaa11696a04c54edaa6dea9461a1d0e82"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ifcfb20b475ea4a74bfb8d9c7da53922a">recognition or measurement are reflected in the period in which those changes in judgment occur. The Company recognizes both interest and penalties related to uncertain tax positions as part of the income tax provision. As of December&#160;31, 2020 and 2019 the Company did not have a liability for unrecognized tax uncertainties. The Company is subject to routine audits by taxing jurisdictions. Management believes the Company is no longer subject to tax examinations for the years prior to 2013.</ix:continuation></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzMw_edbfa031-ccda-43bc-8118-ac09c3bffd61" continuedAt="ibfa21bdfffe54d97acd18588360b1a6d" escape="true">Comprehensive Loss </ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibfa21bdfffe54d97acd18588360b1a6d">&#8211; Comprehensive loss is defined as a change in equity during a period from transactions and other events and circumstances from non-owner sources. There have been no items qualifying as other comprehensive loss and, therefore, the Company's comprehensive loss was the same as its reported net loss for the years ended December&#160;31, 2020 and 2019.</ix:continuation>  </span></div><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4Njg1_a64ea59b-6a16-42f2-92d2-1aa76b9eaf8f" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements Not Yet Adopted</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board ("FASB") issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments and subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04 and ASU 2019-05 (collectively, &#8220;Topic 326&#8221;). Topic 326 requires measurement and recognition of expected credit losses for financial assets held. Topic 326 was to be effective for reporting periods beginning after December 15, 2019, with early adoption permitted. In November 2019, the FASB issued ASU 2019-10, Financial Instruments - Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842) Effective Dates, which deferred the effective dates for the Company, as a smaller reporting company, until fiscal year 2023. The Company currently plans to adopt the guidance at the beginning of fiscal 2023. The Company is currently evaluating the potential impact of Topic 326 on the Company&#8217;s consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes ("ASU 2019-12"), which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistency among reporting entities. The new standard is effective for fiscal years beginning after December 15, 2020. Most amendments within the standard are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company is currently evaluating the potential impact of ASU 2019-12 on the Company&#8217;s consolidated financial statements.</span></div><div><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the FASB issued ASU 2017-04, Intangibles &#8211; Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (&#8220;ASU 2017-04&#8221;), which eliminates Step 2 from the goodwill impairment test. Instead, an entity should perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should then recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity should consider income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. ASU 2017-04 requires the entity to apply these amendments on a prospective basis for which it is required to disclose the nature of and reason for the change in accounting upon transition. This disclosure shall be provided in the first annual period and in the interim period within the first annual period when the entity initially adopts the amendments. This ASU became effective for the Company on January 1, 2020. Adoption of ASU 2017-04 did not have an immediate impact on the Company&#8217;s consolidated financial statements and only has the potential to impact the amount of any goodwill impairment recorded after the adoption of the ASU.</span></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_145"></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> 3.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90ZXh0cmVnaW9uOjI3MzE4NTg0YjgyMjRjNzI5MDRjYzMyMTc4NjY5ZDgyXzMzMQ_bb71a4f0-f9eb-4d4a-8f49-69ec7731480a" continuedAt="i2b84a1865ec64d39b15c7430e1d8a43e" escape="true">INVENTORY</ix:nonNumeric></span></div><ix:continuation id="i2b84a1865ec64d39b15c7430e1d8a43e"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90ZXh0cmVnaW9uOjI3MzE4NTg0YjgyMjRjNzI5MDRjYzMyMTc4NjY5ZDgyXzMzNA_c89c7f65-427e-42c3-828f-1cdb9cb3553a" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory as of December&#160;31, 2020 and 2019 was comprised of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterials" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90YWJsZTo5ZmUwOTA4Yzk5Njg0ZGIyYjY1ZmFhOTJlYzgxMWRlNC90YWJsZXJhbmdlOjlmZTA5MDhjOTk2ODRkYjJiNjVmYWE5MmVjODExZGU0XzItMS0xLTEtMA_d4ae0483-7867-4ba4-84ea-3b170d5e8abc">4,923</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterials" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90YWJsZTo5ZmUwOTA4Yzk5Njg0ZGIyYjY1ZmFhOTJlYzgxMWRlNC90YWJsZXJhbmdlOjlmZTA5MDhjOTk2ODRkYjJiNjVmYWE5MmVjODExZGU0XzItMy0xLTEtMA_247c8bfc-94a6-4167-a615-98efcb7c125a">4,503</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" name="us-gaap:InventoryWorkInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90YWJsZTo5ZmUwOTA4Yzk5Njg0ZGIyYjY1ZmFhOTJlYzgxMWRlNC90YWJsZXJhbmdlOjlmZTA5MDhjOTk2ODRkYjJiNjVmYWE5MmVjODExZGU0XzMtMS0xLTEtMA_37f7d62b-6c14-42a0-891b-6c277137b860">785</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" name="us-gaap:InventoryWorkInProcess" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90YWJsZTo5ZmUwOTA4Yzk5Njg0ZGIyYjY1ZmFhOTJlYzgxMWRlNC90YWJsZXJhbmdlOjlmZTA5MDhjOTk2ODRkYjJiNjVmYWE5MmVjODExZGU0XzMtMy0xLTEtMA_be4468ef-46c3-45e4-90db-b7188fc0fab3">415</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90YWJsZTo5ZmUwOTA4Yzk5Njg0ZGIyYjY1ZmFhOTJlYzgxMWRlNC90YWJsZXJhbmdlOjlmZTA5MDhjOTk2ODRkYjJiNjVmYWE5MmVjODExZGU0XzQtMS0xLTEtMA_832122a1-8fa7-42f8-a7ac-3cbc89fdd267">3,132</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90YWJsZTo5ZmUwOTA4Yzk5Njg0ZGIyYjY1ZmFhOTJlYzgxMWRlNC90YWJsZXJhbmdlOjlmZTA5MDhjOTk2ODRkYjJiNjVmYWE5MmVjODExZGU0XzQtMy0xLTEtMA_5acc747f-8172-49ca-9092-45309986818b">5,053</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90YWJsZTo5ZmUwOTA4Yzk5Njg0ZGIyYjY1ZmFhOTJlYzgxMWRlNC90YWJsZXJhbmdlOjlmZTA5MDhjOTk2ODRkYjJiNjVmYWE5MmVjODExZGU0XzUtMS0xLTEtMA_e4679e7f-f4f8-491b-812c-34825e89c88a">8,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90YWJsZTo5ZmUwOTA4Yzk5Njg0ZGIyYjY1ZmFhOTJlYzgxMWRlNC90YWJsZXJhbmdlOjlmZTA5MDhjOTk2ODRkYjJiNjVmYWE5MmVjODExZGU0XzUtMy0xLTEtMA_71235fe8-7ece-4edb-89e6-a4a20338e90a">9,971</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020 and 2019, the Company recorded an inventory write-down of $<ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InventoryValuationReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90ZXh0cmVnaW9uOjI3MzE4NTg0YjgyMjRjNzI5MDRjYzMyMTc4NjY5ZDgyXzI2NQ_b87ed1e2-c000-44ba-91d9-704f68110934">0.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-5" name="us-gaap:InventoryValuationReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90ZXh0cmVnaW9uOjI3MzE4NTg0YjgyMjRjNzI5MDRjYzMyMTc4NjY5ZDgyXzMyOTg1MzQ4ODM2Nzg_c093171b-3e9b-4f6c-b897-33ab27e0409e">0.2</ix:nonFraction> million, respectively. As of December&#160;31, 2020, the Company had <ix:nonFraction unitRef="usd" contextRef="if25ec98df6e64c53939bb7efcbfb124b_I20201231" decimals="-5" format="ixt-sec:numwordsen" name="us-gaap:InventoryGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90ZXh0cmVnaW9uOjI3MzE4NTg0YjgyMjRjNzI5MDRjYzMyMTc4NjY5ZDgyXzIxOTkwMjMyNTYzMTk_9c94a247-c369-460e-9178-a28b9b395a31">no</ix:nonFraction> inventory outside the United States. As of December&#160;31, 2019, the Company had inventory outside the United States of $<ix:nonFraction unitRef="usd" contextRef="i0d8eb0e4462f4dccb7cee6c898b097bf_I20191231" decimals="-5" name="us-gaap:InventoryGross" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90ZXh0cmVnaW9uOjI3MzE4NTg0YjgyMjRjNzI5MDRjYzMyMTc4NjY5ZDgyXzMyOTg1MzQ4ODM4OTk_e942c5f4-89f2-4b46-b88b-b1d79d740e23">0.3</ix:nonFraction> million.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CV SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div id="ica64940eaba8432cb3e8a74baaac4713_148"></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90ZXh0cmVnaW9uOjAzOTkzYjBmZDE3ODRlOWI5ODIzYmE3NTY2OThhMzVhXzM0MA_b136d5b7-6b20-4748-a57d-cc0ef59d5136" continuedAt="i2f262d0aba24460daac3c3e910217ceb" escape="true">PROPERTY &amp; EQUIPMENT</ix:nonNumeric></span></div><ix:continuation id="i2f262d0aba24460daac3c3e910217ceb"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90ZXh0cmVnaW9uOjAzOTkzYjBmZDE3ODRlOWI5ODIzYmE3NTY2OThhMzVhXzMzOA_a758bd0f-66aa-48b8-bede-884219dd67cd" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net, as of December&#160;31, 2020 and 2019 were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.089%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.848%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.112%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.115%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Useful Lives</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i80b463299c26463ca972ff8dfaeefa07_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzItMS0xLTEtMC90ZXh0cmVnaW9uOjJkNTlmYTM4Yzk3YzQyNDQ5ODA0YTYzNDYyNzE4NGNhXzIxOTkwMjMyNTU1Njg_a9cd0dc6-8f13-43f4-a1b0-6c423fdd703d">3</ix:nonNumeric> - <ix:nonNumeric contextRef="id4f11b83791e4d0b89e930d959aa4d4c_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzItMS0xLTEtMC90ZXh0cmVnaW9uOjJkNTlmYTM4Yzk3YzQyNDQ5ODA0YTYzNDYyNzE4NGNhXzIxOTkwMjMyNTU1NzI_723b2834-403a-4f72-8835-56dcf7b7f061">5</ix:nonNumeric> years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i052975c55e0d4a6d81b116eed98ad8ad_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzItMy0xLTEtMA_8d9686cb-cce9-4960-bc88-c24d1ea95fe5">2,596</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifeda5edcf0e343769d5a4ca6eb1ca2ad_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzItNS0xLTEtMA_faf08968-1146-4c6f-ab56-97132aadaa39">1,285</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tenant improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i28b6a29ef2f34583975d18a2fb7b09a4_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzMtMy0xLTEtMA_99de5e72-5969-4a6d-8ce9-19139d741fdf">1,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i934d7b1779574fc9bec6c9c0df80e88e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzMtNS0xLTEtMA_1b07fc2f-b9bb-4eae-9dea-01d6ce3377d8">1,925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory and other equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia86834c02416429a998a484d9434a8e1_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzQtMS0xLTEtMA_713ddfff-a532-49e7-b797-729e7b61821b">5</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9518c9e514be4d70877b504c26d8c59d_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzQtMy0xLTEtMA_a34ea2fd-8eed-4e76-9106-a20c2bbd1d0f">691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iba1ca127b1714615af145434271838ed_I20191231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzQtNS0xLTEtMA_e95571e0-66dd-4414-9047-980316c5ea96">691</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id25e838c282448c79258da27d6aefa6d_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzUtMy0xLTEtMA_06ff506a-de3c-4146-a895-2c7646d71940">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1d3e49783f149a084f798c4590d9931_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzUtNS0xLTEtMA_af76ba53-721c-4d47-b2e4-b04ddcd4c797">1,269</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzYtMy0xLTEtMA_8302fc49-feb0-48e6-91f4-ec81fe897fa5">5,269</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzYtNS0xLTEtMA_ed229c68-59e8-4c94-b9e2-bd53bec7fe7b">5,170</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzctMy0xLTEtMA_227d54a2-dbdc-4454-b0b8-1043e9de2ecc">2,392</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzctNS0xLTEtMA_19b781f0-08f9-4b7c-bdae-c96f1c1e1068">1,555</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzgtMy0xLTEtMA_cee2f17d-6b3a-4136-b9f5-5b104b70644a">2,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzgtNS0xLTEtMA_1709ff70-b4b2-4c9d-b94a-6e69206f1cd3">3,615</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Tenant improvements are amortized over the lesser of the remaining term of the related lease or the estimated useful life of the tenant improvements.</span></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for the years ended December&#160;31, 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90ZXh0cmVnaW9uOjAzOTkzYjBmZDE3ODRlOWI5ODIzYmE3NTY2OThhMzVhXzMxNQ_e2ff8923-6708-440a-889c-004fc2acb3b9">0.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90ZXh0cmVnaW9uOjAzOTkzYjBmZDE3ODRlOWI5ODIzYmE3NTY2OThhMzVhXzMyMg_08b63506-bf54-41a8-b74b-90ad9100b02e">0.7</ix:nonFraction> million, respectively.</span></div></ix:continuation><div id="ica64940eaba8432cb3e8a74baaac4713_154"></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:IntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90ZXh0cmVnaW9uOmFmOWQ0YjM2NjhhZjQ5NzE5ODNlZGVmMTU5ODU5Yzc5XzM4OQ_064ff4a1-1b0a-41cd-98e7-09fd0fbbfc5d" continuedAt="id77924d49b2747a48d8790612bcb426a" escape="true">INTANGIBLE ASSETS</ix:nonNumeric></span></div><ix:continuation id="id77924d49b2747a48d8790612bcb426a" continuedAt="i6ab83afd25664503b07f0d2b5f241ab2"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90ZXh0cmVnaW9uOmFmOWQ0YjM2NjhhZjQ5NzE5ODNlZGVmMTU5ODU5Yzc5XzM4Ng_51b68b4f-4852-4530-896f-ea6b79b8829c" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of the following as of December&#160;31, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.308%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.836%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.402%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Useful Life (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24523ddf355143439c1af05532a3151a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzItMS0xLTEtMA_07f3e800-19b1-48e2-ac36-dce675f139d1">3,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24523ddf355143439c1af05532a3151a_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzItMy0xLTEtMA_6d21cab7-bfe3-40c4-9aee-605b05346541">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i24523ddf355143439c1af05532a3151a_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzItNS0xLTEtMA_47765f64-9e04-4e38-a848-c2725f14e73e">3,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78a46d9043e74a11aadbd6f65daf06f0_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzMtMS0xLTEtMA_4338dda9-2288-4e15-91b1-9977b7ed38f6">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78a46d9043e74a11aadbd6f65daf06f0_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzMtMy0xLTEtMA_3ebdba29-9f8b-4ad9-96de-ae4de6845f08">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78a46d9043e74a11aadbd6f65daf06f0_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzMtNS0xLTEtMA_339fe9cc-ef50-4459-bd1f-765d78613be9">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ie07b37afc2754e398a196bfcb6c55c30_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzMtNy0xLTEtMA_1fff14b0-2f17-496b-b51d-acd2aa0e1625">5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46bcdf3737e4410c9206873ea3b39599_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzQtMS0xLTEtMA_db02fa39-fe40-4e6e-89f1-37e007d3467c">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46bcdf3737e4410c9206873ea3b39599_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzQtMy0xLTEtMA_03c9b49d-b810-4224-819d-453796fa0134">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46bcdf3737e4410c9206873ea3b39599_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzQtNS0xLTEtMA_1777c5a4-a49a-402a-8edb-b70d503d7d03">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0f8eb91898874f04aea260438b7f2aa9_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzQtNy0xLTEtMA_5f04e394-fe28-45ab-8871-0b7a0b3cdb2e">5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzUtMS0xLTEtMA_dfda86da-997c-4c55-a65c-1fba9f65bebf">3,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzUtMy0xLTEtMA_1ad077be-e058-49ae-a118-50c727f2601e">177</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzUtNS0xLTEtMA_5d68e240-5440-4d4e-850a-afa5dbeab00d">3,730</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - December 31, 2019:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86dca6f99d5c4d1297b510610a68e59e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzgtMS0xLTEtMA_edbb5714-3366-44db-92f9-72ab2b9278ec">3,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86dca6f99d5c4d1297b510610a68e59e_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzgtMy0xLTEtMA_5f3ba2ad-c327-42fa-86d0-9c7d898eb195">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i86dca6f99d5c4d1297b510610a68e59e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzgtNS0xLTEtMA_fe12c939-9080-4dfb-b8f2-c72b5e2e6e95">3,730</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99b603840d5c471597402724690a24b2_I20191231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzktMS0xLTEtMA_9e5eedb4-d31e-4922-a434-d95e71f1cb80">100</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99b603840d5c471597402724690a24b2_I20191231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzktMy0xLTEtMA_2f13cf95-7c37-4caf-b710-73a74dab4824">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99b603840d5c471597402724690a24b2_I20191231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzktNS0xLTEtMA_83cf2e5b-0aea-4d46-80c2-986280acba96">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i4f83a0e15d4f46709af062728537490d_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzktNy0xLTEtMA_20db485d-2987-49c7-9de7-c093dfe2376d">5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6886463cfa747f2937d6827839da75e_I20191231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzEwLTEtMS0xLTA_6c30f359-938a-49e5-9122-c85c3468b684">77</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6886463cfa747f2937d6827839da75e_I20191231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzEwLTMtMS0xLTA_eeedffd3-28ea-41e5-930d-c146ab536fbd">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id6886463cfa747f2937d6827839da75e_I20191231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzEwLTUtMS0xLTA_6134b939-ea34-460c-8165-c2cbd3b78b5f">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9d576fcf864e471bb409eafe4c6155e0_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzEwLTctMS0xLTA_363d1b9b-d3dc-4aa7-b7ad-d04e547d3a30">5</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzExLTEtMS0xLTA_c5d1b19d-e909-47b3-b19b-3f7904f4eaf0">3,907</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzExLTMtMS0xLTA_e9502aa3-2e28-40ae-8f41-d0b197ae0389">141</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzExLTUtMS0xLTA_6f2d4ba9-9103-427d-95e0-14198bded903">3,766</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6ab83afd25664503b07f0d2b5f241ab2">The Company did not incur costs to renew or extend the term of acquired intangible assets for the years ended December&#160;31, 2020 and 2019. Amortization expense for intangible assets was $<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdjustmentForAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90ZXh0cmVnaW9uOmFmOWQ0YjM2NjhhZjQ5NzE5ODNlZGVmMTU5ODU5Yzc5XzI3MQ_8c97ec58-92db-4012-9279-1bed83e66f6c">36</ix:nonFraction> thousand and $<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" name="us-gaap:AdjustmentForAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90ZXh0cmVnaW9uOmFmOWQ0YjM2NjhhZjQ5NzE5ODNlZGVmMTU5ODU5Yzc5XzMyOTg1MzQ4ODM4MTk_8a23b6c8-863f-468b-a5d4-1d2e620c25dd">35</ix:nonFraction> thousand for the years ended December&#160;31, 2020 and 2019, respectively. There is <ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90ZXh0cmVnaW9uOmFmOWQ0YjM2NjhhZjQ5NzE5ODNlZGVmMTU5ODU5Yzc5XzIxOTkwMjMyNTYwMjc_fea57107-06c4-4cd8-ad68-6162c09b361d">no</ix:nonFraction> future amortization expense.</ix:continuation> </span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-15</span></div></div></div><div id="ica64940eaba8432cb3e8a74baaac4713_160"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CV SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjAvZnJhZzo1ZTAyNTA3YzVjMzI0YjQ4ODVlMTBjZDBlMWE5NmY0ZS90ZXh0cmVnaW9uOjVlMDI1MDdjNWMzMjRiNDg4NWUxMGNkMGUxYTk2ZjRlXzkz_7ec0ecbe-ca4b-492f-8adf-3f8f98f1ba8d" continuedAt="idee74fe8d4f947528061844f147e7d92" escape="true">ACCRUED EXPENSES</ix:nonNumeric></span></div><ix:continuation id="idee74fe8d4f947528061844f147e7d92"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjAvZnJhZzo1ZTAyNTA3YzVjMzI0YjQ4ODVlMTBjZDBlMWE5NmY0ZS90ZXh0cmVnaW9uOjVlMDI1MDdjNWMzMjRiNDg4NWUxMGNkMGUxYTk2ZjRlXzk2_aad5f458-774f-48e9-98ba-ba3bd0c49116" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses as of December&#160;31, 2020 and 2019 were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll expenses (1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedSalariesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjAvZnJhZzo1ZTAyNTA3YzVjMzI0YjQ4ODVlMTBjZDBlMWE5NmY0ZS90YWJsZTo1YjQ2ODExNzNlOGI0ZTg0YTk1MTNhYzBhNzgxNDQ4NS90YWJsZXJhbmdlOjViNDY4MTE3M2U4YjRlODRhOTUxM2FjMGE3ODE0NDg1XzItMS0xLTEtMA_2d564286-fa22-4a79-999b-6e5a321d8885">8,324</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedSalariesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjAvZnJhZzo1ZTAyNTA3YzVjMzI0YjQ4ODVlMTBjZDBlMWE5NmY0ZS90YWJsZTo1YjQ2ODExNzNlOGI0ZTg0YTk1MTNhYzBhNzgxNDQ4NS90YWJsZXJhbmdlOjViNDY4MTE3M2U4YjRlODRhOTUxM2FjMGE3ODE0NDg1XzItMy0xLTEtMA_40b3b55f-9c10-4ffc-b89b-d6c2a2937a24">8,787</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjAvZnJhZzo1ZTAyNTA3YzVjMzI0YjQ4ODVlMTBjZDBlMWE5NmY0ZS90YWJsZTo1YjQ2ODExNzNlOGI0ZTg0YTk1MTNhYzBhNzgxNDQ4NS90YWJsZXJhbmdlOjViNDY4MTE3M2U4YjRlODRhOTUxM2FjMGE3ODE0NDg1XzMtMS0xLTEtMA_4f7854bc-f3af-4db4-9336-6bc013f36475">1,481</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjAvZnJhZzo1ZTAyNTA3YzVjMzI0YjQ4ODVlMTBjZDBlMWE5NmY0ZS90YWJsZTo1YjQ2ODExNzNlOGI0ZTg0YTk1MTNhYzBhNzgxNDQ4NS90YWJsZXJhbmdlOjViNDY4MTE3M2U4YjRlODRhOTUxM2FjMGE3ODE0NDg1XzMtMy0xLTEtMA_1cedca39-cebf-4540-9898-4f871a8286df">2,069</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjAvZnJhZzo1ZTAyNTA3YzVjMzI0YjQ4ODVlMTBjZDBlMWE5NmY0ZS90YWJsZTo1YjQ2ODExNzNlOGI0ZTg0YTk1MTNhYzBhNzgxNDQ4NS90YWJsZXJhbmdlOjViNDY4MTE3M2U4YjRlODRhOTUxM2FjMGE3ODE0NDg1XzQtMS0xLTEtMA_86e79598-2346-4af4-a369-8c621cf06678">9,805</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjAvZnJhZzo1ZTAyNTA3YzVjMzI0YjQ4ODVlMTBjZDBlMWE5NmY0ZS90YWJsZTo1YjQ2ODExNzNlOGI0ZTg0YTk1MTNhYzBhNzgxNDQ4NS90YWJsZXJhbmdlOjViNDY4MTE3M2U4YjRlODRhOTUxM2FjMGE3ODE0NDg1XzQtMy0xLTEtMA_79bbbef7-8a76-4c94-8e86-9231c79367c0">10,856</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1) This includes a tax liability associated with a related party transaction as discussed in Note 11 of $<ix:nonFraction unitRef="usd" contextRef="i5dfcb74883a1467d82e99d0d2ce81499_I20201231" decimals="-5" name="us-gaap:AccruedSalariesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjAvZnJhZzo1ZTAyNTA3YzVjMzI0YjQ4ODVlMTBjZDBlMWE5NmY0ZS90YWJsZTo1YjQ2ODExNzNlOGI0ZTg0YTk1MTNhYzBhNzgxNDQ4NS90YWJsZXJhbmdlOjViNDY4MTE3M2U4YjRlODRhOTUxM2FjMGE3ODE0NDg1XzUtMC0xLTEtNjEvdGV4dHJlZ2lvbjpjMmEzYmFhMjIzNGI0NjBjOWE4YzQzZjBjM2M1YTg4M18yMTk5MDIzMjU1Njc1_5d00f312-e02e-4b36-95b1-bceda07c5354">6.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i051b211947594052beb7406aed759748_I20191231" decimals="-5" name="us-gaap:AccruedSalariesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjAvZnJhZzo1ZTAyNTA3YzVjMzI0YjQ4ODVlMTBjZDBlMWE5NmY0ZS90YWJsZTo1YjQ2ODExNzNlOGI0ZTg0YTk1MTNhYzBhNzgxNDQ4NS90YWJsZXJhbmdlOjViNDY4MTE3M2U4YjRlODRhOTUxM2FjMGE3ODE0NDg1XzUtMC0xLTEtNjEvdGV4dHJlZ2lvbjpjMmEzYmFhMjIzNGI0NjBjOWE4YzQzZjBjM2M1YTg4M18zMjk4NTM0ODgzNjYy_03bc678e-bbfe-4288-bbd7-5710a39b2cf3">6.6</ix:nonFraction> million as of December&#160;31, 2020 and 2019, respectively.</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="text-align:center"><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_166"></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzY3NQ_1d9ed12a-77a2-4d12-a429-503651abd53c" continuedAt="i7591bbab06954b58a4280757acecb113" escape="true">DEBT</ix:nonNumeric></span></div><ix:continuation id="i7591bbab06954b58a4280757acecb113" continuedAt="i8d3e86450433428c8399332b5c726c50"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:ScheduleOfDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzY1OTcwNjk3ODI4MTA_303f5720-91fc-4377-a5fb-32be7969b8b4" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt as of December&#160;31, 2020 was as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.717%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP loan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9869509e2682490b9a206064b3920d90_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90YWJsZTphMGQxNzIwOTkzMDg0MjMwYmVkYjYwMzI4YjI5M2NmMC90YWJsZXJhbmdlOmEwZDE3MjA5OTMwODQyMzBiZWRiNjAzMjhiMjkzY2YwXzItMS0xLTEtMzQyMg_96b3b3f9-7c46-4a18-8d92-104d046c3c5b">2,906</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance financing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2f85a3238c7b4681b71554667cce5b1e_I20201231" decimals="-3" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90YWJsZTphMGQxNzIwOTkzMDg0MjMwYmVkYjYwMzI4YjI5M2NmMC90YWJsZXJhbmdlOmEwZDE3MjA5OTMwODQyMzBiZWRiNjAzMjhiMjkzY2YwXzMtMS0xLTEtMzQyMg_89660dbe-773a-4069-9a17-bb799d0781c8">721</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90YWJsZTphMGQxNzIwOTkzMDg0MjMwYmVkYjYwMzI4YjI5M2NmMC90YWJsZXJhbmdlOmEwZDE3MjA5OTMwODQyMzBiZWRiNjAzMjhiMjkzY2YwXzQtMS0xLTEtMzQyMg_a49a1851-8e65-4266-b7e2-31bfd3e9fe66">3,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90YWJsZTphMGQxNzIwOTkzMDg0MjMwYmVkYjYwMzI4YjI5M2NmMC90YWJsZXJhbmdlOmEwZDE3MjA5OTMwODQyMzBiZWRiNjAzMjhiMjkzY2YwXzUtMS0xLTEtMzQ3NA_9611fd1b-f44e-4513-bd6d-98430dab497c">2,174</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion of debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90YWJsZTphMGQxNzIwOTkzMDg0MjMwYmVkYjYwMzI4YjI5M2NmMC90YWJsZXJhbmdlOmEwZDE3MjA5OTMwODQyMzBiZWRiNjAzMjhiMjkzY2YwXzYtMS0xLTEtMzQ4NA_7021206b-1955-476d-adca-ffc577ea13e7">1,453</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any debt as of December&#160;31, 2019.</span></div><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzIxOTkwMjMyNzI0NDQ_b0859d86-0a07-4828-8a72-e9bd1247f861" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments on the debt are as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.083%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.717%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90YWJsZTplNTY5OTJkNTQ4MWU0YzcyYmY3NzM1MWVlZjVlNDM4NC90YWJsZXJhbmdlOmU1Njk5MmQ1NDgxZTRjNzJiZjc3MzUxZWVmNWU0Mzg0XzEtMS0xLTEtNzAxMQ_e5ebcab2-2b38-49fb-9fdf-2d3985abb22f">2,174</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90YWJsZTplNTY5OTJkNTQ4MWU0YzcyYmY3NzM1MWVlZjVlNDM4NC90YWJsZXJhbmdlOmU1Njk5MmQ1NDgxZTRjNzJiZjc3MzUxZWVmNWU0Mzg0XzItMS0xLTEtNzAxNQ_dabe6ac5-90d9-41eb-abcd-b0065d786795">1,453</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90YWJsZTplNTY5OTJkNTQ4MWU0YzcyYmY3NzM1MWVlZjVlNDM4NC90YWJsZXJhbmdlOmU1Njk5MmQ1NDgxZTRjNzJiZjc3MzUxZWVmNWU0Mzg0XzMtMS0xLTEtNzAxOQ_12382ea7-7378-4049-b5de-6ee0900c8df4">3,627</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Paycheck Protection Program</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 15, 2020, the Company applied for a loan from JPMorgan Chase Bank, N.A., as lender, pursuant to the Paycheck Protection Program of the CARES Act as administered by the U.S. Small Business Administration. On April 17, 2020, the loan was approved, and the Company received proceeds in the amount of $<ix:nonFraction unitRef="usd" contextRef="i27feea483e57465a9526919db75d6d01_D20200417-20200417" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfLongTermDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzY1OTcwNjk3ODI4MTI_0f9baa8b-31f0-4e0d-a993-455de77d87e0">2.9</ix:nonFraction>&#160;million (the &#8220;PPP Loan&#8221;).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PPP Loan, which took the form of a promissory note, matures on April 15, 2022 and bears interest at a rate of <ix:nonFraction unitRef="number" contextRef="i0461202b2e27451b9b8caee714491a29_I20200417" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzY1OTcwNjk3ODI4MjY_9a5abcfc-96a1-45cb-a405-61ed742900c8">0.98</ix:nonFraction>% per annum (the &#8220;Promissory Note&#8221;). The Company did not provide any collateral or guarantees for the PPP Loan, nor did the Company pay any facility charge to obtain the PPP Loan. The Promissory Note provides for customary events of default, including, among others, those relating to failure to make payment, bankruptcy, breaches of representations and material adverse effects. The Company may prepay the principal of the PPP Loan at any time without incurring any prepayment charges.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the CARES Act, loan forgiveness is available for the sum of documented payroll costs, covered rent payments, and covered utilities during the covered period of 8 weeks beginning on the date of loan approval. For purposes of the CARES Act, payroll costs exclude compensation of an individual employee in excess of $100,000, prorated annually. Not more than 25% of the forgiven amount may be for non-payroll costs. Forgiveness is reduced if full-time headcount declines, or if salaries and wages for employees with salaries of $100,000 or less annually are reduced by more than 25%. In the event the PPP Loan, or any portion thereof, is forgiven pursuant to the PPP, the amount forgiven is applied to outstanding principal.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Paycheck Protection Program Flexibility Act of 2020 (the &#8220;PPP Flexibility Act&#8221;), enacted on June 5, 2020, amended the Paycheck Protection Program, among others, as follows: (i) extended the covered period from 8 weeks to 24 weeks from the date the PPP Loan is originated, during which PPP funds needed to be expended in order to be forgiven. A borrower may submit a loan forgiveness application any time on or before the maturity date of the loan &#8211; including before the end of the covered period &#8211; </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CV SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i8d3e86450433428c8399332b5c726c50"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">if the borrower has used all of the loan proceeds for which the borrower is requesting forgiveness. (ii) at least 60% of PPP funds must be spent on payroll costs, with the remaining 40% available to spend on other eligible expenses. (iii) payments are deferred until the date on which the amount of forgiveness determined is remitted to the lender. If a borrower fails to seek forgiveness within 10 months after the last day of its covered period, then payments will begin on the date that is 10 months after the last day of the covered period. In addition, the PPP Flexibility Act modified the CARES Act by increasing the maturity date for loans made after the effective date from two years to a minimum maturity of five years from the date on which the borrower applies for loan forgiveness. Existing PPP loans made before the new legislation retain their original two-year term, but may be renegotiated between a lender and a borrower to match the 5-year term permitted under the PPP Flexibility Act.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company intends to apply for loan forgiveness within the required timeframe. No assurance is provided that the Company will obtain forgiveness of the PPP Loan in whole or in part. The promissory note is classified as long-term except for the portion to be paid within twelve months of the year-end, which is classified as current.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unsecured Note Payable</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2018, the Company entered into a finance agreement with First Insurance Funding in order to fund a portion of its insurance policies, which was amended in January 2019. The amount financed was $<ix:nonFraction unitRef="usd" contextRef="ie007d6f497f642ab81bc374925609676_I20181031" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzMyOTg1MzQ4OTc1Nzk_087b93d5-de0b-467b-9990-a44d8d7ce99b">0.5</ix:nonFraction> million and incurred interest at a rate of <ix:nonFraction unitRef="number" contextRef="ie007d6f497f642ab81bc374925609676_I20181031" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzMyOTg1MzQ4OTc1ODg_f8724ac7-6ff8-4e06-83e7-75d21f978ac1">5.15</ix:nonFraction>%. The Company was required to make monthly payments of $<ix:nonFraction unitRef="usd" contextRef="ibcfcb94673094dfa87f562c52cfef25e_D20181001-20181031" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzMyOTg1MzQ4OTc1OTI_80e61275-6d07-4dad-a44d-5968ef6c842f">0.1</ix:nonFraction> million through July 2019. As of December&#160;31, 2019, amounts were repaid in full.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company entered into a finance agreement with First Insurance Funding in order to fund a portion of its insurance policies. The amount financed is $<ix:nonFraction unitRef="usd" contextRef="i3a704f978fb548eca2e891c2407e5390_I20201031" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzMyOTg1MzQ4OTg4MDA_9b328662-a0b8-426c-9989-a88c522ade23">0.7</ix:nonFraction> million and incurs interest at a rate of <ix:nonFraction unitRef="number" contextRef="i3a704f978fb548eca2e891c2407e5390_I20201031" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzMyOTg1MzQ4OTg3ODE_263e040e-5c76-4bf3-8d07-1e08dd58cfab">3.60</ix:nonFraction>%. The Company is required to make monthly payments of $<ix:nonFraction unitRef="usd" contextRef="i794dcec76c204870a043fce5338d2a6f_D20201001-20201031" decimals="-5" name="us-gaap:DebtInstrumentPeriodicPayment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzMyOTg1MzQ4OTk0NzM_52f2a5cd-74e8-43d7-9af9-beb42ece0de7">0.1</ix:nonFraction> million through July 2021. The outstanding balance as of December&#160;31, 2020 was $<ix:nonFraction unitRef="usd" contextRef="i2f85a3238c7b4681b71554667cce5b1e_I20201231" decimals="-5" name="us-gaap:UnsecuredDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzMyOTg1MzQ4OTg4ODY_2f96dc6a-7932-44fe-a18b-e4a069789599">0.7</ix:nonFraction> million.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_169"></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzgzMg_901a90d1-45eb-44f4-a888-91c679c58526" continuedAt="id8a273cec58d48c4be899bebf5b24a8b" escape="true">STOCKHOLDERS EQUITY</ix:nonNumeric></span></div><ix:continuation id="id8a273cec58d48c4be899bebf5b24a8b"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue up to <ix:nonFraction unitRef="shares" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzgy_9a196fd4-f7b3-4977-8479-579b354da6e5"><ix:nonFraction unitRef="shares" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzgy_dcf11c6d-55ff-4e7c-8f77-8deab2192c1f">190,000,000</ix:nonFraction></ix:nonFraction> shares of common stock (par value $<ix:nonFraction unitRef="usdPerShare" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzExOQ_2affef7e-ddb4-4ffe-a6ed-e82376eddeaf"><ix:nonFraction unitRef="usdPerShare" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzExOQ_412ef2e5-af30-4d87-88b4-d61be7ba18c7">0.0001</ix:nonFraction></ix:nonFraction>). As of December&#160;31, 2020 and 2019, the Company had <ix:nonFraction unitRef="shares" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzE1Nw_199b797a-b488-47dc-a08e-8f73d856a6df"><ix:nonFraction unitRef="shares" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzE1Nw_1d25e84c-8edc-4528-af7d-5c8ea6f7289d">100,664,000</ix:nonFraction></ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzE2NA_afdea959-f80c-44be-92a0-201f295815b3"><ix:nonFraction unitRef="shares" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzE2NA_f6f9c367-4969-4237-a3ac-c342f61ce0c5">99,416,000</ix:nonFraction></ix:nonFraction> shares of common stock issued and outstanding, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 8, 2020, the Company entered into a common stock purchase agreement ("SPA") with Tumim Stone Capital, LLC ("Tumim") to issue and sell up to $<ix:nonFraction unitRef="usd" contextRef="i5ce71eb8f7d045f680a63998d5ebc762_D20201208-20201208" decimals="-5" name="cvsi:SaleOfStockMaximumValueOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzMyOTg1MzQ4ODQ0MDg_7ae932eb-fb06-4b68-8da7-6e26534a8e3b">10.0</ix:nonFraction> million in shares of the Company's common stock. The SPA provides, among other things, that the Company may direct, every <ix:nonFraction unitRef="tradingday" contextRef="i5ce71eb8f7d045f680a63998d5ebc762_D20201208-20201208" decimals="INF" format="ixt-sec:numwordsen" name="cvsi:SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzY1OTcwNjk3NzAzNTc_989521e1-281e-4f15-95c4-92dc138957cc">three</ix:nonFraction> trading days, Tumim to purchase a number of shares not to exceed an amount determined based upon the trading volume and stock price of the Company&#8217;s shares. The Company determined that the right to sell shares of common stock to Tumim under the SPA represents a freestanding put option under ASC 815 Derivatives and Hedging. Tumim has no right to require the Company to sell any shares of common stock to Tumim, but Tumim is obligated to purchase up to $<ix:nonFraction unitRef="usd" contextRef="i5ce71eb8f7d045f680a63998d5ebc762_D20201208-20201208" decimals="-5" name="cvsi:SaleOfStockMaximumValueOfSharesIssuedInTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzMyOTg1MzQ4ODYxMjE_7ae932eb-fb06-4b68-8da7-6e26534a8e3b">10.0</ix:nonFraction> million of the Company's common stock. Such sales of common stock by the Company will be subject to certain limitations, and may occur from time to time, at the Company's sole discretion till December 31, 2021. The Company determined that the fair value of the put option is <ix:nonFraction unitRef="usdPerShare" contextRef="ia5dcf374512b4bb6ad637f627f49d3ca_I20201208" decimals="INF" format="ixt-sec:numwordsen" name="cvsi:SaleOfStockFairValueOfPutOption" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzMyOTg1MzQ4ODY0MDc_7260cc7b-5415-4a8a-a92c-0bd6404ba05e">zero</ix:nonFraction> as the shares will be issued at a discount and settled within <ix:nonFraction unitRef="businessday" contextRef="i5ce71eb8f7d045f680a63998d5ebc762_D20201208-20201208" decimals="INF" format="ixt-sec:numwordsen" name="cvsi:SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzY1OTcwNjk3NzAzNzA_821992a7-f632-44a6-870c-9a8f6b5620db">one</ix:nonFraction> business day. During the year ended December&#160;31, 2020, the Company sold <ix:nonFraction unitRef="shares" contextRef="i7e602472f0d2419187a53398197f884a_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzMyOTg1MzQ4ODUxMTU_aa908b36-ecc5-4b52-b1b4-eda04bd53d96">450,000</ix:nonFraction> shares of common stock pursuant to the SPA and recognized proceeds of $<ix:nonFraction unitRef="usd" contextRef="i7e602472f0d2419187a53398197f884a_D20200101-20201231" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzMyOTg1MzQ4ODUxOTE_e5a35bec-73b8-46a4-9bf5-92949140e71a">0.2</ix:nonFraction> million. The Company issued <ix:nonFraction unitRef="shares" contextRef="i7e602472f0d2419187a53398197f884a_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesIssuedForServices" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzMyOTg1MzQ4ODQ3NDE_cd50b086-764c-42ab-bd5a-9f632aea5b54">185,454</ix:nonFraction> shares of common stock to Tumim as commitment fee in connection with entering into the SPA. In addition, the Company incurred offering cost of $<ix:nonFraction unitRef="usd" contextRef="i7e602472f0d2419187a53398197f884a_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzMyOTg1MzQ4ODY2MTQ_89cc4a64-085f-4ba2-a71c-eae34b6b02a3">0.3</ix:nonFraction> million. In accordance with ASC 825-10-25-3, upfront costs and fees related to items for which the fair value option is elected shall be recognized in earnings as incurred and not deferred. As such, the Company recorded the fair value of the commitment fee shares of $<ix:nonFraction unitRef="usd" contextRef="i7e602472f0d2419187a53398197f884a_D20200101-20201231" decimals="-5" name="cvsi:SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzMyOTg1MzQ4ODQ5MDk_7546442b-5d63-4217-a596-155c8684c5a7">0.1</ix:nonFraction> million and offering cost of $<ix:nonFraction unitRef="usd" contextRef="i7e602472f0d2419187a53398197f884a_D20200101-20201231" decimals="-5" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzMyOTg1MzQ4ODU0MzI_89cc4a64-085f-4ba2-a71c-eae34b6b02a3">0.3</ix:nonFraction> million to general and administrative expense. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue up to <ix:nonFraction unitRef="shares" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzI4NQ_327e5d54-0fe3-4764-acad-5ea88b0ecea8"><ix:nonFraction unitRef="shares" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:PreferredStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzI4NQ_8e93021a-e3ae-4c02-aa1e-e2aefc155025">10,000,000</ix:nonFraction></ix:nonFraction> shares of $<ix:nonFraction unitRef="usdPerShare" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzI5OA_33ff0629-ed1d-4cc7-9821-1f4a29e167cc"><ix:nonFraction unitRef="usdPerShare" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzI5OA_dd2b608e-ee2e-48f8-8822-ce1f1b96da19">0.0001</ix:nonFraction></ix:nonFraction> par value preferred stock with designations, rights and preferences to be determined from time to time by the Board of Directors. Each such series or class shall have voting powers, if any, and such preferences and/or other special rights, with such qualifications, limitations or restrictions of such preferences and/or rights as shall be stated in the resolution or resolutions providing for the issuance of such series or class of shares of preferred stock. As of December&#160;31, 2020, and 2019, there is <ix:nonFraction unitRef="shares" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzY1OTcwNjk3NzAzMjg_130f1a66-d7bc-45f8-af3b-00a017553a23"><ix:nonFraction unitRef="shares" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzY1OTcwNjk3NzAzMjg_a4a0fcc0-267d-4079-b97d-267a26265007"><ix:nonFraction unitRef="shares" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzY1OTcwNjk3NzAzMjg_be0300f0-459e-47a9-a39c-90c4badd383c"><ix:nonFraction unitRef="shares" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:PreferredStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzY1OTcwNjk3NzAzMjg_f1823b28-1f1a-4f94-8598-58372cc9aa4b">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> preferred stock issued and outstanding.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_175"></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzY0NTg_f3f46b7d-1160-48ba-b8c7-4b6d3b4d0cdf" continuedAt="i70be0cfcfdf04e67badfcb8e2d363392" escape="true">STOCK-BASED COMPENSATION</ix:nonNumeric></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CV SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><ix:continuation id="i70be0cfcfdf04e67badfcb8e2d363392" continuedAt="i0700ad025f7043b1944ff314c3762209"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, there are <ix:nonFraction unitRef="shares" contextRef="if6de0662d6994f7eb059488a08f7185c_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzMyOTg1MzQ4OTQ4OTM_43dc473f-cc8d-4621-a488-619319d96bf8">34,976,000</ix:nonFraction> shares authorized for issuance under the CV Sciences, Inc. Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). As of&#160;December&#160;31, 2020, the Company had <ix:nonFraction unitRef="shares" contextRef="if6de0662d6994f7eb059488a08f7185c_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzMyOTg1MzQ4OTQ5NzY_5860094d-0c54-4654-8ab1-9cb3ce61186b">6,165,000</ix:nonFraction> authorized unissued shares reserved and available for issuance upon exercise and conversion of outstanding awards under the Amended 2013 Plan. On June 11, 2019, the Company&#8217;s stockholders approved to add an automatic &#8220;evergreen&#8221; provision regarding the number of shares to be annually added to the 2013 Plan. As a result, the number of shares of common stock that will be automatically added to the 2013 Plan on January 1 of each year during the term of the plan, starting with January 1, 2020, will be the lesser of: (a) <ix:nonFraction unitRef="number" contextRef="if9290810e4b94539b8af15efd7d0d1e5_I20190611" decimals="INF" name="cvsi:SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzEwMTY_984693f1-41f5-41e4-9c44-3fdfaa4be3db">4</ix:nonFraction>% of the total shares of the Company&#8217;s common stock outstanding on December 31st of the prior year, (b) <ix:nonFraction unitRef="shares" contextRef="if9290810e4b94539b8af15efd7d0d1e5_I20190611" decimals="INF" format="ixt:numdotdecimal" name="cvsi:SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzExMjE_192186eb-8d78-456d-9b59-8e961769f657">4,000,000</ix:nonFraction> shares of the Company&#8217;s common stock, or (c) a lesser number of shares of the Company&#8217;s common stock as determined by the Company&#8217;s Board of Directors. On January 1, 2021, the Company added <ix:nonFraction unitRef="shares" contextRef="i74658c74a8c3444fa9b7905dcc912472_D20210101-20210101" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzMyOTg1MzQ4OTQ4NjU_467aa958-89a8-4eeb-bab6-fc8b98992bc6">4,000,000</ix:nonFraction> shares to the 2013 Plan. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stock options are exercisable at no less than the fair market value of the underlying shares on the date of grant, and restricted stock and restricted stock units are issued at a value not less than the fair market value of the common stock on the date of the grant. Generally, stock options awarded are vested in equal increments ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzE4NzE_8bd9e890-25d8-4554-b080-b96de69f559a">two</span> to <ix:nonNumeric contextRef="i57a9d80096aa464eac00c8580957daf0_D20200101-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzE4Nzc_de1f7932-79ab-4308-9911-ef871c28ae56">four years</ix:nonNumeric> on the annual anniversary date on which such equity grants were awarded. The stock options generally have a maximum term of <ix:nonNumeric contextRef="i265c122e61ad44b2ba1101201ca25d44_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzIwMTA_49828ef0-17b6-4a70-8b00-88bfba7e0bbd">10</ix:nonNumeric> years.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized stock-based compensation expense of&#160;$<ix:nonFraction unitRef="usd" contextRef="i9ff3f55fc97e475b8bb8bc843ae1b0d2_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzIwNzk_efa5d5ee-6bc0-48d6-a74e-66fc10253170">3.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i910e3383f6764b46b22f1e9d7e5e1aa0_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzIwODY_35681b3c-01d4-43f9-9a9f-6fae2c47464d">15.1</ix:nonFraction> million for the years ended December&#160;31, 2020 and 2019, respectively. During the year ended December&#160;31, 2019, the Company recorded stock-based compensation expense of $<ix:nonFraction unitRef="usd" contextRef="i2b8102c1b9274b8d837c6a3a9496441b_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzY1OTcwNjk3ODE3MDE_43cf1773-9554-40a3-92c5-f0b0276749d4">9.5</ix:nonFraction>&#160;million related to the settlement of the Company's former founder's employment agreements. For more information refer to Note 11, Related Parties. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, the Company&#8217;s board of directors approved a stock option modification that reduced certain employees&#8217; and directors&#8217; stock option exercise prices to $<ix:nonFraction unitRef="usdPerShare" contextRef="idfba81407b1f4dc7bb6ac7356bcb5b8f_D20200601-20200630" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzMyOTg1MzQ4OTA1NzU_ad304791-b1a1-4169-840c-06fdcd2d3a42">0.66</ix:nonFraction>. No other terms were modified. Stock options to purchase a total of <ix:nonFraction unitRef="shares" contextRef="idfba81407b1f4dc7bb6ac7356bcb5b8f_D20200601-20200630" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzMyOTg1MzQ4OTA1ODM_74caa20a-c7e5-403d-a3ed-f4724ec920ab">2,130,000</ix:nonFraction> shares of common stock were modified. The modification to the existing stock options resulted in $<ix:nonFraction unitRef="usd" contextRef="i632c0a45a9a741cfa8a17f0f306a9fe4_I20200630" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzMyOTg1MzQ4OTA1OTc_4a3dac8b-2110-439f-a3f5-7fc857851772">0.2</ix:nonFraction> million incremental value of the stock options. The incremental value associated with the modification will be recognized over the life of the remaining service period of the options. During the year ended December&#160;31, 2020, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="idfba81407b1f4dc7bb6ac7356bcb5b8f_D20200601-20200630" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzMyOTg1MzQ4OTA2MTg_9f50f655-6820-4f2c-a5e4-b6dbd09f7841">0.1</ix:nonFraction> million in stock-based compensation associated with the repriced options.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, total unrecognized compensation cost related to non-vested stock-based compensation arrangements was&#160;$<ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzM5MTU_65bdc364-ee71-4396-930b-be978316ee13">2.7</ix:nonFraction> million which is expected to be recognized over a weighted-average period of <ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzM5ODc_74755491-60f3-4e62-9557-64a3a0a6c78b">1.3</ix:nonNumeric> years. </span></div><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzY0Njc_7c7b9c05-d677-4ced-bb7e-6e34c34b6048" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes activity related to the Company's stock options (in thousands, except per share data):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:44.943%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.410%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.281%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.299%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining Contract<br/>Term (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding - December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ibfbe4fc0a05542b79480de4c56feef6f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzEtMS0xLTEtMA_68fbc6b6-87ea-4793-b6ae-486308536ee2">28,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ibfbe4fc0a05542b79480de4c56feef6f_I20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzEtMy0xLTEtMA_36f8d6bb-e1c8-4a01-8665-c0aebe11fc54">0.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i29ae30a4315946c0b52f15f8e6c4ed26_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzEtNS0xLTEtMA_e4b3b723-d22a-4bf8-b4da-e4907a6008db">5.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibfbe4fc0a05542b79480de4c56feef6f_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzEtNy0xLTEtMA_1dba1e13-0965-469f-bc38-96cfb3803ad0">12,335</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i18b1bfee52e244df92d350109e304526_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzItMS0xLTEtMA_6e91dda4-fa45-4fd0-8b6b-5c9c75a366da">6,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i18b1bfee52e244df92d350109e304526_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzItMy0xLTEtMA_16daf317-7aad-45bb-ab36-a54a9e2420e1">0.41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i18b1bfee52e244df92d350109e304526_D20200101-20201231" decimals="-3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzMtMS0xLTEtMA_ab93db0d-7bfb-4ad3-b8ce-4ea26fb4fc36">612</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i18b1bfee52e244df92d350109e304526_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzMtMy0xLTEtMA_b3387d87-49b1-4882-8f37-9f0efcb5cdea">0.37</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i18b1bfee52e244df92d350109e304526_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzQtMS0xLTEtMA_0de1579d-c5db-46e4-a476-dfdbeeae462c">8,478</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i18b1bfee52e244df92d350109e304526_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzQtMy0xLTEtMA_b7247afd-50ba-4824-bb3e-a7841f62b81c">0.91</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding - December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icffd0f08944b4303b75cda5726a991c1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzYtMS0xLTEtMA_ab89099e-a95e-4cad-9348-62a381123e86">25,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icffd0f08944b4303b75cda5726a991c1_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzYtMy0xLTEtMA_5178ca25-723b-4cdb-be5d-f3a1e73bdf92">0.48</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i18b1bfee52e244df92d350109e304526_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzYtNS0xLTEtMA_32de77b1-5fa7-48af-8090-e1dfd24ef462">5.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icffd0f08944b4303b75cda5726a991c1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzYtNy0xLTEtMA_2e52e866-fd93-4eae-838c-e7c39596a66b">2,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable - December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icffd0f08944b4303b75cda5726a991c1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzgtMS0xLTEtMA_bc64c1b8-2b74-40a8-8ecc-e3f1ee910788">22,254</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icffd0f08944b4303b75cda5726a991c1_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzgtMy0xLTEtMA_2a30d104-b2f9-45a1-9a52-b252df7a393f">0.46</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i18b1bfee52e244df92d350109e304526_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzgtNS0xLTEtMA_4fa81f0a-cd17-4d16-acaf-c4cef932e41b">5.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icffd0f08944b4303b75cda5726a991c1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzgtNy0xLTEtMA_e9721220-7ce7-4b54-846f-0a110e0c2354">2,010</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested or expected to vest - December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icffd0f08944b4303b75cda5726a991c1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzktMS0xLTEtMA_126c2cb9-f0a3-4cd6-a11f-a26c1e5b53e8">25,225</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="icffd0f08944b4303b75cda5726a991c1_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzktMy0xLTEtMA_f89151f7-3906-4186-b6a3-364e69e2cc99">0.48</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i18b1bfee52e244df92d350109e304526_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzktNS0xLTEtMA_c4b7f0ca-b2e6-474e-b085-bbae7c71d2c6">5.7</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icffd0f08944b4303b75cda5726a991c1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzktNy0xLTEtMA_749198cc-fe23-48c1-94bb-4a4e5ceb1651">2,186</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has established performance milestones in connection with the drug development efforts for its lead drug candidate CVSI-007. The above table includes <ix:nonFraction unitRef="shares" contextRef="ifec0d5d2e64345b7942f20ab0f15368e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzMyOTg1MzQ4OTEyNjI_523cc244-e29f-4c7c-b33b-df1c9590a2a0">5,000,000</ix:nonFraction> vested performance-based options as of December&#160;31, 2020, which were issued outside of the 2013 Plan. As of December&#160;31, 2020, there were <ix:nonFraction unitRef="shares" contextRef="ifec0d5d2e64345b7942f20ab0f15368e_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzMyOTg1MzQ4OTEzMjI_89bc6107-f326-4b5f-ad46-1eeac4b20cd7">8,000,000</ix:nonFraction> remaining unvested stock options granted outside of the 2013 Plan which vest upon the completion of future performance conditions, including those related to the Settlement Agreement with Mona Jr. (refer to Note 11).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of stock options exercised during the year ended December&#160;31, 2020 and 2019 was $<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzQyNzc_252a75f3-30de-414d-b509-05959491cec3">0.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzQyODQ_6aa1178c-aaa2-43d8-8514-858f4d0492d4">4.3</ix:nonFraction> million, respectively. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CV SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i0700ad025f7043b1944ff314c3762209" continuedAt="ie66016e2c1f44667af3cbbdc0f76e357"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzY0NzM_14f66130-eacc-433b-a700-096e3153f226" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the weighted average grant date fair value of stock options granted and the weighted-average assumptions used to estimate the fair value on the date of grant using the Black-Scholes valuation model:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:64.991%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.566%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.425%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo2YWRjMDgxYjVhZDg0OWQ4YWU3NWU0MDc0OTkyMzVkZC90YWJsZXJhbmdlOjZhZGMwODFiNWFkODQ5ZDhhZTc1ZTQwNzQ5OTIzNWRkXzItMS0xLTEtMA_1e644e94-7eed-4bee-a51f-f500df3c7ff3">132.9</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo2YWRjMDgxYjVhZDg0OWQ4YWU3NWU0MDc0OTkyMzVkZC90YWJsZXJhbmdlOjZhZGMwODFiNWFkODQ5ZDhhZTc1ZTQwNzQ5OTIzNWRkXzItMy0xLTEtMA_74335bfc-8859-4a7e-a504-fc849facd1c7">126.1</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-Free Interest Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo2YWRjMDgxYjVhZDg0OWQ4YWU3NWU0MDc0OTkyMzVkZC90YWJsZXJhbmdlOjZhZGMwODFiNWFkODQ5ZDhhZTc1ZTQwNzQ5OTIzNWRkXzMtMS0xLTEtMA_20a48670-5846-4c90-81f9-f179799619fa">0.5</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo2YWRjMDgxYjVhZDg0OWQ4YWU3NWU0MDc0OTkyMzVkZC90YWJsZXJhbmdlOjZhZGMwODFiNWFkODQ5ZDhhZTc1ZTQwNzQ5OTIzNWRkXzMtMy0xLTEtMA_5078e1d3-136c-4abc-8014-962a7391d9cc">1.6</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected Term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo2YWRjMDgxYjVhZDg0OWQ4YWU3NWU0MDc0OTkyMzVkZC90YWJsZXJhbmdlOjZhZGMwODFiNWFkODQ5ZDhhZTc1ZTQwNzQ5OTIzNWRkXzQtMS0xLTEtMA_2a2cab4a-5dc2-41aa-bb53-ac5bcc145d31">5.33</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo2YWRjMDgxYjVhZDg0OWQ4YWU3NWU0MDc0OTkyMzVkZC90YWJsZXJhbmdlOjZhZGMwODFiNWFkODQ5ZDhhZTc1ZTQwNzQ5OTIzNWRkXzQtMy0xLTEtMA_ddd5c4ca-2ff6-41ec-9ec3-3f9b2386bf0a">2.74</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo2YWRjMDgxYjVhZDg0OWQ4YWU3NWU0MDc0OTkyMzVkZC90YWJsZXJhbmdlOjZhZGMwODFiNWFkODQ5ZDhhZTc1ZTQwNzQ5OTIzNWRkXzUtMS0xLTEtMA_9dbd28f0-2f42-43d4-8e49-0d8cc81e8c9e">0.0</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo2YWRjMDgxYjVhZDg0OWQ4YWU3NWU0MDc0OTkyMzVkZC90YWJsZXJhbmdlOjZhZGMwODFiNWFkODQ5ZDhhZTc1ZTQwNzQ5OTIzNWRkXzUtMy0xLTEtMA_1329e4fe-0b0f-4791-a8f4-24366a015db2">0.0</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Per Share on Grant Date</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo2YWRjMDgxYjVhZDg0OWQ4YWU3NWU0MDc0OTkyMzVkZC90YWJsZXJhbmdlOjZhZGMwODFiNWFkODQ5ZDhhZTc1ZTQwNzQ5OTIzNWRkXzYtMS0xLTEtMA_a5ea34b1-3232-4be5-b916-5e8c54b93d8e">0.36</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$<ix:nonFraction unitRef="usdPerShare" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo2YWRjMDgxYjVhZDg0OWQ4YWU3NWU0MDc0OTkyMzVkZC90YWJsZXJhbmdlOjZhZGMwODFiNWFkODQ5ZDhhZTc1ZTQwNzQ5OTIzNWRkXzYtMy0xLTEtMA_0177b1cd-b1b0-4d00-97f4-d6093543c989">1.92</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility is based on the historical volatility of the Company's common stock. Expected volatility through September 30, 2019 was calculated based on the Company&#8217;s peer group, consisting of <ix:nonFraction unitRef="company" contextRef="i141553cffe3a4f4bbd6b47ebbf217e1b_D20190101-20190930" decimals="INF" format="ixt-sec:numwordsen" name="cvsi:SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzY1OTcwNjk3ODE3MjU_c5c79b3b-4fe5-465a-8f1c-650cb4b92021">five</ix:nonFraction> companies in the industry in which the Company operates because the Company did not have sufficient historical volatility data. The risk-free interest rates are based on the implied yield available on U.S.&#160;Treasury constant maturities with remaining terms equivalent to the respective expected terms of the options. The Company estimates the expected term for stock options awarded to employees, non-employees, officers and directors using the simplified method in accordance with ASC Topic 718, Stock Compensation, because the Company does not have sufficient relevant historical information to develop reasonable expectations about future exercise patterns.  In the future, as the Company gains historical data for the actual term over which stock options are held, the expected term may change, which could substantially change the grant-date fair value of future stock option awards, and, consequently, compensation of future grants.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ie66016e2c1f44667af3cbbdc0f76e357">During the year ended December&#160;31, 2019 <ix:nonFraction unitRef="shares" contextRef="i928a711d627049609b68b71da873a14b_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzMyOTg1MzQ4OTQwMDE_139078fa-123a-4fd4-bcda-9cda8c1f2edd">2,950,000</ix:nonFraction> restricted stock units ("RSU's") vested with a weighted average grant date fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i928a711d627049609b68b71da873a14b_D20190101-20191231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzY1OTcwNjk3ODE2ODA_1f152753-5d9e-48de-b1a8-14d34a27eac5">2.14</ix:nonFraction> per share. The total fair value of RSU's vested during the year ended December&#160;31, 2019 was $<ix:nonFraction unitRef="usd" contextRef="i928a711d627049609b68b71da873a14b_D20190101-20191231" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzMyOTg1MzQ4OTM5NjA_b3b6fca4-f844-476d-a85d-1533fdc35fc8">6.3</ix:nonFraction> million. There are <ix:nonFraction unitRef="shares" contextRef="ic23cca2bec294144b5380b314f6c1bef_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzY1OTcwNjk3ODE3MzI_511360fc-2702-4e2b-851e-12208040c6bb">no</ix:nonFraction> outstanding RSU's as of December&#160;31, 2020.</ix:continuation>   </span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_181"></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODEvZnJhZzpjNGMzZDNhZDVkMzM0ZWNkYWUyNThmMjJjNjMwYTIxZS90ZXh0cmVnaW9uOmM0YzNkM2FkNWQzMzRlY2RhZTI1OGYyMmM2MzBhMjFlXzEwMzg_eb5e285e-aad8-460f-9f57-9693b7446d53" continuedAt="ib5e1edd4b5574b238d5e057e494419de" escape="true">NET LOSS PER SHARE</ix:nonNumeric></span></div><ix:continuation id="ib5e1edd4b5574b238d5e057e494419de"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company computes basic net loss per share using the weighted-average number of common shares outstanding during the period. Diluted net loss per share is calculated by dividing net loss by the weighted-average number of common shares plus potential common shares. The Company's stock options, including those with performance conditions, are included in the calculation of diluted net loss per share using the treasury stock method when their effect is dilutive. Potential common shares are excluded from the calculation of diluted net loss per share when their effect is anti-dilutive.</span></div><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODEvZnJhZzpjNGMzZDNhZDVkMzM0ZWNkYWUyNThmMjJjNjMwYTIxZS90ZXh0cmVnaW9uOmM0YzNkM2FkNWQzMzRlY2RhZTI1OGYyMmM2MzBhMjFlXzEwNDA_9ead364a-c8cb-4464-b91f-8eafbfa60b7d" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock equivalents were not included in the calculation of net loss per diluted share because their effect were anti-dilutive (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:65.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.273%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.955%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.275%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iea15e228d81c4928a6f435953afcbf22_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODEvZnJhZzpjNGMzZDNhZDVkMzM0ZWNkYWUyNThmMjJjNjMwYTIxZS90YWJsZToyYmIxMTY1ODM5YjU0NjExYjA4Mjc4MmM4MzhhNTk4ZC90YWJsZXJhbmdlOjJiYjExNjU4MzliNTQ2MTFiMDgyNzgyYzgzOGE1OThkXzItMS0xLTEtMTYyNg_44bdf758-2b0e-4424-8a66-70b06efbaf09">20,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2f9d57085cfb485a90040682008ea5ab_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODEvZnJhZzpjNGMzZDNhZDVkMzM0ZWNkYWUyNThmMjJjNjMwYTIxZS90YWJsZToyYmIxMTY1ODM5YjU0NjExYjA4Mjc4MmM4MzhhNTk4ZC90YWJsZXJhbmdlOjJiYjExNjU4MzliNTQ2MTFiMDgyNzgyYzgzOGE1OThkXzItMy0xLTEtMTY0MQ_f25c6443-357b-4a2a-b6c6-84d8ce817523">18,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib7c5476be195460facee7c724fb5e3c7_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODEvZnJhZzpjNGMzZDNhZDVkMzM0ZWNkYWUyNThmMjJjNjMwYTIxZS90YWJsZToyYmIxMTY1ODM5YjU0NjExYjA4Mjc4MmM4MzhhNTk4ZC90YWJsZXJhbmdlOjJiYjExNjU4MzliNTQ2MTFiMDgyNzgyYzgzOGE1OThkXzMtMS0xLTEtMA_10d259e8-7038-4a85-bf00-f755062b1f9d">5,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iabb6a4dc10ab4561a4bd6c32f75acae6_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODEvZnJhZzpjNGMzZDNhZDVkMzM0ZWNkYWUyNThmMjJjNjMwYTIxZS90YWJsZToyYmIxMTY1ODM5YjU0NjExYjA4Mjc4MmM4MzhhNTk4ZC90YWJsZXJhbmdlOjJiYjExNjU4MzliNTQ2MTFiMDgyNzgyYzgzOGE1OThkXzMtMy0xLTEtMA_d4b340f1-b179-4229-aaf7-4e2285a3baf9">10,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODEvZnJhZzpjNGMzZDNhZDVkMzM0ZWNkYWUyNThmMjJjNjMwYTIxZS90YWJsZToyYmIxMTY1ODM5YjU0NjExYjA4Mjc4MmM4MzhhNTk4ZC90YWJsZXJhbmdlOjJiYjExNjU4MzliNTQ2MTFiMDgyNzgyYzgzOGE1OThkXzQtMS0xLTEtMTYzNQ_40290deb-3358-4a6c-8446-8de910d80a78">25,225</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODEvZnJhZzpjNGMzZDNhZDVkMzM0ZWNkYWUyNThmMjJjNjMwYTIxZS90YWJsZToyYmIxMTY1ODM5YjU0NjExYjA4Mjc4MmM4MzhhNTk4ZC90YWJsZXJhbmdlOjJiYjExNjU4MzliNTQ2MTFiMDgyNzgyYzgzOGE1OThkXzQtMy0xLTEtMTY0MQ_857e1fe5-3187-42f6-9d61-b91931d211c8">28,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above table excludes <ix:nonFraction unitRef="shares" contextRef="ibbef676a29a64d80a42a8bffab80309b_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODEvZnJhZzpjNGMzZDNhZDVkMzM0ZWNkYWUyNThmMjJjNjMwYTIxZS90ZXh0cmVnaW9uOmM0YzNkM2FkNWQzMzRlY2RhZTI1OGYyMmM2MzBhMjFlXzMyOTg1MzQ4ODcyODc_6fa68198-73ae-4575-a646-01fd70a713e4"><ix:nonFraction unitRef="shares" contextRef="i70dd93c7ed5b49f6acea67a36d5704e8_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODEvZnJhZzpjNGMzZDNhZDVkMzM0ZWNkYWUyNThmMjJjNjMwYTIxZS90ZXh0cmVnaW9uOmM0YzNkM2FkNWQzMzRlY2RhZTI1OGYyMmM2MzBhMjFlXzMyOTg1MzQ4ODcyODc_ab48fd45-10fc-4ae7-aded-2db54f0af9ff">8,000,000</ix:nonFraction></ix:nonFraction> unvested performance stock options for the years ended December&#160;31, 2020 and 2019, which vest upon the completion of future performance conditions.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_184"></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzIyMzg_b397b331-dc6a-4935-bda9-9545c8c4b03f" continuedAt="i8dcd6690564f46a3a99a8cbe0444f822" escape="true">RELATED PARTIES</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8dcd6690564f46a3a99a8cbe0444f822" continuedAt="iaea88ccb90a546e4829756e602582f07">During the year ended December&#160;31, 2019, the Company's former President and Chief Executive Officer, Michael Mona Jr. ("Mona Jr."), and the Company entered into a Settlement Agreement (the &#8220;Settlement Agreement&#8221;), pursuant to which the Company agreed that Mona Jr.&#8217;s resignation from the Company on January 22, 2019 was for Good Reason (as defined in Mona Jr.&#8217;s Employment Agreement) and agreed to extend the deadline for Mona Jr.&#8217;s exercise of his stock options for a period of <ix:nonNumeric contextRef="i5b538a137f6741c3b99ad8296d75054d_D20190101-20191231" format="ixt-sec:durwordsen" name="cvsi:SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzY1OTcwNjk3Nzc2NzE_cbcd7a46-2ddd-425e-b248-c842ec5953e0">five years</ix:nonNumeric>. As of December&#160;31, 2020, Mona Jr. has <ix:nonFraction unitRef="shares" contextRef="ifd0eb69ed84344f29547d2b900088211_D20200101-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4ODc0ODY_a1bbd11a-8236-48be-8690-83f97df0b7bf">11,300,000</ix:nonFraction> fully vested outstanding stock options with a weighted average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i2c8f78232aff43cb8627c3ae776e97a9_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4ODc1NzE_1cd19496-ebf0-4e23-9467-957979c7e695">0.42</ix:nonFraction> per share. In exchange, Mona Jr. agreed that notwithstanding the terms of his Employment Agreement </ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CV SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="iaea88ccb90a546e4829756e602582f07" continuedAt="i6699ced9ce864b7a836ffb4af32d6dac"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">providing for acceleration of vesting of all stock options and RSU's upon a Good Reason resignation, certain of his unvested stock options would not immediately vest, but rather continue to vest if, and only if, certain Company milestones are achieved related to the Company&#8217;s drug development efforts. These stock options were issued in July 2016 (<ix:nonFraction unitRef="shares" contextRef="i60d2bb9447ef4e4897ab3d30bf70ebab_D20160701-20160731" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzY1OTcwNjk3Nzc2OTM_a7e0488c-cda9-4edc-83ea-46a1bd94c1a7">6,000,000</ix:nonFraction> options) and March 2017 (<ix:nonFraction unitRef="shares" contextRef="ib232e5ef4b084e428542b0fef60816ab_D20170301-20170331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzY1OTcwNjk3Nzc3MTQ_39b03055-8047-4fbd-bb0c-1d0dd4366338">5,000,000</ix:nonFraction> options) and <ix:nonFraction unitRef="shares" contextRef="i2c8f78232aff43cb8627c3ae776e97a9_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4OTIwNDg_6448349a-4344-442d-bc85-02a8ffa658e0">6,750,000</ix:nonFraction> of these stock options have not vested as of December&#160;31, 2020. The Company and Mona Jr. also agreed to mutually release all claims arising out of and related to Mona Jr.&#8217;s resignation and separation from the Company. As a result of the Settlement Agreement, the Company recorded stock-based compensation expense related to the accelerated vesting of the RSU's of $<ix:nonFraction unitRef="usd" contextRef="i6dd1ee59fde04743b61fc6fe09e084f1_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4ODcwMzc_8611992d-085f-4a91-b1e4-d81fea0cf315">5.1</ix:nonFraction> million and the modification of certain stock options of $<ix:nonFraction unitRef="usd" contextRef="i5b538a137f6741c3b99ad8296d75054d_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4ODcwOTA_e6e561de-aeb3-453a-a20c-32da227b79d4">2.7</ix:nonFraction> million during the year ended December&#160;31, 2019. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Settlement Agreement, <ix:nonFraction unitRef="shares" contextRef="i6dd1ee59fde04743b61fc6fe09e084f1_D20190101-20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzY1OTcwNjk3Nzc1OTQ_01615089-33de-4b84-8077-6f2250e05d58">2,950,000</ix:nonFraction> vested RSU's were issued to Mona Jr. The vesting of the RSU's and payment of shares is treated as taxable compensation and thus subject to income tax withholdings. No amounts were withheld (either in cash or the equivalent of shares of common stock from the vesting of the RSU's) or included in the original Company&#8217;s payroll tax filing. The compensation is subject to Federal and State income tax withholding and Federal Insurance Contributions Act (&#8220;FICA&#8221;) taxes withholding estimated to be $<ix:nonFraction unitRef="usd" contextRef="i8b7ec1006fa44a45bcff5a676228a041_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DueFromRelatedPartiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzY1OTcwNjk3Nzc2MTg_626cbfa0-22a4-4f4c-ab6f-8bb42201d89b">6.4</ix:nonFraction>&#160;million for the employee portions. The employer portion of the FICA taxes is $<ix:nonFraction unitRef="usd" contextRef="iad05935855d347f29bdc066d4323531c_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="cvsi:PayrollTaxExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzY1OTcwNjk3Nzc2NDU_4bb20a4e-227a-4834-9fe7-48595c4c4fac">0.2</ix:nonFraction>&#160;million and has been recorded as a component of selling, general and administrative expenses in the consolidated statement of operations for the year ended December&#160;31, 2019. During the year ended December&#160;31, 2020, the Company reported the taxable compensation associated with the RSU release to the taxing authorities and included the amount in Mona Jr.'s W-2 for 2019. In addition, the Company paid the employer and employee portion of the FICA taxes of $<ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-5" name="cvsi:AccruedPayrollTaxesCurrentEmployeePortion" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4OTI0MTE_f9ac12a6-8361-4621-9501-5ea01bc6aa60">0.2</ix:nonFraction> million, respectively. Although the primary tax liability is the responsibility of the employee, the Company is secondarily liable and thus has recorded the liability on its consolidated balance sheet as of December&#160;31, 2020 in an amount of $<ix:nonFraction unitRef="usd" contextRef="i7d7c3395910943ff95580815849b5296_I20201231" decimals="-5" name="us-gaap:AccruedPayrollTaxesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4OTI0Mzc_62b57088-032d-4f06-bbcc-9be68c12f84f">6.2</ix:nonFraction> million which was recorded as a component of accrued expenses. The Company initially recorded an offsetting receivable of $<ix:nonFraction unitRef="usd" contextRef="i0bbd982c5f7748b69d855640a70331d5_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DueFromRelatedPartiesCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4OTI0NzM_8078cc0c-9830-4603-8f9c-39644a392ba1">6.2</ix:nonFraction> million during the second quarter of 2019 for the total estimated Federal and State income taxes which should have been withheld in addition to the employee portion of the FICA payroll taxes as the primary liability is ultimately the responsibility of the employee. The receivable was recorded as a component of prepaid expense and other on the consolidated balance sheet. The deadline to file and pay personal income taxes for 2019 was on October 15, 2020. To date, Mona Jr. has not provided to the Company the appropriate documentation substantiating that he properly filed and paid his taxes for 2019. As a result, the Company derecognized its previously recorded receivable of $<ix:nonFraction unitRef="usd" contextRef="i0d1f25384b814879a0628fe92c2764bc_D20200101-20201231" decimals="-5" name="us-gaap:ProvisionForLoanAndLeaseLosses" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4OTI4ODY_812ef061-4617-4e44-8964-a0fe4f289fe1">6.2</ix:nonFraction> million during the fourth quarter of 2020. The associated liability may be relieved once the tax amount is paid by Mona Jr. and the Company has received the required taxing authority documentation from Mona Jr. If the tax amount is not paid by Mona Jr., the Company would be liable for such withholding tax due. Additionally, the Company could be subject to penalties if the amounts are ultimately not paid. The Company does not believe that any such penalties are probable or reasonably possible as of December&#160;31, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 22, 2020, the Company filed a complaint in the San Diego Superior Court for declaratory relief to confirm the termination of Mona Jr.'s severance and other post-termination compensation and benefits, and to recover amounts owed to the Company by Mona Jr. in connection with his purchase of personal seat licenses for the Raiders stadium and certain advance payments made on Mona Jr.'s behalf. The complaint also requests that Mona Jr. provides the Company with appropriate taxing authority documentation to show that he paid the tax associated with the vesting of the RSU's. Refer also to Note 12, Commitment and Contingencies, for more information. The Company recorded a payable to Mona Jr. of $<ix:nonFraction unitRef="usd" contextRef="i8b7ec1006fa44a45bcff5a676228a041_I20201231" decimals="-5" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4OTMyNDI_07537034-cf0f-431f-afb5-40a843c2ea77">0.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="if9b34d8b19d8479caf351bc959791056_I20191231" decimals="-5" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4OTMyNTQ_3f527ac1-0ce6-450b-be4e-0ba79c9f59ba">0.6</ix:nonFraction> million as of December&#160;31, 2020 and 2019, respectively. The amounts are mostly related to termination benefits associated with his separation from the Company and are payable via regular payroll through June 2021. The Company has not paid any termination benefits to Mona Jr. since filing the complaint. As of December&#160;31, 2020, the entire amount is included in accrued expenses. As of December&#160;31, 2019, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="iaafe986d776f4e188381ad93b70a5c59_I20191231" decimals="-5" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4OTM2NzI_75bdca39-b9d0-43a2-a4be-f964c39c8c98">0.4</ix:nonFraction> million in accrued expenses and $<ix:nonFraction unitRef="usd" contextRef="i0c9d5f9107d5452b85e1137ecfedf90f_I20191231" decimals="-5" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4OTM3MDM_1fa51c27-7413-4ce4-ad7d-47b45864b39a">0.2</ix:nonFraction> million in other liabilities.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6699ced9ce864b7a836ffb4af32d6dac">In addition, on December 31, 2019, the Company's former Chief Operating Officer and co-founder, Michael Mona III ("Mona III"), resigned from the Company. The Company recorded stock-based compensation expense related to the accelerated vesting of Mona III's unvested outstanding options of $<ix:nonFraction unitRef="usd" contextRef="i93952393aa0f490bbfec7462592c6301_D20190101-20191231" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4ODczOTI_24b8183f-5619-4ee4-927f-69b56080bed0">1.7</ix:nonFraction> million during the year ended December&#160;31, 2019 with no assumed forfeiture rate. The Company recorded a payable to Mona III of $<ix:nonFraction unitRef="usd" contextRef="ib47971077b1a4742984a8c6a25cbc462_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzkw_68586b31-220d-4afd-98bd-bee2af68370b">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i8d06315f2bbc4bcf8bad96452ea47672_I20191231" decimals="-5" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4ODU2Mjc_cf78218b-734d-4d7e-b18d-e796565f8a83">0.7</ix:nonFraction> million as of December&#160;31, 2020 and 2019, respectively. The amounts are mostly related to termination benefits associated with his separation from the Company and are payable via regular payroll through June 2021. As of December&#160;31, 2020, the entire amount is included in accrued expenses. As of December&#160;31, 2019, the Company recorded $<ix:nonFraction unitRef="usd" contextRef="i8e03e73784db49a2b0712b19d7179af8_I20191231" decimals="-5" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4ODU2NDM_4e4ff329-b1bc-48ad-b7cd-d188db24dc4e">0.4</ix:nonFraction> million in accrued expenses and $<ix:nonFraction unitRef="usd" contextRef="i3e10759d7520413498f7340ef1cbc70c_I20191231" decimals="-5" name="us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4ODU2OTg_856f8789-92a3-4646-9d77-85bd93e77875">0.2</ix:nonFraction> million in other liabilities.</ix:continuation> </span></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_187"></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:CommitmentsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODcvZnJhZzo3OTFiYzk5NjU4ODc0MTE5YTVmNmU5ZjU4MTA3OGQzOS90ZXh0cmVnaW9uOjc5MWJjOTk2NTg4NzQxMTlhNWY2ZTlmNTgxMDc4ZDM5XzQxMDU_50732adc-8e0b-414c-998f-aba7e1ac7f88" continuedAt="i34a0f06f41ec42a6bd192d9d61936979" escape="true">COMMITMENTS AND CONTINGENCIES</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i34a0f06f41ec42a6bd192d9d61936979" continuedAt="i05bbbe35189640ec9a37fba4a4971d66">On March 17, 2015, Michael Ruth filed a shareholder derivative suit in Nevada District Court alleging breach of fiduciary duty and gross mismanagement (the &#8220;Ruth Complaint&#8221;). The claims are premised on the same events that were the subject of a purported class action filed in the Southern District of New York on April 23, 2014 (the &#8220;Sallustro Case&#8221;). On July 2, 2019, the </ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CV SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i05bbbe35189640ec9a37fba4a4971d66"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">court in the Sallustro Case entered a final order dismissing the complaint with prejudice. The Company did not make any settlement payment, and at no time was there a finding of wrongdoing by the Company or any of its directors. Regarding the Ruth Complaint, the Company and Mr. Ruth previously agreed to stay the action pending the conclusion of discovery in the Sallustro Case. Now that the Sallustro Case has been dismissed, the stay has been lifted. Plaintiff&#8217;s counsel recently informed the Court that Mr. Ruth sold his shares of CVSI stock and thus he no longer has standing to pursue this claim. However, the Court allowed Plaintiff&#8217;s counsel to substitute CVSI shareholder Otilda Lamont as the named plaintiff. On September 20, 2019, the Company filed a motion to dismiss the Ruth Complaint and the Court issued a ruling denying the motion to dismiss on November 24, 2020. A Third Amended Complaint was filed on December 11, 2020 substituting Otilda Lamont as plaintiff. The Company filed an answer to the Ruth Complaint on January 11, 2021 and discovery recently commenced. The Court issued a schedule whereby discovery ends on November 19, 2021. Management intends to vigorously defend the allegations. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 24, 2018, David Smith filed a purported class action complaint in Nevada District Court (the "Smith Complaint") alleging certain misstatements in the Company's public filings that led to stock price fluctuations and financial harm. Several additional individuals filed similar claims, and the Smith Complaint and each of the other suits all arise out of a report published by Citron Research on Twitter on August 20, 2018, suggesting that the Company misled investors by failing to disclose that the Company&#8217;s efforts to secure patent protection for CVSI-007 had been &#8220;finally rejected&#8221; by the United States Patent and Trademark Office ("USPTO"). On November 15, 2018, the court consolidated the actions and appointed Richard Ina, Trustee for the Ina Family Trust, as Lead Plaintiff for the consolidated actions. On January 4, 2019, Counsel for Lead Plaintiff Richard Ina, Trustee for the Ina Family Trust, filed a &#8220;consolidated amended complaint&#8221;. On March 5, 2019, we filed a motion to dismiss the action. The Court denied the motion to dismiss on December 10, 2019, and the parties have commenced discovery in the action with a discovery cutoff date of May 24, 2021. Arising out of the same facts and circumstances in the Smith Complaint, on June 11, 2020, Phillip Berry filed a derivative suit in the United States District Court for the Southern District of California alleging breaches of fiduciary duty against the Company and various defendants, and waste of corporate assets (the &#8220;Berry Complaint&#8221;). The Company has accepted service of the Berry Complaint and a motion to dismiss is currently pending. In addition to the Berry Complaint, <ix:nonFraction unitRef="lawsuit" contextRef="i5c0ab77805bb4407a83db8bc568155ac_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="cvsi:NumberofDerivativeLawsuits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODcvZnJhZzo3OTFiYzk5NjU4ODc0MTE5YTVmNmU5ZjU4MTA3OGQzOS90ZXh0cmVnaW9uOjc5MWJjOTk2NTg4NzQxMTlhNWY2ZTlmNTgxMDc4ZDM5XzY1OTcwNjk3OTEzNzk_baf7642d-5c57-4ca0-b610-112b926682e8">four</ix:nonFraction> additional shareholder derivative suits have been filed which are premised on the same event as the Smith Complaint. All four actions are currently stayed. On May 19, 2020, the USPTO issued a patent pertaining to CVSI-007, which the Company believes negates and defeats any claims that the Company and the various defendants misled the market by not disclosing that the USPTO had finally rejected the patent. Management intends to vigorously defend the allegations in each of these matters as the result of the issuance of a patent and the failure of the plaintiffs&#8217; causes of action on various other grounds.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 3, 2019, Michelene Colette and Leticia Shaw filed a putative class action complaint in the Central District of California, alleging the labeling on the Company&#8217;s products violated the Food, Drug, and Cosmetic Act of 1938 (the &#8220;Colette Complaint&#8221;). On February 6, 2020, the Company filed a motion to dismiss the Colette Complaint. Instead of opposing our motion, plaintiffs elected to file an amended complaint on February 25, 2020. On March 11, 2020, we filed a motion to dismiss the amended complaint. The court issued a ruling on May 22, 2020 that stayed this proceeding in its entirety and dismissed part of the amended complaint. The portion of the proceeding that is stayed will remain stayed until the U.S. Food and Drug Administration promulgates rules that govern cannabidiol products (the &#8220;FDA Rules&#8221;). When such FDA Rules are promulgated, the plaintiffs will be allowed to ask the court to reopen the proceeding. Management intends to vigorously defend the allegations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 22, 2020, the Company filed a complaint in the San Diego Superior Court for declaratory relief to confirm the termination of Mona Jr.&#8217;s severance and other post-termination compensation and benefits, as well as to recover amounts owed to the Company by Mona Jr. in connection with his purchase of a personal seat license for the Raiders Stadium and certain advance payments made on Mona Jr.&#8217;s behalf. The complaint also requests that Mona Jr. provides the Company with appropriate taxing authority documentation to show that he paid the tax associated with the vesting of the RSU's.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company is a party to a variety of agreements pursuant to which they may be obligated to indemnify the other party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations, and the unique facts and circumstances involved in each particular agreement. Historically, payments made by us under these types of agreements have not had a material effect on our business, results of operations or financial condition.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-21</span></div></div></div><div id="ica64940eaba8432cb3e8a74baaac4713_190"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CV SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzI5MzY_32c8b639-9552-4911-b528-452831749d00" continuedAt="id28cfc7d6c02431cb7e750f42755fb16" escape="true">LEASES</ix:nonNumeric></span></div><ix:continuation id="id28cfc7d6c02431cb7e750f42755fb16"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into operating leases primarily for real estate. These leases are for the Company's operations, production, warehouse, sales, marketing and back office functions. On July 27, 2020, the Company entered into a lease termination agreement for <ix:nonFraction unitRef="leaseterminationagreement" contextRef="i62d68f33d7fa4992b1f81cb57f0893fb_I20200727" decimals="INF" format="ixt-sec:numwordsen" name="cvsi:NumberOfLeaseTerminationAgreements" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzY1OTcwNjk3NzIwMDI_070659a9-3598-42ef-9ee1-ca2fa0f74334">one</ix:nonFraction> of its facilities in San Diego, which was effective August 31, 2020. The Company derecognized the related operating lease obligation of $<ix:nonFraction unitRef="usd" contextRef="i791cd87ec1804ff590fd70ba4350941f_I20201231" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzMyOTg1MzQ4ODc2MjU_a23458e0-d2b2-4c63-b100-3fbdb4ccaca8">5.1</ix:nonFraction> million and operating lease asset of $<ix:nonFraction unitRef="usd" contextRef="i791cd87ec1804ff590fd70ba4350941f_I20201231" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzMyOTg1MzQ4ODc2NjI_4005c15e-4969-40fd-b064-a6424b2f051b">4.7</ix:nonFraction> million as of August 31, 2020, and recorded an associated gain from lease termination of $<ix:nonFraction unitRef="usd" contextRef="ie9aebc800dcb4be88f9cb52dea0fefae_D20200101-20201231" decimals="-5" name="us-gaap:GainLossOnTerminationOfLease" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzMyOTg1MzQ4ODc3NTk_08d0502a-6b8c-4b6c-81d2-7874084b6cf7">0.4</ix:nonFraction> million, which is recorded as a component of selling, general and administrative expense in the consolidated statements of operations for the year ended December&#160;31, 2020. As of December&#160;31, 2020, total operating lease assets and operating lease liabilities were $<ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzEyOTg_f70f3ae4-39d3-40ec-839a-955fcc19faa2">3.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzEzMDU_13941b21-4c0d-4b54-8b47-9070979e93ed">4.1</ix:nonFraction> million, respectively. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized total lease costs of $<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzE2NDc_1f9d811e-7f97-4adf-860c-d67e922cc6d8">1.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzMyOTg1MzQ4ODg3NDI_5e8095d9-9916-4262-b9cd-2854ef8db76c">1.5</ix:nonFraction> million for the year ended December&#160;31, 2020 and 2019, respectively. Total lease costs was mostly comprised of operating lease costs. Short-term lease costs related to short-term operating leases and variable lease costs were immaterial.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the rate implicit in each lease is not readily determinable, the Company uses the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment, which the Company determined based on comps obtained from lenders for similar financing. The Company has certain contracts for real estate which may contain lease and nonlease components which it has elected to treat as a single lease component. Cash paid for operating lease liabilities for the year ended December&#160;31, 2020 was $<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLeasePayments" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzI0MTI_2569b805-bd9c-48d9-afed-cb2450400cc7">1.1</ix:nonFraction> million. <ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzI5Mzg_67b7b47f-0324-4ffb-a69d-c780fa73ebc6" continuedAt="i355bc38ce40846119bff91c49a37da16" escape="true">Information related to the Company's operating lease assets and related lease liabilities were as follows:</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i355bc38ce40846119bff91c49a37da16"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:81.802%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.998%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in months)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.64</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTphNzIwYWI0NTE1ZGQ0ZTdlYTNkYmU3ZWJjYWZhNDY4Ny90YWJsZXJhbmdlOmE3MjBhYjQ1MTVkZDRlN2VhM2RiZTdlYmNhZmE0Njg3XzItMS0xLTEtMA_b618246b-9801-4d61-a093-de30d7976243">6.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzI5NDA_0d9fd0cb-ad13-49da-b62f-e329c2b40aff" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of December&#160;31, 2020 were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.687%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.113%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzEtMS0xLTEtMA_1134b1fb-0aa7-4669-9df7-58fae185edf5">928</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzItMS0xLTEtMA_6fa6f17d-c7d0-4ea7-96b4-d64bc475859f">925</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzMtMS0xLTEtMA_74e2cffb-1594-44d2-8340-fc9dc1801076">957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzQtMS0xLTEtMA_001151d1-5ce5-4d57-8612-ef3156bd6f84">986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzUtMS0xLTEtMA_53205887-019c-4e03-91a9-d97815d93a10">1,015</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzYtMS0xLTEtMA_d2a0127f-8871-46a6-8827-656437230228">85</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzctMS0xLTEtMA_8f9e757a-cfc2-45b5-830c-a60a1567972c">4,896</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzgtMS0xLTEtMA_ada00de1-00c4-455a-b782-50ac63e7666a">749</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzktMS0xLTEtMA_b88703a6-fcef-4143-bff8-2b9d83a46331">4,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzExLTEtMS0xLTA_d69167fe-3e2d-4d78-8483-3d17c48cebc4">680</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzEyLTEtMS0xLTA_6e69682a-7dfa-428b-a132-01b608c34a86">3,467</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzEzLTEtMS0xLTA_04d38ac9-3b2d-4748-b92b-d2ca5bba9480">4,147</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_196"></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:SegmentReportingDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90ZXh0cmVnaW9uOjlhM2YxMzhmZjhjYzQzMDA5NWNlZTkyMGQ2MGE3ZmZlXzEyODI_2e20bc8c-ecce-4da2-9f61-67dd0d197b98" continuedAt="i352da8bfdf4243bf8a1f4062cb12301f" escape="true">SEGMENT INFORMATION</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i352da8bfdf4243bf8a1f4062cb12301f" continuedAt="i243e6d4ecd9d45438691b17a8f832c5d">The Company operates in <ix:nonFraction unitRef="segment" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90ZXh0cmVnaW9uOjlhM2YxMzhmZjhjYzQzMDA5NWNlZTkyMGQ2MGE3ZmZlXzUz_4daf5ff0-26d8-4bdc-8fe6-61add9bf3d1d">two</ix:nonFraction> distinct business segments: a consumer products segment in manufacturing, marketing and selling hemp-based CBD products to a range of market sectors; and a specialty pharmaceutical segment focused on developing and commercializing novel therapeutics utilizing CBD. The Company&#8217;s segments maintain separate financial information for which operating results are evaluated on a regular basis by the Company&#8217;s senior management in deciding how to allocate resources and in assessing performance. The Company evaluates its consumer products segment based on net product sales, gross profit and operating income or loss. The Company currently evaluates its specialty pharmaceutical segment based on the progress of its clinical development programs.</ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CV SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="i243e6d4ecd9d45438691b17a8f832c5d"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90ZXh0cmVnaW9uOjlhM2YxMzhmZjhjYzQzMDA5NWNlZTkyMGQ2MGE3ZmZlXzEyODU_e56a7c1c-47e4-4429-adbd-4d404f700ab5" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information by reportable operating segment for the years ended December&#160;31, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"></td><td style="width:54.295%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.288%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.288%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.519%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.291%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consumer Products<br/>Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Specialty Pharmaceutical Segment</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc1a3c97c0d4080885871840e0654af_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzItMS0xLTEtMA_8d5e98c1-2c87-459d-b72a-9446b7b8b0c5">24,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i864c15d843724344970a49378789e8a3_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzItMy0xLTEtMA_ce671bc1-3610-4d34-bff9-eeacb6821775">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzItNS0xLTEtMA_a447ccae-e893-4832-9c03-f148f94cc4fc">24,429</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc1a3c97c0d4080885871840e0654af_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzQtMS0xLTEtMA_2c4dd026-6b70-4438-b6a4-8ee0bfcc50ec">11,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i864c15d843724344970a49378789e8a3_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzQtMy0xLTEtMA_fe4629a7-aed7-4208-be03-73b6fcf22345">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzQtNS0xLTEtMA_961ded36-4064-41f4-86ac-164309cf8010">11,009</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc1a3c97c0d4080885871840e0654af_D20200101-20201231" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzUtMS0xLTEtMA_4a17f885-fecc-49d4-8197-5ac0fac0a624">678</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i864c15d843724344970a49378789e8a3_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzUtMy0xLTEtMA_5a9f12cc-a32b-444d-b00c-7726ea7523e9">2,265</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzUtNS0xLTEtMA_36313568-6b48-4fa9-a366-c1da542ea765">2,943</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iafc1a3c97c0d4080885871840e0654af_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzYtMS0xLTEtMA_3f376106-dc0b-46ef-93b0-1b818e8f4a61">30,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i864c15d843724344970a49378789e8a3_D20200101-20201231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzYtMy0xLTEtMA_f6e806f6-834b-4524-8c61-9b262d900b21">111</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzYtNS0xLTEtMA_9d1a1066-fc27-442f-b724-a728da99422b">30,658</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iafc1a3c97c0d4080885871840e0654af_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzctMS0xLTEtMA_976181ed-002a-498c-a8aa-2b18d9fdc076">20,216</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i864c15d843724344970a49378789e8a3_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzctMy0xLTEtMA_c5fb0d49-002a-4ca5-b781-be3317f38985">2,376</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzctNS0xLTEtMA_f547a6eb-fa43-4bd3-9b5f-ceb5c9fc6de3">22,592</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2019:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ab148dfa19a48ec9bfc7253afd2d8e0_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzEwLTEtMS0xLTA_961c96f6-4561-42bc-a104-a46a170aefb3">53,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a040ed995bb443b9e3e752576188250_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzEwLTMtMS0xLTA_a2aa583f-4480-416b-b515-6f060e5d616b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzEwLTUtMS0xLTA_a37c5c9e-a7da-4a0d-b4e0-1406bf37df13">53,696</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ab148dfa19a48ec9bfc7253afd2d8e0_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzEyLTEtMS0xLTA_177588a3-3afa-44dc-a74b-b472000ffedf">35,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a040ed995bb443b9e3e752576188250_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzEyLTMtMS0xLTA_1c31e4bd-3d48-4c48-9b60-7633b2f26a8f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzEyLTUtMS0xLTA_e4510e52-5b2e-4e0b-8128-cf65e76aa68e">35,088</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ab148dfa19a48ec9bfc7253afd2d8e0_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzEzLTEtMS0xLTA_a19ea7cc-a027-43c7-808d-2dc9709e93ce">2,106</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a040ed995bb443b9e3e752576188250_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzEzLTMtMS0xLTA_8f02074a-42a9-42d5-a496-212212239a32">3,771</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzEzLTUtMS0xLTA_de796fc9-c986-466f-850b-216ea904138d">5,877</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4ab148dfa19a48ec9bfc7253afd2d8e0_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzE0LTEtMS0xLTA_28cd8146-a948-412c-badf-5d21823be134">46,405</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6a040ed995bb443b9e3e752576188250_D20190101-20191231" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzE0LTMtMS0xLTA_00b8ff19-0aba-4e3b-8295-535334162fba">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzE0LTUtMS0xLTA_f07537d5-851e-498e-b497-13a103a26fcf">46,451</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4ab148dfa19a48ec9bfc7253afd2d8e0_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzE1LTEtMS0xLTA_922b01a0-98a7-43c3-ad3d-157ba23f7ad0">13,423</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6a040ed995bb443b9e3e752576188250_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzE1LTMtMS0xLTA_66a4738d-817c-4c6e-8e47-3a855fad22c9">3,817</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzE1LTUtMS0xLTA_aa66d1d7-e56b-46e8-bf00-8a7c6b571bc6">17,240</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's specialty pharmaceutical segment includes goodwill of $<ix:nonFraction unitRef="usd" contextRef="id25294b42e17449aacccb4d1a2701113_I20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90ZXh0cmVnaW9uOjlhM2YxMzhmZjhjYzQzMDA5NWNlZTkyMGQ2MGE3ZmZlXzk4OQ_6ae6f3cf-0929-4a7f-8bb9-90ff6fdcba9d"><ix:nonFraction unitRef="usd" contextRef="i33313851bb654bc197ef8021968d854a_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:Goodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90ZXh0cmVnaW9uOjlhM2YxMzhmZjhjYzQzMDA5NWNlZTkyMGQ2MGE3ZmZlXzk4OQ_e3c36b97-9db1-43d7-9f0f-8087088bf701">2.8</ix:nonFraction></ix:nonFraction> million as of December&#160;31, 2020 and 2019. In addition, the Company's intangible assets of $<ix:nonFraction unitRef="usd" contextRef="i33313851bb654bc197ef8021968d854a_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90ZXh0cmVnaW9uOjlhM2YxMzhmZjhjYzQzMDA5NWNlZTkyMGQ2MGE3ZmZlXzEwNTc_32a9194e-ad5a-4c58-813c-fec051aee122">3.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="id25294b42e17449aacccb4d1a2701113_I20191231" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90ZXh0cmVnaW9uOjlhM2YxMzhmZjhjYzQzMDA5NWNlZTkyMGQ2MGE3ZmZlXzMyOTg1MzQ4ODQ2MTk_a87fddbe-a5fe-47a6-ad39-b18c36f15872">3.8</ix:nonFraction> million as of December&#160;31, 2020 and 2019, respectively, are included in the specialty pharmaceutical segment. All other assets are included in the consumer products segment as of December&#160;31, 2020 and 2019.  The majority of the Company's sales are to U.S. based customers.</span></div></ix:continuation><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_202"></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzQyOTQ_80ef2f76-6938-436e-8316-ba119565f099" continuedAt="i693badcfffc147f6b0fccfc733705177" escape="true">INCOME TAXES</ix:nonNumeric></span></div><ix:continuation id="i693badcfffc147f6b0fccfc733705177" continuedAt="if4b1da4cfad14e6c97eee85378e923bf"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to taxation in the U.S. and California state jurisdictions. The Company&#8217;s pretax loss for the years ended December&#160;31, 2020 and 2019, were generated by domestic operations.  <ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzQyOTc_e349226f-2974-4f03-9f0a-94c50b0a7b72" continuedAt="iccf3c7c6b641489eb774edcf25624001" escape="true">The income tax benefit for the years ended December&#160;31, 2020 and 2019 was comprised of the following (in thousands):</ix:nonNumeric></span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="iccf3c7c6b641489eb774edcf25624001"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.267%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.270%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzMtMS0xLTEtMA_485dac00-8dd2-4fa7-9e47-c90ff12e6031">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzMtMy0xLTEtMA_10e43ee7-4bc7-4b9f-9025-8ebf8454542d">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzQtMS0xLTEtMA_c96d0c52-9edd-4617-931d-9f19591c7d06">52</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzQtMy0xLTEtMA_6fe52767-07ca-41f1-9400-ca5ac4192864">29</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current tax expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzUtMS0xLTEtMA_a972b25a-d2ec-442e-b44f-ae5436dbcf53">52</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzUtMy0xLTEtMA_f5929fcc-77d6-4de1-a071-113e62fe77fa">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzctMS0xLTEtMA_3a76722f-43db-4232-8bac-9d73c4204ce5">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzctMy0xLTEtMA_7f92bd31-73c8-48a3-8672-791ce4554c79">640</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzgtMS0xLTEtMA_9329e9e4-7797-4d51-bfaa-6fa3fd349d6a">264</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzgtMy0xLTEtMA_20fc2bb5-378c-4358-b632-b3798b6ce2fe">4</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax benefit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzktMS0xLTEtMA_841287f4-2adf-432b-a8ac-371cb1e9f636">265</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzktMy0xLTEtMA_779cc002-0529-41a3-9d89-bc42f698e891">644</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzEwLTEtMS0xLTA_da216ad3-7cf8-401f-8607-b3b3a9e27040">317</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzEwLTMtMS0xLTA_07f1786f-62ae-45f2-bed8-5476b44dffd1">615</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzQyOTU_9b707b20-6da4-421d-904f-9711e623dd08" continuedAt="i548a6f341a094aa294cd98cc8b06ae1b" escape="true">A reconciliation of the expected income tax benefit at the federal statutory rate of 21% for the years ended December&#160;31, 2020 and 2019, and the income tax benefit reported in the financial statements is as follows:</ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CV SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="if4b1da4cfad14e6c97eee85378e923bf" continuedAt="ic00e65d0672346de9914cb765d998251"><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><ix:continuation id="i548a6f341a094aa294cd98cc8b06ae1b"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.712%"><tr><td style="width:1.0%"></td><td style="width:56.969%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.842%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.520%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.845%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of pretax income (loss)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of pretax income (loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit at federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzMtMS0xLTEtMA_ddacab2e-f1b5-463d-b035-603aa7b067c9">4,746</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzMtMy0xLTEtMA_5bcfa126-f27b-4184-a634-f131a7f20248">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzMtNS0xLTEtMA_04223153-3543-48b7-8efc-2b2f920a2b82">3,624</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzMtNy0xLTEtMA_295a7e26-394e-4da4-a6ed-5b744100460c">21.0</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes, net of federal effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzQtMS0xLTEtMA_1e829bd3-a829-480e-b042-008f8f2050c3">1,391</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzQtMy0xLTEtMA_3f1573c2-1a28-47c3-b906-8bae60d77c03">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzQtNS0xLTEtMA_1be89007-9fc1-47f1-8783-0e6bd210a41a">1,142</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzQtNy0xLTEtMA_f620dd3c-eee1-4123-88f6-35b9bd1c3d9c">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other permanent differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzUtMS0xLTEtMA_88233592-ef20-4f32-895f-c724ab8523bb">115</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzUtMy0xLTEtMA_d342487b-bd7b-43f4-ac04-a2c0732d6379">0.5</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzUtNS0xLTEtMA_d2ad00fa-0c2f-4da7-ba23-6e8ad705fc75">43</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzUtNy0xLTEtMA_1ef66b36-acbf-479c-adb0-9c4614d9e921">0.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzYtMS0xLTEtMA_762cd52e-a438-4671-9ea9-1c1e3790734e">569</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzYtMy0xLTEtMA_cb64fce2-8963-4d8f-a0e5-8deb60e519ef">2.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzYtNS0xLTEtMA_c560d040-c8ba-4e62-afb2-e51d39a190b9">274</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzYtNy0xLTEtMA_623d0091-4442-4cd4-994b-3e31bdf0ef9c">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible officer compensation (IRC 162(m))</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="cvsi:EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzctMS0xLTEtMA_e6b3d2fe-34bb-4de7-ba95-7c6cb6abf586">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="3" format="ixt:zerodash" name="cvsi:EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzctMy0xLTEtMA_e807df45-a8fb-486f-b01c-9b3c1b70a7ae">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="cvsi:EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzctNS0xLTEtMA_f79c3045-3498-4368-85f4-883195fe4be7">1,242</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="3" sign="-" name="cvsi:EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzctNy0xLTEtMA_b5936ae3-803b-409c-a602-a982dc2752b1">7.2</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzktMS0xLTEtMA_d7ebfdc1-afc3-4703-9387-d38542c60f38">242</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzktMy0xLTEtMA_4a8c95fb-4bf1-493f-8f77-e93a3708821c">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzktNS0xLTEtMA_3bf19eb3-70cd-4e8e-b973-6f8be9545069">320</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzktNy0xLTEtMA_ad4d201a-5906-4016-a1ad-117d9556d027">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzEwLTEtMS0xLTA_1dd030a5-ed12-4c87-b6b4-0e45f6acccd7">769</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzEwLTMtMS0xLTA_60a545cb-6803-453f-b284-427cdead5e98">3.6</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzEwLTUtMS0xLTA_6024c9a7-9715-409e-b5a2-02b1f504b9cb">241</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzEwLTctMS0xLTA_fff2b596-b4a3-49b3-9869-7b9e28e7066f">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzExLTEtMS0xLTA_151a6017-3d90-4ce0-b894-c61c4d1983fd">4,609</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzExLTMtMS0xLTA_1f61190e-1628-44c7-8373-b74a4d96d37d">20.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzExLTUtMS0xLTA_b9116c0b-23eb-44b8-beeb-dfedf60b6f5a">3,701</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="number" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="3" sign="-" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzExLTctMS0xLTA_89afab66-a09c-4f7c-aa75-acc2081fe7c2">21.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzEyLTEtMS0xLTA_50145e10-64bc-4190-a099-523175e80e5f">317</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzEyLTMtMS0xLTA_1f9b1823-e5d1-4fe1-a612-c915eb372aac">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" sign="-" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzEyLTUtMS0xLTA_a17a4993-4939-4b04-a1fe-39b63adcbb17">615</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="3" name="us-gaap:EffectiveIncomeTaxRateContinuingOperations" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzEyLTctMS0xLTA_de29f06c-5d3d-4e1b-a771-f58122e74409">3.6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzQyOTA_88a8e691-694d-42df-9820-74a73da05847" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the significant components of the Company's deferred tax assets and liabilities as of December&#160;31, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzMtMS0xLTEtMA_d4bf89a7-561f-4a59-89d5-32a4282bbf5e">5,876</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzMtMy0xLTEtMA_fcf7685a-91c5-4e1d-88bc-bfc770ddfcce">2,627</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzQtMS0xLTEtMA_7fa9db6d-db1c-43b9-b1f0-b3093d96418a">918</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzQtMy0xLTEtMA_e8687bd1-bd81-4fba-9921-7671ed567bac">620</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzUtMS0xLTEtMA_0fbb8f99-12c1-477f-a50b-8bb4d55e9c27">756</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" name="us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzUtMy0xLTEtMA_ae9ccd93-6d27-474b-b107-8134343f0251">890</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzYtMS0xLTEtMA_01387dac-bb1d-49c9-83fb-c6ed2481d23a">6,470</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzYtMy0xLTEtMA_051c79c2-7e88-48cf-a759-367f1547f0cb">6,740</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change to inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" name="us-gaap:DeferredTaxAssetsInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzctMS0xLTEtMA_70611d7e-a2dc-4a8b-9c19-f46576f262bc">61</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" name="us-gaap:DeferredTaxAssetsInventory" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzctMy0xLTEtMA_ec1542b1-6d1f-4171-ad1a-30352fbff341">268</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="cvsi:DeferredTaxAssetOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzgtMS0xLTEtMA_41a02646-b6c0-4cca-92d1-2892f90fa7a1">1,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cvsi:DeferredTaxAssetOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzgtMy0xLTEtMA_6fd6aac4-dd54-4eac-b951-9267d55428b8">2,866</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals and reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzEwLTEtMS0xLTA_87911fde-877a-491c-810f-6c2fdf639de7">2,275</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzEwLTMtMS0xLTA_2fb6316e-b282-4afc-80ed-82473137fdf3">383</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzExLTEtMS0xLTA_3b500cbf-a537-4000-af89-7773865d3141">17,482</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzExLTMtMS0xLTA_04bf185c-77b0-41c4-baa3-ce24e7da5d93">14,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" name="cvsi:DeferredTaxLiabilityOperatingLeaseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzEzLTEtMS0xLTA_c840ee4a-0c6b-4085-9ca1-fb61ac20517a">830</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="cvsi:DeferredTaxLiabilityOperatingLeaseAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzEzLTMtMS0xLTA_aa45b0e1-c3aa-4fbe-ab53-4de4f89a4e5b">2,437</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE0LTEtMS0xLTA_f5ab2f52-e678-4ac9-b1b6-26bd34abd105">396</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE0LTMtMS0xLTA_1ec443eb-dfeb-4fad-ab2a-2135b2e232d3">390</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CanX intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE1LTEtMS0xLTA_a03ee4f4-7837-4048-89c8-750c4b058cf9">1,013</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE1LTMtMS0xLTA_e8e0df9a-b6f3-46c4-9ca3-f792a17a9399">1,054</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE2LTEtMS0xLTA_4735390b-5428-4759-87c1-174cac072686">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" name="us-gaap:DeferredTaxLiabilitiesOther" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE2LTMtMS0xLTA_a8a057b2-3719-4257-a64b-dd16fb4c06e2">172</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE3LTEtMS0xLTA_755d7f52-1a5e-48a9-bdbc-19ba89c1f354">2,268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredIncomeTaxLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE3LTMtMS0xLTA_83f1dbfa-661e-453c-ae94-cf766cc8321d">4,053</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE4LTEtMS0xLTA_2e4b5a93-fa79-4fdc-92a2-eb7567638e20">15,371</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE4LTMtMS0xLTA_f25d60a3-ddbf-43b6-8606-ce40968f4c3e">10,762</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE5LTEtMS0xLTA_9f902d39-82e9-4649-987a-4f9b7675e052">157</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" name="us-gaap:DeferredIncomeTaxLiabilitiesNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE5LTMtMS0xLTA_47e45f7b-eb3d-4706-825a-6f0834d1ad37">421</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation allowance increased by $<ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzcxOA_a39d2c94-88ed-49e5-ba30-90dcd4dc21ff">4.6</ix:nonFraction> million for the year ended December&#160;31, 2020 and increased by $<ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzc2MA_ac90359e-e6a9-418e-9c56-1f39fba71066">3.7</ix:nonFraction> million for the year ended December&#160;31, 2019.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are provided for significant revenue and expense items recognized in different years for tax and financial reporting purposes. The Company periodically assesses the likelihood that it will be able to recover its deferred tax assets. The Company considers all available evidence, both positive and negative, including historical levels of income, expectations and risks associated with estimates of future taxable income, and ongoing prudent and feasible profits. As of December&#160;31, 2020 and 2019, the Company established valuation allowances equal to the full amount of its deferred tax assets, net of certain tax liabilities, due to the uncertainties regarding the realization of the deferred tax assets in future years.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company has federal, California, and other state net operating loss (&#8220;NOL&#8221;) carryforwards of  $<ix:nonFraction unitRef="usd" contextRef="ib7a85037629e4eada1ad14bd2d8d91a8_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzE2MzQ_58cfa9e9-802c-4935-b11c-bd556c386cce">21.4</ix:nonFraction> million, <ix:nonFraction unitRef="usd" contextRef="i125b29ebd2174a6781154a863a9cf67c_I20201231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzMyOTg1MzQ4ODk3ODM_a9a78d69-7bac-432b-ba84-397cb5b30ad8">16.9</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="i839a4daa37e5474fbf72320ba3f3488e_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzE2NDE_aa52853b-250f-421c-8878-ab86cc1387eb">3.4</ix:nonFraction> million, respectively, which are available to offset future taxable income. Federal NOL carryforwards arising after 2017 of $<ix:nonFraction unitRef="usd" contextRef="ic6419ee2e046444089e8042fa93ef87d_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzE3NzI_8a835562-01e1-4bdc-96cf-04e1cd3d3951">14.2</ix:nonFraction> million do not expire.  Federal NOL carryforwards arising before 2018 of $<ix:nonFraction unitRef="usd" contextRef="iaf5bdfbc65224887baa9c61a983f16cc_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzE4NTI_4cb0643c-7325-467d-894e-d18041a2b635">7.2</ix:nonFraction> million expire from 2036 to 2037.  California NOL carryforwards of <ix:nonFraction unitRef="usd" contextRef="i125b29ebd2174a6781154a863a9cf67c_I20201231" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzMyOTg1MzQ4ODk4MjU_a9a78d69-7bac-432b-ba84-397cb5b30ad8">16.9</ix:nonFraction> million expire from 2036 to 2040. Other state NOL carryforwards of $<ix:nonFraction unitRef="usd" contextRef="i839a4daa37e5474fbf72320ba3f3488e_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OperatingLossCarryforwards" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzE5MjM_aa52853b-250f-421c-8878-ab86cc1387eb">3.4</ix:nonFraction> million have various expirations from 2038 to 2040.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CV SCIENCES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOTES TO CONSOLIDATED FINANCIAL STATEMENTS</span></div><div style="text-align:center"><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="ic00e65d0672346de9914cb765d998251"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company has federal and California R&amp;D credit carryforwards of approximately $<ix:nonFraction unitRef="usd" contextRef="ib7a85037629e4eada1ad14bd2d8d91a8_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzIwNDM_6c55bc8c-8a09-4694-9b94-1ab0bca94eaf">0.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i125b29ebd2174a6781154a863a9cf67c_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzIwNTA_a9e7866a-1be2-4899-9d8e-78c8840cca5d">0.4</ix:nonFraction> million, respectively, which are available to offset future taxable income.  Federal R&amp;D credit carryforwards expire from 2034 to 2040. California R&amp;D credit carryforwards do not expire.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NOL carryforward may be subject to an annual limitation under Section 382 and 383 of the Internal Revenue Code of 1986 (the &#8220;Code&#8221;), and similar state provisions if the Company experienced one or more ownership changes which would limit the amount of NOL and tax credit carryforwards that can be utilized to offset future taxable income and tax, respectively. In general, an ownership change as defined by Section 382 and 383, results from the transactions increasing ownership of certain stockholders or public groups in the stock of the corporation of more than 50% over a three-year period. The Company completed a Section 382 and 383 analysis regarding the limitation of NOL and credit carryforwards from inception in December 2010 through November 4, 2019. The Company experienced multiple ownership changes for the purposes of Section 382 and 383 of the Code with the latest change in April 2017. The ownership changes did not result in the forfeiture of any NOLs or credits generated prior to this date. If a change in ownership occurs in the future, the NOL and tax credits carryforwards could be eliminated or restricted.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes a tax benefit from an uncertain tax position when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits, and uncertain income tax positions must meet a more likely than not recognition threshold to be recognized. The Company recognizes interest and penalties related to unrecognized tax benefits within the income tax expense line in the consolidated statements of operations. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not anticipate a significant change in its uncertain tax benefits over the next 12 months. The Company is subject to taxation in the U.S. and California state jurisdictions. Due to net operating losses all tax years since inception remain open to examination.</span></div><ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzIxOTkwMjMyNjE5ODM_5c3c2544-3190-4412-b018-77fddfbcd7f6" escape="true"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the Company's unrecognized tax benefits for the years ended December&#160;31, 2020 and 2019 is provided in the following table (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.181%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.518%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.401%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1:</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozOTQyNDM3MmQ1MDQ0MWU3Yjc2ZjdkNWM4ZDM4NTNlZS90YWJsZXJhbmdlOjM5NDI0MzcyZDUwNDQxZTdiNzZmN2Q1YzhkMzg1M2VlXzEtMS0xLTEtNjM5NA_3e83e994-fa2a-4aa8-aa75-0164f00762eb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifc2c804db67543dd84291701c746b6fa_I20181231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozOTQyNDM3MmQ1MDQ0MWU3Yjc2ZjdkNWM4ZDM4NTNlZS90YWJsZXJhbmdlOjM5NDI0MzcyZDUwNDQxZTdiNzZmN2Q1YzhkMzg1M2VlXzEtMy0xLTEtNjM5OQ_a05a882d-7dfb-4852-80ca-8029e8f4bce3">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in current year positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozOTQyNDM3MmQ1MDQ0MWU3Yjc2ZjdkNWM4ZDM4NTNlZS90YWJsZXJhbmdlOjM5NDI0MzcyZDUwNDQxZTdiNzZmN2Q1YzhkMzg1M2VlXzItMS0xLTEtNjQwNA_da6811df-06d8-4aa9-8acd-fdfa9d3c587d">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozOTQyNDM3MmQ1MDQ0MWU3Yjc2ZjdkNWM4ZDM4NTNlZS90YWJsZXJhbmdlOjM5NDI0MzcyZDUwNDQxZTdiNzZmN2Q1YzhkMzg1M2VlXzItMy0xLTEtNjQwOA_4e65f352-0989-4a8b-a280-28ce98695210">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in prior year positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozOTQyNDM3MmQ1MDQ0MWU3Yjc2ZjdkNWM4ZDM4NTNlZS90YWJsZXJhbmdlOjM5NDI0MzcyZDUwNDQxZTdiNzZmN2Q1YzhkMzg1M2VlXzMtMS0xLTEtNjQwNA_01634923-8f46-4bd3-834f-084f5ce3cd1a">119</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozOTQyNDM3MmQ1MDQ0MWU3Yjc2ZjdkNWM4ZDM4NTNlZS90YWJsZXJhbmdlOjM5NDI0MzcyZDUwNDQxZTdiNzZmN2Q1YzhkMzg1M2VlXzMtMy0xLTEtNjQwOA_183377f1-4b82-4d3c-8913-c99f80d180fe">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in prior year positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozOTQyNDM3MmQ1MDQ0MWU3Yjc2ZjdkNWM4ZDM4NTNlZS90YWJsZXJhbmdlOjM5NDI0MzcyZDUwNDQxZTdiNzZmN2Q1YzhkMzg1M2VlXzQtMS0xLTEtNjQwNA_bd15b13f-1397-4863-be64-edd9010d2bf2">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozOTQyNDM3MmQ1MDQ0MWU3Yjc2ZjdkNWM4ZDM4NTNlZS90YWJsZXJhbmdlOjM5NDI0MzcyZDUwNDQxZTdiNzZmN2Q1YzhkMzg1M2VlXzQtMy0xLTEtNjQwOA_3c1e1a52-b74b-49f5-bd03-2bc89a5c6fe7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31:</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231" decimals="-3" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozOTQyNDM3MmQ1MDQ0MWU3Yjc2ZjdkNWM4ZDM4NTNlZS90YWJsZXJhbmdlOjM5NDI0MzcyZDUwNDQxZTdiNzZmN2Q1YzhkMzg1M2VlXzUtMS0xLTEtNjQwNA_d0fa2290-c232-4ae6-9baa-4d8d4ed59e2f">166</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib68a40c3668644fc87db08988f699fec_I20191231" decimals="-3" format="ixt:zerodash" name="us-gaap:UnrecognizedTaxBenefits" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozOTQyNDM3MmQ1MDQ0MWU3Yjc2ZjdkNWM4ZDM4NTNlZS90YWJsZXJhbmdlOjM5NDI0MzcyZDUwNDQxZTdiNzZmN2Q1YzhkMzg1M2VlXzUtMy0xLTEtNjQwOA_ff7eb273-f812-4dae-ba61-cae0050f2a7b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div><span><br/></span></div><div id="ica64940eaba8432cb3e8a74baaac4713_208"></div><div style="margin-top:10pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDgvZnJhZzowM2QwNjNlMWI4MjU0MzMyYjAxZThjMTRiY2M4N2RjOS90ZXh0cmVnaW9uOjAzZDA2M2UxYjgyNTQzMzJiMDFlOGMxNGJjYzg3ZGM5XzQzNQ_95f7b06d-ce48-4abe-8f74-339503a786f6" continuedAt="i98b5c2de01b340449d5c4a51254151b1" escape="true">SUBSEQUENT EVENT</ix:nonNumeric></span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i98b5c2de01b340449d5c4a51254151b1">Subsequent to December&#160;31, 2020, through March&#160;19, 2021, the Company sold <ix:nonFraction unitRef="shares" contextRef="ie5001f6661f94fcb9a78097ff24a3842_D20210101-20210319" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDgvZnJhZzowM2QwNjNlMWI4MjU0MzMyYjAxZThjMTRiY2M4N2RjOS90ZXh0cmVnaW9uOjAzZDA2M2UxYjgyNTQzMzJiMDFlOGMxNGJjYzg3ZGM5XzMyOTg1MzQ4ODQyMjg_3914da0c-4384-4685-ad17-884048bf19ee">5,941,816</ix:nonFraction> shares of common stock under its SPA with Tumim at a weighted average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="ie5001f6661f94fcb9a78097ff24a3842_D20210101-20210319" decimals="2" name="cvsi:SaleOfStockWeightedAveragePricePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDgvZnJhZzowM2QwNjNlMWI4MjU0MzMyYjAxZThjMTRiY2M4N2RjOS90ZXh0cmVnaW9uOjAzZDA2M2UxYjgyNTQzMzJiMDFlOGMxNGJjYzg3ZGM5XzMyOTg1MzQ4ODQzMTU_06da066e-d5ff-4fe8-b98b-580cde20bf71">0.53</ix:nonFraction> per share, resulting in proceeds of $<ix:nonFraction unitRef="usd" contextRef="ie5001f6661f94fcb9a78097ff24a3842_D20210101-20210319" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDgvZnJhZzowM2QwNjNlMWI4MjU0MzMyYjAxZThjMTRiY2M4N2RjOS90ZXh0cmVnaW9uOjAzZDA2M2UxYjgyNTQzMzJiMDFlOGMxNGJjYzg3ZGM5XzMyOTg1MzQ4ODQzNTU_e5e98394-8808-4b7b-a34f-86c0b7a65341">3.1</ix:nonFraction> million.</ix:continuation></span></div><div><span><br/></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-25</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>2
<FILENAME>consentex231202010kng.htm
<DESCRIPTION>EX-23.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i959b6d7850b441eb94b23602aafb9b53_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in Registration Statement No. 333-199173 on Form S-8 and No. 333-237772 on Form S-3 of our report dated March&#160;19, 2021, relating to the financial statements of CV Sciences, Inc., appearing in this Annual Report on Form 10-K for the year ended December 31, 2020.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#47;s&#47; DELOITTE &#38; TOUCHE LLP</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Diego, California</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;19, 2021 </font></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>3
<FILENAME>a302certificationceoex3112.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i5cdaa960859f4092a6156d4b3bb69798_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15(d)-14(a), AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Joseph D. Dowling, Chief Executive Officer of CV Sciences, Inc. (the &#8220;Company&#8221;) certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Annual Report on Form 10-K of the Company&#59;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:27pt;text-indent:-9pt"><font><br></font></div><div style="padding-left:45pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:45pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:45pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:45pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:45pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:45pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:45pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:510.00pt"><tr><td style="width:1.0pt"></td><td style="width:253.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:253.00pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; March 19, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Joseph D. Dowling</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joseph D. Dowling<br>Chief Executive Officer<br>(Principal Executive Officer)</font></td><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>4
<FILENAME>a302certificationcfoex3122.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ia23f4294168148b6a215f7929731fdb0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT RULES 13a-14(a) AND 15(d)-14(a), AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Joerg Grasser, Chief Financial Officer of CV Sciences, Inc. (the &#8220;Company&#8221;) certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this Annual Report on Form 10-K of the Company&#59;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="padding-left:27pt;text-indent:-9pt"><font><br></font></div><div style="padding-left:45pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="padding-left:45pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="padding-left:45pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="padding-left:45pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d)&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:45pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:45pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:45pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:510.00pt"><tr><td style="width:1.0pt"></td><td style="width:253.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:253.00pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; March 19, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Joerg Grasser</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:35pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joerg Grasser<br>Chief Financial Officer<br>(Principal Financial Officer)</font></td><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>5
<FILENAME>a906certificationceoex3212.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="id5f7f02e2eb44be9a989b2afc75c33d2_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of CV Sciences, Inc. (the &#8220;Registrant&#8221;) on Form 10-K for the year ended December 31, 2020 (the &#8220;Report&#8221;), I, Joseph D. Dowling, Chief Executive Officer of the Registrant, do hereby certify, pursuant to 18 U.S.C. &#167;1350, as adopted pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge&#58;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) the Report, as filed with the Securities and Exchange Commission, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.</font></div><div style="padding-left:27pt;text-indent:-9pt"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:45pt;text-indent:-9pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:510.00pt"><tr><td style="width:1.0pt"></td><td style="width:253.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:253.00pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; March 19, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Joseph D. Dowling</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joseph D. Dowling<br>Chief Executive Officer<br>(Principal Executive Officer)</font></td><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>6
<FILENAME>a906certificationcfoex3222.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ie7a482d290ab4692a8371156624351f0_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Annual Report of CV Sciences, Inc. (the &#8220;Registrant&#8221;) on Form 10-K for the year ended December 31, 2020 (the &#8220;Report&#8221;), I, Joerg Grasser, Chief Financial Officer of the Registrant, do hereby certify, pursuant to 18 U.S.C. &#167;1350, as adopted pursuant to &#167;906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge&#58;</font></div><div style="padding-left:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1) the Report, as filed with the Securities and Exchange Commission, fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:27pt;text-indent:-9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.</font></div><div style="padding-left:27pt;text-indent:-9pt"><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="padding-left:45pt;text-indent:-9pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:510.00pt"><tr><td style="width:1.0pt"></td><td style="width:253.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:253.00pt"></td><td style="width:1.0pt"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; March 19, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Joerg Grasser</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:36pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Joerg Grasser<br>Chief Financial Officer<br>(Principal Financial Officer)</font></td><td colspan="3" style="display:none"></td></tr></table></div><div><font><br></font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>7
<FILENAME>cvsi-20201231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:eca8e0c2-d550-4e97-a9fa-88ee2e9b3168,g:095536f4-fd9c-45bc-aa88-ebcfe4d45a75-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:cvsi="http://cvsciences.com/20201231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://cvsciences.com/20201231">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/sic/2020-01-31" schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvsi-20201231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvsi-20201231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvsi-20201231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="cvsi-20201231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://cvsciences.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETS" roleURI="http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS">
        <link:definition>1001002 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>1003004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>1004005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONSOLIDATEDSTATEMENTSOFCASHFLOW" roleURI="http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW">
        <link:definition>1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOW</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDBUSINESS" roleURI="http://cvsciences.com/role/ORGANIZATIONANDBUSINESS">
        <link:definition>2101101 - Disclosure - ORGANIZATION AND BUSINESS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ORGANIZATIONANDBUSINESSDetails" roleURI="http://cvsciences.com/role/ORGANIZATIONANDBUSINESSDetails">
        <link:definition>2402401 - Disclosure - ORGANIZATION AND BUSINESS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES">
        <link:definition>2103102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies">
        <link:definition>2204201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables">
        <link:definition>2305301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails">
        <link:definition>2406402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails" roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails">
        <link:definition>2407403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails" roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails">
        <link:definition>2408404 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue Product Sales by Channel (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORY" roleURI="http://cvsciences.com/role/INVENTORY">
        <link:definition>2109103 - Disclosure - INVENTORY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORYTables" roleURI="http://cvsciences.com/role/INVENTORYTables">
        <link:definition>2310302 - Disclosure - INVENTORY (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INVENTORYDetails" roleURI="http://cvsciences.com/role/INVENTORYDetails">
        <link:definition>2411405 - Disclosure - INVENTORY (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYEQUIPMENT" roleURI="http://cvsciences.com/role/PROPERTYEQUIPMENT">
        <link:definition>2112104 - Disclosure - PROPERTY &amp; EQUIPMENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYEQUIPMENTTables" roleURI="http://cvsciences.com/role/PROPERTYEQUIPMENTTables">
        <link:definition>2313303 - Disclosure - PROPERTY &amp; EQUIPMENT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PROPERTYEQUIPMENTDetails" roleURI="http://cvsciences.com/role/PROPERTYEQUIPMENTDetails">
        <link:definition>2414406 - Disclosure - PROPERTY &amp; EQUIPMENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTANGIBLEASSETS" roleURI="http://cvsciences.com/role/INTANGIBLEASSETS">
        <link:definition>2115105 - Disclosure - INTANGIBLE ASSETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTANGIBLEASSETSTables" roleURI="http://cvsciences.com/role/INTANGIBLEASSETSTables">
        <link:definition>2316304 - Disclosure - INTANGIBLE ASSETS (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTANGIBLEASSETSIntangibleAssetScheduleDetails" roleURI="http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails">
        <link:definition>2417407 - Disclosure - INTANGIBLE ASSETS - Intangible Asset Schedule (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INTANGIBLEASSETSNarrativeDetails" roleURI="http://cvsciences.com/role/INTANGIBLEASSETSNarrativeDetails">
        <link:definition>2418408 - Disclosure - INTANGIBLE ASSETS - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDEXPENSES" roleURI="http://cvsciences.com/role/ACCRUEDEXPENSES">
        <link:definition>2119106 - Disclosure - ACCRUED EXPENSES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDEXPENSESTables" roleURI="http://cvsciences.com/role/ACCRUEDEXPENSESTables">
        <link:definition>2320305 - Disclosure - ACCRUED EXPENSES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ACCRUEDEXPENSESDetails" roleURI="http://cvsciences.com/role/ACCRUEDEXPENSESDetails">
        <link:definition>2421409 - Disclosure - ACCRUED EXPENSES (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBT" roleURI="http://cvsciences.com/role/DEBT">
        <link:definition>2122107 - Disclosure - DEBT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTTables" roleURI="http://cvsciences.com/role/DEBTTables">
        <link:definition>2323306 - Disclosure - DEBT (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTScheduleofDebtDetails" roleURI="http://cvsciences.com/role/DEBTScheduleofDebtDetails">
        <link:definition>2424410 - Disclosure - DEBT - Schedule of Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtPrincipalPaymentsonDebtDetails" roleURI="http://cvsciences.com/role/DebtPrincipalPaymentsonDebtDetails">
        <link:definition>2425411 - Disclosure - Debt - Principal Payments on Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DEBTNarrativeDetails" roleURI="http://cvsciences.com/role/DEBTNarrativeDetails">
        <link:definition>2426412 - Disclosure - DEBT - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITY" roleURI="http://cvsciences.com/role/STOCKHOLDERSEQUITY">
        <link:definition>2127108 - Disclosure - STOCKHOLDERS EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKHOLDERSEQUITYNarrativeDetails" roleURI="http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails">
        <link:definition>2428413 - Disclosure - STOCKHOLDERS EQUITY - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATION" roleURI="http://cvsciences.com/role/STOCKBASEDCOMPENSATION">
        <link:definition>2129109 - Disclosure - STOCK-BASED COMPENSATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONTables" roleURI="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONTables">
        <link:definition>2330307 - Disclosure - STOCK-BASED COMPENSATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONNarrativeDetails" roleURI="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails">
        <link:definition>2431414 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails" roleURI="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails">
        <link:definition>2432415 - Disclosure - STOCK-BASED COMPENSATION - Summary of Stock Options Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="STOCKBASEDCOMPENSATIONAssumptionsUsedtoEstimateFairValueDetails" roleURI="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONAssumptionsUsedtoEstimateFairValueDetails">
        <link:definition>2433416 - Disclosure - STOCK-BASED COMPENSATION - Assumptions Used to Estimate Fair Value (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMELOSSPERSHARE" roleURI="http://cvsciences.com/role/NETINCOMELOSSPERSHARE">
        <link:definition>2134110 - Disclosure - NET INCOME (LOSS) PER SHARE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMELOSSPERSHARETables" roleURI="http://cvsciences.com/role/NETINCOMELOSSPERSHARETables">
        <link:definition>2335308 - Disclosure - NET INCOME (LOSS) PER SHARE (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NETINCOMELOSSPERSHAREAntidilutiveSharesDetails" roleURI="http://cvsciences.com/role/NETINCOMELOSSPERSHAREAntidilutiveSharesDetails">
        <link:definition>2436417 - Disclosure - NET INCOME (LOSS) PER SHARE - Antidilutive Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RELATEDPARTIES" roleURI="http://cvsciences.com/role/RELATEDPARTIES">
        <link:definition>2137111 - Disclosure - RELATED PARTIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RELATEDPARTIESNarrativeDetails" roleURI="http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails">
        <link:definition>2438418 - Disclosure - RELATED PARTIES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIES" roleURI="http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIES">
        <link:definition>2139112 - Disclosure - COMMITMENTS AND CONTINGENCIES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="COMMITMENTSANDCONTINGENCIESLawsuitsDetails" roleURI="http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIESLawsuitsDetails">
        <link:definition>2440419 - Disclosure - COMMITMENTS AND CONTINGENCIES - Lawsuits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASES" roleURI="http://cvsciences.com/role/LEASES">
        <link:definition>2141113 - Disclosure - LEASES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESTables" roleURI="http://cvsciences.com/role/LEASESTables">
        <link:definition>2342309 - Disclosure - LEASES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESNarrativeDetails" roleURI="http://cvsciences.com/role/LEASESNarrativeDetails">
        <link:definition>2443420 - Disclosure - LEASES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESRightofuseAssetsandLeaseLiabilitiesDetails" roleURI="http://cvsciences.com/role/LEASESRightofuseAssetsandLeaseLiabilitiesDetails">
        <link:definition>2444421 - Disclosure - LEASES - Right-of-use Assets and Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESMaturityofLeaseLiabilitiesDetails" roleURI="http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails">
        <link:definition>2445422 - Disclosure - LEASES - Maturity of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LEASESMaturityofLeaseLiabilitiesDetails_1" roleURI="http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails_1">
        <link:definition>2445422 - Disclosure - LEASES - Maturity of Lease Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATION" roleURI="http://cvsciences.com/role/SEGMENTINFORMATION">
        <link:definition>2146114 - Disclosure - SEGMENT INFORMATION</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONTables" roleURI="http://cvsciences.com/role/SEGMENTINFORMATIONTables">
        <link:definition>2347310 - Disclosure - SEGMENT INFORMATION (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SEGMENTINFORMATIONDetails" roleURI="http://cvsciences.com/role/SEGMENTINFORMATIONDetails">
        <link:definition>2448423 - Disclosure - SEGMENT INFORMATION (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXES" roleURI="http://cvsciences.com/role/INCOMETAXES">
        <link:definition>2149115 - Disclosure - INCOME TAXES</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESTables" roleURI="http://cvsciences.com/role/INCOMETAXESTables">
        <link:definition>2350311 - Disclosure - INCOME TAXES (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails" roleURI="http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails">
        <link:definition>2451424 - Disclosure - INCOME TAXES INCOME TAXES - Components of Income Tax Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESIncomeTaxProvisionDetails" roleURI="http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails">
        <link:definition>2452425 - Disclosure - INCOME TAXES - Income Tax Provision (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESDeferredIncomeTaxesDetails" roleURI="http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails">
        <link:definition>2453426 - Disclosure - INCOME TAXES - Deferred Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESNarrativeDetails" roleURI="http://cvsciences.com/role/INCOMETAXESNarrativeDetails">
        <link:definition>2454427 - Disclosure - INCOME TAXES - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="INCOMETAXESUnrecognizedTaxBenefitsDetails" roleURI="http://cvsciences.com/role/INCOMETAXESUnrecognizedTaxBenefitsDetails">
        <link:definition>2455428 - Disclosure - INCOME TAXES - Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENT" roleURI="http://cvsciences.com/role/SUBSEQUENTEVENT">
        <link:definition>2156116 - Disclosure - SUBSEQUENT EVENT</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SUBSEQUENTEVENTDetails" roleURI="http://cvsciences.com/role/SUBSEQUENTEVENTDetails">
        <link:definition>2457429 - Disclosure - SUBSEQUENT EVENT (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="cvsi_SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement" abstract="false" name="SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvsi_OptionsOutsidePlanMember" abstract="false" name="OptionsOutsidePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_CannaVestEuropeGmbHMember" abstract="true" name="CannaVestEuropeGmbHMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_After2017Member" abstract="true" name="After2017Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvsi_SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee" abstract="false" name="SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvsi_CommonStockPurchaseAgreementMember" abstract="true" name="CommonStockPurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_CashlessExerciseOfStockOptions" abstract="false" name="CashlessExerciseOfStockOptions" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvsi_RetailNaturalProductsAndOtherMember" abstract="true" name="RetailNaturalProductsAndOtherMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_RecognitionofEquityAwardandWithholdingObligationandReceivable" abstract="false" name="RecognitionofEquityAwardandWithholdingObligationandReceivable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvsi_ImpairmentOfTaxReceivableForRSUSettlement" abstract="false" name="ImpairmentOfTaxReceivableForRSUSettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvsi_AccruedPayrollTaxesCurrentEmployeePortion" abstract="false" name="AccruedPayrollTaxesCurrentEmployeePortion" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvsi_PayrollTaxExpense" abstract="false" name="PayrollTaxExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvsi_StockOptionModificationMember" abstract="true" name="StockOptionModificationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_SaleOfStockFairValueOfPutOption" abstract="false" name="SaleOfStockFairValueOfPutOption" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent" abstract="false" name="SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction" abstract="false" name="SaleOfStockMaximumValueOfSharesIssuedInTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation" abstract="false" name="EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvsi_FormerPresidentandCEOMember" abstract="true" name="FormerPresidentandCEOMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_ECommMember" abstract="true" name="ECommMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_DeferredTaxAssetOperatingLeaseLiabilities" abstract="false" name="DeferredTaxAssetOperatingLeaseLiabilities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvsi_ConsumerProductsMember" abstract="false" name="ConsumerProductsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement" abstract="false" name="AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvsi_PayrollProtectionProgramLoanMember" abstract="true" name="PayrollProtectionProgramLoanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility" abstract="false" name="SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvsi_StatesOtherThanCaliforniaMember" abstract="true" name="StatesOtherThanCaliforniaMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent" abstract="false" name="EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="cvsi_SpecialtyPharmaceuticalSegmentMember" abstract="true" name="SpecialtyPharmaceuticalSegmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock" abstract="false" name="SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvsi_Before2018Member" abstract="true" name="Before2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_TaxLiabilityMember" abstract="true" name="TaxLiabilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_UnvestedStockOptionsMember" abstract="true" name="UnvestedStockOptionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_PremiumFinanceAgreementMember" abstract="false" name="PremiumFinanceAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_SaleOfStockWeightedAveragePricePerShare" abstract="false" name="SaleOfStockWeightedAveragePricePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:perShareItemType"/>
  <xs:element id="cvsi_NumberOfAdditionalSuppliers" abstract="false" name="NumberOfAdditionalSuppliers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvsi_NumberofSuppliers" abstract="false" name="NumberofSuppliers" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvsi_NumberOfLeaseTerminationAgreements" abstract="false" name="NumberOfLeaseTerminationAgreements" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvsi_DeferredTaxLiabilityOperatingLeaseAssets" abstract="false" name="DeferredTaxLiabilityOperatingLeaseAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvsi_StockIssuedDuringPeriodSharesEquityCommitment" abstract="false" name="StockIssuedDuringPeriodSharesEquityCommitment" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvsi_SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory" abstract="false" name="SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvsi_RetailFDMMember" abstract="true" name="RetailFDMMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability" abstract="false" name="RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan" abstract="false" name="SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="cvsi_FirstInsuranceFundingMember" abstract="true" name="FirstInsuranceFundingMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_AccountsReceivableThresholdforDeterminingDelinquentAccount" abstract="false" name="AccountsReceivableThresholdforDeterminingDelinquentAccount" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="cvsi_Amended2013PlanMember" abstract="false" name="Amended2013PlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_FormerChiefOperatingOfficerMember" abstract="true" name="FormerChiefOperatingOfficerMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_SpecialtyPharmaceuticalsMember" abstract="false" name="SpecialtyPharmaceuticalsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_NoncashLeaseExpense" abstract="false" name="NoncashLeaseExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvsi_FormerFoundersMember" abstract="true" name="FormerFoundersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_NumberofDerivativeLawsuits" abstract="false" name="NumberofDerivativeLawsuits" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="cvsi_SmithComplaintMember" abstract="true" name="SmithComplaintMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_StockIssuedDuringPeriodValueEquityCommitment" abstract="false" name="StockIssuedDuringPeriodValueEquityCommitment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="cvsi_SanDiegoFacilityMember" abstract="true" name="SanDiegoFacilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="cvsi_PurchaseOfInsuranceThroughIssuanceOfNotePayable" abstract="false" name="PurchaseOfInsuranceThroughIssuanceOfNotePayable" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>8
<FILENAME>cvsi-20201231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:eca8e0c2-d550-4e97-a9fa-88ee2e9b3168,g:095536f4-fd9c-45bc-aa88-ebcfe4d45a75-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://cvsciences.com/role/Cover" xlink:type="simple" xlink:href="cvsi-20201231.xsd#Cover"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/Cover" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="cvsi-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_2228903e-91a4-4cc3-89f0-f76e0b758b09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_b79eccbb-67dc-45d3-8520-3a9050720cfe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2228903e-91a4-4cc3-89f0-f76e0b758b09" xlink:to="loc_us-gaap_AssetsCurrent_b79eccbb-67dc-45d3-8520-3a9050720cfe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_fbb4626a-267f-42dd-8814-ef4b88ecec20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2228903e-91a4-4cc3-89f0-f76e0b758b09" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_fbb4626a-267f-42dd-8814-ef4b88ecec20" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_35bc1413-3c61-4eb9-b8f8-999eca8af02f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2228903e-91a4-4cc3-89f0-f76e0b758b09" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_35bc1413-3c61-4eb9-b8f8-999eca8af02f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f6b93316-d956-41a2-a68b-cd31abeb0c03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2228903e-91a4-4cc3-89f0-f76e0b758b09" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_f6b93316-d956-41a2-a68b-cd31abeb0c03" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_bc8cc78a-68e5-4b6e-ae68-915aaf2ad76c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2228903e-91a4-4cc3-89f0-f76e0b758b09" xlink:to="loc_us-gaap_Goodwill_bc8cc78a-68e5-4b6e-ae68-915aaf2ad76c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5b7cb6d3-23b8-4916-b233-692a19ecb48b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_2228903e-91a4-4cc3-89f0-f76e0b758b09" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5b7cb6d3-23b8-4916-b233-692a19ecb48b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_0b7980fc-bc4b-4d51-866a-93df73288b0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_107a8725-291b-461b-9f2b-fbea2c510e6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0b7980fc-bc4b-4d51-866a-93df73288b0c" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_107a8725-291b-461b-9f2b-fbea2c510e6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_fd97aef4-a20a-45da-9064-363d4d257031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0b7980fc-bc4b-4d51-866a-93df73288b0c" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_fd97aef4-a20a-45da-9064-363d4d257031" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_fdb49502-6e5a-4a51-856b-0284fed070d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0b7980fc-bc4b-4d51-866a-93df73288b0c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_fdb49502-6e5a-4a51-856b-0284fed070d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_99a3b0df-14b9-4cbf-b143-e044bc241228" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0b7980fc-bc4b-4d51-866a-93df73288b0c" xlink:to="loc_us-gaap_InventoryNet_99a3b0df-14b9-4cbf-b143-e044bc241228" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_5e420268-0208-4d37-a6b7-8b337bc42703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_0b7980fc-bc4b-4d51-866a-93df73288b0c" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_5e420268-0208-4d37-a6b7-8b337bc42703" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_713fece2-8583-4812-892a-54ab99ac8c62" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_46553ba3-a652-4b72-a047-0014330c8703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_713fece2-8583-4812-892a-54ab99ac8c62" xlink:to="loc_us-gaap_PreferredStockValue_46553ba3-a652-4b72-a047-0014330c8703" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_0c59c8d7-956c-4a25-8259-1a231c47910c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_713fece2-8583-4812-892a-54ab99ac8c62" xlink:to="loc_us-gaap_CommonStockValue_0c59c8d7-956c-4a25-8259-1a231c47910c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_287e7595-74cc-40c2-9eee-63aeb5edd7e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_713fece2-8583-4812-892a-54ab99ac8c62" xlink:to="loc_us-gaap_AdditionalPaidInCapital_287e7595-74cc-40c2-9eee-63aeb5edd7e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_db1d96ec-574f-45a9-90bb-2e9502faf8a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_713fece2-8583-4812-892a-54ab99ac8c62" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_db1d96ec-574f-45a9-90bb-2e9502faf8a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7230d7fd-fd6f-4ba1-95ff-5e5c19e26886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_2ba15e60-ac7a-41fc-8b73-a654a1b7bcf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7230d7fd-fd6f-4ba1-95ff-5e5c19e26886" xlink:to="loc_us-gaap_AccountsPayableCurrent_2ba15e60-ac7a-41fc-8b73-a654a1b7bcf6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_03f82f06-ca75-4caa-b826-a7350a5aa4ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7230d7fd-fd6f-4ba1-95ff-5e5c19e26886" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_03f82f06-ca75-4caa-b826-a7350a5aa4ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_cbcd1c22-a395-4be9-9d8b-4514afac44f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7230d7fd-fd6f-4ba1-95ff-5e5c19e26886" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_cbcd1c22-a395-4be9-9d8b-4514afac44f7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_0e0b4a16-a69f-4d28-9d2f-8d0f699ea659" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_7230d7fd-fd6f-4ba1-95ff-5e5c19e26886" xlink:to="loc_us-gaap_NotesPayableCurrent_0e0b4a16-a69f-4d28-9d2f-8d0f699ea659" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ee5bb495-da8c-4b52-bbe5-90452c5926ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_1d6d501e-14f1-4989-ac9c-46b2618f1477" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ee5bb495-da8c-4b52-bbe5-90452c5926ff" xlink:to="loc_us-gaap_StockholdersEquity_1d6d501e-14f1-4989-ac9c-46b2618f1477" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_065c179c-f08b-4c16-8fb9-370cb5ebed2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ee5bb495-da8c-4b52-bbe5-90452c5926ff" xlink:to="loc_us-gaap_Liabilities_065c179c-f08b-4c16-8fb9-370cb5ebed2e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_f0758e7a-6ce7-4a8d-ae36-eb9067f84c0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ee5bb495-da8c-4b52-bbe5-90452c5926ff" xlink:to="loc_us-gaap_CommitmentsAndContingencies_f0758e7a-6ce7-4a8d-ae36-eb9067f84c0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a95af01e-9499-40b3-ac6a-d17ba1120370" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_7a581038-5278-4d11-b822-ea4c2b7bac59" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a95af01e-9499-40b3-ac6a-d17ba1120370" xlink:to="loc_us-gaap_LiabilitiesCurrent_7a581038-5278-4d11-b822-ea4c2b7bac59" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_39728ca3-0de4-4ae1-b160-accfd32ee4a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a95af01e-9499-40b3-ac6a-d17ba1120370" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_39728ca3-0de4-4ae1-b160-accfd32ee4a0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_263db959-e3ca-4698-910f-1d6ff14a03c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a95af01e-9499-40b3-ac6a-d17ba1120370" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_263db959-e3ca-4698-910f-1d6ff14a03c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_303d672f-f5cf-4533-85a8-0ed10c9b6091" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a95af01e-9499-40b3-ac6a-d17ba1120370" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_303d672f-f5cf-4533-85a8-0ed10c9b6091" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_822fb01d-23f4-4481-b200-51b1a8a55e8a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a95af01e-9499-40b3-ac6a-d17ba1120370" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_822fb01d-23f4-4481-b200-51b1a8a55e8a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="cvsi-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="cvsi-20201231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_62ac86a5-7720-4969-8a09-68fe7699e353" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_edf1d5d7-2c05-4df2-b2a4-a5eff2bbd115" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_62ac86a5-7720-4969-8a09-68fe7699e353" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_edf1d5d7-2c05-4df2-b2a4-a5eff2bbd115" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_a2d046fa-9383-4431-8805-76c18b789f82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_62ac86a5-7720-4969-8a09-68fe7699e353" xlink:to="loc_us-gaap_CostOfRevenue_a2d046fa-9383-4431-8805-76c18b789f82" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5a4ea321-512c-4bea-82a5-b4af7f97203d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_21fa2cd0-68dd-4244-a4e9-402f411fc30c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5a4ea321-512c-4bea-82a5-b4af7f97203d" xlink:to="loc_us-gaap_OperatingIncomeLoss_21fa2cd0-68dd-4244-a4e9-402f411fc30c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_da550e9d-3508-41d3-9986-4a92a8628967" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5a4ea321-512c-4bea-82a5-b4af7f97203d" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_da550e9d-3508-41d3-9986-4a92a8628967" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_6c9ace89-3b20-4082-89fd-e6631d06c7ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_4aa734bd-2806-47eb-b103-0304aa5f9bd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_6c9ace89-3b20-4082-89fd-e6631d06c7ef" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_4aa734bd-2806-47eb-b103-0304aa5f9bd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_8c0c5753-ac36-4727-bbd0-cae922675e41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_6c9ace89-3b20-4082-89fd-e6631d06c7ef" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_8c0c5753-ac36-4727-bbd0-cae922675e41" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_fc66a76a-0fa3-459d-b188-91826257c82b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_57348185-4950-48bc-a402-eb7daf3efa68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_fc66a76a-0fa3-459d-b188-91826257c82b" xlink:to="loc_us-gaap_GrossProfit_57348185-4950-48bc-a402-eb7daf3efa68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_aa3415b4-0041-413c-bd70-748d91c86932" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_fc66a76a-0fa3-459d-b188-91826257c82b" xlink:to="loc_us-gaap_OperatingExpenses_aa3415b4-0041-413c-bd70-748d91c86932" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e37e841f-237f-4e89-b274-95d55871b290" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1a2782da-09de-4972-8e97-f78551620ab9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e37e841f-237f-4e89-b274-95d55871b290" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1a2782da-09de-4972-8e97-f78551620ab9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_eecd6503-e187-467a-b23b-9fb9f8015390" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_e37e841f-237f-4e89-b274-95d55871b290" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_eecd6503-e187-467a-b23b-9fb9f8015390" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="cvsi-20201231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW" xlink:type="simple" xlink:href="cvsi-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOW"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4dbaf13c-c399-4712-92fd-ee3cf6f86e94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromUnsecuredNotesPayable_bdd6bab0-1bf5-42e7-bed5-a5386f5b7f97" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromUnsecuredNotesPayable"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4dbaf13c-c399-4712-92fd-ee3cf6f86e94" xlink:to="loc_us-gaap_ProceedsFromUnsecuredNotesPayable_bdd6bab0-1bf5-42e7-bed5-a5386f5b7f97" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_40cc2e0e-9d69-40d8-8e7b-2d4cc8c5119b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4dbaf13c-c399-4712-92fd-ee3cf6f86e94" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_40cc2e0e-9d69-40d8-8e7b-2d4cc8c5119b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a75eb494-fbdb-4d74-a186-fdec06e710d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4dbaf13c-c399-4712-92fd-ee3cf6f86e94" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a75eb494-fbdb-4d74-a186-fdec06e710d4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_e491972b-d7d7-4d70-9f6e-7f0e370a7d79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_4dbaf13c-c399-4712-92fd-ee3cf6f86e94" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_e491972b-d7d7-4d70-9f6e-7f0e370a7d79" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_249ae0db-6cca-4caf-b43f-0441f70f9e46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_fd5e0536-05eb-4c11-8b38-84a0aa9551ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_249ae0db-6cca-4caf-b43f-0441f70f9e46" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_fd5e0536-05eb-4c11-8b38-84a0aa9551ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_13c8b4b0-2bb9-447a-ba76-f61dd80a6e4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ad9dc4ae-f87e-4f26-88f7-84d6c5af9703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_13c8b4b0-2bb9-447a-ba76-f61dd80a6e4a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_ad9dc4ae-f87e-4f26-88f7-84d6c5af9703" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5dfa80af-49fd-4046-82b7-b74a5cfaef9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_13c8b4b0-2bb9-447a-ba76-f61dd80a6e4a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5dfa80af-49fd-4046-82b7-b74a5cfaef9b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ca5c5e64-93b0-49cc-979f-83e74247c5d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_13c8b4b0-2bb9-447a-ba76-f61dd80a6e4a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_ca5c5e64-93b0-49cc-979f-83e74247c5d8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f601a15-f6f4-4bdf-a1f6-2fda9e719e54" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_9a82f338-5cba-477c-b2a0-ae5d0d6095ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f601a15-f6f4-4bdf-a1f6-2fda9e719e54" xlink:to="loc_us-gaap_NetIncomeLoss_9a82f338-5cba-477c-b2a0-ae5d0d6095ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_99df88ad-7b50-4c83-8b65-1d5d3df005be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f601a15-f6f4-4bdf-a1f6-2fda9e719e54" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_99df88ad-7b50-4c83-8b65-1d5d3df005be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_ac604dbe-d011-4713-9743-ff88fab819a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f601a15-f6f4-4bdf-a1f6-2fda9e719e54" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_ac604dbe-d011-4713-9743-ff88fab819a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_dd52eb65-12e2-40bf-8979-87f392424cda" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f601a15-f6f4-4bdf-a1f6-2fda9e719e54" xlink:to="loc_us-gaap_ShareBasedCompensation_dd52eb65-12e2-40bf-8979-87f392424cda" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_28ef5214-72a0-4f7b-b73d-15f0ba97a599" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f601a15-f6f4-4bdf-a1f6-2fda9e719e54" xlink:to="loc_us-gaap_RoyaltyExpense_28ef5214-72a0-4f7b-b73d-15f0ba97a599" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_ImpairmentOfTaxReceivableForRSUSettlement_8ab975cb-0fce-4066-9b7c-0b922a78c81b" xlink:href="cvsi-20201231.xsd#cvsi_ImpairmentOfTaxReceivableForRSUSettlement"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f601a15-f6f4-4bdf-a1f6-2fda9e719e54" xlink:to="loc_cvsi_ImpairmentOfTaxReceivableForRSUSettlement_8ab975cb-0fce-4066-9b7c-0b922a78c81b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_6653ad2b-ed76-4d9c-abeb-b10a0fb9b703" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f601a15-f6f4-4bdf-a1f6-2fda9e719e54" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_6653ad2b-ed76-4d9c-abeb-b10a0fb9b703" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_00807ab1-31b1-4aab-ab9c-f83fcd13e73d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f601a15-f6f4-4bdf-a1f6-2fda9e719e54" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_00807ab1-31b1-4aab-ab9c-f83fcd13e73d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_NoncashLeaseExpense_f9d0757d-2cf3-44f4-ba9e-0f24b45150e7" xlink:href="cvsi-20201231.xsd#cvsi_NoncashLeaseExpense"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f601a15-f6f4-4bdf-a1f6-2fda9e719e54" xlink:to="loc_cvsi_NoncashLeaseExpense_f9d0757d-2cf3-44f4-ba9e-0f24b45150e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_9354b4be-6507-48fa-83a1-9cfed6c0e17c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f601a15-f6f4-4bdf-a1f6-2fda9e719e54" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_9354b4be-6507-48fa-83a1-9cfed6c0e17c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_41d30be5-5e91-4e63-b10d-da638584530c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f601a15-f6f4-4bdf-a1f6-2fda9e719e54" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_41d30be5-5e91-4e63-b10d-da638584530c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5f95e403-24c5-406f-8daf-6319981eea5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f601a15-f6f4-4bdf-a1f6-2fda9e719e54" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_5f95e403-24c5-406f-8daf-6319981eea5e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_62f1e484-1c2f-4a53-8d48-78d86a7c042e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f601a15-f6f4-4bdf-a1f6-2fda9e719e54" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_62f1e484-1c2f-4a53-8d48-78d86a7c042e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_67faa272-6e97-4766-be6e-1e04a82a87a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f601a15-f6f4-4bdf-a1f6-2fda9e719e54" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_67faa272-6e97-4766-be6e-1e04a82a87a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2c8d3038-71a9-4ad3-af69-b19c2f3c2e18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="15" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5f601a15-f6f4-4bdf-a1f6-2fda9e719e54" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_2c8d3038-71a9-4ad3-af69-b19c2f3c2e18" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/ORGANIZATIONANDBUSINESS" xlink:type="simple" xlink:href="cvsi-20201231.xsd#ORGANIZATIONANDBUSINESS"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/ORGANIZATIONANDBUSINESS" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/ORGANIZATIONANDBUSINESSDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#ORGANIZATIONANDBUSINESSDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/ORGANIZATIONANDBUSINESSDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5f84c07a-de92-4b01-8617-c39e36cddeea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_884b8e66-4e11-4d88-a9eb-2b70d1639968" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5f84c07a-de92-4b01-8617-c39e36cddeea" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_884b8e66-4e11-4d88-a9eb-2b70d1639968" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_ab5a208e-2eb4-4646-a49a-9147b9557ae1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_5f84c07a-de92-4b01-8617-c39e36cddeea" xlink:to="loc_us-gaap_RestrictedCash_ab5a208e-2eb4-4646-a49a-9147b9557ae1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/INVENTORY" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INVENTORY"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/INVENTORY" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/INVENTORYTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INVENTORYTables"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/INVENTORYTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/INVENTORYDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INVENTORYDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/INVENTORYDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross_9b626c99-7ff1-4c95-856d-1640cf5a3e7d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_87657aa2-5ef1-4369-9929-c53e263ab491" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryGross_9b626c99-7ff1-4c95-856d-1640cf5a3e7d" xlink:to="loc_us-gaap_InventoryRawMaterials_87657aa2-5ef1-4369-9929-c53e263ab491" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_1a1c4a77-6978-4e4e-8a9d-3ab029d25f7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryGross_9b626c99-7ff1-4c95-856d-1640cf5a3e7d" xlink:to="loc_us-gaap_InventoryWorkInProcess_1a1c4a77-6978-4e4e-8a9d-3ab029d25f7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_5e0278c6-9f72-4c74-bdf1-10376560d8eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryGross_9b626c99-7ff1-4c95-856d-1640cf5a3e7d" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_5e0278c6-9f72-4c74-bdf1-10376560d8eb" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/PROPERTYEQUIPMENT" xlink:type="simple" xlink:href="cvsi-20201231.xsd#PROPERTYEQUIPMENT"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/PROPERTYEQUIPMENT" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/PROPERTYEQUIPMENTTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#PROPERTYEQUIPMENTTables"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/PROPERTYEQUIPMENTTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/PROPERTYEQUIPMENTDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#PROPERTYEQUIPMENTDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/PROPERTYEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7be3c70f-9295-4caf-85b2-6e7484fe25c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_52080481-f8b6-46c0-a416-dc6efd37febc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_7be3c70f-9295-4caf-85b2-6e7484fe25c9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_52080481-f8b6-46c0-a416-dc6efd37febc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f179290e-589a-41a9-be6a-c37103136a04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_7be3c70f-9295-4caf-85b2-6e7484fe25c9" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_f179290e-589a-41a9-be6a-c37103136a04" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INTANGIBLEASSETS" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INTANGIBLEASSETS"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/INTANGIBLEASSETS" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/INTANGIBLEASSETSTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INTANGIBLEASSETSTables"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/INTANGIBLEASSETSTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INTANGIBLEASSETSIntangibleAssetScheduleDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ba190a13-c70a-46c9-852b-3685a887c7b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2acfb2d9-da67-4e4c-9d1a-8bb1e6be42dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ba190a13-c70a-46c9-852b-3685a887c7b2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_2acfb2d9-da67-4e4c-9d1a-8bb1e6be42dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bfc508a3-a8a2-404c-a655-47b18b921589" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_ba190a13-c70a-46c9-852b-3685a887c7b2" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bfc508a3-a8a2-404c-a655-47b18b921589" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INTANGIBLEASSETSNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INTANGIBLEASSETSNarrativeDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/INTANGIBLEASSETSNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/ACCRUEDEXPENSES" xlink:type="simple" xlink:href="cvsi-20201231.xsd#ACCRUEDEXPENSES"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/ACCRUEDEXPENSES" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/ACCRUEDEXPENSESTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#ACCRUEDEXPENSESTables"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/ACCRUEDEXPENSESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/ACCRUEDEXPENSESDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#ACCRUEDEXPENSESDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/ACCRUEDEXPENSESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_8fdcc4d9-ce1a-4c56-b196-6a41b735bbbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_87a14e5c-035c-4c98-96cf-322091a958fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8fdcc4d9-ce1a-4c56-b196-6a41b735bbbf" xlink:to="loc_us-gaap_AccruedSalariesCurrent_87a14e5c-035c-4c98-96cf-322091a958fb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a92a3ad0-d104-401e-a70d-0114a3d3fd1f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_8fdcc4d9-ce1a-4c56-b196-6a41b735bbbf" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a92a3ad0-d104-401e-a70d-0114a3d3fd1f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/DEBT" xlink:type="simple" xlink:href="cvsi-20201231.xsd#DEBT"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/DEBT" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/DEBTTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#DEBTTables"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/DEBTTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/DEBTScheduleofDebtDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#DEBTScheduleofDebtDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/DEBTScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_bbd751e2-eee4-4bb4-ba27-21cbf6c439e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_1cca693c-a5a5-4b50-81f4-f4a4a0714e33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_bbd751e2-eee4-4bb4-ba27-21cbf6c439e7" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_1cca693c-a5a5-4b50-81f4-f4a4a0714e33" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_d07fabe4-1735-4b2e-8b2a-1422cf927957" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_bbd751e2-eee4-4bb4-ba27-21cbf6c439e7" xlink:to="loc_us-gaap_LongTermDebtCurrent_d07fabe4-1735-4b2e-8b2a-1422cf927957" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/DebtPrincipalPaymentsonDebtDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#DebtPrincipalPaymentsonDebtDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/DebtPrincipalPaymentsonDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_36a9e0c4-eeda-4641-8afb-a884e12fbc27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_d4c63991-ab7d-4bb6-b4b3-dd2c63658a95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_36a9e0c4-eeda-4641-8afb-a884e12fbc27" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_d4c63991-ab7d-4bb6-b4b3-dd2c63658a95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_c3f9d63a-0a9d-41f5-8527-67895bac31a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount_36a9e0c4-eeda-4641-8afb-a884e12fbc27" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_c3f9d63a-0a9d-41f5-8527-67895bac31a3" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/DEBTNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#DEBTNarrativeDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/DEBTNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="cvsi-20201231.xsd#STOCKHOLDERSEQUITY"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/STOCKHOLDERSEQUITY" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="cvsi-20201231.xsd#STOCKBASEDCOMPENSATION"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#STOCKBASEDCOMPENSATIONNarrativeDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONAssumptionsUsedtoEstimateFairValueDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#STOCKBASEDCOMPENSATIONAssumptionsUsedtoEstimateFairValueDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONAssumptionsUsedtoEstimateFairValueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/NETINCOMELOSSPERSHARE" xlink:type="simple" xlink:href="cvsi-20201231.xsd#NETINCOMELOSSPERSHARE"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/NETINCOMELOSSPERSHARE" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/NETINCOMELOSSPERSHARETables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#NETINCOMELOSSPERSHARETables"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/NETINCOMELOSSPERSHARETables" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/NETINCOMELOSSPERSHAREAntidilutiveSharesDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#NETINCOMELOSSPERSHAREAntidilutiveSharesDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/NETINCOMELOSSPERSHAREAntidilutiveSharesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/RELATEDPARTIES" xlink:type="simple" xlink:href="cvsi-20201231.xsd#RELATEDPARTIES"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/RELATEDPARTIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#RELATEDPARTIESNarrativeDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="cvsi-20201231.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIESLawsuitsDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#COMMITMENTSANDCONTINGENCIESLawsuitsDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIESLawsuitsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/LEASES" xlink:type="simple" xlink:href="cvsi-20201231.xsd#LEASES"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/LEASES" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/LEASESTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#LEASESTables"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/LEASESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#LEASESNarrativeDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/LEASESNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/LEASESRightofuseAssetsandLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#LEASESRightofuseAssetsandLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/LEASESRightofuseAssetsandLeaseLiabilitiesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#LEASESMaturityofLeaseLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0d208595-2268-4048-abfe-3561c1453f07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5fc641a7-0c12-45d8-99eb-399e4d09b65c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0d208595-2268-4048-abfe-3561c1453f07" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_5fc641a7-0c12-45d8-99eb-399e4d09b65c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_af65ecfc-458b-42cc-a8d5-6d44cd2904e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0d208595-2268-4048-abfe-3561c1453f07" xlink:to="loc_us-gaap_OperatingLeaseLiability_af65ecfc-458b-42cc-a8d5-6d44cd2904e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_13ca5eda-0486-4975-ba0c-720f6ead0c88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8e2107cd-ed7b-45fc-b7fb-2cea41973910" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_13ca5eda-0486-4975-ba0c-720f6ead0c88" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8e2107cd-ed7b-45fc-b7fb-2cea41973910" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_58e88f5f-4e02-4139-86cc-e79b23a970f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_13ca5eda-0486-4975-ba0c-720f6ead0c88" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_58e88f5f-4e02-4139-86cc-e79b23a970f0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="cvsi-20201231.xsd#LEASESMaturityofLeaseLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0ef4af7e-ba8d-44c3-bb61-46455cc6fb95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_612070fa-eb6e-4c28-9a74-3f32359adddf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0ef4af7e-ba8d-44c3-bb61-46455cc6fb95" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_612070fa-eb6e-4c28-9a74-3f32359adddf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_60ff06be-c313-468a-94d6-f8318327b93b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0ef4af7e-ba8d-44c3-bb61-46455cc6fb95" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_60ff06be-c313-468a-94d6-f8318327b93b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_4adb58e4-09d1-4fa8-a556-4208a08d601d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0ef4af7e-ba8d-44c3-bb61-46455cc6fb95" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_4adb58e4-09d1-4fa8-a556-4208a08d601d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_dcdadb38-bfd6-488c-bacc-1c935e6011ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0ef4af7e-ba8d-44c3-bb61-46455cc6fb95" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_dcdadb38-bfd6-488c-bacc-1c935e6011ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_df76ce65-eb9d-4af1-8a8d-e6784fd7c516" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0ef4af7e-ba8d-44c3-bb61-46455cc6fb95" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_df76ce65-eb9d-4af1-8a8d-e6784fd7c516" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_5cac73c4-95d3-4010-9b91-3f708470b677" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0ef4af7e-ba8d-44c3-bb61-46455cc6fb95" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_5cac73c4-95d3-4010-9b91-3f708470b677" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/SEGMENTINFORMATION" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SEGMENTINFORMATION"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/SEGMENTINFORMATION" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/SEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SEGMENTINFORMATIONTables"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/SEGMENTINFORMATIONTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/SEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SEGMENTINFORMATIONDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/SEGMENTINFORMATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_e29b11ba-04fb-49bf-bc43-2a4a84be460c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_d3abd3c8-f8c6-44bf-9571-d1bbecd7ec70" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_e29b11ba-04fb-49bf-bc43-2a4a84be460c" xlink:to="loc_us-gaap_GrossProfit_d3abd3c8-f8c6-44bf-9571-d1bbecd7ec70" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_0699508e-01f3-4797-9825-5405c25e51ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_e29b11ba-04fb-49bf-bc43-2a4a84be460c" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_0699508e-01f3-4797-9825-5405c25e51ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ab54ccd7-64f1-4a86-ad93-5a5f4b27b4b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_e29b11ba-04fb-49bf-bc43-2a4a84be460c" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_ab54ccd7-64f1-4a86-ad93-5a5f4b27b4b1" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INCOMETAXES" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INCOMETAXES"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/INCOMETAXES" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INCOMETAXESTables"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/INCOMETAXESTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f547396e-1737-4966-8d08-082150e97eed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_79191dd2-de75-4bf4-94f9-f4ea13504730" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f547396e-1737-4966-8d08-082150e97eed" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_79191dd2-de75-4bf4-94f9-f4ea13504730" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_5dbbfd93-25ec-496d-9769-60d50435ecf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f547396e-1737-4966-8d08-082150e97eed" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_5dbbfd93-25ec-496d-9769-60d50435ecf4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_7e64bbdd-43e0-4ca6-a5f0-54290fb2fd00" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_682c0bf4-3e0a-4f8f-a9fb-676890495793" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_7e64bbdd-43e0-4ca6-a5f0-54290fb2fd00" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_682c0bf4-3e0a-4f8f-a9fb-676890495793" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_835d2583-75c5-4ae9-9cce-a13301344e6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_7e64bbdd-43e0-4ca6-a5f0-54290fb2fd00" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_835d2583-75c5-4ae9-9cce-a13301344e6c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_05f7b6fe-abfe-4ae4-988b-13fdb23d446f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_c16f981a-587f-4d55-8911-1ae8ce5133d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_05f7b6fe-abfe-4ae4-988b-13fdb23d446f" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_c16f981a-587f-4d55-8911-1ae8ce5133d5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_dec0d527-e510-42ec-a28c-d26bf3e56a36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_05f7b6fe-abfe-4ae4-988b-13fdb23d446f" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_dec0d527-e510-42ec-a28c-d26bf3e56a36" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INCOMETAXESIncomeTaxProvisionDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b37c8808-5acf-46b5-bcf1-9400dfa2062e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_b1102bad-3d39-4cff-a3b2-8a09d92e1de0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b37c8808-5acf-46b5-bcf1-9400dfa2062e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_b1102bad-3d39-4cff-a3b2-8a09d92e1de0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_ec6b335f-b219-4b5b-9d0b-797a4f68af1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b37c8808-5acf-46b5-bcf1-9400dfa2062e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_ec6b335f-b219-4b5b-9d0b-797a4f68af1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_d88ba45c-b5c4-46ee-a7f4-c0a0ccb31371" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b37c8808-5acf-46b5-bcf1-9400dfa2062e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_d88ba45c-b5c4-46ee-a7f4-c0a0ccb31371" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_69598f80-8005-4d99-9ebf-80bd55f2d6df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b37c8808-5acf-46b5-bcf1-9400dfa2062e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_69598f80-8005-4d99-9ebf-80bd55f2d6df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent_3cc0ac8d-c271-459b-a154-8e1e8eb66ee4" xlink:href="cvsi-20201231.xsd#cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b37c8808-5acf-46b5-bcf1-9400dfa2062e" xlink:to="loc_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent_3cc0ac8d-c271-459b-a154-8e1e8eb66ee4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_bfeb87b1-bfc4-44d5-9a7c-3c0e810de13b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b37c8808-5acf-46b5-bcf1-9400dfa2062e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_bfeb87b1-bfc4-44d5-9a7c-3c0e810de13b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_672ea358-55cf-415f-9408-5541df573061" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b37c8808-5acf-46b5-bcf1-9400dfa2062e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_672ea358-55cf-415f-9408-5541df573061" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_98d0c243-4bd0-44d6-8c65-8db0c8c4adb6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_b37c8808-5acf-46b5-bcf1-9400dfa2062e" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_98d0c243-4bd0-44d6-8c65-8db0c8c4adb6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_390a8778-4787-4690-b8cd-687f0a34d86f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3b2aeaea-03c2-48ae-b9c5-a2db4b6b208c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_390a8778-4787-4690-b8cd-687f0a34d86f" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_3b2aeaea-03c2-48ae-b9c5-a2db4b6b208c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_bb9fe132-fe6b-4e92-8526-a397138762e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_390a8778-4787-4690-b8cd-687f0a34d86f" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_bb9fe132-fe6b-4e92-8526-a397138762e2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_f709e841-0c99-4f6c-a316-e4dc53da6677" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_390a8778-4787-4690-b8cd-687f0a34d86f" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_f709e841-0c99-4f6c-a316-e4dc53da6677" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_9871fc87-6bec-42a2-ab46-9b00bd68f8bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_390a8778-4787-4690-b8cd-687f0a34d86f" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_9871fc87-6bec-42a2-ab46-9b00bd68f8bd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation_99848123-0f52-4495-92a0-2bd532124487" xlink:href="cvsi-20201231.xsd#cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_390a8778-4787-4690-b8cd-687f0a34d86f" xlink:to="loc_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation_99848123-0f52-4495-92a0-2bd532124487" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_8c2132d6-6c16-4b08-8166-04513d694363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_390a8778-4787-4690-b8cd-687f0a34d86f" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_8c2132d6-6c16-4b08-8166-04513d694363" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_e4aaaed4-2866-4766-8176-dc4f6ad0f50c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_390a8778-4787-4690-b8cd-687f0a34d86f" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_e4aaaed4-2866-4766-8176-dc4f6ad0f50c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_91a77aca-cf04-45eb-be02-ed050de669fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_390a8778-4787-4690-b8cd-687f0a34d86f" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_91a77aca-cf04-45eb-be02-ed050de669fe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INCOMETAXESDeferredIncomeTaxesDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_b1e14c81-3a92-454b-a71c-b10110ae5410" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_c347549b-3ecf-4b21-bd82-d7abdc84a5b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b1e14c81-3a92-454b-a71c-b10110ae5410" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_c347549b-3ecf-4b21-bd82-d7abdc84a5b4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness_99fd193d-0430-4525-bdda-45b50f104389" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b1e14c81-3a92-454b-a71c-b10110ae5410" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness_99fd193d-0430-4525-bdda-45b50f104389" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_f54d9f46-a84e-4754-806e-346a67468530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b1e14c81-3a92-454b-a71c-b10110ae5410" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_f54d9f46-a84e-4754-806e-346a67468530" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_56aca13b-fe5c-4d26-913f-242884ad35e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b1e14c81-3a92-454b-a71c-b10110ae5410" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_56aca13b-fe5c-4d26-913f-242884ad35e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_6e7273fc-8005-4e44-8e38-1fbaf7a370d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b1e14c81-3a92-454b-a71c-b10110ae5410" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_6e7273fc-8005-4e44-8e38-1fbaf7a370d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_DeferredTaxAssetOperatingLeaseLiabilities_ec7b0833-5581-4d03-a688-c9a2e3ba6822" xlink:href="cvsi-20201231.xsd#cvsi_DeferredTaxAssetOperatingLeaseLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b1e14c81-3a92-454b-a71c-b10110ae5410" xlink:to="loc_cvsi_DeferredTaxAssetOperatingLeaseLiabilities_ec7b0833-5581-4d03-a688-c9a2e3ba6822" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_5c176c4f-3ef7-4eb5-85f5-18124dbed072" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_b1e14c81-3a92-454b-a71c-b10110ae5410" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_5c176c4f-3ef7-4eb5-85f5-18124dbed072" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_fef4585b-b192-488f-97b1-ff9cd3ae09c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_DeferredTaxLiabilityOperatingLeaseAssets_a4f48d5c-260b-4bae-883c-73ae7a0de837" xlink:href="cvsi-20201231.xsd#cvsi_DeferredTaxLiabilityOperatingLeaseAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_fef4585b-b192-488f-97b1-ff9cd3ae09c0" xlink:to="loc_cvsi_DeferredTaxLiabilityOperatingLeaseAssets_a4f48d5c-260b-4bae-883c-73ae7a0de837" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_b23fc397-1f11-42a8-9e43-e03dc083abc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_fef4585b-b192-488f-97b1-ff9cd3ae09c0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_b23fc397-1f11-42a8-9e43-e03dc083abc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_571c8b30-1af0-4ea2-875c-b18b83d4c957" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_fef4585b-b192-488f-97b1-ff9cd3ae09c0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_571c8b30-1af0-4ea2-875c-b18b83d4c957" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_83a2f73c-0f66-4f87-9e0b-888304c372b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_fef4585b-b192-488f-97b1-ff9cd3ae09c0" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_83a2f73c-0f66-4f87-9e0b-888304c372b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5afd5f4c-edb2-4abb-b086-5c4947dbf7cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_1e6f2725-e3af-4af7-bfc3-d24810b429e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5afd5f4c-edb2-4abb-b086-5c4947dbf7cd" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_1e6f2725-e3af-4af7-bfc3-d24810b429e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_422dc5fb-55cf-47b7-82ef-d385e4a58709" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5afd5f4c-edb2-4abb-b086-5c4947dbf7cd" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_422dc5fb-55cf-47b7-82ef-d385e4a58709" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_c8cc82bd-8eea-4e06-8b92-a450d04f2803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_5afd5f4c-edb2-4abb-b086-5c4947dbf7cd" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_c8cc82bd-8eea-4e06-8b92-a450d04f2803" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INCOMETAXESNarrativeDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/INCOMETAXESUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INCOMETAXESUnrecognizedTaxBenefitsDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/INCOMETAXESUnrecognizedTaxBenefitsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/SUBSEQUENTEVENT" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUBSEQUENTEVENT"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/SUBSEQUENTEVENT" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/SUBSEQUENTEVENTDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUBSEQUENTEVENTDetails"/>
  <link:calculationLink xlink:role="http://cvsciences.com/role/SUBSEQUENTEVENTDetails" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>9
<FILENAME>cvsi-20201231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:eca8e0c2-d550-4e97-a9fa-88ee2e9b3168,g:095536f4-fd9c-45bc-aa88-ebcfe4d45a75-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://cvsciences.com/role/Cover" xlink:type="simple" xlink:href="cvsi-20201231.xsd#Cover"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/Cover" xlink:type="extended" id="iff287991a48e4b5d9b3d5a1507dc96ae_Cover"/>
  <link:roleRef roleURI="http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="cvsi-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended" id="ib83b8c643b7a45dfbdb0a0086efa3cac_CONSOLIDATEDBALANCESHEETS"/>
  <link:roleRef roleURI="http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="cvsi-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended" id="i66097d4bff4b4f25b1dfeadf66276dae_CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:roleRef roleURI="http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="cvsi-20201231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended" id="i008b0b7666a84b2bb854a40b1c284208_CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:roleRef roleURI="http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="cvsi-20201231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="i8ca7169da54c4526ae9378f319f767b4_CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_2848acfc-5ba6-428a-8279-a9e66a0c0e02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:to="loc_us-gaap_SharesOutstanding_2848acfc-5ba6-428a-8279-a9e66a0c0e02" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ad5ed022-e573-490e-9e8f-ca6f274d64ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:to="loc_us-gaap_StockholdersEquity_ad5ed022-e573-490e-9e8f-ca6f274d64ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_04ab727d-4b89-41b8-9b29-bd03df9e5a26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_04ab727d-4b89-41b8-9b29-bd03df9e5a26" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_d82c0996-adea-4e59-bf8d-561ec2f685c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_d82c0996-adea-4e59-bf8d-561ec2f685c6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement_c356f1ca-d197-4683-8a99-0fbe0237a189" xlink:href="cvsi-20201231.xsd#cvsi_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:to="loc_cvsi_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement_c356f1ca-d197-4683-8a99-0fbe0237a189" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_StockIssuedDuringPeriodSharesEquityCommitment_540dc593-0c8a-4bf8-8aca-384c2bf803b5" xlink:href="cvsi-20201231.xsd#cvsi_StockIssuedDuringPeriodSharesEquityCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:to="loc_cvsi_StockIssuedDuringPeriodSharesEquityCommitment_540dc593-0c8a-4bf8-8aca-384c2bf803b5" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_StockIssuedDuringPeriodValueEquityCommitment_d4f9faa3-3f4f-4f32-88d0-7cbfdac63b2b" xlink:href="cvsi-20201231.xsd#cvsi_StockIssuedDuringPeriodValueEquityCommitment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:to="loc_cvsi_StockIssuedDuringPeriodValueEquityCommitment_d4f9faa3-3f4f-4f32-88d0-7cbfdac63b2b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_aed958ad-ab97-4252-af7e-56ef4408f955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_aed958ad-ab97-4252-af7e-56ef4408f955" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f8c39a7f-c4ce-4453-bb7b-1487eee7d260" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:to="loc_us-gaap_NetIncomeLoss_f8c39a7f-c4ce-4453-bb7b-1487eee7d260" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_603d0cef-9009-4753-81d3-c95c0c286bfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_312c69c8-306a-463f-b0a5-03128db86862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_00c60ae3-2aca-44c2-a9a1-39edaf62a6ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:to="loc_us-gaap_StatementTable_00c60ae3-2aca-44c2-a9a1-39edaf62a6ec" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ffe49b13-c648-490d-bb6c-921ecf04fba9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_00c60ae3-2aca-44c2-a9a1-39edaf62a6ec" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ffe49b13-c648-490d-bb6c-921ecf04fba9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_ffe49b13-c648-490d-bb6c-921ecf04fba9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ffe49b13-c648-490d-bb6c-921ecf04fba9" xlink:to="loc_us-gaap_EquityComponentDomain_ffe49b13-c648-490d-bb6c-921ecf04fba9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a5ce6ca3-ba39-4297-af64-91352ddfe8ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ffe49b13-c648-490d-bb6c-921ecf04fba9" xlink:to="loc_us-gaap_EquityComponentDomain_a5ce6ca3-ba39-4297-af64-91352ddfe8ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7d44add4-dca4-4583-b0cc-456bf55858d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a5ce6ca3-ba39-4297-af64-91352ddfe8ec" xlink:to="loc_us-gaap_CommonStockMember_7d44add4-dca4-4583-b0cc-456bf55858d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_bf1aaa2b-09ba-4dbe-9aa9-6c8dca102553" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a5ce6ca3-ba39-4297-af64-91352ddfe8ec" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_bf1aaa2b-09ba-4dbe-9aa9-6c8dca102553" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_407cb05f-07f7-4d99-8c6d-504edde01c0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_a5ce6ca3-ba39-4297-af64-91352ddfe8ec" xlink:to="loc_us-gaap_RetainedEarningsMember_407cb05f-07f7-4d99-8c6d-504edde01c0e" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW" xlink:type="simple" xlink:href="cvsi-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOW"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW" xlink:type="extended" id="i31427356c4cb4e978a0952e5b88f82c2_CONSOLIDATEDSTATEMENTSOFCASHFLOW"/>
  <link:roleRef roleURI="http://cvsciences.com/role/ORGANIZATIONANDBUSINESS" xlink:type="simple" xlink:href="cvsi-20201231.xsd#ORGANIZATIONANDBUSINESS"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/ORGANIZATIONANDBUSINESS" xlink:type="extended" id="ia63d45762f014f579c470e8e683a0176_ORGANIZATIONANDBUSINESS"/>
  <link:roleRef roleURI="http://cvsciences.com/role/ORGANIZATIONANDBUSINESSDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#ORGANIZATIONANDBUSINESSDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/ORGANIZATIONANDBUSINESSDetails" xlink:type="extended" id="if88c4d77283c4abdadf04c24cf1e36cf_ORGANIZATIONANDBUSINESSDetails"/>
  <link:roleRef roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended" id="i76012b916005488dbe64d26008d7aab8_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:roleRef roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended" id="i37ffc988a699439cb5ab671ecbc38b2f_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:roleRef roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended" id="ie6ff997dba804aecb08cd8763c7c12f5_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:roleRef roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended" id="ie93f5a1dee0e4f6788482a0c5acae2ab_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_fc7eb3af-a4c2-49b1-901c-480292fc40ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_fc7eb3af-a4c2-49b1-901c-480292fc40ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_debf4e04-958e-41b7-95c2-9ca7a8a2190b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_debf4e04-958e-41b7-95c2-9ca7a8a2190b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashUninsuredAmount_42529a0d-fa46-41eb-b9fc-cb0ee3672ca7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashUninsuredAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_CashUninsuredAmount_42529a0d-fa46-41eb-b9fc-cb0ee3672ca7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_NumberofSuppliers_ff4cdbfc-1d69-4e77-8f9e-a1a5c4b3bbc7" xlink:href="cvsi-20201231.xsd#cvsi_NumberofSuppliers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_cvsi_NumberofSuppliers_ff4cdbfc-1d69-4e77-8f9e-a1a5c4b3bbc7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_NumberOfAdditionalSuppliers_b5ac5ee3-d693-488a-98a0-d4ad7dfbf554" xlink:href="cvsi-20201231.xsd#cvsi_NumberOfAdditionalSuppliers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_cvsi_NumberOfAdditionalSuppliers_b5ac5ee3-d693-488a-98a0-d4ad7dfbf554" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f35da28a-5d4b-43c5-8429-1d4f79827a53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f35da28a-5d4b-43c5-8429-1d4f79827a53" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromUnsecuredNotesPayable_897decf1-46bf-4ac0-9ce5-598763551f5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromUnsecuredNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_ProceedsFromUnsecuredNotesPayable_897decf1-46bf-4ac0-9ce5-598763551f5e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction_29c080d0-7a7a-4b01-b0fa-a911c2b2a052" xlink:href="cvsi-20201231.xsd#cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction_29c080d0-7a7a-4b01-b0fa-a911c2b2a052" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_919e4424-7a2a-4127-9b97-ef99b6e2c180" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_Cash_919e4424-7a2a-4127-9b97-ef99b6e2c180" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_e09045e7-608b-441d-bef7-1335a8b7be31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_e09045e7-608b-441d-bef7-1335a8b7be31" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_AccountsReceivableThresholdforDeterminingDelinquentAccount_d6144d4d-c4d9-41d1-a207-06381d9de519" xlink:href="cvsi-20201231.xsd#cvsi_AccountsReceivableThresholdforDeterminingDelinquentAccount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_cvsi_AccountsReceivableThresholdforDeterminingDelinquentAccount_d6144d4d-c4d9-41d1-a207-06381d9de519" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_6a4a5868-d74d-4e68-bdd1-addb8484ec8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_6a4a5868-d74d-4e68-bdd1-addb8484ec8f" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_99357a33-3066-4339-801d-9f0c9f43a09c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_99357a33-3066-4339-801d-9f0c9f43a09c" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_499c72f1-e2cb-4042-a055-e2fb0e4dd604" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_499c72f1-e2cb-4042-a055-e2fb0e4dd604" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_623c6ecf-acad-4751-b711-f6eafbf9c42f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_623c6ecf-acad-4751-b711-f6eafbf9c42f" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_eef87599-ccc3-48fb-8321-1a9b6bda847e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_eef87599-ccc3-48fb-8321-1a9b6bda847e" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_2050a65c-fce9-488c-a6eb-3579611ac63d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_2050a65c-fce9-488c-a6eb-3579611ac63d" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_340ad867-7bf4-47a2-a26c-830d479e7abf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_AdvertisingExpense_340ad867-7bf4-47a2-a26c-830d479e7abf" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e584f9cd-02dd-4762-8845-318c7de9f953" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e584f9cd-02dd-4762-8845-318c7de9f953" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_333cddd5-3ef6-4e5e-b6a7-6698ab07713d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_333cddd5-3ef6-4e5e-b6a7-6698ab07713d" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5df08e4b-d01f-4ec3-a549-03bb12b3fdd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5df08e4b-d01f-4ec3-a549-03bb12b3fdd6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_5eb87459-9245-4bc4-a768-36f81b27259d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5df08e4b-d01f-4ec3-a549-03bb12b3fdd6" xlink:to="loc_srt_OwnershipAxis_5eb87459-9245-4bc4-a768-36f81b27259d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_5eb87459-9245-4bc4-a768-36f81b27259d_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_OwnershipAxis_5eb87459-9245-4bc4-a768-36f81b27259d" xlink:to="loc_srt_OwnershipDomain_5eb87459-9245-4bc4-a768-36f81b27259d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_e634aef6-ae0c-4796-9e44-f0edad5faf6f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_OwnershipAxis_5eb87459-9245-4bc4-a768-36f81b27259d" xlink:to="loc_srt_OwnershipDomain_e634aef6-ae0c-4796-9e44-f0edad5faf6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_CannaVestEuropeGmbHMember_fa0030db-827f-4998-924a-1f5cbf14c3cc" xlink:href="cvsi-20201231.xsd#cvsi_CannaVestEuropeGmbHMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_OwnershipDomain_e634aef6-ae0c-4796-9e44-f0edad5faf6f" xlink:to="loc_cvsi_CannaVestEuropeGmbHMember_fa0030db-827f-4998-924a-1f5cbf14c3cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_3ef0d247-3eb2-498e-9466-0ca22b27f7d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5df08e4b-d01f-4ec3-a549-03bb12b3fdd6" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_3ef0d247-3eb2-498e-9466-0ca22b27f7d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_3ef0d247-3eb2-498e-9466-0ca22b27f7d7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_3ef0d247-3eb2-498e-9466-0ca22b27f7d7" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_3ef0d247-3eb2-498e-9466-0ca22b27f7d7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_c539126c-588d-4392-9c83-18bc1cf953d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_3ef0d247-3eb2-498e-9466-0ca22b27f7d7" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_c539126c-588d-4392-9c83-18bc1cf953d0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_022f890a-fa0a-4457-80e5-dd1ca50d0a41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_c539126c-588d-4392-9c83-18bc1cf953d0" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_022f890a-fa0a-4457-80e5-dd1ca50d0a41" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31b97b60-38ed-4f73-b73f-3b9cc60334a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5df08e4b-d01f-4ec3-a549-03bb12b3fdd6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31b97b60-38ed-4f73-b73f-3b9cc60334a2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_31b97b60-38ed-4f73-b73f-3b9cc60334a2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31b97b60-38ed-4f73-b73f-3b9cc60334a2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_31b97b60-38ed-4f73-b73f-3b9cc60334a2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_16e5678a-8c7f-45bb-b5c4-4745280632ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31b97b60-38ed-4f73-b73f-3b9cc60334a2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_16e5678a-8c7f-45bb-b5c4-4745280632ca" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_f8b7f6a7-27c0-4c02-8c41-ad2e7ba31172" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_16e5678a-8c7f-45bb-b5c4-4745280632ca" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_f8b7f6a7-27c0-4c02-8c41-ad2e7ba31172" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_02bd3cf4-d0fe-4ac2-b047-b553c3c161d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5df08e4b-d01f-4ec3-a549-03bb12b3fdd6" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_02bd3cf4-d0fe-4ac2-b047-b553c3c161d4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_02bd3cf4-d0fe-4ac2-b047-b553c3c161d4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_02bd3cf4-d0fe-4ac2-b047-b553c3c161d4" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_02bd3cf4-d0fe-4ac2-b047-b553c3c161d4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_bf819efc-a045-4f19-9f0c-43c9ad10d65a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_02bd3cf4-d0fe-4ac2-b047-b553c3c161d4" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_bf819efc-a045-4f19-9f0c-43c9ad10d65a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_CommonStockPurchaseAgreementMember_f6b2dc77-f706-4104-a8be-e6df83e33eb4" xlink:href="cvsi-20201231.xsd#cvsi_CommonStockPurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_bf819efc-a045-4f19-9f0c-43c9ad10d65a" xlink:to="loc_cvsi_CommonStockPurchaseAgreementMember_f6b2dc77-f706-4104-a8be-e6df83e33eb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_51b1856a-2adb-476c-acd2-508b2fb795a8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5df08e4b-d01f-4ec3-a549-03bb12b3fdd6" xlink:to="loc_srt_ProductOrServiceAxis_51b1856a-2adb-476c-acd2-508b2fb795a8" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_51b1856a-2adb-476c-acd2-508b2fb795a8_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_51b1856a-2adb-476c-acd2-508b2fb795a8" xlink:to="loc_srt_ProductsAndServicesDomain_51b1856a-2adb-476c-acd2-508b2fb795a8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0a37a9e8-f9ae-4217-9e49-ee4443dacff1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_51b1856a-2adb-476c-acd2-508b2fb795a8" xlink:to="loc_srt_ProductsAndServicesDomain_0a37a9e8-f9ae-4217-9e49-ee4443dacff1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_4efcb946-576b-43fe-a9fc-1e8947fd9d94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_0a37a9e8-f9ae-4217-9e49-ee4443dacff1" xlink:to="loc_us-gaap_ShippingAndHandlingMember_4efcb946-576b-43fe-a9fc-1e8947fd9d94" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_02c90e18-8d59-431e-aca3-2ffa825b466b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5df08e4b-d01f-4ec3-a549-03bb12b3fdd6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_02c90e18-8d59-431e-aca3-2ffa825b466b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_02c90e18-8d59-431e-aca3-2ffa825b466b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_02c90e18-8d59-431e-aca3-2ffa825b466b" xlink:to="loc_us-gaap_SegmentDomain_02c90e18-8d59-431e-aca3-2ffa825b466b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e3a057f6-062a-4e96-a43f-9a2ea41bf2fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_02c90e18-8d59-431e-aca3-2ffa825b466b" xlink:to="loc_us-gaap_SegmentDomain_e3a057f6-062a-4e96-a43f-9a2ea41bf2fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_ConsumerProductsMember_6b06d6ad-2607-4398-83b8-a5be735b7208" xlink:href="cvsi-20201231.xsd#cvsi_ConsumerProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e3a057f6-062a-4e96-a43f-9a2ea41bf2fc" xlink:to="loc_cvsi_ConsumerProductsMember_6b06d6ad-2607-4398-83b8-a5be735b7208" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SpecialtyPharmaceuticalSegmentMember_4af231a3-65ff-4884-8215-96a89ba914b4" xlink:href="cvsi-20201231.xsd#cvsi_SpecialtyPharmaceuticalSegmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_e3a057f6-062a-4e96-a43f-9a2ea41bf2fc" xlink:to="loc_cvsi_SpecialtyPharmaceuticalSegmentMember_4af231a3-65ff-4884-8215-96a89ba914b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3740f536-60cf-46da-9c0a-341fd4be57da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5df08e4b-d01f-4ec3-a549-03bb12b3fdd6" xlink:to="loc_us-gaap_AwardTypeAxis_3740f536-60cf-46da-9c0a-341fd4be57da" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3740f536-60cf-46da-9c0a-341fd4be57da_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_3740f536-60cf-46da-9c0a-341fd4be57da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_3740f536-60cf-46da-9c0a-341fd4be57da_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_777845a0-5df4-4096-91bd-885df7405e67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_3740f536-60cf-46da-9c0a-341fd4be57da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_777845a0-5df4-4096-91bd-885df7405e67" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_e66e1231-cebd-41cf-b431-1264f43bf28d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_777845a0-5df4-4096-91bd-885df7405e67" xlink:to="loc_us-gaap_StockOptionMember_e66e1231-cebd-41cf-b431-1264f43bf28d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9341c64b-a9ba-4d2c-b434-d5982491e7dc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5df08e4b-d01f-4ec3-a549-03bb12b3fdd6" xlink:to="loc_srt_RangeAxis_9341c64b-a9ba-4d2c-b434-d5982491e7dc" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9341c64b-a9ba-4d2c-b434-d5982491e7dc_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9341c64b-a9ba-4d2c-b434-d5982491e7dc" xlink:to="loc_srt_RangeMember_9341c64b-a9ba-4d2c-b434-d5982491e7dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8e83b00c-936e-4ecc-b150-a377e4cdc40f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9341c64b-a9ba-4d2c-b434-d5982491e7dc" xlink:to="loc_srt_RangeMember_8e83b00c-936e-4ecc-b150-a377e4cdc40f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cdfc3b1d-9c2e-448c-9fc3-38e7bd3e6a4b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8e83b00c-936e-4ecc-b150-a377e4cdc40f" xlink:to="loc_srt_MinimumMember_cdfc3b1d-9c2e-448c-9fc3-38e7bd3e6a4b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_98cdcdcf-ebb0-4629-8120-58cc54f40392" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_8e83b00c-936e-4ecc-b150-a377e4cdc40f" xlink:to="loc_srt_MaximumMember_98cdcdcf-ebb0-4629-8120-58cc54f40392" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended" id="i1604c52184134576888a8e8fa8ac2f02_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:roleRef roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails" xlink:type="extended" id="i9981ad7fd7554614af678efc651d5f13_SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_26063ecc-c0d0-40bf-9037-6fdc1435ba31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2575724e-4636-4b0c-9b06-60eb6052884f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_26063ecc-c0d0-40bf-9037-6fdc1435ba31" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2575724e-4636-4b0c-9b06-60eb6052884f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_6b67d711-e29a-41fc-aecb-4aa19f2846b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_26063ecc-c0d0-40bf-9037-6fdc1435ba31" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_6b67d711-e29a-41fc-aecb-4aa19f2846b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_95c1cf6e-573f-4145-b192-416efce8ffb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_26063ecc-c0d0-40bf-9037-6fdc1435ba31" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_95c1cf6e-573f-4145-b192-416efce8ffb4" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_0f4ab2ce-af13-4e14-b67c-4d09b7e5ce83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_95c1cf6e-573f-4145-b192-416efce8ffb4" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_0f4ab2ce-af13-4e14-b67c-4d09b7e5ce83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_0f4ab2ce-af13-4e14-b67c-4d09b7e5ce83_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_0f4ab2ce-af13-4e14-b67c-4d09b7e5ce83" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_0f4ab2ce-af13-4e14-b67c-4d09b7e5ce83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_12a2380e-6d68-4474-a9c5-63e3eac77533" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_0f4ab2ce-af13-4e14-b67c-4d09b7e5ce83" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_12a2380e-6d68-4474-a9c5-63e3eac77533" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_RetailFDMMember_5db45bf4-2398-4698-8cb2-c05d3c0da794" xlink:href="cvsi-20201231.xsd#cvsi_RetailFDMMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_12a2380e-6d68-4474-a9c5-63e3eac77533" xlink:to="loc_cvsi_RetailFDMMember_5db45bf4-2398-4698-8cb2-c05d3c0da794" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_RetailNaturalProductsAndOtherMember_ab330c29-4339-4b67-87e8-72ff4197f852" xlink:href="cvsi-20201231.xsd#cvsi_RetailNaturalProductsAndOtherMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_12a2380e-6d68-4474-a9c5-63e3eac77533" xlink:to="loc_cvsi_RetailNaturalProductsAndOtherMember_ab330c29-4339-4b67-87e8-72ff4197f852" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_ECommMember_8047814a-d4be-4c5c-be28-1e965412d06c" xlink:href="cvsi-20201231.xsd#cvsi_ECommMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_12a2380e-6d68-4474-a9c5-63e3eac77533" xlink:to="loc_cvsi_ECommMember_8047814a-d4be-4c5c-be28-1e965412d06c" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INVENTORY" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INVENTORY"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/INVENTORY" xlink:type="extended" id="i82ddbffc887b45a496d480a0616e79ed_INVENTORY"/>
  <link:roleRef roleURI="http://cvsciences.com/role/INVENTORYTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INVENTORYTables"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/INVENTORYTables" xlink:type="extended" id="i282faa009018479fb7fd46ab63931128_INVENTORYTables"/>
  <link:roleRef roleURI="http://cvsciences.com/role/INVENTORYDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INVENTORYDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/INVENTORYDetails" xlink:type="extended" id="i4958d988d91b40c8b2e776a591c30fc2_INVENTORYDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_973225a3-1b7a-4fd5-8867-945cb46a2322" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_de582522-fe88-4d34-9fe2-cfc1d908f1f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_973225a3-1b7a-4fd5-8867-945cb46a2322" xlink:to="loc_us-gaap_InventoryRawMaterials_de582522-fe88-4d34-9fe2-cfc1d908f1f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_5add666d-afdd-4aa7-a064-897bc7f1c307" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_973225a3-1b7a-4fd5-8867-945cb46a2322" xlink:to="loc_us-gaap_InventoryWorkInProcess_5add666d-afdd-4aa7-a064-897bc7f1c307" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_cb1b88a4-91e8-437b-8f0d-dbc7a74c0387" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_973225a3-1b7a-4fd5-8867-945cb46a2322" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_cb1b88a4-91e8-437b-8f0d-dbc7a74c0387" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross_0125ad06-9b08-4283-b1a6-f7009e1db943" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_973225a3-1b7a-4fd5-8867-945cb46a2322" xlink:to="loc_us-gaap_InventoryGross_0125ad06-9b08-4283-b1a6-f7009e1db943" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_f5edf03a-a27e-4bed-9fee-3d01e1f8a2bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_InventoryLineItems_973225a3-1b7a-4fd5-8867-945cb46a2322" xlink:to="loc_us-gaap_InventoryValuationReserves_f5edf03a-a27e-4bed-9fee-3d01e1f8a2bc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_5f5997de-dc2f-4d81-b4c1-f3b42b21beae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_InventoryLineItems_973225a3-1b7a-4fd5-8867-945cb46a2322" xlink:to="loc_us-gaap_InventoryCurrentTable_5f5997de-dc2f-4d81-b4c1-f3b42b21beae" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6a4522e9-bba0-44c9-8d46-3194c7da3df7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_InventoryCurrentTable_5f5997de-dc2f-4d81-b4c1-f3b42b21beae" xlink:to="loc_srt_StatementGeographicalAxis_6a4522e9-bba0-44c9-8d46-3194c7da3df7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_6a4522e9-bba0-44c9-8d46-3194c7da3df7_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_6a4522e9-bba0-44c9-8d46-3194c7da3df7" xlink:to="loc_srt_SegmentGeographicalDomain_6a4522e9-bba0-44c9-8d46-3194c7da3df7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1e076113-bbc6-47f2-ae51-c3133ed08d9b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_6a4522e9-bba0-44c9-8d46-3194c7da3df7" xlink:to="loc_srt_SegmentGeographicalDomain_1e076113-bbc6-47f2-ae51-c3133ed08d9b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_6c4cf926-5e85-4e3c-b1ab-3278802c847c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_1e076113-bbc6-47f2-ae51-c3133ed08d9b" xlink:to="loc_us-gaap_NonUsMember_6c4cf926-5e85-4e3c-b1ab-3278802c847c" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cvsciences.com/role/PROPERTYEQUIPMENT" xlink:type="simple" xlink:href="cvsi-20201231.xsd#PROPERTYEQUIPMENT"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/PROPERTYEQUIPMENT" xlink:type="extended" id="i7b58eb98a0fb435eb4e04c2b1b97edd2_PROPERTYEQUIPMENT"/>
  <link:roleRef roleURI="http://cvsciences.com/role/PROPERTYEQUIPMENTTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#PROPERTYEQUIPMENTTables"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/PROPERTYEQUIPMENTTables" xlink:type="extended" id="i08beeded7376493e88bebe6854893371_PROPERTYEQUIPMENTTables"/>
  <link:roleRef roleURI="http://cvsciences.com/role/PROPERTYEQUIPMENTDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#PROPERTYEQUIPMENTDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/PROPERTYEQUIPMENTDetails" xlink:type="extended" id="ia4430acfeeb748eab7f1a9a56369f7c8_PROPERTYEQUIPMENTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ad6a06d4-3732-4e34-a64f-2912d36d5e3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_8cbede0a-618a-4d11-8df9-de5d56c3806e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ad6a06d4-3732-4e34-a64f-2912d36d5e3a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_8cbede0a-618a-4d11-8df9-de5d56c3806e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a4a61669-bdd7-48f1-bd33-dae70f39462a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ad6a06d4-3732-4e34-a64f-2912d36d5e3a" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a4a61669-bdd7-48f1-bd33-dae70f39462a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9888db59-f121-4f66-bee8-167a83fdbce1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ad6a06d4-3732-4e34-a64f-2912d36d5e3a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9888db59-f121-4f66-bee8-167a83fdbce1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_85081aad-12c5-498f-b5a5-23cb6fadb3f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ad6a06d4-3732-4e34-a64f-2912d36d5e3a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_85081aad-12c5-498f-b5a5-23cb6fadb3f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_1928dfcb-3b63-4cff-9bee-3028e49dca26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ad6a06d4-3732-4e34-a64f-2912d36d5e3a" xlink:to="loc_us-gaap_Depreciation_1928dfcb-3b63-4cff-9bee-3028e49dca26" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_85b39b5d-da0e-4043-8615-71a28e20f492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ad6a06d4-3732-4e34-a64f-2912d36d5e3a" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_85b39b5d-da0e-4043-8615-71a28e20f492" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3baaa378-5fad-4c97-92dd-adfd361241f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_85b39b5d-da0e-4043-8615-71a28e20f492" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3baaa378-5fad-4c97-92dd-adfd361241f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3baaa378-5fad-4c97-92dd-adfd361241f4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3baaa378-5fad-4c97-92dd-adfd361241f4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_3baaa378-5fad-4c97-92dd-adfd361241f4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0ecd5837-d495-4a48-8081-0c295bb32247" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3baaa378-5fad-4c97-92dd-adfd361241f4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0ecd5837-d495-4a48-8081-0c295bb32247" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_5daa27f4-f126-4ea1-99d8-b13414dda070" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0ecd5837-d495-4a48-8081-0c295bb32247" xlink:to="loc_us-gaap_OfficeEquipmentMember_5daa27f4-f126-4ea1-99d8-b13414dda070" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember_a96c6ac7-7f15-4fd9-bf8e-0e9ade9f07ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0ecd5837-d495-4a48-8081-0c295bb32247" xlink:to="loc_us-gaap_BuildingImprovementsMember_a96c6ac7-7f15-4fd9-bf8e-0e9ade9f07ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_sic_Z3821_cf8a44b0-c8fb-486b-9fd7-0f4f5a503419" xlink:href="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd#sic_Z3821"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0ecd5837-d495-4a48-8081-0c295bb32247" xlink:to="loc_sic_Z3821_cf8a44b0-c8fb-486b-9fd7-0f4f5a503419" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_3ac8eb18-0dcb-4573-acb8-47f05b0250da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0ecd5837-d495-4a48-8081-0c295bb32247" xlink:to="loc_us-gaap_ConstructionInProgressMember_3ac8eb18-0dcb-4573-acb8-47f05b0250da" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_46be6afd-2fc1-4f5c-b925-1b9f6bbc0c87" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_85b39b5d-da0e-4043-8615-71a28e20f492" xlink:to="loc_srt_RangeAxis_46be6afd-2fc1-4f5c-b925-1b9f6bbc0c87" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_46be6afd-2fc1-4f5c-b925-1b9f6bbc0c87_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_46be6afd-2fc1-4f5c-b925-1b9f6bbc0c87" xlink:to="loc_srt_RangeMember_46be6afd-2fc1-4f5c-b925-1b9f6bbc0c87_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dace5701-617c-47af-b0f9-84c17e6a20ac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_46be6afd-2fc1-4f5c-b925-1b9f6bbc0c87" xlink:to="loc_srt_RangeMember_dace5701-617c-47af-b0f9-84c17e6a20ac" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_66dbb4c0-15d0-4c80-9c7d-8ecff0c043f7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dace5701-617c-47af-b0f9-84c17e6a20ac" xlink:to="loc_srt_MinimumMember_66dbb4c0-15d0-4c80-9c7d-8ecff0c043f7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_18a7e900-a41f-4131-8ae9-b09dae31f939" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dace5701-617c-47af-b0f9-84c17e6a20ac" xlink:to="loc_srt_MaximumMember_18a7e900-a41f-4131-8ae9-b09dae31f939" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INTANGIBLEASSETS" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INTANGIBLEASSETS"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/INTANGIBLEASSETS" xlink:type="extended" id="i4e336e4f641a402e8854de67e8ad775d_INTANGIBLEASSETS"/>
  <link:roleRef roleURI="http://cvsciences.com/role/INTANGIBLEASSETSTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INTANGIBLEASSETSTables"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/INTANGIBLEASSETSTables" xlink:type="extended" id="i7871b98edaed4bda891b0ff951eb9c45_INTANGIBLEASSETSTables"/>
  <link:roleRef roleURI="http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INTANGIBLEASSETSIntangibleAssetScheduleDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails" xlink:type="extended" id="i40885245d6764560ac21f40dde5e6ac5_INTANGIBLEASSETSIntangibleAssetScheduleDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_23c7b936-fa45-4fa9-bd39-b2e114df48ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_51545c37-30a0-4c31-a96c-68292aae0c3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_23c7b936-fa45-4fa9-bd39-b2e114df48ae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_51545c37-30a0-4c31-a96c-68292aae0c3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b89725c1-ac78-4b30-80cd-0c34058e18ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_23c7b936-fa45-4fa9-bd39-b2e114df48ae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b89725c1-ac78-4b30-80cd-0c34058e18ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e410100c-49d9-4765-89c4-3255b7299e2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_23c7b936-fa45-4fa9-bd39-b2e114df48ae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e410100c-49d9-4765-89c4-3255b7299e2e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9a1a21ed-7649-4a71-9efc-de556395f00d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_23c7b936-fa45-4fa9-bd39-b2e114df48ae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9a1a21ed-7649-4a71-9efc-de556395f00d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_55c8562e-3156-4676-a598-0b65c354a04f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_23c7b936-fa45-4fa9-bd39-b2e114df48ae" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_55c8562e-3156-4676-a598-0b65c354a04f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fd957a9d-47d3-41f4-bd24-331cfe67db04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_55c8562e-3156-4676-a598-0b65c354a04f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fd957a9d-47d3-41f4-bd24-331cfe67db04" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fd957a9d-47d3-41f4-bd24-331cfe67db04_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fd957a9d-47d3-41f4-bd24-331cfe67db04" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_fd957a9d-47d3-41f4-bd24-331cfe67db04_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4a87e530-f849-4e03-b359-de1024c9527a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fd957a9d-47d3-41f4-bd24-331cfe67db04" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4a87e530-f849-4e03-b359-de1024c9527a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_ec931194-ac9a-4631-bd20-cd2170d89d9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4a87e530-f849-4e03-b359-de1024c9527a" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_ec931194-ac9a-4631-bd20-cd2170d89d9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_fdbf882d-5c14-4fe1-bc37-3d40515faf29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4a87e530-f849-4e03-b359-de1024c9527a" xlink:to="loc_us-gaap_TradeNamesMember_fdbf882d-5c14-4fe1-bc37-3d40515faf29" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_1028e713-bf5f-492e-a1a1-5a3ba9420536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4a87e530-f849-4e03-b359-de1024c9527a" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_1028e713-bf5f-492e-a1a1-5a3ba9420536" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INTANGIBLEASSETSNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INTANGIBLEASSETSNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/INTANGIBLEASSETSNarrativeDetails" xlink:type="extended" id="i652e32440a6b4549a68d85f4f7b35a89_INTANGIBLEASSETSNarrativeDetails"/>
  <link:roleRef roleURI="http://cvsciences.com/role/ACCRUEDEXPENSES" xlink:type="simple" xlink:href="cvsi-20201231.xsd#ACCRUEDEXPENSES"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/ACCRUEDEXPENSES" xlink:type="extended" id="iee235fd601e549e090ee962d9040a303_ACCRUEDEXPENSES"/>
  <link:roleRef roleURI="http://cvsciences.com/role/ACCRUEDEXPENSESTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#ACCRUEDEXPENSESTables"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/ACCRUEDEXPENSESTables" xlink:type="extended" id="ic52a0285c2a448a5b4de4f40d87d958a_ACCRUEDEXPENSESTables"/>
  <link:roleRef roleURI="http://cvsciences.com/role/ACCRUEDEXPENSESDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#ACCRUEDEXPENSESDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/ACCRUEDEXPENSESDetails" xlink:type="extended" id="i71c523f087cf4a87935bc80f77b482bb_ACCRUEDEXPENSESDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_681d9000-8c41-4779-9083-2e2284d02004" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_0c342fef-d298-40fa-9004-0206d97e9fc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_681d9000-8c41-4779-9083-2e2284d02004" xlink:to="loc_us-gaap_AccruedSalariesCurrent_0c342fef-d298-40fa-9004-0206d97e9fc9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_95c1406e-b4e9-43b0-8adb-b917084c83b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_681d9000-8c41-4779-9083-2e2284d02004" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_95c1406e-b4e9-43b0-8adb-b917084c83b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_c13bb448-6ed8-41a8-a50a-89dc67763f82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_681d9000-8c41-4779-9083-2e2284d02004" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_c13bb448-6ed8-41a8-a50a-89dc67763f82" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9697231c-f65a-4fa9-8542-e2c90fad78a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_681d9000-8c41-4779-9083-2e2284d02004" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9697231c-f65a-4fa9-8542-e2c90fad78a2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_f2648178-ffc2-4391-9cc3-4bbc32657641" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9697231c-f65a-4fa9-8542-e2c90fad78a2" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_f2648178-ffc2-4391-9cc3-4bbc32657641" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_f2648178-ffc2-4391-9cc3-4bbc32657641_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_f2648178-ffc2-4391-9cc3-4bbc32657641" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_f2648178-ffc2-4391-9cc3-4bbc32657641_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_99973b6e-df64-4be2-a0d4-f0ebd1a332b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_f2648178-ffc2-4391-9cc3-4bbc32657641" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_99973b6e-df64-4be2-a0d4-f0ebd1a332b0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_TaxLiabilityMember_4321edd6-b2ce-4325-aad4-55e4bca1065d" xlink:href="cvsi-20201231.xsd#cvsi_TaxLiabilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_99973b6e-df64-4be2-a0d4-f0ebd1a332b0" xlink:to="loc_cvsi_TaxLiabilityMember_4321edd6-b2ce-4325-aad4-55e4bca1065d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cvsciences.com/role/DEBT" xlink:type="simple" xlink:href="cvsi-20201231.xsd#DEBT"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/DEBT" xlink:type="extended" id="i231296c6c9194ae98e3490d49ee9020c_DEBT"/>
  <link:roleRef roleURI="http://cvsciences.com/role/DEBTTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#DEBTTables"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/DEBTTables" xlink:type="extended" id="ie67a9316188c4837aed889eb6a71290a_DEBTTables"/>
  <link:roleRef roleURI="http://cvsciences.com/role/DEBTScheduleofDebtDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#DEBTScheduleofDebtDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/DEBTScheduleofDebtDetails" xlink:type="extended" id="i3e2a35355de54fc9bdf01c4d76c2453f_DEBTScheduleofDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_40018d76-db79-4e58-8815-aed2e734b72a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a6cbdd96-8e70-4198-942b-cc60c7612f87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40018d76-db79-4e58-8815-aed2e734b72a" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a6cbdd96-8e70-4198-942b-cc60c7612f87" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_0f447d71-6f3e-49c8-be52-8b7e5fcfcde2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40018d76-db79-4e58-8815-aed2e734b72a" xlink:to="loc_us-gaap_LongTermDebtCurrent_0f447d71-6f3e-49c8-be52-8b7e5fcfcde2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_20fe107e-b537-47ac-93fa-453a737df7e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40018d76-db79-4e58-8815-aed2e734b72a" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_20fe107e-b537-47ac-93fa-453a737df7e4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a8f78163-d4cd-41a1-9d7a-09f841f8aae3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40018d76-db79-4e58-8815-aed2e734b72a" xlink:to="loc_us-gaap_DebtInstrumentTable_a8f78163-d4cd-41a1-9d7a-09f841f8aae3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_65341747-94e6-4a86-a494-41debd5e12ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a8f78163-d4cd-41a1-9d7a-09f841f8aae3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_65341747-94e6-4a86-a494-41debd5e12ae" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_65341747-94e6-4a86-a494-41debd5e12ae_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_65341747-94e6-4a86-a494-41debd5e12ae" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_65341747-94e6-4a86-a494-41debd5e12ae_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_23746c97-72aa-4eea-bdf2-c35abe8402c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_65341747-94e6-4a86-a494-41debd5e12ae" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_23746c97-72aa-4eea-bdf2-c35abe8402c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_841224c1-3277-4106-9d6a-e845db95c5cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_23746c97-72aa-4eea-bdf2-c35abe8402c2" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_841224c1-3277-4106-9d6a-e845db95c5cd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_6ecc046f-5e11-424c-b3e7-0883d42c4c2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_23746c97-72aa-4eea-bdf2-c35abe8402c2" xlink:to="loc_us-gaap_UnsecuredDebtMember_6ecc046f-5e11-424c-b3e7-0883d42c4c2a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8cd3f49b-28ed-49cf-81eb-0a1462b3454d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_a8f78163-d4cd-41a1-9d7a-09f841f8aae3" xlink:to="loc_us-gaap_DebtInstrumentAxis_8cd3f49b-28ed-49cf-81eb-0a1462b3454d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8cd3f49b-28ed-49cf-81eb-0a1462b3454d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8cd3f49b-28ed-49cf-81eb-0a1462b3454d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8cd3f49b-28ed-49cf-81eb-0a1462b3454d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bc856ab2-2b2c-424f-af62-f2f5e0cd8fc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8cd3f49b-28ed-49cf-81eb-0a1462b3454d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bc856ab2-2b2c-424f-af62-f2f5e0cd8fc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_PayrollProtectionProgramLoanMember_a9f1af3c-8c74-46d1-a507-8f6ebd95e939" xlink:href="cvsi-20201231.xsd#cvsi_PayrollProtectionProgramLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc856ab2-2b2c-424f-af62-f2f5e0cd8fc4" xlink:to="loc_cvsi_PayrollProtectionProgramLoanMember_a9f1af3c-8c74-46d1-a507-8f6ebd95e939" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_FirstInsuranceFundingMember_f1270150-9d9a-4d42-b85a-002e0f9603c5" xlink:href="cvsi-20201231.xsd#cvsi_FirstInsuranceFundingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc856ab2-2b2c-424f-af62-f2f5e0cd8fc4" xlink:to="loc_cvsi_FirstInsuranceFundingMember_f1270150-9d9a-4d42-b85a-002e0f9603c5" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cvsciences.com/role/DebtPrincipalPaymentsonDebtDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#DebtPrincipalPaymentsonDebtDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/DebtPrincipalPaymentsonDebtDetails" xlink:type="extended" id="i04a1d4f6365144e182df01c7dcab1914_DebtPrincipalPaymentsonDebtDetails"/>
  <link:roleRef roleURI="http://cvsciences.com/role/DEBTNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#DEBTNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/DEBTNarrativeDetails" xlink:type="extended" id="ife8708ac1b064c7e804b4cc778599202_DEBTNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_55da2b0f-2c66-41a3-b327-27335d263361" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_a9d96240-39ea-42c0-a59b-3c28469efddb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_55da2b0f-2c66-41a3-b327-27335d263361" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_a9d96240-39ea-42c0-a59b-3c28469efddb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_92f567d0-ab95-47f1-bb2a-760062d59ebf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_55da2b0f-2c66-41a3-b327-27335d263361" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_92f567d0-ab95-47f1-bb2a-760062d59ebf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_edff0204-0d76-4ef3-b0be-e2d5ffa45bc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_55da2b0f-2c66-41a3-b327-27335d263361" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_edff0204-0d76-4ef3-b0be-e2d5ffa45bc9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_f83c0367-3fda-4474-8176-6b7bbe699b2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_55da2b0f-2c66-41a3-b327-27335d263361" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_f83c0367-3fda-4474-8176-6b7bbe699b2b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt_dfda728d-c172-489d-a2ad-ea0c8bcebefc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_55da2b0f-2c66-41a3-b327-27335d263361" xlink:to="loc_us-gaap_UnsecuredDebt_dfda728d-c172-489d-a2ad-ea0c8bcebefc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7f4461ad-61d1-4da1-ac79-5c0ab1179cd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_55da2b0f-2c66-41a3-b327-27335d263361" xlink:to="loc_us-gaap_DebtInstrumentTable_7f4461ad-61d1-4da1-ac79-5c0ab1179cd0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b878a453-d831-47ec-9cd4-47ab73cc0e47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7f4461ad-61d1-4da1-ac79-5c0ab1179cd0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b878a453-d831-47ec-9cd4-47ab73cc0e47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b878a453-d831-47ec-9cd4-47ab73cc0e47_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b878a453-d831-47ec-9cd4-47ab73cc0e47" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b878a453-d831-47ec-9cd4-47ab73cc0e47_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6d006d5a-9e64-455d-b5e6-d0208de4756a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b878a453-d831-47ec-9cd4-47ab73cc0e47" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6d006d5a-9e64-455d-b5e6-d0208de4756a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_dd873f78-96a6-48ac-a613-45bbcf6c7065" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6d006d5a-9e64-455d-b5e6-d0208de4756a" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_dd873f78-96a6-48ac-a613-45bbcf6c7065" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_a8539cab-c561-4aa0-aa6b-196f4f9088ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6d006d5a-9e64-455d-b5e6-d0208de4756a" xlink:to="loc_us-gaap_UnsecuredDebtMember_a8539cab-c561-4aa0-aa6b-196f4f9088ec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b026269a-77ee-4180-900e-12622b58c1e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_7f4461ad-61d1-4da1-ac79-5c0ab1179cd0" xlink:to="loc_us-gaap_DebtInstrumentAxis_b026269a-77ee-4180-900e-12622b58c1e1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_b026269a-77ee-4180-900e-12622b58c1e1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_b026269a-77ee-4180-900e-12622b58c1e1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_b026269a-77ee-4180-900e-12622b58c1e1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_174d6905-d6ae-4150-9566-86884ee15893" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_b026269a-77ee-4180-900e-12622b58c1e1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_174d6905-d6ae-4150-9566-86884ee15893" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_PayrollProtectionProgramLoanMember_149f6e5d-b84a-4fb6-af59-d9177399f282" xlink:href="cvsi-20201231.xsd#cvsi_PayrollProtectionProgramLoanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_174d6905-d6ae-4150-9566-86884ee15893" xlink:to="loc_cvsi_PayrollProtectionProgramLoanMember_149f6e5d-b84a-4fb6-af59-d9177399f282" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_PremiumFinanceAgreementMember_bce8799a-8624-4000-95b3-579a68b6ef70" xlink:href="cvsi-20201231.xsd#cvsi_PremiumFinanceAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_174d6905-d6ae-4150-9566-86884ee15893" xlink:to="loc_cvsi_PremiumFinanceAgreementMember_bce8799a-8624-4000-95b3-579a68b6ef70" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_FirstInsuranceFundingMember_c6d6311c-6a8b-4c2c-b62f-345f34657cea" xlink:href="cvsi-20201231.xsd#cvsi_FirstInsuranceFundingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_174d6905-d6ae-4150-9566-86884ee15893" xlink:to="loc_cvsi_FirstInsuranceFundingMember_c6d6311c-6a8b-4c2c-b62f-345f34657cea" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cvsciences.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="cvsi-20201231.xsd#STOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/STOCKHOLDERSEQUITY" xlink:type="extended" id="ic8c86d7457a54848928cbeb01e59d4a6_STOCKHOLDERSEQUITY"/>
  <link:roleRef roleURI="http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended" id="i5b8b0b2b42da40f18bfd35b6cc08e02a_STOCKHOLDERSEQUITYNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_889acc0c-7e7a-464d-ad0c-bcb8fc3d070f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_889acc0c-7e7a-464d-ad0c-bcb8fc3d070f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_0c878379-3424-49d8-9d96-10140f9fc996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_0c878379-3424-49d8-9d96-10140f9fc996" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_a06c0724-9823-4fa8-8c8d-f3ed0fd172ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_CommonStockSharesIssued_a06c0724-9823-4fa8-8c8d-f3ed0fd172ee" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f5c75859-216d-45be-b5fe-5ee076d9967c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f5c75859-216d-45be-b5fe-5ee076d9967c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction_32dc5b5c-74d8-495e-8ef7-afea861ca6cf" xlink:href="cvsi-20201231.xsd#cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction_32dc5b5c-74d8-495e-8ef7-afea861ca6cf" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock_8ca97be3-91bd-4645-831f-0e72b5ff22bc" xlink:href="cvsi-20201231.xsd#cvsi_SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_cvsi_SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock_8ca97be3-91bd-4645-831f-0e72b5ff22bc" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SaleOfStockFairValueOfPutOption_1ef1e6e9-4584-44eb-9e3f-5a4de13766f8" xlink:href="cvsi-20201231.xsd#cvsi_SaleOfStockFairValueOfPutOption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_cvsi_SaleOfStockFairValueOfPutOption_1ef1e6e9-4584-44eb-9e3f-5a4de13766f8" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement_98971e34-cc23-4145-96d7-e3555b3b1ab6" xlink:href="cvsi-20201231.xsd#cvsi_SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_cvsi_SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement_98971e34-cc23-4145-96d7-e3555b3b1ab6" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_b0d0828e-d4e3-4e7c-ba2a-fcac03f67c89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_b0d0828e-d4e3-4e7c-ba2a-fcac03f67c89" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_fe28550d-3d0b-45f6-bde4-f22ce1ec05ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_fe28550d-3d0b-45f6-bde4-f22ce1ec05ac" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_6d736585-9c91-4103-a24a-4d8fadaf3c52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_6d736585-9c91-4103-a24a-4d8fadaf3c52" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_aad3b313-81ce-4ec7-b2ad-e2e922ba59e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_aad3b313-81ce-4ec7-b2ad-e2e922ba59e7" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee_869a8d5b-3e82-43a4-a5fe-53463c0b0ce0" xlink:href="cvsi-20201231.xsd#cvsi_SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_cvsi_SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee_869a8d5b-3e82-43a4-a5fe-53463c0b0ce0" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_d31c3398-6ded-4dc4-99e3-fc62c354563f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_d31c3398-6ded-4dc4-99e3-fc62c354563f" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_336c8fd6-14a2-4822-8c28-3cf1fe2a0576" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_336c8fd6-14a2-4822-8c28-3cf1fe2a0576" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_98a1c413-079e-4cba-a879-12b4383bfb25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_PreferredStockSharesIssued_98a1c413-079e-4cba-a879-12b4383bfb25" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_fb185b5b-ca08-4f52-a59b-1698f36b345a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_fb185b5b-ca08-4f52-a59b-1698f36b345a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_89309f61-c405-440c-8a3a-d3d96a91f679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_89309f61-c405-440c-8a3a-d3d96a91f679" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2af7dc48-bde2-44be-bb61-df37e8545de1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_89309f61-c405-440c-8a3a-d3d96a91f679" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2af7dc48-bde2-44be-bb61-df37e8545de1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2af7dc48-bde2-44be-bb61-df37e8545de1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2af7dc48-bde2-44be-bb61-df37e8545de1" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2af7dc48-bde2-44be-bb61-df37e8545de1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_baffa888-1d1c-4724-9f80-f49d4b5e29ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2af7dc48-bde2-44be-bb61-df37e8545de1" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_baffa888-1d1c-4724-9f80-f49d4b5e29ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_CommonStockPurchaseAgreementMember_60e841cb-2428-4756-8038-cf04359a54ad" xlink:href="cvsi-20201231.xsd#cvsi_CommonStockPurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_baffa888-1d1c-4724-9f80-f49d4b5e29ef" xlink:to="loc_cvsi_CommonStockPurchaseAgreementMember_60e841cb-2428-4756-8038-cf04359a54ad" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cvsciences.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="cvsi-20201231.xsd#STOCKBASEDCOMPENSATION"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended" id="if08a33f1194f44e8847959013ec72d5b_STOCKBASEDCOMPENSATION"/>
  <link:roleRef roleURI="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended" id="id36a8acb0f4648df92f1052a9a57af97_STOCKBASEDCOMPENSATIONTables"/>
  <link:roleRef roleURI="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#STOCKBASEDCOMPENSATIONNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended" id="ibc3349d44a0d4affba604ad6fdc7a72d_STOCKBASEDCOMPENSATIONNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0be5d2bb-164b-4fa3-80de-115db67a1272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0be5d2bb-164b-4fa3-80de-115db67a1272" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_076a5267-1564-4b60-bdb2-efc6043edf32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_076a5267-1564-4b60-bdb2-efc6043edf32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent_93854e70-ea70-4e88-9fd1-60542efbe26c" xlink:href="cvsi-20201231.xsd#cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent_93854e70-ea70-4e88-9fd1-60542efbe26c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan_2034ff7b-f5b5-4ff6-95d9-5a6b9c426145" xlink:href="cvsi-20201231.xsd#cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan_2034ff7b-f5b5-4ff6-95d9-5a6b9c426145" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_e543d4a2-b387-44c7-9175-598f70226175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_e543d4a2-b387-44c7-9175-598f70226175" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2e92ed21-56fa-4d22-8212-f4aaef3dbb8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2e92ed21-56fa-4d22-8212-f4aaef3dbb8c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_f21f7026-75cd-44ef-9929-3d6e8e35183a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_f21f7026-75cd-44ef-9929-3d6e8e35183a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2a0e2275-b44c-4f60-ad38-e53255cbcf8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2a0e2275-b44c-4f60-ad38-e53255cbcf8c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3cbb3544-ee4f-48b8-a5db-2f6ee32b2ee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3cbb3544-ee4f-48b8-a5db-2f6ee32b2ee3" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_26e993dd-d6e6-4e5e-8a41-0fbbc5cfb131" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_26e993dd-d6e6-4e5e-8a41-0fbbc5cfb131" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b6edf6f7-8e65-4bea-9f33-b9dcc991bccd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b6edf6f7-8e65-4bea-9f33-b9dcc991bccd" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_789f67e5-01f5-4f18-a594-20e7b548d956" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_789f67e5-01f5-4f18-a594-20e7b548d956" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ca3c9f3a-0452-4595-9b60-64a5bd46d07a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ca3c9f3a-0452-4595-9b60-64a5bd46d07a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1c0717c3-9ad3-4ba4-b337-7214b34e2329" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1c0717c3-9ad3-4ba4-b337-7214b34e2329" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility_83c951a5-7bcd-4401-bf71-a690a45b84f9" xlink:href="cvsi-20201231.xsd#cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility_83c951a5-7bcd-4401-bf71-a690a45b84f9" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_fed00fd9-b3a5-44d5-bfb6-f82de904cfec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_fed00fd9-b3a5-44d5-bfb6-f82de904cfec" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_bcf32186-d501-41a0-ae0d-7cf607f0d8fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_bcf32186-d501-41a0-ae0d-7cf607f0d8fc" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_443db930-91b0-43e1-b702-012a125f05cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_443db930-91b0-43e1-b702-012a125f05cf" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_562cffa2-9305-46ea-be4d-f3a35bbcd294" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_562cffa2-9305-46ea-be4d-f3a35bbcd294" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_f6bbbe4c-d7f0-4d78-8781-ba62e7003097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_562cffa2-9305-46ea-be4d-f3a35bbcd294" xlink:to="loc_us-gaap_PlanNameAxis_f6bbbe4c-d7f0-4d78-8781-ba62e7003097" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f6bbbe4c-d7f0-4d78-8781-ba62e7003097_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_f6bbbe4c-d7f0-4d78-8781-ba62e7003097" xlink:to="loc_us-gaap_PlanNameDomain_f6bbbe4c-d7f0-4d78-8781-ba62e7003097_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_814bc2d0-3924-4442-8142-f4a51b9899cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_f6bbbe4c-d7f0-4d78-8781-ba62e7003097" xlink:to="loc_us-gaap_PlanNameDomain_814bc2d0-3924-4442-8142-f4a51b9899cb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_Amended2013PlanMember_60d383fd-7072-44f5-a4d4-016c50beb3df" xlink:href="cvsi-20201231.xsd#cvsi_Amended2013PlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_814bc2d0-3924-4442-8142-f4a51b9899cb" xlink:to="loc_cvsi_Amended2013PlanMember_60d383fd-7072-44f5-a4d4-016c50beb3df" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_34b3024c-5f33-461b-8567-94bb1ee1d0e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_562cffa2-9305-46ea-be4d-f3a35bbcd294" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_34b3024c-5f33-461b-8567-94bb1ee1d0e7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_34b3024c-5f33-461b-8567-94bb1ee1d0e7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_34b3024c-5f33-461b-8567-94bb1ee1d0e7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_34b3024c-5f33-461b-8567-94bb1ee1d0e7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ff56274e-ee25-453e-ba0e-030fdc0c2747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_34b3024c-5f33-461b-8567-94bb1ee1d0e7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ff56274e-ee25-453e-ba0e-030fdc0c2747" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a0b93893-8c1c-490b-a6c3-755b222c9266" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ff56274e-ee25-453e-ba0e-030fdc0c2747" xlink:to="loc_us-gaap_SubsequentEventMember_a0b93893-8c1c-490b-a6c3-755b222c9266" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7e8e175a-3530-4fc4-aaab-1c7f8f9cdd0d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_562cffa2-9305-46ea-be4d-f3a35bbcd294" xlink:to="loc_srt_RangeAxis_7e8e175a-3530-4fc4-aaab-1c7f8f9cdd0d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_7e8e175a-3530-4fc4-aaab-1c7f8f9cdd0d_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_7e8e175a-3530-4fc4-aaab-1c7f8f9cdd0d" xlink:to="loc_srt_RangeMember_7e8e175a-3530-4fc4-aaab-1c7f8f9cdd0d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ed0e09e6-ef3b-40cc-b7a2-30031294352a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_7e8e175a-3530-4fc4-aaab-1c7f8f9cdd0d" xlink:to="loc_srt_RangeMember_ed0e09e6-ef3b-40cc-b7a2-30031294352a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2ea49d8d-afbf-4771-a418-fbfbf76d1c9f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ed0e09e6-ef3b-40cc-b7a2-30031294352a" xlink:to="loc_srt_MinimumMember_2ea49d8d-afbf-4771-a418-fbfbf76d1c9f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7982711f-fc83-4252-b541-5b285745c71d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_ed0e09e6-ef3b-40cc-b7a2-30031294352a" xlink:to="loc_srt_MaximumMember_7982711f-fc83-4252-b541-5b285745c71d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_424773d0-9308-4f1b-a89a-f959d4f26a83" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_562cffa2-9305-46ea-be4d-f3a35bbcd294" xlink:to="loc_srt_TitleOfIndividualAxis_424773d0-9308-4f1b-a89a-f959d4f26a83" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_424773d0-9308-4f1b-a89a-f959d4f26a83_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_TitleOfIndividualAxis_424773d0-9308-4f1b-a89a-f959d4f26a83" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_424773d0-9308-4f1b-a89a-f959d4f26a83_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ee0a549a-2657-49f5-a1e9-9d4d1d4632c7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_TitleOfIndividualAxis_424773d0-9308-4f1b-a89a-f959d4f26a83" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ee0a549a-2657-49f5-a1e9-9d4d1d4632c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_FormerFoundersMember_2b70b9cd-5b90-49bc-b8b6-9f4ec32637c7" xlink:href="cvsi-20201231.xsd#cvsi_FormerFoundersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ee0a549a-2657-49f5-a1e9-9d4d1d4632c7" xlink:to="loc_cvsi_FormerFoundersMember_2b70b9cd-5b90-49bc-b8b6-9f4ec32637c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c8b29ab8-04d9-404c-ba1d-58d47fb27749" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_562cffa2-9305-46ea-be4d-f3a35bbcd294" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c8b29ab8-04d9-404c-ba1d-58d47fb27749" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_c8b29ab8-04d9-404c-ba1d-58d47fb27749_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c8b29ab8-04d9-404c-ba1d-58d47fb27749" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_c8b29ab8-04d9-404c-ba1d-58d47fb27749_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b6bc1151-500a-423b-99c6-c5321e387066" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c8b29ab8-04d9-404c-ba1d-58d47fb27749" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b6bc1151-500a-423b-99c6-c5321e387066" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossMember_a33f7747-7067-4a46-b718-ff09ece9d5f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLossMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b6bc1151-500a-423b-99c6-c5321e387066" xlink:to="loc_us-gaap_OperatingIncomeLossMember_a33f7747-7067-4a46-b718-ff09ece9d5f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b230f88c-6722-4a57-8f41-4bf8cce8fa86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_562cffa2-9305-46ea-be4d-f3a35bbcd294" xlink:to="loc_us-gaap_AwardTypeAxis_b230f88c-6722-4a57-8f41-4bf8cce8fa86" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b230f88c-6722-4a57-8f41-4bf8cce8fa86_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_b230f88c-6722-4a57-8f41-4bf8cce8fa86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_b230f88c-6722-4a57-8f41-4bf8cce8fa86_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_890aec71-0cfd-4758-bb8c-7127b367797d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_b230f88c-6722-4a57-8f41-4bf8cce8fa86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_890aec71-0cfd-4758-bb8c-7127b367797d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_44931486-2bcb-415f-9fb4-dc494d418b26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_890aec71-0cfd-4758-bb8c-7127b367797d" xlink:to="loc_us-gaap_StockOptionMember_44931486-2bcb-415f-9fb4-dc494d418b26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_StockOptionModificationMember_08765dae-8d26-4697-9f3a-783d84561a0a" xlink:href="cvsi-20201231.xsd#cvsi_StockOptionModificationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_890aec71-0cfd-4758-bb8c-7127b367797d" xlink:to="loc_cvsi_StockOptionModificationMember_08765dae-8d26-4697-9f3a-783d84561a0a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_OptionsOutsidePlanMember_ed1d0f4a-1b17-4942-95f8-4da5d2faa92e" xlink:href="cvsi-20201231.xsd#cvsi_OptionsOutsidePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_890aec71-0cfd-4758-bb8c-7127b367797d" xlink:to="loc_cvsi_OptionsOutsidePlanMember_ed1d0f4a-1b17-4942-95f8-4da5d2faa92e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f86d0142-e440-4e1a-8b3e-af6d341bb48d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_890aec71-0cfd-4758-bb8c-7127b367797d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f86d0142-e440-4e1a-8b3e-af6d341bb48d" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails" xlink:type="extended" id="ifb6f0316ece040ceb328e5b34a816935_STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636bcbe1-123c-4fb9-abb1-1b0ef91d4bbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dadfd5b8-7e5c-4fda-b485-baa592890641" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636bcbe1-123c-4fb9-abb1-1b0ef91d4bbb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dadfd5b8-7e5c-4fda-b485-baa592890641" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d3109567-43f1-4cff-881d-d8a0ad740166" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dadfd5b8-7e5c-4fda-b485-baa592890641" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d3109567-43f1-4cff-881d-d8a0ad740166" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_5e605bed-ebf0-44b3-9380-66d3f809b704" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dadfd5b8-7e5c-4fda-b485-baa592890641" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_5e605bed-ebf0-44b3-9380-66d3f809b704" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_01b0628f-2fdc-49ba-b964-08dab550b85e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dadfd5b8-7e5c-4fda-b485-baa592890641" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_01b0628f-2fdc-49ba-b964-08dab550b85e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_a90b080a-2c4e-4179-aebf-929a41a11cae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dadfd5b8-7e5c-4fda-b485-baa592890641" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_a90b080a-2c4e-4179-aebf-929a41a11cae" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e6fc29d9-30c6-4606-bd61-4ec028e2bb27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_cdd7e151-1ca9-4295-ba96-bb6b6a77a614" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636bcbe1-123c-4fb9-abb1-1b0ef91d4bbb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_cdd7e151-1ca9-4295-ba96-bb6b6a77a614" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_23070804-49dc-4736-977d-8e8441e3f953" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636bcbe1-123c-4fb9-abb1-1b0ef91d4bbb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_23070804-49dc-4736-977d-8e8441e3f953" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_646cb8b3-3af1-4cb7-af9a-1df76475d52d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636bcbe1-123c-4fb9-abb1-1b0ef91d4bbb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_646cb8b3-3af1-4cb7-af9a-1df76475d52d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_39c2722f-6457-4528-83ed-531f43104651" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_646cb8b3-3af1-4cb7-af9a-1df76475d52d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_39c2722f-6457-4528-83ed-531f43104651" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_dcc1a04c-b8f6-4dee-aa81-778d89b2776b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_646cb8b3-3af1-4cb7-af9a-1df76475d52d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_dcc1a04c-b8f6-4dee-aa81-778d89b2776b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0b6d742a-237b-4f49-a0ff-87d02ed2a1be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_646cb8b3-3af1-4cb7-af9a-1df76475d52d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0b6d742a-237b-4f49-a0ff-87d02ed2a1be" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_8c6a9661-8bf0-49d1-81e9-17322b62422d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_646cb8b3-3af1-4cb7-af9a-1df76475d52d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_8c6a9661-8bf0-49d1-81e9-17322b62422d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b2362b14-93d0-4376-a47f-73eeec8c66ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_26d699b8-6bfd-4842-980e-c070e2b1a8f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636bcbe1-123c-4fb9-abb1-1b0ef91d4bbb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_26d699b8-6bfd-4842-980e-c070e2b1a8f4" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_e730e72e-a955-4ea2-b780-16745b1b16c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636bcbe1-123c-4fb9-abb1-1b0ef91d4bbb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_e730e72e-a955-4ea2-b780-16745b1b16c4" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_453d3ee9-52f9-4a21-8c44-e01c5274096e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636bcbe1-123c-4fb9-abb1-1b0ef91d4bbb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_453d3ee9-52f9-4a21-8c44-e01c5274096e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_fd6504ff-74c4-4dca-92b0-6628fb2b3e24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_453d3ee9-52f9-4a21-8c44-e01c5274096e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_fd6504ff-74c4-4dca-92b0-6628fb2b3e24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3f0f8462-9294-4127-98d6-555af0850b56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_453d3ee9-52f9-4a21-8c44-e01c5274096e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3f0f8462-9294-4127-98d6-555af0850b56" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_648cc3cd-2d8c-404e-8062-745f8c765dd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_453d3ee9-52f9-4a21-8c44-e01c5274096e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_648cc3cd-2d8c-404e-8062-745f8c765dd8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ef928f21-fcfc-47b7-b411-88b1ae972afb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_453d3ee9-52f9-4a21-8c44-e01c5274096e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ef928f21-fcfc-47b7-b411-88b1ae972afb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_8c598750-e029-42da-b84f-39aafb08598d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_37c15469-b5d0-4b9f-9983-af3dca38a9b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_453d3ee9-52f9-4a21-8c44-e01c5274096e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_37c15469-b5d0-4b9f-9983-af3dca38a9b5" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_caf73695-ac76-404a-b3d7-6b9f2cb31fa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_453d3ee9-52f9-4a21-8c44-e01c5274096e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_caf73695-ac76-404a-b3d7-6b9f2cb31fa0" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2fdb7dfc-8f9a-4643-99f3-1597d2d880cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636bcbe1-123c-4fb9-abb1-1b0ef91d4bbb" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2fdb7dfc-8f9a-4643-99f3-1597d2d880cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2da41155-e982-4b0d-bfe2-365e9be75f99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2fdb7dfc-8f9a-4643-99f3-1597d2d880cf" xlink:to="loc_us-gaap_AwardTypeAxis_2da41155-e982-4b0d-bfe2-365e9be75f99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2da41155-e982-4b0d-bfe2-365e9be75f99_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_2da41155-e982-4b0d-bfe2-365e9be75f99" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2da41155-e982-4b0d-bfe2-365e9be75f99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bec3a729-0653-4038-958d-274034b2ad5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_2da41155-e982-4b0d-bfe2-365e9be75f99" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bec3a729-0653-4038-958d-274034b2ad5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_c61f49cf-ee19-4d8f-bafd-0eb5d7a4afe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bec3a729-0653-4038-958d-274034b2ad5e" xlink:to="loc_us-gaap_StockOptionMember_c61f49cf-ee19-4d8f-bafd-0eb5d7a4afe9" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONAssumptionsUsedtoEstimateFairValueDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#STOCKBASEDCOMPENSATIONAssumptionsUsedtoEstimateFairValueDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONAssumptionsUsedtoEstimateFairValueDetails" xlink:type="extended" id="iec5a1b17e57e4ac69479b923c2326a0f_STOCKBASEDCOMPENSATIONAssumptionsUsedtoEstimateFairValueDetails"/>
  <link:roleRef roleURI="http://cvsciences.com/role/NETINCOMELOSSPERSHARE" xlink:type="simple" xlink:href="cvsi-20201231.xsd#NETINCOMELOSSPERSHARE"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/NETINCOMELOSSPERSHARE" xlink:type="extended" id="i9e5eb116de5644b69ee0471cf221fda0_NETINCOMELOSSPERSHARE"/>
  <link:roleRef roleURI="http://cvsciences.com/role/NETINCOMELOSSPERSHARETables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#NETINCOMELOSSPERSHARETables"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/NETINCOMELOSSPERSHARETables" xlink:type="extended" id="iaf8b0a95c6524c7287e58454183b7789_NETINCOMELOSSPERSHARETables"/>
  <link:roleRef roleURI="http://cvsciences.com/role/NETINCOMELOSSPERSHAREAntidilutiveSharesDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#NETINCOMELOSSPERSHAREAntidilutiveSharesDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/NETINCOMELOSSPERSHAREAntidilutiveSharesDetails" xlink:type="extended" id="i414eac0a750f43c9a567bfc52c48a6ad_NETINCOMELOSSPERSHAREAntidilutiveSharesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_483745f3-338c-4d1c-a8ce-575ecb213ad1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d2dc0adf-fd2e-4e1b-aee3-b59147998f3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_483745f3-338c-4d1c-a8ce-575ecb213ad1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d2dc0adf-fd2e-4e1b-aee3-b59147998f3f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_598bae19-b044-42bb-8085-be66ec05887a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_483745f3-338c-4d1c-a8ce-575ecb213ad1" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_598bae19-b044-42bb-8085-be66ec05887a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_782c9012-bea7-4521-971c-0ba416df9a5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_598bae19-b044-42bb-8085-be66ec05887a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_782c9012-bea7-4521-971c-0ba416df9a5d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_782c9012-bea7-4521-971c-0ba416df9a5d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_782c9012-bea7-4521-971c-0ba416df9a5d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_782c9012-bea7-4521-971c-0ba416df9a5d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_92e29f8a-ab81-4549-abc5-1fb73cb2d26d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_782c9012-bea7-4521-971c-0ba416df9a5d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_92e29f8a-ab81-4549-abc5-1fb73cb2d26d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ee2a5bfc-ea15-41af-b06d-7dd7b6df25c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_92e29f8a-ab81-4549-abc5-1fb73cb2d26d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ee2a5bfc-ea15-41af-b06d-7dd7b6df25c8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_ff08b2fc-f40a-46ef-8108-f37fe25262ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_92e29f8a-ab81-4549-abc5-1fb73cb2d26d" xlink:to="loc_us-gaap_PerformanceSharesMember_ff08b2fc-f40a-46ef-8108-f37fe25262ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_UnvestedStockOptionsMember_c6067de3-6f66-48a2-8898-fb59573074fd" xlink:href="cvsi-20201231.xsd#cvsi_UnvestedStockOptionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_92e29f8a-ab81-4549-abc5-1fb73cb2d26d" xlink:to="loc_cvsi_UnvestedStockOptionsMember_c6067de3-6f66-48a2-8898-fb59573074fd" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cvsciences.com/role/RELATEDPARTIES" xlink:type="simple" xlink:href="cvsi-20201231.xsd#RELATEDPARTIES"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/RELATEDPARTIES" xlink:type="extended" id="i5ea2b43dc4314d7f8eb7dda811ec6275_RELATEDPARTIES"/>
  <link:roleRef roleURI="http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#RELATEDPARTIESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails" xlink:type="extended" id="i39ca1c52062a4cdfa876436834324daf_RELATEDPARTIESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod_bf02f658-0028-4a04-8d45-c3bfdead8c2a" xlink:href="cvsi-20201231.xsd#cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod_bf02f658-0028-4a04-8d45-c3bfdead8c2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_fe873d81-ce6b-4827-b62c-a4e870fe2be8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_fe873d81-ce6b-4827-b62c-a4e870fe2be8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_bf4980ca-876c-4204-8fd6-f8d17d487d94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_bf4980ca-876c-4204-8fd6-f8d17d487d94" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_33d4780a-63b0-4d92-9799-7ab5eace8b58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_33d4780a-63b0-4d92-9799-7ab5eace8b58" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_8a1f6e98-44f3-4ae2-b29e-a785f0daa9b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_8a1f6e98-44f3-4ae2-b29e-a785f0daa9b6" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_a9131894-895b-491b-abbb-e2a25a57d332" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_a9131894-895b-491b-abbb-e2a25a57d332" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_71928952-cab1-464f-82b9-e93cb8ed627e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_71928952-cab1-464f-82b9-e93cb8ed627e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent_ff5295d6-27a2-4e8b-a421-baab2334f25c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_us-gaap_DueFromRelatedPartiesCurrent_ff5295d6-27a2-4e8b-a421-baab2334f25c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_PayrollTaxExpense_d2028743-4281-4ff8-af2c-bb600f478b17" xlink:href="cvsi-20201231.xsd#cvsi_PayrollTaxExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_cvsi_PayrollTaxExpense_d2028743-4281-4ff8-af2c-bb600f478b17" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_AccruedPayrollTaxesCurrentEmployeePortion_30d3a4b7-88f6-4854-a9ad-8f03689c64df" xlink:href="cvsi-20201231.xsd#cvsi_AccruedPayrollTaxesCurrentEmployeePortion"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_cvsi_AccruedPayrollTaxesCurrentEmployeePortion_30d3a4b7-88f6-4854-a9ad-8f03689c64df" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedPayrollTaxesCurrent_f47d9cc9-38d5-4d02-9154-e1f6e931e2a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedPayrollTaxesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_us-gaap_AccruedPayrollTaxesCurrent_f47d9cc9-38d5-4d02-9154-e1f6e931e2a3" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanAndLeaseLosses_d337ecbc-251e-4fc1-bc3b-7f8c584824fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForLoanAndLeaseLosses"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_us-gaap_ProvisionForLoanAndLeaseLosses_d337ecbc-251e-4fc1-bc3b-7f8c584824fb" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_d110c9a7-5d3f-48b2-b399-eb8ce42dcf5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_d110c9a7-5d3f-48b2-b399-eb8ce42dcf5e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d130831d-1dfb-4faf-be32-7237bfedd530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d130831d-1dfb-4faf-be32-7237bfedd530" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cafc21bc-dada-458c-9d49-080a6e79816a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d130831d-1dfb-4faf-be32-7237bfedd530" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cafc21bc-dada-458c-9d49-080a6e79816a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_cafc21bc-dada-458c-9d49-080a6e79816a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cafc21bc-dada-458c-9d49-080a6e79816a" xlink:to="loc_us-gaap_RelatedPartyDomain_cafc21bc-dada-458c-9d49-080a6e79816a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_437b8b70-f49b-41d6-aaea-b96f43e92342" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cafc21bc-dada-458c-9d49-080a6e79816a" xlink:to="loc_us-gaap_RelatedPartyDomain_437b8b70-f49b-41d6-aaea-b96f43e92342" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_FormerPresidentandCEOMember_dbec99b9-eb34-40fb-9d52-5d353db545b1" xlink:href="cvsi-20201231.xsd#cvsi_FormerPresidentandCEOMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_437b8b70-f49b-41d6-aaea-b96f43e92342" xlink:to="loc_cvsi_FormerPresidentandCEOMember_dbec99b9-eb34-40fb-9d52-5d353db545b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_FormerChiefOperatingOfficerMember_4fe65959-12e0-4aaa-b677-5d04e34c2be1" xlink:href="cvsi-20201231.xsd#cvsi_FormerChiefOperatingOfficerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_437b8b70-f49b-41d6-aaea-b96f43e92342" xlink:to="loc_cvsi_FormerChiefOperatingOfficerMember_4fe65959-12e0-4aaa-b677-5d04e34c2be1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_30820050-d132-42b2-a0c3-30a065539d99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d130831d-1dfb-4faf-be32-7237bfedd530" xlink:to="loc_us-gaap_AwardTypeAxis_30820050-d132-42b2-a0c3-30a065539d99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_30820050-d132-42b2-a0c3-30a065539d99_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_30820050-d132-42b2-a0c3-30a065539d99" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_30820050-d132-42b2-a0c3-30a065539d99_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ee85b47-708b-4de8-8e62-c4065a1cca68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_30820050-d132-42b2-a0c3-30a065539d99" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ee85b47-708b-4de8-8e62-c4065a1cca68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_92712368-a603-4da7-838b-a9db68710489" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ee85b47-708b-4de8-8e62-c4065a1cca68" xlink:to="loc_us-gaap_EmployeeStockOptionMember_92712368-a603-4da7-838b-a9db68710489" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f05029a0-23b6-4bc5-8edd-92d16e2a1f02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ee85b47-708b-4de8-8e62-c4065a1cca68" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f05029a0-23b6-4bc5-8edd-92d16e2a1f02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_92f482d2-3b83-44fe-8c40-92f86d412544" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d130831d-1dfb-4faf-be32-7237bfedd530" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_92f482d2-3b83-44fe-8c40-92f86d412544" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_92f482d2-3b83-44fe-8c40-92f86d412544_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_92f482d2-3b83-44fe-8c40-92f86d412544" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_92f482d2-3b83-44fe-8c40-92f86d412544_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e799482f-5e43-4124-9750-0f89b1ef6f7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_92f482d2-3b83-44fe-8c40-92f86d412544" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e799482f-5e43-4124-9750-0f89b1ef6f7e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9074fa79-cde8-4b66-a78a-35016b6eea39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e799482f-5e43-4124-9750-0f89b1ef6f7e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9074fa79-cde8-4b66-a78a-35016b6eea39" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8c36a432-15d6-49a3-82f7-b62e16fdf561" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d130831d-1dfb-4faf-be32-7237bfedd530" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8c36a432-15d6-49a3-82f7-b62e16fdf561" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_8c36a432-15d6-49a3-82f7-b62e16fdf561_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8c36a432-15d6-49a3-82f7-b62e16fdf561" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_8c36a432-15d6-49a3-82f7-b62e16fdf561_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d8e11f9e-f4e9-4ec9-911f-b3a972b02fdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8c36a432-15d6-49a3-82f7-b62e16fdf561" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d8e11f9e-f4e9-4ec9-911f-b3a972b02fdb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_fee06f55-89f5-4658-8e81-5aafcebdddfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d8e11f9e-f4e9-4ec9-911f-b3a972b02fdb" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_fee06f55-89f5-4658-8e81-5aafcebdddfa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_7f51e028-3adf-4a41-9279-60f88d5249b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d8e11f9e-f4e9-4ec9-911f-b3a972b02fdb" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_7f51e028-3adf-4a41-9279-60f88d5249b4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_9b4a4bba-1aeb-4e90-9cca-e4c8e468c409" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d8e11f9e-f4e9-4ec9-911f-b3a972b02fdb" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_9b4a4bba-1aeb-4e90-9cca-e4c8e468c409" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="cvsi-20201231.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended" id="i9d66db2fafba45ec8f3498b242f4416a_COMMITMENTSANDCONTINGENCIES"/>
  <link:roleRef roleURI="http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIESLawsuitsDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#COMMITMENTSANDCONTINGENCIESLawsuitsDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIESLawsuitsDetails" xlink:type="extended" id="i7ecc37f16b1c43fe8b160a89ccb72965_COMMITMENTSANDCONTINGENCIESLawsuitsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_89d111df-849f-4bf6-bd4c-7b987aa4ce5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_NumberofDerivativeLawsuits_b6b8a027-673d-4ca9-bb34-d7f1fa0d6fd7" xlink:href="cvsi-20201231.xsd#cvsi_NumberofDerivativeLawsuits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LossContingenciesLineItems_89d111df-849f-4bf6-bd4c-7b987aa4ce5b" xlink:to="loc_cvsi_NumberofDerivativeLawsuits_b6b8a027-673d-4ca9-bb34-d7f1fa0d6fd7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_08eee369-b40f-41bd-b59c-b7118c93ba2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LossContingenciesLineItems_89d111df-849f-4bf6-bd4c-7b987aa4ce5b" xlink:to="loc_us-gaap_LossContingenciesTable_08eee369-b40f-41bd-b59c-b7118c93ba2c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_6470c17d-5134-421b-b31e-4510c76c1203" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LossContingenciesTable_08eee369-b40f-41bd-b59c-b7118c93ba2c" xlink:to="loc_srt_LitigationCaseAxis_6470c17d-5134-421b-b31e-4510c76c1203" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_6470c17d-5134-421b-b31e-4510c76c1203_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_LitigationCaseAxis_6470c17d-5134-421b-b31e-4510c76c1203" xlink:to="loc_srt_LitigationCaseTypeDomain_6470c17d-5134-421b-b31e-4510c76c1203_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_dcecbc44-0110-4d1e-9b4d-69d8f3f3cd83" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_LitigationCaseAxis_6470c17d-5134-421b-b31e-4510c76c1203" xlink:to="loc_srt_LitigationCaseTypeDomain_dcecbc44-0110-4d1e-9b4d-69d8f3f3cd83" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SmithComplaintMember_1b476055-c436-4bc8-9b0c-bbd1299b39c7" xlink:href="cvsi-20201231.xsd#cvsi_SmithComplaintMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_LitigationCaseTypeDomain_dcecbc44-0110-4d1e-9b4d-69d8f3f3cd83" xlink:to="loc_cvsi_SmithComplaintMember_1b476055-c436-4bc8-9b0c-bbd1299b39c7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cvsciences.com/role/LEASES" xlink:type="simple" xlink:href="cvsi-20201231.xsd#LEASES"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/LEASES" xlink:type="extended" id="i25bc892cef2641bf88076b376db28a67_LEASES"/>
  <link:roleRef roleURI="http://cvsciences.com/role/LEASESTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#LEASESTables"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/LEASESTables" xlink:type="extended" id="i848d2a34160f4a13bac73431288ddee8_LEASESTables"/>
  <link:roleRef roleURI="http://cvsciences.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#LEASESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/LEASESNarrativeDetails" xlink:type="extended" id="i5629f479893a49e186a54b1d9f1fe131_LEASESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_75c636da-1390-4fc1-858c-5dedd9bd3772" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_NumberOfLeaseTerminationAgreements_54662e23-0e3c-4b25-ad1d-4e090df9063d" xlink:href="cvsi-20201231.xsd#cvsi_NumberOfLeaseTerminationAgreements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75c636da-1390-4fc1-858c-5dedd9bd3772" xlink:to="loc_cvsi_NumberOfLeaseTerminationAgreements_54662e23-0e3c-4b25-ad1d-4e090df9063d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_55180a2e-3e30-46d1-94d2-953b1ddd5ec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75c636da-1390-4fc1-858c-5dedd9bd3772" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_55180a2e-3e30-46d1-94d2-953b1ddd5ec6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e230f22e-4d2c-46ba-9d64-c3f1f43e48b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75c636da-1390-4fc1-858c-5dedd9bd3772" xlink:to="loc_us-gaap_OperatingLeaseLiability_e230f22e-4d2c-46ba-9d64-c3f1f43e48b2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_d98861aa-0eb0-47d3-903b-29ef4fc86ee1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75c636da-1390-4fc1-858c-5dedd9bd3772" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_d98861aa-0eb0-47d3-903b-29ef4fc86ee1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_211dd8d3-292d-49f2-bc4f-5591a3bd5b8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75c636da-1390-4fc1-858c-5dedd9bd3772" xlink:to="loc_us-gaap_LeaseCost_211dd8d3-292d-49f2-bc4f-5591a3bd5b8d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_ea0c7e59-c282-4fb8-a6ff-c2bb32651807" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75c636da-1390-4fc1-858c-5dedd9bd3772" xlink:to="loc_us-gaap_OperatingLeasePayments_ea0c7e59-c282-4fb8-a6ff-c2bb32651807" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_c48e3c92-8754-427f-840e-15152356c3cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75c636da-1390-4fc1-858c-5dedd9bd3772" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_c48e3c92-8754-427f-840e-15152356c3cf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_2b7094cd-7704-4b4b-aa2b-5929859136cf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_c48e3c92-8754-427f-840e-15152356c3cf" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_2b7094cd-7704-4b4b-aa2b-5929859136cf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_2b7094cd-7704-4b4b-aa2b-5929859136cf_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_2b7094cd-7704-4b4b-aa2b-5929859136cf" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_2b7094cd-7704-4b4b-aa2b-5929859136cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_43c2c280-53b4-4e76-8f1c-13f609d5bc48" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_2b7094cd-7704-4b4b-aa2b-5929859136cf" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_43c2c280-53b4-4e76-8f1c-13f609d5bc48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SanDiegoFacilityMember_5c17d64a-fbc8-4ef1-9296-a2e0fe1bafd3" xlink:href="cvsi-20201231.xsd#cvsi_SanDiegoFacilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_43c2c280-53b4-4e76-8f1c-13f609d5bc48" xlink:to="loc_cvsi_SanDiegoFacilityMember_5c17d64a-fbc8-4ef1-9296-a2e0fe1bafd3" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cvsciences.com/role/LEASESRightofuseAssetsandLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#LEASESRightofuseAssetsandLeaseLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/LEASESRightofuseAssetsandLeaseLiabilitiesDetails" xlink:type="extended" id="iddc86d5be40a441f80046c59ba8d12eb_LEASESRightofuseAssetsandLeaseLiabilitiesDetails"/>
  <link:roleRef roleURI="http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#LEASESMaturityofLeaseLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails" xlink:type="extended" id="i2f5a952790e24af4810fc857406dfe6c_LEASESMaturityofLeaseLiabilitiesDetails"/>
  <link:roleRef roleURI="http://cvsciences.com/role/SEGMENTINFORMATION" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SEGMENTINFORMATION"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/SEGMENTINFORMATION" xlink:type="extended" id="i76901a8c046d40c6bad25364a17e9f60_SEGMENTINFORMATION"/>
  <link:roleRef roleURI="http://cvsciences.com/role/SEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SEGMENTINFORMATIONTables"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/SEGMENTINFORMATIONTables" xlink:type="extended" id="i15f09599e28c4e7cbef22152be9646c4_SEGMENTINFORMATIONTables"/>
  <link:roleRef roleURI="http://cvsciences.com/role/SEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SEGMENTINFORMATIONDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/SEGMENTINFORMATIONDetails" xlink:type="extended" id="ieb3eabe530eb497eaa47d7d657dc78f8_SEGMENTINFORMATIONDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_22feee26-473b-45ed-9819-1e7eeac47e56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_1ba07450-99f9-4144-99e6-11b0e36286c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_22feee26-473b-45ed-9819-1e7eeac47e56" xlink:to="loc_us-gaap_NumberOfReportableSegments_1ba07450-99f9-4144-99e6-11b0e36286c3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_146f1cd2-d706-437a-b9e6-a4cd4a1da7fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_22feee26-473b-45ed-9819-1e7eeac47e56" xlink:to="loc_us-gaap_Revenues_146f1cd2-d706-437a-b9e6-a4cd4a1da7fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_026edd4b-7ea3-4d97-9218-a70c56ef67b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_22feee26-473b-45ed-9819-1e7eeac47e56" xlink:to="loc_us-gaap_GrossProfit_026edd4b-7ea3-4d97-9218-a70c56ef67b5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_14f6b690-d156-4fe4-84f6-55a38f94c9ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_22feee26-473b-45ed-9819-1e7eeac47e56" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_14f6b690-d156-4fe4-84f6-55a38f94c9ec" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_adf2881b-7c98-469f-8597-49e9ae0062f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_22feee26-473b-45ed-9819-1e7eeac47e56" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_adf2881b-7c98-469f-8597-49e9ae0062f5" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5fa9a16f-3971-468f-9687-3fa7376099ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_22feee26-473b-45ed-9819-1e7eeac47e56" xlink:to="loc_us-gaap_OperatingIncomeLoss_5fa9a16f-3971-468f-9687-3fa7376099ce" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fe1691bb-61bb-4d47-b0c9-f501dd104f4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_22feee26-473b-45ed-9819-1e7eeac47e56" xlink:to="loc_us-gaap_Goodwill_fe1691bb-61bb-4d47-b0c9-f501dd104f4d" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2c07a359-61dd-4824-ad80-63fc1c3413ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_22feee26-473b-45ed-9819-1e7eeac47e56" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2c07a359-61dd-4824-ad80-63fc1c3413ab" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_528a4957-e2cf-4058-ab9d-bfddf8966f84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_22feee26-473b-45ed-9819-1e7eeac47e56" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_528a4957-e2cf-4058-ab9d-bfddf8966f84" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_568984d4-83de-4606-8ad1-46af4d018c57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_528a4957-e2cf-4058-ab9d-bfddf8966f84" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_568984d4-83de-4606-8ad1-46af4d018c57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_568984d4-83de-4606-8ad1-46af4d018c57_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_568984d4-83de-4606-8ad1-46af4d018c57" xlink:to="loc_us-gaap_SegmentDomain_568984d4-83de-4606-8ad1-46af4d018c57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2263e8eb-f610-473c-9ddd-4c42cfcf74ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_568984d4-83de-4606-8ad1-46af4d018c57" xlink:to="loc_us-gaap_SegmentDomain_2263e8eb-f610-473c-9ddd-4c42cfcf74ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_ConsumerProductsMember_6f429738-3458-4b86-8da5-d4d4b23cb0ef" xlink:href="cvsi-20201231.xsd#cvsi_ConsumerProductsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2263e8eb-f610-473c-9ddd-4c42cfcf74ad" xlink:to="loc_cvsi_ConsumerProductsMember_6f429738-3458-4b86-8da5-d4d4b23cb0ef" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SpecialtyPharmaceuticalsMember_ee1736ee-822d-4cb5-afa9-6eeb1b732337" xlink:href="cvsi-20201231.xsd#cvsi_SpecialtyPharmaceuticalsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentDomain_2263e8eb-f610-473c-9ddd-4c42cfcf74ad" xlink:to="loc_cvsi_SpecialtyPharmaceuticalsMember_ee1736ee-822d-4cb5-afa9-6eeb1b732337" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INCOMETAXES" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INCOMETAXES"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/INCOMETAXES" xlink:type="extended" id="iffb00f6d679a436f8fdd9f721650d53e_INCOMETAXES"/>
  <link:roleRef roleURI="http://cvsciences.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INCOMETAXESTables"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/INCOMETAXESTables" xlink:type="extended" id="i2106bb7d89f24952a7aa49ed5bc9a389_INCOMETAXESTables"/>
  <link:roleRef roleURI="http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails" xlink:type="extended" id="ied811ce6810f4e4c8fca66e800aaa4e2_INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails"/>
  <link:roleRef roleURI="http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INCOMETAXESIncomeTaxProvisionDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails" xlink:type="extended" id="i7e29d835242446d88367b5ac7a703d29_INCOMETAXESIncomeTaxProvisionDetails"/>
  <link:roleRef roleURI="http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INCOMETAXESDeferredIncomeTaxesDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails" xlink:type="extended" id="i6773804529284970802274c1f0de0906_INCOMETAXESDeferredIncomeTaxesDetails"/>
  <link:roleRef roleURI="http://cvsciences.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INCOMETAXESNarrativeDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended" id="id9ba1e4a195d473f8e21321d54064b8b_INCOMETAXESNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_7e4d1da3-62b0-4bdf-b3aa-75b14bc33d4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_08eb832f-b061-43cb-b457-787feba5d916" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_7e4d1da3-62b0-4bdf-b3aa-75b14bc33d4a" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_08eb832f-b061-43cb-b457-787feba5d916" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_97e45449-028d-4f11-bb3d-88c8270c8c14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_7e4d1da3-62b0-4bdf-b3aa-75b14bc33d4a" xlink:to="loc_us-gaap_OperatingLossCarryforwards_97e45449-028d-4f11-bb3d-88c8270c8c14" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_11834c5f-cdf3-4ea5-8f9d-bbf3349c597e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_7e4d1da3-62b0-4bdf-b3aa-75b14bc33d4a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_11834c5f-cdf3-4ea5-8f9d-bbf3349c597e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_a3843c4d-8585-44a1-9e95-acb3a2e17f0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_7e4d1da3-62b0-4bdf-b3aa-75b14bc33d4a" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_a3843c4d-8585-44a1-9e95-acb3a2e17f0f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_dd80946a-ef2c-4cfb-ad0a-3cf371fd402e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_a3843c4d-8585-44a1-9e95-acb3a2e17f0f" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_dd80946a-ef2c-4cfb-ad0a-3cf371fd402e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_dd80946a-ef2c-4cfb-ad0a-3cf371fd402e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_dd80946a-ef2c-4cfb-ad0a-3cf371fd402e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_dd80946a-ef2c-4cfb-ad0a-3cf371fd402e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_ea4e938b-3d92-42ab-bd4c-3040bb820d77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_dd80946a-ef2c-4cfb-ad0a-3cf371fd402e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_ea4e938b-3d92-42ab-bd4c-3040bb820d77" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_29d2068b-51a4-461d-bc58-da19f29a61ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ea4e938b-3d92-42ab-bd4c-3040bb820d77" xlink:to="loc_us-gaap_DomesticCountryMember_29d2068b-51a4-461d-bc58-da19f29a61ba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_8d110141-4aab-4d5f-bbca-e02b7dd381f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ea4e938b-3d92-42ab-bd4c-3040bb820d77" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_8d110141-4aab-4d5f-bbca-e02b7dd381f9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_95500d9b-53b5-46d8-b203-e2c4ec5b7c1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_a3843c4d-8585-44a1-9e95-acb3a2e17f0f" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_95500d9b-53b5-46d8-b203-e2c4ec5b7c1a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_95500d9b-53b5-46d8-b203-e2c4ec5b7c1a_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_95500d9b-53b5-46d8-b203-e2c4ec5b7c1a" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_95500d9b-53b5-46d8-b203-e2c4ec5b7c1a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_059f2bb6-f141-417c-8161-bb61a562e582" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_95500d9b-53b5-46d8-b203-e2c4ec5b7c1a" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_059f2bb6-f141-417c-8161-bb61a562e582" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_6932ad09-1481-4a5f-b259-1cd1f416250f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_059f2bb6-f141-417c-8161-bb61a562e582" xlink:to="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_6932ad09-1481-4a5f-b259-1cd1f416250f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_StatesOtherThanCaliforniaMember_7abf19b3-8119-406a-978c-f6d2b6579ee0" xlink:href="cvsi-20201231.xsd#cvsi_StatesOtherThanCaliforniaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_059f2bb6-f141-417c-8161-bb61a562e582" xlink:to="loc_cvsi_StatesOtherThanCaliforniaMember_7abf19b3-8119-406a-978c-f6d2b6579ee0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_a821f344-c88d-45e2-b529-ef467d4c086b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_a3843c4d-8585-44a1-9e95-acb3a2e17f0f" xlink:to="loc_us-gaap_TaxPeriodAxis_a821f344-c88d-45e2-b529-ef467d4c086b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_a821f344-c88d-45e2-b529-ef467d4c086b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxPeriodAxis_a821f344-c88d-45e2-b529-ef467d4c086b" xlink:to="loc_us-gaap_TaxPeriodDomain_a821f344-c88d-45e2-b529-ef467d4c086b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_886b5e0b-deb4-408c-a9c7-e63896cf9937" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxPeriodAxis_a821f344-c88d-45e2-b529-ef467d4c086b" xlink:to="loc_us-gaap_TaxPeriodDomain_886b5e0b-deb4-408c-a9c7-e63896cf9937" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_After2017Member_b91f941e-45f8-4605-b142-56ac3bae0acf" xlink:href="cvsi-20201231.xsd#cvsi_After2017Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_886b5e0b-deb4-408c-a9c7-e63896cf9937" xlink:to="loc_cvsi_After2017Member_b91f941e-45f8-4605-b142-56ac3bae0acf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_Before2018Member_ed4e50fe-5568-4f9a-ac0a-091e79d22e9e" xlink:href="cvsi-20201231.xsd#cvsi_Before2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxPeriodDomain_886b5e0b-deb4-408c-a9c7-e63896cf9937" xlink:to="loc_cvsi_Before2018Member_ed4e50fe-5568-4f9a-ac0a-091e79d22e9e" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INCOMETAXESUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INCOMETAXESUnrecognizedTaxBenefitsDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/INCOMETAXESUnrecognizedTaxBenefitsDetails" xlink:type="extended" id="i06b5294a7e264a0f8e9f6ba5361328e2_INCOMETAXESUnrecognizedTaxBenefitsDetails"/>
  <link:roleRef roleURI="http://cvsciences.com/role/SUBSEQUENTEVENT" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUBSEQUENTEVENT"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/SUBSEQUENTEVENT" xlink:type="extended" id="i6e33b510a72f4ee99e89e93586b2ef2d_SUBSEQUENTEVENT"/>
  <link:roleRef roleURI="http://cvsciences.com/role/SUBSEQUENTEVENTDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUBSEQUENTEVENTDetails"/>
  <link:definitionLink xlink:role="http://cvsciences.com/role/SUBSEQUENTEVENTDetails" xlink:type="extended" id="i128661717a8d416a93eed704b2464883_SUBSEQUENTEVENTDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_2936c9a4-4259-4f37-84ae-e9a34f690e9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_fc56a6cd-bc40-471c-ba5b-0644f6ece452" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_2936c9a4-4259-4f37-84ae-e9a34f690e9e" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_fc56a6cd-bc40-471c-ba5b-0644f6ece452" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_17868f14-6f4e-4adf-bc7c-64b884c82c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_2936c9a4-4259-4f37-84ae-e9a34f690e9e" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_17868f14-6f4e-4adf-bc7c-64b884c82c6a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SaleOfStockWeightedAveragePricePerShare_7bc5029c-d40a-49da-9b16-4293424ed73d" xlink:href="cvsi-20201231.xsd#cvsi_SaleOfStockWeightedAveragePricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_2936c9a4-4259-4f37-84ae-e9a34f690e9e" xlink:to="loc_cvsi_SaleOfStockWeightedAveragePricePerShare_7bc5029c-d40a-49da-9b16-4293424ed73d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_a4d55443-b1fd-48a1-953b-fb6359f8f881" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_2936c9a4-4259-4f37-84ae-e9a34f690e9e" xlink:to="loc_us-gaap_SubsequentEventTable_a4d55443-b1fd-48a1-953b-fb6359f8f881" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8544a997-aa04-4f2c-9a2b-db9f07b95dc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_a4d55443-b1fd-48a1-953b-fb6359f8f881" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8544a997-aa04-4f2c-9a2b-db9f07b95dc3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_8544a997-aa04-4f2c-9a2b-db9f07b95dc3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8544a997-aa04-4f2c-9a2b-db9f07b95dc3" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_8544a997-aa04-4f2c-9a2b-db9f07b95dc3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4d51ff5e-1d27-4821-9dc2-7c5f69c568a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8544a997-aa04-4f2c-9a2b-db9f07b95dc3" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4d51ff5e-1d27-4821-9dc2-7c5f69c568a3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_90dd635a-c8a2-4be2-864f-23f24964e63c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_4d51ff5e-1d27-4821-9dc2-7c5f69c568a3" xlink:to="loc_us-gaap_SubsequentEventMember_90dd635a-c8a2-4be2-864f-23f24964e63c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2789a3d8-fc56-4621-b25f-fe2154d5eb1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_a4d55443-b1fd-48a1-953b-fb6359f8f881" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2789a3d8-fc56-4621-b25f-fe2154d5eb1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2789a3d8-fc56-4621-b25f-fe2154d5eb1e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2789a3d8-fc56-4621-b25f-fe2154d5eb1e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_2789a3d8-fc56-4621-b25f-fe2154d5eb1e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f34107f-afad-463b-834a-07da914a8834" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2789a3d8-fc56-4621-b25f-fe2154d5eb1e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f34107f-afad-463b-834a-07da914a8834" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_CommonStockPurchaseAgreementMember_6c92ad05-f388-4fca-a553-69e51f8b5948" xlink:href="cvsi-20201231.xsd#cvsi_CommonStockPurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f34107f-afad-463b-834a-07da914a8834" xlink:to="loc_cvsi_CommonStockPurchaseAgreementMember_6c92ad05-f388-4fca-a553-69e51f8b5948" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>10
<FILENAME>cvsi-20201231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:eca8e0c2-d550-4e97-a9fa-88ee2e9b3168,g:095536f4-fd9c-45bc-aa88-ebcfe4d45a75-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_DocumentType_bcd456b7-02eb-4469-bbc5-267daf8e4c55_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_89677fcd-342d-450f-9ba5-52fa47c1de77_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_e868e810-cf28-447e-9453-46ec84fd0750_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding beginning balance, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_7b03a330-fe0d-4a7b-9bf5-ad64c50843e6_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding ending balance, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_16b9d271-e5fe-42b3-b27b-048dc21f6717_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options issued (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_NumberofSuppliers_7a0f76cd-a420-4f4f-8b85-08649dec66a1_terseLabel_en-US" xlink:label="lab_cvsi_NumberofSuppliers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of suppliers</link:label>
    <link:label id="lab_cvsi_NumberofSuppliers_label_en-US" xlink:label="lab_cvsi_NumberofSuppliers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Suppliers</link:label>
    <link:label id="lab_cvsi_NumberofSuppliers_documentation_en-US" xlink:label="lab_cvsi_NumberofSuppliers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Suppliers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_NumberofSuppliers" xlink:href="cvsi-20201231.xsd#cvsi_NumberofSuppliers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_NumberofSuppliers" xlink:to="lab_cvsi_NumberofSuppliers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_10bbe96c-2112-452f-884c-28c184ded7c2_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_6f2b8bd8-0ff0-479a-b83c-c0dd4ce5b47c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_43b4740f-5d8b-4425-bbf2-721449922006_terseLabel_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_08422e0c-ac4f-45b1-ad8e-a5bbfa4913d3_terseLabel_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementBusinessSegmentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis" xlink:to="lab_us-gaap_StatementBusinessSegmentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_5455d2cb-a262-4ac1-8f91-4b3a28e532e8_terseLabel_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In-process research and development</link:label>
    <link:label id="lab_us-gaap_InProcessResearchAndDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">In Process Research and Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InProcessResearchAndDevelopmentMember" xlink:to="lab_us-gaap_InProcessResearchAndDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_d6400ce6-804b-4d1e-89aa-aca0fc0457e3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for issuance under the Plan (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_0eaafbf4-e2b4-4c34-977e-0c55e2c5f805_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_2309302b-9943-4dbc-95e4-e7df2a8a5c3f_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_8955cfa7-a902-48c9-8d87-24b0b3d4087e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_33946006-d300-4420-a36b-b1ba6819701f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liability</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_5b095681-a6e7-4fa1-b08f-e77395e0f735_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_af3110ee-d580-4b50-99c6-a8e119feb43d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt periodic payment</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentPeriodicPayment_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Periodic Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentPeriodicPayment" xlink:to="lab_us-gaap_DebtInstrumentPeriodicPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_Before2018Member_93ca2055-d889-4ddb-9237-84693213b69f_terseLabel_en-US" xlink:label="lab_cvsi_Before2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Before 2018</link:label>
    <link:label id="lab_cvsi_Before2018Member_label_en-US" xlink:label="lab_cvsi_Before2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Before 2018 [Member]</link:label>
    <link:label id="lab_cvsi_Before2018Member_documentation_en-US" xlink:label="lab_cvsi_Before2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Before 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_Before2018Member" xlink:href="cvsi-20201231.xsd#cvsi_Before2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_Before2018Member" xlink:to="lab_cvsi_Before2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_7d4dcf4d-cfaa-42b2-a146-b97f2f302f09_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_371edaaf-4d82-4bd0-8948-e70a30d01d24_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_f11d4cad-dfd6-48c0-80ae-4ec53ca6d364_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfLongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_c4cc531c-7eb8-4b03-b1e7-ef2581791a26_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_6761b436-6d40-408d-b130-613a627c0701_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_dead71e5-d143-4815-bc06-745be8160e5c_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance stock options</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_PayrollTaxExpense_5e6ca7b6-6381-4998-8889-657a05cffdcf_terseLabel_en-US" xlink:label="lab_cvsi_PayrollTaxExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll tax expense</link:label>
    <link:label id="lab_cvsi_PayrollTaxExpense_label_en-US" xlink:label="lab_cvsi_PayrollTaxExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll Tax Expense</link:label>
    <link:label id="lab_cvsi_PayrollTaxExpense_documentation_en-US" xlink:label="lab_cvsi_PayrollTaxExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll Tax Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_PayrollTaxExpense" xlink:href="cvsi-20201231.xsd#cvsi_PayrollTaxExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_PayrollTaxExpense" xlink:to="lab_cvsi_PayrollTaxExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_c66ceafb-157d-46c0-b852-61d97e1e8aff_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 12)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_084ef051-270e-4e31-9e38-6505da736310_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in valuation allowance</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_d84b55d1-8987-4344-9558-a70fd9796809_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_085dc7e5-bba4-4fdc-94a0-5e2ceeb32acb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_PremiumFinanceAgreementMember_e0b4f7a6-ad5f-4e27-afb8-bd64a3174fb2_terseLabel_en-US" xlink:label="lab_cvsi_PremiumFinanceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Finance Agreement</link:label>
    <link:label id="lab_cvsi_PremiumFinanceAgreementMember_label_en-US" xlink:label="lab_cvsi_PremiumFinanceAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Premium Finance Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_PremiumFinanceAgreementMember" xlink:href="cvsi-20201231.xsd#cvsi_PremiumFinanceAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_PremiumFinanceAgreementMember" xlink:to="lab_cvsi_PremiumFinanceAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_561499cb-0aa1-483f-9fe2-7723ba374258_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_b1f25047-273e-46c6-81ff-7c3ce9e82f09_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_430b7e05-c155-4345-b82c-c5730637f136_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_0ff30c35-007b-4988-a816-4bf2f3274a43_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_939e6831-4e0e-4cf3-86e0-368805ef07e5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested RSU's (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_0076bd87-a83b-454d-a3fa-511bcb1d4a8e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit at federal statutory rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_0251ab7e-c02b-43f3-aa66-b5bedd54642f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_d7c3c89b-b381-489c-82fe-c2d84e9a185a_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_PurchaseOfInsuranceThroughIssuanceOfNotePayable_c186bd53-43ff-4da8-b86e-cd73a549b453_terseLabel_en-US" xlink:label="lab_cvsi_PurchaseOfInsuranceThroughIssuanceOfNotePayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of insurance through issuance of note payable (Note 7)</link:label>
    <link:label id="lab_cvsi_PurchaseOfInsuranceThroughIssuanceOfNotePayable_label_en-US" xlink:label="lab_cvsi_PurchaseOfInsuranceThroughIssuanceOfNotePayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of insurance through issuance of note payable</link:label>
    <link:label id="lab_cvsi_PurchaseOfInsuranceThroughIssuanceOfNotePayable_documentation_en-US" xlink:label="lab_cvsi_PurchaseOfInsuranceThroughIssuanceOfNotePayable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of insurance through issuance of note payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_PurchaseOfInsuranceThroughIssuanceOfNotePayable" xlink:href="cvsi-20201231.xsd#cvsi_PurchaseOfInsuranceThroughIssuanceOfNotePayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_PurchaseOfInsuranceThroughIssuanceOfNotePayable" xlink:to="lab_cvsi_PurchaseOfInsuranceThroughIssuanceOfNotePayable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_After2017Member_70e03c91-618f-4f7a-822f-7137288d24db_terseLabel_en-US" xlink:label="lab_cvsi_After2017Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After 2017</link:label>
    <link:label id="lab_cvsi_After2017Member_label_en-US" xlink:label="lab_cvsi_After2017Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After 2017 [Member]</link:label>
    <link:label id="lab_cvsi_After2017Member_documentation_en-US" xlink:label="lab_cvsi_After2017Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">After 2017 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_After2017Member" xlink:href="cvsi-20201231.xsd#cvsi_After2017Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_After2017Member" xlink:to="lab_cvsi_After2017Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_387e61e6-d842-4bee-8074-af52709223f5_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_ecba9d48-0584-4771-9a5f-c7e74c1c595a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_c229c9f3-f5d0-40e7-9321-2a7387eaaad1_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_92d326cd-27c2-4991-998b-7a047a8134e5_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Property, Plant and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_a1ef1547-317b-4900-b599-36125c67b183_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CanX intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_b652f8ac-4041-469a-b5bc-f5393ffeb289_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income taxes paid</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_006c6c1e-ecd6-48ed-a7bd-c4876825138a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_42773ba3-67e0-4121-b022-c58ab7946f0b_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding beginning balance (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ee61f84f-c14d-4c18-945b-32957911bf7c_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding ending balance (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_f6e0cc9d-2100-4f69-a24e-0d22dd0d05e4_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_0ec984c1-8298-497f-a6ba-d4f55b45c84d_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_4b61bd8c-9741-467f-ae34-a66a4d47e0bb_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesOutstanding_54bda1ad-3311-4b13-86ef-58e7fa3f034e_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_e8614bd3-17d2-4000-bd8b-ab8a8408ce2c_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesOutstanding_label_en-US" xlink:label="lab_us-gaap_SharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesOutstanding" xlink:to="lab_us-gaap_SharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValue_98140ee4-01bd-4a2e-9593-bf953d6f5c18_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value $0.0001; 10,000 shares authorized; no shares issued and outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockValue_label_en-US" xlink:label="lab_us-gaap_PreferredStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValue" xlink:to="lab_us-gaap_PreferredStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_417f60ec-56f9-4cd4-995a-bd360433f345_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_30e538a7-907b-49db-b93c-bf9cad8ead82_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_4f270cab-3467-4b16-9186-322cbc0afff9_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Operating Expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_c61f3fce-4fe8-4022-949b-ace63cecb657_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_48b0268c-5ab7-403f-a6a3-67f5cf447630_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_e89288f3-5f7e-4fd2-aa8f-b1f97af0e641_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock par value</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_d1880faa-d16c-4d00-885a-6ea5d5586b44_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_d18dd757-5786-4054-bfbe-4ec9f766266d_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_24ed4699-8494-43aa-a24f-c496771ecb3a_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_d3170792-cc96-472c-9036-1567769f3456_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2817f957-7072-48b7-bdad-50da12abe872_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product sales, net</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_0cdf7c06-290d-4766-b986-a639ce90a3c4_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryLineItems_d6b74ed2-e07d-4a08-beb7-1f4adb246ceb_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:label id="lab_us-gaap_InventoryLineItems_label_en-US" xlink:label="lab_us-gaap_InventoryLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryLineItems" xlink:to="lab_us-gaap_InventoryLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_e5605e75-7665-4a1d-abae-cbc069505e06_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">% of product sales, net</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_e740c741-53bb-4980-a645-58f59e83ae4c_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_76dd015d-dcaa-4397-8f4d-9e8a448f8f95_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option, maximum term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_4359ca43-4760-475e-81b4-4d3ab4e1b9a4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnTerminationOfLease_416bf401-5e9f-4c85-8285-3162d552a548_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnTerminationOfLease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain termination of lease</link:label>
    <link:label id="lab_us-gaap_GainLossOnTerminationOfLease_label_en-US" xlink:label="lab_us-gaap_GainLossOnTerminationOfLease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Termination of Lease</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnTerminationOfLease" xlink:to="lab_us-gaap_GainLossOnTerminationOfLease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_6e824399-473b-49b9-9f4e-026a932d782d_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred taxes</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Income Taxes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodAxis_fe1de85e-10a7-4c5e-b72a-905c5be65178_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodAxis_label_en-US" xlink:label="lab_us-gaap_TaxPeriodAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodAxis" xlink:to="lab_us-gaap_TaxPeriodAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_48637e04-65db-46d0-9ab3-6dd67323388a_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity a Voluntary Filer</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAbstract_9088b784-5a2e-444f-b794-891886bb1c58_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Taxes and Other Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxesAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_699f1df8-a085-4341-b709-b0bb20e271f0_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested (shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_dfc3382d-8d99-4da6-8e82-c162b8d05f51_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_a25e4603-0171-49ed-a34e-8e77db836a67_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_AccountsReceivableThresholdforDeterminingDelinquentAccount_db2b3b49-752c-43cc-a2ce-52d1ed9db9a0_terseLabel_en-US" xlink:label="lab_cvsi_AccountsReceivableThresholdforDeterminingDelinquentAccount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Threshold for determining delinquent accounts receivable</link:label>
    <link:label id="lab_cvsi_AccountsReceivableThresholdforDeterminingDelinquentAccount_label_en-US" xlink:label="lab_cvsi_AccountsReceivableThresholdforDeterminingDelinquentAccount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Threshold for Determining Delinquent Account</link:label>
    <link:label id="lab_cvsi_AccountsReceivableThresholdforDeterminingDelinquentAccount_documentation_en-US" xlink:label="lab_cvsi_AccountsReceivableThresholdforDeterminingDelinquentAccount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Threshold for Determining Delinquent Account</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_AccountsReceivableThresholdforDeterminingDelinquentAccount" xlink:href="cvsi-20201231.xsd#cvsi_AccountsReceivableThresholdforDeterminingDelinquentAccount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_AccountsReceivableThresholdforDeterminingDelinquentAccount" xlink:to="lab_cvsi_AccountsReceivableThresholdforDeterminingDelinquentAccount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_4a8c1fa5-a094-4109-a55b-274bc4a901ac_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_06e97515-55ad-48c2-9871-23e7335c95ed_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock issued</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_ConsumerProductsMember_a2ad001f-f0dc-45a7-8553-09ead8f1bf5a_terseLabel_en-US" xlink:label="lab_cvsi_ConsumerProductsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Products Segment</link:label>
    <link:label id="lab_cvsi_ConsumerProductsMember_label_en-US" xlink:label="lab_cvsi_ConsumerProductsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consumer Products [Member]</link:label>
    <link:label id="lab_cvsi_ConsumerProductsMember_documentation_en-US" xlink:label="lab_cvsi_ConsumerProductsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharmaceuticals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_ConsumerProductsMember" xlink:href="cvsi-20201231.xsd#cvsi_ConsumerProductsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_ConsumerProductsMember" xlink:to="lab_cvsi_ConsumerProductsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness_b794abf6-b5a7-467a-bd61-23c7ab2a3d4f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, General Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_StockOptionModificationMember_7e0f158f-f189-45d3-aaaf-b55801266833_terseLabel_en-US" xlink:label="lab_cvsi_StockOptionModificationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Modification</link:label>
    <link:label id="lab_cvsi_StockOptionModificationMember_label_en-US" xlink:label="lab_cvsi_StockOptionModificationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Modification [Member]</link:label>
    <link:label id="lab_cvsi_StockOptionModificationMember_documentation_en-US" xlink:label="lab_cvsi_StockOptionModificationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Modification</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_StockOptionModificationMember" xlink:href="cvsi-20201231.xsd#cvsi_StockOptionModificationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_StockOptionModificationMember" xlink:to="lab_cvsi_StockOptionModificationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashUninsuredAmount_4fa3620c-33b3-4590-9046-417b378f09e0_terseLabel_en-US" xlink:label="lab_us-gaap_CashUninsuredAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash in excess of FDIC limits</link:label>
    <link:label id="lab_us-gaap_CashUninsuredAmount_label_en-US" xlink:label="lab_us-gaap_CashUninsuredAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Uninsured Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashUninsuredAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashUninsuredAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashUninsuredAmount" xlink:to="lab_us-gaap_CashUninsuredAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_22808872-1985-4cf1-8727-e89e79ca0fd5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common share , basic and diluted (in USD per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_1371bf96-0d8f-49c0-b066-9f89f3bdeb89_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_CommonStockPurchaseAgreementMember_3b9ea108-6809-40cb-bf90-d67341ed1cc2_terseLabel_en-US" xlink:label="lab_cvsi_CommonStockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Purchase Agreement</link:label>
    <link:label id="lab_cvsi_CommonStockPurchaseAgreementMember_1a62ed1f-e22f-486b-ba7c-4aaec67a2f6c_verboseLabel_en-US" xlink:label="lab_cvsi_CommonStockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SPA</link:label>
    <link:label id="lab_cvsi_CommonStockPurchaseAgreementMember_label_en-US" xlink:label="lab_cvsi_CommonStockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Purchase Agreement [Member]</link:label>
    <link:label id="lab_cvsi_CommonStockPurchaseAgreementMember_documentation_en-US" xlink:label="lab_cvsi_CommonStockPurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Purchase Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_CommonStockPurchaseAgreementMember" xlink:href="cvsi-20201231.xsd#cvsi_CommonStockPurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_CommonStockPurchaseAgreementMember" xlink:to="lab_cvsi_CommonStockPurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_6e55a365-ab69-49e4-a414-69f30005ce81_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock sold (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_9ce0e813-99c4-4033-93ab-a144d5f19820_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">DEBT</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_16611527-6e11-489e-8bc0-77209944f605_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_4d9dd208-510d-411a-8724-e894048ce4fa_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable, weighted average remaining contract term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_ebb62b4f-e5b7-404c-9842-1605ac3c0521_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_d75ab0c1-060d-4282-89f5-940db43e8764_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_f8c7368f-a3dc-4b63-b48f-5140671d07dd_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of goods sold</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_8cd16101-f109-4219-ba9f-7b51766105c3_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_57d5c5ce-e553-4c0a-9423-4bae7c58f83e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_753f03f4-537c-4313-a4e3-c58cf158bf4b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Computation of Basic and Diluted Earnings per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_StockIssuedDuringPeriodValueEquityCommitment_2df4c48d-187f-4d8e-8220-654cd94dda82_terseLabel_en-US" xlink:label="lab_cvsi_StockIssuedDuringPeriodValueEquityCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under equity commitment</link:label>
    <link:label id="lab_cvsi_StockIssuedDuringPeriodValueEquityCommitment_label_en-US" xlink:label="lab_cvsi_StockIssuedDuringPeriodValueEquityCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued during Period, Value, Equity Commitment</link:label>
    <link:label id="lab_cvsi_StockIssuedDuringPeriodValueEquityCommitment_documentation_en-US" xlink:label="lab_cvsi_StockIssuedDuringPeriodValueEquityCommitment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued during Period, Value, Equity Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_StockIssuedDuringPeriodValueEquityCommitment" xlink:href="cvsi-20201231.xsd#cvsi_StockIssuedDuringPeriodValueEquityCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_StockIssuedDuringPeriodValueEquityCommitment" xlink:to="lab_cvsi_StockIssuedDuringPeriodValueEquityCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsDisclosureTextBlock_7ae75e24-cdd8-4ab2-8c7f-c3071d7f8466_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COMMITMENTS AND CONTINGENCIES</link:label>
    <link:label id="lab_us-gaap_CommitmentsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_449eaec9-69ff-4177-9f48-bce16619b719_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_04d3489b-787b-4c43-95fa-df453c8424fd_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares authorized under plan (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_498e0718-d560-4b5a-998f-cf695b8f6697_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research &amp; Development Expense</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_3ec78d72-6516-43f6-86b6-625f390a73b4_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_SpecialtyPharmaceuticalSegmentMember_35a57814-bb56-4dc7-83d7-290f5815cad5_terseLabel_en-US" xlink:label="lab_cvsi_SpecialtyPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharmaceutical Segment</link:label>
    <link:label id="lab_cvsi_SpecialtyPharmaceuticalSegmentMember_label_en-US" xlink:label="lab_cvsi_SpecialtyPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharmaceutical Segment [Member]</link:label>
    <link:label id="lab_cvsi_SpecialtyPharmaceuticalSegmentMember_documentation_en-US" xlink:label="lab_cvsi_SpecialtyPharmaceuticalSegmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharmaceutical Segment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SpecialtyPharmaceuticalSegmentMember" xlink:href="cvsi-20201231.xsd#cvsi_SpecialtyPharmaceuticalSegmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_SpecialtyPharmaceuticalSegmentMember" xlink:to="lab_cvsi_SpecialtyPharmaceuticalSegmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_f9e1403f-48d1-4575-9a6b-6309037e85c1_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_6656501b-fdb2-456a-8553-2ac85b9af129_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_ec1fed9a-e4c4-45ad-af68-cb3d0f4be97c_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_3e7eab45-a66e-41f2-b893-49d8f51a48b1_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_8c716957-a966-466d-a5bc-56b01993ab14_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation and Benefits</link:label>
    <link:label id="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="lab_us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_5eacfbf8-6e2f-45eb-ab8a-41e2492106b8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_4e3b607f-62a3-41d4-9360-73ebd1f2f4e5_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_1822b915-ffcc-4282-a5f8-f6b3e2ca9793_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of intangible assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_c1eeebd5-4c1a-4fba-813e-0e3de4943052_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_ae6e0f1a-e6cd-4bd9-92f5-51c781499625_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property and equipment in accounts payable and accrued expenses</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_f58ee555-b5a2-4a66-aa9b-0f3ffdd3184b_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_a9fd54e9-3642-4471-a2f7-81f7ed26ca64_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_af633ac0-68ed-4f7e-8acc-d1486338df0f_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUBSEQUENT EVENT</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_b44b5a1f-6f1c-406a-9eb8-d87b7d59f233_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation_956ee5f2-b2d2-444f-8e6e-1fabc5710f98_terseLabel_en-US" xlink:label="lab_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible officer compensation (IRC 162(m))</link:label>
    <link:label id="lab_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation_label_en-US" xlink:label="lab_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Non-deductible Officer Compensation</link:label>
    <link:label id="lab_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation_documentation_en-US" xlink:label="lab_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Non-deductible Officer Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation" xlink:href="cvsi-20201231.xsd#cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation" xlink:to="lab_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentDomain_7ea03842-853e-4c46-b8d8-687206161031_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:label id="lab_us-gaap_SegmentDomain_label_en-US" xlink:label="lab_us-gaap_SegmentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentDomain" xlink:to="lab_us-gaap_SegmentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_7c96b91b-c5f0-48b2-8588-5fdb415432a6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_13527b2d-c076-4d9c-98da-d405f47706fd_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_cd9d45a2-ae2b-4680-9205-00ab61c7630e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_fa021460-ee3f-46ac-95a4-6687c78c1898_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_b387ae6a-9450-48f3-a538-e004dfae1894_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_f6c17911-ce1c-494f-a186-0873114278c0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_c346260a-2b54-4a30-8ced-b123e42fc81b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D tax credits</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_41db3378-765d-4bee-a882-c9b26054dd2b_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8c0b8b65-e719-4112-8933-928e9a3fef9c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">FINANCING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_60aca79b-e8f4-4bb2-800a-4b663374fa4e_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_2e5c97dc-08a5-4a17-ac61-e748ec999d27_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_ca40f3be-dfdf-4fdd-92d4-4b254997429d_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract" xlink:to="lab_us-gaap_StockholdersEquityNoteAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_DeferredTaxLiabilityOperatingLeaseAssets_915987a7-3e66-4ac2-a275-e2f34391c9c0_negatedLabel_en-US" xlink:label="lab_cvsi_DeferredTaxLiabilityOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease assets</link:label>
    <link:label id="lab_cvsi_DeferredTaxLiabilityOperatingLeaseAssets_label_en-US" xlink:label="lab_cvsi_DeferredTaxLiabilityOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liability, Operating Lease Assets</link:label>
    <link:label id="lab_cvsi_DeferredTaxLiabilityOperatingLeaseAssets_documentation_en-US" xlink:label="lab_cvsi_DeferredTaxLiabilityOperatingLeaseAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liability, Operating Lease Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_DeferredTaxLiabilityOperatingLeaseAssets" xlink:href="cvsi-20201231.xsd#cvsi_DeferredTaxLiabilityOperatingLeaseAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_DeferredTaxLiabilityOperatingLeaseAssets" xlink:to="lab_cvsi_DeferredTaxLiabilityOperatingLeaseAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_7929cf51-4ae9-4870-b03b-a337bcd9b697_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other permanent differences</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_635bc2fe-9915-41aa-9916-2ba4201ab8a0_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease Information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_93052d17-048e-4c6e-9104-8b8039fa36f0_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issued as commitment fee (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, Issued for Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_b305903a-9afb-4336-9c51-b2ca2c042afe_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_e3d2b7a9-cc5e-44cf-b968-fb97492c1329_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_d67ddf81-a533-4522-baa4-a73be0304ca6_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SEGMENT INFORMATION</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_11211e02-9796-409b-b43d-de35acd7fcb9_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money market funds classified as cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_40101905-6282-4c3b-bfa9-2f7632c60332_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_a720938d-5503-4f9d-93e3-b36ceb66c3e5_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RELATED PARTIES</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_dcb4eb27-9be5-44d3-9c73-a76b173665a7_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ORGANIZATION AND BUSINESS</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_19d235b9-a1a7-407a-a1ab-0f58f339db3b_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangibles, net</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_36797f77-71b8-4fc3-ae8d-eedf04ecf6f7_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_317a67e0-3483-49c4-87f8-310cea81af3c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Per Share on Grant Date</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_b8149769-468f-42d8-8561-beff533d09f6_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:to="lab_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_cc1fb07c-d7af-4f71-91d2-8acfdbebd334_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_c3ff4c12-2fc5-48b5-b161-38927b8b18ca_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_23709aa9-80e0-4890-a799-a9e4c0f8ae92_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentrations of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForLoanAndLeaseLosses_61e5250a-e063-47db-8795-aea24a43d64b_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForLoanAndLeaseLosses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment charge related to previously recorded receivable</link:label>
    <link:label id="lab_us-gaap_ProvisionForLoanAndLeaseLosses_label_en-US" xlink:label="lab_us-gaap_ProvisionForLoanAndLeaseLosses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for Loan and Lease Losses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanAndLeaseLosses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForLoanAndLeaseLosses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForLoanAndLeaseLosses" xlink:to="lab_us-gaap_ProvisionForLoanAndLeaseLosses" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction_052f9bb5-6c08-4f60-a51f-a5e8c29518a5_terseLabel_en-US" xlink:label="lab_cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Value of shares</link:label>
    <link:label id="lab_cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Maximum Value Of Shares Issued In Transaction</link:label>
    <link:label id="lab_cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction_documentation_en-US" xlink:label="lab_cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Maximum Value Of Shares Issued In Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction" xlink:href="cvsi-20201231.xsd#cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction" xlink:to="lab_cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_0b04352e-12cb-47c0-952e-a4233bc63eb9_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_515d8157-b3c2-4adb-9568-724f5c0aa8b9_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds recognized</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_f4068348-1662-4324-8083-0e3a30a9f669_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_f168de7d-c5f4-4a2d-8a77-d19233fca1bd_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_44d8fb5b-71b2-48b9-9a64-1179279f78b5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of income tax provision</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_64f00cbb-0ab8-43f7-8e63-53f2373eba15_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_d74acdd9-0f0d-4867-95aa-c412043d47b8_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_bbc8ef98-3eb7-4bf5-a3b3-904978fda8d6_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized weighted average period</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_d9cba9c1-0b91-432e-a6aa-fb46ea57ef29_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_bc8601c4-331a-4008-9588-5fd996cc2db3_negatedLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_10fe9bb9-fad3-4328-b4a2-493bcf81dab6_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outside the United States</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_bbf3936f-52ae-4b07-b18e-4bfe5c27e182_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan_2465a0d6-dec5-42c3-93fa-7d47fe6e9552_terseLabel_en-US" xlink:label="lab_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual increase to shares authorized for issuance under the Plan (shares)</link:label>
    <link:label id="lab_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan_label_en-US" xlink:label="lab_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Annual Increase to Shares Authorized for Issuance under the Plan</link:label>
    <link:label id="lab_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan_documentation_en-US" xlink:label="lab_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Annual Increase to Shares Authorized for Issuance under the Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan" xlink:href="cvsi-20201231.xsd#cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan" xlink:to="lab_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_2c044868-78fe-4990-91bc-d3c6c944ebef_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_AccruedPayrollTaxesCurrentEmployeePortion_09cbeeae-bb69-46e6-ada7-5211e50b56ed_terseLabel_en-US" xlink:label="lab_cvsi_AccruedPayrollTaxesCurrentEmployeePortion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee portion of payroll taxes</link:label>
    <link:label id="lab_cvsi_AccruedPayrollTaxesCurrentEmployeePortion_label_en-US" xlink:label="lab_cvsi_AccruedPayrollTaxesCurrentEmployeePortion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Payroll Taxes, Current, Employee Portion</link:label>
    <link:label id="lab_cvsi_AccruedPayrollTaxesCurrentEmployeePortion_documentation_en-US" xlink:label="lab_cvsi_AccruedPayrollTaxesCurrentEmployeePortion" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Payroll Taxes, Current, Employee Portion</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_AccruedPayrollTaxesCurrentEmployeePortion" xlink:href="cvsi-20201231.xsd#cvsi_AccruedPayrollTaxesCurrentEmployeePortion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_AccruedPayrollTaxesCurrentEmployeePortion" xlink:to="lab_cvsi_AccruedPayrollTaxesCurrentEmployeePortion" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_f5bcf5c2-162e-486f-8b92-337340ef5caf_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_2b9c1797-27d4-4639-b3aa-4733a935ace7_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_7107ecaa-5fac-4d6f-8764-87a3124a6c39_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested or expected to vest, weighted average remaining contract term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_2c2e8a0d-5bd9-45bf-bb45-7f8d5228a05b_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_bdb809c7-5e75-4bf8-b40c-294d2176eeab_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance (decrease) increase</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_7881cafb-f597-4e99-96be-30ca1e096b4e_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_58d2aff6-1392-4a16-9159-86d36d42e9dc_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_e5881978-6f27-4513-ba7f-15f544a4b6ed_negatedLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest (income) expense, net</link:label>
    <link:label id="lab_us-gaap_InterestIncomeExpenseNet_label_en-US" xlink:label="lab_us-gaap_InterestIncomeExpenseNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Income (Expense), Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeExpenseNet" xlink:to="lab_us-gaap_InterestIncomeExpenseNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryGross_4572f00c-9609-42f1-b293-e4658b9eb5f1_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total gross inventory</link:label>
    <link:label id="lab_us-gaap_InventoryGross_label_en-US" xlink:label="lab_us-gaap_InventoryGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryGross" xlink:to="lab_us-gaap_InventoryGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_9f03334d-6a5f-44c8-be79-a3e2cf41757a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_613a49c7-c499-4be3-adb3-724b7df6086f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement_label_en-US" xlink:label="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Operating Activities, Cash Flow Statement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="lab_us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_3050d5e6-75f3-4b04-9a04-94c891065025_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Goodwill and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:to="lab_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_a9fd970f-7255-4e05-bcc4-ad36735449d4_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_d00f368b-921c-42b9-96bb-b0d6f5256b61_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_e8215829-ff83-425b-8c52-159358f181df_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash flows used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseAxis_0e590dce-d331-43e0-aca6-3883950b1601_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:label id="lab_srt_LitigationCaseAxis_label_en-US" xlink:label="lab_srt_LitigationCaseAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseAxis" xlink:to="lab_srt_LitigationCaseAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_SaleOfStockWeightedAveragePricePerShare_74d2d684-21cf-4b7e-a5bf-e06777ebf43c_terseLabel_en-US" xlink:label="lab_cvsi_SaleOfStockWeightedAveragePricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average price per share</link:label>
    <link:label id="lab_cvsi_SaleOfStockWeightedAveragePricePerShare_label_en-US" xlink:label="lab_cvsi_SaleOfStockWeightedAveragePricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Weighted Average Price Per Share</link:label>
    <link:label id="lab_cvsi_SaleOfStockWeightedAveragePricePerShare_documentation_en-US" xlink:label="lab_cvsi_SaleOfStockWeightedAveragePricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Weighted Average Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SaleOfStockWeightedAveragePricePerShare" xlink:href="cvsi-20201231.xsd#cvsi_SaleOfStockWeightedAveragePricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_SaleOfStockWeightedAveragePricePerShare" xlink:to="lab_cvsi_SaleOfStockWeightedAveragePricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_09bbf550-6c55-466a-8ac1-f108e5145e25_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments</link:label>
    <link:label id="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy_label_en-US" xlink:label="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value of Financial Instruments, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:to="lab_us-gaap_FairValueOfFinancialInstrumentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_54288616-0006-4947-b67a-9d6f1b599427_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change to inventory</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInventory_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInventory" xlink:to="lab_us-gaap_DeferredTaxAssetsInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_ba7e8b7e-3f12-427d-928a-936b10bc4dba_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_27bdc692-a82a-45c6-a856-52e402ac9179_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - shares outstanding</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_be2d398d-0783-440e-8a13-e21c23a5efd4_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_13b5f05f-b9be-42e9-9ab3-c5d92053c303_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State taxes, net of federal effect</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b0776e29-8bf5-4f96-af94-8772826160cf_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_7240d082-c77d-4a9c-8b64-9243330c759f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested or expected to vest (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_5df636f7-4387-4629-a31c-a05ff492bb7a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price of outstanding vested options (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_55ff155c-28e4-4bc6-8e32-525a0e7be180_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_2717ca95-0682-449b-a4c6-ec5b69d2be99_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_4a5e68d4-5b72-4feb-ac6a-290393afaf5b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_eded172a-0dd5-405d-a99d-0e62b39d0587_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding beginning balance (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_a2c40ccb-c910-47b2-a44a-60f064364a44_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding ending balance (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_cd964544-b7f5-4d71-af6d-4f27b35c167b_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_8c22a5bd-7810-4492-96d2-d5e212acc20b_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Domestic Tax Authority [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_6d0dec6f-2216-4fcc-a1b7-9f5e9af221a3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - shares authorized (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_fca60bda-11b2-4eb6-95da-d341c8fef6d9_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_c4169f72-8801-413b-b6c5-ca7dcdcb71ca_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_f6836938-f584-4d67-8b41-23e179b52934_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_7bb51209-951e-4542-9880-2c17ac5b22d8_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_3b6e5edb-7b80-410e-8e16-378eaf2b28ba_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_Amended2013PlanMember_fdc2ce9b-41ee-415b-bd99-0b1ec67090d4_verboseLabel_en-US" xlink:label="lab_cvsi_Amended2013PlanMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended 2013 Plan</link:label>
    <link:label id="lab_cvsi_Amended2013PlanMember_label_en-US" xlink:label="lab_cvsi_Amended2013PlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended 2013 Plan [Member] [Default Label]</link:label>
    <link:label id="lab_cvsi_Amended2013PlanMember_documentation_en-US" xlink:label="lab_cvsi_Amended2013PlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Information by plan name pertaining to equity-based compensation arrangements.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_Amended2013PlanMember" xlink:href="cvsi-20201231.xsd#cvsi_Amended2013PlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_Amended2013PlanMember" xlink:to="lab_cvsi_Amended2013PlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_15768477-77cb-4eba-a1f8-64f0cec059a4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Segment Reporting Information</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_421984d3-6e3d-4624-bff7-92e003e87e4a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_5944c8d4-9ddd-424b-ab8f-45c9647a7d16_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_470c49d3-effa-4484-a4cc-6baceddceeea_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3e3dda1e-62f2-4e6c-aeb4-0dc7b74d943f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock_84feea19-212f-423f-94bb-d33d1c01dac0_terseLabel_en-US" xlink:label="lab_cvsi_SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of specified trading days between directions to purchase stock</link:label>
    <link:label id="lab_cvsi_SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock_label_en-US" xlink:label="lab_cvsi_SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Number Of Specified Trading Days Between Directions To Purchase Stock</link:label>
    <link:label id="lab_cvsi_SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock_documentation_en-US" xlink:label="lab_cvsi_SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Number Of Specified Trading Days Between Directions To Purchase Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock" xlink:href="cvsi-20201231.xsd#cvsi_SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock" xlink:to="lab_cvsi_SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_689d89d9-6a14-4500-a9ae-ec1151a7ccf4_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_19bd6ce5-94a0-4190-88f5-88f5cba658de_terseLabel_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Domain]</link:label>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_label_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:to="lab_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_3b6beeec-31ad-4cfc-915e-e392c813e7bf_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_441133f0-55f4-41f0-b5ee-80c76342b48e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D tax credits</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_89b72a0a-c0ab-45d5-92be-a740bad0abe4_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_ca2e2bd5-74f9-4a15-9587-cf178dda6baf_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_f20c3309-b1de-4476-90db-bff6ac9376af_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentForAmortization_label_en-US" xlink:label="lab_us-gaap_AdjustmentForAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentForAmortization" xlink:to="lab_us-gaap_AdjustmentForAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_sic_Z3821_4063d66a-c7d3-4413-9dba-0badafb799f1_terseLabel_en-US" xlink:label="lab_sic_Z3821" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory and other equipment</link:label>
    <link:label id="lab_sic_Z3821_label_en-US" xlink:label="lab_sic_Z3821" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">3821 Laboratory Apparatus and Furniture [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_sic_Z3821" xlink:href="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd#sic_Z3821"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_sic_Z3821" xlink:to="lab_sic_Z3821" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_36e5b05b-579f-4806-936f-0b47d02d8bf5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend Rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_68154ac0-42be-444a-adc9-defac5fd295c_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in USD per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_8e0a4194-4864-45f4-b93b-0503554779bf_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock par value</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_68d26e5b-eb05-40da-a19c-87528e891b00_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_580e6a5f-6c38-4c47-a1fc-e937f1e1e803_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of effective income tax rate reconciliation</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_636ec2f1-eb62-401b-aef5-49ae8f590001_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Term Debt, Maturity, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:to="lab_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_57a21042-e1dd-4494-9df4-8c49c77ec276_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_1930119b-3470-47f5-8f4e-030424e984c4_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee_66d79962-69c6-40be-bb6a-79cc7e0547b5_terseLabel_en-US" xlink:label="lab_cvsi_SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of shares issued as commitment fee</link:label>
    <link:label id="lab_cvsi_SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee_label_en-US" xlink:label="lab_cvsi_SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Fair Value Of Shares Issued, Payment Of Commitment Fee</link:label>
    <link:label id="lab_cvsi_SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee_documentation_en-US" xlink:label="lab_cvsi_SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Fair Value Of Shares Issued, Payment Of Commitment Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee" xlink:href="cvsi-20201231.xsd#cvsi_SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee" xlink:to="lab_cvsi_SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_06d92b62-0456-4d11-adfb-b3b4b5fe259c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_4e8210e8-8daf-41a3-8231-87ed17bf5ee7_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DueFromRelatedPartiesCurrent_346eb78b-2c06-4895-84e8-09fc4b985a8f_terseLabel_en-US" xlink:label="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from former President and CEO</link:label>
    <link:label id="lab_us-gaap_DueFromRelatedPartiesCurrent_label_en-US" xlink:label="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Due from Related Parties, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DueFromRelatedPartiesCurrent" xlink:to="lab_us-gaap_DueFromRelatedPartiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_FormerChiefOperatingOfficerMember_f9963c9c-b7b1-42bf-840c-627dd5b73462_terseLabel_en-US" xlink:label="lab_cvsi_FormerChiefOperatingOfficerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Chief Operating Officer</link:label>
    <link:label id="lab_cvsi_FormerChiefOperatingOfficerMember_label_en-US" xlink:label="lab_cvsi_FormerChiefOperatingOfficerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Chief Operating Officer [Member]</link:label>
    <link:label id="lab_cvsi_FormerChiefOperatingOfficerMember_documentation_en-US" xlink:label="lab_cvsi_FormerChiefOperatingOfficerMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Chief Operating Officer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_FormerChiefOperatingOfficerMember" xlink:href="cvsi-20201231.xsd#cvsi_FormerChiefOperatingOfficerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_FormerChiefOperatingOfficerMember" xlink:to="lab_cvsi_FormerChiefOperatingOfficerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_3d69efb1-6170-4b83-a9bb-9585b5928b28_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_530231ea-fa42-452f-ab1d-0553dbb27d97_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Product Sales by Channel</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedPayrollTaxesCurrent_881ec835-9424-4b9c-92ae-151a1ef90ac2_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedPayrollTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll taxes payable</link:label>
    <link:label id="lab_us-gaap_AccruedPayrollTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedPayrollTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Payroll Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedPayrollTaxesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedPayrollTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedPayrollTaxesCurrent" xlink:to="lab_us-gaap_AccruedPayrollTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_6547478f-e6ca-48bd-9b6b-35343c1f7f8e_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment of Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_f76d9e49-80ba-489e-a831-e0691804c71c_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_830244ff-fd22-48d4-a7e7-3aa6c8631b3f_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_fe917835-02b6-4c21-aa4d-23e0f24858b6_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_75ffec53-8cb9-48eb-9e7e-15c348554237_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note Payable, Other</link:label>
    <link:label id="lab_us-gaap_NotesPayableOtherPayablesMember_label_en-US" xlink:label="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Other Payables [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableOtherPayablesMember" xlink:to="lab_us-gaap_NotesPayableOtherPayablesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_e583da10-8df9-4c53-8174-1e999c60b423_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_ImpairmentOfTaxReceivableForRSUSettlement_a8f3f0ef-22a4-4cbc-9bc4-bd6687d7f0f0_terseLabel_en-US" xlink:label="lab_cvsi_ImpairmentOfTaxReceivableForRSUSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derecognition of tax receivable for founder RSU settlement (Note 11)</link:label>
    <link:label id="lab_cvsi_ImpairmentOfTaxReceivableForRSUSettlement_label_en-US" xlink:label="lab_cvsi_ImpairmentOfTaxReceivableForRSUSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Of Tax Receivable For RSU Settlement</link:label>
    <link:label id="lab_cvsi_ImpairmentOfTaxReceivableForRSUSettlement_documentation_en-US" xlink:label="lab_cvsi_ImpairmentOfTaxReceivableForRSUSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment Of Tax Receivable For RSU Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_ImpairmentOfTaxReceivableForRSUSettlement" xlink:href="cvsi-20201231.xsd#cvsi_ImpairmentOfTaxReceivableForRSUSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_ImpairmentOfTaxReceivableForRSUSettlement" xlink:to="lab_cvsi_ImpairmentOfTaxReceivableForRSUSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_da408aad-62e4-4a26-a22a-b5a82c2137c7_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_f20723f0-f3f0-4d6e-8a5b-fc4540d13f48_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebt_6200df69-7515-4c86-8642-6a36fda3b424_verboseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebt" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net carrying amount of debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebt_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebt" xlink:to="lab_us-gaap_UnsecuredDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_ECommMember_81cab3f0-9e4a-4dd4-9f5b-40be08217869_terseLabel_en-US" xlink:label="lab_cvsi_ECommMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E-Comm</link:label>
    <link:label id="lab_cvsi_ECommMember_label_en-US" xlink:label="lab_cvsi_ECommMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E-Comm [Member]</link:label>
    <link:label id="lab_cvsi_ECommMember_documentation_en-US" xlink:label="lab_cvsi_ECommMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">E-Comm</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_ECommMember" xlink:href="cvsi-20201231.xsd#cvsi_ECommMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_ECommMember" xlink:to="lab_cvsi_ECommMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_9c0feb04-8706-4aa4-b523-0db3c55222fa_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INTANGIBLE ASSETS</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_IntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_6fd1bde9-74c1-48ac-b23c-480d39a2090c_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment useful life</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_1fd1b405-218f-4e6e-a0e9-1e672df05348_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_a4591ec8-3495-494e-b51f-80d1359a5901_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_7bc31099-610d-43db-9cf8-77748d059a7d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LEASES</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_8b419227-19c2-4866-ba29-93a6b07f0bbf_verboseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_34b1d376-7e51-452a-9f44-9b5cab3b699c_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalents_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash and Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalents" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_5dd4f0b6-4c0c-47e7-8c96-1653e1a40bb4_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and handling costs</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_a642ab73-1915-4c97-b949-02329c0e0c20_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_fa502c3b-716a-4ef6-9eef-ec97f1095385_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_4959a548-8623-4a3e-b52c-3377412faa6b_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_0fecd2f4-7767-49d3-9b84-8e50f5b88a2f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_66f23333-16da-4834-8a54-86288d304f63_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_f97e021f-25e5-4fe1-8404-e5d6cc61f736_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_7cb45497-3d09-4353-8fb0-ff3da1ae9312_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationDomain_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationDomain" xlink:to="lab_us-gaap_BalanceSheetLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_9908c9c2-cb66-4409-9628-f1972cbc6b73_negatedLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayment of unsecured debt</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfNotesPayable_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments of Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfNotesPayable" xlink:to="lab_us-gaap_RepaymentsOfNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_3e5caee3-e075-4c21-baaa-93a8f185fe1d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of operating lease liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_3de2224f-06c7-49e9-a9e7-1d502c3ebd48_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_6d996694-c1b9-44e0-95b7-8da35324b12e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_fa6147ca-dd0b-4869-a1e1-a4067632f6c0_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_648399dd-eb12-469a-bcf6-4c44378b08d5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_c22f2562-d699-4b83-85ae-ea2fd6344ea8_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued payroll expenses</link:label>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Salaries, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalariesCurrent" xlink:to="lab_us-gaap_AccruedSalariesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_8be2cc1d-f63c-4497-a6aa-a9d9bb0dd14f_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_1e3720c0-0012-41a2-a1bd-2161af134f5d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_1b9a1ae5-3cb5-4c51-a95d-82c1fd118c36_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">OPERATING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_NumberofDerivativeLawsuits_964bb08e-2385-4fcb-8036-3aa799613578_terseLabel_en-US" xlink:label="lab_cvsi_NumberofDerivativeLawsuits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shareholder derivative suits filed</link:label>
    <link:label id="lab_cvsi_NumberofDerivativeLawsuits_label_en-US" xlink:label="lab_cvsi_NumberofDerivativeLawsuits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Derivative Lawsuits</link:label>
    <link:label id="lab_cvsi_NumberofDerivativeLawsuits_documentation_en-US" xlink:label="lab_cvsi_NumberofDerivativeLawsuits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Derivative Lawsuits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_NumberofDerivativeLawsuits" xlink:href="cvsi-20201231.xsd#cvsi_NumberofDerivativeLawsuits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_NumberofDerivativeLawsuits" xlink:to="lab_cvsi_NumberofDerivativeLawsuits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_942593e7-c4d3-4976-bc63-e65d49d1d1c5_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCKHOLDERS EQUITY</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_243480c9-1f69-4549-ade3-a7f4763923bf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Option Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_20f5cd68-fe6f-48d3-a574-fb518652dae8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_62d2bcd2-50f0-423b-982c-f99ceb8a502d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_f5749db2-5814-4aaa-aa5f-46ac8d83a790_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_ad468d47-7095-470f-a42c-20fde623ccde_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_020c2794-f4d5-430a-9580-4908150c562d_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested stock options (shares)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_97802dc7-457a-4b8c-aa47-56861c3cf244_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_865d238f-e613-42ec-9e90-b1672982b339_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average discount rate</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_86037981-75f5-436d-99c3-f1aed14fdf70_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_70320fe0-099b-46e9-b0c7-6f832ca599eb_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability_dc2bd8da-c7a3-48c1-a24a-23c7cae84848_negatedTerseLabel_en-US" xlink:label="lab_cvsi_RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derecognition of operating ROU asset related to operating lease termination</link:label>
    <link:label id="lab_cvsi_RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability_label_en-US" xlink:label="lab_cvsi_RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Foregone in Exchange for Reduction in Operating Lease Liability</link:label>
    <link:label id="lab_cvsi_RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability_documentation_en-US" xlink:label="lab_cvsi_RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Foregone in Exchange for Reduction in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability" xlink:href="cvsi-20201231.xsd#cvsi_RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability" xlink:to="lab_cvsi_RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_096ff4e6-5a8c-42aa-aa81-849cffada1d0_terseLabel_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling</link:label>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_label_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShippingAndHandlingMember" xlink:to="lab_us-gaap_ShippingAndHandlingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_e0324b9c-7678-46ba-9cad-ee9c348712e2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_4ab9cce7-2128-476a-b43d-987b3a5db351_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_NumberOfLeaseTerminationAgreements_df430e60-8bb2-49ed-a49d-6ce2aeb94313_terseLabel_en-US" xlink:label="lab_cvsi_NumberOfLeaseTerminationAgreements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of lease termination agreements</link:label>
    <link:label id="lab_cvsi_NumberOfLeaseTerminationAgreements_label_en-US" xlink:label="lab_cvsi_NumberOfLeaseTerminationAgreements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Lease Termination Agreements</link:label>
    <link:label id="lab_cvsi_NumberOfLeaseTerminationAgreements_documentation_en-US" xlink:label="lab_cvsi_NumberOfLeaseTerminationAgreements" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Lease Termination Agreements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_NumberOfLeaseTerminationAgreements" xlink:href="cvsi-20201231.xsd#cvsi_NumberOfLeaseTerminationAgreements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_NumberOfLeaseTerminationAgreements" xlink:to="lab_cvsi_NumberOfLeaseTerminationAgreements" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_295f9857-ca38-4538-97e5-ff298264e1ce_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesMember_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesMember" xlink:to="lab_us-gaap_AccruedLiabilitiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_2f702ca6-9f59-41c0-b98e-5669f17cf2fa_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_162b9c46-fb70-49ea-8f21-d1ad77614eb0_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_NoncashLeaseExpense_d7315ad8-55aa-4396-8f7b-60b49912bf97_terseLabel_en-US" xlink:label="lab_cvsi_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash lease expense</link:label>
    <link:label id="lab_cvsi_NoncashLeaseExpense_label_en-US" xlink:label="lab_cvsi_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Lease Expense</link:label>
    <link:label id="lab_cvsi_NoncashLeaseExpense_documentation_en-US" xlink:label="lab_cvsi_NoncashLeaseExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Lease Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_NoncashLeaseExpense" xlink:href="cvsi-20201231.xsd#cvsi_NoncashLeaseExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_NoncashLeaseExpense" xlink:to="lab_cvsi_NoncashLeaseExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_8aec0fec-7812-489d-95fb-f8e30ea391fe_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_0c244141-45ae-43fc-a0e6-5f8e01426931_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease payments due</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_7a0dc281-b631-4604-97cc-158a6e0dc423_terseLabel_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership interest (percent)</link:label>
    <link:label id="lab_us-gaap_MinorityInterestOwnershipPercentageByParent_label_en-US" xlink:label="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncontrolling Interest, Ownership Percentage by Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:to="lab_us-gaap_MinorityInterestOwnershipPercentageByParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_0ea94b71-69ac-45ca-ab28-029169b98c76_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash, Cash Equivalents and Restricted Cash</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Cash and Cash Equivalents [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_b5520eb4-ef48-450f-8435-8471cf115c68_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_a8e2f564-e941-4060-b2b2-3bfb7cd4219c_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_bfa43f8f-3f40-49fe-9be0-6b885678dea9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_17099c30-23d3-45e8-a34d-9ab4f9025c66_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average common shares outstanding, basic and diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_cce3e172-e5e5-490c-aa75-3c3b71008590_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ACCRUED EXPENSES</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="lab_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Cash_d0e83938-71f6-4267-89fa-e49e71c943cb_terseLabel_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_Cash_label_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_d9184135-d6fc-450b-9269-12306071380e_verboseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_c335ab01-4e48-485a-a462-b82e7dfea6eb_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_9a2b2a23-88aa-435a-88b9-3aa513acd972_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualAxis_adca750e-5b2c-4eda-9790-80e717ff0204_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:label id="lab_srt_TitleOfIndividualAxis_label_en-US" xlink:label="lab_srt_TitleOfIndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualAxis" xlink:to="lab_srt_TitleOfIndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_bbf1503f-27e0-4c30-8d4a-a3d793cb0421_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_a5a0b116-32b5-4a36-b12c-10cf6f51901b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_3c74ad8e-5a8c-4e18-a06e-0d4f890c3b00_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt face value</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_39a1ef87-a77a-498d-b22e-d3cc348b9bc4_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_b7924dad-95ec-4e60-ad20-bcd944c9cd6c_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_StatesOtherThanCaliforniaMember_936d144d-6a7a-4015-8ecf-bd1a37f32e9b_terseLabel_en-US" xlink:label="lab_cvsi_StatesOtherThanCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">States Other than California</link:label>
    <link:label id="lab_cvsi_StatesOtherThanCaliforniaMember_label_en-US" xlink:label="lab_cvsi_StatesOtherThanCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">States Other than California [Member]</link:label>
    <link:label id="lab_cvsi_StatesOtherThanCaliforniaMember_documentation_en-US" xlink:label="lab_cvsi_StatesOtherThanCaliforniaMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">States Other than California</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_StatesOtherThanCaliforniaMember" xlink:href="cvsi-20201231.xsd#cvsi_StatesOtherThanCaliforniaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_StatesOtherThanCaliforniaMember" xlink:to="lab_cvsi_StatesOtherThanCaliforniaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_8811875a-fc6b-42d0-b007-cfa6b42a3b0d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromUnsecuredNotesPayable_ba87be87-657e-480d-94b7-3792559dc100_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromUnsecuredNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from debt</link:label>
    <link:label id="lab_us-gaap_ProceedsFromUnsecuredNotesPayable_label_en-US" xlink:label="lab_us-gaap_ProceedsFromUnsecuredNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Unsecured Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromUnsecuredNotesPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromUnsecuredNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromUnsecuredNotesPayable" xlink:to="lab_us-gaap_ProceedsFromUnsecuredNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_e63f18cd-9c7a-495c-94ee-ae4462888c54_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_b3210b31-8bf7-4e85-94a9-157015f5b374_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accruals and reserves</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_f8fd951f-e27a-4c15-8014-30b2f53d4e00_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent_580eb10e-0f0a-476a-b7db-b669c5fb1055_terseLabel_en-US" xlink:label="lab_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Annual increase in shares available for issuance as percent of total shares outstanding (percent)</link:label>
    <link:label id="lab_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent_label_en-US" xlink:label="lab_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Annual Increase to Shares Authorized for Issuance under the Plan as Percent of Common Stock Outstanding, Percent</link:label>
    <link:label id="lab_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent_documentation_en-US" xlink:label="lab_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation, Annual Increase to Shares Authorized for Issuance under the Plan as Percent of Common Stock Outstanding, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent" xlink:href="cvsi-20201231.xsd#cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent" xlink:to="lab_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_35446fa3-63a1-40a7-aa48-afb7b00110f8_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested or expected to vest (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LitigationCaseTypeDomain_35119d09-71f4-4a32-96dd-d48ea7666b59_terseLabel_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:label id="lab_srt_LitigationCaseTypeDomain_label_en-US" xlink:label="lab_srt_LitigationCaseTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Litigation Case [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LitigationCaseTypeDomain" xlink:to="lab_srt_LitigationCaseTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod_5ff30d86-4c85-4484-a69a-6bcb56f77d3f_terseLabel_en-US" xlink:label="lab_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option exercise period extension</link:label>
    <link:label id="lab_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod_label_en-US" xlink:label="lab_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Extension of Expiration Period</link:label>
    <link:label id="lab_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod_documentation_en-US" xlink:label="lab_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Extension of Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod" xlink:href="cvsi-20201231.xsd#cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod" xlink:to="lab_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingImprovementsMember_43e450c0-27af-4f26-b787-83f486d397e3_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tenant improvements</link:label>
    <link:label id="lab_us-gaap_BuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_619e9061-f043-4106-b17b-782788e4a75b_verboseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Expected Term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_d703d3d1-5143-4352-a97e-a952010551cd_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_eb7b7935-5197-48d7-8367-836e10fcd002_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_2c757f50-fa0b-468c-8e61-478bb2a8f58b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of accrued expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_2e4cd83a-c023-4b71-8891-3699874cdbbf_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5d6979fa-7883-4f5c-86f6-d616d2a34af4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average remaining lease term</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryCurrentTable_313ee7d1-0043-4432-ac9c-af75eee1680c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:label id="lab_us-gaap_InventoryCurrentTable_label_en-US" xlink:label="lab_us-gaap_InventoryCurrentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Current [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryCurrentTable" xlink:to="lab_us-gaap_InventoryCurrentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_61a6ffc4-8a56-4825-879a-b18ac7d5cb47_terseLabel_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt</link:label>
    <link:label id="lab_us-gaap_UnsecuredDebtMember_label_en-US" xlink:label="lab_us-gaap_UnsecuredDebtMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unsecured Debt [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnsecuredDebtMember" xlink:to="lab_us-gaap_UnsecuredDebtMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_TaxLiabilityMember_584d3cef-b116-44e4-9ad7-5ccec992a80b_terseLabel_en-US" xlink:label="lab_cvsi_TaxLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax liability</link:label>
    <link:label id="lab_cvsi_TaxLiabilityMember_label_en-US" xlink:label="lab_cvsi_TaxLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Liability [Member]</link:label>
    <link:label id="lab_cvsi_TaxLiabilityMember_documentation_en-US" xlink:label="lab_cvsi_TaxLiabilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Liability [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_TaxLiabilityMember" xlink:href="cvsi-20201231.xsd#cvsi_TaxLiabilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_TaxLiabilityMember" xlink:to="lab_cvsi_TaxLiabilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_9fbd0201-e598-49f3-8f05-7a006c553eb8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_27623f34-dcd5-404f-9f4d-f8b2e20ea2fd_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_bc4fbaaf-cb02-4990-a834-0a32d707522e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory write-down</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_b64ac83a-2262-4a9d-8f63-0c48ec7835ad_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options vested or expected to vest, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_24b38968-103a-4c14-8ea9-f4db0c96ba53_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_c41f18cb-3209-4b80-9ad8-e6b1bfa9c133_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of January 1:</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_91892e47-aa63-4f60-9c35-70d0c1b5373a_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance as of December 31:</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_c683e921-aa5e-41b6-9f72-60f03d00d389_terseLabel_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:label id="lab_us-gaap_BalanceSheetLocationAxis_label_en-US" xlink:label="lab_us-gaap_BalanceSheetLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BalanceSheetLocationAxis" xlink:to="lab_us-gaap_BalanceSheetLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_753fd965-a645-43bd-a192-edeb30270a92_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value $0.0001; 190,000 shares authorized; 100,664 and 99,416 shares issued and outstanding as of December 31, 2020 and 2019, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_83dc1039-fe4d-441d-b85a-e412ca3e1d6e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_aac04ef1-f08b-41c2-896c-e447670eadc6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_26e97bd0-94ef-4aae-a4e0-028647235295_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_3ad9233c-b845-4375-ab12-6c4b6e6c75ee_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_eb1b116e-125e-4502-a5d7-d9b7254bdc6d_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future amortization expense</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_509c9300-4e54-44aa-aeb8-1fe2289cce77_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options exercisable, aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_685c25ff-0164-4486-baa6-a9d7ee656cfb_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Current portion of debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtCurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtCurrent" xlink:to="lab_us-gaap_LongTermDebtCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_ca7d93e7-332c-4468-a835-dc055db40947_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity's Reporting Status Current</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility_132038bb-0a09-4e4d-b155-13bcfed56659_terseLabel_en-US" xlink:label="lab_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of peers included in calculation of expected volatility</link:label>
    <link:label id="lab_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility_label_en-US" xlink:label="lab_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Peers Included in Calculation of Expected Volatility</link:label>
    <link:label id="lab_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility_documentation_en-US" xlink:label="lab_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Number of Peers Included in Calculation of Expected Volatility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility" xlink:href="cvsi-20201231.xsd#cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility" xlink:to="lab_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_44e7cf9b-cd37-4f4c-a0c0-2ef61dd6b5e7_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_415758df-5179-49c1-ad8b-5568144cab79_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_420e7b81-3df8-4c0a-9196-b2af4a533d10_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_ea17108e-38ad-42ac-9bbd-9f3611ca690c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_056c9f08-b35f-4a3a-8550-82d0e96fe26c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVESTING ACTIVITIES</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_48b4cfb5-0135-4dc1-8c99-4a2b49cb8326_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock - shares issued (shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_dfa22bd6-d182-45c1-b39d-1db0d20ae2ba_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_e8f72777-5eb8-4052-9af8-82c7f25a1b8b_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_FirstInsuranceFundingMember_4d31cd14-43fd-43f5-9e21-0c6447ed1711_terseLabel_en-US" xlink:label="lab_cvsi_FirstInsuranceFundingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Insurance financing</link:label>
    <link:label id="lab_cvsi_FirstInsuranceFundingMember_label_en-US" xlink:label="lab_cvsi_FirstInsuranceFundingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Insurance Funding [Member]</link:label>
    <link:label id="lab_cvsi_FirstInsuranceFundingMember_documentation_en-US" xlink:label="lab_cvsi_FirstInsuranceFundingMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">First Insurance Funding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_FirstInsuranceFundingMember" xlink:href="cvsi-20201231.xsd#cvsi_FirstInsuranceFundingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_FirstInsuranceFundingMember" xlink:to="lab_cvsi_FirstInsuranceFundingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_d98b9e61-e285-4d18-9b18-cd848c748cdb_terseLabel_en-US" xlink:label="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock issued for commitment fee</link:label>
    <link:label id="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_label_en-US" xlink:label="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of Stock and Warrants for Services or Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_2d3c265a-868d-4141-98a7-2c493072b166_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares unissued and reserved for issuance (shares)</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:to="lab_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_cddda7ad-9dc8-4056-8ebf-dc02c486bdda_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_ce604ed8-c8cb-4369-88fc-2c778bccf2b1_netLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease liabilities for operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_caa28b06-ffe5-4ff8-a73f-041ea3d59906_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement_5aab9fce-6350-4b66-a614-56d8d6809ecc_terseLabel_en-US" xlink:label="lab_cvsi_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation associated with founders employment settlements</link:label>
    <link:label id="lab_cvsi_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement_label_en-US" xlink:label="lab_cvsi_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Share-based Compensation, Employment Settlement</link:label>
    <link:label id="lab_cvsi_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement_documentation_en-US" xlink:label="lab_cvsi_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Additional Paid in Capital, Share-based Compensation, Employment Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement" xlink:href="cvsi-20201231.xsd#cvsi_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement" xlink:to="lab_cvsi_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_3e7917b4-7b29-4e3d-95e2-ccd3a0a62fce_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term portion of debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_43e96200-5abb-4feb-a3c8-965f93a89a36_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_66ea716f-40f3-4c70-a92d-8d97e41bdf56_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_4d09d4b1-f72c-4640-ba64-fda66bbbfad9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_6479f86b-0163-4d04-b98f-7d8a5716f40a_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_f7f79588-fd1f-47fb-9ce3-83fa73512eb2_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_d3819432-141d-41ab-9d98-59c1428a3782_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_SpecialtyPharmaceuticalsMember_03868c82-d279-43cc-ad33-48818f7cf49a_terseLabel_en-US" xlink:label="lab_cvsi_SpecialtyPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharmaceutical Segment</link:label>
    <link:label id="lab_cvsi_SpecialtyPharmaceuticalsMember_label_en-US" xlink:label="lab_cvsi_SpecialtyPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharmaceuticals [Member]</link:label>
    <link:label id="lab_cvsi_SpecialtyPharmaceuticalsMember_documentation_en-US" xlink:label="lab_cvsi_SpecialtyPharmaceuticalsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Specialty Pharmaceuticals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SpecialtyPharmaceuticalsMember" xlink:href="cvsi-20201231.xsd#cvsi_SpecialtyPharmaceuticalsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_SpecialtyPharmaceuticalsMember" xlink:to="lab_cvsi_SpecialtyPharmaceuticalsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_a3c128d2-869d-45cd-8a24-55af4ce19a27_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock offering cost</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_66a30ba4-ed0b-45c5-bffb-f2f65f59d601_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_013d89ee-6501-460e-a138-7027daac11f9_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders' equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_ff1c17d0-b48a-4de2-b794-30207571ccc3_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesLineItems_label_en-US" xlink:label="lab_us-gaap_LossContingenciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesLineItems" xlink:to="lab_us-gaap_LossContingenciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_438b42a7-bc18-4f25-8086-fda1e2b8825a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INCOME TAXES</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterials_49f43fb4-8492-4b2c-ae25-c0b764f9ced8_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterials_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterials" xlink:to="lab_us-gaap_InventoryRawMaterials" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_9b5aec70-5dc1-4387-b51b-8f7d6fb74a23_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_75f11ed6-8aa2-4a9c-9a89-2b7089f5dbfe_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_36cd6805-9711-4b30-a056-223fa5538cee_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_OptionsOutsidePlanMember_514524ac-9f48-408f-8043-1a781d42bfcf_terseLabel_en-US" xlink:label="lab_cvsi_OptionsOutsidePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Outside the Amended 2013 Plan</link:label>
    <link:label id="lab_cvsi_OptionsOutsidePlanMember_label_en-US" xlink:label="lab_cvsi_OptionsOutsidePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Outside the Amended 2013 Plan [Member]</link:label>
    <link:label id="lab_cvsi_OptionsOutsidePlanMember_documentation_en-US" xlink:label="lab_cvsi_OptionsOutsidePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options Outside the Amended 2013 Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_OptionsOutsidePlanMember" xlink:href="cvsi-20201231.xsd#cvsi_OptionsOutsidePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_OptionsOutsidePlanMember" xlink:to="lab_cvsi_OptionsOutsidePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_SanDiegoFacilityMember_45a7545d-b7b4-4ad7-ab0e-924c420716eb_terseLabel_en-US" xlink:label="lab_cvsi_SanDiegoFacilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Terminated San Diego Facility</link:label>
    <link:label id="lab_cvsi_SanDiegoFacilityMember_label_en-US" xlink:label="lab_cvsi_SanDiegoFacilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">San Diego Facility [Member]</link:label>
    <link:label id="lab_cvsi_SanDiegoFacilityMember_documentation_en-US" xlink:label="lab_cvsi_SanDiegoFacilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">San Diego Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SanDiegoFacilityMember" xlink:href="cvsi-20201231.xsd#cvsi_SanDiegoFacilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_SanDiegoFacilityMember" xlink:to="lab_cvsi_SanDiegoFacilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_e24a876e-3660-4301-8a0f-ecf4dbd01965_terseLabel_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_GeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_GeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_97ed2950-6567-4636-ad55-be02cd5dbd8b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_6d67d7b2-8757-45e2-bccd-4219f4abe5c8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other permanent differences</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_9b9b20ab-152e-4f26-8d88-eec5fd14c037_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive shares</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_c5cbfbb0-2e94-4086-96b4-cb931d6fd7ac_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current tax expense (benefit)</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_f48a7d79-bae6-4948-8e57-1d92444bc305_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss on disposal of fixed assets</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c1377a2c-61c9-4b1b-91b3-b5279323ac82_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in prior year positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_8737cf26-6826-40bf-a51f-1dd62fa2ea34_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in current year positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_d416f0b9-6b4f-437c-88f5-51f803a41bd7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Useful Life (Years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_388eeaf9-a54a-400a-a7f4-68e820197d8c_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_44ec02c8-4ef7-4683-8c52-fddb78dee4ec_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_8bd335e2-f820-4f02-befb-27b90d1b4b6e_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_b7efcae6-b27c-4e79-b7d5-55f027efee51_terseLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_97a179a0-9f79-46ce-a787-b212fa2b539f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property &amp; equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_b5ca1e4f-cb18-4bd5-910f-8e080afae25d_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment,net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_ec8cee2e-7cc8-4635-a8d8-9f0f6c64b2cd_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_1ef334a2-8b5a-4354-be04-8e58383f6859_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_be6b7b60-59b2-4b8a-bd6f-7d30f208c91b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_11ddd5b1-15f2-4094-aa89-0ce673caacea_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_862c8348-482f-4861-9721-40ecd9a2831e_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">STOCK-BASED COMPENSATION</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_5be783f4-a4c6-4c6d-ba27-269fd2867425_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_0607c443-80c6-4f14-855c-afe587f6895f_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6b858849-da9f-43ae-a927-889e6fbfb37a_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_a79d5442-1ba3-45aa-a16f-a9f43fe110a4_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">INVENTORY</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_RetailFDMMember_29a4e297-f1a7-496a-a315-2bee1ffe12ae_terseLabel_en-US" xlink:label="lab_cvsi_RetailFDMMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail - FDM</link:label>
    <link:label id="lab_cvsi_RetailFDMMember_label_en-US" xlink:label="lab_cvsi_RetailFDMMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail - FDM [Member]</link:label>
    <link:label id="lab_cvsi_RetailFDMMember_documentation_en-US" xlink:label="lab_cvsi_RetailFDMMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail - FDM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_RetailFDMMember" xlink:href="cvsi-20201231.xsd#cvsi_RetailFDMMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_RetailFDMMember" xlink:to="lab_cvsi_RetailFDMMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TradeNamesMember_b591d43a-a818-4eff-9d70-87d159028aef_terseLabel_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade names</link:label>
    <link:label id="lab_us-gaap_TradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TradeNamesMember" xlink:to="lab_us-gaap_TradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_51a1a613-e001-49d2-b8eb-f26278b58ff8_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcess_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcess" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcess" xlink:to="lab_us-gaap_InventoryWorkInProcess" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_86fc317c-c736-4573-a752-ca48724fef84_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_d058ae38-829b-4677-aeff-eea5d11b19b6_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_027cd201-0787-42af-b06d-a36e60e617e7_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_c83aef31-8442-4f2c-9ef9-fd1878826280_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_ef545a82-ec92-4461-8b3e-ea8bd43e2ed0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_32e7bdc1-96eb-4ee3-8eba-588526b6c085_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net operating loss carryforward</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_a27e007e-8578-49e3-92c0-f5e296445f5c_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_bda61d85-b146-4df5-a571-e8e02e489697_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityNameAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Authority, Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_PayrollProtectionProgramLoanMember_b08c1339-f48e-43cd-ba44-109e689c8085_terseLabel_en-US" xlink:label="lab_cvsi_PayrollProtectionProgramLoanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PPP loan</link:label>
    <link:label id="lab_cvsi_PayrollProtectionProgramLoanMember_label_en-US" xlink:label="lab_cvsi_PayrollProtectionProgramLoanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll Protection Program Loan [Member]</link:label>
    <link:label id="lab_cvsi_PayrollProtectionProgramLoanMember_documentation_en-US" xlink:label="lab_cvsi_PayrollProtectionProgramLoanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll Protection Program Loan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_PayrollProtectionProgramLoanMember" xlink:href="cvsi-20201231.xsd#cvsi_PayrollProtectionProgramLoanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_PayrollProtectionProgramLoanMember" xlink:to="lab_cvsi_PayrollProtectionProgramLoanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_4c7a45e7-fb96-4d82-8fe1-b8d50c9c1e2e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of deferred tax assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b4ceb841-7843-44d7-97a2-6a73584d0827_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_a80048c0-8bbe-4723-86ac-aea79e3c746d_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State taxes, net of federal effect</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLossMember_a1251e4b-b469-443a-bb49-2b3754cb3139_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLossMember_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLossMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLossMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLossMember" xlink:to="lab_us-gaap_OperatingIncomeLossMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_SaleOfStockFairValueOfPutOption_0fe00209-8943-4839-9357-b1a384ff3f83_terseLabel_en-US" xlink:label="lab_cvsi_SaleOfStockFairValueOfPutOption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of put option (in USD per share)</link:label>
    <link:label id="lab_cvsi_SaleOfStockFairValueOfPutOption_label_en-US" xlink:label="lab_cvsi_SaleOfStockFairValueOfPutOption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Fair Value Of Put Option</link:label>
    <link:label id="lab_cvsi_SaleOfStockFairValueOfPutOption_documentation_en-US" xlink:label="lab_cvsi_SaleOfStockFairValueOfPutOption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Fair Value Of Put Option</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SaleOfStockFairValueOfPutOption" xlink:href="cvsi-20201231.xsd#cvsi_SaleOfStockFairValueOfPutOption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_SaleOfStockFairValueOfPutOption" xlink:to="lab_cvsi_SaleOfStockFairValueOfPutOption" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_NumberOfAdditionalSuppliers_9fa34309-8d44-4439-9e4b-28e6c5e0a9fa_terseLabel_en-US" xlink:label="lab_cvsi_NumberOfAdditionalSuppliers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of additional suppliers</link:label>
    <link:label id="lab_cvsi_NumberOfAdditionalSuppliers_label_en-US" xlink:label="lab_cvsi_NumberOfAdditionalSuppliers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Additional Suppliers</link:label>
    <link:label id="lab_cvsi_NumberOfAdditionalSuppliers_documentation_en-US" xlink:label="lab_cvsi_NumberOfAdditionalSuppliers" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Additional Suppliers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_NumberOfAdditionalSuppliers" xlink:href="cvsi-20201231.xsd#cvsi_NumberOfAdditionalSuppliers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_NumberOfAdditionalSuppliers" xlink:to="lab_cvsi_NumberOfAdditionalSuppliers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_c20d4843-8a1e-4d76-ad2a-00ccb4aa304a_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_008357bb-a74d-45e6-b3f3-7d5ebbd5129a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_da36fbdf-fb80-46c4-927f-689e035e55cc_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_CashlessExerciseOfStockOptions_4c922b66-ee4f-4924-bc45-6bc2d5d2b522_terseLabel_en-US" xlink:label="lab_cvsi_CashlessExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cashless exercise of options</link:label>
    <link:label id="lab_cvsi_CashlessExerciseOfStockOptions_label_en-US" xlink:label="lab_cvsi_CashlessExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cashless Exercise of Stock Options</link:label>
    <link:label id="lab_cvsi_CashlessExerciseOfStockOptions_documentation_en-US" xlink:label="lab_cvsi_CashlessExerciseOfStockOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cashless Exercise of Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_CashlessExerciseOfStockOptions" xlink:href="cvsi-20201231.xsd#cvsi_CashlessExerciseOfStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_CashlessExerciseOfStockOptions" xlink:to="lab_cvsi_CashlessExerciseOfStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory_cbc08d17-635e-4ecf-be6d-774f66889aa1_terseLabel_en-US" xlink:label="lab_cvsi_SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of property and equipment in exchange for note receivable (recorded in prepaid expense and other) and inventory</link:label>
    <link:label id="lab_cvsi_SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory_label_en-US" xlink:label="lab_cvsi_SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Property and Equipment in Exchange for Prepaid Expenses and Other and Inventory</link:label>
    <link:label id="lab_cvsi_SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory_documentation_en-US" xlink:label="lab_cvsi_SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Property and Equipment in Exchange for Prepaid Expenses and Other and Inventory</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory" xlink:href="cvsi-20201231.xsd#cvsi_SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory" xlink:to="lab_cvsi_SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_FormerPresidentandCEOMember_607966bf-dc93-4e8e-989b-9b6331e35852_terseLabel_en-US" xlink:label="lab_cvsi_FormerPresidentandCEOMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former President and CEO</link:label>
    <link:label id="lab_cvsi_FormerPresidentandCEOMember_label_en-US" xlink:label="lab_cvsi_FormerPresidentandCEOMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former President and CEO [Member]</link:label>
    <link:label id="lab_cvsi_FormerPresidentandCEOMember_documentation_en-US" xlink:label="lab_cvsi_FormerPresidentandCEOMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former President and CEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_FormerPresidentandCEOMember" xlink:href="cvsi-20201231.xsd#cvsi_FormerPresidentandCEOMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_FormerPresidentandCEOMember" xlink:to="lab_cvsi_FormerPresidentandCEOMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfRevenueExtensibleList_17cf7e7e-f854-452f-86a8-98eede7ee967_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfRevenueExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Product and Service [Extensible List]</link:label>
    <link:label id="lab_us-gaap_TypeOfRevenueExtensibleList_label_en-US" xlink:label="lab_us-gaap_TypeOfRevenueExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Product and Service [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRevenueExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRevenueExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfRevenueExtensibleList" xlink:to="lab_us-gaap_TypeOfRevenueExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent_9d082b24-bfa2-4e25-a2fa-1a5ee4526eed_terseLabel_en-US" xlink:label="lab_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-deductible officer compensation (IRC 162(m))</link:label>
    <link:label id="lab_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent_label_en-US" xlink:label="lab_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Non-deductible Officer Compensation, Percent</link:label>
    <link:label id="lab_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent_documentation_en-US" xlink:label="lab_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Reconciliation, Non-deductible Officer Compensation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent" xlink:href="cvsi-20201231.xsd#cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent" xlink:to="lab_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_71766567-4c0e-44c3-b342-69b7607fa919_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_8a64df6e-bcb2-42fd-bb86-ff4eb860b823_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Concentration Risk</link:label>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierConcentrationRiskMember" xlink:to="lab_us-gaap_SupplierConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_05d086ee-21f1-49e9-a779-b77dc31e1308_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested options granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_d0ef5968-a6f6-47ff-8438-824b06998d8a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_b0812503-ed5b-4dad-aa6d-32d7bddf454a_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental cash flow disclosures:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_49ab436e-d825-4845-9a2c-d9cc8563adab_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Percent of pretax income (loss)</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RoyaltyExpense_218a3c68-a98f-455f-8c1b-ec4496fb8965_netLabel_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation associated with founders employment settlements (Note 11)</link:label>
    <link:label id="lab_us-gaap_RoyaltyExpense_label_en-US" xlink:label="lab_us-gaap_RoyaltyExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Royalty Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RoyaltyExpense" xlink:to="lab_us-gaap_RoyaltyExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_54b6ca7e-af99-4b94-af90-a83ceff73d6f_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_e03b3975-5f0d-4ddb-aa05-c61c3f1ea312_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_378b822a-efd1-43e9-98d3-dd8a021b34c6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_169ef275-6bc0-4085-8bca-70e1d525a7d1_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_7592fa30-f64a-4be2-bbfb-9768dc07c4e5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_cea18cc6-da8b-4f23-9f61-82558e9b850f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_a68004bd-dee2-46dc-82b5-ae807cf91436_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_RecognitionofEquityAwardandWithholdingObligationandReceivable_594aaa42-b545-408b-bf53-ed1c47b0df7b_terseLabel_en-US" xlink:label="lab_cvsi_RecognitionofEquityAwardandWithholdingObligationandReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognition of founder RSU tax withholding obligation and receivable (Note 11)</link:label>
    <link:label id="lab_cvsi_RecognitionofEquityAwardandWithholdingObligationandReceivable_label_en-US" xlink:label="lab_cvsi_RecognitionofEquityAwardandWithholdingObligationandReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognition of Equity Award and Withholding Obligation and Receivable</link:label>
    <link:label id="lab_cvsi_RecognitionofEquityAwardandWithholdingObligationandReceivable_documentation_en-US" xlink:label="lab_cvsi_RecognitionofEquityAwardandWithholdingObligationandReceivable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recognition of Equity Award and Withholding Obligation and Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_RecognitionofEquityAwardandWithholdingObligationandReceivable" xlink:href="cvsi-20201231.xsd#cvsi_RecognitionofEquityAwardandWithholdingObligationandReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_RecognitionofEquityAwardandWithholdingObligationandReceivable" xlink:to="lab_cvsi_RecognitionofEquityAwardandWithholdingObligationandReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_ad9d44a2-c06f-406e-bbdf-bf537b19ed62_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt interest rate (percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_30ae46bb-61d2-4228-9148-1bfdd8ff7695_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_SmithComplaintMember_95cae2c0-8d53-4978-af7a-08fee897bad0_terseLabel_en-US" xlink:label="lab_cvsi_SmithComplaintMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smith Complaint</link:label>
    <link:label id="lab_cvsi_SmithComplaintMember_label_en-US" xlink:label="lab_cvsi_SmithComplaintMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smith Complaint [Member]</link:label>
    <link:label id="lab_cvsi_SmithComplaintMember_documentation_en-US" xlink:label="lab_cvsi_SmithComplaintMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Smith Complaint [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SmithComplaintMember" xlink:href="cvsi-20201231.xsd#cvsi_SmithComplaintMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_SmithComplaintMember" xlink:to="lab_cvsi_SmithComplaintMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_030ef2d8-3977-4bc8-90ae-c3abe16f528a_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bad debt expense</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_716bff7a-6872-4c31-8abf-d77094fb0d65_negatedLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_ba0ffba4-4a90-41a7-8ab9-4b3855917bfa_terseLabel_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Axis]</link:label>
    <link:label id="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_label_en-US" xlink:label="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Property [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:to="lab_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_6abbc383-f23d-4805-ad12-f2a2b8c8807a_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosure of non-cash transactions:</link:label>
    <link:label id="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract_label_en-US" xlink:label="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Investing and Financing Items [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:to="lab_us-gaap_NoncashInvestingAndFinancingItemsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_f75d21c4-15ca-43d4-84ea-e1ca64e0fa6c_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">R&amp;D credit carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_FormerFoundersMember_5a03a78c-070a-4b12-9103-fc91ec4964e1_terseLabel_en-US" xlink:label="lab_cvsi_FormerFoundersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Founders</link:label>
    <link:label id="lab_cvsi_FormerFoundersMember_label_en-US" xlink:label="lab_cvsi_FormerFoundersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Founders [Member]</link:label>
    <link:label id="lab_cvsi_FormerFoundersMember_documentation_en-US" xlink:label="lab_cvsi_FormerFoundersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Former Founders</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_FormerFoundersMember" xlink:href="cvsi-20201231.xsd#cvsi_FormerFoundersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_FormerFoundersMember" xlink:to="lab_cvsi_FormerFoundersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_f5d038bc-9419-4928-a06b-1669a7abeb90_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock from exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_8c681a37-94bc-45cb-93f3-c95afad57da6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_cc780945-0b52-4b2f-a5f2-aea7881ac736_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_369cfb77-7c47-423d-be4e-fe4957f9fa74_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_f1e4527c-4f39-4f51-a02b-0b2a9810420f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maturities of Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_d95d163c-8057-472c-ac71-ca0550ceb5b5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amount</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_e7890e1a-42ad-4694-966a-f0c2418105e1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_b7a9bcb1-b382-4f4b-99a0-0e5d933ae6f1_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_154ba0fd-c54f-4489-8203-319aa86397b5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_cfd422a9-3662-48fd-9c5d-108b0dce9a90_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-Free Interest Rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_0e7aedf5-30a4-4ee6-85a1-c09e113a704b_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_d282e9d5-b866-4b16-9eef-28c13182759f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipAxis_b32b2e47-2066-402c-8757-0700868817d6_terseLabel_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:label id="lab_srt_OwnershipAxis_label_en-US" xlink:label="lab_srt_OwnershipAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipAxis" xlink:to="lab_srt_OwnershipAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_d15e7eb8-a170-4a31-92ef-2bd9d0befb2e_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_7bc17564-0895-4523-b1f4-dda4bc20d146_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LossContingenciesTable_54c04b63-8713-4dac-b79d-d6f61bc66764_terseLabel_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:label id="lab_us-gaap_LossContingenciesTable_label_en-US" xlink:label="lab_us-gaap_LossContingenciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss Contingencies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LossContingenciesTable" xlink:to="lab_us-gaap_LossContingenciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_OwnershipDomain_e9d1fc2c-156b-414a-9de9-18e9eb567091_terseLabel_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:label id="lab_srt_OwnershipDomain_label_en-US" xlink:label="lab_srt_OwnershipDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ownership [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_OwnershipDomain" xlink:to="lab_srt_OwnershipDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_d81678f0-d68d-4bf8-9eff-bc963438d787_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_fc80f062-04c6-4bdc-9e7b-ed8e7e2fc7df_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity a Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_2bebcb45-61b0-4193-a317-f4a191b044c9_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest paid</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxPeriodDomain_3ab12001-056d-42dc-8821-b36c74b13e6f_terseLabel_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxPeriodDomain_label_en-US" xlink:label="lab_us-gaap_TaxPeriodDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxPeriodDomain" xlink:to="lab_us-gaap_TaxPeriodDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockOptionMember_692cb495-5917-4a56-b73a-3c7c9bcbe858_terseLabel_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option</link:label>
    <link:label id="lab_us-gaap_StockOptionMember_label_en-US" xlink:label="lab_us-gaap_StockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockOptionMember" xlink:to="lab_us-gaap_StockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_d10f3ae0-c32a-4fa2-918f-80e9f6163f26_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating ROU lease assets obtained in exchange for operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_d8250f13-d394-4678-b032-5ef0f1b8abf7_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CaliforniaFranchiseTaxBoardMember_c6d06b5b-358c-4357-88ef-b7391b9af4a9_terseLabel_en-US" xlink:label="lab_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California Franchise Tax Board</link:label>
    <link:label id="lab_us-gaap_CaliforniaFranchiseTaxBoardMember_label_en-US" xlink:label="lab_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">California Franchise Tax Board [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:to="lab_us-gaap_CaliforniaFranchiseTaxBoardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_8da40065-4afc-44b8-af0b-0cb3f3a79577_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product sales, net</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_818ea2d5-bb58-4eef-b0e9-57598d69bcac_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_5a6bbb28-a7e6-43f5-b866-4a7922255b98_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_cc39b69c-7b47-46ae-b96f-87b9fc17a0ee_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_c82a758e-148f-4089-9e3d-dc5c15ac4bdb_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a5ff8a10-9bb2-4e85-aae9-4b9ad9092da4_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, beginning of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_cc99ca8a-d2e9-430e-86bd-00592baa07ff_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, end of year</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_80cd31b9-926b-4213-b2e3-ab662f352172_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash and restricted cash shown in the statements of cash flows</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_216d8914-297e-4048-9f20-7f5edff94948_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Matching contribution to 401(k) plan</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_d920640a-9f34-48e8-b4d8-bb6a27425d73_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_fbe82e40-83ff-409f-97bc-3224b8572310_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Principal Payments on Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Maturities of Long-term Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_1eabdc5c-4257-4414-a972-92d7cffc0027_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_eb87e906-a72c-4a63-b769-84096edd286d_terseLabel_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:label id="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain_label_en-US" xlink:label="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of Individual [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:to="lab_srt_TitleOfIndividualWithRelationshipToEntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_30a1cd91-b381-4be4-8ba6-3308cd3f3471_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_3acdd11c-cd1c-4ba4-bb7b-5a4c5637bc99_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total accrued expenses</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_2be38629-daec-487b-8dae-3cba8f3a8b47_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_aa746394-638c-40db-a900-b6d0c627197a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_9c9acb83-2093-429d-80fa-7d8d2a431553_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2149433d-26c9-48ac-adf5-9fc52cf2e5a5_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value, exercised in period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_23bd47ba-bae5-4442-a47c-657db9187e30_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_04b66ded-835a-485f-a66f-bde98d868169_totalLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term debt, gross</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_a6ca8c7b-010d-41cb-9874-0ff38a7e238c_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_RetailNaturalProductsAndOtherMember_6959bb86-919a-4493-9c71-ecde7e470318_terseLabel_en-US" xlink:label="lab_cvsi_RetailNaturalProductsAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail - Natural products and other</link:label>
    <link:label id="lab_cvsi_RetailNaturalProductsAndOtherMember_label_en-US" xlink:label="lab_cvsi_RetailNaturalProductsAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail - Natural Products And Other [Member]</link:label>
    <link:label id="lab_cvsi_RetailNaturalProductsAndOtherMember_documentation_en-US" xlink:label="lab_cvsi_RetailNaturalProductsAndOtherMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retail - Natural Products And Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_RetailNaturalProductsAndOtherMember" xlink:href="cvsi-20201231.xsd#cvsi_RetailNaturalProductsAndOtherMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_RetailNaturalProductsAndOtherMember" xlink:to="lab_cvsi_RetailNaturalProductsAndOtherMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_ad444b4c-5769-4b64-a932-62f02c568206_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_1f5a160e-b7bb-4bb6-bb4a-93e6472c69c8_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Decrease in prior year positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_caf15b31-9b12-45df-bd31-8608f5b4ee62_terseLabel_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-compete agreements</link:label>
    <link:label id="lab_us-gaap_NoncompeteAgreementsMember_label_en-US" xlink:label="lab_us-gaap_NoncompeteAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncompete Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncompeteAgreementsMember" xlink:to="lab_us-gaap_NoncompeteAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_StockIssuedDuringPeriodSharesEquityCommitment_48ef1d30-1eb3-45e2-8653-22f4f5bedb04_terseLabel_en-US" xlink:label="lab_cvsi_StockIssuedDuringPeriodSharesEquityCommitment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock under equity commitment (in shares)</link:label>
    <link:label id="lab_cvsi_StockIssuedDuringPeriodSharesEquityCommitment_label_en-US" xlink:label="lab_cvsi_StockIssuedDuringPeriodSharesEquityCommitment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued during Period, Shares, Equity Commitment</link:label>
    <link:label id="lab_cvsi_StockIssuedDuringPeriodSharesEquityCommitment_documentation_en-US" xlink:label="lab_cvsi_StockIssuedDuringPeriodSharesEquityCommitment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued during Period, Shares, Equity Commitment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_StockIssuedDuringPeriodSharesEquityCommitment" xlink:href="cvsi-20201231.xsd#cvsi_StockIssuedDuringPeriodSharesEquityCommitment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_StockIssuedDuringPeriodSharesEquityCommitment" xlink:to="lab_cvsi_StockIssuedDuringPeriodSharesEquityCommitment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_73834598-aebd-475a-a4d3-86905929e29f_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain" xlink:to="lab_us-gaap_RelatedPartyTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_dd21ebad-e2bf-4aa8-80a8-c41e5cd2e16e_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_271d7fd0-b9d2-4b24-916d-a7876148e43e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_6d6bfe73-53e0-4da4-9c8a-f2476fba64bf_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_9c8d0ff5-b2f8-4e43-b6f8-cdfcd512f177_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total deferred tax benefit</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_UnvestedStockOptionsMember_e5d5ed8c-80b0-466c-a01a-1f63dd6b7b7b_terseLabel_en-US" xlink:label="lab_cvsi_UnvestedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested Stock Options</link:label>
    <link:label id="lab_cvsi_UnvestedStockOptionsMember_label_en-US" xlink:label="lab_cvsi_UnvestedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested Stock Options [Member]</link:label>
    <link:label id="lab_cvsi_UnvestedStockOptionsMember_documentation_en-US" xlink:label="lab_cvsi_UnvestedStockOptionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unvested Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_UnvestedStockOptionsMember" xlink:href="cvsi-20201231.xsd#cvsi_UnvestedStockOptionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_UnvestedStockOptionsMember" xlink:to="lab_cvsi_UnvestedStockOptionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_92002fcb-54de-46b0-9342-50c9215c8615_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_b349be25-d415-4a6a-b65d-fa3f1bd488fd_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_label_en-US" xlink:label="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expenses and Other Current Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:to="lab_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_7d1e61ba-5230-4d13-8b18-e9da21f74378_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_853291f4-baad-4eab-9c99-45808f3e3d16_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of RSU's vested</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_933d1eaf-14f7-43c1-a526-b9a5d57d2d71_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_22714f47-7342-436c-b6c5-0083165f295b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_22e6d7ba-c5e3-4e64-8108-226bdaf13c54_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock authorized</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_CannaVestEuropeGmbHMember_9f969c3a-6b4e-4497-b2c3-6cf883141522_terseLabel_en-US" xlink:label="lab_cvsi_CannaVestEuropeGmbHMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CannaVest Europe, GmbH</link:label>
    <link:label id="lab_cvsi_CannaVestEuropeGmbHMember_label_en-US" xlink:label="lab_cvsi_CannaVestEuropeGmbHMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CannaVest Europe, GmbH [Member]</link:label>
    <link:label id="lab_cvsi_CannaVestEuropeGmbHMember_documentation_en-US" xlink:label="lab_cvsi_CannaVestEuropeGmbHMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">CannaVest Europe, GmbH [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_CannaVestEuropeGmbHMember" xlink:href="cvsi-20201231.xsd#cvsi_CannaVestEuropeGmbHMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_CannaVestEuropeGmbHMember" xlink:to="lab_cvsi_CannaVestEuropeGmbHMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_177db362-11eb-488c-9ad9-bb106b03fa4c_verboseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_3ad67c3d-ad65-4c9b-b8ba-b63a1fc8f38d_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_9c46a409-3367-4d02-b581-5cc082d7c19c_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_65a6dbaa-9447-4f90-9721-fa4faa31b7f3_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_8eb0734a-c8f4-4c3b-8ec8-cb946a3cc910_verboseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock outstanding</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_36e13186-81dd-4590-b6f1-7c56ec5e8319_totalLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateContinuingOperations" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_98b3e828-b661-4c6c-966e-b1b251fcecc1_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_9e403074-cdbd-45f8-a525-0339b7d0497d_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_93436d00-7f54-4e75-a9d3-338f041ce281_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_7132bb31-b62d-41bd-9ecf-3954a1fefd62_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding balance, weighted average remaining contract term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_07c6e094-ea77-49eb-a29f-f752543fefc7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_c52f03b8-7ff5-4794-b08f-967d2f1b1c15_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f5e63e37-0f15-4616-86d7-6891e41e6707_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_DeferredTaxAssetOperatingLeaseLiabilities_d4c85046-8390-4cc0-96af-b87f42ef82a7_terseLabel_en-US" xlink:label="lab_cvsi_DeferredTaxAssetOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_cvsi_DeferredTaxAssetOperatingLeaseLiabilities_label_en-US" xlink:label="lab_cvsi_DeferredTaxAssetOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Operating Lease Liabilities</link:label>
    <link:label id="lab_cvsi_DeferredTaxAssetOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_cvsi_DeferredTaxAssetOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Tax Asset, Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_DeferredTaxAssetOperatingLeaseLiabilities" xlink:href="cvsi-20201231.xsd#cvsi_DeferredTaxAssetOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_DeferredTaxAssetOperatingLeaseLiabilities" xlink:to="lab_cvsi_DeferredTaxAssetOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_4082674b-bc6c-4768-b8a3-c270332c2eae_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercisable (USD per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesPayableCurrent_a92a7eeb-c4f7-4323-833f-106c8a44a5b2_terseLabel_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current portion of long-term debt</link:label>
    <link:label id="lab_us-gaap_NotesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_NotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Notes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesPayableCurrent" xlink:to="lab_us-gaap_NotesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_119db23a-1346-44d0-8e55-699a750adcc2_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PROPERTY &amp; EQUIPMENT</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_cvsi_SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement_dddf2227-a0ec-4eb2-8290-0e01ac70211d_terseLabel_en-US" xlink:label="lab_cvsi_SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of business days between issuance and settlement</link:label>
    <link:label id="lab_cvsi_SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement_label_en-US" xlink:label="lab_cvsi_SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Number Of Business Days Between Issuance And Settlement</link:label>
    <link:label id="lab_cvsi_SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement_documentation_en-US" xlink:label="lab_cvsi_SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Number Of Business Days Between Issuance And Settlement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement" xlink:href="cvsi-20201231.xsd#cvsi_SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_cvsi_SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement" xlink:to="lab_cvsi_SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_735933a7-7ead-4a17-ae2b-d21b496e2220_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NET INCOME (LOSS) PER SHARE</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_2c79987e-0a27-42f0-8268-d22889a8b066_terseLabel_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office furniture and equipment</link:label>
    <link:label id="lab_us-gaap_OfficeEquipmentMember_label_en-US" xlink:label="lab_us-gaap_OfficeEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Office Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OfficeEquipmentMember" xlink:to="lab_us-gaap_OfficeEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e1a448ae-4097-4d24-aa27-6e88c8421771_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_5a35e94e-343d-46ef-a833-dd7d2a7eac67_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_00ce9bcb-7f64-4939-9aab-5ede83fbc6ed_terseLabel_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax benefit at federal statutory rate</link:label>
    <link:label id="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_90b72029-b75c-4568-8f1d-f33f55d75aeb_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_adfaf208-529c-451e-ab77-4c4496ef6636_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_0fa2b15f-e2d3-4ff8-8359-7c3bbdd39ce7_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Issued and Newly Adopted Accounting Pronouncements</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_51ea9509-6ccc-4b9b-8ea4-5ce74e655f71_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_7a8bc76f-39a7-4381-ae14-5cc0e73b0125_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>11
<FILENAME>cvsi-20201231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:eca8e0c2-d550-4e97-a9fa-88ee2e9b3168,g:095536f4-fd9c-45bc-aa88-ebcfe4d45a75-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://cvsciences.com/role/Cover" xlink:type="simple" xlink:href="cvsi-20201231.xsd#Cover"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_053259a9-1f36-42c2-91dc-7c68aca39014" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_DocumentType_053259a9-1f36-42c2-91dc-7c68aca39014" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_678ded2f-5d50-43f3-a68c-a27751e0d8e0" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_DocumentAnnualReport_678ded2f-5d50-43f3-a68c-a27751e0d8e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_20648679-824e-49a8-81c9-3814ad796c3a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_DocumentPeriodEndDate_20648679-824e-49a8-81c9-3814ad796c3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_1a1718ff-3e59-43fc-a0a2-f1e0ecba103b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_CurrentFiscalYearEndDate_1a1718ff-3e59-43fc-a0a2-f1e0ecba103b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_961608c5-656d-4419-b64e-46f992a7b15b" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_DocumentTransitionReport_961608c5-656d-4419-b64e-46f992a7b15b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_52741ad7-16c2-4672-aa20-0447137c8e2c" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_EntityFileNumber_52741ad7-16c2-4672-aa20-0447137c8e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5b36b516-7a63-407a-b0b0-e2022894501a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_EntityRegistrantName_5b36b516-7a63-407a-b0b0-e2022894501a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_bf1e819f-1c58-48ba-9d5e-6c482afba1d7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_EntityIncorporationStateCountryCode_bf1e819f-1c58-48ba-9d5e-6c482afba1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b9369b67-8d94-47d9-9efe-f834bed5eefd" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_EntityTaxIdentificationNumber_b9369b67-8d94-47d9-9efe-f834bed5eefd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_b8bdea75-0026-4e15-a8dc-034ca29b4420" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_EntityAddressAddressLine1_b8bdea75-0026-4e15-a8dc-034ca29b4420" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_be661a85-e073-4cb3-8397-fa9988f4fe4f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_EntityAddressCityOrTown_be661a85-e073-4cb3-8397-fa9988f4fe4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_1da785c0-180c-4557-aaf6-093f304f22ea" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_EntityAddressStateOrProvince_1da785c0-180c-4557-aaf6-093f304f22ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_98e07a96-3232-4670-89c3-0c9e4c8af434" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_EntityAddressPostalZipCode_98e07a96-3232-4670-89c3-0c9e4c8af434" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_303b4c7f-f3ae-4010-ac2d-f0ae0646fc32" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_CityAreaCode_303b4c7f-f3ae-4010-ac2d-f0ae0646fc32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_6f8d8347-a116-4d45-9c97-6beb1708cd4e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_LocalPhoneNumber_6f8d8347-a116-4d45-9c97-6beb1708cd4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_a7fabea5-7cae-4b3b-95df-786675e1311a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_a7fabea5-7cae-4b3b-95df-786675e1311a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_331316aa-3769-4b62-87e6-8fca48972215" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_EntityVoluntaryFilers_331316aa-3769-4b62-87e6-8fca48972215" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_e607d8d6-8b21-4907-b42e-943a86ff57fb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_EntityCurrentReportingStatus_e607d8d6-8b21-4907-b42e-943a86ff57fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_537e7efd-39bb-43f2-a864-f60abfa14eeb" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_EntityInteractiveDataCurrent_537e7efd-39bb-43f2-a864-f60abfa14eeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_a481f1be-d498-4bba-83f4-f59ef4c16be7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_EntityFilerCategory_a481f1be-d498-4bba-83f4-f59ef4c16be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_0bb3c5de-ff3f-4f95-85bb-1bb8cf72ab36" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_EntitySmallBusiness_0bb3c5de-ff3f-4f95-85bb-1bb8cf72ab36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_baf9a101-cf6e-434d-8151-c18ce512aaa7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_EntityEmergingGrowthCompany_baf9a101-cf6e-434d-8151-c18ce512aaa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_71e04d20-f4f2-4d44-8c6f-134d0571e949" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_IcfrAuditorAttestationFlag_71e04d20-f4f2-4d44-8c6f-134d0571e949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_dad6fb6d-031d-4952-bd2c-553af85eda88" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_EntityShellCompany_dad6fb6d-031d-4952-bd2c-553af85eda88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_e37e128e-c31e-45b9-a126-6c2ff3c48507" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_EntityPublicFloat_e37e128e-c31e-45b9-a126-6c2ff3c48507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_0fa1d677-e039-46e0-9e4b-5660f68d3947" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_0fa1d677-e039-46e0-9e4b-5660f68d3947" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_589c5a8a-728a-45e4-904f-5105457f67bf" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_589c5a8a-728a-45e4-904f-5105457f67bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_07a13f66-35b6-4ac3-9f89-f5efb4c5a404" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_EntityCentralIndexKey_07a13f66-35b6-4ac3-9f89-f5efb4c5a404" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c51ef4d2-f3d7-4eba-a9c8-fecb0f8e6ec4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_AmendmentFlag_c51ef4d2-f3d7-4eba-a9c8-fecb0f8e6ec4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_ab898c24-33da-421d-9676-0abc2802169a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_DocumentFiscalPeriodFocus_ab898c24-33da-421d-9676-0abc2802169a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_a771dc80-15a2-4d1c-b562-797ca8a7b120" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_438b90b4-5fe6-463e-9a47-facab005e3aa" xlink:to="loc_dei_DocumentFiscalYearFocus_a771dc80-15a2-4d1c-b562-797ca8a7b120" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="cvsi-20201231.xsd#CONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_1536d92e-7e08-4f7b-8697-cd597dffcb15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_5e586bf0-ddf1-4140-b313-1dd0d69eb218" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1536d92e-7e08-4f7b-8697-cd597dffcb15" xlink:to="loc_us-gaap_AssetsAbstract_5e586bf0-ddf1-4140-b313-1dd0d69eb218" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_11c4b9f7-8a4c-46b8-97b6-4666fcbc3c29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5e586bf0-ddf1-4140-b313-1dd0d69eb218" xlink:to="loc_us-gaap_AssetsCurrentAbstract_11c4b9f7-8a4c-46b8-97b6-4666fcbc3c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5f7adca7-5f52-4eec-8ea6-2f6c327360f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_11c4b9f7-8a4c-46b8-97b6-4666fcbc3c29" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_5f7adca7-5f52-4eec-8ea6-2f6c327360f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_bcec3c87-3431-4cc4-b472-0091ebfd0c82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_11c4b9f7-8a4c-46b8-97b6-4666fcbc3c29" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_bcec3c87-3431-4cc4-b472-0091ebfd0c82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_c8ecb366-2e88-4a2f-b8e1-1f5aef357d2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_11c4b9f7-8a4c-46b8-97b6-4666fcbc3c29" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_c8ecb366-2e88-4a2f-b8e1-1f5aef357d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_c4da4d65-a269-4046-8ba9-496d1ffaa752" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_11c4b9f7-8a4c-46b8-97b6-4666fcbc3c29" xlink:to="loc_us-gaap_InventoryNet_c4da4d65-a269-4046-8ba9-496d1ffaa752" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_fc5169cf-1bda-4455-bdd0-5cca1aade64d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_11c4b9f7-8a4c-46b8-97b6-4666fcbc3c29" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_fc5169cf-1bda-4455-bdd0-5cca1aade64d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e24c2364-f393-466e-9d53-0f2fb3f8cbf5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_11c4b9f7-8a4c-46b8-97b6-4666fcbc3c29" xlink:to="loc_us-gaap_AssetsCurrent_e24c2364-f393-466e-9d53-0f2fb3f8cbf5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_641265f9-e6b5-4836-9128-6ec55816b0ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_11c4b9f7-8a4c-46b8-97b6-4666fcbc3c29" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_641265f9-e6b5-4836-9128-6ec55816b0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_754db1c0-3003-4952-9cc9-e44a8361f6ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_11c4b9f7-8a4c-46b8-97b6-4666fcbc3c29" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_754db1c0-3003-4952-9cc9-e44a8361f6ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b3b90229-98a8-4640-9bab-77bb230b3267" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_11c4b9f7-8a4c-46b8-97b6-4666fcbc3c29" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b3b90229-98a8-4640-9bab-77bb230b3267" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_b592bd97-c329-4400-95f4-a84cc550aee1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_11c4b9f7-8a4c-46b8-97b6-4666fcbc3c29" xlink:to="loc_us-gaap_Goodwill_b592bd97-c329-4400-95f4-a84cc550aee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_33202989-6d01-47e8-a104-cc167c8253aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_11c4b9f7-8a4c-46b8-97b6-4666fcbc3c29" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_33202989-6d01-47e8-a104-cc167c8253aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_d32864e1-cf90-4bdf-9b82-4bfac7ce9c7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_5e586bf0-ddf1-4140-b313-1dd0d69eb218" xlink:to="loc_us-gaap_Assets_d32864e1-cf90-4bdf-9b82-4bfac7ce9c7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5cc7cac3-972b-4784-b0d8-4264a1a5f62d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1536d92e-7e08-4f7b-8697-cd597dffcb15" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5cc7cac3-972b-4784-b0d8-4264a1a5f62d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_ae6104ab-85db-4069-abbb-eb133d6dc6cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5cc7cac3-972b-4784-b0d8-4264a1a5f62d" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_ae6104ab-85db-4069-abbb-eb133d6dc6cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_fc6e3e5c-f0a8-4225-b0dc-124346498744" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ae6104ab-85db-4069-abbb-eb133d6dc6cc" xlink:to="loc_us-gaap_AccountsPayableCurrent_fc6e3e5c-f0a8-4225-b0dc-124346498744" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_80d0bcde-8510-4a58-8c44-4cda2c56c990" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ae6104ab-85db-4069-abbb-eb133d6dc6cc" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_80d0bcde-8510-4a58-8c44-4cda2c56c990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_de18e7f2-b48d-48c6-86d6-1a4e00b888f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ae6104ab-85db-4069-abbb-eb133d6dc6cc" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_de18e7f2-b48d-48c6-86d6-1a4e00b888f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableCurrent_24e825b7-679f-41b9-a06f-30e16a6f1283" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ae6104ab-85db-4069-abbb-eb133d6dc6cc" xlink:to="loc_us-gaap_NotesPayableCurrent_24e825b7-679f-41b9-a06f-30e16a6f1283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_2e0d9d15-e744-4713-b1f5-2cf7c4e88aba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_ae6104ab-85db-4069-abbb-eb133d6dc6cc" xlink:to="loc_us-gaap_LiabilitiesCurrent_2e0d9d15-e744-4713-b1f5-2cf7c4e88aba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_748fd6f5-1cba-4743-b6f6-d1d7e611918f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5cc7cac3-972b-4784-b0d8-4264a1a5f62d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_748fd6f5-1cba-4743-b6f6-d1d7e611918f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_4242311d-2809-4563-bb48-3a3c17eb7efa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5cc7cac3-972b-4784-b0d8-4264a1a5f62d" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_4242311d-2809-4563-bb48-3a3c17eb7efa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_42ad4fe2-38de-4548-aac4-1f2432231dcd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5cc7cac3-972b-4784-b0d8-4264a1a5f62d" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_42ad4fe2-38de-4548-aac4-1f2432231dcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_ee1df2fa-5662-42c9-9699-99b655960701" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5cc7cac3-972b-4784-b0d8-4264a1a5f62d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_ee1df2fa-5662-42c9-9699-99b655960701" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_99ede170-10e3-4562-acb5-fc50044f0fdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_5cc7cac3-972b-4784-b0d8-4264a1a5f62d" xlink:to="loc_us-gaap_Liabilities_99ede170-10e3-4562-acb5-fc50044f0fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_c5425b8a-a0a3-4289-8dce-57df8e7c4359" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1536d92e-7e08-4f7b-8697-cd597dffcb15" xlink:to="loc_us-gaap_CommitmentsAndContingencies_c5425b8a-a0a3-4289-8dce-57df8e7c4359" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_38701965-0ddd-4795-b87c-07f222963bb8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_1536d92e-7e08-4f7b-8697-cd597dffcb15" xlink:to="loc_us-gaap_StockholdersEquityAbstract_38701965-0ddd-4795-b87c-07f222963bb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValue_fd479981-3067-4ab7-b7e3-b23da5fb55fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38701965-0ddd-4795-b87c-07f222963bb8" xlink:to="loc_us-gaap_PreferredStockValue_fd479981-3067-4ab7-b7e3-b23da5fb55fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_fe4df176-b445-42a1-919e-9a6736491149" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38701965-0ddd-4795-b87c-07f222963bb8" xlink:to="loc_us-gaap_CommonStockValue_fe4df176-b445-42a1-919e-9a6736491149" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_5d126e15-b114-4ad1-ae53-fdc34b31b4f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38701965-0ddd-4795-b87c-07f222963bb8" xlink:to="loc_us-gaap_AdditionalPaidInCapital_5d126e15-b114-4ad1-ae53-fdc34b31b4f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_183dd4f1-f558-4db2-8d40-88acbecb1afa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38701965-0ddd-4795-b87c-07f222963bb8" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_183dd4f1-f558-4db2-8d40-88acbecb1afa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_8d6d72de-fbd6-4ea1-9817-66554826551c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38701965-0ddd-4795-b87c-07f222963bb8" xlink:to="loc_us-gaap_StockholdersEquity_8d6d72de-fbd6-4ea1-9817-66554826551c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_5e4e1936-613b-4947-8599-ecb86f6f3a8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_38701965-0ddd-4795-b87c-07f222963bb8" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_5e4e1936-613b-4947-8599-ecb86f6f3a8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="cvsi-20201231.xsd#CONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_df8f7c3a-c682-4969-93f4-92fede22e2bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9f2c365a-530e-4219-87be-7370efffca65" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_df8f7c3a-c682-4969-93f4-92fede22e2bb" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_9f2c365a-530e-4219-87be-7370efffca65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_479f21fc-bffe-4885-85f9-6453c69772c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_df8f7c3a-c682-4969-93f4-92fede22e2bb" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_479f21fc-bffe-4885-85f9-6453c69772c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_fefdc02f-e02d-4907-af32-997d46e8b98d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_df8f7c3a-c682-4969-93f4-92fede22e2bb" xlink:to="loc_us-gaap_PreferredStockSharesIssued_fefdc02f-e02d-4907-af32-997d46e8b98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_05b0eba2-28c7-4411-b46f-52b1240661af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_df8f7c3a-c682-4969-93f4-92fede22e2bb" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_05b0eba2-28c7-4411-b46f-52b1240661af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_ccc64765-678a-492a-8807-4b2f15e2fefd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_df8f7c3a-c682-4969-93f4-92fede22e2bb" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_ccc64765-678a-492a-8807-4b2f15e2fefd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_4e93adfe-c04c-45e9-b275-6bcb0230a0d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_df8f7c3a-c682-4969-93f4-92fede22e2bb" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_4e93adfe-c04c-45e9-b275-6bcb0230a0d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_7525a8ef-d02a-4b04-b465-c706d156342f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_df8f7c3a-c682-4969-93f4-92fede22e2bb" xlink:to="loc_us-gaap_CommonStockSharesIssued_7525a8ef-d02a-4b04-b465-c706d156342f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_0d4e89b6-f1ca-4903-976f-3b32cdb70d7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_df8f7c3a-c682-4969-93f4-92fede22e2bb" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_0d4e89b6-f1ca-4903-976f-3b32cdb70d7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="cvsi-20201231.xsd#CONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_de6d5e55-f3ca-44d1-bdb7-a4aa4a1483ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f5eecbe2-c1b9-4357-9ae8-095b503efdab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_de6d5e55-f3ca-44d1-bdb7-a4aa4a1483ce" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f5eecbe2-c1b9-4357-9ae8-095b503efdab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_bd8c136f-0223-461b-9690-20606a077b94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_de6d5e55-f3ca-44d1-bdb7-a4aa4a1483ce" xlink:to="loc_us-gaap_CostOfRevenue_bd8c136f-0223-461b-9690-20606a077b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_dac5501f-7606-4bce-98c0-c769593da57a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_de6d5e55-f3ca-44d1-bdb7-a4aa4a1483ce" xlink:to="loc_us-gaap_GrossProfit_dac5501f-7606-4bce-98c0-c769593da57a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_57d50a53-2e39-495f-b560-8b26f8523f4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_de6d5e55-f3ca-44d1-bdb7-a4aa4a1483ce" xlink:to="loc_us-gaap_OperatingExpensesAbstract_57d50a53-2e39-495f-b560-8b26f8523f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_f701b3da-4eb4-41b1-948f-00127bf48b35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_57d50a53-2e39-495f-b560-8b26f8523f4e" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_f701b3da-4eb4-41b1-948f-00127bf48b35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeneralAndAdministrativeExpense_0a24012a-c4a0-4a28-957a-f6ed6a8419da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_57d50a53-2e39-495f-b560-8b26f8523f4e" xlink:to="loc_us-gaap_GeneralAndAdministrativeExpense_0a24012a-c4a0-4a28-957a-f6ed6a8419da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_46dd43d2-a19e-42a2-a517-656739d2870a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_de6d5e55-f3ca-44d1-bdb7-a4aa4a1483ce" xlink:to="loc_us-gaap_OperatingExpenses_46dd43d2-a19e-42a2-a517-656739d2870a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_67b2190d-f91a-4cc5-bad8-f769276258af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_de6d5e55-f3ca-44d1-bdb7-a4aa4a1483ce" xlink:to="loc_us-gaap_OperatingIncomeLoss_67b2190d-f91a-4cc5-bad8-f769276258af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeExpenseNet_83dcab7b-8d63-4f28-8230-3500db2c763f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestIncomeExpenseNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_de6d5e55-f3ca-44d1-bdb7-a4aa4a1483ce" xlink:to="loc_us-gaap_InterestIncomeExpenseNet_83dcab7b-8d63-4f28-8230-3500db2c763f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b5e7038d-e808-42d2-9c07-0ca84673ad38" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_de6d5e55-f3ca-44d1-bdb7-a4aa4a1483ce" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b5e7038d-e808-42d2-9c07-0ca84673ad38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_f37a5b74-df2f-4155-ab11-aea6847f3f17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_de6d5e55-f3ca-44d1-bdb7-a4aa4a1483ce" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_f37a5b74-df2f-4155-ab11-aea6847f3f17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_bacab2ea-6d74-4fd1-aea8-99963be81df0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_de6d5e55-f3ca-44d1-bdb7-a4aa4a1483ce" xlink:to="loc_us-gaap_NetIncomeLoss_bacab2ea-6d74-4fd1-aea8-99963be81df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_d9562c6c-7da3-44ba-a6d0-17785bea56fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_de6d5e55-f3ca-44d1-bdb7-a4aa4a1483ce" xlink:to="loc_us-gaap_EarningsPerShareAbstract_d9562c6c-7da3-44ba-a6d0-17785bea56fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_94ece522-6947-47e1-9446-5db163600e64" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d9562c6c-7da3-44ba-a6d0-17785bea56fa" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_94ece522-6947-47e1-9446-5db163600e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_ecba6fca-773f-47d0-821a-094282edb941" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_d9562c6c-7da3-44ba-a6d0-17785bea56fa" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_ecba6fca-773f-47d0-821a-094282edb941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfRevenueExtensibleList_76b81b2e-1d64-4960-93cc-8fa9f6d3e33a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TypeOfRevenueExtensibleList"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_de6d5e55-f3ca-44d1-bdb7-a4aa4a1483ce" xlink:to="loc_us-gaap_TypeOfRevenueExtensibleList_76b81b2e-1d64-4960-93cc-8fa9f6d3e33a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="cvsi-20201231.xsd#CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_648b6dd5-367e-4a5d-a1a1-d41a6297b609" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_00c60ae3-2aca-44c2-a9a1-39edaf62a6ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_648b6dd5-367e-4a5d-a1a1-d41a6297b609" xlink:to="loc_us-gaap_StatementTable_00c60ae3-2aca-44c2-a9a1-39edaf62a6ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_ffe49b13-c648-490d-bb6c-921ecf04fba9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_00c60ae3-2aca-44c2-a9a1-39edaf62a6ec" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_ffe49b13-c648-490d-bb6c-921ecf04fba9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_a5ce6ca3-ba39-4297-af64-91352ddfe8ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_ffe49b13-c648-490d-bb6c-921ecf04fba9" xlink:to="loc_us-gaap_EquityComponentDomain_a5ce6ca3-ba39-4297-af64-91352ddfe8ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_7d44add4-dca4-4583-b0cc-456bf55858d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a5ce6ca3-ba39-4297-af64-91352ddfe8ec" xlink:to="loc_us-gaap_CommonStockMember_7d44add4-dca4-4583-b0cc-456bf55858d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_bf1aaa2b-09ba-4dbe-9aa9-6c8dca102553" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a5ce6ca3-ba39-4297-af64-91352ddfe8ec" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_bf1aaa2b-09ba-4dbe-9aa9-6c8dca102553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_407cb05f-07f7-4d99-8c6d-504edde01c0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_a5ce6ca3-ba39-4297-af64-91352ddfe8ec" xlink:to="loc_us-gaap_RetainedEarningsMember_407cb05f-07f7-4d99-8c6d-504edde01c0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_00c60ae3-2aca-44c2-a9a1-39edaf62a6ec" xlink:to="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_2848acfc-5ba6-428a-8279-a9e66a0c0e02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:to="loc_us-gaap_SharesOutstanding_2848acfc-5ba6-428a-8279-a9e66a0c0e02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_ad5ed022-e573-490e-9e8f-ca6f274d64ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:to="loc_us-gaap_StockholdersEquity_ad5ed022-e573-490e-9e8f-ca6f274d64ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_04ab727d-4b89-41b8-9b29-bd03df9e5a26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_04ab727d-4b89-41b8-9b29-bd03df9e5a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_d82c0996-adea-4e59-bf8d-561ec2f685c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_d82c0996-adea-4e59-bf8d-561ec2f685c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement_c356f1ca-d197-4683-8a99-0fbe0237a189" xlink:href="cvsi-20201231.xsd#cvsi_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:to="loc_cvsi_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement_c356f1ca-d197-4683-8a99-0fbe0237a189" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_StockIssuedDuringPeriodSharesEquityCommitment_540dc593-0c8a-4bf8-8aca-384c2bf803b5" xlink:href="cvsi-20201231.xsd#cvsi_StockIssuedDuringPeriodSharesEquityCommitment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:to="loc_cvsi_StockIssuedDuringPeriodSharesEquityCommitment_540dc593-0c8a-4bf8-8aca-384c2bf803b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_StockIssuedDuringPeriodValueEquityCommitment_d4f9faa3-3f4f-4f32-88d0-7cbfdac63b2b" xlink:href="cvsi-20201231.xsd#cvsi_StockIssuedDuringPeriodValueEquityCommitment"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:to="loc_cvsi_StockIssuedDuringPeriodValueEquityCommitment_d4f9faa3-3f4f-4f32-88d0-7cbfdac63b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_aed958ad-ab97-4252-af7e-56ef4408f955" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_aed958ad-ab97-4252-af7e-56ef4408f955" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f8c39a7f-c4ce-4453-bb7b-1487eee7d260" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:to="loc_us-gaap_NetIncomeLoss_f8c39a7f-c4ce-4453-bb7b-1487eee7d260" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesOutstanding_603d0cef-9009-4753-81d3-c95c0c286bfc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesOutstanding"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:to="loc_us-gaap_SharesOutstanding_603d0cef-9009-4753-81d3-c95c0c286bfc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_312c69c8-306a-463f-b0a5-03128db86862" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_3035e8be-1e59-4060-8034-658b175d3b20" xlink:to="loc_us-gaap_StockholdersEquity_312c69c8-306a-463f-b0a5-03128db86862" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW" xlink:type="simple" xlink:href="cvsi-20201231.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOW"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_dd8dd435-7fc1-4706-b2dc-3642125ab544" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b06aac0f-2322-48b5-8e5b-df369040225d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_dd8dd435-7fc1-4706-b2dc-3642125ab544" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b06aac0f-2322-48b5-8e5b-df369040225d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_f8894a7f-456a-47d1-9c08-5604010f2645" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b06aac0f-2322-48b5-8e5b-df369040225d" xlink:to="loc_us-gaap_NetIncomeLoss_f8894a7f-456a-47d1-9c08-5604010f2645" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ab7fa46-05a7-4c60-9db8-a357ebe352ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b06aac0f-2322-48b5-8e5b-df369040225d" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ab7fa46-05a7-4c60-9db8-a357ebe352ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_623ad7ea-85fd-4d61-ad95-2a621536a93a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ab7fa46-05a7-4c60-9db8-a357ebe352ab" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_623ad7ea-85fd-4d61-ad95-2a621536a93a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_986c00e6-9dd0-47ce-856c-48fd4428d7d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ab7fa46-05a7-4c60-9db8-a357ebe352ab" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_986c00e6-9dd0-47ce-856c-48fd4428d7d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_d795498a-a413-4bd2-92d4-5875dbe54026" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ab7fa46-05a7-4c60-9db8-a357ebe352ab" xlink:to="loc_us-gaap_ShareBasedCompensation_d795498a-a413-4bd2-92d4-5875dbe54026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RoyaltyExpense_92e2efd2-315c-463d-80ad-e66636155374" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RoyaltyExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ab7fa46-05a7-4c60-9db8-a357ebe352ab" xlink:to="loc_us-gaap_RoyaltyExpense_92e2efd2-315c-463d-80ad-e66636155374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_ImpairmentOfTaxReceivableForRSUSettlement_8d73f265-d9f0-460b-8b54-7a538c93684a" xlink:href="cvsi-20201231.xsd#cvsi_ImpairmentOfTaxReceivableForRSUSettlement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ab7fa46-05a7-4c60-9db8-a357ebe352ab" xlink:to="loc_cvsi_ImpairmentOfTaxReceivableForRSUSettlement_8d73f265-d9f0-460b-8b54-7a538c93684a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_447a8665-6154-45fd-a620-de35af10b82d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ab7fa46-05a7-4c60-9db8-a357ebe352ab" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_447a8665-6154-45fd-a620-de35af10b82d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_5e848f35-db3b-4c85-93c2-ac5b8c1a204a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ab7fa46-05a7-4c60-9db8-a357ebe352ab" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_5e848f35-db3b-4c85-93c2-ac5b8c1a204a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_NoncashLeaseExpense_8e273d60-a8c0-4a55-8cc0-6712387d7beb" xlink:href="cvsi-20201231.xsd#cvsi_NoncashLeaseExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ab7fa46-05a7-4c60-9db8-a357ebe352ab" xlink:to="loc_cvsi_NoncashLeaseExpense_8e273d60-a8c0-4a55-8cc0-6712387d7beb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_0f3b2b4b-4c5b-47fa-84de-3f6de22c5248" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInDeferredIncomeTaxes"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ab7fa46-05a7-4c60-9db8-a357ebe352ab" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes_0f3b2b4b-4c5b-47fa-84de-3f6de22c5248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_4ceb975e-4e8e-455c-9e9f-b61ce39d5805" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5ab7fa46-05a7-4c60-9db8-a357ebe352ab" xlink:to="loc_us-gaap_OtherOperatingActivitiesCashFlowStatement_4ceb975e-4e8e-455c-9e9f-b61ce39d5805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d5d8f63b-6d08-45d2-97a8-45c23abeec03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b06aac0f-2322-48b5-8e5b-df369040225d" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d5d8f63b-6d08-45d2-97a8-45c23abeec03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_3e26b672-1285-4680-96d7-44e7ed748544" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d5d8f63b-6d08-45d2-97a8-45c23abeec03" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_3e26b672-1285-4680-96d7-44e7ed748544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_7cbc170f-2fe6-4a81-b48e-ac91a796c5c9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d5d8f63b-6d08-45d2-97a8-45c23abeec03" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_7cbc170f-2fe6-4a81-b48e-ac91a796c5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_19edadfe-27a5-4164-b9d8-d092fb7e772d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d5d8f63b-6d08-45d2-97a8-45c23abeec03" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_19edadfe-27a5-4164-b9d8-d092fb7e772d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_afe0417b-1a56-4970-9308-4f52a9a73372" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_d5d8f63b-6d08-45d2-97a8-45c23abeec03" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_afe0417b-1a56-4970-9308-4f52a9a73372" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0133dfe6-f578-424d-b7ec-a14230ecdff7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_b06aac0f-2322-48b5-8e5b-df369040225d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_0133dfe6-f578-424d-b7ec-a14230ecdff7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d70ed015-acb6-4f31-9686-51bd6b374e0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_dd8dd435-7fc1-4706-b2dc-3642125ab544" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d70ed015-acb6-4f31-9686-51bd6b374e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cd600357-a69b-4261-830b-e9a3fa30fa92" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d70ed015-acb6-4f31-9686-51bd6b374e0e" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_cd600357-a69b-4261-830b-e9a3fa30fa92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0e25180c-16de-406c-8c07-2187287179af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_d70ed015-acb6-4f31-9686-51bd6b374e0e" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_0e25180c-16de-406c-8c07-2187287179af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8c59306c-4c4f-4671-ab35-1b578b3a1eb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_dd8dd435-7fc1-4706-b2dc-3642125ab544" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8c59306c-4c4f-4671-ab35-1b578b3a1eb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromUnsecuredNotesPayable_e3ecb3c1-b72f-4488-a6c0-fa337c09128a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromUnsecuredNotesPayable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8c59306c-4c4f-4671-ab35-1b578b3a1eb1" xlink:to="loc_us-gaap_ProceedsFromUnsecuredNotesPayable_e3ecb3c1-b72f-4488-a6c0-fa337c09128a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfNotesPayable_4d1d950b-6278-40bb-84c3-97f3acf10ddc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RepaymentsOfNotesPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8c59306c-4c4f-4671-ab35-1b578b3a1eb1" xlink:to="loc_us-gaap_RepaymentsOfNotesPayable_4d1d950b-6278-40bb-84c3-97f3acf10ddc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_3ce569a3-6d0e-41c6-a85c-aea1a41c7dcc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8c59306c-4c4f-4671-ab35-1b578b3a1eb1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_3ce569a3-6d0e-41c6-a85c-aea1a41c7dcc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_f059240e-661a-44bd-906d-85df13c19ecd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8c59306c-4c4f-4671-ab35-1b578b3a1eb1" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_f059240e-661a-44bd-906d-85df13c19ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9428a409-fe2d-4e4d-95a5-58d04113c594" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8c59306c-4c4f-4671-ab35-1b578b3a1eb1" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_9428a409-fe2d-4e4d-95a5-58d04113c594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d02207a0-983c-461b-90bb-b5fb9bce02ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8c59306c-4c4f-4671-ab35-1b578b3a1eb1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_d02207a0-983c-461b-90bb-b5fb9bce02ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f70d5146-73eb-4b21-a036-2e9c591a47e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8c59306c-4c4f-4671-ab35-1b578b3a1eb1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f70d5146-73eb-4b21-a036-2e9c591a47e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_246fb90d-399a-4601-b0bc-85c72e5e1820" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_8c59306c-4c4f-4671-ab35-1b578b3a1eb1" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_246fb90d-399a-4601-b0bc-85c72e5e1820" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_f93c8465-9572-4e5c-b9b3-8e9063280f3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_dd8dd435-7fc1-4706-b2dc-3642125ab544" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_f93c8465-9572-4e5c-b9b3-8e9063280f3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_46e2f6a4-819b-4587-ab91-19a4d55b84fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f93c8465-9572-4e5c-b9b3-8e9063280f3a" xlink:to="loc_us-gaap_InterestPaidNet_46e2f6a4-819b-4587-ab91-19a4d55b84fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_d2e39b95-7991-47ac-9896-0f701dd7f10e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_f93c8465-9572-4e5c-b9b3-8e9063280f3a" xlink:to="loc_us-gaap_IncomeTaxesPaid_d2e39b95-7991-47ac-9896-0f701dd7f10e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f83ad9d0-205f-4233-8abb-6736d9d5e1eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncashInvestingAndFinancingItemsAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_dd8dd435-7fc1-4706-b2dc-3642125ab544" xlink:to="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f83ad9d0-205f-4233-8abb-6736d9d5e1eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_5756d6a6-9172-465f-8f2b-c1743a4c39ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f83ad9d0-205f-4233-8abb-6736d9d5e1eb" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_5756d6a6-9172-465f-8f2b-c1743a4c39ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability_cf9fc85f-13f2-4508-9566-0d66fb5e683f" xlink:href="cvsi-20201231.xsd#cvsi_RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f83ad9d0-205f-4233-8abb-6736d9d5e1eb" xlink:to="loc_cvsi_RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability_cf9fc85f-13f2-4508-9566-0d66fb5e683f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory_48cf848e-4cdd-4b30-a3ff-dd315e7a80ec" xlink:href="cvsi-20201231.xsd#cvsi_SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f83ad9d0-205f-4233-8abb-6736d9d5e1eb" xlink:to="loc_cvsi_SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory_48cf848e-4cdd-4b30-a3ff-dd315e7a80ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_PurchaseOfInsuranceThroughIssuanceOfNotePayable_26a27785-4686-4404-b125-7a0e72e24fb2" xlink:href="cvsi-20201231.xsd#cvsi_PurchaseOfInsuranceThroughIssuanceOfNotePayable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f83ad9d0-205f-4233-8abb-6736d9d5e1eb" xlink:to="loc_cvsi_PurchaseOfInsuranceThroughIssuanceOfNotePayable_26a27785-4686-4404-b125-7a0e72e24fb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_e60eac23-edb4-4083-aec2-c2d084b8b602" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f83ad9d0-205f-4233-8abb-6736d9d5e1eb" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_e60eac23-edb4-4083-aec2-c2d084b8b602" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_RecognitionofEquityAwardandWithholdingObligationandReceivable_79e8463c-1bee-4ac0-b075-51f9c62d1b75" xlink:href="cvsi-20201231.xsd#cvsi_RecognitionofEquityAwardandWithholdingObligationandReceivable"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f83ad9d0-205f-4233-8abb-6736d9d5e1eb" xlink:to="loc_cvsi_RecognitionofEquityAwardandWithholdingObligationandReceivable_79e8463c-1bee-4ac0-b075-51f9c62d1b75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_CashlessExerciseOfStockOptions_bf4d849e-9310-4fae-98dd-7f0db18614fa" xlink:href="cvsi-20201231.xsd#cvsi_CashlessExerciseOfStockOptions"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NoncashInvestingAndFinancingItemsAbstract_f83ad9d0-205f-4233-8abb-6736d9d5e1eb" xlink:to="loc_cvsi_CashlessExerciseOfStockOptions_bf4d849e-9310-4fae-98dd-7f0db18614fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/ORGANIZATIONANDBUSINESS" xlink:type="simple" xlink:href="cvsi-20201231.xsd#ORGANIZATIONANDBUSINESS"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/ORGANIZATIONANDBUSINESS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_22201ae6-2530-4f6d-b8c5-c7d70045a6fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_f1e6d26a-c32d-4736-bb9e-370321cfb2f8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_22201ae6-2530-4f6d-b8c5-c7d70045a6fa" xlink:to="loc_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock_f1e6d26a-c32d-4736-bb9e-370321cfb2f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/ORGANIZATIONANDBUSINESSDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#ORGANIZATIONANDBUSINESSDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/ORGANIZATIONANDBUSINESSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c29ae516-080f-48d4-866b-0551ff9e289e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_e425a54b-6c6e-43cf-9a75-89c67b95fd24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c29ae516-080f-48d4-866b-0551ff9e289e" xlink:to="loc_us-gaap_NumberOfOperatingSegments_e425a54b-6c6e-43cf-9a75-89c67b95fd24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4e1f298d-7c13-487c-80b6-b66b643f0a7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_d4d4b236-b993-44e0-8666-46ecdb291060" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4e1f298d-7c13-487c-80b6-b66b643f0a7f" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_d4d4b236-b993-44e0-8666-46ecdb291060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_ac401652-c9b7-4826-9acd-55b0918682eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4662ab8e-e4bd-4e78-8218-650337a1178a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ac401652-c9b7-4826-9acd-55b0918682eb" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_4662ab8e-e4bd-4e78-8218-650337a1178a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_77b89cae-e3c9-44eb-84bd-c996e0148414" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ac401652-c9b7-4826-9acd-55b0918682eb" xlink:to="loc_us-gaap_UseOfEstimates_77b89cae-e3c9-44eb-84bd-c996e0148414" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_ceb713ba-9327-4895-8bb3-f32a4e695972" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ac401652-c9b7-4826-9acd-55b0918682eb" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_ceb713ba-9327-4895-8bb3-f32a4e695972" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_21f56e63-0ee0-4dcd-a91e-4d5fe9ae7b1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOfFinancialInstrumentsPolicy"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ac401652-c9b7-4826-9acd-55b0918682eb" xlink:to="loc_us-gaap_FairValueOfFinancialInstrumentsPolicy_21f56e63-0ee0-4dcd-a91e-4d5fe9ae7b1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_e4437a71-07bd-4bf2-9a0a-4489b40a7f5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ac401652-c9b7-4826-9acd-55b0918682eb" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_e4437a71-07bd-4bf2-9a0a-4489b40a7f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_06ac1db0-786f-4da3-b1d0-19115fd9b57e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ac401652-c9b7-4826-9acd-55b0918682eb" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_06ac1db0-786f-4da3-b1d0-19115fd9b57e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_102a4e74-a9d9-4c35-a242-9acc0fa38010" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ac401652-c9b7-4826-9acd-55b0918682eb" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_102a4e74-a9d9-4c35-a242-9acc0fa38010" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_75192627-7629-46f6-b45b-70554beeb6fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ac401652-c9b7-4826-9acd-55b0918682eb" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_75192627-7629-46f6-b45b-70554beeb6fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1d1c6388-25ea-4f5b-bb64-ed053b15f403" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ac401652-c9b7-4826-9acd-55b0918682eb" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_1d1c6388-25ea-4f5b-bb64-ed053b15f403" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_971cf1cd-083b-45c7-a5e4-817cd4f64997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ac401652-c9b7-4826-9acd-55b0918682eb" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_971cf1cd-083b-45c7-a5e4-817cd4f64997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_b01353ce-60d5-4c8e-8cc2-19270041cded" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ac401652-c9b7-4826-9acd-55b0918682eb" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy_b01353ce-60d5-4c8e-8cc2-19270041cded" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_16e86c38-00d5-4cfa-9472-8000e3c73d03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ac401652-c9b7-4826-9acd-55b0918682eb" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_16e86c38-00d5-4cfa-9472-8000e3c73d03" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_f1ea8bae-fdc9-46b1-b652-9d61411c4aed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ac401652-c9b7-4826-9acd-55b0918682eb" xlink:to="loc_us-gaap_CompensationRelatedCostsPolicyTextBlock_f1ea8bae-fdc9-46b1-b652-9d61411c4aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_bb660f93-8de1-48e9-af6a-23efc4d45b2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ac401652-c9b7-4826-9acd-55b0918682eb" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_bb660f93-8de1-48e9-af6a-23efc4d45b2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_2951c0d5-0bfd-4abd-a707-dbad20c6f1bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ac401652-c9b7-4826-9acd-55b0918682eb" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_2951c0d5-0bfd-4abd-a707-dbad20c6f1bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_d3880c3e-96ab-4669-a9e0-5f6e8c5cd1e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ac401652-c9b7-4826-9acd-55b0918682eb" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_d3880c3e-96ab-4669-a9e0-5f6e8c5cd1e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_88715963-ab50-46f2-b47b-00dc6966ab25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ac401652-c9b7-4826-9acd-55b0918682eb" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_88715963-ab50-46f2-b47b-00dc6966ab25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_98279c99-f47c-4cb6-81a4-c5395eb0f2b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ac401652-c9b7-4826-9acd-55b0918682eb" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_98279c99-f47c-4cb6-81a4-c5395eb0f2b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_bc0a83a8-26d6-4a2c-8f00-565d9206c5d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_ac401652-c9b7-4826-9acd-55b0918682eb" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_bc0a83a8-26d6-4a2c-8f00-565d9206c5d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bd8a06c7-b44d-46b0-b051-c40584556bb2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_54b3f190-90d2-4ee4-a6ca-35aedb4c10e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bd8a06c7-b44d-46b0-b051-c40584556bb2" xlink:to="loc_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock_54b3f190-90d2-4ee4-a6ca-35aedb4c10e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_34eedfec-c0e8-44ab-afb0-826479a24faf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bd8a06c7-b44d-46b0-b051-c40584556bb2" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_34eedfec-c0e8-44ab-afb0-826479a24faf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_4088c55a-23ce-49f3-84ce-ead63e94a4c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5df08e4b-d01f-4ec3-a549-03bb12b3fdd6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_4088c55a-23ce-49f3-84ce-ead63e94a4c0" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5df08e4b-d01f-4ec3-a549-03bb12b3fdd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipAxis_5eb87459-9245-4bc4-a768-36f81b27259d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5df08e4b-d01f-4ec3-a549-03bb12b3fdd6" xlink:to="loc_srt_OwnershipAxis_5eb87459-9245-4bc4-a768-36f81b27259d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_OwnershipDomain_e634aef6-ae0c-4796-9e44-f0edad5faf6f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_OwnershipDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipAxis_5eb87459-9245-4bc4-a768-36f81b27259d" xlink:to="loc_srt_OwnershipDomain_e634aef6-ae0c-4796-9e44-f0edad5faf6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_CannaVestEuropeGmbHMember_fa0030db-827f-4998-924a-1f5cbf14c3cc" xlink:href="cvsi-20201231.xsd#cvsi_CannaVestEuropeGmbHMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_OwnershipDomain_e634aef6-ae0c-4796-9e44-f0edad5faf6f" xlink:to="loc_cvsi_CannaVestEuropeGmbHMember_fa0030db-827f-4998-924a-1f5cbf14c3cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_3ef0d247-3eb2-498e-9466-0ca22b27f7d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5df08e4b-d01f-4ec3-a549-03bb12b3fdd6" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_3ef0d247-3eb2-498e-9466-0ca22b27f7d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_c539126c-588d-4392-9c83-18bc1cf953d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_3ef0d247-3eb2-498e-9466-0ca22b27f7d7" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_c539126c-588d-4392-9c83-18bc1cf953d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_022f890a-fa0a-4457-80e5-dd1ca50d0a41" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_c539126c-588d-4392-9c83-18bc1cf953d0" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_022f890a-fa0a-4457-80e5-dd1ca50d0a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31b97b60-38ed-4f73-b73f-3b9cc60334a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5df08e4b-d01f-4ec3-a549-03bb12b3fdd6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31b97b60-38ed-4f73-b73f-3b9cc60334a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_16e5678a-8c7f-45bb-b5c4-4745280632ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_31b97b60-38ed-4f73-b73f-3b9cc60334a2" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_16e5678a-8c7f-45bb-b5c4-4745280632ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_f8b7f6a7-27c0-4c02-8c41-ad2e7ba31172" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_16e5678a-8c7f-45bb-b5c4-4745280632ca" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_f8b7f6a7-27c0-4c02-8c41-ad2e7ba31172" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_02bd3cf4-d0fe-4ac2-b047-b553c3c161d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5df08e4b-d01f-4ec3-a549-03bb12b3fdd6" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_02bd3cf4-d0fe-4ac2-b047-b553c3c161d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_bf819efc-a045-4f19-9f0c-43c9ad10d65a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_02bd3cf4-d0fe-4ac2-b047-b553c3c161d4" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_bf819efc-a045-4f19-9f0c-43c9ad10d65a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_CommonStockPurchaseAgreementMember_f6b2dc77-f706-4104-a8be-e6df83e33eb4" xlink:href="cvsi-20201231.xsd#cvsi_CommonStockPurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_bf819efc-a045-4f19-9f0c-43c9ad10d65a" xlink:to="loc_cvsi_CommonStockPurchaseAgreementMember_f6b2dc77-f706-4104-a8be-e6df83e33eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_51b1856a-2adb-476c-acd2-508b2fb795a8" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5df08e4b-d01f-4ec3-a549-03bb12b3fdd6" xlink:to="loc_srt_ProductOrServiceAxis_51b1856a-2adb-476c-acd2-508b2fb795a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_0a37a9e8-f9ae-4217-9e49-ee4443dacff1" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_51b1856a-2adb-476c-acd2-508b2fb795a8" xlink:to="loc_srt_ProductsAndServicesDomain_0a37a9e8-f9ae-4217-9e49-ee4443dacff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_4efcb946-576b-43fe-a9fc-1e8947fd9d94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_0a37a9e8-f9ae-4217-9e49-ee4443dacff1" xlink:to="loc_us-gaap_ShippingAndHandlingMember_4efcb946-576b-43fe-a9fc-1e8947fd9d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_02c90e18-8d59-431e-aca3-2ffa825b466b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5df08e4b-d01f-4ec3-a549-03bb12b3fdd6" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_02c90e18-8d59-431e-aca3-2ffa825b466b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_e3a057f6-062a-4e96-a43f-9a2ea41bf2fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_02c90e18-8d59-431e-aca3-2ffa825b466b" xlink:to="loc_us-gaap_SegmentDomain_e3a057f6-062a-4e96-a43f-9a2ea41bf2fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_ConsumerProductsMember_6b06d6ad-2607-4398-83b8-a5be735b7208" xlink:href="cvsi-20201231.xsd#cvsi_ConsumerProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e3a057f6-062a-4e96-a43f-9a2ea41bf2fc" xlink:to="loc_cvsi_ConsumerProductsMember_6b06d6ad-2607-4398-83b8-a5be735b7208" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SpecialtyPharmaceuticalSegmentMember_4af231a3-65ff-4884-8215-96a89ba914b4" xlink:href="cvsi-20201231.xsd#cvsi_SpecialtyPharmaceuticalSegmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_e3a057f6-062a-4e96-a43f-9a2ea41bf2fc" xlink:to="loc_cvsi_SpecialtyPharmaceuticalSegmentMember_4af231a3-65ff-4884-8215-96a89ba914b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_3740f536-60cf-46da-9c0a-341fd4be57da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5df08e4b-d01f-4ec3-a549-03bb12b3fdd6" xlink:to="loc_us-gaap_AwardTypeAxis_3740f536-60cf-46da-9c0a-341fd4be57da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_777845a0-5df4-4096-91bd-885df7405e67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_3740f536-60cf-46da-9c0a-341fd4be57da" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_777845a0-5df4-4096-91bd-885df7405e67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_e66e1231-cebd-41cf-b431-1264f43bf28d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_777845a0-5df4-4096-91bd-885df7405e67" xlink:to="loc_us-gaap_StockOptionMember_e66e1231-cebd-41cf-b431-1264f43bf28d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9341c64b-a9ba-4d2c-b434-d5982491e7dc" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5df08e4b-d01f-4ec3-a549-03bb12b3fdd6" xlink:to="loc_srt_RangeAxis_9341c64b-a9ba-4d2c-b434-d5982491e7dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_8e83b00c-936e-4ecc-b150-a377e4cdc40f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9341c64b-a9ba-4d2c-b434-d5982491e7dc" xlink:to="loc_srt_RangeMember_8e83b00c-936e-4ecc-b150-a377e4cdc40f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_cdfc3b1d-9c2e-448c-9fc3-38e7bd3e6a4b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8e83b00c-936e-4ecc-b150-a377e4cdc40f" xlink:to="loc_srt_MinimumMember_cdfc3b1d-9c2e-448c-9fc3-38e7bd3e6a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_98cdcdcf-ebb0-4629-8120-58cc54f40392" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_8e83b00c-936e-4ecc-b150-a377e4cdc40f" xlink:to="loc_srt_MaximumMember_98cdcdcf-ebb0-4629-8120-58cc54f40392" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_5df08e4b-d01f-4ec3-a549-03bb12b3fdd6" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_fc7eb3af-a4c2-49b1-901c-480292fc40ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MinorityInterestOwnershipPercentageByParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_MinorityInterestOwnershipPercentageByParent_fc7eb3af-a4c2-49b1-901c-480292fc40ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalents_debf4e04-958e-41b7-95c2-9ca7a8a2190b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCashAndCashEquivalents"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalents_debf4e04-958e-41b7-95c2-9ca7a8a2190b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashUninsuredAmount_42529a0d-fa46-41eb-b9fc-cb0ee3672ca7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashUninsuredAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_CashUninsuredAmount_42529a0d-fa46-41eb-b9fc-cb0ee3672ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_NumberofSuppliers_ff4cdbfc-1d69-4e77-8f9e-a1a5c4b3bbc7" xlink:href="cvsi-20201231.xsd#cvsi_NumberofSuppliers"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_cvsi_NumberofSuppliers_ff4cdbfc-1d69-4e77-8f9e-a1a5c4b3bbc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_NumberOfAdditionalSuppliers_b5ac5ee3-d693-488a-98a0-d4ad7dfbf554" xlink:href="cvsi-20201231.xsd#cvsi_NumberOfAdditionalSuppliers"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_cvsi_NumberOfAdditionalSuppliers_b5ac5ee3-d693-488a-98a0-d4ad7dfbf554" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f35da28a-5d4b-43c5-8429-1d4f79827a53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_f35da28a-5d4b-43c5-8429-1d4f79827a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromUnsecuredNotesPayable_897decf1-46bf-4ac0-9ce5-598763551f5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromUnsecuredNotesPayable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_ProceedsFromUnsecuredNotesPayable_897decf1-46bf-4ac0-9ce5-598763551f5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction_29c080d0-7a7a-4b01-b0fa-a911c2b2a052" xlink:href="cvsi-20201231.xsd#cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction_29c080d0-7a7a-4b01-b0fa-a911c2b2a052" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_919e4424-7a2a-4127-9b97-ef99b6e2c180" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_Cash_919e4424-7a2a-4127-9b97-ef99b6e2c180" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_e09045e7-608b-441d-bef7-1335a8b7be31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_e09045e7-608b-441d-bef7-1335a8b7be31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_AccountsReceivableThresholdforDeterminingDelinquentAccount_d6144d4d-c4d9-41d1-a207-06381d9de519" xlink:href="cvsi-20201231.xsd#cvsi_AccountsReceivableThresholdforDeterminingDelinquentAccount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_cvsi_AccountsReceivableThresholdforDeterminingDelinquentAccount_d6144d4d-c4d9-41d1-a207-06381d9de519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_6a4a5868-d74d-4e68-bdd1-addb8484ec8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_6a4a5868-d74d-4e68-bdd1-addb8484ec8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_99357a33-3066-4339-801d-9f0c9f43a09c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_99357a33-3066-4339-801d-9f0c9f43a09c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_499c72f1-e2cb-4042-a055-e2fb0e4dd604" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_499c72f1-e2cb-4042-a055-e2fb0e4dd604" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_623c6ecf-acad-4751-b711-f6eafbf9c42f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_623c6ecf-acad-4751-b711-f6eafbf9c42f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_eef87599-ccc3-48fb-8321-1a9b6bda847e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_eef87599-ccc3-48fb-8321-1a9b6bda847e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_2050a65c-fce9-488c-a6eb-3579611ac63d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_2050a65c-fce9-488c-a6eb-3579611ac63d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_340ad867-7bf4-47a2-a26c-830d479e7abf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_AdvertisingExpense_340ad867-7bf4-47a2-a26c-830d479e7abf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e584f9cd-02dd-4762-8845-318c7de9f953" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e584f9cd-02dd-4762-8845-318c7de9f953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_333cddd5-3ef6-4e5e-b6a7-6698ab07713d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_10a652ce-2434-4050-804f-79b599ba1185" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_333cddd5-3ef6-4e5e-b6a7-6698ab07713d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_b02cdcbf-38a9-4c42-89b6-e51b37b069bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8fe33266-a45e-4698-be3e-d9dd70432282" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b02cdcbf-38a9-4c42-89b6-e51b37b069bf" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_8fe33266-a45e-4698-be3e-d9dd70432282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_7a399e1a-560f-4f75-a03d-d1f0d5132fa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b02cdcbf-38a9-4c42-89b6-e51b37b069bf" xlink:to="loc_us-gaap_RestrictedCash_7a399e1a-560f-4f75-a03d-d1f0d5132fa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9767678a-1864-4e31-8cfd-72d154cf3bd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_b02cdcbf-38a9-4c42-89b6-e51b37b069bf" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9767678a-1864-4e31-8cfd-72d154cf3bd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_1d8f72b8-15f4-4aeb-afb3-62f0cdf7bd28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_95c1cf6e-573f-4145-b192-416efce8ffb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_1d8f72b8-15f4-4aeb-afb3-62f0cdf7bd28" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_95c1cf6e-573f-4145-b192-416efce8ffb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_0f4ab2ce-af13-4e14-b67c-4d09b7e5ce83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_95c1cf6e-573f-4145-b192-416efce8ffb4" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_0f4ab2ce-af13-4e14-b67c-4d09b7e5ce83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_12a2380e-6d68-4474-a9c5-63e3eac77533" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_0f4ab2ce-af13-4e14-b67c-4d09b7e5ce83" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_12a2380e-6d68-4474-a9c5-63e3eac77533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_RetailFDMMember_5db45bf4-2398-4698-8cb2-c05d3c0da794" xlink:href="cvsi-20201231.xsd#cvsi_RetailFDMMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_12a2380e-6d68-4474-a9c5-63e3eac77533" xlink:to="loc_cvsi_RetailFDMMember_5db45bf4-2398-4698-8cb2-c05d3c0da794" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_RetailNaturalProductsAndOtherMember_ab330c29-4339-4b67-87e8-72ff4197f852" xlink:href="cvsi-20201231.xsd#cvsi_RetailNaturalProductsAndOtherMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_12a2380e-6d68-4474-a9c5-63e3eac77533" xlink:to="loc_cvsi_RetailNaturalProductsAndOtherMember_ab330c29-4339-4b67-87e8-72ff4197f852" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_ECommMember_8047814a-d4be-4c5c-be28-1e965412d06c" xlink:href="cvsi-20201231.xsd#cvsi_ECommMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_12a2380e-6d68-4474-a9c5-63e3eac77533" xlink:to="loc_cvsi_ECommMember_8047814a-d4be-4c5c-be28-1e965412d06c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_26063ecc-c0d0-40bf-9037-6fdc1435ba31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_95c1cf6e-573f-4145-b192-416efce8ffb4" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_26063ecc-c0d0-40bf-9037-6fdc1435ba31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2575724e-4636-4b0c-9b06-60eb6052884f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_26063ecc-c0d0-40bf-9037-6fdc1435ba31" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2575724e-4636-4b0c-9b06-60eb6052884f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_6b67d711-e29a-41fc-aecb-4aa19f2846b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_26063ecc-c0d0-40bf-9037-6fdc1435ba31" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_6b67d711-e29a-41fc-aecb-4aa19f2846b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INVENTORY" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INVENTORY"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/INVENTORY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_aa49bad9-4478-4ba1-981a-9294a14a688b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_f87e8fa6-cc8b-4aee-95eb-10c10be80df3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_aa49bad9-4478-4ba1-981a-9294a14a688b" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_f87e8fa6-cc8b-4aee-95eb-10c10be80df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INVENTORYTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INVENTORYTables"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/INVENTORYTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_e438af52-b4bb-41d7-83e4-4d444666a5ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_c06e1876-5b8e-4ff7-8dc7-fd5225e0339c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_e438af52-b4bb-41d7-83e4-4d444666a5ae" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_c06e1876-5b8e-4ff7-8dc7-fd5225e0339c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INVENTORYDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INVENTORYDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/INVENTORYDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_66e9bc9f-fd83-402c-8dd7-087bea8c140b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryCurrentTable_5f5997de-dc2f-4d81-b4c1-f3b42b21beae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryCurrentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_66e9bc9f-fd83-402c-8dd7-087bea8c140b" xlink:to="loc_us-gaap_InventoryCurrentTable_5f5997de-dc2f-4d81-b4c1-f3b42b21beae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_6a4522e9-bba0-44c9-8d46-3194c7da3df7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_5f5997de-dc2f-4d81-b4c1-f3b42b21beae" xlink:to="loc_srt_StatementGeographicalAxis_6a4522e9-bba0-44c9-8d46-3194c7da3df7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_1e076113-bbc6-47f2-ae51-c3133ed08d9b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_6a4522e9-bba0-44c9-8d46-3194c7da3df7" xlink:to="loc_srt_SegmentGeographicalDomain_1e076113-bbc6-47f2-ae51-c3133ed08d9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_6c4cf926-5e85-4e3c-b1ab-3278802c847c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_1e076113-bbc6-47f2-ae51-c3133ed08d9b" xlink:to="loc_us-gaap_NonUsMember_6c4cf926-5e85-4e3c-b1ab-3278802c847c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryLineItems_973225a3-1b7a-4fd5-8867-945cb46a2322" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryCurrentTable_5f5997de-dc2f-4d81-b4c1-f3b42b21beae" xlink:to="loc_us-gaap_InventoryLineItems_973225a3-1b7a-4fd5-8867-945cb46a2322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterials_de582522-fe88-4d34-9fe2-cfc1d908f1f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterials"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_973225a3-1b7a-4fd5-8867-945cb46a2322" xlink:to="loc_us-gaap_InventoryRawMaterials_de582522-fe88-4d34-9fe2-cfc1d908f1f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcess_5add666d-afdd-4aa7-a064-897bc7f1c307" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcess"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_973225a3-1b7a-4fd5-8867-945cb46a2322" xlink:to="loc_us-gaap_InventoryWorkInProcess_5add666d-afdd-4aa7-a064-897bc7f1c307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_cb1b88a4-91e8-437b-8f0d-dbc7a74c0387" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_973225a3-1b7a-4fd5-8867-945cb46a2322" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_cb1b88a4-91e8-437b-8f0d-dbc7a74c0387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryGross_0125ad06-9b08-4283-b1a6-f7009e1db943" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_973225a3-1b7a-4fd5-8867-945cb46a2322" xlink:to="loc_us-gaap_InventoryGross_0125ad06-9b08-4283-b1a6-f7009e1db943" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_f5edf03a-a27e-4bed-9fee-3d01e1f8a2bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryLineItems_973225a3-1b7a-4fd5-8867-945cb46a2322" xlink:to="loc_us-gaap_InventoryValuationReserves_f5edf03a-a27e-4bed-9fee-3d01e1f8a2bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/PROPERTYEQUIPMENT" xlink:type="simple" xlink:href="cvsi-20201231.xsd#PROPERTYEQUIPMENT"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/PROPERTYEQUIPMENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_cbfa01ed-956f-4ebe-b185-2691fac83755" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_39dfab08-955d-459c-8ea6-dfce17b5b54b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_cbfa01ed-956f-4ebe-b185-2691fac83755" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_39dfab08-955d-459c-8ea6-dfce17b5b54b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/PROPERTYEQUIPMENTTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#PROPERTYEQUIPMENTTables"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/PROPERTYEQUIPMENTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_4a767bcb-eda3-4e5e-95ba-b069e93d044c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_4657fb5e-a0e1-47e2-ab49-5dd71e4c9e5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_4a767bcb-eda3-4e5e-95ba-b069e93d044c" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_4657fb5e-a0e1-47e2-ab49-5dd71e4c9e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/PROPERTYEQUIPMENTDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#PROPERTYEQUIPMENTDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/PROPERTYEQUIPMENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_7981472e-b10c-470d-8ce0-c888c078fd2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_85b39b5d-da0e-4043-8615-71a28e20f492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_7981472e-b10c-470d-8ce0-c888c078fd2e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_85b39b5d-da0e-4043-8615-71a28e20f492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3baaa378-5fad-4c97-92dd-adfd361241f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_85b39b5d-da0e-4043-8615-71a28e20f492" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3baaa378-5fad-4c97-92dd-adfd361241f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0ecd5837-d495-4a48-8081-0c295bb32247" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_3baaa378-5fad-4c97-92dd-adfd361241f4" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0ecd5837-d495-4a48-8081-0c295bb32247" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OfficeEquipmentMember_5daa27f4-f126-4ea1-99d8-b13414dda070" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OfficeEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0ecd5837-d495-4a48-8081-0c295bb32247" xlink:to="loc_us-gaap_OfficeEquipmentMember_5daa27f4-f126-4ea1-99d8-b13414dda070" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember_a96c6ac7-7f15-4fd9-bf8e-0e9ade9f07ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0ecd5837-d495-4a48-8081-0c295bb32247" xlink:to="loc_us-gaap_BuildingImprovementsMember_a96c6ac7-7f15-4fd9-bf8e-0e9ade9f07ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_sic_Z3821_cf8a44b0-c8fb-486b-9fd7-0f4f5a503419" xlink:href="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd#sic_Z3821"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0ecd5837-d495-4a48-8081-0c295bb32247" xlink:to="loc_sic_Z3821_cf8a44b0-c8fb-486b-9fd7-0f4f5a503419" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_3ac8eb18-0dcb-4573-acb8-47f05b0250da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_0ecd5837-d495-4a48-8081-0c295bb32247" xlink:to="loc_us-gaap_ConstructionInProgressMember_3ac8eb18-0dcb-4573-acb8-47f05b0250da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_46be6afd-2fc1-4f5c-b925-1b9f6bbc0c87" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_85b39b5d-da0e-4043-8615-71a28e20f492" xlink:to="loc_srt_RangeAxis_46be6afd-2fc1-4f5c-b925-1b9f6bbc0c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dace5701-617c-47af-b0f9-84c17e6a20ac" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_46be6afd-2fc1-4f5c-b925-1b9f6bbc0c87" xlink:to="loc_srt_RangeMember_dace5701-617c-47af-b0f9-84c17e6a20ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_66dbb4c0-15d0-4c80-9c7d-8ecff0c043f7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dace5701-617c-47af-b0f9-84c17e6a20ac" xlink:to="loc_srt_MinimumMember_66dbb4c0-15d0-4c80-9c7d-8ecff0c043f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_18a7e900-a41f-4131-8ae9-b09dae31f939" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dace5701-617c-47af-b0f9-84c17e6a20ac" xlink:to="loc_srt_MaximumMember_18a7e900-a41f-4131-8ae9-b09dae31f939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ad6a06d4-3732-4e34-a64f-2912d36d5e3a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_85b39b5d-da0e-4043-8615-71a28e20f492" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ad6a06d4-3732-4e34-a64f-2912d36d5e3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_8cbede0a-618a-4d11-8df9-de5d56c3806e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ad6a06d4-3732-4e34-a64f-2912d36d5e3a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_8cbede0a-618a-4d11-8df9-de5d56c3806e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a4a61669-bdd7-48f1-bd33-dae70f39462a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ad6a06d4-3732-4e34-a64f-2912d36d5e3a" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_a4a61669-bdd7-48f1-bd33-dae70f39462a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9888db59-f121-4f66-bee8-167a83fdbce1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ad6a06d4-3732-4e34-a64f-2912d36d5e3a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9888db59-f121-4f66-bee8-167a83fdbce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_85081aad-12c5-498f-b5a5-23cb6fadb3f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ad6a06d4-3732-4e34-a64f-2912d36d5e3a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_85081aad-12c5-498f-b5a5-23cb6fadb3f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_1928dfcb-3b63-4cff-9bee-3028e49dca26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_ad6a06d4-3732-4e34-a64f-2912d36d5e3a" xlink:to="loc_us-gaap_Depreciation_1928dfcb-3b63-4cff-9bee-3028e49dca26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INTANGIBLEASSETS" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INTANGIBLEASSETS"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/INTANGIBLEASSETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_496e24f7-23cd-4763-9b93-28947e17c6c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_6067fcdc-9fe2-4885-ba8d-2a59ff4941dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_496e24f7-23cd-4763-9b93-28947e17c6c8" xlink:to="loc_us-gaap_IntangibleAssetsDisclosureTextBlock_6067fcdc-9fe2-4885-ba8d-2a59ff4941dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INTANGIBLEASSETSTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INTANGIBLEASSETSTables"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/INTANGIBLEASSETSTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_21c75b27-3cb1-4e22-ac04-06d8bd8f3ee7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_eccd4838-c7bc-4a28-919a-ccf1d24490e3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_21c75b27-3cb1-4e22-ac04-06d8bd8f3ee7" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_eccd4838-c7bc-4a28-919a-ccf1d24490e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INTANGIBLEASSETSIntangibleAssetScheduleDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7f5dc1c4-f9e1-41a7-af6d-bc8d6188d332" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_55c8562e-3156-4676-a598-0b65c354a04f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7f5dc1c4-f9e1-41a7-af6d-bc8d6188d332" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_55c8562e-3156-4676-a598-0b65c354a04f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fd957a9d-47d3-41f4-bd24-331cfe67db04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_55c8562e-3156-4676-a598-0b65c354a04f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fd957a9d-47d3-41f4-bd24-331cfe67db04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4a87e530-f849-4e03-b359-de1024c9527a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_fd957a9d-47d3-41f4-bd24-331cfe67db04" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4a87e530-f849-4e03-b359-de1024c9527a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InProcessResearchAndDevelopmentMember_ec931194-ac9a-4631-bd20-cd2170d89d9d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InProcessResearchAndDevelopmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4a87e530-f849-4e03-b359-de1024c9527a" xlink:to="loc_us-gaap_InProcessResearchAndDevelopmentMember_ec931194-ac9a-4631-bd20-cd2170d89d9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TradeNamesMember_fdbf882d-5c14-4fe1-bc37-3d40515faf29" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TradeNamesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4a87e530-f849-4e03-b359-de1024c9527a" xlink:to="loc_us-gaap_TradeNamesMember_fdbf882d-5c14-4fe1-bc37-3d40515faf29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncompeteAgreementsMember_1028e713-bf5f-492e-a1a1-5a3ba9420536" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NoncompeteAgreementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4a87e530-f849-4e03-b359-de1024c9527a" xlink:to="loc_us-gaap_NoncompeteAgreementsMember_1028e713-bf5f-492e-a1a1-5a3ba9420536" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_23c7b936-fa45-4fa9-bd39-b2e114df48ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_55c8562e-3156-4676-a598-0b65c354a04f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_23c7b936-fa45-4fa9-bd39-b2e114df48ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_51545c37-30a0-4c31-a96c-68292aae0c3d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_23c7b936-fa45-4fa9-bd39-b2e114df48ae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_51545c37-30a0-4c31-a96c-68292aae0c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b89725c1-ac78-4b30-80cd-0c34058e18ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_23c7b936-fa45-4fa9-bd39-b2e114df48ae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_b89725c1-ac78-4b30-80cd-0c34058e18ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e410100c-49d9-4765-89c4-3255b7299e2e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_23c7b936-fa45-4fa9-bd39-b2e114df48ae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e410100c-49d9-4765-89c4-3255b7299e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9a1a21ed-7649-4a71-9efc-de556395f00d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_23c7b936-fa45-4fa9-bd39-b2e114df48ae" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_9a1a21ed-7649-4a71-9efc-de556395f00d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INTANGIBLEASSETSNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INTANGIBLEASSETSNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/INTANGIBLEASSETSNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0a8de57c-2f68-4776-9800-87f1b2f6f4e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentForAmortization_64f9e72d-7fef-47b7-a90a-8dc46cf97370" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentForAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0a8de57c-2f68-4776-9800-87f1b2f6f4e0" xlink:to="loc_us-gaap_AdjustmentForAmortization_64f9e72d-7fef-47b7-a90a-8dc46cf97370" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_9b9c32e6-8d95-407f-8829-06561b985913" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_0a8de57c-2f68-4776-9800-87f1b2f6f4e0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_9b9c32e6-8d95-407f-8829-06561b985913" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/ACCRUEDEXPENSES" xlink:type="simple" xlink:href="cvsi-20201231.xsd#ACCRUEDEXPENSES"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/ACCRUEDEXPENSES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_7939f535-a5a7-46cb-9855-e615acdc687b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_5ae64075-0a2b-48d1-933a-8f99ee04807d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_7939f535-a5a7-46cb-9855-e615acdc687b" xlink:to="loc_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_5ae64075-0a2b-48d1-933a-8f99ee04807d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/ACCRUEDEXPENSESTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#ACCRUEDEXPENSESTables"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/ACCRUEDEXPENSESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_8d348cfb-10b0-4e1c-b0f5-f6100c495d0a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_dc746e80-f04d-4a25-82f4-4e6a374e7205" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_8d348cfb-10b0-4e1c-b0f5-f6100c495d0a" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_dc746e80-f04d-4a25-82f4-4e6a374e7205" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/ACCRUEDEXPENSESDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#ACCRUEDEXPENSESDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/ACCRUEDEXPENSESDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_927940e5-470f-44c9-bed7-204875359ea1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9697231c-f65a-4fa9-8542-e2c90fad78a2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_927940e5-470f-44c9-bed7-204875359ea1" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9697231c-f65a-4fa9-8542-e2c90fad78a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionAxis_f2648178-ffc2-4391-9cc3-4bbc32657641" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9697231c-f65a-4fa9-8542-e2c90fad78a2" xlink:to="loc_us-gaap_RelatedPartyTransactionAxis_f2648178-ffc2-4391-9cc3-4bbc32657641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionDomain_99973b6e-df64-4be2-a0d4-f0ebd1a332b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionAxis_f2648178-ffc2-4391-9cc3-4bbc32657641" xlink:to="loc_us-gaap_RelatedPartyTransactionDomain_99973b6e-df64-4be2-a0d4-f0ebd1a332b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_TaxLiabilityMember_4321edd6-b2ce-4325-aad4-55e4bca1065d" xlink:href="cvsi-20201231.xsd#cvsi_TaxLiabilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionDomain_99973b6e-df64-4be2-a0d4-f0ebd1a332b0" xlink:to="loc_cvsi_TaxLiabilityMember_4321edd6-b2ce-4325-aad4-55e4bca1065d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_681d9000-8c41-4779-9083-2e2284d02004" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_9697231c-f65a-4fa9-8542-e2c90fad78a2" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_681d9000-8c41-4779-9083-2e2284d02004" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_0c342fef-d298-40fa-9004-0206d97e9fc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_681d9000-8c41-4779-9083-2e2284d02004" xlink:to="loc_us-gaap_AccruedSalariesCurrent_0c342fef-d298-40fa-9004-0206d97e9fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_95c1406e-b4e9-43b0-8adb-b917084c83b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_681d9000-8c41-4779-9083-2e2284d02004" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_95c1406e-b4e9-43b0-8adb-b917084c83b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_c13bb448-6ed8-41a8-a50a-89dc67763f82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_681d9000-8c41-4779-9083-2e2284d02004" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_c13bb448-6ed8-41a8-a50a-89dc67763f82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/DEBT" xlink:type="simple" xlink:href="cvsi-20201231.xsd#DEBT"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/DEBT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2551c23c-6cbe-42f8-92d9-dcf1da89f240" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_8b3b571e-7bec-4cf9-87bd-99254f871c58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2551c23c-6cbe-42f8-92d9-dcf1da89f240" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_8b3b571e-7bec-4cf9-87bd-99254f871c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/DEBTTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#DEBTTables"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/DEBTTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_20995c2d-5007-46b4-8e09-8276b6b50ba5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtTableTextBlock_cc25190d-4d06-4109-b831-64eda29edecf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_20995c2d-5007-46b4-8e09-8276b6b50ba5" xlink:to="loc_us-gaap_ScheduleOfDebtTableTextBlock_cc25190d-4d06-4109-b831-64eda29edecf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_61ef6125-a972-447d-a1db-24136fa9be22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_20995c2d-5007-46b4-8e09-8276b6b50ba5" xlink:to="loc_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock_61ef6125-a972-447d-a1db-24136fa9be22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/DEBTScheduleofDebtDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#DEBTScheduleofDebtDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/DEBTScheduleofDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_c31c0e0e-2762-49f0-95fe-8c9ec11dddcb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_a8f78163-d4cd-41a1-9d7a-09f841f8aae3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_c31c0e0e-2762-49f0-95fe-8c9ec11dddcb" xlink:to="loc_us-gaap_DebtInstrumentTable_a8f78163-d4cd-41a1-9d7a-09f841f8aae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_65341747-94e6-4a86-a494-41debd5e12ae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a8f78163-d4cd-41a1-9d7a-09f841f8aae3" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_65341747-94e6-4a86-a494-41debd5e12ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_23746c97-72aa-4eea-bdf2-c35abe8402c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_65341747-94e6-4a86-a494-41debd5e12ae" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_23746c97-72aa-4eea-bdf2-c35abe8402c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_841224c1-3277-4106-9d6a-e845db95c5cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_23746c97-72aa-4eea-bdf2-c35abe8402c2" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_841224c1-3277-4106-9d6a-e845db95c5cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_6ecc046f-5e11-424c-b3e7-0883d42c4c2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_23746c97-72aa-4eea-bdf2-c35abe8402c2" xlink:to="loc_us-gaap_UnsecuredDebtMember_6ecc046f-5e11-424c-b3e7-0883d42c4c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8cd3f49b-28ed-49cf-81eb-0a1462b3454d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a8f78163-d4cd-41a1-9d7a-09f841f8aae3" xlink:to="loc_us-gaap_DebtInstrumentAxis_8cd3f49b-28ed-49cf-81eb-0a1462b3454d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_bc856ab2-2b2c-424f-af62-f2f5e0cd8fc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8cd3f49b-28ed-49cf-81eb-0a1462b3454d" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_bc856ab2-2b2c-424f-af62-f2f5e0cd8fc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_PayrollProtectionProgramLoanMember_a9f1af3c-8c74-46d1-a507-8f6ebd95e939" xlink:href="cvsi-20201231.xsd#cvsi_PayrollProtectionProgramLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc856ab2-2b2c-424f-af62-f2f5e0cd8fc4" xlink:to="loc_cvsi_PayrollProtectionProgramLoanMember_a9f1af3c-8c74-46d1-a507-8f6ebd95e939" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_FirstInsuranceFundingMember_f1270150-9d9a-4d42-b85a-002e0f9603c5" xlink:href="cvsi-20201231.xsd#cvsi_FirstInsuranceFundingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_bc856ab2-2b2c-424f-af62-f2f5e0cd8fc4" xlink:to="loc_cvsi_FirstInsuranceFundingMember_f1270150-9d9a-4d42-b85a-002e0f9603c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_40018d76-db79-4e58-8815-aed2e734b72a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_a8f78163-d4cd-41a1-9d7a-09f841f8aae3" xlink:to="loc_us-gaap_DebtInstrumentLineItems_40018d76-db79-4e58-8815-aed2e734b72a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_a6cbdd96-8e70-4198-942b-cc60c7612f87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40018d76-db79-4e58-8815-aed2e734b72a" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_a6cbdd96-8e70-4198-942b-cc60c7612f87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtCurrent_0f447d71-6f3e-49c8-be52-8b7e5fcfcde2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40018d76-db79-4e58-8815-aed2e734b72a" xlink:to="loc_us-gaap_LongTermDebtCurrent_0f447d71-6f3e-49c8-be52-8b7e5fcfcde2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_20fe107e-b537-47ac-93fa-453a737df7e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_40018d76-db79-4e58-8815-aed2e734b72a" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_20fe107e-b537-47ac-93fa-453a737df7e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/DebtPrincipalPaymentsonDebtDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#DebtPrincipalPaymentsonDebtDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/DebtPrincipalPaymentsonDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_623d1f0b-b27a-4ce2-a718-2a9084eff556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_61b87640-d270-4139-bdd3-a62a7757d28f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_623d1f0b-b27a-4ce2-a718-2a9084eff556" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_61b87640-d270-4139-bdd3-a62a7757d28f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_696dd9a7-c56c-420a-af87-4d6da20b4b8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_623d1f0b-b27a-4ce2-a718-2a9084eff556" xlink:to="loc_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_696dd9a7-c56c-420a-af87-4d6da20b4b8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_ef5beaa5-6064-4fff-9765-d5d10393539c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_623d1f0b-b27a-4ce2-a718-2a9084eff556" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_ef5beaa5-6064-4fff-9765-d5d10393539c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/DEBTNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#DEBTNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/DEBTNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d92d471c-56e1-42d3-ae31-451cfa7e399d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_7f4461ad-61d1-4da1-ac79-5c0ab1179cd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d92d471c-56e1-42d3-ae31-451cfa7e399d" xlink:to="loc_us-gaap_DebtInstrumentTable_7f4461ad-61d1-4da1-ac79-5c0ab1179cd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b878a453-d831-47ec-9cd4-47ab73cc0e47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7f4461ad-61d1-4da1-ac79-5c0ab1179cd0" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b878a453-d831-47ec-9cd4-47ab73cc0e47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6d006d5a-9e64-455d-b5e6-d0208de4756a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b878a453-d831-47ec-9cd4-47ab73cc0e47" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6d006d5a-9e64-455d-b5e6-d0208de4756a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesPayableOtherPayablesMember_dd873f78-96a6-48ac-a613-45bbcf6c7065" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NotesPayableOtherPayablesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6d006d5a-9e64-455d-b5e6-d0208de4756a" xlink:to="loc_us-gaap_NotesPayableOtherPayablesMember_dd873f78-96a6-48ac-a613-45bbcf6c7065" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebtMember_a8539cab-c561-4aa0-aa6b-196f4f9088ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebtMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_6d006d5a-9e64-455d-b5e6-d0208de4756a" xlink:to="loc_us-gaap_UnsecuredDebtMember_a8539cab-c561-4aa0-aa6b-196f4f9088ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_b026269a-77ee-4180-900e-12622b58c1e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7f4461ad-61d1-4da1-ac79-5c0ab1179cd0" xlink:to="loc_us-gaap_DebtInstrumentAxis_b026269a-77ee-4180-900e-12622b58c1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_174d6905-d6ae-4150-9566-86884ee15893" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_b026269a-77ee-4180-900e-12622b58c1e1" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_174d6905-d6ae-4150-9566-86884ee15893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_PayrollProtectionProgramLoanMember_149f6e5d-b84a-4fb6-af59-d9177399f282" xlink:href="cvsi-20201231.xsd#cvsi_PayrollProtectionProgramLoanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_174d6905-d6ae-4150-9566-86884ee15893" xlink:to="loc_cvsi_PayrollProtectionProgramLoanMember_149f6e5d-b84a-4fb6-af59-d9177399f282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_PremiumFinanceAgreementMember_bce8799a-8624-4000-95b3-579a68b6ef70" xlink:href="cvsi-20201231.xsd#cvsi_PremiumFinanceAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_174d6905-d6ae-4150-9566-86884ee15893" xlink:to="loc_cvsi_PremiumFinanceAgreementMember_bce8799a-8624-4000-95b3-579a68b6ef70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_FirstInsuranceFundingMember_c6d6311c-6a8b-4c2c-b62f-345f34657cea" xlink:href="cvsi-20201231.xsd#cvsi_FirstInsuranceFundingMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_174d6905-d6ae-4150-9566-86884ee15893" xlink:to="loc_cvsi_FirstInsuranceFundingMember_c6d6311c-6a8b-4c2c-b62f-345f34657cea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_55da2b0f-2c66-41a3-b327-27335d263361" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_7f4461ad-61d1-4da1-ac79-5c0ab1179cd0" xlink:to="loc_us-gaap_DebtInstrumentLineItems_55da2b0f-2c66-41a3-b327-27335d263361" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_a9d96240-39ea-42c0-a59b-3c28469efddb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfLongTermDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_55da2b0f-2c66-41a3-b327-27335d263361" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfLongTermDebt_a9d96240-39ea-42c0-a59b-3c28469efddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_92f567d0-ab95-47f1-bb2a-760062d59ebf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_55da2b0f-2c66-41a3-b327-27335d263361" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_92f567d0-ab95-47f1-bb2a-760062d59ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_edff0204-0d76-4ef3-b0be-e2d5ffa45bc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_55da2b0f-2c66-41a3-b327-27335d263361" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_edff0204-0d76-4ef3-b0be-e2d5ffa45bc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentPeriodicPayment_f83c0367-3fda-4474-8176-6b7bbe699b2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentPeriodicPayment"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_55da2b0f-2c66-41a3-b327-27335d263361" xlink:to="loc_us-gaap_DebtInstrumentPeriodicPayment_f83c0367-3fda-4474-8176-6b7bbe699b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnsecuredDebt_dfda728d-c172-489d-a2ad-ea0c8bcebefc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnsecuredDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_55da2b0f-2c66-41a3-b327-27335d263361" xlink:to="loc_us-gaap_UnsecuredDebt_dfda728d-c172-489d-a2ad-ea0c8bcebefc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/STOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="cvsi-20201231.xsd#STOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/STOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_19a94cb5-3d67-45bc-8aea-44b4e7d5a262" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_4c206b94-b69e-4637-8eb3-7ab00a321c6b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_19a94cb5-3d67-45bc-8aea-44b4e7d5a262" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_4c206b94-b69e-4637-8eb3-7ab00a321c6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#STOCKHOLDERSEQUITYNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteAbstract_cb56274c-2794-45e6-9d3c-86c1d02d7dff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_89309f61-c405-440c-8a3a-d3d96a91f679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityNoteAbstract_cb56274c-2794-45e6-9d3c-86c1d02d7dff" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_89309f61-c405-440c-8a3a-d3d96a91f679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2af7dc48-bde2-44be-bb61-df37e8545de1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_89309f61-c405-440c-8a3a-d3d96a91f679" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2af7dc48-bde2-44be-bb61-df37e8545de1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_baffa888-1d1c-4724-9f80-f49d4b5e29ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2af7dc48-bde2-44be-bb61-df37e8545de1" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_baffa888-1d1c-4724-9f80-f49d4b5e29ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_CommonStockPurchaseAgreementMember_60e841cb-2428-4756-8038-cf04359a54ad" xlink:href="cvsi-20201231.xsd#cvsi_CommonStockPurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_baffa888-1d1c-4724-9f80-f49d4b5e29ef" xlink:to="loc_cvsi_CommonStockPurchaseAgreementMember_60e841cb-2428-4756-8038-cf04359a54ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_89309f61-c405-440c-8a3a-d3d96a91f679" xlink:to="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_889acc0c-7e7a-464d-ad0c-bcb8fc3d070f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_889acc0c-7e7a-464d-ad0c-bcb8fc3d070f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_0c878379-3424-49d8-9d96-10140f9fc996" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_0c878379-3424-49d8-9d96-10140f9fc996" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_a06c0724-9823-4fa8-8c8d-f3ed0fd172ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_CommonStockSharesIssued_a06c0724-9823-4fa8-8c8d-f3ed0fd172ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_f5c75859-216d-45be-b5fe-5ee076d9967c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_f5c75859-216d-45be-b5fe-5ee076d9967c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction_32dc5b5c-74d8-495e-8ef7-afea861ca6cf" xlink:href="cvsi-20201231.xsd#cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction_32dc5b5c-74d8-495e-8ef7-afea861ca6cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock_8ca97be3-91bd-4645-831f-0e72b5ff22bc" xlink:href="cvsi-20201231.xsd#cvsi_SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_cvsi_SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock_8ca97be3-91bd-4645-831f-0e72b5ff22bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SaleOfStockFairValueOfPutOption_1ef1e6e9-4584-44eb-9e3f-5a4de13766f8" xlink:href="cvsi-20201231.xsd#cvsi_SaleOfStockFairValueOfPutOption"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_cvsi_SaleOfStockFairValueOfPutOption_1ef1e6e9-4584-44eb-9e3f-5a4de13766f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement_98971e34-cc23-4145-96d7-e3555b3b1ab6" xlink:href="cvsi-20201231.xsd#cvsi_SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_cvsi_SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement_98971e34-cc23-4145-96d7-e3555b3b1ab6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_b0d0828e-d4e3-4e7c-ba2a-fcac03f67c89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_b0d0828e-d4e3-4e7c-ba2a-fcac03f67c89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_fe28550d-3d0b-45f6-bde4-f22ce1ec05ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_fe28550d-3d0b-45f6-bde4-f22ce1ec05ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_6d736585-9c91-4103-a24a-4d8fadaf3c52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesIssuedForServices"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices_6d736585-9c91-4103-a24a-4d8fadaf3c52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_aad3b313-81ce-4ec7-b2ad-e2e922ba59e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_aad3b313-81ce-4ec7-b2ad-e2e922ba59e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee_869a8d5b-3e82-43a4-a5fe-53463c0b0ce0" xlink:href="cvsi-20201231.xsd#cvsi_SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_cvsi_SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee_869a8d5b-3e82-43a4-a5fe-53463c0b0ce0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_d31c3398-6ded-4dc4-99e3-fc62c354563f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_d31c3398-6ded-4dc4-99e3-fc62c354563f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_336c8fd6-14a2-4822-8c28-3cf1fe2a0576" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_336c8fd6-14a2-4822-8c28-3cf1fe2a0576" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_98a1c413-079e-4cba-a879-12b4383bfb25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_PreferredStockSharesIssued_98a1c413-079e-4cba-a879-12b4383bfb25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_fb185b5b-ca08-4f52-a59b-1698f36b345a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_a5753ab6-a30e-40cd-92e4-17031695dfdb" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_fb185b5b-ca08-4f52-a59b-1698f36b345a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/STOCKBASEDCOMPENSATION" xlink:type="simple" xlink:href="cvsi-20201231.xsd#STOCKBASEDCOMPENSATION"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/STOCKBASEDCOMPENSATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_31355983-078c-4c06-a445-4c0f347326fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_f8283d0e-3b94-440c-90cb-e6f90b1da69f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_31355983-078c-4c06-a445-4c0f347326fb" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_f8283d0e-3b94-440c-90cb-e6f90b1da69f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#STOCKBASEDCOMPENSATIONTables"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fa21b50a-c32d-401a-9521-ee02a604b9a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ed027ab7-535d-43dd-a34a-38ca9545f1a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fa21b50a-c32d-401a-9521-ee02a604b9a1" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_ed027ab7-535d-43dd-a34a-38ca9545f1a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_f3716813-a7ac-4128-8917-c9ab7d925081" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_fa21b50a-c32d-401a-9521-ee02a604b9a1" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_f3716813-a7ac-4128-8917-c9ab7d925081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#STOCKBASEDCOMPENSATIONNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8241e701-56a1-4de7-b5e6-875b02b8c6c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_562cffa2-9305-46ea-be4d-f3a35bbcd294" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_8241e701-56a1-4de7-b5e6-875b02b8c6c2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_562cffa2-9305-46ea-be4d-f3a35bbcd294" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_f6bbbe4c-d7f0-4d78-8781-ba62e7003097" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_562cffa2-9305-46ea-be4d-f3a35bbcd294" xlink:to="loc_us-gaap_PlanNameAxis_f6bbbe4c-d7f0-4d78-8781-ba62e7003097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_814bc2d0-3924-4442-8142-f4a51b9899cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_f6bbbe4c-d7f0-4d78-8781-ba62e7003097" xlink:to="loc_us-gaap_PlanNameDomain_814bc2d0-3924-4442-8142-f4a51b9899cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_Amended2013PlanMember_60d383fd-7072-44f5-a4d4-016c50beb3df" xlink:href="cvsi-20201231.xsd#cvsi_Amended2013PlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_814bc2d0-3924-4442-8142-f4a51b9899cb" xlink:to="loc_cvsi_Amended2013PlanMember_60d383fd-7072-44f5-a4d4-016c50beb3df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_34b3024c-5f33-461b-8567-94bb1ee1d0e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_562cffa2-9305-46ea-be4d-f3a35bbcd294" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_34b3024c-5f33-461b-8567-94bb1ee1d0e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_ff56274e-ee25-453e-ba0e-030fdc0c2747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_34b3024c-5f33-461b-8567-94bb1ee1d0e7" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_ff56274e-ee25-453e-ba0e-030fdc0c2747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_a0b93893-8c1c-490b-a6c3-755b222c9266" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_ff56274e-ee25-453e-ba0e-030fdc0c2747" xlink:to="loc_us-gaap_SubsequentEventMember_a0b93893-8c1c-490b-a6c3-755b222c9266" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_7e8e175a-3530-4fc4-aaab-1c7f8f9cdd0d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_562cffa2-9305-46ea-be4d-f3a35bbcd294" xlink:to="loc_srt_RangeAxis_7e8e175a-3530-4fc4-aaab-1c7f8f9cdd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_ed0e09e6-ef3b-40cc-b7a2-30031294352a" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_7e8e175a-3530-4fc4-aaab-1c7f8f9cdd0d" xlink:to="loc_srt_RangeMember_ed0e09e6-ef3b-40cc-b7a2-30031294352a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_2ea49d8d-afbf-4771-a418-fbfbf76d1c9f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ed0e09e6-ef3b-40cc-b7a2-30031294352a" xlink:to="loc_srt_MinimumMember_2ea49d8d-afbf-4771-a418-fbfbf76d1c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_7982711f-fc83-4252-b541-5b285745c71d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_ed0e09e6-ef3b-40cc-b7a2-30031294352a" xlink:to="loc_srt_MaximumMember_7982711f-fc83-4252-b541-5b285745c71d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualAxis_424773d0-9308-4f1b-a89a-f959d4f26a83" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_562cffa2-9305-46ea-be4d-f3a35bbcd294" xlink:to="loc_srt_TitleOfIndividualAxis_424773d0-9308-4f1b-a89a-f959d4f26a83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ee0a549a-2657-49f5-a1e9-9d4d1d4632c7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_TitleOfIndividualWithRelationshipToEntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualAxis_424773d0-9308-4f1b-a89a-f959d4f26a83" xlink:to="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ee0a549a-2657-49f5-a1e9-9d4d1d4632c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_FormerFoundersMember_2b70b9cd-5b90-49bc-b8b6-9f4ec32637c7" xlink:href="cvsi-20201231.xsd#cvsi_FormerFoundersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_TitleOfIndividualWithRelationshipToEntityDomain_ee0a549a-2657-49f5-a1e9-9d4d1d4632c7" xlink:to="loc_cvsi_FormerFoundersMember_2b70b9cd-5b90-49bc-b8b6-9f4ec32637c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_c8b29ab8-04d9-404c-ba1d-58d47fb27749" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_562cffa2-9305-46ea-be4d-f3a35bbcd294" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_c8b29ab8-04d9-404c-ba1d-58d47fb27749" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_b6bc1151-500a-423b-99c6-c5321e387066" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_c8b29ab8-04d9-404c-ba1d-58d47fb27749" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_b6bc1151-500a-423b-99c6-c5321e387066" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLossMember_a33f7747-7067-4a46-b718-ff09ece9d5f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLossMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_b6bc1151-500a-423b-99c6-c5321e387066" xlink:to="loc_us-gaap_OperatingIncomeLossMember_a33f7747-7067-4a46-b718-ff09ece9d5f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_b230f88c-6722-4a57-8f41-4bf8cce8fa86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_562cffa2-9305-46ea-be4d-f3a35bbcd294" xlink:to="loc_us-gaap_AwardTypeAxis_b230f88c-6722-4a57-8f41-4bf8cce8fa86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_890aec71-0cfd-4758-bb8c-7127b367797d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_b230f88c-6722-4a57-8f41-4bf8cce8fa86" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_890aec71-0cfd-4758-bb8c-7127b367797d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_44931486-2bcb-415f-9fb4-dc494d418b26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_890aec71-0cfd-4758-bb8c-7127b367797d" xlink:to="loc_us-gaap_StockOptionMember_44931486-2bcb-415f-9fb4-dc494d418b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_StockOptionModificationMember_08765dae-8d26-4697-9f3a-783d84561a0a" xlink:href="cvsi-20201231.xsd#cvsi_StockOptionModificationMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_890aec71-0cfd-4758-bb8c-7127b367797d" xlink:to="loc_cvsi_StockOptionModificationMember_08765dae-8d26-4697-9f3a-783d84561a0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_OptionsOutsidePlanMember_ed1d0f4a-1b17-4942-95f8-4da5d2faa92e" xlink:href="cvsi-20201231.xsd#cvsi_OptionsOutsidePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_890aec71-0cfd-4758-bb8c-7127b367797d" xlink:to="loc_cvsi_OptionsOutsidePlanMember_ed1d0f4a-1b17-4942-95f8-4da5d2faa92e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f86d0142-e440-4e1a-8b3e-af6d341bb48d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_890aec71-0cfd-4758-bb8c-7127b367797d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f86d0142-e440-4e1a-8b3e-af6d341bb48d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_562cffa2-9305-46ea-be4d-f3a35bbcd294" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0be5d2bb-164b-4fa3-80de-115db67a1272" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0be5d2bb-164b-4fa3-80de-115db67a1272" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_076a5267-1564-4b60-bdb2-efc6043edf32" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance_076a5267-1564-4b60-bdb2-efc6043edf32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent_93854e70-ea70-4e88-9fd1-60542efbe26c" xlink:href="cvsi-20201231.xsd#cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent_93854e70-ea70-4e88-9fd1-60542efbe26c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan_2034ff7b-f5b5-4ff6-95d9-5a6b9c426145" xlink:href="cvsi-20201231.xsd#cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan_2034ff7b-f5b5-4ff6-95d9-5a6b9c426145" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_e543d4a2-b387-44c7-9175-598f70226175" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized_e543d4a2-b387-44c7-9175-598f70226175" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2e92ed21-56fa-4d22-8212-f4aaef3dbb8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_2e92ed21-56fa-4d22-8212-f4aaef3dbb8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_f21f7026-75cd-44ef-9929-3d6e8e35183a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_f21f7026-75cd-44ef-9929-3d6e8e35183a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_2a0e2275-b44c-4f60-ad38-e53255cbcf8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_2a0e2275-b44c-4f60-ad38-e53255cbcf8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3cbb3544-ee4f-48b8-a5db-2f6ee32b2ee3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_3cbb3544-ee4f-48b8-a5db-2f6ee32b2ee3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_26e993dd-d6e6-4e5e-8a41-0fbbc5cfb131" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_26e993dd-d6e6-4e5e-8a41-0fbbc5cfb131" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b6edf6f7-8e65-4bea-9f33-b9dcc991bccd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_b6edf6f7-8e65-4bea-9f33-b9dcc991bccd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_789f67e5-01f5-4f18-a594-20e7b548d956" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_789f67e5-01f5-4f18-a594-20e7b548d956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ca3c9f3a-0452-4595-9b60-64a5bd46d07a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_ca3c9f3a-0452-4595-9b60-64a5bd46d07a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1c0717c3-9ad3-4ba4-b337-7214b34e2329" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1c0717c3-9ad3-4ba4-b337-7214b34e2329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility_83c951a5-7bcd-4401-bf71-a690a45b84f9" xlink:href="cvsi-20201231.xsd#cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility_83c951a5-7bcd-4401-bf71-a690a45b84f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_fed00fd9-b3a5-44d5-bfb6-f82de904cfec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_fed00fd9-b3a5-44d5-bfb6-f82de904cfec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_bcf32186-d501-41a0-ae0d-7cf607f0d8fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_bcf32186-d501-41a0-ae0d-7cf607f0d8fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_443db930-91b0-43e1-b702-012a125f05cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_450c7393-96a1-4948-aeba-1e297a9a9429" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_443db930-91b0-43e1-b702-012a125f05cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_62932d3d-07f8-4fc4-b13b-9c5512a081d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2fdb7dfc-8f9a-4643-99f3-1597d2d880cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_62932d3d-07f8-4fc4-b13b-9c5512a081d5" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2fdb7dfc-8f9a-4643-99f3-1597d2d880cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_2da41155-e982-4b0d-bfe2-365e9be75f99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2fdb7dfc-8f9a-4643-99f3-1597d2d880cf" xlink:to="loc_us-gaap_AwardTypeAxis_2da41155-e982-4b0d-bfe2-365e9be75f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bec3a729-0653-4038-958d-274034b2ad5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_2da41155-e982-4b0d-bfe2-365e9be75f99" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bec3a729-0653-4038-958d-274034b2ad5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockOptionMember_c61f49cf-ee19-4d8f-bafd-0eb5d7a4afe9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_bec3a729-0653-4038-958d-274034b2ad5e" xlink:to="loc_us-gaap_StockOptionMember_c61f49cf-ee19-4d8f-bafd-0eb5d7a4afe9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636bcbe1-123c-4fb9-abb1-1b0ef91d4bbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_2fdb7dfc-8f9a-4643-99f3-1597d2d880cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636bcbe1-123c-4fb9-abb1-1b0ef91d4bbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dadfd5b8-7e5c-4fda-b485-baa592890641" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636bcbe1-123c-4fb9-abb1-1b0ef91d4bbb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dadfd5b8-7e5c-4fda-b485-baa592890641" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d3109567-43f1-4cff-881d-d8a0ad740166" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dadfd5b8-7e5c-4fda-b485-baa592890641" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_d3109567-43f1-4cff-881d-d8a0ad740166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_5e605bed-ebf0-44b3-9380-66d3f809b704" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dadfd5b8-7e5c-4fda-b485-baa592890641" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod_5e605bed-ebf0-44b3-9380-66d3f809b704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_01b0628f-2fdc-49ba-b964-08dab550b85e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dadfd5b8-7e5c-4fda-b485-baa592890641" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_01b0628f-2fdc-49ba-b964-08dab550b85e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_a90b080a-2c4e-4179-aebf-929a41a11cae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dadfd5b8-7e5c-4fda-b485-baa592890641" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_a90b080a-2c4e-4179-aebf-929a41a11cae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e6fc29d9-30c6-4606-bd61-4ec028e2bb27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_dadfd5b8-7e5c-4fda-b485-baa592890641" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_e6fc29d9-30c6-4606-bd61-4ec028e2bb27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_cdd7e151-1ca9-4295-ba96-bb6b6a77a614" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636bcbe1-123c-4fb9-abb1-1b0ef91d4bbb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_cdd7e151-1ca9-4295-ba96-bb6b6a77a614" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_23070804-49dc-4736-977d-8e8441e3f953" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636bcbe1-123c-4fb9-abb1-1b0ef91d4bbb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_23070804-49dc-4736-977d-8e8441e3f953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_646cb8b3-3af1-4cb7-af9a-1df76475d52d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636bcbe1-123c-4fb9-abb1-1b0ef91d4bbb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_646cb8b3-3af1-4cb7-af9a-1df76475d52d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_39c2722f-6457-4528-83ed-531f43104651" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_646cb8b3-3af1-4cb7-af9a-1df76475d52d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_39c2722f-6457-4528-83ed-531f43104651" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_dcc1a04c-b8f6-4dee-aa81-778d89b2776b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_646cb8b3-3af1-4cb7-af9a-1df76475d52d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_dcc1a04c-b8f6-4dee-aa81-778d89b2776b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0b6d742a-237b-4f49-a0ff-87d02ed2a1be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_646cb8b3-3af1-4cb7-af9a-1df76475d52d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_0b6d742a-237b-4f49-a0ff-87d02ed2a1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_8c6a9661-8bf0-49d1-81e9-17322b62422d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_646cb8b3-3af1-4cb7-af9a-1df76475d52d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_8c6a9661-8bf0-49d1-81e9-17322b62422d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b2362b14-93d0-4376-a47f-73eeec8c66ff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_646cb8b3-3af1-4cb7-af9a-1df76475d52d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_b2362b14-93d0-4376-a47f-73eeec8c66ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_26d699b8-6bfd-4842-980e-c070e2b1a8f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636bcbe1-123c-4fb9-abb1-1b0ef91d4bbb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_26d699b8-6bfd-4842-980e-c070e2b1a8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_e730e72e-a955-4ea2-b780-16745b1b16c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636bcbe1-123c-4fb9-abb1-1b0ef91d4bbb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_e730e72e-a955-4ea2-b780-16745b1b16c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_453d3ee9-52f9-4a21-8c44-e01c5274096e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_636bcbe1-123c-4fb9-abb1-1b0ef91d4bbb" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_453d3ee9-52f9-4a21-8c44-e01c5274096e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_fd6504ff-74c4-4dca-92b0-6628fb2b3e24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_453d3ee9-52f9-4a21-8c44-e01c5274096e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_fd6504ff-74c4-4dca-92b0-6628fb2b3e24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3f0f8462-9294-4127-98d6-555af0850b56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_453d3ee9-52f9-4a21-8c44-e01c5274096e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_3f0f8462-9294-4127-98d6-555af0850b56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_648cc3cd-2d8c-404e-8062-745f8c765dd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_453d3ee9-52f9-4a21-8c44-e01c5274096e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_648cc3cd-2d8c-404e-8062-745f8c765dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ef928f21-fcfc-47b7-b411-88b1ae972afb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_453d3ee9-52f9-4a21-8c44-e01c5274096e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_ef928f21-fcfc-47b7-b411-88b1ae972afb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_8c598750-e029-42da-b84f-39aafb08598d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_453d3ee9-52f9-4a21-8c44-e01c5274096e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_8c598750-e029-42da-b84f-39aafb08598d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_37c15469-b5d0-4b9f-9983-af3dca38a9b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_453d3ee9-52f9-4a21-8c44-e01c5274096e" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_37c15469-b5d0-4b9f-9983-af3dca38a9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_caf73695-ac76-404a-b3d7-6b9f2cb31fa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_453d3ee9-52f9-4a21-8c44-e01c5274096e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_caf73695-ac76-404a-b3d7-6b9f2cb31fa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONAssumptionsUsedtoEstimateFairValueDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#STOCKBASEDCOMPENSATIONAssumptionsUsedtoEstimateFairValueDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/STOCKBASEDCOMPENSATIONAssumptionsUsedtoEstimateFairValueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_acb8c2ed-1ce3-490f-a62a-1efb7293560b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_d41d63e3-850e-4d19-81f2-bf63c9cb51cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_acb8c2ed-1ce3-490f-a62a-1efb7293560b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_d41d63e3-850e-4d19-81f2-bf63c9cb51cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1e9e7362-ecf2-4fa4-b0e6-5545a5aeb398" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_acb8c2ed-1ce3-490f-a62a-1efb7293560b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1e9e7362-ecf2-4fa4-b0e6-5545a5aeb398" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1b6cfeab-d87d-4b56-ba6b-20c75d254767" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_acb8c2ed-1ce3-490f-a62a-1efb7293560b" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_1b6cfeab-d87d-4b56-ba6b-20c75d254767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_d002ccd4-407c-4297-861e-9f1d577c4dd8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_acb8c2ed-1ce3-490f-a62a-1efb7293560b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_d002ccd4-407c-4297-861e-9f1d577c4dd8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a459f45c-c489-4361-aa82-31ea9c9e0f40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_acb8c2ed-1ce3-490f-a62a-1efb7293560b" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a459f45c-c489-4361-aa82-31ea9c9e0f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/NETINCOMELOSSPERSHARE" xlink:type="simple" xlink:href="cvsi-20201231.xsd#NETINCOMELOSSPERSHARE"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/NETINCOMELOSSPERSHARE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_5bd9de01-ea3b-4f17-b5b1-36eeb10a9652" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_15bbdb6b-f506-43c1-bcf9-2feff0dba211" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_5bd9de01-ea3b-4f17-b5b1-36eeb10a9652" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_15bbdb6b-f506-43c1-bcf9-2feff0dba211" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/NETINCOMELOSSPERSHARETables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#NETINCOMELOSSPERSHARETables"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/NETINCOMELOSSPERSHARETables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_3f68d548-2609-45b9-b911-d003585722ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a344889e-4db6-40b2-b729-9bb27b7a1d85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_3f68d548-2609-45b9-b911-d003585722ce" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a344889e-4db6-40b2-b729-9bb27b7a1d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/NETINCOMELOSSPERSHAREAntidilutiveSharesDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#NETINCOMELOSSPERSHAREAntidilutiveSharesDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/NETINCOMELOSSPERSHAREAntidilutiveSharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_59f2f4d6-e196-48b4-97f1-c07bc3edcaa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_598bae19-b044-42bb-8085-be66ec05887a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_59f2f4d6-e196-48b4-97f1-c07bc3edcaa3" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_598bae19-b044-42bb-8085-be66ec05887a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_782c9012-bea7-4521-971c-0ba416df9a5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_598bae19-b044-42bb-8085-be66ec05887a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_782c9012-bea7-4521-971c-0ba416df9a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_92e29f8a-ab81-4549-abc5-1fb73cb2d26d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_782c9012-bea7-4521-971c-0ba416df9a5d" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_92e29f8a-ab81-4549-abc5-1fb73cb2d26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_ee2a5bfc-ea15-41af-b06d-7dd7b6df25c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_92e29f8a-ab81-4549-abc5-1fb73cb2d26d" xlink:to="loc_us-gaap_EmployeeStockOptionMember_ee2a5bfc-ea15-41af-b06d-7dd7b6df25c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_ff08b2fc-f40a-46ef-8108-f37fe25262ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_92e29f8a-ab81-4549-abc5-1fb73cb2d26d" xlink:to="loc_us-gaap_PerformanceSharesMember_ff08b2fc-f40a-46ef-8108-f37fe25262ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_UnvestedStockOptionsMember_c6067de3-6f66-48a2-8898-fb59573074fd" xlink:href="cvsi-20201231.xsd#cvsi_UnvestedStockOptionsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_92e29f8a-ab81-4549-abc5-1fb73cb2d26d" xlink:to="loc_cvsi_UnvestedStockOptionsMember_c6067de3-6f66-48a2-8898-fb59573074fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_483745f3-338c-4d1c-a8ce-575ecb213ad1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_598bae19-b044-42bb-8085-be66ec05887a" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_483745f3-338c-4d1c-a8ce-575ecb213ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d2dc0adf-fd2e-4e1b-aee3-b59147998f3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_483745f3-338c-4d1c-a8ce-575ecb213ad1" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d2dc0adf-fd2e-4e1b-aee3-b59147998f3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/RELATEDPARTIES" xlink:type="simple" xlink:href="cvsi-20201231.xsd#RELATEDPARTIES"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/RELATEDPARTIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_bc7b8fdd-716b-423d-869f-418db29b618d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_3fc9a2b8-2790-46d4-8319-43fe66c6ed22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_bc7b8fdd-716b-423d-869f-418db29b618d" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_3fc9a2b8-2790-46d4-8319-43fe66c6ed22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#RELATEDPARTIESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_e4eed6ea-55fc-4c4b-9a63-a7689e25c492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d130831d-1dfb-4faf-be32-7237bfedd530" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_e4eed6ea-55fc-4c4b-9a63-a7689e25c492" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d130831d-1dfb-4faf-be32-7237bfedd530" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cafc21bc-dada-458c-9d49-080a6e79816a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d130831d-1dfb-4faf-be32-7237bfedd530" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cafc21bc-dada-458c-9d49-080a6e79816a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_437b8b70-f49b-41d6-aaea-b96f43e92342" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_cafc21bc-dada-458c-9d49-080a6e79816a" xlink:to="loc_us-gaap_RelatedPartyDomain_437b8b70-f49b-41d6-aaea-b96f43e92342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_FormerPresidentandCEOMember_dbec99b9-eb34-40fb-9d52-5d353db545b1" xlink:href="cvsi-20201231.xsd#cvsi_FormerPresidentandCEOMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_437b8b70-f49b-41d6-aaea-b96f43e92342" xlink:to="loc_cvsi_FormerPresidentandCEOMember_dbec99b9-eb34-40fb-9d52-5d353db545b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_FormerChiefOperatingOfficerMember_4fe65959-12e0-4aaa-b677-5d04e34c2be1" xlink:href="cvsi-20201231.xsd#cvsi_FormerChiefOperatingOfficerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_437b8b70-f49b-41d6-aaea-b96f43e92342" xlink:to="loc_cvsi_FormerChiefOperatingOfficerMember_4fe65959-12e0-4aaa-b677-5d04e34c2be1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_30820050-d132-42b2-a0c3-30a065539d99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d130831d-1dfb-4faf-be32-7237bfedd530" xlink:to="loc_us-gaap_AwardTypeAxis_30820050-d132-42b2-a0c3-30a065539d99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ee85b47-708b-4de8-8e62-c4065a1cca68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_30820050-d132-42b2-a0c3-30a065539d99" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ee85b47-708b-4de8-8e62-c4065a1cca68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_92712368-a603-4da7-838b-a9db68710489" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ee85b47-708b-4de8-8e62-c4065a1cca68" xlink:to="loc_us-gaap_EmployeeStockOptionMember_92712368-a603-4da7-838b-a9db68710489" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_f05029a0-23b6-4bc5-8edd-92d16e2a1f02" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_8ee85b47-708b-4de8-8e62-c4065a1cca68" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_f05029a0-23b6-4bc5-8edd-92d16e2a1f02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_92f482d2-3b83-44fe-8c40-92f86d412544" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d130831d-1dfb-4faf-be32-7237bfedd530" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_92f482d2-3b83-44fe-8c40-92f86d412544" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_e799482f-5e43-4124-9750-0f89b1ef6f7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_92f482d2-3b83-44fe-8c40-92f86d412544" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_e799482f-5e43-4124-9750-0f89b1ef6f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9074fa79-cde8-4b66-a78a-35016b6eea39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_e799482f-5e43-4124-9750-0f89b1ef6f7e" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_9074fa79-cde8-4b66-a78a-35016b6eea39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationAxis_8c36a432-15d6-49a3-82f7-b62e16fdf561" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d130831d-1dfb-4faf-be32-7237bfedd530" xlink:to="loc_us-gaap_BalanceSheetLocationAxis_8c36a432-15d6-49a3-82f7-b62e16fdf561" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BalanceSheetLocationDomain_d8e11f9e-f4e9-4ec9-911f-b3a972b02fdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BalanceSheetLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationAxis_8c36a432-15d6-49a3-82f7-b62e16fdf561" xlink:to="loc_us-gaap_BalanceSheetLocationDomain_d8e11f9e-f4e9-4ec9-911f-b3a972b02fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesMember_fee06f55-89f5-4658-8e81-5aafcebdddfa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d8e11f9e-f4e9-4ec9-911f-b3a972b02fdb" xlink:to="loc_us-gaap_AccruedLiabilitiesMember_fee06f55-89f5-4658-8e81-5aafcebdddfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_7f51e028-3adf-4a41-9279-60f88d5249b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d8e11f9e-f4e9-4ec9-911f-b3a972b02fdb" xlink:to="loc_us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember_7f51e028-3adf-4a41-9279-60f88d5249b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesMember_9b4a4bba-1aeb-4e90-9cca-e4c8e468c409" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BalanceSheetLocationDomain_d8e11f9e-f4e9-4ec9-911f-b3a972b02fdb" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesMember_9b4a4bba-1aeb-4e90-9cca-e4c8e468c409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_d130831d-1dfb-4faf-be32-7237bfedd530" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod_bf02f658-0028-4a04-8d45-c3bfdead8c2a" xlink:href="cvsi-20201231.xsd#cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod_bf02f658-0028-4a04-8d45-c3bfdead8c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_fe873d81-ce6b-4827-b62c-a4e870fe2be8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_fe873d81-ce6b-4827-b62c-a4e870fe2be8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_bf4980ca-876c-4204-8fd6-f8d17d487d94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_bf4980ca-876c-4204-8fd6-f8d17d487d94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_33d4780a-63b0-4d92-9799-7ab5eace8b58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_33d4780a-63b0-4d92-9799-7ab5eace8b58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_8a1f6e98-44f3-4ae2-b29e-a785f0daa9b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_8a1f6e98-44f3-4ae2-b29e-a785f0daa9b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_a9131894-895b-491b-abbb-e2a25a57d332" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_a9131894-895b-491b-abbb-e2a25a57d332" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_71928952-cab1-464f-82b9-e93cb8ed627e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_71928952-cab1-464f-82b9-e93cb8ed627e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DueFromRelatedPartiesCurrent_ff5295d6-27a2-4e8b-a421-baab2334f25c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DueFromRelatedPartiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_us-gaap_DueFromRelatedPartiesCurrent_ff5295d6-27a2-4e8b-a421-baab2334f25c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_PayrollTaxExpense_d2028743-4281-4ff8-af2c-bb600f478b17" xlink:href="cvsi-20201231.xsd#cvsi_PayrollTaxExpense"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_cvsi_PayrollTaxExpense_d2028743-4281-4ff8-af2c-bb600f478b17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_AccruedPayrollTaxesCurrentEmployeePortion_30d3a4b7-88f6-4854-a9ad-8f03689c64df" xlink:href="cvsi-20201231.xsd#cvsi_AccruedPayrollTaxesCurrentEmployeePortion"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_cvsi_AccruedPayrollTaxesCurrentEmployeePortion_30d3a4b7-88f6-4854-a9ad-8f03689c64df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedPayrollTaxesCurrent_f47d9cc9-38d5-4d02-9154-e1f6e931e2a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedPayrollTaxesCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_us-gaap_AccruedPayrollTaxesCurrent_f47d9cc9-38d5-4d02-9154-e1f6e931e2a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForLoanAndLeaseLosses_d337ecbc-251e-4fc1-bc3b-7f8c584824fb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForLoanAndLeaseLosses"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_us-gaap_ProvisionForLoanAndLeaseLosses_d337ecbc-251e-4fc1-bc3b-7f8c584824fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_d110c9a7-5d3f-48b2-b399-eb8ce42dcf5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_59f9ab48-b6b5-405f-9b10-a057f8926f36" xlink:to="loc_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent_d110c9a7-5d3f-48b2-b399-eb8ce42dcf5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="simple" xlink:href="cvsi-20201231.xsd#COMMITMENTSANDCONTINGENCIES"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0eae573e-8e41-4e61-aeb2-a2ccfeefb39f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsDisclosureTextBlock_0d27e4bf-021b-4313-956c-9e87f81a46a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_0eae573e-8e41-4e61-aeb2-a2ccfeefb39f" xlink:to="loc_us-gaap_CommitmentsDisclosureTextBlock_0d27e4bf-021b-4313-956c-9e87f81a46a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIESLawsuitsDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#COMMITMENTSANDCONTINGENCIESLawsuitsDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIESLawsuitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a6d6cbe3-5990-4785-af0b-3cb63f2225ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesTable_08eee369-b40f-41bd-b59c-b7118c93ba2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a6d6cbe3-5990-4785-af0b-3cb63f2225ac" xlink:to="loc_us-gaap_LossContingenciesTable_08eee369-b40f-41bd-b59c-b7118c93ba2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseAxis_6470c17d-5134-421b-b31e-4510c76c1203" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_08eee369-b40f-41bd-b59c-b7118c93ba2c" xlink:to="loc_srt_LitigationCaseAxis_6470c17d-5134-421b-b31e-4510c76c1203" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LitigationCaseTypeDomain_dcecbc44-0110-4d1e-9b4d-69d8f3f3cd83" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LitigationCaseTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseAxis_6470c17d-5134-421b-b31e-4510c76c1203" xlink:to="loc_srt_LitigationCaseTypeDomain_dcecbc44-0110-4d1e-9b4d-69d8f3f3cd83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SmithComplaintMember_1b476055-c436-4bc8-9b0c-bbd1299b39c7" xlink:href="cvsi-20201231.xsd#cvsi_SmithComplaintMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_LitigationCaseTypeDomain_dcecbc44-0110-4d1e-9b4d-69d8f3f3cd83" xlink:to="loc_cvsi_SmithComplaintMember_1b476055-c436-4bc8-9b0c-bbd1299b39c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LossContingenciesLineItems_89d111df-849f-4bf6-bd4c-7b987aa4ce5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LossContingenciesLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesTable_08eee369-b40f-41bd-b59c-b7118c93ba2c" xlink:to="loc_us-gaap_LossContingenciesLineItems_89d111df-849f-4bf6-bd4c-7b987aa4ce5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_NumberofDerivativeLawsuits_b6b8a027-673d-4ca9-bb34-d7f1fa0d6fd7" xlink:href="cvsi-20201231.xsd#cvsi_NumberofDerivativeLawsuits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LossContingenciesLineItems_89d111df-849f-4bf6-bd4c-7b987aa4ce5b" xlink:to="loc_cvsi_NumberofDerivativeLawsuits_b6b8a027-673d-4ca9-bb34-d7f1fa0d6fd7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/LEASES" xlink:type="simple" xlink:href="cvsi-20201231.xsd#LEASES"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/LEASES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5ba75f6c-928d-421a-9bac-900e5dbf4fae" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_44669057-2a77-40d1-b20e-ffc2e0f6c3a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5ba75f6c-928d-421a-9bac-900e5dbf4fae" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_44669057-2a77-40d1-b20e-ffc2e0f6c3a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/LEASESTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#LEASESTables"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/LEASESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_080ad006-9b1f-41f1-8f26-77cffe4797dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_8b6694ac-8d2b-4bfa-a843-e2327500b98b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_080ad006-9b1f-41f1-8f26-77cffe4797dc" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_8b6694ac-8d2b-4bfa-a843-e2327500b98b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_8da06708-710e-44be-9e99-e21a7d38e986" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_080ad006-9b1f-41f1-8f26-77cffe4797dc" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_8da06708-710e-44be-9e99-e21a7d38e986" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/LEASESNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#LEASESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/LEASESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_612cfef1-ceac-4949-8cdc-c972bec28ef3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_c48e3c92-8754-427f-840e-15152356c3cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_612cfef1-ceac-4949-8cdc-c972bec28ef3" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_c48e3c92-8754-427f-840e-15152356c3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_2b7094cd-7704-4b4b-aa2b-5929859136cf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_c48e3c92-8754-427f-840e-15152356c3cf" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_2b7094cd-7704-4b4b-aa2b-5929859136cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_43c2c280-53b4-4e76-8f1c-13f609d5bc48" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis_2b7094cd-7704-4b4b-aa2b-5929859136cf" xlink:to="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_43c2c280-53b4-4e76-8f1c-13f609d5bc48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SanDiegoFacilityMember_5c17d64a-fbc8-4ef1-9296-a2e0fe1bafd3" xlink:href="cvsi-20201231.xsd#cvsi_SanDiegoFacilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain_43c2c280-53b4-4e76-8f1c-13f609d5bc48" xlink:to="loc_cvsi_SanDiegoFacilityMember_5c17d64a-fbc8-4ef1-9296-a2e0fe1bafd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_75c636da-1390-4fc1-858c-5dedd9bd3772" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_c48e3c92-8754-427f-840e-15152356c3cf" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_75c636da-1390-4fc1-858c-5dedd9bd3772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_NumberOfLeaseTerminationAgreements_54662e23-0e3c-4b25-ad1d-4e090df9063d" xlink:href="cvsi-20201231.xsd#cvsi_NumberOfLeaseTerminationAgreements"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75c636da-1390-4fc1-858c-5dedd9bd3772" xlink:to="loc_cvsi_NumberOfLeaseTerminationAgreements_54662e23-0e3c-4b25-ad1d-4e090df9063d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_55180a2e-3e30-46d1-94d2-953b1ddd5ec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75c636da-1390-4fc1-858c-5dedd9bd3772" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_55180a2e-3e30-46d1-94d2-953b1ddd5ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_e230f22e-4d2c-46ba-9d64-c3f1f43e48b2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75c636da-1390-4fc1-858c-5dedd9bd3772" xlink:to="loc_us-gaap_OperatingLeaseLiability_e230f22e-4d2c-46ba-9d64-c3f1f43e48b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnTerminationOfLease_d98861aa-0eb0-47d3-903b-29ef4fc86ee1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnTerminationOfLease"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75c636da-1390-4fc1-858c-5dedd9bd3772" xlink:to="loc_us-gaap_GainLossOnTerminationOfLease_d98861aa-0eb0-47d3-903b-29ef4fc86ee1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_211dd8d3-292d-49f2-bc4f-5591a3bd5b8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75c636da-1390-4fc1-858c-5dedd9bd3772" xlink:to="loc_us-gaap_LeaseCost_211dd8d3-292d-49f2-bc4f-5591a3bd5b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_ea0c7e59-c282-4fb8-a6ff-c2bb32651807" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_75c636da-1390-4fc1-858c-5dedd9bd3772" xlink:to="loc_us-gaap_OperatingLeasePayments_ea0c7e59-c282-4fb8-a6ff-c2bb32651807" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/LEASESRightofuseAssetsandLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#LEASESRightofuseAssetsandLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/LEASESRightofuseAssetsandLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_5ef45240-01f0-4f6e-b69c-f6dc4e55ba74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_6fb489fa-28e1-4b05-bf74-0c7a3d41c2be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5ef45240-01f0-4f6e-b69c-f6dc4e55ba74" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_6fb489fa-28e1-4b05-bf74-0c7a3d41c2be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_43ce3c09-8cef-4721-9de4-2e68635e5979" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_5ef45240-01f0-4f6e-b69c-f6dc4e55ba74" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_43ce3c09-8cef-4721-9de4-2e68635e5979" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#LEASESMaturityofLeaseLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_afa7ff01-97bc-465d-b716-dd55035c7873" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_e9fdd1e2-1f42-445a-aaaf-eb7f3daf11d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_afa7ff01-97bc-465d-b716-dd55035c7873" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths_e9fdd1e2-1f42-445a-aaaf-eb7f3daf11d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_d5f8ef3d-098f-4816-af00-c2fdba6e4507" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_afa7ff01-97bc-465d-b716-dd55035c7873" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo_d5f8ef3d-098f-4816-af00-c2fdba6e4507" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_9ca60fdb-e50c-452f-a883-265955440a50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_afa7ff01-97bc-465d-b716-dd55035c7873" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree_9ca60fdb-e50c-452f-a883-265955440a50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_ab49e4b8-6b67-4fff-a6bd-2bc70d4839cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_afa7ff01-97bc-465d-b716-dd55035c7873" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour_ab49e4b8-6b67-4fff-a6bd-2bc70d4839cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_0b0a23c5-9031-47a8-adfe-0489be5fb349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_afa7ff01-97bc-465d-b716-dd55035c7873" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive_0b0a23c5-9031-47a8-adfe-0489be5fb349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_9af54f4b-029b-49e5-8e2c-184de7f49b28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_afa7ff01-97bc-465d-b716-dd55035c7873" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive_9af54f4b-029b-49e5-8e2c-184de7f49b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1f705174-b400-424e-a17c-d804d3375451" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_afa7ff01-97bc-465d-b716-dd55035c7873" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1f705174-b400-424e-a17c-d804d3375451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d21b4e49-3cd8-44b2-8cd6-5ff95bab3350" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_afa7ff01-97bc-465d-b716-dd55035c7873" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_d21b4e49-3cd8-44b2-8cd6-5ff95bab3350" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_8dccddd8-b010-4f41-b8dd-11869167d268" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_afa7ff01-97bc-465d-b716-dd55035c7873" xlink:to="loc_us-gaap_OperatingLeaseLiability_8dccddd8-b010-4f41-b8dd-11869167d268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_c24a923c-8eb6-4464-a449-67744e3f2876" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_afa7ff01-97bc-465d-b716-dd55035c7873" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_c24a923c-8eb6-4464-a449-67744e3f2876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_24f076ed-bd6e-431e-ae9d-6023e29d1f4e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_afa7ff01-97bc-465d-b716-dd55035c7873" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_24f076ed-bd6e-431e-ae9d-6023e29d1f4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails_1" xlink:type="simple" xlink:href="cvsi-20201231.xsd#LEASESMaturityofLeaseLiabilitiesDetails_1"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://cvsciences.com/role/SEGMENTINFORMATION" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SEGMENTINFORMATION"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/SEGMENTINFORMATION" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_0e47e470-9ff7-4dea-ab25-892daad45a18" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_42c28ee2-afad-4286-bdc1-27b6c8352fe8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_0e47e470-9ff7-4dea-ab25-892daad45a18" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_42c28ee2-afad-4286-bdc1-27b6c8352fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/SEGMENTINFORMATIONTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SEGMENTINFORMATIONTables"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/SEGMENTINFORMATIONTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_8d785595-a554-4da9-ba5f-60f02eb0af17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_26807baf-4732-45e7-ae09-d795568a5349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8d785595-a554-4da9-ba5f-60f02eb0af17" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock_26807baf-4732-45e7-ae09-d795568a5349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/SEGMENTINFORMATIONDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SEGMENTINFORMATIONDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/SEGMENTINFORMATIONDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ecea78c3-d102-4c6b-974f-e39b0c447c7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_528a4957-e2cf-4058-ab9d-bfddf8966f84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ecea78c3-d102-4c6b-974f-e39b0c447c7b" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_528a4957-e2cf-4058-ab9d-bfddf8966f84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementBusinessSegmentsAxis_568984d4-83de-4606-8ad1-46af4d018c57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementBusinessSegmentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_528a4957-e2cf-4058-ab9d-bfddf8966f84" xlink:to="loc_us-gaap_StatementBusinessSegmentsAxis_568984d4-83de-4606-8ad1-46af4d018c57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentDomain_2263e8eb-f610-473c-9ddd-4c42cfcf74ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementBusinessSegmentsAxis_568984d4-83de-4606-8ad1-46af4d018c57" xlink:to="loc_us-gaap_SegmentDomain_2263e8eb-f610-473c-9ddd-4c42cfcf74ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_ConsumerProductsMember_6f429738-3458-4b86-8da5-d4d4b23cb0ef" xlink:href="cvsi-20201231.xsd#cvsi_ConsumerProductsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2263e8eb-f610-473c-9ddd-4c42cfcf74ad" xlink:to="loc_cvsi_ConsumerProductsMember_6f429738-3458-4b86-8da5-d4d4b23cb0ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SpecialtyPharmaceuticalsMember_ee1736ee-822d-4cb5-afa9-6eeb1b732337" xlink:href="cvsi-20201231.xsd#cvsi_SpecialtyPharmaceuticalsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentDomain_2263e8eb-f610-473c-9ddd-4c42cfcf74ad" xlink:to="loc_cvsi_SpecialtyPharmaceuticalsMember_ee1736ee-822d-4cb5-afa9-6eeb1b732337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_22feee26-473b-45ed-9819-1e7eeac47e56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_528a4957-e2cf-4058-ab9d-bfddf8966f84" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_22feee26-473b-45ed-9819-1e7eeac47e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_1ba07450-99f9-4144-99e6-11b0e36286c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_22feee26-473b-45ed-9819-1e7eeac47e56" xlink:to="loc_us-gaap_NumberOfReportableSegments_1ba07450-99f9-4144-99e6-11b0e36286c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_146f1cd2-d706-437a-b9e6-a4cd4a1da7fd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_22feee26-473b-45ed-9819-1e7eeac47e56" xlink:to="loc_us-gaap_Revenues_146f1cd2-d706-437a-b9e6-a4cd4a1da7fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_026edd4b-7ea3-4d97-9218-a70c56ef67b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_22feee26-473b-45ed-9819-1e7eeac47e56" xlink:to="loc_us-gaap_GrossProfit_026edd4b-7ea3-4d97-9218-a70c56ef67b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_14f6b690-d156-4fe4-84f6-55a38f94c9ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_22feee26-473b-45ed-9819-1e7eeac47e56" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_14f6b690-d156-4fe4-84f6-55a38f94c9ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_adf2881b-7c98-469f-8597-49e9ae0062f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_22feee26-473b-45ed-9819-1e7eeac47e56" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_adf2881b-7c98-469f-8597-49e9ae0062f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5fa9a16f-3971-468f-9687-3fa7376099ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_22feee26-473b-45ed-9819-1e7eeac47e56" xlink:to="loc_us-gaap_OperatingIncomeLoss_5fa9a16f-3971-468f-9687-3fa7376099ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_fe1691bb-61bb-4d47-b0c9-f501dd104f4d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_22feee26-473b-45ed-9819-1e7eeac47e56" xlink:to="loc_us-gaap_Goodwill_fe1691bb-61bb-4d47-b0c9-f501dd104f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2c07a359-61dd-4824-ad80-63fc1c3413ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_22feee26-473b-45ed-9819-1e7eeac47e56" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2c07a359-61dd-4824-ad80-63fc1c3413ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INCOMETAXES" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INCOMETAXES"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/INCOMETAXES" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_46a6437e-05e3-4925-9467-213df6f11985" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_ee97a033-4364-4e34-8708-644823776aa7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_46a6437e-05e3-4925-9467-213df6f11985" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_ee97a033-4364-4e34-8708-644823776aa7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INCOMETAXESTables" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INCOMETAXESTables"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/INCOMETAXESTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_d49b4abb-5733-40d4-ac92-44d55cfc93f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_eca8a1fd-a7d6-4709-8cd5-f8df32b0f6dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d49b4abb-5733-40d4-ac92-44d55cfc93f2" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_eca8a1fd-a7d6-4709-8cd5-f8df32b0f6dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1f89a43c-a5df-42a6-b0fe-81d2614567aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d49b4abb-5733-40d4-ac92-44d55cfc93f2" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_1f89a43c-a5df-42a6-b0fe-81d2614567aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_4d978728-da4d-4fc7-8990-3ed6bf6b7b96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d49b4abb-5733-40d4-ac92-44d55cfc93f2" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_4d978728-da4d-4fc7-8990-3ed6bf6b7b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_23e5a86f-8177-44cd-a786-de096193cc2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_d49b4abb-5733-40d4-ac92-44d55cfc93f2" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_23e5a86f-8177-44cd-a786-de096193cc2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_0a13ebd8-7ca6-46c0-9ac8-63ad762da9f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b3d57d48-9969-4888-b7be-2f44cc87a7a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0a13ebd8-7ca6-46c0-9ac8-63ad762da9f6" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b3d57d48-9969-4888-b7be-2f44cc87a7a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_dc43ebdd-f493-40a1-b735-3a21bdbe7fd0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b3d57d48-9969-4888-b7be-2f44cc87a7a6" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_dc43ebdd-f493-40a1-b735-3a21bdbe7fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_3136505f-5bd9-4319-85a5-1695bca9ed05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_b3d57d48-9969-4888-b7be-2f44cc87a7a6" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_3136505f-5bd9-4319-85a5-1695bca9ed05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e402532f-745b-465b-a60b-c532a9a05f39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0a13ebd8-7ca6-46c0-9ac8-63ad762da9f6" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_e402532f-745b-465b-a60b-c532a9a05f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d764d822-2b9b-42fa-b005-56721953c00b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0a13ebd8-7ca6-46c0-9ac8-63ad762da9f6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d764d822-2b9b-42fa-b005-56721953c00b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_d52e4165-b759-4123-8676-2705d02227dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d764d822-2b9b-42fa-b005-56721953c00b" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_d52e4165-b759-4123-8676-2705d02227dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_bd2b457c-296d-4f3f-9a19-303934be0a89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_d764d822-2b9b-42fa-b005-56721953c00b" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_bd2b457c-296d-4f3f-9a19-303934be0a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3611f82f-59b3-41fe-bf01-5a1a150c3524" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0a13ebd8-7ca6-46c0-9ac8-63ad762da9f6" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_3611f82f-59b3-41fe-bf01-5a1a150c3524" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1c29c94a-1238-4529-904d-b568d2750741" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_0a13ebd8-7ca6-46c0-9ac8-63ad762da9f6" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1c29c94a-1238-4529-904d-b568d2750741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INCOMETAXESIncomeTaxProvisionDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_1a841a09-f88f-4bf3-9962-392b365484bd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_a3778e12-feea-4871-860a-7ef162006b46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1a841a09-f88f-4bf3-9962-392b365484bd" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_a3778e12-feea-4871-860a-7ef162006b46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_696c0837-d5ba-465d-883d-7056082f2989" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_a3778e12-feea-4871-860a-7ef162006b46" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_696c0837-d5ba-465d-883d-7056082f2989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_0eaf7bcd-3956-4e67-9e09-022cbf941b28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_a3778e12-feea-4871-860a-7ef162006b46" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_0eaf7bcd-3956-4e67-9e09-022cbf941b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_51e025a2-8701-4dad-95b2-6ac32118e7c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_a3778e12-feea-4871-860a-7ef162006b46" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther_51e025a2-8701-4dad-95b2-6ac32118e7c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_fd391fda-ac62-457f-be3a-cd72f56d6951" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_a3778e12-feea-4871-860a-7ef162006b46" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_fd391fda-ac62-457f-be3a-cd72f56d6951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation_bfefd74a-805d-4a56-9020-9f6de89179ed" xlink:href="cvsi-20201231.xsd#cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_a3778e12-feea-4871-860a-7ef162006b46" xlink:to="loc_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation_bfefd74a-805d-4a56-9020-9f6de89179ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_c5f72d50-8448-4f39-8664-93a1250d90b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_a3778e12-feea-4871-860a-7ef162006b46" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_c5f72d50-8448-4f39-8664-93a1250d90b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_61b0207e-f343-48e5-9055-377c2f5e03ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_a3778e12-feea-4871-860a-7ef162006b46" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_61b0207e-f343-48e5-9055-377c2f5e03ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_736922fa-674a-4625-bbac-6ed6adb2363b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_a3778e12-feea-4871-860a-7ef162006b46" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_736922fa-674a-4625-bbac-6ed6adb2363b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_02ee8c91-2017-42b0-be25-c4c63363ff93" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_a3778e12-feea-4871-860a-7ef162006b46" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_02ee8c91-2017-42b0-be25-c4c63363ff93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_6b35e7a6-dfac-4841-a7cc-e31e8500c2cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_1a841a09-f88f-4bf3-9962-392b365484bd" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_6b35e7a6-dfac-4841-a7cc-e31e8500c2cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_6df90c9a-ace8-44b7-b3ff-b5777a44220d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_6b35e7a6-dfac-4841-a7cc-e31e8500c2cf" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_6df90c9a-ace8-44b7-b3ff-b5777a44220d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_f24108d6-8c7f-4d93-9fcd-6633dc9f2c51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_6b35e7a6-dfac-4841-a7cc-e31e8500c2cf" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_f24108d6-8c7f-4d93-9fcd-6633dc9f2c51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_40b95b9e-9a13-45a1-b33b-b7b385ebbadb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_6b35e7a6-dfac-4841-a7cc-e31e8500c2cf" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther_40b95b9e-9a13-45a1-b33b-b7b385ebbadb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_6a0451c2-9c87-45ff-b77a-a22441c83f9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_6b35e7a6-dfac-4841-a7cc-e31e8500c2cf" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_6a0451c2-9c87-45ff-b77a-a22441c83f9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent_ee47fecf-e154-468f-8759-44b675a85dc7" xlink:href="cvsi-20201231.xsd#cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_6b35e7a6-dfac-4841-a7cc-e31e8500c2cf" xlink:to="loc_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent_ee47fecf-e154-468f-8759-44b675a85dc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_dfc5a9c8-57d7-4188-b430-8c35e468db98" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_6b35e7a6-dfac-4841-a7cc-e31e8500c2cf" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_dfc5a9c8-57d7-4188-b430-8c35e468db98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_857b16a9-bd2d-4d15-8d34-3a2e1224dd3f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_6b35e7a6-dfac-4841-a7cc-e31e8500c2cf" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_857b16a9-bd2d-4d15-8d34-3a2e1224dd3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_16b702de-ec2d-4f16-be31-deb944db617d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_6b35e7a6-dfac-4841-a7cc-e31e8500c2cf" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_16b702de-ec2d-4f16-be31-deb944db617d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_41d0b712-ba24-40c9-807d-cbda433c50f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectiveIncomeTaxRateContinuingOperations"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract_6b35e7a6-dfac-4841-a7cc-e31e8500c2cf" xlink:to="loc_us-gaap_EffectiveIncomeTaxRateContinuingOperations_41d0b712-ba24-40c9-807d-cbda433c50f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INCOMETAXESDeferredIncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_dac6e301-96a0-4b53-b65c-2250b2737b6d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxesAbstract_90affd1b-f524-4edd-99ae-2cc21c2aa6a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dac6e301-96a0-4b53-b65c-2250b2737b6d" xlink:to="loc_us-gaap_DeferredIncomeTaxesAbstract_90affd1b-f524-4edd-99ae-2cc21c2aa6a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_64163bbc-e465-4199-b749-4e1aa5337036" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxesAbstract_90affd1b-f524-4edd-99ae-2cc21c2aa6a3" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_64163bbc-e465-4199-b749-4e1aa5337036" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness_d2525de5-dc6e-4574-a22d-a38963e68479" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxesAbstract_90affd1b-f524-4edd-99ae-2cc21c2aa6a3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness_d2525de5-dc6e-4574-a22d-a38963e68479" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_febd0194-c46b-4797-95da-f0d860b772cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxesAbstract_90affd1b-f524-4edd-99ae-2cc21c2aa6a3" xlink:to="loc_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets_febd0194-c46b-4797-95da-f0d860b772cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_ec162281-be11-4729-972b-80516276729b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxesAbstract_90affd1b-f524-4edd-99ae-2cc21c2aa6a3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_ec162281-be11-4729-972b-80516276729b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInventory_487ba0da-6259-4780-96f5-d6e1a4905c14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsInventory"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxesAbstract_90affd1b-f524-4edd-99ae-2cc21c2aa6a3" xlink:to="loc_us-gaap_DeferredTaxAssetsInventory_487ba0da-6259-4780-96f5-d6e1a4905c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_DeferredTaxAssetOperatingLeaseLiabilities_4fe186c0-c385-46c9-9f04-c34a870eb7a9" xlink:href="cvsi-20201231.xsd#cvsi_DeferredTaxAssetOperatingLeaseLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxesAbstract_90affd1b-f524-4edd-99ae-2cc21c2aa6a3" xlink:to="loc_cvsi_DeferredTaxAssetOperatingLeaseLiabilities_4fe186c0-c385-46c9-9f04-c34a870eb7a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_d65bea25-0926-43b2-896e-4c56e2430fc2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxesAbstract_90affd1b-f524-4edd-99ae-2cc21c2aa6a3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals_d65bea25-0926-43b2-896e-4c56e2430fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_aa9d6454-b43b-4c35-ad79-ac8e53c81dc5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxesAbstract_90affd1b-f524-4edd-99ae-2cc21c2aa6a3" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_aa9d6454-b43b-4c35-ad79-ac8e53c81dc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_d763dc27-39b8-4844-bdcc-c7a39212ea51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dac6e301-96a0-4b53-b65c-2250b2737b6d" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_d763dc27-39b8-4844-bdcc-c7a39212ea51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_DeferredTaxLiabilityOperatingLeaseAssets_f8ccc176-f0b5-4ee7-9b03-21fe606c5409" xlink:href="cvsi-20201231.xsd#cvsi_DeferredTaxLiabilityOperatingLeaseAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_d763dc27-39b8-4844-bdcc-c7a39212ea51" xlink:to="loc_cvsi_DeferredTaxLiabilityOperatingLeaseAssets_f8ccc176-f0b5-4ee7-9b03-21fe606c5409" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_fcb1b0a5-bb03-4294-a783-cb8cba7cc0d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_d763dc27-39b8-4844-bdcc-c7a39212ea51" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment_fcb1b0a5-bb03-4294-a783-cb8cba7cc0d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_40d91f9f-6e96-43d8-93c1-2380d7966886" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_d763dc27-39b8-4844-bdcc-c7a39212ea51" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets_40d91f9f-6e96-43d8-93c1-2380d7966886" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_195c46d5-96e0-42eb-ac52-f3a1b587fdf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_d763dc27-39b8-4844-bdcc-c7a39212ea51" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_195c46d5-96e0-42eb-ac52-f3a1b587fdf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_07af81ef-c730-4782-bd01-7a6b06d48df1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_d763dc27-39b8-4844-bdcc-c7a39212ea51" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_07af81ef-c730-4782-bd01-7a6b06d48df1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0bbef1da-3559-4053-a316-a07bdd075549" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dac6e301-96a0-4b53-b65c-2250b2737b6d" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_0bbef1da-3559-4053-a316-a07bdd075549" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2a03e420-60e8-4189-bd5f-63eac5ebb074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredIncomeTaxLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_dac6e301-96a0-4b53-b65c-2250b2737b6d" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilitiesNet_2a03e420-60e8-4189-bd5f-63eac5ebb074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INCOMETAXESNarrativeDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INCOMETAXESNarrativeDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/INCOMETAXESNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_78574484-9329-4fd2-b162-138c44d79e22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_a3843c4d-8585-44a1-9e95-acb3a2e17f0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_78574484-9329-4fd2-b162-138c44d79e22" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_a3843c4d-8585-44a1-9e95-acb3a2e17f0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_dd80946a-ef2c-4cfb-ad0a-3cf371fd402e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_a3843c4d-8585-44a1-9e95-acb3a2e17f0f" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_dd80946a-ef2c-4cfb-ad0a-3cf371fd402e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_ea4e938b-3d92-42ab-bd4c-3040bb820d77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_dd80946a-ef2c-4cfb-ad0a-3cf371fd402e" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_ea4e938b-3d92-42ab-bd4c-3040bb820d77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_29d2068b-51a4-461d-bc58-da19f29a61ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ea4e938b-3d92-42ab-bd4c-3040bb820d77" xlink:to="loc_us-gaap_DomesticCountryMember_29d2068b-51a4-461d-bc58-da19f29a61ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_8d110141-4aab-4d5f-bbca-e02b7dd381f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_ea4e938b-3d92-42ab-bd4c-3040bb820d77" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_8d110141-4aab-4d5f-bbca-e02b7dd381f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameAxis_95500d9b-53b5-46d8-b203-e2c4ec5b7c1a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_a3843c4d-8585-44a1-9e95-acb3a2e17f0f" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameAxis_95500d9b-53b5-46d8-b203-e2c4ec5b7c1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityNameDomain_059f2bb6-f141-417c-8161-bb61a562e582" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxAuthorityNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameAxis_95500d9b-53b5-46d8-b203-e2c4ec5b7c1a" xlink:to="loc_us-gaap_IncomeTaxAuthorityNameDomain_059f2bb6-f141-417c-8161-bb61a562e582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_6932ad09-1481-4a5f-b259-1cd1f416250f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CaliforniaFranchiseTaxBoardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_059f2bb6-f141-417c-8161-bb61a562e582" xlink:to="loc_us-gaap_CaliforniaFranchiseTaxBoardMember_6932ad09-1481-4a5f-b259-1cd1f416250f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_StatesOtherThanCaliforniaMember_7abf19b3-8119-406a-978c-f6d2b6579ee0" xlink:href="cvsi-20201231.xsd#cvsi_StatesOtherThanCaliforniaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityNameDomain_059f2bb6-f141-417c-8161-bb61a562e582" xlink:to="loc_cvsi_StatesOtherThanCaliforniaMember_7abf19b3-8119-406a-978c-f6d2b6579ee0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodAxis_a821f344-c88d-45e2-b529-ef467d4c086b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_a3843c4d-8585-44a1-9e95-acb3a2e17f0f" xlink:to="loc_us-gaap_TaxPeriodAxis_a821f344-c88d-45e2-b529-ef467d4c086b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxPeriodDomain_886b5e0b-deb4-408c-a9c7-e63896cf9937" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TaxPeriodDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodAxis_a821f344-c88d-45e2-b529-ef467d4c086b" xlink:to="loc_us-gaap_TaxPeriodDomain_886b5e0b-deb4-408c-a9c7-e63896cf9937" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_After2017Member_b91f941e-45f8-4605-b142-56ac3bae0acf" xlink:href="cvsi-20201231.xsd#cvsi_After2017Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_886b5e0b-deb4-408c-a9c7-e63896cf9937" xlink:to="loc_cvsi_After2017Member_b91f941e-45f8-4605-b142-56ac3bae0acf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_Before2018Member_ed4e50fe-5568-4f9a-ac0a-091e79d22e9e" xlink:href="cvsi-20201231.xsd#cvsi_Before2018Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxPeriodDomain_886b5e0b-deb4-408c-a9c7-e63896cf9937" xlink:to="loc_cvsi_Before2018Member_ed4e50fe-5568-4f9a-ac0a-091e79d22e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_7e4d1da3-62b0-4bdf-b3aa-75b14bc33d4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_a3843c4d-8585-44a1-9e95-acb3a2e17f0f" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_7e4d1da3-62b0-4bdf-b3aa-75b14bc33d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_08eb832f-b061-43cb-b457-787feba5d916" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_7e4d1da3-62b0-4bdf-b3aa-75b14bc33d4a" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_08eb832f-b061-43cb-b457-787feba5d916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_97e45449-028d-4f11-bb3d-88c8270c8c14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_7e4d1da3-62b0-4bdf-b3aa-75b14bc33d4a" xlink:to="loc_us-gaap_OperatingLossCarryforwards_97e45449-028d-4f11-bb3d-88c8270c8c14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_11834c5f-cdf3-4ea5-8f9d-bbf3349c597e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_7e4d1da3-62b0-4bdf-b3aa-75b14bc33d4a" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_11834c5f-cdf3-4ea5-8f9d-bbf3349c597e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/INCOMETAXESUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#INCOMETAXESUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/INCOMETAXESUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8a85deb9-1293-4669-9b89-43fd758c5b03" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_87bb4c7c-e5d4-463f-9377-ad9c6c7a432a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8a85deb9-1293-4669-9b89-43fd758c5b03" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_87bb4c7c-e5d4-463f-9377-ad9c6c7a432a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_040d6019-1660-4084-b6e0-013d349b963d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_87bb4c7c-e5d4-463f-9377-ad9c6c7a432a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_040d6019-1660-4084-b6e0-013d349b963d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_c6fe8442-4369-432e-8796-4bf6335b9922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_87bb4c7c-e5d4-463f-9377-ad9c6c7a432a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_c6fe8442-4369-432e-8796-4bf6335b9922" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_60eba069-e544-4911-8f5e-5a99dc32c110" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_87bb4c7c-e5d4-463f-9377-ad9c6c7a432a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_60eba069-e544-4911-8f5e-5a99dc32c110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_80fb7920-2419-439e-8ff1-d6c1a2cfa447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_87bb4c7c-e5d4-463f-9377-ad9c6c7a432a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_80fb7920-2419-439e-8ff1-d6c1a2cfa447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_772c5365-94cf-4814-be26-708c8f9f54a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_87bb4c7c-e5d4-463f-9377-ad9c6c7a432a" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_772c5365-94cf-4814-be26-708c8f9f54a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/SUBSEQUENTEVENT" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUBSEQUENTEVENT"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/SUBSEQUENTEVENT" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_4c89ab6c-d7af-4b0f-86c7-1b39a0fd1974" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_2e30e696-6c00-4b08-a7e2-3157723f5bc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_4c89ab6c-d7af-4b0f-86c7-1b39a0fd1974" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_2e30e696-6c00-4b08-a7e2-3157723f5bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://cvsciences.com/role/SUBSEQUENTEVENTDetails" xlink:type="simple" xlink:href="cvsi-20201231.xsd#SUBSEQUENTEVENTDetails"/>
  <link:presentationLink xlink:role="http://cvsciences.com/role/SUBSEQUENTEVENTDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_f86cfe86-ada0-410a-80fe-115e1f279377" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_a4d55443-b1fd-48a1-953b-fb6359f8f881" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_f86cfe86-ada0-410a-80fe-115e1f279377" xlink:to="loc_us-gaap_SubsequentEventTable_a4d55443-b1fd-48a1-953b-fb6359f8f881" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_8544a997-aa04-4f2c-9a2b-db9f07b95dc3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a4d55443-b1fd-48a1-953b-fb6359f8f881" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_8544a997-aa04-4f2c-9a2b-db9f07b95dc3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_4d51ff5e-1d27-4821-9dc2-7c5f69c568a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_8544a997-aa04-4f2c-9a2b-db9f07b95dc3" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_4d51ff5e-1d27-4821-9dc2-7c5f69c568a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_90dd635a-c8a2-4be2-864f-23f24964e63c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_4d51ff5e-1d27-4821-9dc2-7c5f69c568a3" xlink:to="loc_us-gaap_SubsequentEventMember_90dd635a-c8a2-4be2-864f-23f24964e63c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_2789a3d8-fc56-4621-b25f-fe2154d5eb1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a4d55443-b1fd-48a1-953b-fb6359f8f881" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_2789a3d8-fc56-4621-b25f-fe2154d5eb1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f34107f-afad-463b-834a-07da914a8834" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_2789a3d8-fc56-4621-b25f-fe2154d5eb1e" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f34107f-afad-463b-834a-07da914a8834" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_CommonStockPurchaseAgreementMember_6c92ad05-f388-4fca-a553-69e51f8b5948" xlink:href="cvsi-20201231.xsd#cvsi_CommonStockPurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_6f34107f-afad-463b-834a-07da914a8834" xlink:to="loc_cvsi_CommonStockPurchaseAgreementMember_6c92ad05-f388-4fca-a553-69e51f8b5948" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_2936c9a4-4259-4f37-84ae-e9a34f690e9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_a4d55443-b1fd-48a1-953b-fb6359f8f881" xlink:to="loc_us-gaap_SubsequentEventLineItems_2936c9a4-4259-4f37-84ae-e9a34f690e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_fc56a6cd-bc40-471c-ba5b-0644f6ece452" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_2936c9a4-4259-4f37-84ae-e9a34f690e9e" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_fc56a6cd-bc40-471c-ba5b-0644f6ece452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_17868f14-6f4e-4adf-bc7c-64b884c82c6a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_2936c9a4-4259-4f37-84ae-e9a34f690e9e" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_17868f14-6f4e-4adf-bc7c-64b884c82c6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_cvsi_SaleOfStockWeightedAveragePricePerShare_7bc5029c-d40a-49da-9b16-4293424ed73d" xlink:href="cvsi-20201231.xsd#cvsi_SaleOfStockWeightedAveragePricePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_2936c9a4-4259-4f37-84ae-e9a34f690e9e" xlink:to="loc_cvsi_SaleOfStockWeightedAveragePricePerShare_7bc5029c-d40a-49da-9b16-4293424ed73d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>cvsi-20201231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:cvsi="http://cvsciences.com/20201231"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="cvsi-20201231.xsd" xlink:type="simple"/>
    <context id="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ieb170334852144ef80f82c113af94f9a_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="i1aa88da6c8d9457692e0febdb65cb1cf_I20210316">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
        </entity>
        <period>
            <instant>2021-03-16</instant>
        </period>
    </context>
    <context id="i95335529356f4afbb8b76a88b727d1d2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib68a40c3668644fc87db08988f699fec_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i131f52df83994257bc0a0cfa19c3a287_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i7937d2f589d84d8fb67618c8a842735b_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i6e7fe9b796a34c8bb8a1612cb22866da_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ifc2c804db67543dd84291701c746b6fa_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="i8ff8bfc5f83647a4892aab327120d79e_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7cbd69ac9b3b4f10a86a91c48e412fad_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id718b729adc144caa3a6bf9c95dc04de_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i162f6e60104546399b0dd90dbead19b3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i37c881596124431c92dfe85bd94a4cea_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ib0027a2179d842fe82581b40a11ca56d_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4789842d4b954973b49e7fed17e8c8eb_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i05bf25010f5e4bfc8fdea3b99d63f2ba_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i421a1d1328f941c893389dbf40b7b314_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3c2ab9e7b8f8470ca661e005ae40f9cb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if96d39e36198411b85070b25ac1ee3f6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i598932caa7504ab8a4125324d9bbd23d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia430bcca043b4606a1c759ed7eaa8883_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:OwnershipAxis">cvsi:CannaVestEuropeGmbHMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1eb2e25e3bc14d80a5c0329eebbc85a5_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if5456eaf29c94cbf9434311c42b7d007_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i3019b5e0eea94dff87d9cf02a903f261_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3100b80a9d7c4d53bf9d8e711e804a24_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i796f849901b445a9a1017431e7f0feb3_D20200417-20200417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
        </entity>
        <period>
            <startDate>2020-04-17</startDate>
            <endDate>2020-04-17</endDate>
        </period>
    </context>
    <context id="i5ce71eb8f7d045f680a63998d5ebc762_D20201208-20201208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cvsi:CommonStockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-08</startDate>
            <endDate>2020-12-08</endDate>
        </period>
    </context>
    <context id="if01f3c8b8a7e46bfb048274a7d4ddc6a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2f6446e2781145b58aadd810c3831360_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if8aa597259fe4304b7b63ce40ce227b4_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvsi:RetailFDMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ie7864245a6d34e58aacbabaa8179f74f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvsi:RetailFDMMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i70f9d718799644699f10f809156bd286_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvsi:RetailNaturalProductsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if54d7cb037ac4f8e8327ff809a2b2c0f_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvsi:RetailNaturalProductsAndOtherMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="if3d15c156ba349c48d60f8791891481a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvsi:ECommMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="icf894d15f551418abe1ae2f318b3c813_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">cvsi:ECommMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="iafc1a3c97c0d4080885871840e0654af_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvsi:ConsumerProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i4ab148dfa19a48ec9bfc7253afd2d8e0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvsi:ConsumerProductsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8c7e853cfb97488bafd77f77828becba_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvsi:SpecialtyPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ic13b530da3e44e4384e40cfb677c6d60_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvsi:SpecialtyPharmaceuticalSegmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i85b38ef36bb04db7be1a75cdedabb16e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i7a9055c1eb65417caab586e37cae413e_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i18b1bfee52e244df92d350109e304526_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if25ec98df6e64c53939bb7efcbfb124b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0d8eb0e4462f4dccb7cee6c898b097bf_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i80b463299c26463ca972ff8dfaeefa07_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id4f11b83791e4d0b89e930d959aa4d4c_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i052975c55e0d4a6d81b116eed98ad8ad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifeda5edcf0e343769d5a4ca6eb1ca2ad_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:OfficeEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i28b6a29ef2f34583975d18a2fb7b09a4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i934d7b1779574fc9bec6c9c0df80e88e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ia86834c02416429a998a484d9434a8e1_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sic:Z3821</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9518c9e514be4d70877b504c26d8c59d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sic:Z3821</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iba1ca127b1714615af145434271838ed_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">sic:Z3821</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="id25e838c282448c79258da27d6aefa6d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic1d3e49783f149a084f798c4590d9931_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i24523ddf355143439c1af05532a3151a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i78a46d9043e74a11aadbd6f65daf06f0_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie07b37afc2754e398a196bfcb6c55c30_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i46bcdf3737e4410c9206873ea3b39599_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0f8eb91898874f04aea260438b7f2aa9_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i86dca6f99d5c4d1297b510610a68e59e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:InProcessResearchAndDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i99b603840d5c471597402724690a24b2_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i4f83a0e15d4f46709af062728537490d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id6886463cfa747f2937d6827839da75e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9d576fcf864e471bb409eafe4c6155e0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:NoncompeteAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i5dfcb74883a1467d82e99d0d2ce81499_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cvsi:TaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i051b211947594052beb7406aed759748_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionAxis">cvsi:TaxLiabilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9869509e2682490b9a206064b3920d90_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvsi:PayrollProtectionProgramLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2f85a3238c7b4681b71554667cce5b1e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvsi:FirstInsuranceFundingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i27feea483e57465a9526919db75d6d01_D20200417-20200417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvsi:PayrollProtectionProgramLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-04-17</startDate>
            <endDate>2020-04-17</endDate>
        </period>
    </context>
    <context id="i0461202b2e27451b9b8caee714491a29_I20200417">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvsi:PayrollProtectionProgramLoanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:NotesPayableOtherPayablesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-04-17</instant>
        </period>
    </context>
    <context id="ie007d6f497f642ab81bc374925609676_I20181031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvsi:PremiumFinanceAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-10-31</instant>
        </period>
    </context>
    <context id="ibcfcb94673094dfa87f562c52cfef25e_D20181001-20181031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvsi:PremiumFinanceAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-10-31</endDate>
        </period>
    </context>
    <context id="i3a704f978fb548eca2e891c2407e5390_I20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvsi:FirstInsuranceFundingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="i794dcec76c204870a043fce5338d2a6f_D20201001-20201031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">cvsi:FirstInsuranceFundingMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:UnsecuredDebtMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="ia5dcf374512b4bb6ad637f627f49d3ca_I20201208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cvsi:CommonStockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-08</instant>
        </period>
    </context>
    <context id="i7e602472f0d2419187a53398197f884a_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cvsi:CommonStockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if6de0662d6994f7eb059488a08f7185c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvsi:Amended2013PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if9290810e4b94539b8af15efd7d0d1e5_I20190611">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvsi:Amended2013PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-11</instant>
        </period>
    </context>
    <context id="i74658c74a8c3444fa9b7905dcc912472_D20210101-20210101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvsi:Amended2013PlanMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-01-01</endDate>
        </period>
    </context>
    <context id="i32add06262af4753ba901af35fd023f3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvsi:Amended2013PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i57a9d80096aa464eac00c8580957daf0_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvsi:Amended2013PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i265c122e61ad44b2ba1101201ca25d44_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">cvsi:Amended2013PlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9ff3f55fc97e475b8bb8bc843ae1b0d2_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i910e3383f6764b46b22f1e9d7e5e1aa0_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:OperatingIncomeLossMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i2b8102c1b9274b8d837c6a3a9496441b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:TitleOfIndividualAxis">cvsi:FormerFoundersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="idfba81407b1f4dc7bb6ac7356bcb5b8f_D20200601-20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvsi:StockOptionModificationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-01</startDate>
            <endDate>2020-06-30</endDate>
        </period>
    </context>
    <context id="i632c0a45a9a741cfa8a17f0f306a9fe4_I20200630">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvsi:StockOptionModificationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-06-30</instant>
        </period>
    </context>
    <context id="ibfbe4fc0a05542b79480de4c56feef6f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i29ae30a4315946c0b52f15f8e6c4ed26_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="icffd0f08944b4303b75cda5726a991c1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:StockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ifec0d5d2e64345b7942f20ab0f15368e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">cvsi:OptionsOutsidePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i141553cffe3a4f4bbd6b47ebbf217e1b_D20190101-20190930">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-09-30</endDate>
        </period>
    </context>
    <context id="i928a711d627049609b68b71da873a14b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ic23cca2bec294144b5380b314f6c1bef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iea15e228d81c4928a6f435953afcbf22_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2f9d57085cfb485a90040682008ea5ab_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib7c5476be195460facee7c724fb5e3c7_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="iabb6a4dc10ab4561a4bd6c32f75acae6_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ibbef676a29a64d80a42a8bffab80309b_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvsi:UnvestedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i70dd93c7ed5b49f6acea67a36d5704e8_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">cvsi:UnvestedStockOptionsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i5b538a137f6741c3b99ad8296d75054d_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ifd0eb69ed84344f29547d2b900088211_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i2c8f78232aff43cb8627c3ae776e97a9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i60d2bb9447ef4e4897ab3d30bf70ebab_D20160701-20160731">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-07-01</startDate>
            <endDate>2016-07-31</endDate>
        </period>
    </context>
    <context id="ib232e5ef4b084e428542b0fef60816ab_D20170301-20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-03-01</startDate>
            <endDate>2017-03-31</endDate>
        </period>
    </context>
    <context id="i6dd1ee59fde04743b61fc6fe09e084f1_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i8b7ec1006fa44a45bcff5a676228a041_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iad05935855d347f29bdc066d4323531c_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="i7d7c3395910943ff95580815849b5296_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0bbd982c5f7748b69d855640a70331d5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i0d1f25384b814879a0628fe92c2764bc_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="if9b34d8b19d8479caf351bc959791056_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="iaafe986d776f4e188381ad93b70a5c59_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i0c9d5f9107d5452b85e1137ecfedf90f_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerPresidentandCEOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i93952393aa0f490bbfec7462592c6301_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerChiefOperatingOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="ib47971077b1a4742984a8c6a25cbc462_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerChiefOperatingOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i8d06315f2bbc4bcf8bad96452ea47672_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerChiefOperatingOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i8e03e73784db49a2b0712b19d7179af8_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:AccruedLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerChiefOperatingOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i3e10759d7520413498f7340ef1cbc70c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherNoncurrentLiabilitiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">cvsi:FormerChiefOperatingOfficerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i5c0ab77805bb4407a83db8bc568155ac_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:LitigationCaseAxis">cvsi:SmithComplaintMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i62d68f33d7fa4992b1f81cb57f0893fb_I20200727">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">cvsi:SanDiegoFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-07-27</instant>
        </period>
    </context>
    <context id="i791cd87ec1804ff590fd70ba4350941f_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">cvsi:SanDiegoFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie9aebc800dcb4be88f9cb52dea0fefae_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis">cvsi:SanDiegoFacilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i864c15d843724344970a49378789e8a3_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvsi:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6a040ed995bb443b9e3e752576188250_D20190101-20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvsi:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="id25294b42e17449aacccb4d1a2701113_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvsi:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i33313851bb654bc197ef8021968d854a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementBusinessSegmentsAxis">cvsi:SpecialtyPharmaceuticalsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ib7a85037629e4eada1ad14bd2d8d91a8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i125b29ebd2174a6781154a863a9cf67c_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">us-gaap:CaliforniaFranchiseTaxBoardMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i839a4daa37e5474fbf72320ba3f3488e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityNameAxis">cvsi:StatesOtherThanCaliforniaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic6419ee2e046444089e8042fa93ef87d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">cvsi:After2017Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="iaf5bdfbc65224887baa9c61a983f16cc_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxPeriodAxis">cvsi:Before2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie5001f6661f94fcb9a78097ff24a3842_D20210101-20210319">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001510964</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">cvsi:CommonStockPurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-19</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="segment">
        <measure>cvsi:segment</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="supplier">
        <measure>cvsi:supplier</measure>
    </unit>
    <unit id="company">
        <measure>cvsi:company</measure>
    </unit>
    <unit id="tradingday">
        <measure>cvsi:tradingDay</measure>
    </unit>
    <unit id="businessday">
        <measure>cvsi:businessDay</measure>
    </unit>
    <unit id="lawsuit">
        <measure>cvsi:lawsuit</measure>
    </unit>
    <unit id="leaseterminationagreement">
        <measure>cvsi:leaseTerminationAgreement</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM180L2ZyYWc6ZmJiMDgwYWIyZjRlNGFlZjgyYzVlMjE3ZTY3MDY4NmYvdGFibGU6ZWZkYjNjNGRlZDZlNDE3OWEwNDU2NGVjOWVhMzMzNWUvdGFibGVyYW5nZTplZmRiM2M0ZGVkNmU0MTc5YTA0NTY0ZWM5ZWEzMzM1ZV8zLTEtMS0xLTA_6d585226-024c-4b4d-9fb1-291929947a7d">0001510964</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM180L2ZyYWc6ZmJiMDgwYWIyZjRlNGFlZjgyYzVlMjE3ZTY3MDY4NmYvdGFibGU6ZWZkYjNjNGRlZDZlNDE3OWEwNDU2NGVjOWVhMzMzNWUvdGFibGVyYW5nZTplZmRiM2M0ZGVkNmU0MTc5YTA0NTY0ZWM5ZWEzMzM1ZV83LTEtMS0xLTA_b90fe62e-a723-470d-80d0-584342c56222">false</dei:AmendmentFlag>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM180L2ZyYWc6ZmJiMDgwYWIyZjRlNGFlZjgyYzVlMjE3ZTY3MDY4NmYvdGFibGU6ZWZkYjNjNGRlZDZlNDE3OWEwNDU2NGVjOWVhMzMzNWUvdGFibGVyYW5nZTplZmRiM2M0ZGVkNmU0MTc5YTA0NTY0ZWM5ZWEzMzM1ZV8xOS0xLTEtMS0w_fe158ad1-40fd-4e3c-8ca8-97c8c8edd701">FY</dei:DocumentFiscalPeriodFocus>
    <dei:DocumentFiscalYearFocus
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM180L2ZyYWc6ZmJiMDgwYWIyZjRlNGFlZjgyYzVlMjE3ZTY3MDY4NmYvdGFibGU6ZWZkYjNjNGRlZDZlNDE3OWEwNDU2NGVjOWVhMzMzNWUvdGFibGVyYW5nZTplZmRiM2M0ZGVkNmU0MTc5YTA0NTY0ZWM5ZWEzMzM1ZV8yMC0xLTEtMS0w_b3534acf-86a4-4cfa-bfe3-593a14a2be92">2020</dei:DocumentFiscalYearFocus>
    <us-gaap:TypeOfRevenueExtensibleList
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzItMC0xLTEtMA_21e27cb9-2ecc-40f1-a3e5-fb173f0ff2f4">us-gaap:ProductMember</us-gaap:TypeOfRevenueExtensibleList>
    <us-gaap:TypeOfRevenueExtensibleList
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzItMC0xLTEtMA_85a5bcce-34c7-4688-b42a-3948caec6542">us-gaap:ProductMember</us-gaap:TypeOfRevenueExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i85b38ef36bb04db7be1a75cdedabb16e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzY1OTcwNjk4MDk1ODc_f5674a51-c511-43ac-a681-83d953908b76">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i18b1bfee52e244df92d350109e304526_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzIxOTkwMjMzMTk0MDU_d0b87cf7-bf22-4fdd-a58e-c194e22353b3">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i32add06262af4753ba901af35fd023f3_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzE4NzE_8bd9e890-25d8-4554-b080-b96de69f559a">P2Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMTE2L2ZyYWc6YTQ3MDFlOGM2NDA3NDQxMmFkNTgxOGYyNjhiZmY0ZTkvdGFibGU6M2Y5OWE1ZTVmYzhhNDE3MmI2ZWMyYWRiOWE2ZDc0NDcvdGFibGVyYW5nZTozZjk5YTVlNWZjOGE0MTcyYjZlYzJhZGI5YTZkNzQ0N181LTEtMS0xLTYyMTE_c49e0f7f-d87e-420e-bcef-9bc93e278c98">P5Y19D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <dei:DocumentType
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGV4dHJlZ2lvbjpmZmJmOGY2Nzk0Y2U0NzliODEyZTkzZTZmZDJjZTcwM18yMTk5MDIzMjU4NTg1_cedcc301-0ede-44fa-870e-224184282c79">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M18wLTAtMS0xLTM4_9035939f-465e-4f61-8d27-a25a4f61dc91">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M18xLTEtMS0xLTA_96ebae99-38a4-4d04-937e-3f69fa68968a">2020-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M18xLTEtMS0xLTA_4134b48b-615e-415c-bf7c-e7077919747c">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M18zLTAtMS0xLTM1_1c97393f-1e56-4f7a-9711-4ab88c3b57be">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M181LTAtMS0xLTE0Ni90ZXh0cmVnaW9uOjdkZGE4NWUyMDM1YTQ5YmFiYmI1ZTgwNjQ2YWFhOTU0XzIxOTkwMjMyNTU2MDE_a1cff8fd-5984-451f-b496-bc5ad7ac1fcd">000-54677</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M183LTAtMS0xLTE1MS90ZXh0cmVnaW9uOmNmOTM0Mjc3ZDI3ZTRhZDNiZmJmMjlhM2IzMTllNjc3XzIxOTkwMjMyNTU2NDY_ae71a10e-c606-429a-bb34-ed07df7c5ba5">CV Sciences, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M185LTAtMS0xLTE3OS90ZXh0cmVnaW9uOjliM2E5MzljOTYyMTQwYjY4NzMwYWVhMmQzNThlZmIwXzIxOTkwMjMyNTU2MzY_f6f56b51-0e6d-4b35-9ff3-3b96b247ed46">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M185LTItMS0xLTE5Mi90ZXh0cmVnaW9uOjNlYTQ0OGU2OTBmMDQ0MWRhOTUwOWQyMzI5MjBlODE3XzIxOTkwMjMyNTU2MTQ_c30b9dab-88f9-48c1-a5df-a0faac67e87d">80-0944974</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M18xMS0wLTEtMS0yMDIvdGV4dHJlZ2lvbjoyMzYyMWUyZjVjNDE0NWQ1OWQ4MGI3OWE2NTg3OGM1ZV8yMTk5MDIzMjU1OTAx_b1d54156-a3f6-453b-a968-eebacbf5963d">10070 Barnes Canyon Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M18xMS0wLTEtMS0yMDIvdGV4dHJlZ2lvbjoyMzYyMWUyZjVjNDE0NWQ1OWQ4MGI3OWE2NTg3OGM1ZV8yMTk5MDIzMjU1OTEz_d53a5f53-0097-4a3f-bb98-b0f41b136227">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M18xMS0wLTEtMS0yMDIvdGV4dHJlZ2lvbjoyMzYyMWUyZjVjNDE0NWQ1OWQ4MGI3OWE2NTg3OGM1ZV8yMTk5MDIzMjU1OTE4_a2817d03-3c2c-4994-9b3d-a2693f9c1667">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M18xMS0wLTEtMS0yMDIvdGV4dHJlZ2lvbjoyMzYyMWUyZjVjNDE0NWQ1OWQ4MGI3OWE2NTg3OGM1ZV8yMTk5MDIzMjU1OTI2_a1cc6509-54cc-4c35-831e-1f8c091610a0">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M18xMS0wLTEtMS0yMDIvdGV4dHJlZ2lvbjoyMzYyMWUyZjVjNDE0NWQ1OWQ4MGI3OWE2NTg3OGM1ZV8yMTk5MDIzMjU1OTMy_7972e091-155d-4519-a7fc-deda6a76ae7b">866</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6ZTMxMjkxODQxMjk5NDE0NmFhY2E4ODkxMjFlYmE5ODMvdGFibGVyYW5nZTplMzEyOTE4NDEyOTk0MTQ2YWFjYTg4OTEyMWViYTk4M18xMS0wLTEtMS0yMDIvdGV4dHJlZ2lvbjoyMzYyMWUyZjVjNDE0NWQ1OWQ4MGI3OWE2NTg3OGM1ZV8yMTk5MDIzMjU1ODU0_f8651d7e-5223-4b0e-81de-64011b554504">290-2157</dei:LocalPhoneNumber>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGV4dHJlZ2lvbjpmZmJmOGY2Nzk0Y2U0NzliODEyZTkzZTZmZDJjZTcwM18yMTk5MDIzMjU4NTg3_c0216340-c360-4ab3-842f-5b52e5bc3d40">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGV4dHJlZ2lvbjpmZmJmOGY2Nzk0Y2U0NzliODEyZTkzZTZmZDJjZTcwM18yMTk5MDIzMjU4NTg4_9b46c1e1-35a7-4cc7-afad-ed7874f87124">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGV4dHJlZ2lvbjpmZmJmOGY2Nzk0Y2U0NzliODEyZTkzZTZmZDJjZTcwM18yMTk5MDIzMjU4NTg5_84d73307-7e5f-4999-a2c2-5f6a6b3b311b">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGV4dHJlZ2lvbjpmZmJmOGY2Nzk0Y2U0NzliODEyZTkzZTZmZDJjZTcwM18yMTk5MDIzMjU4NTkw_d87f9449-7c48-4345-928c-b2d731d28011">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6YTQ4OGFhY2Q0MTFhNDgwN2E4ZDViMDQyNmRlNjdkMTAvdGFibGVyYW5nZTphNDg4YWFjZDQxMWE0ODA3YThkNWIwNDI2ZGU2N2QxMF8xLTAtMS0xLTY4MjM_3bb2dc63-662d-423d-bc5a-2c9d6ea1cc9a">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6YTQ4OGFhY2Q0MTFhNDgwN2E4ZDViMDQyNmRlNjdkMTAvdGFibGVyYW5nZTphNDg4YWFjZDQxMWE0ODA3YThkNWIwNDI2ZGU2N2QxMF8xLTMtMS0xLTMyMA_71a30c04-d6c5-43a1-840c-af0801698100">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGFibGU6YTQ4OGFhY2Q0MTFhNDgwN2E4ZDViMDQyNmRlNjdkMTAvdGFibGVyYW5nZTphNDg4YWFjZDQxMWE0ODA3YThkNWIwNDI2ZGU2N2QxMF8yLTMtMS0xLTMyOQ_911ba741-2a40-42eb-a241-54661bccf898">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGV4dHJlZ2lvbjpmZmJmOGY2Nzk0Y2U0NzliODEyZTkzZTZmZDJjZTcwM18yMTk5MDIzMjU5ODE2_d58bcb2f-35c7-4c32-bdf6-6f513184f04c">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGV4dHJlZ2lvbjpmZmJmOGY2Nzk0Y2U0NzliODEyZTkzZTZmZDJjZTcwM18yMTk5MDIzMjU4NTk4_7a5b87c6-0902-43b7-a1aa-67b1bff416ab">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="ieb170334852144ef80f82c113af94f9a_I20200630"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGV4dHJlZ2lvbjpmZmJmOGY2Nzk0Y2U0NzliODEyZTkzZTZmZDJjZTcwM18zMjk4NTM0ODg3MjUz_84f74634-bf6d-4ed6-a485-1845fc8e38c1"
      unitRef="usd">60000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i1aa88da6c8d9457692e0febdb65cb1cf_I20210316"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGV4dHJlZ2lvbjpmZmJmOGY2Nzk0Y2U0NzliODEyZTkzZTZmZDJjZTcwM18zMjk4NTM0ODg2Mzk0_67bdcd98-243b-4346-a4f9-e91c80aa7d49"
      unitRef="shares">106605784</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xL2ZyYWc6ZmZiZjhmNjc5NGNlNDc5YjgxMmU5M2U2ZmQyY2U3MDMvdGV4dHJlZ2lvbjpmZmJmOGY2Nzk0Y2U0NzliODEyZTkzZTZmZDJjZTcwM18yMTk5MDIzMjU4NTg2_6f0d87b8-148c-4aeb-a4c9-eebe593140b6">Certain sections of the registrant&#x2019;s definitive proxy statement for its 2021 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the end of the registrant&#x2019;s fiscal year ended December&#160;31, 2020, are incorporated by reference into Part III of this Form 10-K.</dei:DocumentsIncorporatedByReferenceTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzQtMS0xLTEtMA_ee6cea2b-cb1a-42d7-8e8c-c0263d6d229e"
      unitRef="usd">4024000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzQtMy0xLTEtMA_cbda31ff-ea79-401f-b30e-4402ada7e92e"
      unitRef="usd">9107000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzUtMS0xLTEtMA_0899c172-36cf-48ae-8a11-5f005e064b15"
      unitRef="usd">501000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzUtMy0xLTEtMA_8b82f8e4-c167-48da-b44b-96afcfe5cb11"
      unitRef="usd">501000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzYtMS0xLTEtMA_348c49db-554d-4e88-8722-3dc0062c000b"
      unitRef="usd">1126000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzYtMy0xLTEtMA_9ae92218-c7e4-4b60-ab40-afaa04be1edb"
      unitRef="usd">2177000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzctMS0xLTEtMA_a8dc78cc-725d-4855-ad6a-ac43038e2dc1"
      unitRef="usd">8840000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzctMy0xLTEtMA_32dfd111-e1f2-47c2-871a-2085541dbd78"
      unitRef="usd">9971000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzgtMS0xLTEtMA_e5d3c8d5-5989-4984-813d-48d3f96a19a4"
      unitRef="usd">2372000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzgtMy0xLTEtMA_0d44c90d-9bbe-4e6a-b91f-44fee03530e7"
      unitRef="usd">10611000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzktMS0xLTEtMA_94a241fc-1bb8-40ec-b865-e104f0d6fa08"
      unitRef="usd">16863000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzktMy0xLTEtMA_2cc9e392-d510-4554-a06e-eeff80e0483e"
      unitRef="usd">32367000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzEyLTEtMS0xLTA_5acbdc80-264a-4df9-a8ae-3f80c16c66b6"
      unitRef="usd">2877000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzEyLTMtMS0xLTA_9202dccc-ce7c-48bb-9719-74c98853b22e"
      unitRef="usd">3615000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzEzLTEtMS0xLTA_8ea0caa2-5474-4937-9d2a-902620d1e0a2"
      unitRef="usd">3057000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzEzLTMtMS0xLTA_1e97fbeb-de1d-4d06-a5a1-f377fa57e7d1"
      unitRef="usd">8709000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzE0LTEtMS0xLTA_59968d18-ca41-4f56-b335-924dd52714ec"
      unitRef="usd">3730000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzE0LTMtMS0xLTA_7162db35-e27a-46e7-bb47-d5dc7a503922"
      unitRef="usd">3766000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:Goodwill
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzE1LTEtMS0xLTA_a9fdafdd-4295-4205-9b12-df44ddcf9e04"
      unitRef="usd">2788000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzE1LTMtMS0xLTA_f27888b8-bcc5-4f7b-99e7-2ca886188993"
      unitRef="usd">2788000</us-gaap:Goodwill>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzE2LTEtMS0xLTA_21198a94-2437-4d83-af1a-b6a672559094"
      unitRef="usd">1310000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzE2LTMtMS0xLTA_e44a6db4-8783-4d83-b95d-9805cf00ab2a"
      unitRef="usd">1442000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzE3LTEtMS0xLTA_c09de08e-dc47-4b85-be7d-8b9fcfdfa0b7"
      unitRef="usd">30625000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzE3LTMtMS0xLTA_ac42ecd2-feae-4498-89d1-fa4a033ef838"
      unitRef="usd">52687000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzIxLTEtMS0xLTA_e818d041-5ada-4bd2-9dd3-e3ce0d0dafe8"
      unitRef="usd">1677000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzIxLTMtMS0xLTA_e468244f-bde4-44d6-a4ae-16453f6e62d4"
      unitRef="usd">1617000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzIyLTEtMS0xLTA_65c048eb-e206-4403-92ed-a7fedf4ef579"
      unitRef="usd">9805000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzIyLTMtMS0xLTA_9cf2fd53-2564-4d4a-8354-ef892a3d7208"
      unitRef="usd">10856000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzIzLTEtMS0xLTA_74b95ddc-0bf2-40d5-83c9-daa7ad491ab6"
      unitRef="usd">680000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzIzLTMtMS0xLTA_ce3a8ebc-128b-4103-943d-ceb28c2b2e88"
      unitRef="usd">723000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzI0LTEtMS0xLTA_481d20b9-de12-49c9-b4dd-cbdc72c92517"
      unitRef="usd">2174000</us-gaap:NotesPayableCurrent>
    <us-gaap:NotesPayableCurrent
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzI0LTMtMS0xLTA_4dfc1b51-a607-48b1-bf97-d491a601359d"
      unitRef="usd">0</us-gaap:NotesPayableCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzI1LTEtMS0xLTA_e689abc5-3149-4df2-9829-c6f12fdcbc68"
      unitRef="usd">14336000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzI1LTMtMS0xLTA_79b2bf9d-ed32-4b91-a070-3c40102ea143"
      unitRef="usd">13196000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzI3LTEtMS0xLTA_122b8cfd-dfc1-438e-9283-16dfe0776f0e"
      unitRef="usd">3467000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzI3LTMtMS0xLTA_2f2ff8af-2f71-45df-acfe-1db0d702277c"
      unitRef="usd">9517000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzI4LTEtMS0xLTA_8239bdbf-f188-4ce4-a592-6af15a497b59"
      unitRef="usd">1453000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzI4LTMtMS0xLTA_586fb0fb-8ffd-4f93-84b2-9b31b4fe3d27"
      unitRef="usd">0</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzI5LTEtMS0xLTA_06adca67-ab45-402a-852e-d452841a602d"
      unitRef="usd">157000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzI5LTMtMS0xLTA_32188e88-a88c-4ec0-bf7a-8cf5d1e956ad"
      unitRef="usd">421000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzMwLTEtMS0xLTA_11825c59-4584-4573-bfea-96f6f3edae44"
      unitRef="usd">0</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzMwLTMtMS0xLTA_b4eb04c5-ea40-49da-a68c-64742800d409"
      unitRef="usd">406000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzMxLTEtMS0xLTA_cb93c949-5e5d-419c-a2d0-ae58b62dc240"
      unitRef="usd">19413000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzMxLTMtMS0xLTA_0376f815-a386-47b3-8344-baefa4c98101"
      unitRef="usd">23540000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzMzLTEtMS0xLTA_0df3d5ab-18aa-4948-9152-360cf90e05b6"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzMzLTMtMS0xLTA_f7f9eefd-5433-4076-a22e-b88d86e914d6"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjozMGNhNGQ1MzkzMzY0MjY4YTVkMDYzNWFhM2M2MjgwOF8yMTk5MDIzMjU1NjU4_7e411abe-9c95-4cc5-8370-81845ebc936c"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjozMGNhNGQ1MzkzMzY0MjY4YTVkMDYzNWFhM2M2MjgwOF8yMTk5MDIzMjU1NjU4_a55c3f72-9cbd-422f-8ac5-1cfb074777c3"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjozMGNhNGQ1MzkzMzY0MjY4YTVkMDYzNWFhM2M2MjgwOF8yMTk5MDIzMjU1NjY4_10b2b179-fe3f-4cde-abd3-ae8e54e47e65"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjozMGNhNGQ1MzkzMzY0MjY4YTVkMDYzNWFhM2M2MjgwOF8yMTk5MDIzMjU1NjY4_154b9330-2f83-4a03-ad1e-a310b7091314"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjozMGNhNGQ1MzkzMzY0MjY4YTVkMDYzNWFhM2M2MjgwOF8yMTk5MDIzMjU1Njcz_3e8f3838-8817-4179-ab63-2a3799bfa77b"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjozMGNhNGQ1MzkzMzY0MjY4YTVkMDYzNWFhM2M2MjgwOF8yMTk5MDIzMjU1Njcz_8697929c-09a6-4260-9528-c1d762226c10"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjozMGNhNGQ1MzkzMzY0MjY4YTVkMDYzNWFhM2M2MjgwOF8yMTk5MDIzMjU1Njcz_8fc4c8ea-44d3-4afc-8f80-4fb0758dbd53"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM2LTAtMS0xLTAvdGV4dHJlZ2lvbjozMGNhNGQ1MzkzMzY0MjY4YTVkMDYzNWFhM2M2MjgwOF8yMTk5MDIzMjU1Njcz_95b84fe4-d8f4-415e-a69d-d119fe20c81f"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockValue
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM2LTEtMS0xLTA_16d42fe6-e791-4bbc-8bd0-b18dd8b533aa"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:PreferredStockValue
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM2LTMtMS0xLTA_c2e2d3a7-a233-4970-9c35-3c411f676c67"
      unitRef="usd">0</us-gaap:PreferredStockValue>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjpkZDZhNmM4NGE5M2I0YTY1OGQzMjI5MDE1YzRiOTQ4M18yMTk5MDIzMjU1NzA3_2f3f6ea5-5feb-4d00-be83-989b318cd727"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjpkZDZhNmM4NGE5M2I0YTY1OGQzMjI5MDE1YzRiOTQ4M18yMTk5MDIzMjU1NzA3_d22c52e4-135e-4078-83fe-0210f809283c"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjpkZDZhNmM4NGE5M2I0YTY1OGQzMjI5MDE1YzRiOTQ4M18yMTk5MDIzMjU1NzE3_15279fff-a477-4e85-8b55-8912066983f3"
      unitRef="shares">190000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjpkZDZhNmM4NGE5M2I0YTY1OGQzMjI5MDE1YzRiOTQ4M18yMTk5MDIzMjU1NzE3_83fbbde6-b4a7-4167-a30f-a1f4fcb2ee2e"
      unitRef="shares">190000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjpkZDZhNmM4NGE5M2I0YTY1OGQzMjI5MDE1YzRiOTQ4M18yMTk5MDIzMjU1NzM4_066fe133-d0b3-4abc-97ec-c09d5275b169"
      unitRef="shares">100664000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjpkZDZhNmM4NGE5M2I0YTY1OGQzMjI5MDE1YzRiOTQ4M18yMTk5MDIzMjU1NzM4_4aba45e0-84ec-4fd2-beac-27edb97ecce6"
      unitRef="shares">100664000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjpkZDZhNmM4NGE5M2I0YTY1OGQzMjI5MDE1YzRiOTQ4M18yMTk5MDIzMjU1NzQ3_0043ae6f-bfb0-4c92-9694-3c8119b4b84a"
      unitRef="shares">99416000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM3LTAtMS0xLTAvdGV4dHJlZ2lvbjpkZDZhNmM4NGE5M2I0YTY1OGQzMjI5MDE1YzRiOTQ4M18yMTk5MDIzMjU1NzQ3_4b660435-808e-432a-94d8-a2171e778644"
      unitRef="shares">99416000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockValue
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM3LTEtMS0xLTA_8b04324f-5703-4ac2-96ef-87b7c62883c6"
      unitRef="usd">10000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM3LTMtMS0xLTA_35f73949-c5d7-47fd-ab85-0d11338885de"
      unitRef="usd">10000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM4LTEtMS0xLTA_ec1daa07-c445-4167-8fe9-f84df33b3a8b"
      unitRef="usd">75123000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM4LTMtMS0xLTA_aaee47cb-9d0d-48d8-9c40-bb6849dcb846"
      unitRef="usd">70774000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM5LTEtMS0xLTA_f2f458cb-9a94-4bea-8f0a-290befd46c92"
      unitRef="usd">-63921000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzM5LTMtMS0xLTA_1bdb8784-5a46-42ed-bdd3-6b3cca0b01d8"
      unitRef="usd">-41637000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzQwLTEtMS0xLTA_e5e99d6b-f53a-40c7-bf2d-b0ea18f18712"
      unitRef="usd">11212000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzQwLTMtMS0xLTA_4648e775-b90b-4ab9-8338-2519a78eb56b"
      unitRef="usd">29147000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzQyLTEtMS0xLTA_f9adfd82-f6f2-4227-8cd5-7fe41ab8663c"
      unitRef="usd">30625000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMTgvZnJhZzozNDc1MTE5NjFjZDc0MTRiYWU2MWMyNzUxMzk1YmE4NS90YWJsZTozYjlhMDY0OGMxNjY0ZGFmYTQwNjEyY2Q1MGU2NmU4Yi90YWJsZXJhbmdlOjNiOWEwNjQ4YzE2NjRkYWZhNDA2MTJjZDUwZTY2ZThiXzQyLTMtMS0xLTA_6ad4800a-276e-45bf-88ff-67512054f6f4"
      unitRef="usd">52687000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzItMS0xLTEtMA_bb106bf1-104a-4c9e-ac47-7e33e4039189"
      unitRef="usd">24429000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzItMy0xLTEtMA_c8ddacf7-d2d1-48bd-9973-e5a9156664fd"
      unitRef="usd">53696000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzMtMS0xLTEtMA_e6983bd9-18e0-42c7-abd8-dcfc27d2278b"
      unitRef="usd">13420000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzMtMy0xLTEtMA_393f96ea-15b5-45ea-8875-9b6313cdfc1c"
      unitRef="usd">18608000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzQtMS0xLTEtMA_31c6df44-c584-4f12-9be5-23641068a0e3"
      unitRef="usd">11009000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzQtMy0xLTEtMA_8e8ed87e-82b9-4296-9c79-f5e5c3bd84ba"
      unitRef="usd">35088000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzctMS0xLTEtMA_24adf661-9db2-4063-b931-c15d7dbbcb2e"
      unitRef="usd">2943000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzctMy0xLTEtMA_326bfc39-77f1-491d-86f2-c25821591eaa"
      unitRef="usd">5877000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzgtMS0xLTEtMA_617877ac-1ac0-4899-b9d1-f74636ce98a0"
      unitRef="usd">30658000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzgtMy0xLTEtMA_d8dbedf4-83fd-4666-90f2-bbabfaae419e"
      unitRef="usd">46451000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzktMS0xLTEtMA_26f10d44-946e-451a-ade9-4fa70d0a91f6"
      unitRef="usd">33601000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzktMy0xLTEtMA_d399ea89-023b-4aaa-a953-002725bab20c"
      unitRef="usd">52328000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzExLTEtMS0xLTA_7e443833-2938-472d-9be5-dfe531e01aeb"
      unitRef="usd">-22592000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzExLTMtMS0xLTA_f5ac2449-f287-491c-9c3b-22dab9175e35"
      unitRef="usd">-17240000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzEzLTEtMS0xLTA_12a8a896-eb97-477e-aff6-60cc72589173"
      unitRef="usd">-9000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:InterestIncomeExpenseNet
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzEzLTMtMS0xLTA_219e9235-d965-4f45-a194-305394004535"
      unitRef="usd">15000</us-gaap:InterestIncomeExpenseNet>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzE1LTEtMS0xLTA_369afa57-dfd7-4915-9a7f-27f767567793"
      unitRef="usd">-22601000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzE1LTMtMS0xLTA_8e531a5e-d919-4188-a1c3-afab05201fee"
      unitRef="usd">-17225000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzE2LTEtMS0xLTA_659b9714-cd18-450f-9d4b-c60fd1b02ea7"
      unitRef="usd">-317000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzE2LTMtMS0xLTA_47de3c89-c209-4589-adbe-665b8a7b0f7b"
      unitRef="usd">-615000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzE3LTEtMS0xLTA_afb50103-94aa-4fae-b9a8-82ef71e1d6ab"
      unitRef="usd">-22284000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzE3LTMtMS0xLTA_7f94c0bf-90db-41be-a2b5-2dbbe7228161"
      unitRef="usd">-16610000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzIwLTEtMS0xLTA_db51ad84-18d5-4d32-9bc0-5698645ead0a"
      unitRef="shares">99913000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzIwLTMtMS0xLTA_4c39737d-13ac-4599-8434-7c8ab9afe266"
      unitRef="shares">97861000</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzI0LTEtMS0xLTA_e73a7dea-70b7-42cd-a4e0-0d9accbaaf44"
      unitRef="usdPerShare">-0.22</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjQvZnJhZzo3Y2JiNGUxYmIwN2M0ZjRhOTdhNDM4MmE0YjAzMTI4Yi90YWJsZTplNzUwMDNjMjYyZWU0YzU5ODQwMjQwMDJlM2ZlNTU0MS90YWJsZXJhbmdlOmU3NTAwM2MyNjJlZTRjNTk4NDAyNDAwMmUzZmU1NTQxXzI0LTMtMS0xLTA_544265de-6d40-4b46-ab9d-2b92b2b89e72"
      unitRef="usdPerShare">-0.17</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:SharesOutstanding
      contextRef="i131f52df83994257bc0a0cfa19c3a287_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzItMS0xLTEtMA_492c409c-f9db-4f5e-ae1a-9ea0632090f1"
      unitRef="shares">94940000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i131f52df83994257bc0a0cfa19c3a287_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzItMy0xLTEtMA_72c42df7-9471-4da0-b48c-23bd4b8a73d7"
      unitRef="usd">9000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7937d2f589d84d8fb67618c8a842735b_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzItNS0xLTEtMA_af017d89-6717-427a-ae67-8fc56fd098fa"
      unitRef="usd">55134000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6e7fe9b796a34c8bb8a1612cb22866da_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzItNy0xLTEtMA_a477a70b-7fd1-42a4-bab4-2bea26387ce3"
      unitRef="usd">-25027000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifc2c804db67543dd84291701c746b6fa_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzItOS0xLTEtMA_7b3fd08e-7c8b-4f34-9c15-4d53e667a034"
      unitRef="usd">30116000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i8ff8bfc5f83647a4892aab327120d79e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzQtMS0xLTEtMA_61df70ad-0949-4aa9-9090-81615c5720e4"
      unitRef="shares">4476000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i8ff8bfc5f83647a4892aab327120d79e_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzQtMy0xLTEtMA_031ff7d8-517e-4d1a-b8cf-4a08b23b523e"
      unitRef="usd">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i7cbd69ac9b3b4f10a86a91c48e412fad_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzQtNS0xLTEtMA_5ad8e43c-27e8-4d4e-9662-d134dc82f577"
      unitRef="usd">520000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzQtOS0xLTEtMA_4854dc3c-360d-4350-96f3-ab06d8d7191a"
      unitRef="usd">521000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i7cbd69ac9b3b4f10a86a91c48e412fad_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzYtNS0xLTEtMA_9d9f7de8-1152-4de8-875c-57ed8257618e"
      unitRef="usd">5589000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzYtOS0xLTEtMA_12cfab22-20ca-46e3-86d0-62a670efe52f"
      unitRef="usd">5589000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <cvsi:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement
      contextRef="i7cbd69ac9b3b4f10a86a91c48e412fad_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzUtNS0xLTEtNDgx_78772dca-70c2-42a7-9d58-b5798d46473d"
      unitRef="usd">9531000</cvsi:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement>
    <cvsi:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzUtOS0xLTEtNDg5_70c84614-0e7b-4586-866c-5f1ed3ef70ac"
      unitRef="usd">9531000</cvsi:AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement>
    <us-gaap:NetIncomeLoss
      contextRef="id718b729adc144caa3a6bf9c95dc04de_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzctNy0xLTEtMA_514133e8-35a7-417c-8ffa-5bd5a2c5090b"
      unitRef="usd">-16610000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzctOS0xLTEtMA_868b9f44-1ce4-4d52-813c-3d4382f4d471"
      unitRef="usd">-16610000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i162f6e60104546399b0dd90dbead19b3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzgtMS0xLTEtMA_5d6a1105-6884-4dc7-b148-97101a097310"
      unitRef="shares">99416000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i162f6e60104546399b0dd90dbead19b3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzgtMy0xLTEtMA_ab55bb7d-7346-4c29-8d21-37944de6592b"
      unitRef="usd">10000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i37c881596124431c92dfe85bd94a4cea_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzgtNS0xLTEtMA_e1e0d00b-11e1-42b7-b0f5-e5934c6616c7"
      unitRef="usd">70774000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib0027a2179d842fe82581b40a11ca56d_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzgtNy0xLTEtMA_cd6d9a6a-27b9-4f50-bf9a-fe392fa5a5c3"
      unitRef="usd">-41637000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzgtOS0xLTEtMA_1d085f90-a1c9-4d07-b1bb-993d989641e1"
      unitRef="usd">29147000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i4789842d4b954973b49e7fed17e8c8eb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzktMS0xLTEtMA_c4e223ab-5b1d-4c85-b1fd-e212e277bb29"
      unitRef="shares">613000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i05bf25010f5e4bfc8fdea3b99d63f2ba_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzktNS0xLTEtMA_226c2231-027d-4472-9fc4-0ea86ae41916"
      unitRef="usd">175000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzktOS0xLTEtMA_013fa5eb-1ac6-4841-9b85-5626338a10df"
      unitRef="usd">175000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <cvsi:StockIssuedDuringPeriodSharesEquityCommitment
      contextRef="i4789842d4b954973b49e7fed17e8c8eb_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzktMS0xLTEtNDk2_510b0d2e-8fcc-4c2c-89ed-46d6b8350d7a"
      unitRef="shares">635000</cvsi:StockIssuedDuringPeriodSharesEquityCommitment>
    <cvsi:StockIssuedDuringPeriodValueEquityCommitment
      contextRef="i05bf25010f5e4bfc8fdea3b99d63f2ba_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzktNS0xLTEtNTA0_5ee5680e-3c1b-4839-b247-7caf04fdf6ba"
      unitRef="usd">293000</cvsi:StockIssuedDuringPeriodValueEquityCommitment>
    <cvsi:StockIssuedDuringPeriodValueEquityCommitment
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzktOS0xLTEtNTEy_fcec9635-c266-45e5-88f7-2c3123b6d3a4"
      unitRef="usd">293000</cvsi:StockIssuedDuringPeriodValueEquityCommitment>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i05bf25010f5e4bfc8fdea3b99d63f2ba_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzEwLTUtMS0xLTA_718763ce-926d-40ac-9ddb-3cf4578fe271"
      unitRef="usd">3881000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzEwLTktMS0xLTA_8564d279-683e-4496-ab99-6412213a379b"
      unitRef="usd">3881000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="i421a1d1328f941c893389dbf40b7b314_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzEyLTctMS0xLTA_2b740d06-649a-4b55-9ebc-8d33d48bce8a"
      unitRef="usd">-22284000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzEyLTktMS0xLTA_d53086d4-ec89-4964-a631-f65539a26c89"
      unitRef="usd">-22284000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesOutstanding
      contextRef="i3c2ab9e7b8f8470ca661e005ae40f9cb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzEzLTEtMS0xLTA_07373907-15b3-4fdf-b5df-41b2e23fda32"
      unitRef="shares">100664000</us-gaap:SharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i3c2ab9e7b8f8470ca661e005ae40f9cb_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzEzLTMtMS0xLTA_fef98096-752b-48a2-92d9-540a3c193163"
      unitRef="usd">10000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="if96d39e36198411b85070b25ac1ee3f6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzEzLTUtMS0xLTA_1367e6ce-90a7-44cb-b32d-984401ddf81f"
      unitRef="usd">75123000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i598932caa7504ab8a4125324d9bbd23d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzEzLTctMS0xLTA_8f030db3-9be4-40ed-b722-037c13d3db14"
      unitRef="usd">-63921000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMjcvZnJhZzoxM2YyMWQ0ZGIxNzU0ZmFiYjVmY2Q2ZGUyOGM5YWJjYi90YWJsZToyNDM4MGJjNGVjOTQ0MWNmOWU3MmUyNzQ4ODQ5ODk0MC90YWJsZXJhbmdlOjI0MzgwYmM0ZWM5NDQxY2Y5ZTcyZTI3NDg4NDk4OTQwXzEzLTktMS0xLTA_4556f56f-eb09-48d5-855e-0d0c41a1d3a9"
      unitRef="usd">11212000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzMtMS0xLTEtMA_b825cba8-14cb-41c3-9613-72db59d9a9ea"
      unitRef="usd">-22284000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzMtMy0xLTEtMA_1c05c9ff-06d1-4cf8-a987-9a14352cf9ce"
      unitRef="usd">-16610000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzUtMS0xLTEtMA_1a884d9b-267e-4f1b-9529-a73a5be6ca67"
      unitRef="usd">872000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzUtMy0xLTEtMA_9407dcf4-d86a-4a20-b074-5baddd46931e"
      unitRef="usd">716000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzctMS0xLTEtMA_f9a7f047-2169-4ce2-8ddf-6094e76962e2"
      unitRef="usd">100000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzctMy0xLTEtMA_2e7ee567-d0eb-4406-a323-e3eef75e7d57"
      unitRef="usd">0</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:ShareBasedCompensation
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzgtMS0xLTEtMA_4a8056ee-e07e-4233-85a0-1528575bfb87"
      unitRef="usd">3881000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzgtMy0xLTEtMA_9abf6f55-9e3c-41fc-b123-04b16c0b82ba"
      unitRef="usd">5589000</us-gaap:ShareBasedCompensation>
    <us-gaap:RoyaltyExpense
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzktMS0xLTEtMA_6d570efe-ef5e-41f4-8319-f59a5c1ac44f"
      unitRef="usd">0</us-gaap:RoyaltyExpense>
    <us-gaap:RoyaltyExpense
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzktMy0xLTEtMA_70f933c4-7474-4c3e-8706-9bf54d02722c"
      unitRef="usd">9531000</us-gaap:RoyaltyExpense>
    <cvsi:ImpairmentOfTaxReceivableForRSUSettlement
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzktMS0xLTEtMzAyMw_09bf4343-ca7d-4af4-8fd0-ca0fb767e85e"
      unitRef="usd">6229000</cvsi:ImpairmentOfTaxReceivableForRSUSettlement>
    <cvsi:ImpairmentOfTaxReceivableForRSUSettlement
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzktMy0xLTEtMzAxOQ_b2f2e0d4-d6d9-4654-9804-d144b9b42fba"
      unitRef="usd">0</cvsi:ImpairmentOfTaxReceivableForRSUSettlement>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzEwLTEtMS0xLTUzNzA_028199fa-788e-4623-b616-707ab8cb67d9"
      unitRef="usd">-191000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzEwLTMtMS0xLTUzNzQ_7f107168-98a2-4e43-b84b-16471fc1aa64"
      unitRef="usd">0</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzEwLTEtMS0xLTA_625202e1-1ea9-419f-8059-4c24d96ae016"
      unitRef="usd">133000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzEwLTMtMS0xLTA_9d316e42-3b8a-48f4-8940-750202159b34"
      unitRef="usd">236000</us-gaap:ProvisionForDoubtfulAccounts>
    <cvsi:NoncashLeaseExpense
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzEyLTEtMS0xLTA_489a5270-6a11-471d-81a0-50efa192103a"
      unitRef="usd">598000</cvsi:NoncashLeaseExpense>
    <cvsi:NoncashLeaseExpense
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzEyLTMtMS0xLTA_238391e8-b7ee-4f50-aa41-891408c4988e"
      unitRef="usd">817000</cvsi:NoncashLeaseExpense>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzEzLTEtMS0xLTA_67632a80-c18a-40a8-a831-6c4ab200041a"
      unitRef="usd">264000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:IncreaseDecreaseInDeferredIncomeTaxes
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzEzLTMtMS0xLTA_2d0e138f-664b-4e18-a43e-c2ed7303167a"
      unitRef="usd">644000</us-gaap:IncreaseDecreaseInDeferredIncomeTaxes>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzE0LTEtMS0xLTQzNzA_88067de6-dfb2-4d12-85fe-75367d47018f"
      unitRef="usd">134000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzE0LTMtMS0xLTQzNjY_c0ec155d-f02b-4dbf-9912-35d6e87d919c"
      unitRef="usd">0</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzE1LTEtMS0xLTA_81941a6d-2ebb-461f-9017-28bf39b1aee9"
      unitRef="usd">-918000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzE1LTMtMS0xLTA_55a6382b-8f8a-42e4-b0be-9d27f0e400a3"
      unitRef="usd">-927000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzE2LTEtMS0xLTA_45468723-1e48-4f9c-b78f-1a2d880ac8b5"
      unitRef="usd">-1703000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzE2LTMtMS0xLTA_1e1b1924-5d4b-4306-8788-c1f5aa6fe8e8"
      unitRef="usd">1421000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzE3LTEtMS0xLTA_0ebc78b7-025f-4119-9929-1bd990668d41"
      unitRef="usd">-2959000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzE3LTMtMS0xLTA_3ec178de-6b57-4db9-9bf9-faecb9a7815e"
      unitRef="usd">3016000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzE4LTEtMS0xLTA_fd4501c1-cc25-4986-9762-a7c183f955a4"
      unitRef="usd">-2470000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzE4LTMtMS0xLTA_004523fa-01e2-4c01-93ab-ea685b2d240e"
      unitRef="usd">1648000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzIwLTEtMS0xLTA_a2859109-cd6b-4c19-89fd-21a81e81a468"
      unitRef="usd">-7300000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzIwLTMtMS0xLTA_e7e29cb3-f6a0-49f7-b22c-586b62d2df09"
      unitRef="usd">-2227000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzIzLTEtMS0xLTA_7a97735f-5732-4c1d-8510-3b4dc38e9d01"
      unitRef="usd">1057000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzIzLTMtMS0xLTA_f2bc3f9c-01b9-4e3f-9e0c-fce223d7822f"
      unitRef="usd">1147000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzI1LTEtMS0xLTA_c5ee1703-79ca-4771-a1fe-14e1db8395d0"
      unitRef="usd">-1057000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzI1LTMtMS0xLTA_3dc86498-a536-4859-9c4a-472f3001cbfd"
      unitRef="usd">-1147000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromUnsecuredNotesPayable
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzI4LTEtMS0xLTA_1e1538eb-3967-4843-9db4-d2b15166a610"
      unitRef="usd">2906000</us-gaap:ProceedsFromUnsecuredNotesPayable>
    <us-gaap:ProceedsFromUnsecuredNotesPayable
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzI4LTMtMS0xLTA_2805c56a-7dae-47f6-92f5-659f445653d1"
      unitRef="usd">0</us-gaap:ProceedsFromUnsecuredNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzI5LTEtMS0xLTA_7eb62f2e-c745-43bf-bbf5-1e9b584c27f3"
      unitRef="usd">0</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:RepaymentsOfNotesPayable
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzI5LTMtMS0xLTA_c51f0a6a-4b1e-47ae-93e1-406c42366973"
      unitRef="usd">474000</us-gaap:RepaymentsOfNotesPayable>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzI4LTEtMS0xLTQxMTE_7eeb380f-9252-4385-be61-f0c986987a81"
      unitRef="usd">193000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzI4LTMtMS0xLTQxMTU_4f8fa55c-f6c4-49dc-848f-5334a486c869"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzMwLTEtMS0xLTA_ef96446a-1ffd-4df7-932e-ccf16d732431"
      unitRef="usd">175000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzMwLTMtMS0xLTA_70e64826-2ab7-40d1-b48e-9b9f79ba4ba7"
      unitRef="usd">521000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzMxLTEtMS0xLTA_45e6c9c8-f425-43f6-a2be-729795f122be"
      unitRef="usd">3274000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzMxLTMtMS0xLTA_40668825-3d1b-42c2-8d15-660204643bea"
      unitRef="usd">47000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzMzLTEtMS0xLTA_7d9fa045-150c-45a0-8bed-98e79189347e"
      unitRef="usd">-5083000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzMzLTMtMS0xLTA_db215836-37e4-484c-a71f-b1848d0c718f"
      unitRef="usd">-3327000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzM0LTEtMS0xLTA_e78bd6af-01cb-444f-b1a2-86ba817f4491"
      unitRef="usd">9608000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifc2c804db67543dd84291701c746b6fa_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzM0LTMtMS0xLTA_1247c99b-e001-4980-a078-7665af8ef93a"
      unitRef="usd">12935000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzM1LTEtMS0xLTA_02f82811-fcd6-48d2-80f4-382f22cdf65f"
      unitRef="usd">4525000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZTo3MTc4MzJmZjYzZjE0ODA2ODc0MzFhZjk2OGFjOWZhMi90YWJsZXJhbmdlOjcxNzgzMmZmNjNmMTQ4MDY4NzQzMWFmOTY4YWM5ZmEyXzM1LTMtMS0xLTA_bcac5a4a-ecc7-4087-95fa-5dd75af8b74c"
      unitRef="usd">9608000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzMtMS0xLTEtMA_f9e681e2-3a5b-4a65-b5b8-c8698cdf9b71"
      unitRef="usd">0</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzMtMy0xLTEtMA_94c5a0f2-14e3-4256-b7b4-3c9ea1274e9b"
      unitRef="usd">9000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzQtMS0xLTEtMA_7d33d108-f30f-4590-ad1f-26d3c014801c"
      unitRef="usd">20000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzQtMy0xLTEtMA_05afa28d-a5bb-4980-95f3-7132372573d6"
      unitRef="usd">99000</us-gaap:IncomeTaxesPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzctMS0xLTEtMA_900b72b6-b1cc-459d-b9ef-6c01b979f6c2"
      unitRef="usd">15000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzctMy0xLTEtMA_02a9654c-190d-496f-b078-2bd0a5a282cd"
      unitRef="usd">89000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <cvsi:RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzgtMS0xLTEtNDM5Ng_9d9e8cbf-123f-4b08-ac24-c84b6e668fc3"
      unitRef="usd">4704000</cvsi:RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability>
    <cvsi:RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzgtMy0xLTEtNDQxNw_8569c3c9-b92b-42cb-b58d-e7f7b597ad4b"
      unitRef="usd">0</cvsi:RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability>
    <cvsi:SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzktMS0xLTEtNDM4OA_6f553385-940b-4c81-ba63-48aad145b2a5"
      unitRef="usd">675000</cvsi:SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory>
    <cvsi:SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzktMy0xLTEtNDM5Mg_53c25c2a-6f51-4cea-a91a-5e795e2894b1"
      unitRef="usd">0</cvsi:SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory>
    <cvsi:PurchaseOfInsuranceThroughIssuanceOfNotePayable
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzEwLTEtMS0xLTQ0MDY_231aebb6-0500-482b-a418-36acaac7eb1a"
      unitRef="usd">721000</cvsi:PurchaseOfInsuranceThroughIssuanceOfNotePayable>
    <cvsi:PurchaseOfInsuranceThroughIssuanceOfNotePayable
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzEwLTMtMS0xLTQ0MDk_ae918815-301c-4491-ba49-d9544d46b7b9"
      unitRef="usd">0</cvsi:PurchaseOfInsuranceThroughIssuanceOfNotePayable>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzgtMS0xLTEtMA_42a9e29f-9baa-4685-a914-260bceb7fadc"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzgtMy0xLTEtMA_8869c7a4-340b-4794-9ce2-52222063ef1b"
      unitRef="usd">5405000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <cvsi:RecognitionofEquityAwardandWithholdingObligationandReceivable
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzktMS0xLTEtMA_27d67c6e-6e1e-4024-95d1-40c344491475"
      unitRef="usd">0</cvsi:RecognitionofEquityAwardandWithholdingObligationandReceivable>
    <cvsi:RecognitionofEquityAwardandWithholdingObligationandReceivable
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzktMy0xLTEtMA_c7660c01-1178-4eae-9da5-55c5a9951c11"
      unitRef="usd">6409000</cvsi:RecognitionofEquityAwardandWithholdingObligationandReceivable>
    <cvsi:CashlessExerciseOfStockOptions
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzEzLTEtMS0xLTY5ODU_85ba5a2c-4dfd-4116-91ae-2341085f7681"
      unitRef="usd">108000</cvsi:CashlessExerciseOfStockOptions>
    <cvsi:CashlessExerciseOfStockOptions
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzAvZnJhZzplMWEzMDliODM4NTk0ODA5OTljMTQ5OGRhODE4ZjY1Mi90YWJsZToxZWQ3OWJlN2M3Yjc0NDhiOWJkM2I1MjM2NDIxNzhlZi90YWJsZXJhbmdlOjFlZDc5YmU3YzdiNzQ0OGI5YmQzYjUyMzY0MjE3OGVmXzEzLTMtMS0xLTY5OTA_effcac8c-5460-476e-b3ad-d9c1ddcee4bd"
      unitRef="usd">39000</cvsi:CashlessExerciseOfStockOptions>
    <us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzYvZnJhZzoyYjIzYmE0ODRlYzQ0NGI5OGFhOGU0NmNkMTE0NGNlNi90ZXh0cmVnaW9uOjJiMjNiYTQ4NGVjNDQ0Yjk4YWE4ZTQ2Y2QxMTQ0Y2U2XzExNTU_4a9725ff-22b2-42e9-847e-1802b45ba1d2">ORGANIZATION AND BUSINESS&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;CV Sciences, Inc. (the &#x201c;Company&#x201d;) was incorporated under the name Foreclosure Solutions, Inc. in the State of Texas on December 9, 2010. On July 25, 2013, CannaVest Corp., a Texas corporation (&#x201c;CannaVest Texas&#x201d;), merged with the Company, a wholly-owned Delaware subsidiary of CannaVest Texas, to effectuate a change in the Company&#x2019;s state of incorporation from Texas to Delaware. On January 4, 2016, the Company filed a Certificate of Amendment of Certificate of Incorporation reflecting its corporate name change to &#x201c;CV Sciences, Inc.&#x201d;, effective on January 5, 2016. In addition, on January 4, 2016, the Company amended its Bylaws to reflect its corporate name change to &#x201c;CV Sciences, Inc.&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has two operating segments; consumer products and specialty pharmaceutical. The consumer products segment develops, manufactures, markets and sells plant-based dietary supplements and hemp-based cannabidiol ("CBD"). The Company sells its products under tradenames, such as &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;PlusCBD&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2122;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;HappyLane&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2122;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;ProCBD&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2122;, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;CV&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Acute&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;CV&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2122;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Defenese. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's products are sold in a variety of market sectors including nutraceutical, beauty care and specialty foods. The specialty pharmaceutical segment is developing drug candidates which use CBD as a primary active ingredient.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzYvZnJhZzoyYjIzYmE0ODRlYzQ0NGI5OGFhOGU0NmNkMTE0NGNlNi90ZXh0cmVnaW9uOjJiMjNiYTQ4NGVjNDQ0Yjk4YWE4ZTQ2Y2QxMTQ0Y2U2Xzc0Mw_7ff25deb-cfec-4c22-bd41-4dc4df6973d3"
      unitRef="segment">2</us-gaap:NumberOfOperatingSegments>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzE5_6ed18314-06f9-4f05-aff2-3794075c30b7">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; - The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"). The consolidated financial statements include the accounts of CV Sciences, Inc., the accounts of its wholly-owned subsidiaries of Plus CBD, LLC and CANNAVEST Acquisition, LLC, and the accounts of a 70% interest in CannaVest Europe, GmbH. On January 20, 2017, the Company filed for dissolution of CannaVest Europe, GmbH, with the District Court, Dusseldorf Germany, effective December&#160;31, 2017. CANNAVEST Acquisition, LLC, a Delaware limited liability company formed in connection with the CanX Acquisition, was dissolved in 2018, with administrative approval in Florida carrying over into January 2019 before final resolution. On August 7, 2019, the Company filed for dissolution of Plus CBD, LLC (formerly, &#x201c;Global Hemp Source, LLC&#x201d;) with the Secretary of State of California. As a result, the Company no longer owns interests in any subsidiaries as of December&#160;31, 2020. All intercompany accounts and transactions have been eliminated in consolidation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results may differ from these estimates. Significant estimates include the valuation of intangible assets, inputs for valuing equity awards, and assumptions related to revenue recognition.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; As of December&#160;31, 2020, the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) provided insurance coverage of up to $0.3 million per depositor per bank. The Company has not experienced any losses in such accounts and does not believe that the Company is exposed to significant risks from excess deposits. The Company&#x2019;s cash balance in excess of FDIC limits totaled $3.3 million as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the Company's raw materials purchases for the year ended December&#160;31, 2019 were sourced from one supplier in Europe. During the year ended December&#160;31, 2020 the Company added one additional domestic supplier. There was no concentration of accounts receivable or revenue as of and for the years ended December&#160;31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Fair value is defined as the price that would be received from the sale of an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The carrying values of accounts receivable, other current assets, accounts payable, and certain accrued expenses as of December&#160;31, 2020 and 2019, approximate their fair value due to the short-term nature of these items. The Company's notes payable balance also approximates fair value as of December&#160;31, 2020, as the interest rate on the notes payable approximates the rates available to the Company as of this date. The accounting guidance establishes a three-level hierarchy for disclosure that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 - uses unadjusted quoted prices that are available in active markets for identical assets or liabilities. The Company's Level 1 assets are comprised of $2.4 million and $4.0 million in money market funds which are classified as cash equivalents as of December&#160;31, 2020 and 2019, respectively. In addition, the Company's restricted cash of $0.5 million as of December&#160;31, 2020 and 2019 is comprised of certificates of deposits. The carrying value of the cash &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;equivalents and restricted cash equals the fair value as of December&#160;31, 2020 and 2019. The Company does not have any liabilities that are valued using inputs identified under a Level 1 hierarchy as of December&#160;31, 2020 and 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 - uses inputs other than quoted prices included in Level 1 that are either directly or indirectly observable through correlation with market data. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data. The Company did not have any assets or liabilities that are valued using inputs identified under a Level 2 hierarchy as of December&#160;31, 2020 and 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 - uses one or more significant inputs that are unobservable and supported by little or no market activity, and that reflect the use of significant management judgment. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques, and significant management judgment or estimation. The Company did not have any assets or liabilities that are valued using inputs identified under a Level 3 hierarchy as of December&#160;31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Liquidity Considerations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; COVID-19 has spread (and continues to spread) worldwide, resulting in shutdowns of manufacturing and commerce. COVID-19 has resulted in government authorities implementing numerous measures to try to contain it, such as travel bans and restrictions, quarantines, shelter-in-place orders, and shutdowns. These measures have impacted, and may further impact, the Company's workforce and operations, the operations of our customers and our partners, and those of our respective vendors and suppliers. The Company's critical business operations, including its headquarters, and many of its key suppliers, are located in regions which have been impacted by COVID-19. The Company's customers and suppliers worldwide have also been affected and may continue to be affected by COVID-19 related restrictions and closures. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;COVID-19, along with the resulting&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; government-imposed restrictions on businesses, shelter-in place orders, and temporary retail and grocery store closures had a significant impact on the Company's results of operations for the year ended December 31, 2020, and the Company's management expects that it will continue &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;to negatively impact its operations due to decreased consumer demand as well as potential production and warehouse limitations which results in an event or condition, before consideration of management&#x2019;s plans, that could impact its ability to meet future obligations&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition, while the extent and duration of the COVID-19 pandemic on the global economy and the Company's business in particular is difficult to assess or predict, the pandemic has resulted in, and may continue to result in, significant disruption of global financial markets, which may reduce the Company's ability to access capital or its customers&#x2019; ability to pay for past or future purchases, which could negatively affect the Company's liquidity. A recession or financial market correction resulting from the lack of containment and spread of COVID-19 could impact overall spending, adversely affecting demand for the Company's products, its business, and the value of its common stock.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 17, 2020, the Company received $2.9 million pursuant to the Paycheck Protection Program ("PPP") under the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") as administered by the U.S. Small Business Administration (the "SBA"), as further discussed in Note 7. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 8, 2020, the Company entered into a common stock purchase agreement with Tumim Stone Capital, LLC to issue and sell up to $10.0 million in shares of the Company's common stock, from time to time, as further discussed in Note 8. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In response to the continuing uncertainty resulting from COVID-19, management has implemented, and as necessary will continue to make strategic cost reductions, including reductions in employee headcount, vendor spending, and the delay of expenses related to its drug development activities. &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management believes that its cash and cash equivalents on hand &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;together with the equity commitment with Tumim and &lt;/span&gt;&lt;span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;these cost reduction measures, as needed, will provide sufficient liquidity to fund its operations for the next 12 months from the issuance of the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; For purposes of the consolidated statements of cash flows, the Company considers amounts held by financial institutions and short-term investments with an original maturity of three months or less when purchased to be cash and cash equivalents. As of December&#160;31, 2020, the Company had cash of $1.6 million and cash equivalents of $2.4 million. As of December&#160;31, 2019, the Company had cash of $5.1 million and cash equivalents of $4.0 million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The Company&#x2019;s restricted cash as of  December&#160;31, 2020 and 2019 consists of certificates of deposits related to the Company's corporate credit card program. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets to the total of the same amounts shown in the statement of cash flows as of December&#160;31, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash and restricted cash shown in the statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Generally, the Company requires payment prior to shipment. However, in certain circumstances, the Company extends credit to companies located throughout the U.S. Accounts receivable consists of trade accounts arising in the normal course of business. Accounts for which no payments have been received after 30 days are considered delinquent and customary collection efforts are initiated. Accounts receivable are carried at original invoice amount less a reserve made for doubtful receivables based on a review of all outstanding amounts on a quarterly basis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management has determined the allowance for doubtful accounts by regularly evaluating individual customer receivables and considering a customer&#x2019;s financial condition and credit history, and current economic conditions. As of each December&#160;31, 2020 and 2019, the Company maintained an allowance for doubtful accounts related to accounts receivable in the amount of $0.6 million and $0.4 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Inventory is stated at lower of cost or net realizable value, with cost being determined on an average cost basis. Cost includes costs directly related to manufacturing and distribution of the products. Primary costs include raw materials, packaging, manufacturing overhead, shipping and depreciation of manufacturing equipment and production facilities. Manufacturing overhead includes payroll, employee benefits, utilities, maintenance and property taxes. Total shipping and handling costs were $1.7 million and $2.7 million for the years ended December&#160;31, 2020 and 2019, respectively, and are recorded in cost of goods sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company performs an assessment of inventory obsolescence to measure inventory at the lower of cost or net realizable value. Factors considered in the determination of obsolescence include slow-moving or non-marketable items. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's inventory production process includes the cultivation of botanical raw material. Because of the duration of the cultivation process, a portion of our inventory will not be sold within one year. Starting April 1, 2019, consistent with the practice in other industries that cultivate botanical raw materials, all inventory is classified as a current asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property &amp;amp; Equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Equipment is stated at cost less accumulated depreciation. Cost represents the purchase price of the asset and other costs incurred to bring the asset into its existing use. Depreciation is provided on a straight-line basis over the assets estimated useful lives. Tenant improvements are amortized on a straight-line basis over the shorter of the useful life or the remaining life of the related lease. Maintenance or repairs are charged to expense as incurred. Upon sale or disposition, the historically-recorded asset cost and accumulated depreciation are removed from the respective accounts and any related gain or loss is recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; In accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 360, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for the Impairment or Disposal of Long-Lived Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of property and equipment is measured by comparing its carrying value to the undiscounted projected future cash flows that the assets are expected to generate. If the carrying amount of an asset is not recoverable, the Company recognizes an impairment loss based on the excess of the carrying amount of the long-lived asset over its respective fair value, which is generally determined as the present value of estimated future cash flows or at the appraised value. The impairment analysis is based on significant assumptions of future results made by management, including revenue and cash flow projections. Circumstances that may lead to impairment of property and equipment include a significant decrease in the market price of a long-lived asset, a significant adverse change in the extent or manner in which a long-lived asset is being used or in its physical condition and a significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset including an adverse action or assessment by a regulator. As of December&#160;31, 2020 and 2019, the Company determined that long-lived assets were not impaired.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Intangible Assets &#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company evaluates the carrying value of goodwill and intangible assets annually during the fourth quarter in accordance with ASC Topic 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles Goodwill and Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and between annual evaluations if events &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;occur or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Such circumstances could include, but are not limited to (1) a significant adverse change in legal factors or in business climate, (2) unanticipated competition, or (3) an adverse action or assessment by a regulator. All of the Company's goodwill and intangible assets are assigned to the Company's specialty pharmaceutical segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is evaluated for impairment by first performing a qualitative assessment to determine whether a quantitative goodwill test is necessary. If it is determined, based on qualitative factors, that the fair value of the reporting unit may be more likely than not less than carrying amount, or if significant adverse changes in the Company's future financial performance occur that could materially impact fair value, a quantitative goodwill impairment test would be required. Additionally, management can elect to forgo the qualitative assessment and perform the quantitative test. If the qualitative assessment indicates that the quantitative analysis should be performed, or if management elects to bypass a qualitative assessment, the Company then evaluates goodwill for impairment by comparing the fair value of the reporting unit to its carrying amount, including goodwill. The quantitative assessment for goodwill requires management to estimate the fair value of the Company's reporting units using either an income or market approach or a combination thereof. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management makes critical assumptions and estimates in completing impairment assessments of goodwill and other intangible assets. The Company's cash flow projections look several years into the future and include assumptions on variables such as future sales and operating margin growth rates, economic conditions, probability of success, market competition, inflation and discount rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2020, the Company performed its annual goodwill impairment test and determined, after performing a qualitative test of the reporting unit, that it is more likely than not that the fair value of the reporting unit exceeds its carrying amount. Accordingly, there was no indication of impairment and the quantitative impairment test was not performed. The Company did not record any goodwill impairment charges for the years ended December&#160;31, 2020 or 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company classifies intangible assets into three categories: (1) intangible assets with definite lives subject to amortization; (2) intangible assets with indefinite lives not subject to amortization; and (3) goodwill. The Company determines the useful lives of its identifiable intangible assets after considering the specific facts and circumstances related to each intangible asset. Factors considered when determining useful lives include the contractual term of any agreement related to the asset, the historical performance of the asset, the Company's long-term strategy for using the asset, any laws or regulations which could impact the useful life of the asset and other economic factors, including competition and specific market conditions. Intangible assets that are deemed to have definite lives are amortized, primarily on a straight-line basis, over their useful lives to their estimated residual values, generally five years. In-process research &amp;amp; development ("&lt;/span&gt;&lt;span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;IPR&amp;amp;D") has an indefinite life and is not amortized until completion and development of the project, at which time the IPR&amp;amp;D becomes an amortizable asset. Until such time as the projects are either completed or abandoned, the Company test those assets for impairment at least annually at year end, or more frequently at interim periods, by evaluating qualitative factors which could be indicative of impairment. Qualitative factors being considered include, but are not limited to, macro-economic conditions, progress on drug development activities, and overall financial performance. If impairment indicators are present as a result of the Company's qualitative assessment, the Company will test those assets for impairment by comparing the fair value of the assets to their carrying value. Quantitative factors being considered include, but are not limited to, the current project status, forecasted changes in the timing or amounts required to complete the project, forecasted changes in timing or changes in the future cash flows to be generated by the completed products, a probability of success of the ultimate project and changes to other market-based assumptions, such as discount rates. Upon completion or abandonment, the value of the IPR&amp;amp;D assets will be amortized to expense over the anticipated useful life of the developed products, if completed, or charged to expense when abandoned if no alternative future use exists. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company completed its annual impairment assessment during the fourth quarter of 2020 and 2019. No impairments were identified during the years ended December&#160;31, 2020 and 2019.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The majority of the Company's revenue contracts represent a single performance obligation related to the fulfillment of customer orders for the purchase of its products. Net sales reflect the transaction prices for these contracts based on the Company's selling list price, which is then reduced by estimated costs for trade promotional programs, consumer incentives, and allowances and discounts used to incentivize sales growth and build brand awareness. The Company recognizes revenue at the point in time that control of the ordered product is transferred to the customer, which is typically upon shipment to the customer or other customer-designated delivery point. The Company accrues for estimated sales returns by customers based on historical sales return results. The computation of the sales return and discount allowances require that management makes certain estimates and assumptions that effect the timing and amounts of revenue and liabilities recorded. Shipping and handling fees charged to customers are included in product sales and totaled $0.2 million and $0.3 million for the years ended December&#160;31, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2020 and 2019, respectively. Taxes collected from customers that are remitted to governmental agencies are accounted for on a net basis and not included as revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents product sales by channel for food, drug and mass ("FDM"), natural product and other, and e-commerce for the years ended December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of product sales, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of prodct sales, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retail - FDM&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retail - Natural products and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;E-Comm&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product sales, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Compensation and Benefits&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The Company records compensation and benefits expense for all cash and deferred compensation, benefits, and related taxes as earned by its employees. Compensation and benefits expense also includes compensation earned by temporary employees and contractors who perform similar services to those performed by the Company&#x2019;s employees, primarily information technology and project management activities. The Company maintains a defined contribution 401(k) plan available to eligible employees. Employee contributions are voluntary and are determined on an individual basis, limited to the maximum amount allowable under federal tax regulations. The Company, at its discretion, may make certain matching contributions to the 401(k) plan. The Company suspended its matching contributions in April 2020. The Company made matching contributions of $0.1 million and $0.2 million for the years ended December&#160;31, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development Expense&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Research and development costs are charged to expense as incurred and include, but are not limited to, employee salaries and benefits, cost of inventory used in product development, consulting service fees, the cost of renting and maintaining our laboratory facility and depreciation of laboratory equipment. Research and development expense for the consumer products segment was $0.7 million and $2.1 million for the years ended December&#160;31, 2020 and 2019, respectively. Research and development expense for the specialty pharmaceutical segment was $2.2 million and $3.8 million for the years ended December&#160;31, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The Company supports its products with advertising to build brand awareness of the Company&#x2019;s various products in addition to other marketing programs executed by the Company&#x2019;s marketing team. The Company believes the continual investment in advertising is critical to the development and sale of its products. Advertising costs of $1.3 million and $2.5 million were expensed as incurred during the years ending December&#160;31, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Certain employees, officers, directors, and consultants of the Company participate in various long-term incentive plans that provide for granting stock options, restricted stock awards, restricted stock units, stock bonus awards and performance-based awards. Stock options generally vest in equal increments over a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzY1OTcwNjk4MDk1ODc_f5674a51-c511-43ac-a681-83d953908b76"&gt;two&lt;/span&gt;- to four-year period and expire on the &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzIxOTkwMjMzMTk0MDU_d0b87cf7-bf22-4fdd-a58e-c194e22353b3"&gt;ten&lt;/span&gt;th anniversary following the date of grant. Performance-based stock options vest once the applicable performance condition is satisfied. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes stock-based compensation for equity awards granted to employees, officers and directors as compensation and benefits expense in the consolidated statements of operations. The fair value of stock options is estimated using a Black-Scholes valuation model on the date of grant. The fair value of restricted stock awards is equal to the closing price of the Company&#x2019;s stock on the date of grant. Stock-based compensation is recognized over the requisite service period of the individual awards, which generally equals the vesting period. For performance-based stock options, compensation is recognized once the applicable performance condition is satisfied.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2013; Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the related temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized when the rate change is enacted. Valuation allowances are recorded to reduce deferred tax assets to the amount that will more likely than not be realized. In accordance with ASC Topic 740, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company recognizes the effect of uncertain income tax positions only if the positions are more likely than not of being sustained in an audit, based on the technical merits of the position. Recognized uncertain income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;recognition or measurement are reflected in the period in which those changes in judgment occur. The Company recognizes both interest and penalties related to uncertain tax positions as part of the income tax provision. As of December&#160;31, 2020 and 2019 the Company did not have a liability for unrecognized tax uncertainties. The Company is subject to routine audits by taxing jurisdictions. Management believes the Company is no longer subject to tax examinations for the years prior to 2013.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive Loss &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2013; Comprehensive loss is defined as a change in equity during a period from transactions and other events and circumstances from non-owner sources. There have been no items qualifying as other comprehensive loss and, therefore, the Company's comprehensive loss was the same as its reported net loss for the years ended December&#160;31, 2020 and 2019.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board ("FASB") issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments and subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04 and ASU 2019-05 (collectively, &#x201c;Topic 326&#x201d;). Topic 326 requires measurement and recognition of expected credit losses for financial assets held. Topic 326 was to be effective for reporting periods beginning after December 15, 2019, with early adoption permitted. In November 2019, the FASB issued ASU 2019-10, Financial Instruments - Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842) Effective Dates, which deferred the effective dates for the Company, as a smaller reporting company, until fiscal year 2023. The Company currently plans to adopt the guidance at the beginning of fiscal 2023. The Company is currently evaluating the potential impact of Topic 326 on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes ("ASU 2019-12"), which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistency among reporting entities. The new standard is effective for fiscal years beginning after December 15, 2020. Most amendments within the standard are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company is currently evaluating the potential impact of ASU 2019-12 on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2017, the FASB issued ASU 2017-04, Intangibles &#x2013; Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (&#x201c;ASU 2017-04&#x201d;), which eliminates Step 2 from the goodwill impairment test. Instead, an entity should perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should then recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit&#x2019;s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity should consider income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. ASU 2017-04 requires the entity to apply these amendments on a prospective basis for which it is required to disclose the nature of and reason for the change in accounting upon transition. This disclosure shall be provided in the first annual period and in the interim period within the first annual period when the entity initially adopts the amendments. This ASU became effective for the Company on January 1, 2020. Adoption of ASU 2017-04 did not have an immediate impact on the Company&#x2019;s consolidated financial statements and only has the potential to impact the amount of any goodwill impairment recorded after the adoption of the ASU.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzA1_1be76080-b3dd-4cea-9cdc-71189232c17d">Basis of Presentation - The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"). The consolidated financial statements include the accounts of CV Sciences, Inc., the accounts of its wholly-owned subsidiaries of Plus CBD, LLC and CANNAVEST Acquisition, LLC, and the accounts of a 70% interest in CannaVest Europe, GmbH. On January 20, 2017, the Company filed for dissolution of CannaVest Europe, GmbH, with the District Court, Dusseldorf Germany, effective December&#160;31, 2017. CANNAVEST Acquisition, LLC, a Delaware limited liability company formed in connection with the CanX Acquisition, was dissolved in 2018, with administrative approval in Florida carrying over into January 2019 before final resolution. On August 7, 2019, the Company filed for dissolution of Plus CBD, LLC (formerly, &#x201c;Global Hemp Source, LLC&#x201d;) with the Secretary of State of California. As a result, the Company no longer owns interests in any subsidiaries as of December&#160;31, 2020. All intercompany accounts and transactions have been eliminated in consolidation.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:MinorityInterestOwnershipPercentageByParent
      contextRef="ia430bcca043b4606a1c759ed7eaa8883_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzQyNg_d612bea4-901a-484f-a6b7-82e1f4ee4884"
      unitRef="number">0.70</us-gaap:MinorityInterestOwnershipPercentageByParent>
    <us-gaap:UseOfEstimates
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzM1_eaade5ec-a515-4669-b377-30554a6ebe84">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results may differ from these estimates. Significant estimates include the valuation of intangible assets, inputs for valuing equity awards, and assumptions related to revenue recognition.&lt;/span&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4Njkx_48afaa88-2990-438f-9b58-34ec129d9a42">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; As of December&#160;31, 2020, the Federal Deposit Insurance Corporation (&#x201c;FDIC&#x201d;) provided insurance coverage of up to $0.3 million per depositor per bank. The Company has not experienced any losses in such accounts and does not believe that the Company is exposed to significant risks from excess deposits. The Company&#x2019;s cash balance in excess of FDIC limits totaled $3.3 million as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the Company's raw materials purchases for the year ended December&#160;31, 2019 were sourced from one supplier in Europe. During the year ended December&#160;31, 2020 the Company added one additional domestic supplier. There was no concentration of accounts receivable or revenue as of and for the years ended December&#160;31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:CashUninsuredAmount
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzIwNDY_b3af6cb7-b8c9-4a93-8c05-9db0ecc78d29"
      unitRef="usd">3300000</us-gaap:CashUninsuredAmount>
    <cvsi:NumberofSuppliers
      contextRef="i1eb2e25e3bc14d80a5c0329eebbc85a5_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzIxNTE_1735745a-4359-423e-95cd-7026a58307e5"
      unitRef="supplier">1</cvsi:NumberofSuppliers>
    <cvsi:NumberOfAdditionalSuppliers
      contextRef="if5456eaf29c94cbf9434311c42b7d007_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzIxOTkwMjMzMDAwNjY_e1557afb-81ec-48be-b342-affd1b75ac9e"
      unitRef="company">1</cvsi:NumberOfAdditionalSuppliers>
    <us-gaap:FairValueOfFinancialInstrumentsPolicy
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4Njkz_180afb31-2e87-4d21-b134-5463e37df192">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Fair value is defined as the price that would be received from the sale of an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The carrying values of accounts receivable, other current assets, accounts payable, and certain accrued expenses as of December&#160;31, 2020 and 2019, approximate their fair value due to the short-term nature of these items. The Company's notes payable balance also approximates fair value as of December&#160;31, 2020, as the interest rate on the notes payable approximates the rates available to the Company as of this date. The accounting guidance establishes a three-level hierarchy for disclosure that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 1 - uses unadjusted quoted prices that are available in active markets for identical assets or liabilities. The Company's Level 1 assets are comprised of $2.4 million and $4.0 million in money market funds which are classified as cash equivalents as of December&#160;31, 2020 and 2019, respectively. In addition, the Company's restricted cash of $0.5 million as of December&#160;31, 2020 and 2019 is comprised of certificates of deposits. The carrying value of the cash &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;equivalents and restricted cash equals the fair value as of December&#160;31, 2020 and 2019. The Company does not have any liabilities that are valued using inputs identified under a Level 1 hierarchy as of December&#160;31, 2020 and 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 2 - uses inputs other than quoted prices included in Level 1 that are either directly or indirectly observable through correlation with market data. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data. The Company did not have any assets or liabilities that are valued using inputs identified under a Level 2 hierarchy as of December&#160;31, 2020 and 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="padding-left:36pt;text-align:justify;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level 3 - uses one or more significant inputs that are unobservable and supported by little or no market activity, and that reflect the use of significant management judgment. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques, and significant management judgment or estimation. The Company did not have any assets or liabilities that are valued using inputs identified under a Level 3 hierarchy as of December&#160;31, 2020 and 2019.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueOfFinancialInstrumentsPolicy>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i3019b5e0eea94dff87d9cf02a903f261_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzMyOTg1MzQ5MjM4MDI_3943222e-3c53-4642-9047-d0554c2207e2"
      unitRef="usd">2400000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i3100b80a9d7c4d53bf9d8e711e804a24_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzMyOTg1MzQ5MjM4MTE_c3449dfd-c011-4f79-8505-8c302168a447"
      unitRef="usd">4000000.0</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i3019b5e0eea94dff87d9cf02a903f261_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzMwNDU_0d60105e-6f6d-44d4-95a7-c2370ba121c1"
      unitRef="usd">500000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:RestrictedCashAndCashEquivalents
      contextRef="i3100b80a9d7c4d53bf9d8e711e804a24_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzMwNDU_a75574f6-36b8-46e8-908e-c8963b83d327"
      unitRef="usd">500000</us-gaap:RestrictedCashAndCashEquivalents>
    <us-gaap:ProceedsFromUnsecuredNotesPayable
      contextRef="i796f849901b445a9a1017431e7f0feb3_D20200417-20200417"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzMyOTg1MzQ5MTI3NTY_301dfafe-f64e-4ed9-a083-3df1157e5301"
      unitRef="usd">2900000</us-gaap:ProceedsFromUnsecuredNotesPayable>
    <cvsi:SaleOfStockMaximumValueOfSharesIssuedInTransaction
      contextRef="i5ce71eb8f7d045f680a63998d5ebc762_D20201208-20201208"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzMyOTg1MzQ5MTMxNzU_ead9d3fc-3414-4665-8464-ccc9b1c049d2"
      unitRef="usd">10000000.0</cvsi:SaleOfStockMaximumValueOfSharesIssuedInTransaction>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzAx_7df4b331-a7ad-43d3-ad5d-d7a3bd78f071">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; For purposes of the consolidated statements of cash flows, the Company considers amounts held by financial institutions and short-term investments with an original maturity of three months or less when purchased to be cash and cash equivalents. As of December&#160;31, 2020, the Company had cash of $1.6 million and cash equivalents of $2.4 million. As of December&#160;31, 2019, the Company had cash of $5.1 million and cash equivalents of $4.0 million.&lt;/span&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:Cash
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzMyOTg1MzQ5MjM4MTk_d2d7f11b-f8c6-497d-a561-de9b306dda28"
      unitRef="usd">1600000</us-gaap:Cash>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzMyOTg1MzQ5MjM4Mjk_1a8ba94b-7eb6-426d-aa5f-a2a7298b9727"
      unitRef="usd">2400000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:Cash
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzMyOTg1MzQ5MjM4NDA_b1110c4d-4189-4213-934e-beced08b5861"
      unitRef="usd">5100000</us-gaap:Cash>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzMyOTg1MzQ5MjM4NTE_fa3d9aa6-bd0e-43ff-8883-69c318fbf8f3"
      unitRef="usd">4000000.0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzEw_6820e282-810a-460d-aac7-c7ff5d13463d">Restricted Cash &#x2013; The Company&#x2019;s restricted cash as of  December&#160;31, 2020 and 2019 consists of certificates of deposits related to the Company's corporate credit card program.</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4Njky_90536c11-2b01-4859-93c9-071485083ca0">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets to the total of the same amounts shown in the statement of cash flows as of December&#160;31, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;As of December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash and cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,107&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Restricted cash&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;501&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total cash and restricted cash shown in the statements of cash flows&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZToyYjQ3YTM0MTI3N2E0MDcwODA0MTU4MmQ3ZmExMDA3YS90YWJsZXJhbmdlOjJiNDdhMzQxMjc3YTQwNzA4MDQxNTgyZDdmYTEwMDdhXzItMS0xLTEtMA_0262dde6-aa1e-459e-9946-bdc66abba562"
      unitRef="usd">4024000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZToyYjQ3YTM0MTI3N2E0MDcwODA0MTU4MmQ3ZmExMDA3YS90YWJsZXJhbmdlOjJiNDdhMzQxMjc3YTQwNzA4MDQxNTgyZDdmYTEwMDdhXzItMy0xLTEtMA_c5a82fbc-bb7e-401b-ab88-3304d999b133"
      unitRef="usd">9107000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZToyYjQ3YTM0MTI3N2E0MDcwODA0MTU4MmQ3ZmExMDA3YS90YWJsZXJhbmdlOjJiNDdhMzQxMjc3YTQwNzA4MDQxNTgyZDdmYTEwMDdhXzMtMS0xLTEtMA_30cb85d3-6cff-4cc5-9eea-1fdfe1655479"
      unitRef="usd">501000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZToyYjQ3YTM0MTI3N2E0MDcwODA0MTU4MmQ3ZmExMDA3YS90YWJsZXJhbmdlOjJiNDdhMzQxMjc3YTQwNzA4MDQxNTgyZDdmYTEwMDdhXzMtMy0xLTEtMA_b7edb322-d60a-4fc9-810c-e8f8d5e55577"
      unitRef="usd">501000</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZToyYjQ3YTM0MTI3N2E0MDcwODA0MTU4MmQ3ZmExMDA3YS90YWJsZXJhbmdlOjJiNDdhMzQxMjc3YTQwNzA4MDQxNTgyZDdmYTEwMDdhXzQtMS0xLTEtMA_61ef057f-377b-43e9-80cc-c45910065d80"
      unitRef="usd">4525000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZToyYjQ3YTM0MTI3N2E0MDcwODA0MTU4MmQ3ZmExMDA3YS90YWJsZXJhbmdlOjJiNDdhMzQxMjc3YTQwNzA4MDQxNTgyZDdmYTEwMDdhXzQtMy0xLTEtMA_5169d32e-a3a6-40d1-a549-bbaf0cc539a1"
      unitRef="usd">9608000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:ReceivablesPolicyTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzI4_1b8828d0-20f3-40af-939f-444f7097c84f">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Generally, the Company requires payment prior to shipment. However, in certain circumstances, the Company extends credit to companies located throughout the U.S. Accounts receivable consists of trade accounts arising in the normal course of business. Accounts for which no payments have been received after 30 days are considered delinquent and customary collection efforts are initiated. Accounts receivable are carried at original invoice amount less a reserve made for doubtful receivables based on a review of all outstanding amounts on a quarterly basis.&lt;/span&gt;Management has determined the allowance for doubtful accounts by regularly evaluating individual customer receivables and considering a customer&#x2019;s financial condition and credit history, and current economic conditions.</us-gaap:ReceivablesPolicyTextBlock>
    <cvsi:AccountsReceivableThresholdforDeterminingDelinquentAccount
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzc4OTA_eac00255-86d7-492c-9b0c-17a67595511b">P30D</cvsi:AccountsReceivableThresholdforDeterminingDelinquentAccount>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzg0OTE_f0103152-f125-4fc7-8b9e-ba15c6c74ce0"
      unitRef="usd">600000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzg0OTg_1ea41d66-71ae-4786-8cd7-ffe7306240ec"
      unitRef="usd">400000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzMx_176f6d6d-36ca-4dda-838a-a4198155aa6a">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Inventory is stated at lower of cost or net realizable value, with cost being determined on an average cost basis. Cost includes costs directly related to manufacturing and distribution of the products. Primary costs include raw materials, packaging, manufacturing overhead, shipping and depreciation of manufacturing equipment and production facilities. Manufacturing overhead includes payroll, employee benefits, utilities, maintenance and property taxes. Total shipping and handling costs were $1.7 million and $2.7 million for the years ended December&#160;31, 2020 and 2019, respectively, and are recorded in cost of goods sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company performs an assessment of inventory obsolescence to measure inventory at the lower of cost or net realizable value. Factors considered in the determination of obsolescence include slow-moving or non-marketable items. &lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's inventory production process includes the cultivation of botanical raw material. Because of the duration of the cultivation process, a portion of our inventory will not be sold within one year. Starting April 1, 2019, consistent with the practice in other industries that cultivate botanical raw materials, all inventory is classified as a current asset.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="if01f3c8b8a7e46bfb048274a7d4ddc6a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzkwMjU_40f14a45-53f8-4601-8bfe-09a79e0e2677"
      unitRef="usd">1700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold
      contextRef="i2f6446e2781145b58aadd810c3831360_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzkwMzI_520bb358-eb04-44c3-8dbf-e071714253cf"
      unitRef="usd">2700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzEy_bad6e669-63b1-4799-ade3-710a0d769ef2">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property &amp;amp; Equipment&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Equipment is stated at cost less accumulated depreciation. Cost represents the purchase price of the asset and other costs incurred to bring the asset into its existing use. Depreciation is provided on a straight-line basis over the assets estimated useful lives. Tenant improvements are amortized on a straight-line basis over the shorter of the useful life or the remaining life of the related lease. Maintenance or repairs are charged to expense as incurred. Upon sale or disposition, the historically-recorded asset cost and accumulated depreciation are removed from the respective accounts and any related gain or loss is recognized.&lt;/span&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzIw_613cf900-416a-4768-939e-b9775282b30a">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; In accordance with Accounting Standards Codification (&#x201c;ASC&#x201d;) Topic 360, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Accounting for the Impairment or Disposal of Long-Lived Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of property and equipment is measured by comparing its carrying value to the undiscounted projected future cash flows that the assets are expected to generate. If the carrying amount of an asset is not recoverable, the Company recognizes an impairment loss based on the excess of the carrying amount of the long-lived asset over its respective fair value, which is generally determined as the present value of estimated future cash flows or at the appraised value. The impairment analysis is based on significant assumptions of future results made by management, including revenue and cash flow projections. Circumstances that may lead to impairment of property and equipment include a significant decrease in the market price of a long-lived asset, a significant adverse change in the extent or manner in which a long-lived asset is being used or in its physical condition and a significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset including an adverse action or assessment by a regulator. As of December&#160;31, 2020 and 2019, the Company determined that long-lived assets were not impaired.&lt;/span&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzE2_fcfebff1-cd07-4687-a0a4-f870fbadeb5c">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Intangible Assets &#x2013;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company evaluates the carrying value of goodwill and intangible assets annually during the fourth quarter in accordance with ASC Topic 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles Goodwill and Other&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and between annual evaluations if events &lt;/span&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;occur or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Such circumstances could include, but are not limited to (1) a significant adverse change in legal factors or in business climate, (2) unanticipated competition, or (3) an adverse action or assessment by a regulator. All of the Company's goodwill and intangible assets are assigned to the Company's specialty pharmaceutical segment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill is evaluated for impairment by first performing a qualitative assessment to determine whether a quantitative goodwill test is necessary. If it is determined, based on qualitative factors, that the fair value of the reporting unit may be more likely than not less than carrying amount, or if significant adverse changes in the Company's future financial performance occur that could materially impact fair value, a quantitative goodwill impairment test would be required. Additionally, management can elect to forgo the qualitative assessment and perform the quantitative test. If the qualitative assessment indicates that the quantitative analysis should be performed, or if management elects to bypass a qualitative assessment, the Company then evaluates goodwill for impairment by comparing the fair value of the reporting unit to its carrying amount, including goodwill. The quantitative assessment for goodwill requires management to estimate the fair value of the Company's reporting units using either an income or market approach or a combination thereof. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management makes critical assumptions and estimates in completing impairment assessments of goodwill and other intangible assets. The Company's cash flow projections look several years into the future and include assumptions on variables such as future sales and operating margin growth rates, economic conditions, probability of success, market competition, inflation and discount rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the fourth quarter of 2020, the Company performed its annual goodwill impairment test and determined, after performing a qualitative test of the reporting unit, that it is more likely than not that the fair value of the reporting unit exceeds its carrying amount. Accordingly, there was no indication of impairment and the quantitative impairment test was not performed. The Company did not record any goodwill impairment charges for the years ended December&#160;31, 2020 or 2019.&lt;/span&gt;&lt;/div&gt;The Company classifies intangible assets into three categories: (1) intangible assets with definite lives subject to amortization; (2) intangible assets with indefinite lives not subject to amortization; and (3) goodwill. The Company determines the useful lives of its identifiable intangible assets after considering the specific facts and circumstances related to each intangible asset. Factors considered when determining useful lives include the contractual term of any agreement related to the asset, the historical performance of the asset, the Company's long-term strategy for using the asset, any laws or regulations which could impact the useful life of the asset and other economic factors, including competition and specific market conditions. Intangible assets that are deemed to have definite lives are amortized, primarily on a straight-line basis, over their useful lives to their estimated residual values, generally five years. In-process research &amp;amp; development ("IPR&amp;amp;D") has an indefinite life and is not amortized until completion and development of the project, at which time the IPR&amp;amp;D becomes an amortizable asset. Until such time as the projects are either completed or abandoned, the Company test those assets for impairment at least annually at year end, or more frequently at interim periods, by evaluating qualitative factors which could be indicative of impairment. Qualitative factors being considered include, but are not limited to, macro-economic conditions, progress on drug development activities, and overall financial performance. If impairment indicators are present as a result of the Company's qualitative assessment, the Company will test those assets for impairment by comparing the fair value of the assets to their carrying value. Quantitative factors being considered include, but are not limited to, the current project status, forecasted changes in the timing or amounts required to complete the project, forecasted changes in timing or changes in the future cash flows to be generated by the completed products, a probability of success of the ultimate project and changes to other market-based assumptions, such as discount rates. Upon completion or abandonment, the value of the IPR&amp;amp;D assets will be amortized to expense over the anticipated useful life of the developed products, if completed, or charged to expense when abandoned if no alternative future use exists.</us-gaap:GoodwillAndIntangibleAssetsIntangibleAssetsPolicy>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzIxOTkwMjMzMTg0MTU_6472f81a-0f9c-4c2f-9b1b-637eceeece43"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-6"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzIxOTkwMjMzMTg0MTU_e2552cf6-ec7d-48da-b1a7-b3f5e7b6b60a"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzMy_29aef42f-a77d-465a-8866-e92db7a4331d">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; The majority of the Company's revenue contracts represent a single performance obligation related to the fulfillment of customer orders for the purchase of its products. Net sales reflect the transaction prices for these contracts based on the Company's selling list price, which is then reduced by estimated costs for trade promotional programs, consumer incentives, and allowances and discounts used to incentivize sales growth and build brand awareness. The Company recognizes revenue at the point in time that control of the ordered product is transferred to the customer, which is typically upon shipment to the customer or other customer-designated delivery point. The Company accrues for estimated sales returns by customers based on historical sales return results. The computation of the sales return and discount allowances require that management makes certain estimates and assumptions that effect the timing and amounts of revenue and liabilities recorded. Shipping and handling fees charged to customers are included in product sales and totaled $0.2 million and $0.3 million for the years ended December&#160;31, &lt;/span&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2020 and 2019, respectively. Taxes collected from customers that are remitted to governmental agencies are accounted for on a net basis and not included as revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents product sales by channel for food, drug and mass ("FDM"), natural product and other, and e-commerce for the years ended December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of product sales, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of prodct sales, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retail - FDM&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retail - Natural products and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;E-Comm&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product sales, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if01f3c8b8a7e46bfb048274a7d4ddc6a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzE2NTE1_40e26413-b749-4c34-9458-c3509d649c22"
      unitRef="usd">200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i2f6446e2781145b58aadd810c3831360_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzE2NTIy_0e46f8a5-a8c2-4d10-9971-e65aecf94482"
      unitRef="usd">300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzY1OTcwNjk4MDk1Nzk_b0e435c7-95f6-4144-9793-8521f97292bf">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following represents product sales by channel for food, drug and mass ("FDM"), natural product and other, and e-commerce for the years ended December&#160;31, 2020 and 2019:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.767%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.397%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of product sales, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of prodct sales, net&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retail - FDM&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,651&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,229&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Retail - Natural products and other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15,073&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;41,534&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;E-Comm&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,705&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,933&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-27pt;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product sales, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if8aa597259fe4304b7b63ce40ce227b4_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzMtMS0xLTEtMTAwNw_02b0d6fa-90d9-47ef-bd0f-49fa40deb0a3"
      unitRef="usd">1651000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if8aa597259fe4304b7b63ce40ce227b4_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzMtMy0xLTEtMTAyMw_7568c199-c270-4ba2-8c8f-1a7b9664efb8"
      unitRef="number">0.068</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ie7864245a6d34e58aacbabaa8179f74f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzMtNS0xLTEtMTAyNw_02b66014-4f5f-47fa-ac50-5b19b10d7207"
      unitRef="usd">2229000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ie7864245a6d34e58aacbabaa8179f74f_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzMtNy0xLTEtMTAzMQ_ed821161-d28e-440e-bee2-409d3648d247"
      unitRef="number">0.042</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i70f9d718799644699f10f809156bd286_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzQtMS0xLTEtMTAxMQ_2aa5ab25-8604-4894-871e-5d18efe2bfc9"
      unitRef="usd">15073000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i70f9d718799644699f10f809156bd286_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzQtMy0xLTEtMTAyMw_bcdd185d-c2ac-4f1e-a0e5-3cc7d694cc61"
      unitRef="number">0.617</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if54d7cb037ac4f8e8327ff809a2b2c0f_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzQtNS0xLTEtMTAyNw_edb11d1c-fa16-4108-bd39-f6a565090a76"
      unitRef="usd">41534000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if54d7cb037ac4f8e8327ff809a2b2c0f_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzQtNy0xLTEtMTAzMQ_ca60c138-e112-4192-a2e2-76dc8f5a3551"
      unitRef="number">0.773</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="if3d15c156ba349c48d60f8791891481a_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzUtMS0xLTEtMTAxNQ_bd176256-ce1e-4812-b743-0033bada40a6"
      unitRef="usd">7705000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="if3d15c156ba349c48d60f8791891481a_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzUtMy0xLTEtMTAyMw_41beca9c-9e9e-4478-8c27-494a23b2eaef"
      unitRef="number">0.315</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="icf894d15f551418abe1ae2f318b3c813_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzUtNS0xLTEtMTAyNw_1daaadcc-0746-4830-9e93-dcc393ef169c"
      unitRef="usd">9933000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="icf894d15f551418abe1ae2f318b3c813_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzUtNy0xLTEtMTAzMQ_2fd77bfd-7959-4a39-8057-8df47413f207"
      unitRef="number">0.185</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzYtMS0xLTEtMTAxOQ_8331a620-c18a-4e17-8153-603761ffb4eb"
      unitRef="usd">24429000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzYtMy0xLTEtMTAyMw_95b17c73-510d-45da-85dc-785251845788"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzYtNS0xLTEtMTAyNw_a9fe349d-c43f-4629-8bf3-b9d41659e01d"
      unitRef="usd">53696000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90YWJsZTo0YTVjNzg1MWRiMmI0OTdkODk3ZTY0NGE3MDJiMmM0NS90YWJsZXJhbmdlOjRhNWM3ODUxZGIyYjQ5N2Q4OTdlNjQ0YTcwMmIyYzQ1XzYtNy0xLTEtMTAzMQ_854f2ada-fd65-47e4-9baf-b2cc20d8c8b6"
      unitRef="number">1.000</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4Njg4_33875a09-7434-43d7-99ed-d8f86fe5a683">Compensation and Benefits &#x2013; The Company records compensation and benefits expense for all cash and deferred compensation, benefits, and related taxes as earned by its employees. Compensation and benefits expense also includes compensation earned by temporary employees and contractors who perform similar services to those performed by the Company&#x2019;s employees, primarily information technology and project management activities. The Company maintains a defined contribution 401(k) plan available to eligible employees. Employee contributions are voluntary and are determined on an individual basis, limited to the maximum amount allowable under federal tax regulations. The Company, at its discretion, may make certain matching contributions to the 401(k) plan.</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzE3NTY5_bc84275c-0445-4e4a-9f43-feb843592574"
      unitRef="usd">100000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzE3NTc2_7c005d74-6f83-48ef-9d62-df5863cbb8ab"
      unitRef="usd">200000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4Njgz_37c6217e-4b29-465c-91ec-0b99e62322a8">Research and Development Expense &#x2013; Research and development costs are charged to expense as incurred and include, but are not limited to, employee salaries and benefits, cost of inventory used in product development, consulting service fees, the cost of renting and maintaining our laboratory facility and depreciation of laboratory equipment.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="iafc1a3c97c0d4080885871840e0654af_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzE4MDM5_6f5dbc19-44c9-453c-b020-df7eec5e6542"
      unitRef="usd">700000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i4ab148dfa19a48ec9bfc7253afd2d8e0_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzE4MDQ2_86a1512f-12a7-4a18-af3d-c0f72bcb2182"
      unitRef="usd">2100000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i8c7e853cfb97488bafd77f77828becba_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzMyOTg1MzQ5MjYyMDc_05d62228-3c45-46e0-ac30-ecb01f51e502"
      unitRef="usd">2200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ic13b530da3e44e4384e40cfb677c6d60_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzE4MTc5_ad07c7ec-59e1-468b-9506-8371d1a8ac62"
      unitRef="usd">3800000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:AdvertisingCostsPolicyTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzA4_7ae3ab5a-8d56-4ed5-aa4d-89271614c190">Advertising &#x2013; The Company supports its products with advertising to build brand awareness of the Company&#x2019;s various products in addition to other marketing programs executed by the Company&#x2019;s marketing team. The Company believes the continual investment in advertising is critical to the development and sale of its products.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzE4NTg5_623f0ca3-ac7f-430a-8a80-7aa21c5efa49"
      unitRef="usd">1300000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzE4NTk2_3f4913fe-89b6-4d4f-8626-dce6202ef1dd"
      unitRef="usd">2500000</us-gaap:AdvertisingExpense>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzI5_a77448f6-6754-470a-8760-65b6f2a36228">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock-Based Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; &#x2013; Certain employees, officers, directors, and consultants of the Company participate in various long-term incentive plans that provide for granting stock options, restricted stock awards, restricted stock units, stock bonus awards and performance-based awards. Stock options generally vest in equal increments over a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzY1OTcwNjk4MDk1ODc_f5674a51-c511-43ac-a681-83d953908b76"&gt;two&lt;/span&gt;- to four-year period and expire on the &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzIxOTkwMjMzMTk0MDU_d0b87cf7-bf22-4fdd-a58e-c194e22353b3"&gt;ten&lt;/span&gt;th anniversary following the date of grant. Performance-based stock options vest once the applicable performance condition is satisfied. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes stock-based compensation for equity awards granted to employees, officers and directors as compensation and benefits expense in the consolidated statements of operations. The fair value of stock options is estimated using a Black-Scholes valuation model on the date of grant. The fair value of restricted stock awards is equal to the closing price of the Company&#x2019;s stock on the date of grant. Stock-based compensation is recognized over the requisite service period of the individual awards, which generally equals the vesting period. For performance-based stock options, compensation is recognized once the applicable performance condition is satisfied.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i7a9055c1eb65417caab586e37cae413e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzY1OTcwNjk4MDk2MDU_21203a6f-20c7-4b05-8985-165c0e6463a3">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzA5_21586e54-12fa-4e85-9996-81f67d32e4f5">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2013; Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the related temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized when the rate change is enacted. Valuation allowances are recorded to reduce deferred tax assets to the amount that will more likely than not be realized. In accordance with ASC Topic 740, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company recognizes the effect of uncertain income tax positions only if the positions are more likely than not of being sustained in an audit, based on the technical merits of the position. Recognized uncertain income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in &lt;/span&gt;recognition or measurement are reflected in the period in which those changes in judgment occur. The Company recognizes both interest and penalties related to uncertain tax positions as part of the income tax provision. As of December&#160;31, 2020 and 2019 the Company did not have a liability for unrecognized tax uncertainties. The Company is subject to routine audits by taxing jurisdictions. Management believes the Company is no longer subject to tax examinations for the years prior to 2013.</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4NzMw_edbfa031-ccda-43bc-8118-ac09c3bffd61">Comprehensive Loss &#x2013; Comprehensive loss is defined as a change in equity during a period from transactions and other events and circumstances from non-owner sources. There have been no items qualifying as other comprehensive loss and, therefore, the Company's comprehensive loss was the same as its reported net loss for the years ended December&#160;31, 2020 and 2019.</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzI4Njg1_a64ea59b-6a16-42f2-92d2-1aa76b9eaf8f">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the Financial Accounting Standards Board ("FASB") issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments and subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04 and ASU 2019-05 (collectively, &#x201c;Topic 326&#x201d;). Topic 326 requires measurement and recognition of expected credit losses for financial assets held. Topic 326 was to be effective for reporting periods beginning after December 15, 2019, with early adoption permitted. In November 2019, the FASB issued ASU 2019-10, Financial Instruments - Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842) Effective Dates, which deferred the effective dates for the Company, as a smaller reporting company, until fiscal year 2023. The Company currently plans to adopt the guidance at the beginning of fiscal 2023. The Company is currently evaluating the potential impact of Topic 326 on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes ("ASU 2019-12"), which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistency among reporting entities. The new standard is effective for fiscal years beginning after December 15, 2020. Most amendments within the standard are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company is currently evaluating the potential impact of ASU 2019-12 on the Company&#x2019;s consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In January 2017, the FASB issued ASU 2017-04, Intangibles &#x2013; Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (&#x201c;ASU 2017-04&#x201d;), which eliminates Step 2 from the goodwill impairment test. Instead, an entity should perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should then recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit&#x2019;s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity should consider income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. ASU 2017-04 requires the entity to apply these amendments on a prospective basis for which it is required to disclose the nature of and reason for the change in accounting upon transition. This disclosure shall be provided in the first annual period and in the interim period within the first annual period when the entity initially adopts the amendments. This ASU became effective for the Company on January 1, 2020. Adoption of ASU 2017-04 did not have an immediate impact on the Company&#x2019;s consolidated financial statements and only has the potential to impact the amount of any goodwill impairment recorded after the adoption of the ASU.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90ZXh0cmVnaW9uOjI3MzE4NTg0YjgyMjRjNzI5MDRjYzMyMTc4NjY5ZDgyXzMzMQ_bb71a4f0-f9eb-4d4a-8f49-69ec7731480a">INVENTORY&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory as of December&#160;31, 2020 and 2019 was comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2020 and 2019, the Company recorded an inventory write-down of $0.3 million and $0.2 million, respectively. As of December&#160;31, 2020, the Company had no inventory outside the United States. As of December&#160;31, 2019, the Company had inventory outside the United States of $0.3 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90ZXh0cmVnaW9uOjI3MzE4NTg0YjgyMjRjNzI5MDRjYzMyMTc4NjY5ZDgyXzMzNA_c89c7f65-427e-42c3-828f-1cdb9cb3553a">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory as of December&#160;31, 2020 and 2019 was comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,503&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;415&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,132&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,053&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterials
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90YWJsZTo5ZmUwOTA4Yzk5Njg0ZGIyYjY1ZmFhOTJlYzgxMWRlNC90YWJsZXJhbmdlOjlmZTA5MDhjOTk2ODRkYjJiNjVmYWE5MmVjODExZGU0XzItMS0xLTEtMA_d4ae0483-7867-4ba4-84ea-3b170d5e8abc"
      unitRef="usd">4923000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryRawMaterials
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90YWJsZTo5ZmUwOTA4Yzk5Njg0ZGIyYjY1ZmFhOTJlYzgxMWRlNC90YWJsZXJhbmdlOjlmZTA5MDhjOTk2ODRkYjJiNjVmYWE5MmVjODExZGU0XzItMy0xLTEtMA_247c8bfc-94a6-4167-a615-98efcb7c125a"
      unitRef="usd">4503000</us-gaap:InventoryRawMaterials>
    <us-gaap:InventoryWorkInProcess
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90YWJsZTo5ZmUwOTA4Yzk5Njg0ZGIyYjY1ZmFhOTJlYzgxMWRlNC90YWJsZXJhbmdlOjlmZTA5MDhjOTk2ODRkYjJiNjVmYWE5MmVjODExZGU0XzMtMS0xLTEtMA_37f7d62b-6c14-42a0-891b-6c277137b860"
      unitRef="usd">785000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryWorkInProcess
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90YWJsZTo5ZmUwOTA4Yzk5Njg0ZGIyYjY1ZmFhOTJlYzgxMWRlNC90YWJsZXJhbmdlOjlmZTA5MDhjOTk2ODRkYjJiNjVmYWE5MmVjODExZGU0XzMtMy0xLTEtMA_be4468ef-46c3-45e4-90db-b7188fc0fab3"
      unitRef="usd">415000</us-gaap:InventoryWorkInProcess>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90YWJsZTo5ZmUwOTA4Yzk5Njg0ZGIyYjY1ZmFhOTJlYzgxMWRlNC90YWJsZXJhbmdlOjlmZTA5MDhjOTk2ODRkYjJiNjVmYWE5MmVjODExZGU0XzQtMS0xLTEtMA_832122a1-8fa7-42f8-a7ac-3cbc89fdd267"
      unitRef="usd">3132000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90YWJsZTo5ZmUwOTA4Yzk5Njg0ZGIyYjY1ZmFhOTJlYzgxMWRlNC90YWJsZXJhbmdlOjlmZTA5MDhjOTk2ODRkYjJiNjVmYWE5MmVjODExZGU0XzQtMy0xLTEtMA_5acc747f-8172-49ca-9092-45309986818b"
      unitRef="usd">5053000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryGross
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90YWJsZTo5ZmUwOTA4Yzk5Njg0ZGIyYjY1ZmFhOTJlYzgxMWRlNC90YWJsZXJhbmdlOjlmZTA5MDhjOTk2ODRkYjJiNjVmYWE5MmVjODExZGU0XzUtMS0xLTEtMA_e4679e7f-f4f8-491b-812c-34825e89c88a"
      unitRef="usd">8840000</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90YWJsZTo5ZmUwOTA4Yzk5Njg0ZGIyYjY1ZmFhOTJlYzgxMWRlNC90YWJsZXJhbmdlOjlmZTA5MDhjOTk2ODRkYjJiNjVmYWE5MmVjODExZGU0XzUtMy0xLTEtMA_71235fe8-7ece-4edb-89e6-a4a20338e90a"
      unitRef="usd">9971000</us-gaap:InventoryGross>
    <us-gaap:InventoryValuationReserves
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90ZXh0cmVnaW9uOjI3MzE4NTg0YjgyMjRjNzI5MDRjYzMyMTc4NjY5ZDgyXzI2NQ_b87ed1e2-c000-44ba-91d9-704f68110934"
      unitRef="usd">300000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90ZXh0cmVnaW9uOjI3MzE4NTg0YjgyMjRjNzI5MDRjYzMyMTc4NjY5ZDgyXzMyOTg1MzQ4ODM2Nzg_c093171b-3e9b-4f6c-b897-33ab27e0409e"
      unitRef="usd">200000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryGross
      contextRef="if25ec98df6e64c53939bb7efcbfb124b_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90ZXh0cmVnaW9uOjI3MzE4NTg0YjgyMjRjNzI5MDRjYzMyMTc4NjY5ZDgyXzIxOTkwMjMyNTYzMTk_9c94a247-c369-460e-9178-a28b9b395a31"
      unitRef="usd">0</us-gaap:InventoryGross>
    <us-gaap:InventoryGross
      contextRef="i0d8eb0e4462f4dccb7cee6c898b097bf_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDUvZnJhZzoyNzMxODU4NGI4MjI0YzcyOTA0Y2MzMjE3ODY2OWQ4Mi90ZXh0cmVnaW9uOjI3MzE4NTg0YjgyMjRjNzI5MDRjYzMyMTc4NjY5ZDgyXzMyOTg1MzQ4ODM4OTk_e942c5f4-89f2-4b46-b88b-b1d79d740e23"
      unitRef="usd">300000</us-gaap:InventoryGross>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90ZXh0cmVnaW9uOjAzOTkzYjBmZDE3ODRlOWI5ODIzYmE3NTY2OThhMzVhXzM0MA_b136d5b7-6b20-4748-a57d-cc0ef59d5136">PROPERTY &amp;amp; EQUIPMENT&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net, as of December&#160;31, 2020 and 2019 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.089%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tenant improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory and other equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* Tenant improvements are amortized over the lesser of the remaining term of the related lease or the estimated useful life of the tenant improvements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense for the years ended December&#160;31, 2020 and 2019 was $0.8 million and $0.7 million, respectively.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90ZXh0cmVnaW9uOjAzOTkzYjBmZDE3ODRlOWI5ODIzYmE3NTY2OThhMzVhXzMzOA_a758bd0f-66aa-48b8-bede-884219dd67cd">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment, net, as of December&#160;31, 2020 and 2019 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:57.089%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.848%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.112%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.115%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Office furniture and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3 - 5 years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,596&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,285&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Tenant improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Laboratory and other equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;691&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,269&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,170&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,392)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,555)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,615&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;* Tenant improvements are amortized over the lesser of the remaining term of the related lease or the estimated useful life of the tenant improvements.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i80b463299c26463ca972ff8dfaeefa07_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzItMS0xLTEtMC90ZXh0cmVnaW9uOjJkNTlmYTM4Yzk3YzQyNDQ5ODA0YTYzNDYyNzE4NGNhXzIxOTkwMjMyNTU1Njg_a9cd0dc6-8f13-43f4-a1b0-6c423fdd703d">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="id4f11b83791e4d0b89e930d959aa4d4c_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzItMS0xLTEtMC90ZXh0cmVnaW9uOjJkNTlmYTM4Yzk3YzQyNDQ5ODA0YTYzNDYyNzE4NGNhXzIxOTkwMjMyNTU1NzI_723b2834-403a-4f72-8835-56dcf7b7f061">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i052975c55e0d4a6d81b116eed98ad8ad_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzItMy0xLTEtMA_8d9686cb-cce9-4960-bc88-c24d1ea95fe5"
      unitRef="usd">2596000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ifeda5edcf0e343769d5a4ca6eb1ca2ad_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzItNS0xLTEtMA_faf08968-1146-4c6f-ab56-97132aadaa39"
      unitRef="usd">1285000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i28b6a29ef2f34583975d18a2fb7b09a4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzMtMy0xLTEtMA_99de5e72-5969-4a6d-8ce9-19139d741fdf"
      unitRef="usd">1967000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i934d7b1779574fc9bec6c9c0df80e88e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzMtNS0xLTEtMA_1b07fc2f-b9bb-4eae-9dea-01d6ce3377d8"
      unitRef="usd">1925000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="ia86834c02416429a998a484d9434a8e1_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzQtMS0xLTEtMA_713ddfff-a532-49e7-b797-729e7b61821b">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9518c9e514be4d70877b504c26d8c59d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzQtMy0xLTEtMA_a34ea2fd-8eed-4e76-9106-a20c2bbd1d0f"
      unitRef="usd">691000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iba1ca127b1714615af145434271838ed_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzQtNS0xLTEtMA_e95571e0-66dd-4414-9047-980316c5ea96"
      unitRef="usd">691000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id25e838c282448c79258da27d6aefa6d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzUtMy0xLTEtMA_06ff506a-de3c-4146-a895-2c7646d71940"
      unitRef="usd">15000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic1d3e49783f149a084f798c4590d9931_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzUtNS0xLTEtMA_af76ba53-721c-4d47-b2e4-b04ddcd4c797"
      unitRef="usd">1269000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzYtMy0xLTEtMA_8302fc49-feb0-48e6-91f4-ec81fe897fa5"
      unitRef="usd">5269000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzYtNS0xLTEtMA_ed229c68-59e8-4c94-b9e2-bd53bec7fe7b"
      unitRef="usd">5170000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzctMy0xLTEtMA_227d54a2-dbdc-4454-b0b8-1043e9de2ecc"
      unitRef="usd">2392000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzctNS0xLTEtMA_19b781f0-08f9-4b7c-bdae-c96f1c1e1068"
      unitRef="usd">1555000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzgtMy0xLTEtMA_cee2f17d-6b3a-4136-b9f5-5b104b70644a"
      unitRef="usd">2877000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90YWJsZTo2MGU0NTNjYmY4OWU0MDA3OGYwNjBmODUwZTlmMTY3OS90YWJsZXJhbmdlOjYwZTQ1M2NiZjg5ZTQwMDc4ZjA2MGY4NTBlOWYxNjc5XzgtNS0xLTEtMA_1709ff70-b4b2-4c9d-b94a-6e69206f1cd3"
      unitRef="usd">3615000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90ZXh0cmVnaW9uOjAzOTkzYjBmZDE3ODRlOWI5ODIzYmE3NTY2OThhMzVhXzMxNQ_e2ff8923-6708-440a-889c-004fc2acb3b9"
      unitRef="usd">800000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNDgvZnJhZzowMzk5M2IwZmQxNzg0ZTliOTgyM2JhNzU2Njk4YTM1YS90ZXh0cmVnaW9uOjAzOTkzYjBmZDE3ODRlOWI5ODIzYmE3NTY2OThhMzVhXzMyMg_08b63506-bf54-41a8-b74b-90ad9100b02e"
      unitRef="usd">700000</us-gaap:Depreciation>
    <us-gaap:IntangibleAssetsDisclosureTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90ZXh0cmVnaW9uOmFmOWQ0YjM2NjhhZjQ5NzE5ODNlZGVmMTU5ODU5Yzc5XzM4OQ_064ff4a1-1b0a-41cd-98e7-09fd0fbbfc5d">INTANGIBLE ASSETS&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consist of the following as of December&#160;31, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.836%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Useful Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - December 31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - December 31, 2019:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The Company did not incur costs to renew or extend the term of acquired intangible assets for the years ended December&#160;31, 2020 and 2019. Amortization expense for intangible assets was $36 thousand and $35 thousand for the years ended December&#160;31, 2020 and 2019, respectively. There is no future amortization expense.</us-gaap:IntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90ZXh0cmVnaW9uOmFmOWQ0YjM2NjhhZjQ5NzE5ODNlZGVmMTU5ODU5Yzc5XzM4Ng_51b68b4f-4852-4530-896f-ea6b79b8829c">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets consist of the following as of December&#160;31, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.308%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.836%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.402%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Useful Life (Years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - December 31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;177&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance - December 31, 2019:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;In-process research and development&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,730&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Trade names&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-compete agreements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;77&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,907&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,766&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i24523ddf355143439c1af05532a3151a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzItMS0xLTEtMA_07f3e800-19b1-48e2-ac36-dce675f139d1"
      unitRef="usd">3730000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i24523ddf355143439c1af05532a3151a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzItMy0xLTEtMA_6d21cab7-bfe3-40c4-9aee-605b05346541"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i24523ddf355143439c1af05532a3151a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzItNS0xLTEtMA_47765f64-9e04-4e38-a848-c2725f14e73e"
      unitRef="usd">3730000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i78a46d9043e74a11aadbd6f65daf06f0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzMtMS0xLTEtMA_4338dda9-2288-4e15-91b1-9977b7ed38f6"
      unitRef="usd">100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i78a46d9043e74a11aadbd6f65daf06f0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzMtMy0xLTEtMA_3ebdba29-9f8b-4ad9-96de-ae4de6845f08"
      unitRef="usd">100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i78a46d9043e74a11aadbd6f65daf06f0_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzMtNS0xLTEtMA_339fe9cc-ef50-4459-bd1f-765d78613be9"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ie07b37afc2754e398a196bfcb6c55c30_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzMtNy0xLTEtMA_1fff14b0-2f17-496b-b51d-acd2aa0e1625">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i46bcdf3737e4410c9206873ea3b39599_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzQtMS0xLTEtMA_db02fa39-fe40-4e6e-89f1-37e007d3467c"
      unitRef="usd">77000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i46bcdf3737e4410c9206873ea3b39599_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzQtMy0xLTEtMA_03c9b49d-b810-4224-819d-453796fa0134"
      unitRef="usd">77000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i46bcdf3737e4410c9206873ea3b39599_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzQtNS0xLTEtMA_1777c5a4-a49a-402a-8edb-b70d503d7d03"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i0f8eb91898874f04aea260438b7f2aa9_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzQtNy0xLTEtMA_5f04e394-fe28-45ab-8871-0b7a0b3cdb2e">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzUtMS0xLTEtMA_dfda86da-997c-4c55-a65c-1fba9f65bebf"
      unitRef="usd">3907000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzUtMy0xLTEtMA_1ad077be-e058-49ae-a118-50c727f2601e"
      unitRef="usd">177000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzUtNS0xLTEtMA_5d68e240-5440-4d4e-850a-afa5dbeab00d"
      unitRef="usd">3730000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i86dca6f99d5c4d1297b510610a68e59e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzgtMS0xLTEtMA_edbb5714-3366-44db-92f9-72ab2b9278ec"
      unitRef="usd">3730000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i86dca6f99d5c4d1297b510610a68e59e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzgtMy0xLTEtMA_5f3ba2ad-c327-42fa-86d0-9c7d898eb195"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i86dca6f99d5c4d1297b510610a68e59e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzgtNS0xLTEtMA_fe12c939-9080-4dfb-b8f2-c72b5e2e6e95"
      unitRef="usd">3730000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i99b603840d5c471597402724690a24b2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzktMS0xLTEtMA_9e5eedb4-d31e-4922-a434-d95e71f1cb80"
      unitRef="usd">100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i99b603840d5c471597402724690a24b2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzktMy0xLTEtMA_2f13cf95-7c37-4caf-b710-73a74dab4824"
      unitRef="usd">80000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i99b603840d5c471597402724690a24b2_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzktNS0xLTEtMA_83cf2e5b-0aea-4d46-80c2-986280acba96"
      unitRef="usd">20000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i4f83a0e15d4f46709af062728537490d_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzktNy0xLTEtMA_20db485d-2987-49c7-9de7-c093dfe2376d">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id6886463cfa747f2937d6827839da75e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzEwLTEtMS0xLTA_6c30f359-938a-49e5-9122-c85c3468b684"
      unitRef="usd">77000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id6886463cfa747f2937d6827839da75e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzEwLTMtMS0xLTA_eeedffd3-28ea-41e5-930d-c146ab536fbd"
      unitRef="usd">61000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id6886463cfa747f2937d6827839da75e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzEwLTUtMS0xLTA_6134b939-ea34-460c-8165-c2cbd3b78b5f"
      unitRef="usd">16000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i9d576fcf864e471bb409eafe4c6155e0_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzEwLTctMS0xLTA_363d1b9b-d3dc-4aa7-b7ad-d04e547d3a30">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzExLTEtMS0xLTA_c5d1b19d-e909-47b3-b19b-3f7904f4eaf0"
      unitRef="usd">3907000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzExLTMtMS0xLTA_e9502aa3-2e28-40ae-8f41-d0b197ae0389"
      unitRef="usd">141000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90YWJsZTpjZjczZTI5ZGU4NDU0Y2E4YWIxMWI0M2ZkNjM2NTA5YS90YWJsZXJhbmdlOmNmNzNlMjlkZTg0NTRjYThhYjExYjQzZmQ2MzY1MDlhXzExLTUtMS0xLTA_6f2d4ba9-9103-427d-95e0-14198bded903"
      unitRef="usd">3766000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:AdjustmentForAmortization
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90ZXh0cmVnaW9uOmFmOWQ0YjM2NjhhZjQ5NzE5ODNlZGVmMTU5ODU5Yzc5XzI3MQ_8c97ec58-92db-4012-9279-1bed83e66f6c"
      unitRef="usd">36000</us-gaap:AdjustmentForAmortization>
    <us-gaap:AdjustmentForAmortization
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90ZXh0cmVnaW9uOmFmOWQ0YjM2NjhhZjQ5NzE5ODNlZGVmMTU5ODU5Yzc5XzMyOTg1MzQ4ODM4MTk_8a23b6c8-863f-468b-a5d4-1d2e620c25dd"
      unitRef="usd">35000</us-gaap:AdjustmentForAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNTQvZnJhZzphZjlkNGIzNjY4YWY0OTcxOTgzZWRlZjE1OTg1OWM3OS90ZXh0cmVnaW9uOmFmOWQ0YjM2NjhhZjQ5NzE5ODNlZGVmMTU5ODU5Yzc5XzIxOTkwMjMyNTYwMjc_fea57107-06c4-4cd8-ad68-6162c09b361d"
      unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjAvZnJhZzo1ZTAyNTA3YzVjMzI0YjQ4ODVlMTBjZDBlMWE5NmY0ZS90ZXh0cmVnaW9uOjVlMDI1MDdjNWMzMjRiNDg4NWUxMGNkMGUxYTk2ZjRlXzkz_7ec0ecbe-ca4b-492f-8adf-3f8f98f1ba8d">ACCRUED EXPENSES&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses as of December&#160;31, 2020 and 2019 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued payroll expenses (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1) This includes a tax liability associated with a related party transaction as discussed in Note 11 of $6.2 million and $6.6 million as of December&#160;31, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjAvZnJhZzo1ZTAyNTA3YzVjMzI0YjQ4ODVlMTBjZDBlMWE5NmY0ZS90ZXh0cmVnaW9uOjVlMDI1MDdjNWMzMjRiNDg4NWUxMGNkMGUxYTk2ZjRlXzk2_aad5f458-774f-48e9-98ba-ba3bd0c49116">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued expenses as of December&#160;31, 2020 and 2019 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued payroll expenses (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,324&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,787&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,069&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,805&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,856&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1) This includes a tax liability associated with a related party transaction as discussed in Note 11 of $6.2 million and $6.6 million as of December&#160;31, 2020 and 2019, respectively.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedSalariesCurrent
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjAvZnJhZzo1ZTAyNTA3YzVjMzI0YjQ4ODVlMTBjZDBlMWE5NmY0ZS90YWJsZTo1YjQ2ODExNzNlOGI0ZTg0YTk1MTNhYzBhNzgxNDQ4NS90YWJsZXJhbmdlOjViNDY4MTE3M2U4YjRlODRhOTUxM2FjMGE3ODE0NDg1XzItMS0xLTEtMA_2d564286-fa22-4a79-999b-6e5a321d8885"
      unitRef="usd">8324000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjAvZnJhZzo1ZTAyNTA3YzVjMzI0YjQ4ODVlMTBjZDBlMWE5NmY0ZS90YWJsZTo1YjQ2ODExNzNlOGI0ZTg0YTk1MTNhYzBhNzgxNDQ4NS90YWJsZXJhbmdlOjViNDY4MTE3M2U4YjRlODRhOTUxM2FjMGE3ODE0NDg1XzItMy0xLTEtMA_40b3b55f-9c10-4ffc-b89b-d6c2a2937a24"
      unitRef="usd">8787000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjAvZnJhZzo1ZTAyNTA3YzVjMzI0YjQ4ODVlMTBjZDBlMWE5NmY0ZS90YWJsZTo1YjQ2ODExNzNlOGI0ZTg0YTk1MTNhYzBhNzgxNDQ4NS90YWJsZXJhbmdlOjViNDY4MTE3M2U4YjRlODRhOTUxM2FjMGE3ODE0NDg1XzMtMS0xLTEtMA_4f7854bc-f3af-4db4-9336-6bc013f36475"
      unitRef="usd">1481000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjAvZnJhZzo1ZTAyNTA3YzVjMzI0YjQ4ODVlMTBjZDBlMWE5NmY0ZS90YWJsZTo1YjQ2ODExNzNlOGI0ZTg0YTk1MTNhYzBhNzgxNDQ4NS90YWJsZXJhbmdlOjViNDY4MTE3M2U4YjRlODRhOTUxM2FjMGE3ODE0NDg1XzMtMy0xLTEtMA_1cedca39-cebf-4540-9898-4f871a8286df"
      unitRef="usd">2069000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjAvZnJhZzo1ZTAyNTA3YzVjMzI0YjQ4ODVlMTBjZDBlMWE5NmY0ZS90YWJsZTo1YjQ2ODExNzNlOGI0ZTg0YTk1MTNhYzBhNzgxNDQ4NS90YWJsZXJhbmdlOjViNDY4MTE3M2U4YjRlODRhOTUxM2FjMGE3ODE0NDg1XzQtMS0xLTEtMA_86e79598-2346-4af4-a369-8c621cf06678"
      unitRef="usd">9805000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjAvZnJhZzo1ZTAyNTA3YzVjMzI0YjQ4ODVlMTBjZDBlMWE5NmY0ZS90YWJsZTo1YjQ2ODExNzNlOGI0ZTg0YTk1MTNhYzBhNzgxNDQ4NS90YWJsZXJhbmdlOjViNDY4MTE3M2U4YjRlODRhOTUxM2FjMGE3ODE0NDg1XzQtMy0xLTEtMA_79bbbef7-8a76-4c94-8e86-9231c79367c0"
      unitRef="usd">10856000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="i5dfcb74883a1467d82e99d0d2ce81499_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjAvZnJhZzo1ZTAyNTA3YzVjMzI0YjQ4ODVlMTBjZDBlMWE5NmY0ZS90YWJsZTo1YjQ2ODExNzNlOGI0ZTg0YTk1MTNhYzBhNzgxNDQ4NS90YWJsZXJhbmdlOjViNDY4MTE3M2U4YjRlODRhOTUxM2FjMGE3ODE0NDg1XzUtMC0xLTEtNjEvdGV4dHJlZ2lvbjpjMmEzYmFhMjIzNGI0NjBjOWE4YzQzZjBjM2M1YTg4M18yMTk5MDIzMjU1Njc1_5d00f312-e02e-4b36-95b1-bceda07c5354"
      unitRef="usd">6200000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="i051b211947594052beb7406aed759748_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjAvZnJhZzo1ZTAyNTA3YzVjMzI0YjQ4ODVlMTBjZDBlMWE5NmY0ZS90YWJsZTo1YjQ2ODExNzNlOGI0ZTg0YTk1MTNhYzBhNzgxNDQ4NS90YWJsZXJhbmdlOjViNDY4MTE3M2U4YjRlODRhOTUxM2FjMGE3ODE0NDg1XzUtMC0xLTEtNjEvdGV4dHJlZ2lvbjpjMmEzYmFhMjIzNGI0NjBjOWE4YzQzZjBjM2M1YTg4M18zMjk4NTM0ODgzNjYy_03bc678e-bbfe-4288-bbd7-5710a39b2cf3"
      unitRef="usd">6600000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzY3NQ_1d9ed12a-77a2-4d12-a429-503651abd53c">DEBT&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt as of December&#160;31, 2020 was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.717%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PPP loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion of debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion of debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company did not have any debt as of December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Principal payments on the debt are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.717%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total principal payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Paycheck Protection Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April 15, 2020, the Company applied for a loan from JPMorgan Chase Bank, N.A., as lender, pursuant to the Paycheck Protection Program of the CARES Act as administered by the U.S. Small Business Administration. On April 17, 2020, the loan was approved, and the Company received proceeds in the amount of $2.9&#160;million (the &#x201c;PPP Loan&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The PPP Loan, which took the form of a promissory note, matures on April 15, 2022 and bears interest at a rate of 0.98% per annum (the &#x201c;Promissory Note&#x201d;). The Company did not provide any collateral or guarantees for the PPP Loan, nor did the Company pay any facility charge to obtain the PPP Loan. The Promissory Note provides for customary events of default, including, among others, those relating to failure to make payment, bankruptcy, breaches of representations and material adverse effects. The Company may prepay the principal of the PPP Loan at any time without incurring any prepayment charges.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the CARES Act, loan forgiveness is available for the sum of documented payroll costs, covered rent payments, and covered utilities during the covered period of 8 weeks beginning on the date of loan approval. For purposes of the CARES Act, payroll costs exclude compensation of an individual employee in excess of $100,000, prorated annually. Not more than 25% of the forgiven amount may be for non-payroll costs. Forgiveness is reduced if full-time headcount declines, or if salaries and wages for employees with salaries of $100,000 or less annually are reduced by more than 25%. In the event the PPP Loan, or any portion thereof, is forgiven pursuant to the PPP, the amount forgiven is applied to outstanding principal.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Paycheck Protection Program Flexibility Act of 2020 (the &#x201c;PPP Flexibility Act&#x201d;), enacted on June 5, 2020, amended the Paycheck Protection Program, among others, as follows: (i) extended the covered period from 8 weeks to 24 weeks from the date the PPP Loan is originated, during which PPP funds needed to be expended in order to be forgiven. A borrower may submit a loan forgiveness application any time on or before the maturity date of the loan &#x2013; including before the end of the covered period &#x2013; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;if the borrower has used all of the loan proceeds for which the borrower is requesting forgiveness. (ii) at least 60% of PPP funds must be spent on payroll costs, with the remaining 40% available to spend on other eligible expenses. (iii) payments are deferred until the date on which the amount of forgiveness determined is remitted to the lender. If a borrower fails to seek forgiveness within 10 months after the last day of its covered period, then payments will begin on the date that is 10 months after the last day of the covered period. In addition, the PPP Flexibility Act modified the CARES Act by increasing the maturity date for loans made after the effective date from two years to a minimum maturity of five years from the date on which the borrower applies for loan forgiveness. Existing PPP loans made before the new legislation retain their original two-year term, but may be renegotiated between a lender and a borrower to match the 5-year term permitted under the PPP Flexibility Act.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company intends to apply for loan forgiveness within the required timeframe. No assurance is provided that the Company will obtain forgiveness of the PPP Loan in whole or in part. The promissory note is classified as long-term except for the portion to be paid within twelve months of the year-end, which is classified as current.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Unsecured Note Payable&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2018, the Company entered into a finance agreement with First Insurance Funding in order to fund a portion of its insurance policies, which was amended in January 2019. The amount financed was $0.5 million and incurred interest at a rate of 5.15%. The Company was required to make monthly payments of $0.1 million through July 2019. As of December&#160;31, 2019, amounts were repaid in full.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2020, the Company entered into a finance agreement with First Insurance Funding in order to fund a portion of its insurance policies. The amount financed is $0.7 million and incurs interest at a rate of 3.60%. The Company is required to make monthly payments of $0.1 million through July 2021. The outstanding balance as of December&#160;31, 2020 was $0.7 million.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfDebtTableTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzY1OTcwNjk3ODI4MTA_303f5720-91fc-4377-a5fb-32be7969b8b4">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt as of December&#160;31, 2020 was as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.717%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PPP loan&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,906&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Insurance financing&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;721&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Current portion of debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,174)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Long-term portion of debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtTableTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9869509e2682490b9a206064b3920d90_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90YWJsZTphMGQxNzIwOTkzMDg0MjMwYmVkYjYwMzI4YjI5M2NmMC90YWJsZXJhbmdlOmEwZDE3MjA5OTMwODQyMzBiZWRiNjAzMjhiMjkzY2YwXzItMS0xLTEtMzQyMg_96b3b3f9-7c46-4a18-8d92-104d046c3c5b"
      unitRef="usd">2906000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i2f85a3238c7b4681b71554667cce5b1e_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90YWJsZTphMGQxNzIwOTkzMDg0MjMwYmVkYjYwMzI4YjI5M2NmMC90YWJsZXJhbmdlOmEwZDE3MjA5OTMwODQyMzBiZWRiNjAzMjhiMjkzY2YwXzMtMS0xLTEtMzQyMg_89660dbe-773a-4069-9a17-bb799d0781c8"
      unitRef="usd">721000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90YWJsZTphMGQxNzIwOTkzMDg0MjMwYmVkYjYwMzI4YjI5M2NmMC90YWJsZXJhbmdlOmEwZDE3MjA5OTMwODQyMzBiZWRiNjAzMjhiMjkzY2YwXzQtMS0xLTEtMzQyMg_a49a1851-8e65-4266-b7e2-31bfd3e9fe66"
      unitRef="usd">3627000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:LongTermDebtCurrent
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90YWJsZTphMGQxNzIwOTkzMDg0MjMwYmVkYjYwMzI4YjI5M2NmMC90YWJsZXJhbmdlOmEwZDE3MjA5OTMwODQyMzBiZWRiNjAzMjhiMjkzY2YwXzUtMS0xLTEtMzQ3NA_9611fd1b-f44e-4513-bd6d-98430dab497c"
      unitRef="usd">2174000</us-gaap:LongTermDebtCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90YWJsZTphMGQxNzIwOTkzMDg0MjMwYmVkYjYwMzI4YjI5M2NmMC90YWJsZXJhbmdlOmEwZDE3MjA5OTMwODQyMzBiZWRiNjAzMjhiMjkzY2YwXzYtMS0xLTEtMzQ4NA_7021206b-1955-476d-adca-ffc577ea13e7"
      unitRef="usd">1453000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzIxOTkwMjMyNzI0NDQ_b0859d86-0a07-4828-8a72-e9bd1247f861">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Principal payments on the debt are as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.717%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,174&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,453&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total principal payments&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90YWJsZTplNTY5OTJkNTQ4MWU0YzcyYmY3NzM1MWVlZjVlNDM4NC90YWJsZXJhbmdlOmU1Njk5MmQ1NDgxZTRjNzJiZjc3MzUxZWVmNWU0Mzg0XzEtMS0xLTEtNzAxMQ_e5ebcab2-2b38-49fb-9fdf-2d3985abb22f"
      unitRef="usd">2174000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths>
    <us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90YWJsZTplNTY5OTJkNTQ4MWU0YzcyYmY3NzM1MWVlZjVlNDM4NC90YWJsZXJhbmdlOmU1Njk5MmQ1NDgxZTRjNzJiZjc3MzUxZWVmNWU0Mzg0XzItMS0xLTEtNzAxNQ_dabe6ac5-90d9-41eb-abcd-b0065d786795"
      unitRef="usd">1453000</us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90YWJsZTplNTY5OTJkNTQ4MWU0YzcyYmY3NzM1MWVlZjVlNDM4NC90YWJsZXJhbmdlOmU1Njk5MmQ1NDgxZTRjNzJiZjc3MzUxZWVmNWU0Mzg0XzMtMS0xLTEtNzAxOQ_12382ea7-7378-4049-b5de-6ee0900c8df4"
      unitRef="usd">3627000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:ProceedsFromIssuanceOfLongTermDebt
      contextRef="i27feea483e57465a9526919db75d6d01_D20200417-20200417"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzY1OTcwNjk3ODI4MTI_0f9baa8b-31f0-4e0d-a993-455de77d87e0"
      unitRef="usd">2900000</us-gaap:ProceedsFromIssuanceOfLongTermDebt>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i0461202b2e27451b9b8caee714491a29_I20200417"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzY1OTcwNjk3ODI4MjY_9a5abcfc-96a1-45cb-a405-61ed742900c8"
      unitRef="number">0.0098</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="ie007d6f497f642ab81bc374925609676_I20181031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzMyOTg1MzQ4OTc1Nzk_087b93d5-de0b-467b-9990-a44d8d7ce99b"
      unitRef="usd">500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="ie007d6f497f642ab81bc374925609676_I20181031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzMyOTg1MzQ4OTc1ODg_f8724ac7-6ff8-4e06-83e7-75d21f978ac1"
      unitRef="number">0.0515</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="ibcfcb94673094dfa87f562c52cfef25e_D20181001-20181031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzMyOTg1MzQ4OTc1OTI_80e61275-6d07-4dad-a44d-5968ef6c842f"
      unitRef="usd">100000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:DebtInstrumentFaceAmount
      contextRef="i3a704f978fb548eca2e891c2407e5390_I20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzMyOTg1MzQ4OTg4MDA_9b328662-a0b8-426c-9989-a88c522ade23"
      unitRef="usd">700000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="i3a704f978fb548eca2e891c2407e5390_I20201031"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzMyOTg1MzQ4OTg3ODE_263e040e-5c76-4bf3-8d07-1e08dd58cfab"
      unitRef="number">0.0360</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentPeriodicPayment
      contextRef="i794dcec76c204870a043fce5338d2a6f_D20201001-20201031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzMyOTg1MzQ4OTk0NzM_52f2a5cd-74e8-43d7-9af9-beb42ece0de7"
      unitRef="usd">100000</us-gaap:DebtInstrumentPeriodicPayment>
    <us-gaap:UnsecuredDebt
      contextRef="i2f85a3238c7b4681b71554667cce5b1e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjYvZnJhZzo4ZmY2MTI0NjFkZDA0MTQ3OWZlODVjOTc5Njk2NjdlMi90ZXh0cmVnaW9uOjhmZjYxMjQ2MWRkMDQxNDc5ZmU4NWM5Nzk2OTY2N2UyXzMyOTg1MzQ4OTg4ODY_2f96dc6a-7932-44fe-a18b-e4a069789599"
      unitRef="usd">700000</us-gaap:UnsecuredDebt>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzgzMg_901a90d1-45eb-44f4-a888-91c679c58526">STOCKHOLDERS EQUITY&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Common Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is authorized to issue up to 190,000,000 shares of common stock (par value $0.0001). As of December&#160;31, 2020 and 2019, the Company had 100,664,000 and 99,416,000 shares of common stock issued and outstanding, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 8, 2020, the Company entered into a common stock purchase agreement ("SPA") with Tumim Stone Capital, LLC ("Tumim") to issue and sell up to $10.0 million in shares of the Company's common stock. The SPA provides, among other things, that the Company may direct, every three trading days, Tumim to purchase a number of shares not to exceed an amount determined based upon the trading volume and stock price of the Company&#x2019;s shares. The Company determined that the right to sell shares of common stock to Tumim under the SPA represents a freestanding put option under ASC 815 Derivatives and Hedging. Tumim has no right to require the Company to sell any shares of common stock to Tumim, but Tumim is obligated to purchase up to $10.0 million of the Company's common stock. Such sales of common stock by the Company will be subject to certain limitations, and may occur from time to time, at the Company's sole discretion till December 31, 2021. The Company determined that the fair value of the put option is zero as the shares will be issued at a discount and settled within one business day. During the year ended December&#160;31, 2020, the Company sold 450,000 shares of common stock pursuant to the SPA and recognized proceeds of $0.2 million. The Company issued 185,454 shares of common stock to Tumim as commitment fee in connection with entering into the SPA. In addition, the Company incurred offering cost of $0.3 million. In accordance with ASC 825-10-25-3, upfront costs and fees related to items for which the fair value option is elected shall be recognized in earnings as incurred and not deferred. As such, the Company recorded the fair value of the commitment fee shares of $0.1 million and offering cost of $0.3 million to general and administrative expense. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is authorized to issue up to 10,000,000 shares of $0.0001 par value preferred stock with designations, rights and preferences to be determined from time to time by the Board of Directors. Each such series or class shall have voting powers, if any, and such preferences and/or other special rights, with such qualifications, limitations or restrictions of such preferences and/or rights as shall be stated in the resolution or resolutions providing for the issuance of such series or class of shares of preferred stock. As of December&#160;31, 2020, and 2019, there is no preferred stock issued and outstanding.&lt;/span&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzgy_9a196fd4-f7b3-4977-8479-579b354da6e5"
      unitRef="shares">190000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzgy_dcf11c6d-55ff-4e7c-8f77-8deab2192c1f"
      unitRef="shares">190000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzExOQ_2affef7e-ddb4-4ffe-a6ed-e82376eddeaf"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzExOQ_412ef2e5-af30-4d87-88b4-d61be7ba18c7"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzE1Nw_199b797a-b488-47dc-a08e-8f73d856a6df"
      unitRef="shares">100664000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzE1Nw_1d25e84c-8edc-4528-af7d-5c8ea6f7289d"
      unitRef="shares">100664000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzE2NA_afdea959-f80c-44be-92a0-201f295815b3"
      unitRef="shares">99416000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzE2NA_f6f9c367-4969-4237-a3ac-c342f61ce0c5"
      unitRef="shares">99416000</us-gaap:CommonStockSharesIssued>
    <cvsi:SaleOfStockMaximumValueOfSharesIssuedInTransaction
      contextRef="i5ce71eb8f7d045f680a63998d5ebc762_D20201208-20201208"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzMyOTg1MzQ4ODQ0MDg_7ae932eb-fb06-4b68-8da7-6e26534a8e3b"
      unitRef="usd">10000000.0</cvsi:SaleOfStockMaximumValueOfSharesIssuedInTransaction>
    <cvsi:SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock
      contextRef="i5ce71eb8f7d045f680a63998d5ebc762_D20201208-20201208"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzY1OTcwNjk3NzAzNTc_989521e1-281e-4f15-95c4-92dc138957cc"
      unitRef="tradingday">3</cvsi:SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock>
    <cvsi:SaleOfStockMaximumValueOfSharesIssuedInTransaction
      contextRef="i5ce71eb8f7d045f680a63998d5ebc762_D20201208-20201208"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzMyOTg1MzQ4ODYxMjE_7ae932eb-fb06-4b68-8da7-6e26534a8e3b"
      unitRef="usd">10000000.0</cvsi:SaleOfStockMaximumValueOfSharesIssuedInTransaction>
    <cvsi:SaleOfStockFairValueOfPutOption
      contextRef="ia5dcf374512b4bb6ad637f627f49d3ca_I20201208"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzMyOTg1MzQ4ODY0MDc_7260cc7b-5415-4a8a-a92c-0bd6404ba05e"
      unitRef="usdPerShare">0</cvsi:SaleOfStockFairValueOfPutOption>
    <cvsi:SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement
      contextRef="i5ce71eb8f7d045f680a63998d5ebc762_D20201208-20201208"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzY1OTcwNjk3NzAzNzA_821992a7-f632-44a6-870c-9a8f6b5620db"
      unitRef="businessday">1</cvsi:SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i7e602472f0d2419187a53398197f884a_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzMyOTg1MzQ4ODUxMTU_aa908b36-ecc5-4b52-b1b4-eda04bd53d96"
      unitRef="shares">450000</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i7e602472f0d2419187a53398197f884a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzMyOTg1MzQ4ODUxOTE_e5a35bec-73b8-46a4-9bf5-92949140e71a"
      unitRef="usd">200000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <us-gaap:StockIssuedDuringPeriodSharesIssuedForServices
      contextRef="i7e602472f0d2419187a53398197f884a_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzMyOTg1MzQ4ODQ3NDE_cd50b086-764c-42ab-bd5a-9f632aea5b54"
      unitRef="shares">185454</us-gaap:StockIssuedDuringPeriodSharesIssuedForServices>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i7e602472f0d2419187a53398197f884a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzMyOTg1MzQ4ODY2MTQ_89cc4a64-085f-4ba2-a71c-eae34b6b02a3"
      unitRef="usd">300000</us-gaap:PaymentsOfStockIssuanceCosts>
    <cvsi:SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee
      contextRef="i7e602472f0d2419187a53398197f884a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzMyOTg1MzQ4ODQ5MDk_7546442b-5d63-4217-a596-155c8684c5a7"
      unitRef="usd">100000</cvsi:SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="i7e602472f0d2419187a53398197f884a_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzMyOTg1MzQ4ODU0MzI_89cc4a64-085f-4ba2-a71c-eae34b6b02a3"
      unitRef="usd">300000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzI4NQ_327e5d54-0fe3-4764-acad-5ea88b0ecea8"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzI4NQ_8e93021a-e3ae-4c02-aa1e-e2aefc155025"
      unitRef="shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzI5OA_33ff0629-ed1d-4cc7-9821-1f4a29e167cc"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzI5OA_dd2b608e-ee2e-48f8-8822-ce1f1b96da19"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzY1OTcwNjk3NzAzMjg_130f1a66-d7bc-45f8-af3b-00a017553a23"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzY1OTcwNjk3NzAzMjg_a4a0fcc0-267d-4079-b97d-267a26265007"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzY1OTcwNjk3NzAzMjg_be0300f0-459e-47a9-a39c-90c4badd383c"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNjkvZnJhZzo3YWIzM2IzODNkZWY0OGQyYmNmMzk2NjFlY2RlNzkyMi90ZXh0cmVnaW9uOjdhYjMzYjM4M2RlZjQ4ZDJiY2YzOTY2MWVjZGU3OTIyXzY1OTcwNjk3NzAzMjg_f1823b28-1f1a-4f94-8598-58372cc9aa4b"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzY0NTg_f3f46b7d-1160-48ba-b8c7-4b6d3b4d0cdf">STOCK-BASED COMPENSATION&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, there are 34,976,000 shares authorized for issuance under the CV Sciences, Inc. Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). As of&#160;December&#160;31, 2020, the Company had 6,165,000 authorized unissued shares reserved and available for issuance upon exercise and conversion of outstanding awards under the Amended 2013 Plan. On June 11, 2019, the Company&#x2019;s stockholders approved to add an automatic &#x201c;evergreen&#x201d; provision regarding the number of shares to be annually added to the 2013 Plan. As a result, the number of shares of common stock that will be automatically added to the 2013 Plan on January 1 of each year during the term of the plan, starting with January 1, 2020, will be the lesser of: (a) 4% of the total shares of the Company&#x2019;s common stock outstanding on December 31st of the prior year, (b) 4,000,000 shares of the Company&#x2019;s common stock, or (c) a lesser number of shares of the Company&#x2019;s common stock as determined by the Company&#x2019;s Board of Directors. On January 1, 2021, the Company added 4,000,000 shares to the 2013 Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The stock options are exercisable at no less than the fair market value of the underlying shares on the date of grant, and restricted stock and restricted stock units are issued at a value not less than the fair market value of the common stock on the date of the grant. Generally, stock options awarded are vested in equal increments ranging from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzE4NzE_8bd9e890-25d8-4554-b080-b96de69f559a"&gt;two&lt;/span&gt; to four years on the annual anniversary date on which such equity grants were awarded. The stock options generally have a maximum term of 10 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized stock-based compensation expense of&#160;$3.9 million and $15.1 million for the years ended December&#160;31, 2020 and 2019, respectively. During the year ended December&#160;31, 2019, the Company recorded stock-based compensation expense of $9.5&#160;million related to the settlement of the Company's former founder's employment agreements. For more information refer to Note 11, Related Parties. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2020, the Company&#x2019;s board of directors approved a stock option modification that reduced certain employees&#x2019; and directors&#x2019; stock option exercise prices to $0.66. No other terms were modified. Stock options to purchase a total of 2,130,000 shares of common stock were modified. The modification to the existing stock options resulted in $0.2 million incremental value of the stock options. The incremental value associated with the modification will be recognized over the life of the remaining service period of the options. During the year ended December&#160;31, 2020, the Company recorded $0.1 million in stock-based compensation associated with the repriced options.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, total unrecognized compensation cost related to non-vested stock-based compensation arrangements was&#160;$2.7 million which is expected to be recognized over a weighted-average period of 1.3 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes activity related to the Company's stock options (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.281%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.299%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining Contract&lt;br/&gt;Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding - December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,478)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding - December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable - December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested or expected to vest - December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has established performance milestones in connection with the drug development efforts for its lead drug candidate CVSI-007. The above table includes 5,000,000 vested performance-based options as of December&#160;31, 2020, which were issued outside of the 2013 Plan. As of December&#160;31, 2020, there were 8,000,000 remaining unvested stock options granted outside of the 2013 Plan which vest upon the completion of future performance conditions, including those related to the Settlement Agreement with Mona Jr. (refer to Note 11).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total intrinsic value of stock options exercised during the year ended December&#160;31, 2020 and 2019 was $0.1 million and $4.3 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the weighted average grant date fair value of stock options granted and the weighted-average assumptions used to estimate the fair value on the date of grant using the Black-Scholes valuation model:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.425%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-Free Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.33&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.74&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value Per Share on Grant Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$0.36&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.92&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected volatility is based on the historical volatility of the Company's common stock. Expected volatility through September 30, 2019 was calculated based on the Company&#x2019;s peer group, consisting of five companies in the industry in which the Company operates because the Company did not have sufficient historical volatility data. The risk-free interest rates are based on the implied yield available on U.S.&#160;Treasury constant maturities with remaining terms equivalent to the respective expected terms of the options. The Company estimates the expected term for stock options awarded to employees, non-employees, officers and directors using the simplified method in accordance with ASC Topic 718, Stock Compensation, because the Company does not have sufficient relevant historical information to develop reasonable expectations about future exercise patterns.  In the future, as the Company gains historical data for the actual term over which stock options are held, the expected term may change, which could substantially change the grant-date fair value of future stock option awards, and, consequently, compensation of future grants.&lt;/span&gt;&lt;/div&gt;During the year ended December&#160;31, 2019 2,950,000 restricted stock units ("RSU's") vested with a weighted average grant date fair value of $2.14 per share. The total fair value of RSU's vested during the year ended December&#160;31, 2019 was $6.3 million. There are no outstanding RSU's as of December&#160;31, 2020.</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="if6de0662d6994f7eb059488a08f7185c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzMyOTg1MzQ4OTQ4OTM_43dc473f-cc8d-4621-a488-619319d96bf8"
      unitRef="shares">34976000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
      contextRef="if6de0662d6994f7eb059488a08f7185c_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzMyOTg1MzQ4OTQ5NzY_5860094d-0c54-4654-8ab1-9cb3ce61186b"
      unitRef="shares">6165000</us-gaap:DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance>
    <cvsi:SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent
      contextRef="if9290810e4b94539b8af15efd7d0d1e5_I20190611"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzEwMTY_984693f1-41f5-41e4-9c44-3fdfaa4be3db"
      unitRef="number">0.04</cvsi:SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent>
    <cvsi:SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan
      contextRef="if9290810e4b94539b8af15efd7d0d1e5_I20190611"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzExMjE_192186eb-8d78-456d-9b59-8e961769f657"
      unitRef="shares">4000000</cvsi:SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized
      contextRef="i74658c74a8c3444fa9b7905dcc912472_D20210101-20210101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzMyOTg1MzQ4OTQ4NjU_467aa958-89a8-4eeb-bab6-fc8b98992bc6"
      unitRef="shares">4000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i57a9d80096aa464eac00c8580957daf0_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzE4Nzc_de1f7932-79ab-4308-9911-ef871c28ae56">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="i265c122e61ad44b2ba1101201ca25d44_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzIwMTA_49828ef0-17b6-4a70-8b00-88bfba7e0bbd">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9ff3f55fc97e475b8bb8bc843ae1b0d2_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzIwNzk_efa5d5ee-6bc0-48d6-a74e-66fc10253170"
      unitRef="usd">3900000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i910e3383f6764b46b22f1e9d7e5e1aa0_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzIwODY_35681b3c-01d4-43f9-9a9f-6fae2c47464d"
      unitRef="usd">15100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i2b8102c1b9274b8d837c6a3a9496441b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzY1OTcwNjk3ODE3MDE_43cf1773-9554-40a3-92c5-f0b0276749d4"
      unitRef="usd">9500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="idfba81407b1f4dc7bb6ac7356bcb5b8f_D20200601-20200630"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzMyOTg1MzQ4OTA1NzU_ad304791-b1a1-4169-840c-06fdcd2d3a42"
      unitRef="usdPerShare">0.66</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="idfba81407b1f4dc7bb6ac7356bcb5b8f_D20200601-20200630"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzMyOTg1MzQ4OTA1ODM_74caa20a-c7e5-403d-a3ed-f4724ec920ab"
      unitRef="shares">2130000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i632c0a45a9a741cfa8a17f0f306a9fe4_I20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzMyOTg1MzQ4OTA1OTc_4a3dac8b-2110-439f-a3f5-7fc857851772"
      unitRef="usd">200000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="idfba81407b1f4dc7bb6ac7356bcb5b8f_D20200601-20200630"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzMyOTg1MzQ4OTA2MTg_9f50f655-6820-4f2c-a5e4-b6dbd09f7841"
      unitRef="usd">100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzM5MTU_65bdc364-ee71-4396-930b-be978316ee13"
      unitRef="usd">2700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzM5ODc_74755491-60f3-4e62-9557-64a3a0a6c78b">P1Y3M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzY0Njc_7c7b9c05-d677-4ced-bb7e-6e34c34b6048">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following summarizes activity related to the Company's stock options (in thousands, except per share data):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:44.943%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.410%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.281%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.299%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Number of Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Weighted Average&lt;br/&gt;Remaining Contract&lt;br/&gt;Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding - December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,335&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.41&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(612)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(8,478)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.91&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding - December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercisable - December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,254&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested or expected to vest - December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.48&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,186&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ibfbe4fc0a05542b79480de4c56feef6f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzEtMS0xLTEtMA_68fbc6b6-87ea-4793-b6ae-486308536ee2"
      unitRef="shares">28105000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ibfbe4fc0a05542b79480de4c56feef6f_I20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzEtMy0xLTEtMA_36f8d6bb-e1c8-4a01-8665-c0aebe11fc54"
      unitRef="usdPerShare">0.80</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i29ae30a4315946c0b52f15f8e6c4ed26_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzEtNS0xLTEtMA_e4b3b723-d22a-4bf8-b4da-e4907a6008db">P5Y4M24D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ibfbe4fc0a05542b79480de4c56feef6f_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzEtNy0xLTEtMA_1dba1e13-0965-469f-bc38-96cfb3803ad0"
      unitRef="usd">12335000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
      contextRef="i18b1bfee52e244df92d350109e304526_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzItMS0xLTEtMA_6e91dda4-fa45-4fd0-8b6b-5c9c75a366da"
      unitRef="shares">6210000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i18b1bfee52e244df92d350109e304526_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzItMy0xLTEtMA_16daf317-7aad-45bb-ab36-a54a9e2420e1"
      unitRef="usdPerShare">0.41</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i18b1bfee52e244df92d350109e304526_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzMtMS0xLTEtMA_ab93db0d-7bfb-4ad3-b8ce-4ea26fb4fc36"
      unitRef="shares">612000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i18b1bfee52e244df92d350109e304526_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzMtMy0xLTEtMA_b3387d87-49b1-4882-8f37-9f0efcb5cdea"
      unitRef="usdPerShare">0.37</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i18b1bfee52e244df92d350109e304526_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzQtMS0xLTEtMA_0de1579d-c5db-46e4-a476-dfdbeeae462c"
      unitRef="shares">8478000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="i18b1bfee52e244df92d350109e304526_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzQtMy0xLTEtMA_b7247afd-50ba-4824-bb3e-a7841f62b81c"
      unitRef="usdPerShare">0.91</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="icffd0f08944b4303b75cda5726a991c1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzYtMS0xLTEtMA_ab89099e-a95e-4cad-9348-62a381123e86"
      unitRef="shares">25225000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="icffd0f08944b4303b75cda5726a991c1_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzYtMy0xLTEtMA_5178ca25-723b-4cdb-be5d-f3a1e73bdf92"
      unitRef="usdPerShare">0.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i18b1bfee52e244df92d350109e304526_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzYtNS0xLTEtMA_32de77b1-5fa7-48af-8090-e1dfd24ef462">P5Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="icffd0f08944b4303b75cda5726a991c1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzYtNy0xLTEtMA_2e52e866-fd93-4eae-838c-e7c39596a66b"
      unitRef="usd">2186000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="icffd0f08944b4303b75cda5726a991c1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzgtMS0xLTEtMA_bc64c1b8-2b74-40a8-8ecc-e3f1ee910788"
      unitRef="shares">22254000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="icffd0f08944b4303b75cda5726a991c1_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzgtMy0xLTEtMA_2a30d104-b2f9-45a1-9a52-b252df7a393f"
      unitRef="usdPerShare">0.46</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i18b1bfee52e244df92d350109e304526_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzgtNS0xLTEtMA_4fa81f0a-cd17-4d16-acaf-c4cef932e41b">P5Y3M18D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="icffd0f08944b4303b75cda5726a991c1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzgtNy0xLTEtMA_e9721220-7ce7-4b54-846f-0a110e0c2354"
      unitRef="usd">2010000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="icffd0f08944b4303b75cda5726a991c1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzktMS0xLTEtMA_126c2cb9-f0a3-4cd6-a11f-a26c1e5b53e8"
      unitRef="shares">25225000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="icffd0f08944b4303b75cda5726a991c1_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzktMy0xLTEtMA_f89151f7-3906-4186-b6a3-364e69e2cc99"
      unitRef="usdPerShare">0.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
      contextRef="i18b1bfee52e244df92d350109e304526_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzktNS0xLTEtMA_c4b7f0ca-b2e6-474e-b085-bbae7c71d2c6">P5Y8M12D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="icffd0f08944b4303b75cda5726a991c1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo1ZTJjMjNlM2I0OTY0YzhjYmIxYjAxYTA4ODRmNmRhNi90YWJsZXJhbmdlOjVlMmMyM2UzYjQ5NjRjOGNiYjFiMDFhMDg4NGY2ZGE2XzktNy0xLTEtMA_749198cc-fe23-48c1-94bb-4a4e5ceb1651"
      unitRef="usd">2186000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ifec0d5d2e64345b7942f20ab0f15368e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzMyOTg1MzQ4OTEyNjI_523cc244-e29f-4c7c-b33b-df1c9590a2a0"
      unitRef="shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="ifec0d5d2e64345b7942f20ab0f15368e_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzMyOTg1MzQ4OTEzMjI_89bc6107-f326-4b5f-ad46-1eeac4b20cd7"
      unitRef="shares">8000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzQyNzc_252a75f3-30de-414d-b509-05959491cec3"
      unitRef="usd">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzQyODQ_6aa1178c-aaa2-43d8-8514-858f4d0492d4"
      unitRef="usd">4300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzY0NzM_14f66130-eacc-433b-a700-096e3153f226">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the weighted average grant date fair value of stock options granted and the weighted-average assumptions used to estimate the fair value on the date of grant using the Black-Scholes valuation model:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:64.991%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.566%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.425%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;132.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;126.1%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-Free Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.5%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Expected Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.33&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2.74&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.0%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Fair Value Per Share on Grant Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$0.36&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$1.92&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo2YWRjMDgxYjVhZDg0OWQ4YWU3NWU0MDc0OTkyMzVkZC90YWJsZXJhbmdlOjZhZGMwODFiNWFkODQ5ZDhhZTc1ZTQwNzQ5OTIzNWRkXzItMS0xLTEtMA_1e644e94-7eed-4bee-a51f-f500df3c7ff3"
      unitRef="number">1.329</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo2YWRjMDgxYjVhZDg0OWQ4YWU3NWU0MDc0OTkyMzVkZC90YWJsZXJhbmdlOjZhZGMwODFiNWFkODQ5ZDhhZTc1ZTQwNzQ5OTIzNWRkXzItMy0xLTEtMA_74335bfc-8859-4a7e-a504-fc849facd1c7"
      unitRef="number">1.261</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo2YWRjMDgxYjVhZDg0OWQ4YWU3NWU0MDc0OTkyMzVkZC90YWJsZXJhbmdlOjZhZGMwODFiNWFkODQ5ZDhhZTc1ZTQwNzQ5OTIzNWRkXzMtMS0xLTEtMA_20a48670-5846-4c90-81f9-f179799619fa"
      unitRef="number">0.005</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo2YWRjMDgxYjVhZDg0OWQ4YWU3NWU0MDc0OTkyMzVkZC90YWJsZXJhbmdlOjZhZGMwODFiNWFkODQ5ZDhhZTc1ZTQwNzQ5OTIzNWRkXzMtMy0xLTEtMA_5078e1d3-136c-4abc-8014-962a7391d9cc"
      unitRef="number">0.016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo2YWRjMDgxYjVhZDg0OWQ4YWU3NWU0MDc0OTkyMzVkZC90YWJsZXJhbmdlOjZhZGMwODFiNWFkODQ5ZDhhZTc1ZTQwNzQ5OTIzNWRkXzQtMS0xLTEtMA_2a2cab4a-5dc2-41aa-bb53-ac5bcc145d31">P5Y3M29D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo2YWRjMDgxYjVhZDg0OWQ4YWU3NWU0MDc0OTkyMzVkZC90YWJsZXJhbmdlOjZhZGMwODFiNWFkODQ5ZDhhZTc1ZTQwNzQ5OTIzNWRkXzQtMy0xLTEtMA_ddd5c4ca-2ff6-41ec-9ec3-3f9b2386bf0a">P2Y8M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo2YWRjMDgxYjVhZDg0OWQ4YWU3NWU0MDc0OTkyMzVkZC90YWJsZXJhbmdlOjZhZGMwODFiNWFkODQ5ZDhhZTc1ZTQwNzQ5OTIzNWRkXzUtMS0xLTEtMA_9dbd28f0-2f42-43d4-8e49-0d8cc81e8c9e"
      unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo2YWRjMDgxYjVhZDg0OWQ4YWU3NWU0MDc0OTkyMzVkZC90YWJsZXJhbmdlOjZhZGMwODFiNWFkODQ5ZDhhZTc1ZTQwNzQ5OTIzNWRkXzUtMy0xLTEtMA_1329e4fe-0b0f-4791-a8f4-24366a015db2"
      unitRef="number">0.000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo2YWRjMDgxYjVhZDg0OWQ4YWU3NWU0MDc0OTkyMzVkZC90YWJsZXJhbmdlOjZhZGMwODFiNWFkODQ5ZDhhZTc1ZTQwNzQ5OTIzNWRkXzYtMS0xLTEtMA_a5ea34b1-3232-4be5-b916-5e8c54b93d8e"
      unitRef="usdPerShare">0.36</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90YWJsZTo2YWRjMDgxYjVhZDg0OWQ4YWU3NWU0MDc0OTkyMzVkZC90YWJsZXJhbmdlOjZhZGMwODFiNWFkODQ5ZDhhZTc1ZTQwNzQ5OTIzNWRkXzYtMy0xLTEtMA_0177b1cd-b1b0-4d00-97f4-d6093543c989"
      unitRef="usdPerShare">1.92</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <cvsi:SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility
      contextRef="i141553cffe3a4f4bbd6b47ebbf217e1b_D20190101-20190930"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzY1OTcwNjk3ODE3MjU_c5c79b3b-4fe5-465a-8f1c-650cb4b92021"
      unitRef="company">5</cvsi:SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="i928a711d627049609b68b71da873a14b_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzMyOTg1MzQ4OTQwMDE_139078fa-123a-4fd4-bcda-9cda8c1f2edd"
      unitRef="shares">2950000000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i928a711d627049609b68b71da873a14b_D20190101-20191231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzY1OTcwNjk3ODE2ODA_1f152753-5d9e-48de-b1a8-14d34a27eac5"
      unitRef="usdPerShare">2.14</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i928a711d627049609b68b71da873a14b_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzMyOTg1MzQ4OTM5NjA_b3b6fca4-f844-476d-a85d-1533fdc35fc8"
      unitRef="usd">6300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ic23cca2bec294144b5380b314f6c1bef_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzY1OTcwNjk3ODE3MzI_511360fc-2702-4e2b-851e-12208040c6bb"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODEvZnJhZzpjNGMzZDNhZDVkMzM0ZWNkYWUyNThmMjJjNjMwYTIxZS90ZXh0cmVnaW9uOmM0YzNkM2FkNWQzMzRlY2RhZTI1OGYyMmM2MzBhMjFlXzEwMzg_eb5e285e-aad8-460f-9f57-9693b7446d53">NET LOSS PER SHARE&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company computes basic net loss per share using the weighted-average number of common shares outstanding during the period. Diluted net loss per share is calculated by dividing net loss by the weighted-average number of common shares plus potential common shares. The Company's stock options, including those with performance conditions, are included in the calculation of diluted net loss per share using the treasury stock method when their effect is dilutive. Potential common shares are excluded from the calculation of diluted net loss per share when their effect is anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following common stock equivalents were not included in the calculation of net loss per diluted share because their effect were anti-dilutive (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The above table excludes 8,000,000 unvested performance stock options for the years ended December&#160;31, 2020 and 2019, which vest upon the completion of future performance conditions.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODEvZnJhZzpjNGMzZDNhZDVkMzM0ZWNkYWUyNThmMjJjNjMwYTIxZS90ZXh0cmVnaW9uOmM0YzNkM2FkNWQzMzRlY2RhZTI1OGYyMmM2MzBhMjFlXzEwNDA_9ead364a-c8cb-4464-b91f-8eafbfa60b7d">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following common stock equivalents were not included in the calculation of net loss per diluted share because their effect were anti-dilutive (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:65.997%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.273%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.955%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.275%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,225&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iea15e228d81c4928a6f435953afcbf22_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODEvZnJhZzpjNGMzZDNhZDVkMzM0ZWNkYWUyNThmMjJjNjMwYTIxZS90YWJsZToyYmIxMTY1ODM5YjU0NjExYjA4Mjc4MmM4MzhhNTk4ZC90YWJsZXJhbmdlOjJiYjExNjU4MzliNTQ2MTFiMDgyNzgyYzgzOGE1OThkXzItMS0xLTEtMTYyNg_44bdf758-2b0e-4424-8a66-70b06efbaf09"
      unitRef="shares">20225000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i2f9d57085cfb485a90040682008ea5ab_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODEvZnJhZzpjNGMzZDNhZDVkMzM0ZWNkYWUyNThmMjJjNjMwYTIxZS90YWJsZToyYmIxMTY1ODM5YjU0NjExYjA4Mjc4MmM4MzhhNTk4ZC90YWJsZXJhbmdlOjJiYjExNjU4MzliNTQ2MTFiMDgyNzgyYzgzOGE1OThkXzItMy0xLTEtMTY0MQ_f25c6443-357b-4a2a-b6c6-84d8ce817523"
      unitRef="shares">18105000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib7c5476be195460facee7c724fb5e3c7_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODEvZnJhZzpjNGMzZDNhZDVkMzM0ZWNkYWUyNThmMjJjNjMwYTIxZS90YWJsZToyYmIxMTY1ODM5YjU0NjExYjA4Mjc4MmM4MzhhNTk4ZC90YWJsZXJhbmdlOjJiYjExNjU4MzliNTQ2MTFiMDgyNzgyYzgzOGE1OThkXzMtMS0xLTEtMA_10d259e8-7038-4a85-bf00-f755062b1f9d"
      unitRef="shares">5000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iabb6a4dc10ab4561a4bd6c32f75acae6_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODEvZnJhZzpjNGMzZDNhZDVkMzM0ZWNkYWUyNThmMjJjNjMwYTIxZS90YWJsZToyYmIxMTY1ODM5YjU0NjExYjA4Mjc4MmM4MzhhNTk4ZC90YWJsZXJhbmdlOjJiYjExNjU4MzliNTQ2MTFiMDgyNzgyYzgzOGE1OThkXzMtMy0xLTEtMA_d4b340f1-b179-4229-aaf7-4e2285a3baf9"
      unitRef="shares">10000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODEvZnJhZzpjNGMzZDNhZDVkMzM0ZWNkYWUyNThmMjJjNjMwYTIxZS90YWJsZToyYmIxMTY1ODM5YjU0NjExYjA4Mjc4MmM4MzhhNTk4ZC90YWJsZXJhbmdlOjJiYjExNjU4MzliNTQ2MTFiMDgyNzgyYzgzOGE1OThkXzQtMS0xLTEtMTYzNQ_40290deb-3358-4a6c-8446-8de910d80a78"
      unitRef="shares">25225000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODEvZnJhZzpjNGMzZDNhZDVkMzM0ZWNkYWUyNThmMjJjNjMwYTIxZS90YWJsZToyYmIxMTY1ODM5YjU0NjExYjA4Mjc4MmM4MzhhNTk4ZC90YWJsZXJhbmdlOjJiYjExNjU4MzliNTQ2MTFiMDgyNzgyYzgzOGE1OThkXzQtMy0xLTEtMTY0MQ_857e1fe5-3187-42f6-9d61-b91931d211c8"
      unitRef="shares">28105000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ibbef676a29a64d80a42a8bffab80309b_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODEvZnJhZzpjNGMzZDNhZDVkMzM0ZWNkYWUyNThmMjJjNjMwYTIxZS90ZXh0cmVnaW9uOmM0YzNkM2FkNWQzMzRlY2RhZTI1OGYyMmM2MzBhMjFlXzMyOTg1MzQ4ODcyODc_6fa68198-73ae-4575-a646-01fd70a713e4"
      unitRef="shares">8000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i70dd93c7ed5b49f6acea67a36d5704e8_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODEvZnJhZzpjNGMzZDNhZDVkMzM0ZWNkYWUyNThmMjJjNjMwYTIxZS90ZXh0cmVnaW9uOmM0YzNkM2FkNWQzMzRlY2RhZTI1OGYyMmM2MzBhMjFlXzMyOTg1MzQ4ODcyODc_ab48fd45-10fc-4ae7-aded-2db54f0af9ff"
      unitRef="shares">8000000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzIyMzg_b397b331-dc6a-4935-bda9-9545c8c4b03f">RELATED PARTIESDuring the year ended December&#160;31, 2019, the Company's former President and Chief Executive Officer, Michael Mona Jr. ("Mona Jr."), and the Company entered into a Settlement Agreement (the &#x201c;Settlement Agreement&#x201d;), pursuant to which the Company agreed that Mona Jr.&#x2019;s resignation from the Company on January 22, 2019 was for Good Reason (as defined in Mona Jr.&#x2019;s Employment Agreement) and agreed to extend the deadline for Mona Jr.&#x2019;s exercise of his stock options for a period of five years. As of December&#160;31, 2020, Mona Jr. has 11,300,000 fully vested outstanding stock options with a weighted average exercise price of $0.42 per share. In exchange, Mona Jr. agreed that notwithstanding the terms of his Employment Agreement &lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;providing for acceleration of vesting of all stock options and RSU's upon a Good Reason resignation, certain of his unvested stock options would not immediately vest, but rather continue to vest if, and only if, certain Company milestones are achieved related to the Company&#x2019;s drug development efforts. These stock options were issued in July 2016 (6,000,000 options) and March 2017 (5,000,000 options) and 6,750,000 of these stock options have not vested as of December&#160;31, 2020. The Company and Mona Jr. also agreed to mutually release all claims arising out of and related to Mona Jr.&#x2019;s resignation and separation from the Company. As a result of the Settlement Agreement, the Company recorded stock-based compensation expense related to the accelerated vesting of the RSU's of $5.1 million and the modification of certain stock options of $2.7 million during the year ended December&#160;31, 2019. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As part of the Settlement Agreement, 2,950,000 vested RSU's were issued to Mona Jr. The vesting of the RSU's and payment of shares is treated as taxable compensation and thus subject to income tax withholdings. No amounts were withheld (either in cash or the equivalent of shares of common stock from the vesting of the RSU's) or included in the original Company&#x2019;s payroll tax filing. The compensation is subject to Federal and State income tax withholding and Federal Insurance Contributions Act (&#x201c;FICA&#x201d;) taxes withholding estimated to be $6.4&#160;million for the employee portions. The employer portion of the FICA taxes is $0.2&#160;million and has been recorded as a component of selling, general and administrative expenses in the consolidated statement of operations for the year ended December&#160;31, 2019. During the year ended December&#160;31, 2020, the Company reported the taxable compensation associated with the RSU release to the taxing authorities and included the amount in Mona Jr.'s W-2 for 2019. In addition, the Company paid the employer and employee portion of the FICA taxes of $0.2 million, respectively. Although the primary tax liability is the responsibility of the employee, the Company is secondarily liable and thus has recorded the liability on its consolidated balance sheet as of December&#160;31, 2020 in an amount of $6.2 million which was recorded as a component of accrued expenses. The Company initially recorded an offsetting receivable of $6.2 million during the second quarter of 2019 for the total estimated Federal and State income taxes which should have been withheld in addition to the employee portion of the FICA payroll taxes as the primary liability is ultimately the responsibility of the employee. The receivable was recorded as a component of prepaid expense and other on the consolidated balance sheet. The deadline to file and pay personal income taxes for 2019 was on October 15, 2020. To date, Mona Jr. has not provided to the Company the appropriate documentation substantiating that he properly filed and paid his taxes for 2019. As a result, the Company derecognized its previously recorded receivable of $6.2 million during the fourth quarter of 2020. The associated liability may be relieved once the tax amount is paid by Mona Jr. and the Company has received the required taxing authority documentation from Mona Jr. If the tax amount is not paid by Mona Jr., the Company would be liable for such withholding tax due. Additionally, the Company could be subject to penalties if the amounts are ultimately not paid. The Company does not believe that any such penalties are probable or reasonably possible as of December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 22, 2020, the Company filed a complaint in the San Diego Superior Court for declaratory relief to confirm the termination of Mona Jr.'s severance and other post-termination compensation and benefits, and to recover amounts owed to the Company by Mona Jr. in connection with his purchase of personal seat licenses for the Raiders stadium and certain advance payments made on Mona Jr.'s behalf. The complaint also requests that Mona Jr. provides the Company with appropriate taxing authority documentation to show that he paid the tax associated with the vesting of the RSU's. Refer also to Note 12, Commitment and Contingencies, for more information. The Company recorded a payable to Mona Jr. of $0.4 million and $0.6 million as of December&#160;31, 2020 and 2019, respectively. The amounts are mostly related to termination benefits associated with his separation from the Company and are payable via regular payroll through June 2021. The Company has not paid any termination benefits to Mona Jr. since filing the complaint. As of December&#160;31, 2020, the entire amount is included in accrued expenses. As of December&#160;31, 2019, the Company recorded $0.4 million in accrued expenses and $0.2 million in other liabilities.&lt;/span&gt;&lt;/div&gt;In addition, on December 31, 2019, the Company's former Chief Operating Officer and co-founder, Michael Mona III ("Mona III"), resigned from the Company. The Company recorded stock-based compensation expense related to the accelerated vesting of Mona III's unvested outstanding options of $1.7 million during the year ended December&#160;31, 2019 with no assumed forfeiture rate. The Company recorded a payable to Mona III of $0.2 million and $0.7 million as of December&#160;31, 2020 and 2019, respectively. The amounts are mostly related to termination benefits associated with his separation from the Company and are payable via regular payroll through June 2021. As of December&#160;31, 2020, the entire amount is included in accrued expenses. As of December&#160;31, 2019, the Company recorded $0.4 million in accrued expenses and $0.2 million in other liabilities.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <cvsi:SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod
      contextRef="i5b538a137f6741c3b99ad8296d75054d_D20190101-20191231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzY1OTcwNjk3Nzc2NzE_cbcd7a46-2ddd-425e-b248-c842ec5953e0">P5Y</cvsi:SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
      contextRef="ifd0eb69ed84344f29547d2b900088211_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4ODc0ODY_a1bbd11a-8236-48be-8690-83f97df0b7bf"
      unitRef="shares">11300000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="i2c8f78232aff43cb8627c3ae776e97a9_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4ODc1NzE_1cd19496-ebf0-4e23-9467-957979c7e695"
      unitRef="usdPerShare">0.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i60d2bb9447ef4e4897ab3d30bf70ebab_D20160701-20160731"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzY1OTcwNjk3Nzc2OTM_a7e0488c-cda9-4edc-83ea-46a1bd94c1a7"
      unitRef="shares">6000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="ib232e5ef4b084e428542b0fef60816ab_D20170301-20170331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzY1OTcwNjk3Nzc3MTQ_39b03055-8047-4fbd-bb0c-1d0dd4366338"
      unitRef="shares">5000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="i2c8f78232aff43cb8627c3ae776e97a9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4OTIwNDg_6448349a-4344-442d-bc85-02a8ffa658e0"
      unitRef="shares">6750000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i6dd1ee59fde04743b61fc6fe09e084f1_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4ODcwMzc_8611992d-085f-4a91-b1e4-d81fea0cf315"
      unitRef="usd">5100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i5b538a137f6741c3b99ad8296d75054d_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4ODcwOTA_e6e561de-aeb3-453a-a20c-32da227b79d4"
      unitRef="usd">2700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i6dd1ee59fde04743b61fc6fe09e084f1_D20190101-20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzY1OTcwNjk3Nzc1OTQ_01615089-33de-4b84-8077-6f2250e05d58"
      unitRef="shares">2950000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="i8b7ec1006fa44a45bcff5a676228a041_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzY1OTcwNjk3Nzc2MTg_626cbfa0-22a4-4f4c-ab6f-8bb42201d89b"
      unitRef="usd">6400000</us-gaap:DueFromRelatedPartiesCurrent>
    <cvsi:PayrollTaxExpense
      contextRef="iad05935855d347f29bdc066d4323531c_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzY1OTcwNjk3Nzc2NDU_4bb20a4e-227a-4834-9fe7-48595c4c4fac"
      unitRef="usd">200000</cvsi:PayrollTaxExpense>
    <cvsi:AccruedPayrollTaxesCurrentEmployeePortion
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4OTI0MTE_f9ac12a6-8361-4621-9501-5ea01bc6aa60"
      unitRef="usd">200000</cvsi:AccruedPayrollTaxesCurrentEmployeePortion>
    <us-gaap:AccruedPayrollTaxesCurrent
      contextRef="i7d7c3395910943ff95580815849b5296_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4OTI0Mzc_62b57088-032d-4f06-bbcc-9be68c12f84f"
      unitRef="usd">6200000</us-gaap:AccruedPayrollTaxesCurrent>
    <us-gaap:DueFromRelatedPartiesCurrent
      contextRef="i0bbd982c5f7748b69d855640a70331d5_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4OTI0NzM_8078cc0c-9830-4603-8f9c-39644a392ba1"
      unitRef="usd">6200000</us-gaap:DueFromRelatedPartiesCurrent>
    <us-gaap:ProvisionForLoanAndLeaseLosses
      contextRef="i0d1f25384b814879a0628fe92c2764bc_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4OTI4ODY_812ef061-4617-4e44-8964-a0fe4f289fe1"
      unitRef="usd">6200000</us-gaap:ProvisionForLoanAndLeaseLosses>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="i8b7ec1006fa44a45bcff5a676228a041_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4OTMyNDI_07537034-cf0f-431f-afb5-40a843c2ea77"
      unitRef="usd">400000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="if9b34d8b19d8479caf351bc959791056_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4OTMyNTQ_3f527ac1-0ce6-450b-be4e-0ba79c9f59ba"
      unitRef="usd">600000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="iaafe986d776f4e188381ad93b70a5c59_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4OTM2NzI_75bdca39-b9d0-43a2-a4be-f964c39c8c98"
      unitRef="usd">400000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="i0c9d5f9107d5452b85e1137ecfedf90f_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4OTM3MDM_1fa51c27-7413-4ce4-ad7d-47b45864b39a"
      unitRef="usd">200000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i93952393aa0f490bbfec7462592c6301_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4ODczOTI_24b8183f-5619-4ee4-927f-69b56080bed0"
      unitRef="usd">1700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="ib47971077b1a4742984a8c6a25cbc462_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzkw_68586b31-220d-4afd-98bd-bee2af68370b"
      unitRef="usd">200000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="i8d06315f2bbc4bcf8bad96452ea47672_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4ODU2Mjc_cf78218b-734d-4d7e-b18d-e796565f8a83"
      unitRef="usd">700000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="i8e03e73784db49a2b0712b19d7179af8_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4ODU2NDM_4e4ff329-b1bc-48ad-b7cd-d188db24dc4e"
      unitRef="usd">400000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent
      contextRef="i3e10759d7520413498f7340ef1cbc70c_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODQvZnJhZzpkMWM2ZmFiYmY0Mzc0M2RjYjkyYjE2ZmUwZWI0MWIwYS90ZXh0cmVnaW9uOmQxYzZmYWJiZjQzNzQzZGNiOTJiMTZmZTBlYjQxYjBhXzMyOTg1MzQ4ODU2OTg_856f8789-92a3-4646-9d77-85bd93e77875"
      unitRef="usd">200000</us-gaap:AccountsPayableRelatedPartiesCurrentAndNoncurrent>
    <us-gaap:CommitmentsDisclosureTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODcvZnJhZzo3OTFiYzk5NjU4ODc0MTE5YTVmNmU5ZjU4MTA3OGQzOS90ZXh0cmVnaW9uOjc5MWJjOTk2NTg4NzQxMTlhNWY2ZTlmNTgxMDc4ZDM5XzQxMDU_50732adc-8e0b-414c-998f-aba7e1ac7f88">COMMITMENTS AND CONTINGENCIESOn March 17, 2015, Michael Ruth filed a shareholder derivative suit in Nevada District Court alleging breach of fiduciary duty and gross mismanagement (the &#x201c;Ruth Complaint&#x201d;). The claims are premised on the same events that were the subject of a purported class action filed in the Southern District of New York on April 23, 2014 (the &#x201c;Sallustro Case&#x201d;). On July 2, 2019, the &lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;court in the Sallustro Case entered a final order dismissing the complaint with prejudice. The Company did not make any settlement payment, and at no time was there a finding of wrongdoing by the Company or any of its directors. Regarding the Ruth Complaint, the Company and Mr. Ruth previously agreed to stay the action pending the conclusion of discovery in the Sallustro Case. Now that the Sallustro Case has been dismissed, the stay has been lifted. Plaintiff&#x2019;s counsel recently informed the Court that Mr. Ruth sold his shares of CVSI stock and thus he no longer has standing to pursue this claim. However, the Court allowed Plaintiff&#x2019;s counsel to substitute CVSI shareholder Otilda Lamont as the named plaintiff. On September 20, 2019, the Company filed a motion to dismiss the Ruth Complaint and the Court issued a ruling denying the motion to dismiss on November 24, 2020. A Third Amended Complaint was filed on December 11, 2020 substituting Otilda Lamont as plaintiff. The Company filed an answer to the Ruth Complaint on January 11, 2021 and discovery recently commenced. The Court issued a schedule whereby discovery ends on November 19, 2021. Management intends to vigorously defend the allegations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 24, 2018, David Smith filed a purported class action complaint in Nevada District Court (the "Smith Complaint") alleging certain misstatements in the Company's public filings that led to stock price fluctuations and financial harm. Several additional individuals filed similar claims, and the Smith Complaint and each of the other suits all arise out of a report published by Citron Research on Twitter on August 20, 2018, suggesting that the Company misled investors by failing to disclose that the Company&#x2019;s efforts to secure patent protection for CVSI-007 had been &#x201c;finally rejected&#x201d; by the United States Patent and Trademark Office ("USPTO"). On November 15, 2018, the court consolidated the actions and appointed Richard Ina, Trustee for the Ina Family Trust, as Lead Plaintiff for the consolidated actions. On January 4, 2019, Counsel for Lead Plaintiff Richard Ina, Trustee for the Ina Family Trust, filed a &#x201c;consolidated amended complaint&#x201d;. On March 5, 2019, we filed a motion to dismiss the action. The Court denied the motion to dismiss on December 10, 2019, and the parties have commenced discovery in the action with a discovery cutoff date of May 24, 2021. Arising out of the same facts and circumstances in the Smith Complaint, on June 11, 2020, Phillip Berry filed a derivative suit in the United States District Court for the Southern District of California alleging breaches of fiduciary duty against the Company and various defendants, and waste of corporate assets (the &#x201c;Berry Complaint&#x201d;). The Company has accepted service of the Berry Complaint and a motion to dismiss is currently pending. In addition to the Berry Complaint, four additional shareholder derivative suits have been filed which are premised on the same event as the Smith Complaint. All four actions are currently stayed. On May 19, 2020, the USPTO issued a patent pertaining to CVSI-007, which the Company believes negates and defeats any claims that the Company and the various defendants misled the market by not disclosing that the USPTO had finally rejected the patent. Management intends to vigorously defend the allegations in each of these matters as the result of the issuance of a patent and the failure of the plaintiffs&#x2019; causes of action on various other grounds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On December 3, 2019, Michelene Colette and Leticia Shaw filed a putative class action complaint in the Central District of California, alleging the labeling on the Company&#x2019;s products violated the Food, Drug, and Cosmetic Act of 1938 (the &#x201c;Colette Complaint&#x201d;). On February 6, 2020, the Company filed a motion to dismiss the Colette Complaint. Instead of opposing our motion, plaintiffs elected to file an amended complaint on February 25, 2020. On March 11, 2020, we filed a motion to dismiss the amended complaint. The court issued a ruling on May 22, 2020 that stayed this proceeding in its entirety and dismissed part of the amended complaint. The portion of the proceeding that is stayed will remain stayed until the U.S. Food and Drug Administration promulgates rules that govern cannabidiol products (the &#x201c;FDA Rules&#x201d;). When such FDA Rules are promulgated, the plaintiffs will be allowed to ask the court to reopen the proceeding. Management intends to vigorously defend the allegations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On July 22, 2020, the Company filed a complaint in the San Diego Superior Court for declaratory relief to confirm the termination of Mona Jr.&#x2019;s severance and other post-termination compensation and benefits, as well as to recover amounts owed to the Company by Mona Jr. in connection with his purchase of a personal seat license for the Raiders Stadium and certain advance payments made on Mona Jr.&#x2019;s behalf. The complaint also requests that Mona Jr. provides the Company with appropriate taxing authority documentation to show that he paid the tax associated with the vesting of the RSU's.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the normal course of business, the Company is a party to a variety of agreements pursuant to which they may be obligated to indemnify the other party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations, and the unique facts and circumstances involved in each particular agreement. Historically, payments made by us under these types of agreements have not had a material effect on our business, results of operations or financial condition.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsDisclosureTextBlock>
    <cvsi:NumberofDerivativeLawsuits
      contextRef="i5c0ab77805bb4407a83db8bc568155ac_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xODcvZnJhZzo3OTFiYzk5NjU4ODc0MTE5YTVmNmU5ZjU4MTA3OGQzOS90ZXh0cmVnaW9uOjc5MWJjOTk2NTg4NzQxMTlhNWY2ZTlmNTgxMDc4ZDM5XzY1OTcwNjk3OTEzNzk_baf7642d-5c57-4ca0-b610-112b926682e8"
      unitRef="lawsuit">4</cvsi:NumberofDerivativeLawsuits>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzI5MzY_32c8b639-9552-4911-b528-452831749d00">LEASES&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has entered into operating leases primarily for real estate. These leases are for the Company's operations, production, warehouse, sales, marketing and back office functions. On July 27, 2020, the Company entered into a lease termination agreement for one of its facilities in San Diego, which was effective August 31, 2020. The Company derecognized the related operating lease obligation of $5.1 million and operating lease asset of $4.7 million as of August 31, 2020, and recorded an associated gain from lease termination of $0.4 million, which is recorded as a component of selling, general and administrative expense in the consolidated statements of operations for the year ended December&#160;31, 2020. As of December&#160;31, 2020, total operating lease assets and operating lease liabilities were $3.1 million and $4.1 million, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognized total lease costs of $1.0 million and $1.5 million for the year ended December&#160;31, 2020 and 2019, respectively. Total lease costs was mostly comprised of operating lease costs. Short-term lease costs related to short-term operating leases and variable lease costs were immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Because the rate implicit in each lease is not readily determinable, the Company uses the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment, which the Company determined based on comps obtained from lenders for similar financing. The Company has certain contracts for real estate which may contain lease and nonlease components which it has elected to treat as a single lease component. Cash paid for operating lease liabilities for the year ended December&#160;31, 2020 was $1.1 million. Information related to the Company's operating lease assets and related lease liabilities were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (in months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.64&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of December&#160;31, 2020 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.687%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(749)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <cvsi:NumberOfLeaseTerminationAgreements
      contextRef="i62d68f33d7fa4992b1f81cb57f0893fb_I20200727"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzY1OTcwNjk3NzIwMDI_070659a9-3598-42ef-9ee1-ca2fa0f74334"
      unitRef="leaseterminationagreement">1</cvsi:NumberOfLeaseTerminationAgreements>
    <us-gaap:OperatingLeaseLiability
      contextRef="i791cd87ec1804ff590fd70ba4350941f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzMyOTg1MzQ4ODc2MjU_a23458e0-d2b2-4c63-b100-3fbdb4ccaca8"
      unitRef="usd">5100000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i791cd87ec1804ff590fd70ba4350941f_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzMyOTg1MzQ4ODc2NjI_4005c15e-4969-40fd-b064-a6424b2f051b"
      unitRef="usd">4700000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:GainLossOnTerminationOfLease
      contextRef="ie9aebc800dcb4be88f9cb52dea0fefae_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzMyOTg1MzQ4ODc3NTk_08d0502a-6b8c-4b6c-81d2-7874084b6cf7"
      unitRef="usd">400000</us-gaap:GainLossOnTerminationOfLease>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzEyOTg_f70f3ae4-39d3-40ec-839a-955fcc19faa2"
      unitRef="usd">3100000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiability
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzEzMDU_13941b21-4c0d-4b54-8b47-9070979e93ed"
      unitRef="usd">4100000</us-gaap:OperatingLeaseLiability>
    <us-gaap:LeaseCost
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzE2NDc_1f9d811e-7f97-4adf-860c-d67e922cc6d8"
      unitRef="usd">1000000.0</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzMyOTg1MzQ4ODg3NDI_5e8095d9-9916-4262-b9cd-2854ef8db76c"
      unitRef="usd">1500000</us-gaap:LeaseCost>
    <us-gaap:OperatingLeasePayments
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzI0MTI_2569b805-bd9c-48d9-afed-cb2450400cc7"
      unitRef="usd">1100000</us-gaap:OperatingLeasePayments>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzI5Mzg_67b7b47f-0324-4ffb-a69d-c780fa73ebc6">Information related to the Company's operating lease assets and related lease liabilities were as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:81.802%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:15.998%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average remaining lease term (in months)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60.64&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average discount rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTphNzIwYWI0NTE1ZGQ0ZTdlYTNkYmU3ZWJjYWZhNDY4Ny90YWJsZXJhbmdlOmE3MjBhYjQ1MTVkZDRlN2VhM2RiZTdlYmNhZmE0Njg3XzItMS0xLTEtMA_b618246b-9801-4d61-a093-de30d7976243"
      unitRef="number">0.065</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90ZXh0cmVnaW9uOmMwNWM2NDIyYzU1ZjQ2YWRhNWU1MGNjY2MyZDcyMTI0XzI5NDA_0d9fd0cb-ad13-49da-b62f-e329c2b40aff">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of December&#160;31, 2020 were as follows (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:86.687%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.113%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;928&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;925&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,015&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,896&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less imputed interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(749)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;680&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-current operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,467&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzEtMS0xLTEtMA_1134b1fb-0aa7-4669-9df7-58fae185edf5"
      unitRef="usd">928000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzItMS0xLTEtMA_6fa6f17d-c7d0-4ea7-96b4-d64bc475859f"
      unitRef="usd">925000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzMtMS0xLTEtMA_74e2cffb-1594-44d2-8340-fc9dc1801076"
      unitRef="usd">957000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzQtMS0xLTEtMA_001151d1-5ce5-4d57-8612-ef3156bd6f84"
      unitRef="usd">986000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzUtMS0xLTEtMA_53205887-019c-4e03-91a9-d97815d93a10"
      unitRef="usd">1015000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzYtMS0xLTEtMA_d2a0127f-8871-46a6-8827-656437230228"
      unitRef="usd">85000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzctMS0xLTEtMA_8f9e757a-cfc2-45b5-830c-a60a1567972c"
      unitRef="usd">4896000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzgtMS0xLTEtMA_ada00de1-00c4-455a-b782-50ac63e7666a"
      unitRef="usd">749000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzktMS0xLTEtMA_b88703a6-fcef-4143-bff8-2b9d83a46331"
      unitRef="usd">4147000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzExLTEtMS0xLTA_d69167fe-3e2d-4d78-8483-3d17c48cebc4"
      unitRef="usd">680000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzEyLTEtMS0xLTA_6e69682a-7dfa-428b-a132-01b608c34a86"
      unitRef="usd">3467000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTAvZnJhZzpjMDVjNjQyMmM1NWY0NmFkYTVlNTBjY2NjMmQ3MjEyNC90YWJsZTpmNzFlYTgzZDk2MGU0YWNjOTkwODNiNjllY2Q5MWQxNS90YWJsZXJhbmdlOmY3MWVhODNkOTYwZTRhY2M5OTA4M2I2OWVjZDkxZDE1XzEzLTEtMS0xLTA_04d38ac9-3b2d-4748-b92b-d2ca5bba9480"
      unitRef="usd">4147000</us-gaap:OperatingLeaseLiability>
    <us-gaap:SegmentReportingDisclosureTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90ZXh0cmVnaW9uOjlhM2YxMzhmZjhjYzQzMDA5NWNlZTkyMGQ2MGE3ZmZlXzEyODI_2e20bc8c-ecce-4da2-9f61-67dd0d197b98">SEGMENT INFORMATIONThe Company operates in two distinct business segments: a consumer products segment in manufacturing, marketing and selling hemp-based CBD products to a range of market sectors; and a specialty pharmaceutical segment focused on developing and commercializing novel therapeutics utilizing CBD. The Company&#x2019;s segments maintain separate financial information for which operating results are evaluated on a regular basis by the Company&#x2019;s senior management in deciding how to allocate resources and in assessing performance. The Company evaluates its consumer products segment based on net product sales, gross profit and operating income or loss. The Company currently evaluates its specialty pharmaceutical segment based on the progress of its clinical development programs.&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents information by reportable operating segment for the years ended December&#160;31, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consumer Products&lt;br/&gt;Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Specialty Pharmaceutical Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product sales, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,592)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2019:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product sales, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,423)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,817)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company's specialty pharmaceutical segment includes goodwill of $2.8 million as of December&#160;31, 2020 and 2019. In addition, the Company's intangible assets of $3.7 million and $3.8 million as of December&#160;31, 2020 and 2019, respectively, are included in the specialty pharmaceutical segment. All other assets are included in the consumer products segment as of December&#160;31, 2020 and 2019.  The majority of the Company's sales are to U.S. based customers.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90ZXh0cmVnaW9uOjlhM2YxMzhmZjhjYzQzMDA5NWNlZTkyMGQ2MGE3ZmZlXzUz_4daf5ff0-26d8-4bdc-8fe6-61add9bf3d1d"
      unitRef="segment">2</us-gaap:NumberOfReportableSegments>
    <us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90ZXh0cmVnaW9uOjlhM2YxMzhmZjhjYzQzMDA5NWNlZTkyMGQ2MGE3ZmZlXzEyODU_e56a7c1c-47e4-4429-adbd-4d404f700ab5">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents information by reportable operating segment for the years ended December&#160;31, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:54.295%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.288%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.291%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consumer Products&lt;br/&gt;Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Specialty Pharmaceutical Segment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Consolidated Totals&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2020:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product sales, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,429&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,009&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;678&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,265&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,943&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;111&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,658&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20,216)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,376)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(22,592)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Year ended December 31, 2019:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Product sales, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;53,696&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross profit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35,088&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,106&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,771&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,877&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,405&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46,451&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(13,423)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,817)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,240)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock>
    <us-gaap:Revenues
      contextRef="iafc1a3c97c0d4080885871840e0654af_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzItMS0xLTEtMA_8d5e98c1-2c87-459d-b72a-9446b7b8b0c5"
      unitRef="usd">24429000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i864c15d843724344970a49378789e8a3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzItMy0xLTEtMA_ce671bc1-3610-4d34-bff9-eeacb6821775"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzItNS0xLTEtMA_a447ccae-e893-4832-9c03-f148f94cc4fc"
      unitRef="usd">24429000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="iafc1a3c97c0d4080885871840e0654af_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzQtMS0xLTEtMA_2c4dd026-6b70-4438-b6a4-8ee0bfcc50ec"
      unitRef="usd">11009000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i864c15d843724344970a49378789e8a3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzQtMy0xLTEtMA_fe4629a7-aed7-4208-be03-73b6fcf22345"
      unitRef="usd">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzQtNS0xLTEtMA_961ded36-4064-41f4-86ac-164309cf8010"
      unitRef="usd">11009000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="iafc1a3c97c0d4080885871840e0654af_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzUtMS0xLTEtMA_4a17f885-fecc-49d4-8197-5ac0fac0a624"
      unitRef="usd">678000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i864c15d843724344970a49378789e8a3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzUtMy0xLTEtMA_5a9f12cc-a32b-444d-b00c-7726ea7523e9"
      unitRef="usd">2265000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzUtNS0xLTEtMA_36313568-6b48-4fa9-a366-c1da542ea765"
      unitRef="usd">2943000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iafc1a3c97c0d4080885871840e0654af_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzYtMS0xLTEtMA_3f376106-dc0b-46ef-93b0-1b818e8f4a61"
      unitRef="usd">30547000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i864c15d843724344970a49378789e8a3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzYtMy0xLTEtMA_f6e806f6-834b-4524-8c61-9b262d900b21"
      unitRef="usd">111000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzYtNS0xLTEtMA_9d1a1066-fc27-442f-b724-a728da99422b"
      unitRef="usd">30658000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="iafc1a3c97c0d4080885871840e0654af_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzctMS0xLTEtMA_976181ed-002a-498c-a8aa-2b18d9fdc076"
      unitRef="usd">-20216000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i864c15d843724344970a49378789e8a3_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzctMy0xLTEtMA_c5fb0d49-002a-4ca5-b781-be3317f38985"
      unitRef="usd">-2376000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzctNS0xLTEtMA_f547a6eb-fa43-4bd3-9b5f-ceb5c9fc6de3"
      unitRef="usd">-22592000</us-gaap:OperatingIncomeLoss>
    <us-gaap:Revenues
      contextRef="i4ab148dfa19a48ec9bfc7253afd2d8e0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzEwLTEtMS0xLTA_961c96f6-4561-42bc-a104-a46a170aefb3"
      unitRef="usd">53696000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6a040ed995bb443b9e3e752576188250_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzEwLTMtMS0xLTA_a2aa583f-4480-416b-b515-6f060e5d616b"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzEwLTUtMS0xLTA_a37c5c9e-a7da-4a0d-b4e0-1406bf37df13"
      unitRef="usd">53696000</us-gaap:Revenues>
    <us-gaap:GrossProfit
      contextRef="i4ab148dfa19a48ec9bfc7253afd2d8e0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzEyLTEtMS0xLTA_177588a3-3afa-44dc-a74b-b472000ffedf"
      unitRef="usd">35088000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i6a040ed995bb443b9e3e752576188250_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzEyLTMtMS0xLTA_1c31e4bd-3d48-4c48-9b60-7633b2f26a8f"
      unitRef="usd">0</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzEyLTUtMS0xLTA_e4510e52-5b2e-4e0b-8128-cf65e76aa68e"
      unitRef="usd">35088000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i4ab148dfa19a48ec9bfc7253afd2d8e0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzEzLTEtMS0xLTA_a19ea7cc-a027-43c7-808d-2dc9709e93ce"
      unitRef="usd">2106000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i6a040ed995bb443b9e3e752576188250_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzEzLTMtMS0xLTA_8f02074a-42a9-42d5-a496-212212239a32"
      unitRef="usd">3771000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzEzLTUtMS0xLTA_de796fc9-c986-466f-850b-216ea904138d"
      unitRef="usd">5877000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i4ab148dfa19a48ec9bfc7253afd2d8e0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzE0LTEtMS0xLTA_28cd8146-a948-412c-badf-5d21823be134"
      unitRef="usd">46405000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i6a040ed995bb443b9e3e752576188250_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzE0LTMtMS0xLTA_00b8ff19-0aba-4e3b-8295-535334162fba"
      unitRef="usd">46000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzE0LTUtMS0xLTA_f07537d5-851e-498e-b497-13a103a26fcf"
      unitRef="usd">46451000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingIncomeLoss
      contextRef="i4ab148dfa19a48ec9bfc7253afd2d8e0_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzE1LTEtMS0xLTA_922b01a0-98a7-43c3-ad3d-157ba23f7ad0"
      unitRef="usd">-13423000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i6a040ed995bb443b9e3e752576188250_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzE1LTMtMS0xLTA_66a4738d-817c-4c6e-8e47-3a855fad22c9"
      unitRef="usd">-3817000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90YWJsZTozMDJhNDJiMDRmNTk0ZjYxODhmY2NhZThjNjIzOTZlYi90YWJsZXJhbmdlOjMwMmE0MmIwNGY1OTRmNjE4OGZjY2FlOGM2MjM5NmViXzE1LTUtMS0xLTA_aa66d1d7-e56b-46e8-bf00-8a7c6b571bc6"
      unitRef="usd">-17240000</us-gaap:OperatingIncomeLoss>
    <us-gaap:Goodwill
      contextRef="id25294b42e17449aacccb4d1a2701113_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90ZXh0cmVnaW9uOjlhM2YxMzhmZjhjYzQzMDA5NWNlZTkyMGQ2MGE3ZmZlXzk4OQ_6ae6f3cf-0929-4a7f-8bb9-90ff6fdcba9d"
      unitRef="usd">2800000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="i33313851bb654bc197ef8021968d854a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90ZXh0cmVnaW9uOjlhM2YxMzhmZjhjYzQzMDA5NWNlZTkyMGQ2MGE3ZmZlXzk4OQ_e3c36b97-9db1-43d7-9f0f-8087088bf701"
      unitRef="usd">2800000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i33313851bb654bc197ef8021968d854a_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90ZXh0cmVnaW9uOjlhM2YxMzhmZjhjYzQzMDA5NWNlZTkyMGQ2MGE3ZmZlXzEwNTc_32a9194e-ad5a-4c58-813c-fec051aee122"
      unitRef="usd">3700000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="id25294b42e17449aacccb4d1a2701113_I20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xOTYvZnJhZzo5YTNmMTM4ZmY4Y2M0MzAwOTVjZWU5MjBkNjBhN2ZmZS90ZXh0cmVnaW9uOjlhM2YxMzhmZjhjYzQzMDA5NWNlZTkyMGQ2MGE3ZmZlXzMyOTg1MzQ4ODQ2MTk_a87fddbe-a5fe-47a6-ad39-b18c36f15872"
      unitRef="usd">3800000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzQyOTQ_80ef2f76-6938-436e-8316-ba119565f099">INCOME TAXES&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is subject to taxation in the U.S. and California state jurisdictions. The Company&#x2019;s pretax loss for the years ended December&#160;31, 2020 and 2019, were generated by domestic operations.  The income tax benefit for the years ended December&#160;31, 2020 and 2019 was comprised of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(640)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(644)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the expected income tax benefit at the federal statutory rate of 21% for the years ended December&#160;31, 2020 and 2019, and the income tax benefit reported in the financial statements is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of pretax income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of pretax income (loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,746)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State taxes, net of federal effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible officer compensation (IRC 162(m))&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;R&amp;amp;D tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the significant components of the Company's deferred tax assets and liabilities as of December&#160;31, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change to inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals and reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(830)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,437)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(396)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(390)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CanX intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,054)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,053)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,762)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The valuation allowance increased by $4.6 million for the year ended December&#160;31, 2020 and increased by $3.7 million for the year ended December&#160;31, 2019.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets and liabilities are provided for significant revenue and expense items recognized in different years for tax and financial reporting purposes. The Company periodically assesses the likelihood that it will be able to recover its deferred tax assets. The Company considers all available evidence, both positive and negative, including historical levels of income, expectations and risks associated with estimates of future taxable income, and ongoing prudent and feasible profits. As of December&#160;31, 2020 and 2019, the Company established valuation allowances equal to the full amount of its deferred tax assets, net of certain tax liabilities, due to the uncertainties regarding the realization of the deferred tax assets in future years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the Company has federal, California, and other state net operating loss (&#x201c;NOL&#x201d;) carryforwards of  $21.4 million, 16.9 million, and $3.4 million, respectively, which are available to offset future taxable income. Federal NOL carryforwards arising after 2017 of $14.2 million do not expire.  Federal NOL carryforwards arising before 2018 of $7.2 million expire from 2036 to 2037.  California NOL carryforwards of 16.9 million expire from 2036 to 2040. Other state NOL carryforwards of $3.4 million have various expirations from 2038 to 2040.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2020, the Company has federal and California R&amp;amp;D credit carryforwards of approximately $0.7 million and $0.4 million, respectively, which are available to offset future taxable income.  Federal R&amp;amp;D credit carryforwards expire from 2034 to 2040. California R&amp;amp;D credit carryforwards do not expire.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The NOL carryforward may be subject to an annual limitation under Section 382 and 383 of the Internal Revenue Code of 1986 (the &#x201c;Code&#x201d;), and similar state provisions if the Company experienced one or more ownership changes which would limit the amount of NOL and tax credit carryforwards that can be utilized to offset future taxable income and tax, respectively. In general, an ownership change as defined by Section 382 and 383, results from the transactions increasing ownership of certain stockholders or public groups in the stock of the corporation of more than 50% over a three-year period. The Company completed a Section 382 and 383 analysis regarding the limitation of NOL and credit carryforwards from inception in December 2010 through November 4, 2019. The Company experienced multiple ownership changes for the purposes of Section 382 and 383 of the Code with the latest change in April 2017. The ownership changes did not result in the forfeiture of any NOLs or credits generated prior to this date. If a change in ownership occurs in the future, the NOL and tax credits carryforwards could be eliminated or restricted.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes a tax benefit from an uncertain tax position when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits, and uncertain income tax positions must meet a more likely than not recognition threshold to be recognized. The Company recognizes interest and penalties related to unrecognized tax benefits within the income tax expense line in the consolidated statements of operations. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company does not anticipate a significant change in its uncertain tax benefits over the next 12 months. The Company is subject to taxation in the U.S. and California state jurisdictions. Due to net operating losses all tax years since inception remain open to examination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the Company's unrecognized tax benefits for the years ended December&#160;31, 2020 and 2019 is provided in the following table (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in current year positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in prior year positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease in prior year positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzQyOTc_e349226f-2974-4f03-9f0a-94c50b0a7b72">The income tax benefit for the years ended December&#160;31, 2020 and 2019 was comprised of the following (in thousands):&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.267%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.270%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total current tax expense (benefit)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(52)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(640)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(264)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total deferred tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(265)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(644)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzMtMS0xLTEtMA_485dac00-8dd2-4fa7-9e47-c90ff12e6031"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzMtMy0xLTEtMA_10e43ee7-4bc7-4b9f-9025-8ebf8454542d"
      unitRef="usd">0</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzQtMS0xLTEtMA_c96d0c52-9edd-4617-931d-9f19591c7d06"
      unitRef="usd">-52000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzQtMy0xLTEtMA_6fe52767-07ca-41f1-9400-ca5ac4192864"
      unitRef="usd">29000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzUtMS0xLTEtMA_a972b25a-d2ec-442e-b44f-ae5436dbcf53"
      unitRef="usd">-52000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzUtMy0xLTEtMA_f5929fcc-77d6-4de1-a071-113e62fe77fa"
      unitRef="usd">29000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzctMS0xLTEtMA_3a76722f-43db-4232-8bac-9d73c4204ce5"
      unitRef="usd">-1000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzctMy0xLTEtMA_7f92bd31-73c8-48a3-8672-791ce4554c79"
      unitRef="usd">-640000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzgtMS0xLTEtMA_9329e9e4-7797-4d51-bfaa-6fa3fd349d6a"
      unitRef="usd">-264000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzgtMy0xLTEtMA_20fc2bb5-378c-4358-b632-b3798b6ce2fe"
      unitRef="usd">-4000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzktMS0xLTEtMA_841287f4-2adf-432b-a8ac-371cb1e9f636"
      unitRef="usd">-265000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzktMy0xLTEtMA_779cc002-0529-41a3-9d89-bc42f698e891"
      unitRef="usd">-644000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzEwLTEtMS0xLTA_da216ad3-7cf8-401f-8607-b3b3a9e27040"
      unitRef="usd">-317000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZToyOWNjODZmNWU0M2Y0OGNiOTE4ZjIxNzQxMzIyNGY2OS90YWJsZXJhbmdlOjI5Y2M4NmY1ZTQzZjQ4Y2I5MThmMjE3NDEzMjI0ZjY5XzEwLTMtMS0xLTA_07f1786f-62ae-45f2-bed8-5476b44dffd1"
      unitRef="usd">-615000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzQyOTU_9b707b20-6da4-421d-904f-9711e623dd08">A reconciliation of the expected income tax benefit at the federal statutory rate of 21% for the years ended December&#160;31, 2020 and 2019, and the income tax benefit reported in the financial statements is as follows:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.712%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:56.969%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.842%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.520%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:8.845%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;For the years ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of pretax income (loss)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;% of pretax income (loss)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit at federal statutory rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,746)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,624)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;21.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;State taxes, net of federal effect&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,391)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,142)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other permanent differences&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;115&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;43&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;569&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(274)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Non-deductible officer compensation (IRC 162(m))&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,242&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;R&amp;amp;D tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(242)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(320)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;769&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(241)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,609&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(20.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,701&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(21.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Income tax benefit&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(317)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(615)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzMtMS0xLTEtMA_ddacab2e-f1b5-463d-b035-603aa7b067c9"
      unitRef="usd">-4746000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzMtMy0xLTEtMA_5bcfa126-f27b-4184-a634-f131a7f20248"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzMtNS0xLTEtMA_04223153-3543-48b7-8efc-2b2f920a2b82"
      unitRef="usd">-3624000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzMtNy0xLTEtMA_295a7e26-394e-4da4-a6ed-5b744100460c"
      unitRef="number">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzQtMS0xLTEtMA_1e829bd3-a829-480e-b042-008f8f2050c3"
      unitRef="usd">-1391000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzQtMy0xLTEtMA_3f1573c2-1a28-47c3-b906-8bae60d77c03"
      unitRef="number">0.062</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzQtNS0xLTEtMA_1be89007-9fc1-47f1-8783-0e6bd210a41a"
      unitRef="usd">-1142000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzQtNy0xLTEtMA_f620dd3c-eee1-4123-88f6-35b9bd1c3d9c"
      unitRef="number">0.066</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzUtMS0xLTEtMA_88233592-ef20-4f32-895f-c724ab8523bb"
      unitRef="usd">115000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzUtMy0xLTEtMA_d342487b-bd7b-43f4-ac04-a2c0732d6379"
      unitRef="number">-0.005</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzUtNS0xLTEtMA_d2ad00fa-0c2f-4da7-ba23-6e8ad705fc75"
      unitRef="usd">43000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzUtNy0xLTEtMA_1ef66b36-acbf-479c-adb0-9c4614d9e921"
      unitRef="number">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzYtMS0xLTEtMA_762cd52e-a438-4671-9ea9-1c1e3790734e"
      unitRef="usd">569000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzYtMy0xLTEtMA_cb64fce2-8963-4d8f-a0e5-8deb60e519ef"
      unitRef="number">-0.025</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzYtNS0xLTEtMA_c560d040-c8ba-4e62-afb2-e51d39a190b9"
      unitRef="usd">-274000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzYtNy0xLTEtMA_623d0091-4442-4cd4-994b-3e31bdf0ef9c"
      unitRef="number">0.016</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <cvsi:EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzctMS0xLTEtMA_e6b3d2fe-34bb-4de7-ba95-7c6cb6abf586"
      unitRef="usd">0</cvsi:EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation>
    <cvsi:EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzctMy0xLTEtMA_e807df45-a8fb-486f-b01c-9b3c1b70a7ae"
      unitRef="number">0</cvsi:EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent>
    <cvsi:EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzctNS0xLTEtMA_f79c3045-3498-4368-85f4-883195fe4be7"
      unitRef="usd">1242000</cvsi:EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation>
    <cvsi:EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzctNy0xLTEtMA_b5936ae3-803b-409c-a602-a982dc2752b1"
      unitRef="number">-0.072</cvsi:EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzktMS0xLTEtMA_d7ebfdc1-afc3-4703-9387-d38542c60f38"
      unitRef="usd">242000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzktMy0xLTEtMA_4a8c95fb-4bf1-493f-8f77-e93a3708821c"
      unitRef="number">-0.011</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzktNS0xLTEtMA_3bf19eb3-70cd-4e8e-b973-6f8be9545069"
      unitRef="usd">320000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzktNy0xLTEtMA_ad4d201a-5906-4016-a1ad-117d9556d027"
      unitRef="number">-0.019</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzEwLTEtMS0xLTA_1dd030a5-ed12-4c87-b6b4-0e45f6acccd7"
      unitRef="usd">769000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzEwLTMtMS0xLTA_60a545cb-6803-453f-b284-427cdead5e98"
      unitRef="number">-0.036</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzEwLTUtMS0xLTA_6024c9a7-9715-409e-b5a2-02b1f504b9cb"
      unitRef="usd">-241000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzEwLTctMS0xLTA_fff2b596-b4a3-49b3-9869-7b9e28e7066f"
      unitRef="number">0.014</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzExLTEtMS0xLTA_151a6017-3d90-4ce0-b894-c61c4d1983fd"
      unitRef="usd">4609000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzExLTMtMS0xLTA_1f61190e-1628-44c7-8373-b74a4d96d37d"
      unitRef="number">-0.204</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzExLTUtMS0xLTA_b9116c0b-23eb-44b8-beeb-dfedf60b6f5a"
      unitRef="usd">3701000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzExLTctMS0xLTA_89afab66-a09c-4f7c-aa75-acc2081fe7c2"
      unitRef="number">-0.215</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzEyLTEtMS0xLTA_50145e10-64bc-4190-a099-523175e80e5f"
      unitRef="usd">-317000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzEyLTMtMS0xLTA_1f9b1823-e5d1-4fe1-a612-c915eb372aac"
      unitRef="number">0.013</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzEyLTUtMS0xLTA_a17a4993-4939-4b04-a1fe-39b63adcbb17"
      unitRef="usd">-615000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:EffectiveIncomeTaxRateContinuingOperations
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozNzJlYTczY2VlZWM0YWY3YTg2NWFiNmNmNTlhNDJlNC90YWJsZXJhbmdlOjM3MmVhNzNjZWVlYzRhZjdhODY1YWI2Y2Y1OWE0MmU0XzEyLTctMS0xLTA_de29f06c-5d3d-4e1b-a771-f58122e74409"
      unitRef="number">0.036</us-gaap:EffectiveIncomeTaxRateContinuingOperations>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzQyOTA_88a8e691-694d-42df-9820-74a73da05847">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the significant components of the Company's deferred tax assets and liabilities as of December&#160;31, 2020 and 2019 (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,876&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,627&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Business credit carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;918&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;620&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;756&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;890&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,740&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change to inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,866&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accruals and reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,275&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;383&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;17,482&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,394&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(830)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,437)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(396)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(390)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;CanX intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,013)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,054)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(172)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,268)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(4,053)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,371)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,762)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(157)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(421)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzMtMS0xLTEtMA_d4bf89a7-561f-4a59-89d5-32a4282bbf5e"
      unitRef="usd">5876000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzMtMy0xLTEtMA_fcf7685a-91c5-4e1d-88bc-bfc770ddfcce"
      unitRef="usd">2627000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzQtMS0xLTEtMA_7fa9db6d-db1c-43b9-b1f0-b3093d96418a"
      unitRef="usd">918000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzQtMy0xLTEtMA_e8687bd1-bd81-4fba-9921-7671ed567bac"
      unitRef="usd">620000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzUtMS0xLTEtMA_0fbb8f99-12c1-477f-a50b-8bb4d55e9c27"
      unitRef="usd">756000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzUtMy0xLTEtMA_ae9ccd93-6d27-474b-b107-8134343f0251"
      unitRef="usd">890000</us-gaap:DeferredTaxAssetsGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzYtMS0xLTEtMA_01387dac-bb1d-49c9-83fb-c6ed2481d23a"
      unitRef="usd">6470000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzYtMy0xLTEtMA_051c79c2-7e88-48cf-a759-367f1547f0cb"
      unitRef="usd">6740000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzctMS0xLTEtMA_70611d7e-a2dc-4a8b-9c19-f46576f262bc"
      unitRef="usd">61000</us-gaap:DeferredTaxAssetsInventory>
    <us-gaap:DeferredTaxAssetsInventory
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzctMy0xLTEtMA_ec1542b1-6d1f-4171-ad1a-30352fbff341"
      unitRef="usd">268000</us-gaap:DeferredTaxAssetsInventory>
    <cvsi:DeferredTaxAssetOperatingLeaseLiabilities
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzgtMS0xLTEtMA_41a02646-b6c0-4cca-92d1-2892f90fa7a1"
      unitRef="usd">1126000</cvsi:DeferredTaxAssetOperatingLeaseLiabilities>
    <cvsi:DeferredTaxAssetOperatingLeaseLiabilities
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzgtMy0xLTEtMA_6fd6aac4-dd54-4eac-b951-9267d55428b8"
      unitRef="usd">2866000</cvsi:DeferredTaxAssetOperatingLeaseLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzEwLTEtMS0xLTA_87911fde-877a-491c-810f-6c2fdf639de7"
      unitRef="usd">2275000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzEwLTMtMS0xLTA_2fb6316e-b282-4afc-80ed-82473137fdf3"
      unitRef="usd">383000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzExLTEtMS0xLTA_3b500cbf-a537-4000-af89-7773865d3141"
      unitRef="usd">17482000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzExLTMtMS0xLTA_04bf185c-77b0-41c4-baa3-ce24e7da5d93"
      unitRef="usd">14394000</us-gaap:DeferredTaxAssetsGross>
    <cvsi:DeferredTaxLiabilityOperatingLeaseAssets
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzEzLTEtMS0xLTA_c840ee4a-0c6b-4085-9ca1-fb61ac20517a"
      unitRef="usd">830000</cvsi:DeferredTaxLiabilityOperatingLeaseAssets>
    <cvsi:DeferredTaxLiabilityOperatingLeaseAssets
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzEzLTMtMS0xLTA_aa45b0e1-c3aa-4fbe-ab53-4de4f89a4e5b"
      unitRef="usd">2437000</cvsi:DeferredTaxLiabilityOperatingLeaseAssets>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE0LTEtMS0xLTA_f5ab2f52-e678-4ac9-b1b6-26bd34abd105"
      unitRef="usd">396000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE0LTMtMS0xLTA_1ec443eb-dfeb-4fad-ab2a-2135b2e232d3"
      unitRef="usd">390000</us-gaap:DeferredTaxLiabilitiesPropertyPlantAndEquipment>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE1LTEtMS0xLTA_a03ee4f4-7837-4048-89c8-750c4b058cf9"
      unitRef="usd">1013000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE1LTMtMS0xLTA_e8e0df9a-b6f3-46c4-9ca3-f792a17a9399"
      unitRef="usd">1054000</us-gaap:DeferredTaxLiabilitiesGoodwillAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE2LTEtMS0xLTA_4735390b-5428-4759-87c1-174cac072686"
      unitRef="usd">29000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE2LTMtMS0xLTA_a8a057b2-3719-4257-a64b-dd16fb4c06e2"
      unitRef="usd">172000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE3LTEtMS0xLTA_755d7f52-1a5e-48a9-bdbc-19ba89c1f354"
      unitRef="usd">2268000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE3LTMtMS0xLTA_83f1dbfa-661e-453c-ae94-cf766cc8321d"
      unitRef="usd">4053000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE4LTEtMS0xLTA_2e4b5a93-fa79-4fdc-92a2-eb7567638e20"
      unitRef="usd">15371000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE4LTMtMS0xLTA_f25d60a3-ddbf-43b6-8606-ce40968f4c3e"
      unitRef="usd">10762000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE5LTEtMS0xLTA_9f902d39-82e9-4649-987a-4f9b7675e052"
      unitRef="usd">157000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:DeferredIncomeTaxLiabilitiesNet
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozYmU2M2I5ZTBjZjI0YzZmODE4NWQxZDRjYTdlNGU4Yy90YWJsZXJhbmdlOjNiZTYzYjllMGNmMjRjNmY4MTg1ZDFkNGNhN2U0ZThjXzE5LTMtMS0xLTA_47e45f7b-eb3d-4706-825a-6f0834d1ad37"
      unitRef="usd">421000</us-gaap:DeferredIncomeTaxLiabilitiesNet>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzcxOA_a39d2c94-88ed-49e5-ba30-90dcd4dc21ff"
      unitRef="usd">4600000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzc2MA_ac90359e-e6a9-418e-9c56-1f39fba71066"
      unitRef="usd">3700000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ib7a85037629e4eada1ad14bd2d8d91a8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzE2MzQ_58cfa9e9-802c-4935-b11c-bd556c386cce"
      unitRef="usd">21400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i125b29ebd2174a6781154a863a9cf67c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzMyOTg1MzQ4ODk3ODM_a9a78d69-7bac-432b-ba84-397cb5b30ad8"
      unitRef="usd">16900000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i839a4daa37e5474fbf72320ba3f3488e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzE2NDE_aa52853b-250f-421c-8878-ab86cc1387eb"
      unitRef="usd">3400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="ic6419ee2e046444089e8042fa93ef87d_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzE3NzI_8a835562-01e1-4bdc-96cf-04e1cd3d3951"
      unitRef="usd">14200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="iaf5bdfbc65224887baa9c61a983f16cc_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzE4NTI_4cb0643c-7325-467d-894e-d18041a2b635"
      unitRef="usd">7200000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i125b29ebd2174a6781154a863a9cf67c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzMyOTg1MzQ4ODk4MjU_a9a78d69-7bac-432b-ba84-397cb5b30ad8"
      unitRef="usd">16900000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards
      contextRef="i839a4daa37e5474fbf72320ba3f3488e_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzE5MjM_aa52853b-250f-421c-8878-ab86cc1387eb"
      unitRef="usd">3400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="ib7a85037629e4eada1ad14bd2d8d91a8_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzIwNDM_6c55bc8c-8a09-4694-9b94-1ab0bca94eaf"
      unitRef="usd">700000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="i125b29ebd2174a6781154a863a9cf67c_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzIwNTA_a9e7866a-1be2-4899-9d8e-78c8840cca5d"
      unitRef="usd">400000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90ZXh0cmVnaW9uOjA2MDZjMTgzNTZmZjQ3MjFiOTMzNjA5ODE5ODFlZDBlXzIxOTkwMjMyNjE5ODM_5c3c2544-3190-4412-b018-77fddfbcd7f6">&lt;div style="margin-top:10pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A reconciliation of the Company's unrecognized tax benefits for the years ended December&#160;31, 2020 and 2019 is provided in the following table (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.181%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.400%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.518%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.401%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of January 1:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in current year positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Increase in prior year positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;119&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Decrease in prior year positions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance as of December 31:&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;166&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozOTQyNDM3MmQ1MDQ0MWU3Yjc2ZjdkNWM4ZDM4NTNlZS90YWJsZXJhbmdlOjM5NDI0MzcyZDUwNDQxZTdiNzZmN2Q1YzhkMzg1M2VlXzEtMS0xLTEtNjM5NA_3e83e994-fa2a-4aa8-aa75-0164f00762eb"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ifc2c804db67543dd84291701c746b6fa_I20181231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozOTQyNDM3MmQ1MDQ0MWU3Yjc2ZjdkNWM4ZDM4NTNlZS90YWJsZXJhbmdlOjM5NDI0MzcyZDUwNDQxZTdiNzZmN2Q1YzhkMzg1M2VlXzEtMy0xLTEtNjM5OQ_a05a882d-7dfb-4852-80ca-8029e8f4bce3"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozOTQyNDM3MmQ1MDQ0MWU3Yjc2ZjdkNWM4ZDM4NTNlZS90YWJsZXJhbmdlOjM5NDI0MzcyZDUwNDQxZTdiNzZmN2Q1YzhkMzg1M2VlXzItMS0xLTEtNjQwNA_da6811df-06d8-4aa9-8acd-fdfa9d3c587d"
      unitRef="usd">47000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozOTQyNDM3MmQ1MDQ0MWU3Yjc2ZjdkNWM4ZDM4NTNlZS90YWJsZXJhbmdlOjM5NDI0MzcyZDUwNDQxZTdiNzZmN2Q1YzhkMzg1M2VlXzItMy0xLTEtNjQwOA_4e65f352-0989-4a8b-a280-28ce98695210"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozOTQyNDM3MmQ1MDQ0MWU3Yjc2ZjdkNWM4ZDM4NTNlZS90YWJsZXJhbmdlOjM5NDI0MzcyZDUwNDQxZTdiNzZmN2Q1YzhkMzg1M2VlXzMtMS0xLTEtNjQwNA_01634923-8f46-4bd3-834f-084f5ce3cd1a"
      unitRef="usd">119000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozOTQyNDM3MmQ1MDQ0MWU3Yjc2ZjdkNWM4ZDM4NTNlZS90YWJsZXJhbmdlOjM5NDI0MzcyZDUwNDQxZTdiNzZmN2Q1YzhkMzg1M2VlXzMtMy0xLTEtNjQwOA_183377f1-4b82-4d3c-8913-c99f80d180fe"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozOTQyNDM3MmQ1MDQ0MWU3Yjc2ZjdkNWM4ZDM4NTNlZS90YWJsZXJhbmdlOjM5NDI0MzcyZDUwNDQxZTdiNzZmN2Q1YzhkMzg1M2VlXzQtMS0xLTEtNjQwNA_bd15b13f-1397-4863-be64-edd9010d2bf2"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
      contextRef="ic53c3cbedd7c487abe2c90d633feb337_D20190101-20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozOTQyNDM3MmQ1MDQ0MWU3Yjc2ZjdkNWM4ZDM4NTNlZS90YWJsZXJhbmdlOjM5NDI0MzcyZDUwNDQxZTdiNzZmN2Q1YzhkMzg1M2VlXzQtMy0xLTEtNjQwOA_3c1e1a52-b74b-49f5-bd03-2bc89a5c6fe7"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="i95335529356f4afbb8b76a88b727d1d2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozOTQyNDM3MmQ1MDQ0MWU3Yjc2ZjdkNWM4ZDM4NTNlZS90YWJsZXJhbmdlOjM5NDI0MzcyZDUwNDQxZTdiNzZmN2Q1YzhkMzg1M2VlXzUtMS0xLTEtNjQwNA_d0fa2290-c232-4ae6-9baa-4d8d4ed59e2f"
      unitRef="usd">166000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="ib68a40c3668644fc87db08988f699fec_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDIvZnJhZzowNjA2YzE4MzU2ZmY0NzIxYjkzMzYwOTgxOTgxZWQwZS90YWJsZTozOTQyNDM3MmQ1MDQ0MWU3Yjc2ZjdkNWM4ZDM4NTNlZS90YWJsZXJhbmdlOjM5NDI0MzcyZDUwNDQxZTdiNzZmN2Q1YzhkMzg1M2VlXzUtMy0xLTEtNjQwOA_ff7eb273-f812-4dae-ba61-cae0050f2a7b"
      unitRef="usd">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDgvZnJhZzowM2QwNjNlMWI4MjU0MzMyYjAxZThjMTRiY2M4N2RjOS90ZXh0cmVnaW9uOjAzZDA2M2UxYjgyNTQzMzJiMDFlOGMxNGJjYzg3ZGM5XzQzNQ_95f7b06d-ce48-4abe-8f74-339503a786f6">SUBSEQUENT EVENTSubsequent to December&#160;31, 2020, through March&#160;19, 2021, the Company sold 5,941,816 shares of common stock under its SPA with Tumim at a weighted average price of $0.53 per share, resulting in proceeds of $3.1 million.</us-gaap:SubsequentEventsTextBlock>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="ie5001f6661f94fcb9a78097ff24a3842_D20210101-20210319"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDgvZnJhZzowM2QwNjNlMWI4MjU0MzMyYjAxZThjMTRiY2M4N2RjOS90ZXh0cmVnaW9uOjAzZDA2M2UxYjgyNTQzMzJiMDFlOGMxNGJjYzg3ZGM5XzMyOTg1MzQ4ODQyMjg_3914da0c-4384-4685-ad17-884048bf19ee"
      unitRef="shares">5941816</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <cvsi:SaleOfStockWeightedAveragePricePerShare
      contextRef="ie5001f6661f94fcb9a78097ff24a3842_D20210101-20210319"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDgvZnJhZzowM2QwNjNlMWI4MjU0MzMyYjAxZThjMTRiY2M4N2RjOS90ZXh0cmVnaW9uOjAzZDA2M2UxYjgyNTQzMzJiMDFlOGMxNGJjYzg3ZGM5XzMyOTg1MzQ4ODQzMTU_06da066e-d5ff-4fe8-b98b-580cde20bf71"
      unitRef="usdPerShare">0.53</cvsi:SaleOfStockWeightedAveragePricePerShare>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="ie5001f6661f94fcb9a78097ff24a3842_D20210101-20210319"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18yMDgvZnJhZzowM2QwNjNlMWI4MjU0MzMyYjAxZThjMTRiY2M4N2RjOS90ZXh0cmVnaW9uOjAzZDA2M2UxYjgyNTQzMzJiMDFlOGMxNGJjYzg3ZGM5XzMyOTg1MzQ4ODQzNTU_e5e98394-8808-4b7b-a34f-86c0b7a65341"
      unitRef="usd">3100000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355891301192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 16, 2021</div></th>
<th class="th"><div>Jun. 30, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-54677<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">CV Sciences, Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">80-0944974<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">10070 Barnes Canyon Road<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">290-2157<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity a Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity a Voluntary Filer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity's Reporting Status Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 60<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106,605,784<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents Incorporated by Reference</a></td>
<td class="text">Certain sections of the registrant&#8217;s definitive proxy statement for its 2021 Annual Meeting of Stockholders to be filed with the Securities and Exchange Commission pursuant to Regulation 14A not later than 120 days after the end of the registrant&#8217;s fiscal year ended December&#160;31, 2020, are incorporated by reference into Part III of this Form 10-K.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001510964<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2020<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355894816248">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 4,024<span></span>
</td>
<td class="nump">$ 9,107<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="nump">501<span></span>
</td>
<td class="nump">501<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">1,126<span></span>
</td>
<td class="nump">2,177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">8,840<span></span>
</td>
<td class="nump">9,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses and other</a></td>
<td class="nump">2,372<span></span>
</td>
<td class="nump">10,611<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">16,863<span></span>
</td>
<td class="nump">32,367<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property &amp; equipment, net</a></td>
<td class="nump">2,877<span></span>
</td>
<td class="nump">3,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease assets</a></td>
<td class="nump">3,057<span></span>
</td>
<td class="nump">8,709<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Intangibles, net</a></td>
<td class="nump">3,730<span></span>
</td>
<td class="nump">3,766<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,788<span></span>
</td>
<td class="nump">2,788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">1,310<span></span>
</td>
<td class="nump">1,442<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">30,625<span></span>
</td>
<td class="nump">52,687<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,677<span></span>
</td>
<td class="nump">1,617<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">9,805<span></span>
</td>
<td class="nump">10,856<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current portion of operating lease liability</a></td>
<td class="nump">680<span></span>
</td>
<td class="nump">723<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NotesPayableCurrent', window );">Current portion of long-term debt</a></td>
<td class="nump">2,174<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">14,336<span></span>
</td>
<td class="nump">13,196<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liability</a></td>
<td class="nump">3,467<span></span>
</td>
<td class="nump">9,517<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Debt</a></td>
<td class="nump">1,453<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Deferred tax liability</a></td>
<td class="nump">157<span></span>
</td>
<td class="nump">421<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">406<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">19,413<span></span>
</td>
<td class="nump">23,540<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 12)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders' equity</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, par value $0.0001; 10,000 shares authorized; no shares issued and outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, par value $0.0001; 190,000 shares authorized; 100,664 and 99,416 shares issued and outstanding as of December 31, 2020 and 2019, respectively</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">10<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in capital</a></td>
<td class="nump">75,123<span></span>
</td>
<td class="nump">70,774<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(63,921)<span></span>
</td>
<td class="num">(41,637)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity</a></td>
<td class="nump">11,212<span></span>
</td>
<td class="nump">29,147<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders' equity</a></td>
<td class="nump">$ 30,625<span></span>
</td>
<td class="nump">$ 52,687<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68074540&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355920649848">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in USD per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (shares)</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock - par value (in USD per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock - shares authorized (shares)</a></td>
<td class="nump">190,000,000<span></span>
</td>
<td class="nump">190,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock - shares issued (shares)</a></td>
<td class="nump">100,664,000<span></span>
</td>
<td class="nump">99,416,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock - shares outstanding (shares)</a></td>
<td class="nump">100,664,000<span></span>
</td>
<td class="nump">99,416,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355889442232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales, net</a></td>
<td class="nump">$ 24,429<span></span>
</td>
<td class="nump">$ 53,696<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of goods sold</a></td>
<td class="nump">13,420<span></span>
</td>
<td class="nump">18,608<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">11,009<span></span>
</td>
<td class="nump">35,088<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">2,943<span></span>
</td>
<td class="nump">5,877<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">30,658<span></span>
</td>
<td class="nump">46,451<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total Operating Expenses</a></td>
<td class="nump">33,601<span></span>
</td>
<td class="nump">52,328<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(22,592)<span></span>
</td>
<td class="num">(17,240)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestIncomeExpenseNet', window );">Interest (income) expense, net</a></td>
<td class="nump">9<span></span>
</td>
<td class="num">(15)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(22,601)<span></span>
</td>
<td class="num">(17,225)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">(317)<span></span>
</td>
<td class="num">(615)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (22,284)<span></span>
</td>
<td class="num">$ (16,610)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average common shares outstanding, basic and diluted (in shares)</a></td>
<td class="nump">99,913<span></span>
</td>
<td class="nump">97,861<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per common share , basic and diluted (in USD per share)</a></td>
<td class="num">$ (0.22)<span></span>
</td>
<td class="num">$ (0.17)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfRevenueExtensibleList', window );">Revenue, Product and Service [Extensible List]</a></td>
<td class="text">us-gaap:ProductMember<span></span>
</td>
<td class="text">us-gaap:ProductMember<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeExpenseNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net amount of operating interest income (expense).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.10)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeExpenseNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfRevenueExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates type of revenue from product and service. Includes, but is not limited to, revenue from contract with customer and other sources.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfRevenueExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355894812920">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY - USD ($)<br> shares in Thousands, $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Beginning balance (in shares) at Dec. 31, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">94,940<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2018</a></td>
<td class="nump">$ 30,116<span></span>
</td>
<td class="nump">$ 9<span></span>
</td>
<td class="nump">$ 55,134<span></span>
</td>
<td class="num">$ (25,027)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock from exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock from exercise of stock options</a></td>
<td class="nump">521<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">520<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement', window );">Stock-based compensation associated with founders employment settlements</a></td>
<td class="nump">9,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,531<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">5,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,589<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(16,610)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(16,610)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">99,416<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2019</a></td>
<td class="nump">29,147<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">70,774<span></span>
</td>
<td class="num">(41,637)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock from exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">613<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock from exercise of stock options</a></td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_StockIssuedDuringPeriodSharesEquityCommitment', window );">Issuance of common stock under equity commitment (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">635<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_StockIssuedDuringPeriodValueEquityCommitment', window );">Issuance of common stock under equity commitment</a></td>
<td class="nump">293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">293<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">3,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,881<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(22,284)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(22,284)<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesOutstanding', window );">Ending balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,664<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Dec. 31, 2020</a></td>
<td class="nump">$ 11,212<span></span>
</td>
<td class="nump">$ 10<span></span>
</td>
<td class="nump">$ 75,123<span></span>
</td>
<td class="num">$ (63,921)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Share-based Compensation, Employment Settlement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_StockIssuedDuringPeriodSharesEquityCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued during Period, Shares, Equity Commitment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_StockIssuedDuringPeriodSharesEquityCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_StockIssuedDuringPeriodValueEquityCommitment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock Issued during Period, Value, Equity Commitment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_StockIssuedDuringPeriodValueEquityCommitment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=120383193&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121326096&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued which are neither cancelled nor held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355894827032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOW - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>OPERATING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (22,284)<span></span>
</td>
<td class="num">$ (16,610)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash flows used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">872<span></span>
</td>
<td class="nump">716<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Common stock issued for commitment fee</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">3,881<span></span>
</td>
<td class="nump">5,589<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RoyaltyExpense', window );">Stock-based compensation associated with founders employment settlements (Note 11)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9,531<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_ImpairmentOfTaxReceivableForRSUSettlement', window );">Derecognition of tax receivable for founder RSU settlement (Note 11)</a></td>
<td class="nump">6,229<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of fixed assets</a></td>
<td class="nump">191<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Bad debt expense</a></td>
<td class="nump">133<span></span>
</td>
<td class="nump">236<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_NoncashLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">598<span></span>
</td>
<td class="nump">817<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes', window );">Deferred taxes</a></td>
<td class="num">(264)<span></span>
</td>
<td class="num">(644)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="nump">134<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Change in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">918<span></span>
</td>
<td class="nump">927<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="nump">1,703<span></span>
</td>
<td class="num">(1,421)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">2,959<span></span>
</td>
<td class="num">(3,016)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="num">(2,470)<span></span>
</td>
<td class="nump">1,648<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(7,300)<span></span>
</td>
<td class="num">(2,227)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>INVESTING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of equipment</a></td>
<td class="num">(1,057)<span></span>
</td>
<td class="num">(1,147)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,057)<span></span>
</td>
<td class="num">(1,147)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>FINANCING ACTIVITIES</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromUnsecuredNotesPayable', window );">Proceeds from debt</a></td>
<td class="nump">2,906<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RepaymentsOfNotesPayable', window );">Repayment of unsecured debt</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(474)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of common stock</a></td>
<td class="nump">193<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">175<span></span>
</td>
<td class="nump">521<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">3,274<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash, cash equivalents and restricted cash</a></td>
<td class="num">(5,083)<span></span>
</td>
<td class="num">(3,327)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, beginning of year</a></td>
<td class="nump">9,608<span></span>
</td>
<td class="nump">12,935<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, end of year</a></td>
<td class="nump">4,525<span></span>
</td>
<td class="nump">9,608<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Interest paid</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Income taxes paid</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">99<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract', window );"><strong>Supplemental disclosure of non-cash transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchase of property and equipment in accounts payable and accrued expenses</a></td>
<td class="nump">15<span></span>
</td>
<td class="nump">89<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability', window );">Derecognition of operating ROU asset related to operating lease termination</a></td>
<td class="num">(4,704)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory', window );">Sale of property and equipment in exchange for note receivable (recorded in prepaid expense and other) and inventory</a></td>
<td class="nump">675<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_PurchaseOfInsuranceThroughIssuanceOfNotePayable', window );">Purchase of insurance through issuance of note payable (Note 7)</a></td>
<td class="nump">721<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating ROU lease assets obtained in exchange for operating lease liabilities</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">5,405<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_RecognitionofEquityAwardandWithholdingObligationandReceivable', window );">Recognition of founder RSU tax withholding obligation and receivable (Note 11)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">6,409<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_CashlessExerciseOfStockOptions', window );">Cashless exercise of options</a></td>
<td class="nump">$ 108<span></span>
</td>
<td class="nump">$ 39<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_CashlessExerciseOfStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cashless Exercise of Stock Options</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_CashlessExerciseOfStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_ImpairmentOfTaxReceivableForRSUSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Impairment Of Tax Receivable For RSU Settlement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_ImpairmentOfTaxReceivableForRSUSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_NoncashLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash Lease Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_NoncashLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_PurchaseOfInsuranceThroughIssuanceOfNotePayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Purchase of insurance through issuance of note payable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_PurchaseOfInsuranceThroughIssuanceOfNotePayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_RecognitionofEquityAwardandWithholdingObligationandReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recognition of Equity Award and Withholding Obligation and Receivable</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_RecognitionofEquityAwardandWithholdingObligationandReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right-of-Use Asset Foregone in Exchange for Reduction in Operating Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of Property and Equipment in Exchange for Prepaid Expenses and Other and Inventory</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashInvestingAndFinancingItemsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashInvestingAndFinancingItemsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromUnsecuredNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowings supported by a written promise to pay an obligation that is uncollateralized (where debt is not backed by the pledge of collateral).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromUnsecuredNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for a borrowing supported by a written promise to pay an obligation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RoyaltyExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RoyaltyExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355887721016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND BUSINESS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock', window );">ORGANIZATION AND BUSINESS</a></td>
<td class="text">ORGANIZATION AND BUSINESS<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CV Sciences, Inc. (the &#8220;Company&#8221;) was incorporated under the name Foreclosure Solutions, Inc. in the State of Texas on December 9, 2010. On July 25, 2013, CannaVest Corp., a Texas corporation (&#8220;CannaVest Texas&#8221;), merged with the Company, a wholly-owned Delaware subsidiary of CannaVest Texas, to effectuate a change in the Company&#8217;s state of incorporation from Texas to Delaware. On January 4, 2016, the Company filed a Certificate of Amendment of Certificate of Incorporation reflecting its corporate name change to &#8220;CV Sciences, Inc.&#8221;, effective on January 5, 2016. In addition, on January 4, 2016, the Company amended its Bylaws to reflect its corporate name change to &#8220;CV Sciences, Inc.&#8221; </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has two operating segments; consumer products and specialty pharmaceutical. The consumer products segment develops, manufactures, markets and sells plant-based dietary supplements and hemp-based cannabidiol ("CBD"). The Company sells its products under tradenames, such as </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PlusCBD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8482;, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HappyLane</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8482;, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">ProCBD</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8482;, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Acute</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CV</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8482;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Defenese. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's products are sold in a variety of market sectors including nutraceutical, beauty care and specialty foods. The specialty pharmaceutical segment is developing drug candidates which use CBD as a primary active ingredient.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -URI http://asc.fasb.org/topic&amp;trid=2122394<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355887404088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</a></td>
<td class="text">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"). The consolidated financial statements include the accounts of CV Sciences, Inc., the accounts of its wholly-owned subsidiaries of Plus CBD, LLC and CANNAVEST Acquisition, LLC, and the accounts of a 70% interest in CannaVest Europe, GmbH. On January 20, 2017, the Company filed for dissolution of CannaVest Europe, GmbH, with the District Court, Dusseldorf Germany, effective December&#160;31, 2017. CANNAVEST Acquisition, LLC, a Delaware limited liability company formed in connection with the CanX Acquisition, was dissolved in 2018, with administrative approval in Florida carrying over into January 2019 before final resolution. On August 7, 2019, the Company filed for dissolution of Plus CBD, LLC (formerly, &#8220;Global Hemp Source, LLC&#8221;) with the Secretary of State of California. As a result, the Company no longer owns interests in any subsidiaries as of December&#160;31, 2020. All intercompany accounts and transactions have been eliminated in consolidation. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results may differ from these estimates. Significant estimates include the valuation of intangible assets, inputs for valuing equity awards, and assumptions related to revenue recognition.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; As of December&#160;31, 2020, the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) provided insurance coverage of up to $0.3 million per depositor per bank. The Company has not experienced any losses in such accounts and does not believe that the Company is exposed to significant risks from excess deposits. The Company&#8217;s cash balance in excess of FDIC limits totaled $3.3 million as of December&#160;31, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company's raw materials purchases for the year ended December&#160;31, 2019 were sourced from one supplier in Europe. During the year ended December&#160;31, 2020 the Company added one additional domestic supplier. There was no concentration of accounts receivable or revenue as of and for the years ended December&#160;31, 2020 and 2019.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Fair value is defined as the price that would be received from the sale of an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The carrying values of accounts receivable, other current assets, accounts payable, and certain accrued expenses as of December&#160;31, 2020 and 2019, approximate their fair value due to the short-term nature of these items. The Company's notes payable balance also approximates fair value as of December&#160;31, 2020, as the interest rate on the notes payable approximates the rates available to the Company as of this date. The accounting guidance establishes a three-level hierarchy for disclosure that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 - uses unadjusted quoted prices that are available in active markets for identical assets or liabilities. The Company's Level 1 assets are comprised of $2.4 million and $4.0 million in money market funds which are classified as cash equivalents as of December&#160;31, 2020 and 2019, respectively. In addition, the Company's restricted cash of $0.5 million as of December&#160;31, 2020 and 2019 is comprised of certificates of deposits. The carrying value of the cash </span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">equivalents and restricted cash equals the fair value as of December&#160;31, 2020 and 2019. The Company does not have any liabilities that are valued using inputs identified under a Level 1 hierarchy as of December&#160;31, 2020 and 2019. </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 - uses inputs other than quoted prices included in Level 1 that are either directly or indirectly observable through correlation with market data. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data. The Company did not have any assets or liabilities that are valued using inputs identified under a Level 2 hierarchy as of December&#160;31, 2020 and 2019. </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 - uses one or more significant inputs that are unobservable and supported by little or no market activity, and that reflect the use of significant management judgment. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques, and significant management judgment or estimation. The Company did not have any assets or liabilities that are valued using inputs identified under a Level 3 hierarchy as of December&#160;31, 2020 and 2019.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Liquidity Considerations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; COVID-19 has spread (and continues to spread) worldwide, resulting in shutdowns of manufacturing and commerce. COVID-19 has resulted in government authorities implementing numerous measures to try to contain it, such as travel bans and restrictions, quarantines, shelter-in-place orders, and shutdowns. These measures have impacted, and may further impact, the Company's workforce and operations, the operations of our customers and our partners, and those of our respective vendors and suppliers. The Company's critical business operations, including its headquarters, and many of its key suppliers, are located in regions which have been impacted by COVID-19. The Company's customers and suppliers worldwide have also been affected and may continue to be affected by COVID-19 related restrictions and closures. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">COVID-19, along with the resulting</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> government-imposed restrictions on businesses, shelter-in place orders, and temporary retail and grocery store closures had a significant impact on the Company's results of operations for the year ended December 31, 2020, and the Company's management expects that it will continue </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to negatively impact its operations due to decreased consumer demand as well as potential production and warehouse limitations which results in an event or condition, before consideration of management&#8217;s plans, that could impact its ability to meet future obligations</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, while the extent and duration of the COVID-19 pandemic on the global economy and the Company's business in particular is difficult to assess or predict, the pandemic has resulted in, and may continue to result in, significant disruption of global financial markets, which may reduce the Company's ability to access capital or its customers&#8217; ability to pay for past or future purchases, which could negatively affect the Company's liquidity. A recession or financial market correction resulting from the lack of containment and spread of COVID-19 could impact overall spending, adversely affecting demand for the Company's products, its business, and the value of its common stock.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 17, 2020, the Company received $2.9 million pursuant to the Paycheck Protection Program ("PPP") under the Coronavirus Aid, Relief, and Economic Security Act (the "CARES Act") as administered by the U.S. Small Business Administration (the "SBA"), as further discussed in Note 7. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 8, 2020, the Company entered into a common stock purchase agreement with Tumim Stone Capital, LLC to issue and sell up to $10.0 million in shares of the Company's common stock, from time to time, as further discussed in Note 8. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the continuing uncertainty resulting from COVID-19, management has implemented, and as necessary will continue to make strategic cost reductions, including reductions in employee headcount, vendor spending, and the delay of expenses related to its drug development activities. </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that its cash and cash equivalents on hand </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">together with the equity commitment with Tumim and </span><span style="color:#212529;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">these cost reduction measures, as needed, will provide sufficient liquidity to fund its operations for the next 12 months from the issuance of the consolidated financial statements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; For purposes of the consolidated statements of cash flows, the Company considers amounts held by financial institutions and short-term investments with an original maturity of three months or less when purchased to be cash and cash equivalents. As of December&#160;31, 2020, the Company had cash of $1.6 million and cash equivalents of $2.4 million. As of December&#160;31, 2019, the Company had cash of $5.1 million and cash equivalents of $4.0 million.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Cash</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company&#8217;s restricted cash as of  December&#160;31, 2020 and 2019 consists of certificates of deposits related to the Company's corporate credit card program. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets to the total of the same amounts shown in the statement of cash flows as of December&#160;31, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.181%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,024&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and restricted cash shown in the statements of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,525&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,608&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Generally, the Company requires payment prior to shipment. However, in certain circumstances, the Company extends credit to companies located throughout the U.S. Accounts receivable consists of trade accounts arising in the normal course of business. Accounts for which no payments have been received after 30 days are considered delinquent and customary collection efforts are initiated. Accounts receivable are carried at original invoice amount less a reserve made for doubtful receivables based on a review of all outstanding amounts on a quarterly basis.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management has determined the allowance for doubtful accounts by regularly evaluating individual customer receivables and considering a customer&#8217;s financial condition and credit history, and current economic conditions. As of each December&#160;31, 2020 and 2019, the Company maintained an allowance for doubtful accounts related to accounts receivable in the amount of $0.6 million and $0.4 million, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Inventory is stated at lower of cost or net realizable value, with cost being determined on an average cost basis. Cost includes costs directly related to manufacturing and distribution of the products. Primary costs include raw materials, packaging, manufacturing overhead, shipping and depreciation of manufacturing equipment and production facilities. Manufacturing overhead includes payroll, employee benefits, utilities, maintenance and property taxes. Total shipping and handling costs were $1.7 million and $2.7 million for the years ended December&#160;31, 2020 and 2019, respectively, and are recorded in cost of goods sold.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs an assessment of inventory obsolescence to measure inventory at the lower of cost or net realizable value. Factors considered in the determination of obsolescence include slow-moving or non-marketable items. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's inventory production process includes the cultivation of botanical raw material. Because of the duration of the cultivation process, a portion of our inventory will not be sold within one year. Starting April 1, 2019, consistent with the practice in other industries that cultivate botanical raw materials, all inventory is classified as a current asset.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property &amp; Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Equipment is stated at cost less accumulated depreciation. Cost represents the purchase price of the asset and other costs incurred to bring the asset into its existing use. Depreciation is provided on a straight-line basis over the assets estimated useful lives. Tenant improvements are amortized on a straight-line basis over the shorter of the useful life or the remaining life of the related lease. Maintenance or repairs are charged to expense as incurred. Upon sale or disposition, the historically-recorded asset cost and accumulated depreciation are removed from the respective accounts and any related gain or loss is recognized.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; In accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 360, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for the Impairment or Disposal of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of property and equipment is measured by comparing its carrying value to the undiscounted projected future cash flows that the assets are expected to generate. If the carrying amount of an asset is not recoverable, the Company recognizes an impairment loss based on the excess of the carrying amount of the long-lived asset over its respective fair value, which is generally determined as the present value of estimated future cash flows or at the appraised value. The impairment analysis is based on significant assumptions of future results made by management, including revenue and cash flow projections. Circumstances that may lead to impairment of property and equipment include a significant decrease in the market price of a long-lived asset, a significant adverse change in the extent or manner in which a long-lived asset is being used or in its physical condition and a significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset including an adverse action or assessment by a regulator. As of December&#160;31, 2020 and 2019, the Company determined that long-lived assets were not impaired.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company evaluates the carrying value of goodwill and intangible assets annually during the fourth quarter in accordance with ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and between annual evaluations if events </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">occur or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Such circumstances could include, but are not limited to (1) a significant adverse change in legal factors or in business climate, (2) unanticipated competition, or (3) an adverse action or assessment by a regulator. All of the Company's goodwill and intangible assets are assigned to the Company's specialty pharmaceutical segment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is evaluated for impairment by first performing a qualitative assessment to determine whether a quantitative goodwill test is necessary. If it is determined, based on qualitative factors, that the fair value of the reporting unit may be more likely than not less than carrying amount, or if significant adverse changes in the Company's future financial performance occur that could materially impact fair value, a quantitative goodwill impairment test would be required. Additionally, management can elect to forgo the qualitative assessment and perform the quantitative test. If the qualitative assessment indicates that the quantitative analysis should be performed, or if management elects to bypass a qualitative assessment, the Company then evaluates goodwill for impairment by comparing the fair value of the reporting unit to its carrying amount, including goodwill. The quantitative assessment for goodwill requires management to estimate the fair value of the Company's reporting units using either an income or market approach or a combination thereof. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management makes critical assumptions and estimates in completing impairment assessments of goodwill and other intangible assets. The Company's cash flow projections look several years into the future and include assumptions on variables such as future sales and operating margin growth rates, economic conditions, probability of success, market competition, inflation and discount rates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company performed its annual goodwill impairment test and determined, after performing a qualitative test of the reporting unit, that it is more likely than not that the fair value of the reporting unit exceeds its carrying amount. Accordingly, there was no indication of impairment and the quantitative impairment test was not performed. The Company did not record any goodwill impairment charges for the years ended December&#160;31, 2020 or 2019.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company classifies intangible assets into three categories: (1) intangible assets with definite lives subject to amortization; (2) intangible assets with indefinite lives not subject to amortization; and (3) goodwill. The Company determines the useful lives of its identifiable intangible assets after considering the specific facts and circumstances related to each intangible asset. Factors considered when determining useful lives include the contractual term of any agreement related to the asset, the historical performance of the asset, the Company's long-term strategy for using the asset, any laws or regulations which could impact the useful life of the asset and other economic factors, including competition and specific market conditions. Intangible assets that are deemed to have definite lives are amortized, primarily on a straight-line basis, over their useful lives to their estimated residual values, generally five years. In-process research &amp; development ("</span><span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPR&amp;D") has an indefinite life and is not amortized until completion and development of the project, at which time the IPR&amp;D becomes an amortizable asset. Until such time as the projects are either completed or abandoned, the Company test those assets for impairment at least annually at year end, or more frequently at interim periods, by evaluating qualitative factors which could be indicative of impairment. Qualitative factors being considered include, but are not limited to, macro-economic conditions, progress on drug development activities, and overall financial performance. If impairment indicators are present as a result of the Company's qualitative assessment, the Company will test those assets for impairment by comparing the fair value of the assets to their carrying value. Quantitative factors being considered include, but are not limited to, the current project status, forecasted changes in the timing or amounts required to complete the project, forecasted changes in timing or changes in the future cash flows to be generated by the completed products, a probability of success of the ultimate project and changes to other market-based assumptions, such as discount rates. Upon completion or abandonment, the value of the IPR&amp;D assets will be amortized to expense over the anticipated useful life of the developed products, if completed, or charged to expense when abandoned if no alternative future use exists. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#222222;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company completed its annual impairment assessment during the fourth quarter of 2020 and 2019. No impairments were identified during the years ended December&#160;31, 2020 and 2019.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The majority of the Company's revenue contracts represent a single performance obligation related to the fulfillment of customer orders for the purchase of its products. Net sales reflect the transaction prices for these contracts based on the Company's selling list price, which is then reduced by estimated costs for trade promotional programs, consumer incentives, and allowances and discounts used to incentivize sales growth and build brand awareness. The Company recognizes revenue at the point in time that control of the ordered product is transferred to the customer, which is typically upon shipment to the customer or other customer-designated delivery point. The Company accrues for estimated sales returns by customers based on historical sales return results. The computation of the sales return and discount allowances require that management makes certain estimates and assumptions that effect the timing and amounts of revenue and liabilities recorded. Shipping and handling fees charged to customers are included in product sales and totaled $0.2 million and $0.3 million for the years ended December&#160;31, </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020 and 2019, respectively. Taxes collected from customers that are remitted to governmental agencies are accounted for on a net basis and not included as revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents product sales by channel for food, drug and mass ("FDM"), natural product and other, and e-commerce for the years ended December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of product sales, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of prodct sales, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail - FDM</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,651&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail - Natural products and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-Comm</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,429&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,696&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation and Benefits</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company records compensation and benefits expense for all cash and deferred compensation, benefits, and related taxes as earned by its employees. Compensation and benefits expense also includes compensation earned by temporary employees and contractors who perform similar services to those performed by the Company&#8217;s employees, primarily information technology and project management activities. The Company maintains a defined contribution 401(k) plan available to eligible employees. Employee contributions are voluntary and are determined on an individual basis, limited to the maximum amount allowable under federal tax regulations. The Company, at its discretion, may make certain matching contributions to the 401(k) plan. The Company suspended its matching contributions in April 2020. The Company made matching contributions of $0.1 million and $0.2 million for the years ended December&#160;31, 2020 and 2019, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expense</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Research and development costs are charged to expense as incurred and include, but are not limited to, employee salaries and benefits, cost of inventory used in product development, consulting service fees, the cost of renting and maintaining our laboratory facility and depreciation of laboratory equipment. Research and development expense for the consumer products segment was $0.7 million and $2.1 million for the years ended December&#160;31, 2020 and 2019, respectively. Research and development expense for the specialty pharmaceutical segment was $2.2 million and $3.8 million for the years ended December&#160;31, 2020 and 2019, respectively.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Advertising</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The Company supports its products with advertising to build brand awareness of the Company&#8217;s various products in addition to other marketing programs executed by the Company&#8217;s marketing team. The Company believes the continual investment in advertising is critical to the development and sale of its products. Advertising costs of $1.3 million and $2.5 million were expensed as incurred during the years ending December&#160;31, 2020 and 2019, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Certain employees, officers, directors, and consultants of the Company participate in various long-term incentive plans that provide for granting stock options, restricted stock awards, restricted stock units, stock bonus awards and performance-based awards. Stock options generally vest in equal increments over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzY1OTcwNjk4MDk1ODc_f5674a51-c511-43ac-a681-83d953908b76">two</span>- to four-year period and expire on the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzIxOTkwMjMzMTk0MDU_d0b87cf7-bf22-4fdd-a58e-c194e22353b3">ten</span>th anniversary following the date of grant. Performance-based stock options vest once the applicable performance condition is satisfied. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes stock-based compensation for equity awards granted to employees, officers and directors as compensation and benefits expense in the consolidated statements of operations. The fair value of stock options is estimated using a Black-Scholes valuation model on the date of grant. The fair value of restricted stock awards is equal to the closing price of the Company&#8217;s stock on the date of grant. Stock-based compensation is recognized over the requisite service period of the individual awards, which generally equals the vesting period. For performance-based stock options, compensation is recognized once the applicable performance condition is satisfied.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the related temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized when the rate change is enacted. Valuation allowances are recorded to reduce deferred tax assets to the amount that will more likely than not be realized. In accordance with ASC Topic 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recognizes the effect of uncertain income tax positions only if the positions are more likely than not of being sustained in an audit, based on the technical merits of the position. Recognized uncertain income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">recognition or measurement are reflected in the period in which those changes in judgment occur. The Company recognizes both interest and penalties related to uncertain tax positions as part of the income tax provision. As of December&#160;31, 2020 and 2019 the Company did not have a liability for unrecognized tax uncertainties. The Company is subject to routine audits by taxing jurisdictions. Management believes the Company is no longer subject to tax examinations for the years prior to 2013.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Loss </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Comprehensive loss is defined as a change in equity during a period from transactions and other events and circumstances from non-owner sources. There have been no items qualifying as other comprehensive loss and, therefore, the Company's comprehensive loss was the same as its reported net loss for the years ended December&#160;31, 2020 and 2019.  </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements Not Yet Adopted</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board ("FASB") issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments and subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04 and ASU 2019-05 (collectively, &#8220;Topic 326&#8221;). Topic 326 requires measurement and recognition of expected credit losses for financial assets held. Topic 326 was to be effective for reporting periods beginning after December 15, 2019, with early adoption permitted. In November 2019, the FASB issued ASU 2019-10, Financial Instruments - Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842) Effective Dates, which deferred the effective dates for the Company, as a smaller reporting company, until fiscal year 2023. The Company currently plans to adopt the guidance at the beginning of fiscal 2023. The Company is currently evaluating the potential impact of Topic 326 on the Company&#8217;s consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes ("ASU 2019-12"), which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistency among reporting entities. The new standard is effective for fiscal years beginning after December 15, 2020. Most amendments within the standard are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company is currently evaluating the potential impact of ASU 2019-12 on the Company&#8217;s consolidated financial statements.</span></div><div><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the FASB issued ASU 2017-04, Intangibles &#8211; Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (&#8220;ASU 2017-04&#8221;), which eliminates Step 2 from the goodwill impairment test. Instead, an entity should perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should then recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity should consider income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. ASU 2017-04 requires the entity to apply these amendments on a prospective basis for which it is required to disclose the nature of and reason for the change in accounting upon transition. This disclosure shall be provided in the first annual period and in the interim period within the first annual period when the entity initially adopts the amendments. This ASU became effective for the Company on January 1, 2020. Adoption of ASU 2017-04 did not have an immediate impact on the Company&#8217;s consolidated financial statements and only has the potential to impact the amount of any goodwill impairment recorded after the adoption of the ASU.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355887724664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">INVENTORY</a></td>
<td class="text">INVENTORY<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory as of December&#160;31, 2020 and 2019 was comprised of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.181%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,840&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,971&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020 and 2019, the Company recorded an inventory write-down of $0.3 million and $0.2 million, respectively. As of December&#160;31, 2020, the Company had no inventory outside the United States. As of December&#160;31, 2019, the Company had inventory outside the United States of $0.3 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355888093304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY &amp; EQUIPMENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">PROPERTY &amp; EQUIPMENT</a></td>
<td class="text">PROPERTY &amp; EQUIPMENT<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net, as of December&#160;31, 2020 and 2019 were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.089%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.115%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Useful Lives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 5 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,596&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tenant improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory and other equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,269&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,170&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,392)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,555)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,877&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,615&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Tenant improvements are amortized over the lesser of the remaining term of the related lease or the estimated useful life of the tenant improvements.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense for the years ended December&#160;31, 2020 and 2019 was $0.8 million and $0.7 million, respectively.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355891238072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsDisclosureTextBlock', window );">INTANGIBLE ASSETS</a></td>
<td class="text">INTANGIBLE ASSETS<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of the following as of December&#160;31, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.308%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.836%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Useful Life (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,907&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,730&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - December 31, 2019:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,907&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,766&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div>The Company did not incur costs to renew or extend the term of acquired intangible assets for the years ended December&#160;31, 2020 and 2019. Amortization expense for intangible assets was $36 thousand and $35 thousand for the years ended December&#160;31, 2020 and 2019, respectively. There is no future amortization expense.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all or part of the information related to intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355888088520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">ACCRUED EXPENSES</a></td>
<td class="text">ACCRUED EXPENSES<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses as of December&#160;31, 2020 and 2019 were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.181%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll expenses (1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,069&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,805&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1) This includes a tax liability associated with a related party transaction as discussed in Note 11 of $6.2 million and $6.6 million as of December&#160;31, 2020 and 2019, respectively.</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355979471144">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">DEBT</a></td>
<td class="text">DEBT<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt as of December&#160;31, 2020 was as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.083%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.717%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP loan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance financing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,627&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion of debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company did not have any debt as of December&#160;31, 2019.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments on the debt are as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.083%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.717%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,627&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Paycheck Protection Program</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April 15, 2020, the Company applied for a loan from JPMorgan Chase Bank, N.A., as lender, pursuant to the Paycheck Protection Program of the CARES Act as administered by the U.S. Small Business Administration. On April 17, 2020, the loan was approved, and the Company received proceeds in the amount of $2.9&#160;million (the &#8220;PPP Loan&#8221;).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PPP Loan, which took the form of a promissory note, matures on April 15, 2022 and bears interest at a rate of 0.98% per annum (the &#8220;Promissory Note&#8221;). The Company did not provide any collateral or guarantees for the PPP Loan, nor did the Company pay any facility charge to obtain the PPP Loan. The Promissory Note provides for customary events of default, including, among others, those relating to failure to make payment, bankruptcy, breaches of representations and material adverse effects. The Company may prepay the principal of the PPP Loan at any time without incurring any prepayment charges.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the CARES Act, loan forgiveness is available for the sum of documented payroll costs, covered rent payments, and covered utilities during the covered period of 8 weeks beginning on the date of loan approval. For purposes of the CARES Act, payroll costs exclude compensation of an individual employee in excess of $100,000, prorated annually. Not more than 25% of the forgiven amount may be for non-payroll costs. Forgiveness is reduced if full-time headcount declines, or if salaries and wages for employees with salaries of $100,000 or less annually are reduced by more than 25%. In the event the PPP Loan, or any portion thereof, is forgiven pursuant to the PPP, the amount forgiven is applied to outstanding principal.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Paycheck Protection Program Flexibility Act of 2020 (the &#8220;PPP Flexibility Act&#8221;), enacted on June 5, 2020, amended the Paycheck Protection Program, among others, as follows: (i) extended the covered period from 8 weeks to 24 weeks from the date the PPP Loan is originated, during which PPP funds needed to be expended in order to be forgiven. A borrower may submit a loan forgiveness application any time on or before the maturity date of the loan &#8211; including before the end of the covered period &#8211; </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">if the borrower has used all of the loan proceeds for which the borrower is requesting forgiveness. (ii) at least 60% of PPP funds must be spent on payroll costs, with the remaining 40% available to spend on other eligible expenses. (iii) payments are deferred until the date on which the amount of forgiveness determined is remitted to the lender. If a borrower fails to seek forgiveness within 10 months after the last day of its covered period, then payments will begin on the date that is 10 months after the last day of the covered period. In addition, the PPP Flexibility Act modified the CARES Act by increasing the maturity date for loans made after the effective date from two years to a minimum maturity of five years from the date on which the borrower applies for loan forgiveness. Existing PPP loans made before the new legislation retain their original two-year term, but may be renegotiated between a lender and a borrower to match the 5-year term permitted under the PPP Flexibility Act.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company intends to apply for loan forgiveness within the required timeframe. No assurance is provided that the Company will obtain forgiveness of the PPP Loan in whole or in part. The promissory note is classified as long-term except for the portion to be paid within twelve months of the year-end, which is classified as current.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unsecured Note Payable</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2018, the Company entered into a finance agreement with First Insurance Funding in order to fund a portion of its insurance policies, which was amended in January 2019. The amount financed was $0.5 million and incurred interest at a rate of 5.15%. The Company was required to make monthly payments of $0.1 million through July 2019. As of December&#160;31, 2019, amounts were repaid in full.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2020, the Company entered into a finance agreement with First Insurance Funding in order to fund a portion of its insurance policies. The amount financed is $0.7 million and incurs interest at a rate of 3.60%. The Company is required to make monthly payments of $0.1 million through July 2021. The outstanding balance as of December&#160;31, 2020 was $0.7 million.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355886379256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS EQUITY<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteAbstract', window );"><strong>Stockholders' Equity Note [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">STOCKHOLDERS EQUITY</a></td>
<td class="text">STOCKHOLDERS EQUITY<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue up to 190,000,000 shares of common stock (par value $0.0001). As of December&#160;31, 2020 and 2019, the Company had 100,664,000 and 99,416,000 shares of common stock issued and outstanding, respectively.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 8, 2020, the Company entered into a common stock purchase agreement ("SPA") with Tumim Stone Capital, LLC ("Tumim") to issue and sell up to $10.0 million in shares of the Company's common stock. The SPA provides, among other things, that the Company may direct, every three trading days, Tumim to purchase a number of shares not to exceed an amount determined based upon the trading volume and stock price of the Company&#8217;s shares. The Company determined that the right to sell shares of common stock to Tumim under the SPA represents a freestanding put option under ASC 815 Derivatives and Hedging. Tumim has no right to require the Company to sell any shares of common stock to Tumim, but Tumim is obligated to purchase up to $10.0 million of the Company's common stock. Such sales of common stock by the Company will be subject to certain limitations, and may occur from time to time, at the Company's sole discretion till December 31, 2021. The Company determined that the fair value of the put option is zero as the shares will be issued at a discount and settled within one business day. During the year ended December&#160;31, 2020, the Company sold 450,000 shares of common stock pursuant to the SPA and recognized proceeds of $0.2 million. The Company issued 185,454 shares of common stock to Tumim as commitment fee in connection with entering into the SPA. In addition, the Company incurred offering cost of $0.3 million. In accordance with ASC 825-10-25-3, upfront costs and fees related to items for which the fair value option is elected shall be recognized in earnings as incurred and not deferred. As such, the Company recorded the fair value of the commitment fee shares of $0.1 million and offering cost of $0.3 million to general and administrative expense. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Preferred Stock</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is authorized to issue up to 10,000,000 shares of $0.0001 par value preferred stock with designations, rights and preferences to be determined from time to time by the Board of Directors. Each such series or class shall have voting powers, if any, and such preferences and/or other special rights, with such qualifications, limitations or restrictions of such preferences and/or rights as shall be stated in the resolution or resolutions providing for the issuance of such series or class of shares of preferred stock. As of December&#160;31, 2020, and 2019, there is no preferred stock issued and outstanding.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355886058520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">STOCK-BASED COMPENSATION</a></td>
<td class="text">STOCK-BASED COMPENSATION<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, there are 34,976,000 shares authorized for issuance under the CV Sciences, Inc. Amended and Restated 2013 Equity Incentive Plan (the "2013 Plan"). As of&#160;December&#160;31, 2020, the Company had 6,165,000 authorized unissued shares reserved and available for issuance upon exercise and conversion of outstanding awards under the Amended 2013 Plan. On June 11, 2019, the Company&#8217;s stockholders approved to add an automatic &#8220;evergreen&#8221; provision regarding the number of shares to be annually added to the 2013 Plan. As a result, the number of shares of common stock that will be automatically added to the 2013 Plan on January 1 of each year during the term of the plan, starting with January 1, 2020, will be the lesser of: (a) 4% of the total shares of the Company&#8217;s common stock outstanding on December 31st of the prior year, (b) 4,000,000 shares of the Company&#8217;s common stock, or (c) a lesser number of shares of the Company&#8217;s common stock as determined by the Company&#8217;s Board of Directors. On January 1, 2021, the Company added 4,000,000 shares to the 2013 Plan. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stock options are exercisable at no less than the fair market value of the underlying shares on the date of grant, and restricted stock and restricted stock units are issued at a value not less than the fair market value of the common stock on the date of the grant. Generally, stock options awarded are vested in equal increments ranging from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xNzUvZnJhZzoxMjI4MzgzYjAzYTg0OWE2YmZjODJiYzM1YWY5NjEzZC90ZXh0cmVnaW9uOjEyMjgzODNiMDNhODQ5YTZiZmM4MmJjMzVhZjk2MTNkXzE4NzE_8bd9e890-25d8-4554-b080-b96de69f559a">two</span> to four years on the annual anniversary date on which such equity grants were awarded. The stock options generally have a maximum term of 10 years.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized stock-based compensation expense of&#160;$3.9 million and $15.1 million for the years ended December&#160;31, 2020 and 2019, respectively. During the year ended December&#160;31, 2019, the Company recorded stock-based compensation expense of $9.5&#160;million related to the settlement of the Company's former founder's employment agreements. For more information refer to Note 11, Related Parties. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2020, the Company&#8217;s board of directors approved a stock option modification that reduced certain employees&#8217; and directors&#8217; stock option exercise prices to $0.66. No other terms were modified. Stock options to purchase a total of 2,130,000 shares of common stock were modified. The modification to the existing stock options resulted in $0.2 million incremental value of the stock options. The incremental value associated with the modification will be recognized over the life of the remaining service period of the options. During the year ended December&#160;31, 2020, the Company recorded $0.1 million in stock-based compensation associated with the repriced options.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, total unrecognized compensation cost related to non-vested stock-based compensation arrangements was&#160;$2.7 million which is expected to be recognized over a weighted-average period of 1.3 years. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes activity related to the Company's stock options (in thousands, except per share data):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:44.943%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.281%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.299%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining Contract<br/>Term (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding - December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(612)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,478)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding - December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable - December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,010&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested or expected to vest - December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,225&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has established performance milestones in connection with the drug development efforts for its lead drug candidate CVSI-007. The above table includes 5,000,000 vested performance-based options as of December&#160;31, 2020, which were issued outside of the 2013 Plan. As of December&#160;31, 2020, there were 8,000,000 remaining unvested stock options granted outside of the 2013 Plan which vest upon the completion of future performance conditions, including those related to the Settlement Agreement with Mona Jr. (refer to Note 11).</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total intrinsic value of stock options exercised during the year ended December&#160;31, 2020 and 2019 was $0.1 million and $4.3 million, respectively. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the weighted average grant date fair value of stock options granted and the weighted-average assumptions used to estimate the fair value on the date of grant using the Black-Scholes valuation model:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.991%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.425%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.1%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-Free Interest Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected Term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.33</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.74</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Per Share on Grant Date</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.36</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.92</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility is based on the historical volatility of the Company's common stock. Expected volatility through September 30, 2019 was calculated based on the Company&#8217;s peer group, consisting of five companies in the industry in which the Company operates because the Company did not have sufficient historical volatility data. The risk-free interest rates are based on the implied yield available on U.S.&#160;Treasury constant maturities with remaining terms equivalent to the respective expected terms of the options. The Company estimates the expected term for stock options awarded to employees, non-employees, officers and directors using the simplified method in accordance with ASC Topic 718, Stock Compensation, because the Company does not have sufficient relevant historical information to develop reasonable expectations about future exercise patterns.  In the future, as the Company gains historical data for the actual term over which stock options are held, the expected term may change, which could substantially change the grant-date fair value of future stock option awards, and, consequently, compensation of future grants.</span></div>During the year ended December&#160;31, 2019 2,950,000 restricted stock units ("RSU's") vested with a weighted average grant date fair value of $2.14 per share. The total fair value of RSU's vested during the year ended December&#160;31, 2019 was $6.3 million. There are no outstanding RSU's as of December&#160;31, 2020.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355887385992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME (LOSS) PER SHARE<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">NET INCOME (LOSS) PER SHARE</a></td>
<td class="text">NET LOSS PER SHARE<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company computes basic net loss per share using the weighted-average number of common shares outstanding during the period. Diluted net loss per share is calculated by dividing net loss by the weighted-average number of common shares plus potential common shares. The Company's stock options, including those with performance conditions, are included in the calculation of diluted net loss per share using the treasury stock method when their effect is dilutive. Potential common shares are excluded from the calculation of diluted net loss per share when their effect is anti-dilutive.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock equivalents were not included in the calculation of net loss per diluted share because their effect were anti-dilutive (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.997%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.955%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.275%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,225&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,105&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The above table excludes 8,000,000 unvested performance stock options for the years ended December&#160;31, 2020 and 2019, which vest upon the completion of future performance conditions.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355887424344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">RELATED PARTIES</a></td>
<td class="text">RELATED PARTIESDuring the year ended December&#160;31, 2019, the Company's former President and Chief Executive Officer, Michael Mona Jr. ("Mona Jr."), and the Company entered into a Settlement Agreement (the &#8220;Settlement Agreement&#8221;), pursuant to which the Company agreed that Mona Jr.&#8217;s resignation from the Company on January 22, 2019 was for Good Reason (as defined in Mona Jr.&#8217;s Employment Agreement) and agreed to extend the deadline for Mona Jr.&#8217;s exercise of his stock options for a period of five years. As of December&#160;31, 2020, Mona Jr. has 11,300,000 fully vested outstanding stock options with a weighted average exercise price of $0.42 per share. In exchange, Mona Jr. agreed that notwithstanding the terms of his Employment Agreement <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">providing for acceleration of vesting of all stock options and RSU's upon a Good Reason resignation, certain of his unvested stock options would not immediately vest, but rather continue to vest if, and only if, certain Company milestones are achieved related to the Company&#8217;s drug development efforts. These stock options were issued in July 2016 (6,000,000 options) and March 2017 (5,000,000 options) and 6,750,000 of these stock options have not vested as of December&#160;31, 2020. The Company and Mona Jr. also agreed to mutually release all claims arising out of and related to Mona Jr.&#8217;s resignation and separation from the Company. As a result of the Settlement Agreement, the Company recorded stock-based compensation expense related to the accelerated vesting of the RSU's of $5.1 million and the modification of certain stock options of $2.7 million during the year ended December&#160;31, 2019. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Settlement Agreement, 2,950,000 vested RSU's were issued to Mona Jr. The vesting of the RSU's and payment of shares is treated as taxable compensation and thus subject to income tax withholdings. No amounts were withheld (either in cash or the equivalent of shares of common stock from the vesting of the RSU's) or included in the original Company&#8217;s payroll tax filing. The compensation is subject to Federal and State income tax withholding and Federal Insurance Contributions Act (&#8220;FICA&#8221;) taxes withholding estimated to be $6.4&#160;million for the employee portions. The employer portion of the FICA taxes is $0.2&#160;million and has been recorded as a component of selling, general and administrative expenses in the consolidated statement of operations for the year ended December&#160;31, 2019. During the year ended December&#160;31, 2020, the Company reported the taxable compensation associated with the RSU release to the taxing authorities and included the amount in Mona Jr.'s W-2 for 2019. In addition, the Company paid the employer and employee portion of the FICA taxes of $0.2 million, respectively. Although the primary tax liability is the responsibility of the employee, the Company is secondarily liable and thus has recorded the liability on its consolidated balance sheet as of December&#160;31, 2020 in an amount of $6.2 million which was recorded as a component of accrued expenses. The Company initially recorded an offsetting receivable of $6.2 million during the second quarter of 2019 for the total estimated Federal and State income taxes which should have been withheld in addition to the employee portion of the FICA payroll taxes as the primary liability is ultimately the responsibility of the employee. The receivable was recorded as a component of prepaid expense and other on the consolidated balance sheet. The deadline to file and pay personal income taxes for 2019 was on October 15, 2020. To date, Mona Jr. has not provided to the Company the appropriate documentation substantiating that he properly filed and paid his taxes for 2019. As a result, the Company derecognized its previously recorded receivable of $6.2 million during the fourth quarter of 2020. The associated liability may be relieved once the tax amount is paid by Mona Jr. and the Company has received the required taxing authority documentation from Mona Jr. If the tax amount is not paid by Mona Jr., the Company would be liable for such withholding tax due. Additionally, the Company could be subject to penalties if the amounts are ultimately not paid. The Company does not believe that any such penalties are probable or reasonably possible as of December&#160;31, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 22, 2020, the Company filed a complaint in the San Diego Superior Court for declaratory relief to confirm the termination of Mona Jr.'s severance and other post-termination compensation and benefits, and to recover amounts owed to the Company by Mona Jr. in connection with his purchase of personal seat licenses for the Raiders stadium and certain advance payments made on Mona Jr.'s behalf. The complaint also requests that Mona Jr. provides the Company with appropriate taxing authority documentation to show that he paid the tax associated with the vesting of the RSU's. Refer also to Note 12, Commitment and Contingencies, for more information. The Company recorded a payable to Mona Jr. of $0.4 million and $0.6 million as of December&#160;31, 2020 and 2019, respectively. The amounts are mostly related to termination benefits associated with his separation from the Company and are payable via regular payroll through June 2021. The Company has not paid any termination benefits to Mona Jr. since filing the complaint. As of December&#160;31, 2020, the entire amount is included in accrued expenses. As of December&#160;31, 2019, the Company recorded $0.4 million in accrued expenses and $0.2 million in other liabilities.</span></div>In addition, on December 31, 2019, the Company's former Chief Operating Officer and co-founder, Michael Mona III ("Mona III"), resigned from the Company. The Company recorded stock-based compensation expense related to the accelerated vesting of Mona III's unvested outstanding options of $1.7 million during the year ended December&#160;31, 2019 with no assumed forfeiture rate. The Company recorded a payable to Mona III of $0.2 million and $0.7 million as of December&#160;31, 2020 and 2019, respectively. The amounts are mostly related to termination benefits associated with his separation from the Company and are payable via regular payroll through June 2021. As of December&#160;31, 2020, the entire amount is included in accrued expenses. As of December&#160;31, 2019, the Company recorded $0.4 million in accrued expenses and $0.2 million in other liabilities.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355886297688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsDisclosureTextBlock', window );">COMMITMENTS AND CONTINGENCIES</a></td>
<td class="text">COMMITMENTS AND CONTINGENCIESOn March 17, 2015, Michael Ruth filed a shareholder derivative suit in Nevada District Court alleging breach of fiduciary duty and gross mismanagement (the &#8220;Ruth Complaint&#8221;). The claims are premised on the same events that were the subject of a purported class action filed in the Southern District of New York on April 23, 2014 (the &#8220;Sallustro Case&#8221;). On July 2, 2019, the <div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">court in the Sallustro Case entered a final order dismissing the complaint with prejudice. The Company did not make any settlement payment, and at no time was there a finding of wrongdoing by the Company or any of its directors. Regarding the Ruth Complaint, the Company and Mr. Ruth previously agreed to stay the action pending the conclusion of discovery in the Sallustro Case. Now that the Sallustro Case has been dismissed, the stay has been lifted. Plaintiff&#8217;s counsel recently informed the Court that Mr. Ruth sold his shares of CVSI stock and thus he no longer has standing to pursue this claim. However, the Court allowed Plaintiff&#8217;s counsel to substitute CVSI shareholder Otilda Lamont as the named plaintiff. On September 20, 2019, the Company filed a motion to dismiss the Ruth Complaint and the Court issued a ruling denying the motion to dismiss on November 24, 2020. A Third Amended Complaint was filed on December 11, 2020 substituting Otilda Lamont as plaintiff. The Company filed an answer to the Ruth Complaint on January 11, 2021 and discovery recently commenced. The Court issued a schedule whereby discovery ends on November 19, 2021. Management intends to vigorously defend the allegations. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 24, 2018, David Smith filed a purported class action complaint in Nevada District Court (the "Smith Complaint") alleging certain misstatements in the Company's public filings that led to stock price fluctuations and financial harm. Several additional individuals filed similar claims, and the Smith Complaint and each of the other suits all arise out of a report published by Citron Research on Twitter on August 20, 2018, suggesting that the Company misled investors by failing to disclose that the Company&#8217;s efforts to secure patent protection for CVSI-007 had been &#8220;finally rejected&#8221; by the United States Patent and Trademark Office ("USPTO"). On November 15, 2018, the court consolidated the actions and appointed Richard Ina, Trustee for the Ina Family Trust, as Lead Plaintiff for the consolidated actions. On January 4, 2019, Counsel for Lead Plaintiff Richard Ina, Trustee for the Ina Family Trust, filed a &#8220;consolidated amended complaint&#8221;. On March 5, 2019, we filed a motion to dismiss the action. The Court denied the motion to dismiss on December 10, 2019, and the parties have commenced discovery in the action with a discovery cutoff date of May 24, 2021. Arising out of the same facts and circumstances in the Smith Complaint, on June 11, 2020, Phillip Berry filed a derivative suit in the United States District Court for the Southern District of California alleging breaches of fiduciary duty against the Company and various defendants, and waste of corporate assets (the &#8220;Berry Complaint&#8221;). The Company has accepted service of the Berry Complaint and a motion to dismiss is currently pending. In addition to the Berry Complaint, four additional shareholder derivative suits have been filed which are premised on the same event as the Smith Complaint. All four actions are currently stayed. On May 19, 2020, the USPTO issued a patent pertaining to CVSI-007, which the Company believes negates and defeats any claims that the Company and the various defendants misled the market by not disclosing that the USPTO had finally rejected the patent. Management intends to vigorously defend the allegations in each of these matters as the result of the issuance of a patent and the failure of the plaintiffs&#8217; causes of action on various other grounds.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 3, 2019, Michelene Colette and Leticia Shaw filed a putative class action complaint in the Central District of California, alleging the labeling on the Company&#8217;s products violated the Food, Drug, and Cosmetic Act of 1938 (the &#8220;Colette Complaint&#8221;). On February 6, 2020, the Company filed a motion to dismiss the Colette Complaint. Instead of opposing our motion, plaintiffs elected to file an amended complaint on February 25, 2020. On March 11, 2020, we filed a motion to dismiss the amended complaint. The court issued a ruling on May 22, 2020 that stayed this proceeding in its entirety and dismissed part of the amended complaint. The portion of the proceeding that is stayed will remain stayed until the U.S. Food and Drug Administration promulgates rules that govern cannabidiol products (the &#8220;FDA Rules&#8221;). When such FDA Rules are promulgated, the plaintiffs will be allowed to ask the court to reopen the proceeding. Management intends to vigorously defend the allegations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On July 22, 2020, the Company filed a complaint in the San Diego Superior Court for declaratory relief to confirm the termination of Mona Jr.&#8217;s severance and other post-termination compensation and benefits, as well as to recover amounts owed to the Company by Mona Jr. in connection with his purchase of a personal seat license for the Raiders Stadium and certain advance payments made on Mona Jr.&#8217;s behalf. The complaint also requests that Mona Jr. provides the Company with appropriate taxing authority documentation to show that he paid the tax associated with the vesting of the RSU's.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the normal course of business, the Company is a party to a variety of agreements pursuant to which they may be obligated to indemnify the other party. It is not possible to predict the maximum potential amount of future payments under these types of agreements due to the conditional nature of our obligations, and the unique facts and circumstances involved in each particular agreement. Historically, payments made by us under these types of agreements have not had a material effect on our business, results of operations or financial condition.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355887474184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">LEASES</a></td>
<td class="text">LEASES<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into operating leases primarily for real estate. These leases are for the Company's operations, production, warehouse, sales, marketing and back office functions. On July 27, 2020, the Company entered into a lease termination agreement for one of its facilities in San Diego, which was effective August 31, 2020. The Company derecognized the related operating lease obligation of $5.1 million and operating lease asset of $4.7 million as of August 31, 2020, and recorded an associated gain from lease termination of $0.4 million, which is recorded as a component of selling, general and administrative expense in the consolidated statements of operations for the year ended December&#160;31, 2020. As of December&#160;31, 2020, total operating lease assets and operating lease liabilities were $3.1 million and $4.1 million, respectively. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognized total lease costs of $1.0 million and $1.5 million for the year ended December&#160;31, 2020 and 2019, respectively. Total lease costs was mostly comprised of operating lease costs. Short-term lease costs related to short-term operating leases and variable lease costs were immaterial.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because the rate implicit in each lease is not readily determinable, the Company uses the rate of interest that a lessee would have to pay to borrow on a collateralized basis over a similar term an amount equal to the lease payments in a similar economic environment, which the Company determined based on comps obtained from lenders for similar financing. The Company has certain contracts for real estate which may contain lease and nonlease components which it has elected to treat as a single lease component. Cash paid for operating lease liabilities for the year ended December&#160;31, 2020 was $1.1 million. Information related to the Company's operating lease assets and related lease liabilities were as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.802%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.998%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in months)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.64</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of December&#160;31, 2020 were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.687%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,896&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(749)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,147&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355887421624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">SEGMENT INFORMATION</a></td>
<td class="text">SEGMENT INFORMATIONThe Company operates in two distinct business segments: a consumer products segment in manufacturing, marketing and selling hemp-based CBD products to a range of market sectors; and a specialty pharmaceutical segment focused on developing and commercializing novel therapeutics utilizing CBD. The Company&#8217;s segments maintain separate financial information for which operating results are evaluated on a regular basis by the Company&#8217;s senior management in deciding how to allocate resources and in assessing performance. The Company evaluates its consumer products segment based on net product sales, gross profit and operating income or loss. The Company currently evaluates its specialty pharmaceutical segment based on the progress of its clinical development programs.<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information by reportable operating segment for the years ended December&#160;31, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:54.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.291%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consumer Products<br/>Segment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Specialty Pharmaceutical Segment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,216)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,376)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,592)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2019:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,423)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,817)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,240)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's specialty pharmaceutical segment includes goodwill of $2.8 million as of December&#160;31, 2020 and 2019. In addition, the Company's intangible assets of $3.7 million and $3.8 million as of December&#160;31, 2020 and 2019, respectively, are included in the specialty pharmaceutical segment. All other assets are included in the consumer products segment as of December&#160;31, 2020 and 2019.  The majority of the Company's sales are to U.S. based customers.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 34<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8981-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 26<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8844-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8657-108599<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8721-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -URI http://asc.fasb.org/topic&amp;trid=2134510<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355887737784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">INCOME TAXES</a></td>
<td class="text">INCOME TAXES<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to taxation in the U.S. and California state jurisdictions. The Company&#8217;s pretax loss for the years ended December&#160;31, 2020 and 2019, were generated by domestic operations.  The income tax benefit for the years ended December&#160;31, 2020 and 2019 was comprised of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.270%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current tax expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(640)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax benefit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(265)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(644)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(615)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the expected income tax benefit at the federal statutory rate of 21% for the years ended December&#160;31, 2020 and 2019, and the income tax benefit reported in the financial statements is as follows:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.712%"><tr><td style="width:1.0%"/><td style="width:56.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of pretax income (loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of pretax income (loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit at federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,746)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,624)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes, net of federal effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,391)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other permanent differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible officer compensation (IRC 162(m))</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(320)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(615)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><div style="margin-top:10pt;text-align:justify"><span><br/></span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the significant components of the Company's deferred tax assets and liabilities as of December&#160;31, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.181%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change to inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals and reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,482&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,394&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(830)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,437)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(396)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(390)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CanX intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,013)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,054)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,268)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,053)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,371)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,762)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The valuation allowance increased by $4.6 million for the year ended December&#160;31, 2020 and increased by $3.7 million for the year ended December&#160;31, 2019.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets and liabilities are provided for significant revenue and expense items recognized in different years for tax and financial reporting purposes. The Company periodically assesses the likelihood that it will be able to recover its deferred tax assets. The Company considers all available evidence, both positive and negative, including historical levels of income, expectations and risks associated with estimates of future taxable income, and ongoing prudent and feasible profits. As of December&#160;31, 2020 and 2019, the Company established valuation allowances equal to the full amount of its deferred tax assets, net of certain tax liabilities, due to the uncertainties regarding the realization of the deferred tax assets in future years.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company has federal, California, and other state net operating loss (&#8220;NOL&#8221;) carryforwards of  $21.4 million, 16.9 million, and $3.4 million, respectively, which are available to offset future taxable income. Federal NOL carryforwards arising after 2017 of $14.2 million do not expire.  Federal NOL carryforwards arising before 2018 of $7.2 million expire from 2036 to 2037.  California NOL carryforwards of 16.9 million expire from 2036 to 2040. Other state NOL carryforwards of $3.4 million have various expirations from 2038 to 2040.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2020, the Company has federal and California R&amp;D credit carryforwards of approximately $0.7 million and $0.4 million, respectively, which are available to offset future taxable income.  Federal R&amp;D credit carryforwards expire from 2034 to 2040. California R&amp;D credit carryforwards do not expire.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The NOL carryforward may be subject to an annual limitation under Section 382 and 383 of the Internal Revenue Code of 1986 (the &#8220;Code&#8221;), and similar state provisions if the Company experienced one or more ownership changes which would limit the amount of NOL and tax credit carryforwards that can be utilized to offset future taxable income and tax, respectively. In general, an ownership change as defined by Section 382 and 383, results from the transactions increasing ownership of certain stockholders or public groups in the stock of the corporation of more than 50% over a three-year period. The Company completed a Section 382 and 383 analysis regarding the limitation of NOL and credit carryforwards from inception in December 2010 through November 4, 2019. The Company experienced multiple ownership changes for the purposes of Section 382 and 383 of the Code with the latest change in April 2017. The ownership changes did not result in the forfeiture of any NOLs or credits generated prior to this date. If a change in ownership occurs in the future, the NOL and tax credits carryforwards could be eliminated or restricted.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes a tax benefit from an uncertain tax position when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits, and uncertain income tax positions must meet a more likely than not recognition threshold to be recognized. The Company recognizes interest and penalties related to unrecognized tax benefits within the income tax expense line in the consolidated statements of operations. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company does not anticipate a significant change in its uncertain tax benefits over the next 12 months. The Company is subject to taxation in the U.S. and California state jurisdictions. Due to net operating losses all tax years since inception remain open to examination.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the Company's unrecognized tax benefits for the years ended December&#160;31, 2020 and 2019 is provided in the following table (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.181%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1:</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in current year positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in prior year positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in prior year positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31:</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355886028056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENT<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">SUBSEQUENT EVENT</a></td>
<td class="text">SUBSEQUENT EVENTSubsequent to December&#160;31, 2020, through March&#160;19, 2021, the Company sold 5,941,816 shares of common stock under its SPA with Tumim at a weighted average price of $0.53 per share, resulting in proceeds of $3.1 million.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI http://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355891827624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text">Basis of Presentation - The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP"). The consolidated financial statements include the accounts of CV Sciences, Inc., the accounts of its wholly-owned subsidiaries of Plus CBD, LLC and CANNAVEST Acquisition, LLC, and the accounts of a 70% interest in CannaVest Europe, GmbH. On January 20, 2017, the Company filed for dissolution of CannaVest Europe, GmbH, with the District Court, Dusseldorf Germany, effective December&#160;31, 2017. CANNAVEST Acquisition, LLC, a Delaware limited liability company formed in connection with the CanX Acquisition, was dissolved in 2018, with administrative approval in Florida carrying over into January 2019 before final resolution. On August 7, 2019, the Company filed for dissolution of Plus CBD, LLC (formerly, &#8220;Global Hemp Source, LLC&#8221;) with the Secretary of State of California. As a result, the Company no longer owns interests in any subsidiaries as of December&#160;31, 2020. All intercompany accounts and transactions have been eliminated in consolidation.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The preparation of the consolidated financial statements in conformity with U.S. GAAP requires management to make judgments, estimates and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results may differ from these estimates. Significant estimates include the valuation of intangible assets, inputs for valuing equity awards, and assumptions related to revenue recognition.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentrations of Credit Risk</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; As of December&#160;31, 2020, the Federal Deposit Insurance Corporation (&#8220;FDIC&#8221;) provided insurance coverage of up to $0.3 million per depositor per bank. The Company has not experienced any losses in such accounts and does not believe that the Company is exposed to significant risks from excess deposits. The Company&#8217;s cash balance in excess of FDIC limits totaled $3.3 million as of December&#160;31, 2020.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company's raw materials purchases for the year ended December&#160;31, 2019 were sourced from one supplier in Europe. During the year ended December&#160;31, 2020 the Company added one additional domestic supplier. There was no concentration of accounts receivable or revenue as of and for the years ended December&#160;31, 2020 and 2019.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueOfFinancialInstrumentsPolicy', window );">Fair Value of Financial Instruments</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Fair value is defined as the price that would be received from the sale of an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The carrying values of accounts receivable, other current assets, accounts payable, and certain accrued expenses as of December&#160;31, 2020 and 2019, approximate their fair value due to the short-term nature of these items. The Company's notes payable balance also approximates fair value as of December&#160;31, 2020, as the interest rate on the notes payable approximates the rates available to the Company as of this date. The accounting guidance establishes a three-level hierarchy for disclosure that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities.</span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 1 - uses unadjusted quoted prices that are available in active markets for identical assets or liabilities. The Company's Level 1 assets are comprised of $2.4 million and $4.0 million in money market funds which are classified as cash equivalents as of December&#160;31, 2020 and 2019, respectively. In addition, the Company's restricted cash of $0.5 million as of December&#160;31, 2020 and 2019 is comprised of certificates of deposits. The carrying value of the cash </span></div><div style="padding-left:36pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">equivalents and restricted cash equals the fair value as of December&#160;31, 2020 and 2019. The Company does not have any liabilities that are valued using inputs identified under a Level 1 hierarchy as of December&#160;31, 2020 and 2019. </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 2 - uses inputs other than quoted prices included in Level 1 that are either directly or indirectly observable through correlation with market data. These include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data. The Company did not have any assets or liabilities that are valued using inputs identified under a Level 2 hierarchy as of December&#160;31, 2020 and 2019. </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level 3 - uses one or more significant inputs that are unobservable and supported by little or no market activity, and that reflect the use of significant management judgment. Level 3 assets and liabilities include those whose fair value measurements are determined using pricing models, discounted cash flow methodologies or similar valuation techniques, and significant management judgment or estimation. The Company did not have any assets or liabilities that are valued using inputs identified under a Level 3 hierarchy as of December&#160;31, 2020 and 2019.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; For purposes of the consolidated statements of cash flows, the Company considers amounts held by financial institutions and short-term investments with an original maturity of three months or less when purchased to be cash and cash equivalents. As of December&#160;31, 2020, the Company had cash of $1.6 million and cash equivalents of $2.4 million. As of December&#160;31, 2019, the Company had cash of $5.1 million and cash equivalents of $4.0 million.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text">Restricted Cash &#8211; The Company&#8217;s restricted cash as of  December&#160;31, 2020 and 2019 consists of certificates of deposits related to the Company's corporate credit card program.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivable</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Generally, the Company requires payment prior to shipment. However, in certain circumstances, the Company extends credit to companies located throughout the U.S. Accounts receivable consists of trade accounts arising in the normal course of business. Accounts for which no payments have been received after 30 days are considered delinquent and customary collection efforts are initiated. Accounts receivable are carried at original invoice amount less a reserve made for doubtful receivables based on a review of all outstanding amounts on a quarterly basis.</span>Management has determined the allowance for doubtful accounts by regularly evaluating individual customer receivables and considering a customer&#8217;s financial condition and credit history, and current economic conditions.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Inventory is stated at lower of cost or net realizable value, with cost being determined on an average cost basis. Cost includes costs directly related to manufacturing and distribution of the products. Primary costs include raw materials, packaging, manufacturing overhead, shipping and depreciation of manufacturing equipment and production facilities. Manufacturing overhead includes payroll, employee benefits, utilities, maintenance and property taxes. Total shipping and handling costs were $1.7 million and $2.7 million for the years ended December&#160;31, 2020 and 2019, respectively, and are recorded in cost of goods sold.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company performs an assessment of inventory obsolescence to measure inventory at the lower of cost or net realizable value. Factors considered in the determination of obsolescence include slow-moving or non-marketable items. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's inventory production process includes the cultivation of botanical raw material. Because of the duration of the cultivation process, a portion of our inventory will not be sold within one year. Starting April 1, 2019, consistent with the practice in other industries that cultivate botanical raw materials, all inventory is classified as a current asset.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property &amp; Equipment</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Equipment is stated at cost less accumulated depreciation. Cost represents the purchase price of the asset and other costs incurred to bring the asset into its existing use. Depreciation is provided on a straight-line basis over the assets estimated useful lives. Tenant improvements are amortized on a straight-line basis over the shorter of the useful life or the remaining life of the related lease. Maintenance or repairs are charged to expense as incurred. Upon sale or disposition, the historically-recorded asset cost and accumulated depreciation are removed from the respective accounts and any related gain or loss is recognized.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impairment of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; In accordance with Accounting Standards Codification (&#8220;ASC&#8221;) Topic 360, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accounting for the Impairment or Disposal of Long-Lived Assets</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company reviews property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Recoverability of property and equipment is measured by comparing its carrying value to the undiscounted projected future cash flows that the assets are expected to generate. If the carrying amount of an asset is not recoverable, the Company recognizes an impairment loss based on the excess of the carrying amount of the long-lived asset over its respective fair value, which is generally determined as the present value of estimated future cash flows or at the appraised value. The impairment analysis is based on significant assumptions of future results made by management, including revenue and cash flow projections. Circumstances that may lead to impairment of property and equipment include a significant decrease in the market price of a long-lived asset, a significant adverse change in the extent or manner in which a long-lived asset is being used or in its physical condition and a significant adverse change in legal factors or in the business climate that could affect the value of a long-lived asset including an adverse action or assessment by a regulator. As of December&#160;31, 2020 and 2019, the Company determined that long-lived assets were not impaired.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy', window );">Goodwill and Intangible Assets</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets &#8211;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company evaluates the carrying value of goodwill and intangible assets annually during the fourth quarter in accordance with ASC Topic 350, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles Goodwill and Other</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and between annual evaluations if events </span><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">occur or circumstances change that would more likely than not reduce the fair value of the reporting unit below its carrying amount. Such circumstances could include, but are not limited to (1) a significant adverse change in legal factors or in business climate, (2) unanticipated competition, or (3) an adverse action or assessment by a regulator. All of the Company's goodwill and intangible assets are assigned to the Company's specialty pharmaceutical segment.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill is evaluated for impairment by first performing a qualitative assessment to determine whether a quantitative goodwill test is necessary. If it is determined, based on qualitative factors, that the fair value of the reporting unit may be more likely than not less than carrying amount, or if significant adverse changes in the Company's future financial performance occur that could materially impact fair value, a quantitative goodwill impairment test would be required. Additionally, management can elect to forgo the qualitative assessment and perform the quantitative test. If the qualitative assessment indicates that the quantitative analysis should be performed, or if management elects to bypass a qualitative assessment, the Company then evaluates goodwill for impairment by comparing the fair value of the reporting unit to its carrying amount, including goodwill. The quantitative assessment for goodwill requires management to estimate the fair value of the Company's reporting units using either an income or market approach or a combination thereof. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management makes critical assumptions and estimates in completing impairment assessments of goodwill and other intangible assets. The Company's cash flow projections look several years into the future and include assumptions on variables such as future sales and operating margin growth rates, economic conditions, probability of success, market competition, inflation and discount rates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the fourth quarter of 2020, the Company performed its annual goodwill impairment test and determined, after performing a qualitative test of the reporting unit, that it is more likely than not that the fair value of the reporting unit exceeds its carrying amount. Accordingly, there was no indication of impairment and the quantitative impairment test was not performed. The Company did not record any goodwill impairment charges for the years ended December&#160;31, 2020 or 2019.</span></div>The Company classifies intangible assets into three categories: (1) intangible assets with definite lives subject to amortization; (2) intangible assets with indefinite lives not subject to amortization; and (3) goodwill. The Company determines the useful lives of its identifiable intangible assets after considering the specific facts and circumstances related to each intangible asset. Factors considered when determining useful lives include the contractual term of any agreement related to the asset, the historical performance of the asset, the Company's long-term strategy for using the asset, any laws or regulations which could impact the useful life of the asset and other economic factors, including competition and specific market conditions. Intangible assets that are deemed to have definite lives are amortized, primarily on a straight-line basis, over their useful lives to their estimated residual values, generally five years. In-process research &amp; development ("IPR&amp;D") has an indefinite life and is not amortized until completion and development of the project, at which time the IPR&amp;D becomes an amortizable asset. Until such time as the projects are either completed or abandoned, the Company test those assets for impairment at least annually at year end, or more frequently at interim periods, by evaluating qualitative factors which could be indicative of impairment. Qualitative factors being considered include, but are not limited to, macro-economic conditions, progress on drug development activities, and overall financial performance. If impairment indicators are present as a result of the Company's qualitative assessment, the Company will test those assets for impairment by comparing the fair value of the assets to their carrying value. Quantitative factors being considered include, but are not limited to, the current project status, forecasted changes in the timing or amounts required to complete the project, forecasted changes in timing or changes in the future cash flows to be generated by the completed products, a probability of success of the ultimate project and changes to other market-based assumptions, such as discount rates. Upon completion or abandonment, the value of the IPR&amp;D assets will be amortized to expense over the anticipated useful life of the developed products, if completed, or charged to expense when abandoned if no alternative future use exists.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; The majority of the Company's revenue contracts represent a single performance obligation related to the fulfillment of customer orders for the purchase of its products. Net sales reflect the transaction prices for these contracts based on the Company's selling list price, which is then reduced by estimated costs for trade promotional programs, consumer incentives, and allowances and discounts used to incentivize sales growth and build brand awareness. The Company recognizes revenue at the point in time that control of the ordered product is transferred to the customer, which is typically upon shipment to the customer or other customer-designated delivery point. The Company accrues for estimated sales returns by customers based on historical sales return results. The computation of the sales return and discount allowances require that management makes certain estimates and assumptions that effect the timing and amounts of revenue and liabilities recorded. Shipping and handling fees charged to customers are included in product sales and totaled $0.2 million and $0.3 million for the years ended December&#160;31, </span><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020 and 2019, respectively. Taxes collected from customers that are remitted to governmental agencies are accounted for on a net basis and not included as revenue.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents product sales by channel for food, drug and mass ("FDM"), natural product and other, and e-commerce for the years ended December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of product sales, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of prodct sales, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail - FDM</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,651&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail - Natural products and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-Comm</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,429&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,696&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Compensation and Benefits</a></td>
<td class="text">Compensation and Benefits &#8211; The Company records compensation and benefits expense for all cash and deferred compensation, benefits, and related taxes as earned by its employees. Compensation and benefits expense also includes compensation earned by temporary employees and contractors who perform similar services to those performed by the Company&#8217;s employees, primarily information technology and project management activities. The Company maintains a defined contribution 401(k) plan available to eligible employees. Employee contributions are voluntary and are determined on an individual basis, limited to the maximum amount allowable under federal tax regulations. The Company, at its discretion, may make certain matching contributions to the 401(k) plan.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research &amp; Development Expense</a></td>
<td class="text">Research and Development Expense &#8211; Research and development costs are charged to expense as incurred and include, but are not limited to, employee salaries and benefits, cost of inventory used in product development, consulting service fees, the cost of renting and maintaining our laboratory facility and depreciation of laboratory equipment.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising</a></td>
<td class="text">Advertising &#8211; The Company supports its products with advertising to build brand awareness of the Company&#8217;s various products in addition to other marketing programs executed by the Company&#8217;s marketing team. The Company believes the continual investment in advertising is critical to the development and sale of its products.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Stock Based Compensation</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock-Based Compensation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; Certain employees, officers, directors, and consultants of the Company participate in various long-term incentive plans that provide for granting stock options, restricted stock awards, restricted stock units, stock bonus awards and performance-based awards. Stock options generally vest in equal increments over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzY1OTcwNjk4MDk1ODc_f5674a51-c511-43ac-a681-83d953908b76">two</span>- to four-year period and expire on the <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOmNhNjQ5NDBlYWJhODQzMmNiM2U4YTc0YmFhYWM0NzEzL3NlYzpjYTY0OTQwZWFiYTg0MzJjYjNlOGE3NGJhYWFjNDcxM18xMzkvZnJhZzplN2RlYmNmZmE0MGE0ZDBkYjQ1MzhhNzJjYTI4MzY1MS90ZXh0cmVnaW9uOmU3ZGViY2ZmYTQwYTRkMGRiNDUzOGE3MmNhMjgzNjUxXzIxOTkwMjMzMTk0MDU_d0b87cf7-bf22-4fdd-a58e-c194e22353b3">ten</span>th anniversary following the date of grant. Performance-based stock options vest once the applicable performance condition is satisfied. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes stock-based compensation for equity awards granted to employees, officers and directors as compensation and benefits expense in the consolidated statements of operations. The fair value of stock options is estimated using a Black-Scholes valuation model on the date of grant. The fair value of restricted stock awards is equal to the closing price of the Company&#8217;s stock on the date of grant. Stock-based compensation is recognized over the requisite service period of the individual awards, which generally equals the vesting period. For performance-based stock options, compensation is recognized once the applicable performance condition is satisfied.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the related temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized when the rate change is enacted. Valuation allowances are recorded to reduce deferred tax assets to the amount that will more likely than not be realized. In accordance with ASC Topic 740, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company recognizes the effect of uncertain income tax positions only if the positions are more likely than not of being sustained in an audit, based on the technical merits of the position. Recognized uncertain income tax positions are measured at the largest amount that is greater than 50% likely of being realized. Changes in </span>recognition or measurement are reflected in the period in which those changes in judgment occur. The Company recognizes both interest and penalties related to uncertain tax positions as part of the income tax provision. As of December&#160;31, 2020 and 2019 the Company did not have a liability for unrecognized tax uncertainties. The Company is subject to routine audits by taxing jurisdictions. Management believes the Company is no longer subject to tax examinations for the years prior to 2013.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income</a></td>
<td class="text">Comprehensive Loss &#8211; Comprehensive loss is defined as a change in equity during a period from transactions and other events and circumstances from non-owner sources. There have been no items qualifying as other comprehensive loss and, therefore, the Company's comprehensive loss was the same as its reported net loss for the years ended December&#160;31, 2020 and 2019.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Issued and Newly Adopted Accounting Pronouncements</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Pronouncements Not Yet Adopted</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board ("FASB") issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments and subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04 and ASU 2019-05 (collectively, &#8220;Topic 326&#8221;). Topic 326 requires measurement and recognition of expected credit losses for financial assets held. Topic 326 was to be effective for reporting periods beginning after December 15, 2019, with early adoption permitted. In November 2019, the FASB issued ASU 2019-10, Financial Instruments - Credit Losses (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842) Effective Dates, which deferred the effective dates for the Company, as a smaller reporting company, until fiscal year 2023. The Company currently plans to adopt the guidance at the beginning of fiscal 2023. The Company is currently evaluating the potential impact of Topic 326 on the Company&#8217;s consolidated financial statements.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU 2019-12, Simplifying the Accounting for Income Taxes ("ASU 2019-12"), which simplifies the accounting for income taxes, eliminates certain exceptions within ASC 740, Income Taxes, and clarifies certain aspects of the current guidance to promote consistency among reporting entities. The new standard is effective for fiscal years beginning after December 15, 2020. Most amendments within the standard are required to be applied on a prospective basis, while certain amendments must be applied on a retrospective or modified retrospective basis. The Company is currently evaluating the potential impact of ASU 2019-12 on the Company&#8217;s consolidated financial statements.</span></div><div><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In January 2017, the FASB issued ASU 2017-04, Intangibles &#8211; Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment (&#8220;ASU 2017-04&#8221;), which eliminates Step 2 from the goodwill impairment test. Instead, an entity should perform its annual or interim goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should then recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit&#8217;s fair value; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. Additionally, an entity should consider income tax effects from any tax deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. ASU 2017-04 requires the entity to apply these amendments on a prospective basis for which it is required to disclose the nature of and reason for the change in accounting upon transition. This disclosure shall be provided in the first annual period and in the interim period within the first annual period when the entity initially adopts the amendments. This ASU became effective for the Company on January 1, 2020. Adoption of ASU 2017-04 did not have an immediate impact on the Company&#8217;s consolidated financial statements and only has the potential to impact the amount of any goodwill impairment recorded after the adoption of the ASU.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18726-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueOfFinancialInstrumentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the fair value of financial instruments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 60<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=7493716&amp;loc=d3e21868-110260<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13279-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueOfFinancialInstrumentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5033-111524<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10178-111534<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10149-111534<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=84159169&amp;loc=d3e10133-111534<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355887706952">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock', window );">Schedule of Cash, Cash Equivalents and Restricted Cash</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the consolidated balance sheets to the total of the same amounts shown in the statement of cash flows as of December&#160;31, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.181%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">As of December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,024&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,107&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash and restricted cash shown in the statements of cash flows</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,525&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,608&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Revenue Product Sales by Channel</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following represents product sales by channel for food, drug and mass ("FDM"), natural product and other, and e-commerce for the years ended December&#160;31, 2020 and 2019:</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.767%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.394%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.397%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of product sales, net</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of prodct sales, net</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail - FDM</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,651&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.8&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,229&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retail - Natural products and other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,073&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">41,534&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-Comm</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,705&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.5&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;text-indent:-27pt;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,429&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,696&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of cash and cash equivalents.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355895316664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INVENTORY (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventory</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory as of December&#160;31, 2020 and 2019 was comprised of the following (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.181%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,923&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,503&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">415&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,132&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,053&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,840&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,971&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355886231992">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY &amp; EQUIPMENT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net, as of December&#160;31, 2020 and 2019 were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.089%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.848%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.112%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.115%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Useful Lives</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Office furniture and equipment</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 - 5 years</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,596&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,285&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tenant improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,967&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Laboratory and other equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 years</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">691&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,269&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,269&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,170&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,392)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,555)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,877&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,615&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;padding-left:18pt;text-align:justify;text-indent:-9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">* Tenant improvements are amortized over the lesser of the remaining term of the related lease or the estimated useful life of the tenant improvements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355886308072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of intangible assets</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets consist of the following as of December&#160;31, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.308%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.836%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.402%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Useful Life (Years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,907&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">177&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,730&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance - December 31, 2019:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">In-process research and development</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,730&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trade names</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-compete agreements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,907&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">141&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,766&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355911887480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of accrued expenses</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued expenses as of December&#160;31, 2020 and 2019 were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.181%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued payroll expenses (1)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,324&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,787&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,481&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,069&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,805&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,856&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1) This includes a tax liability associated with a related party transaction as discussed in Note 11 of $6.2 million and $6.6 million as of December&#160;31, 2020 and 2019, respectively.</span></div></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355886009560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtTableTextBlock', window );">Schedule of Debt</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt as of December&#160;31, 2020 was as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.083%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.717%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PPP loan</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,906&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Insurance financing</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">721&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,627&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Current portion of debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,174)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term portion of debt</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock', window );">Schedule of Principal Payments on Debt</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal payments on the debt are as follows (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.083%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.717%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,174&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,453&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total principal payments</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,627&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of maturity and sinking fund requirement for long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355887448376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Stock Option Activity</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes activity related to the Company's stock options (in thousands, except per share data):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:44.943%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.410%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.281%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.299%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Number of Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Weighted Average<br/>Remaining Contract<br/>Term (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding - December 31, 2019</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,335&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.41&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(612)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.37&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(8,478)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.91&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding - December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,225&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.48&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercisable - December 31, 2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,254&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.46&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.3</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,010&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested or expected to vest - December 31, 2020</span></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,225&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.48&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,186&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Fair value assumptions</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the weighted average grant date fair value of stock options granted and the weighted-average assumptions used to estimate the fair value on the date of grant using the Black-Scholes valuation model:</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.991%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.425%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">132.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">126.1%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-Free Interest Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.5%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected Term (in years)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.33</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.74</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend Rate</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.0%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fair Value Per Share on Grant Date</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$0.36</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$1.92</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355886281208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME (LOSS) PER SHARE (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Computation of Basic and Diluted Earnings per Share</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following common stock equivalents were not included in the calculation of net loss per diluted share because their effect were anti-dilutive (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:65.997%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.273%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.955%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.275%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,225&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,105&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 1.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,225&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,105&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355886301304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease Information</a></td>
<td class="text">Information related to the Company's operating lease assets and related lease liabilities were as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:81.802%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.998%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average remaining lease term (in months)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60.64</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average discount rate</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Maturities of Lease Liabilities</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of December&#160;31, 2020 were as follows (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.687%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.113%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">928&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">925&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,015&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,896&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less imputed interest</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(749)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,147&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current operating lease liabilities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">680&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,467&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total lease liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,147&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355886364648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock', window );">Schedule Of Segment Reporting Information</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents information by reportable operating segment for the years ended December&#160;31, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.856%"><tr><td style="width:1.0%"/><td style="width:54.295%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.519%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.291%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consumer Products<br/>Segment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Specialty Pharmaceutical Segment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Consolidated Totals</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2020:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,009&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">678&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,265&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,943&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,547&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">111&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,658&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20,216)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,376)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(22,592)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Year ended December 31, 2019:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Product sales, net</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,696&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,088&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,106&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,771&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,877&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,405&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46,451&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(13,423)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,817)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,240)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8813-108599<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355889278296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2020</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Reconciliation of income tax provision</a></td>
<td class="text">The income tax benefit for the years ended December&#160;31, 2020 and 2019 was comprised of the following (in thousands):<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.267%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.270%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current tax expense (benefit)</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(52)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Federal</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(640)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(264)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total deferred tax benefit</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(265)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(644)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(615)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of effective income tax rate reconciliation</a></td>
<td class="text">A reconciliation of the expected income tax benefit at the federal statutory rate of 21% for the years ended December&#160;31, 2020 and 2019, and the income tax benefit reported in the financial statements is as follows:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.712%"><tr><td style="width:1.0%"/><td style="width:56.969%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.842%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.520%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.845%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">For the years ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of pretax income (loss)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% of pretax income (loss)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit at federal statutory rate</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,746)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,624)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21.0&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State taxes, net of federal effect</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,391)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,142)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other permanent differences</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.5)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">43&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">569&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(274)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-deductible officer compensation (IRC 162(m))</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,242&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7.2)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">R&amp;D tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(242)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(320)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">769&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3.6)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(241)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.4&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,609&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(20.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,701&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(21.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Income tax benefit</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(317)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.3&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(615)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.6&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of deferred tax assets</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the significant components of the Company's deferred tax assets and liabilities as of December&#160;31, 2020 and 2019 (in thousands):</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.181%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,876&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,627&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Business credit carryforwards</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">918&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">620&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">890&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,470&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,740&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change to inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accruals and reserves</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,275&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">383&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,482&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,394&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(830)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,437)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property and equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(396)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(390)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CanX intangible assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,013)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,054)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(172)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,268)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(4,053)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,371)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,762)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net deferred tax liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(157)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(421)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits</a></td>
<td class="text"><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A reconciliation of the Company's unrecognized tax benefits for the years ended December&#160;31, 2020 and 2019 is provided in the following table (in thousands):</span></div><div style="margin-bottom:6pt;margin-top:10pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.181%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.400%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.518%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.401%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of January 1:</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in current year positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Increase in prior year positions</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">119&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Decrease in prior year positions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31:</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">166&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 55<br> -Paragraph 217<br> -URI http://asc.fasb.org/extlink&amp;oid=121610041&amp;loc=d3e36027-109320<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355887410472">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>ORGANIZATION AND BUSINESS (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>segment</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355891110808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 08, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Apr. 17, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>company</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>supplier</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 501<span></span>
</td>
<td class="nump">$ 501<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashUninsuredAmount', window );">Cash in excess of FDIC limits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromUnsecuredNotesPayable', window );">Proceeds from debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,900<span></span>
</td>
<td class="nump">2,906<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600<span></span>
</td>
<td class="nump">5,100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="nump">4,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_AccountsReceivableThresholdforDeterminingDelinquentAccount', window );">Threshold for determining delinquent accounts receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Allowance for doubtful accounts</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="nump">400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,429<span></span>
</td>
<td class="nump">53,696<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Matching contribution to 401(k) plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,943<span></span>
</td>
<td class="nump">5,877<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300<span></span>
</td>
<td class="nump">2,500<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Equity Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock option, maximum term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Equity Option | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Equity Option | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvsi_ConsumerProductsMember', window );">Consumer Products Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 678<span></span>
</td>
<td class="nump">2,106<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvsi_SpecialtyPharmaceuticalSegmentMember', window );">Specialty Pharmaceutical Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,200<span></span>
</td>
<td class="nump">3,800<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember', window );">Shipping and Handling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Shipping and handling costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,700<span></span>
</td>
<td class="nump">2,700<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales, net</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200<span></span>
</td>
<td class="nump">300<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cvsi_CommonStockPurchaseAgreementMember', window );">Common Stock Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction', window );">Value of shares</a></td>
<td class="nump">$ 10,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashAndCashEquivalents', window );">Restricted cash</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">500<span></span>
</td>
<td class="nump">500<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Money market funds classified as cash and cash equivalents</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember', window );">Supplier Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_NumberofSuppliers', window );">Number of suppliers | supplier</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_NumberOfAdditionalSuppliers', window );">Number of additional suppliers | company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_OwnershipAxis=cvsi_CannaVestEuropeGmbHMember', window );">CannaVest Europe, GmbH</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MinorityInterestOwnershipPercentageByParent', window );">Ownership interest (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">70.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_AccountsReceivableThresholdforDeterminingDelinquentAccount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Threshold for Determining Delinquent Account</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_AccountsReceivableThresholdforDeterminingDelinquentAccount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_NumberOfAdditionalSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Additional Suppliers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_NumberOfAdditionalSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_NumberofSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Suppliers</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_NumberofSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Maximum Value Of Shares Issued In Transaction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashUninsuredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashUninsuredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2(a),(d))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MinorityInterestOwnershipPercentageByParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The parent entity's interest in net assets of the subsidiary, expressed as a percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MinorityInterestOwnershipPercentageByParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromUnsecuredNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from borrowings supported by a written promise to pay an obligation that is uncollateralized (where debt is not backed by the pledge of collateral).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromUnsecuredNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashAndCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashAndCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvsi_ConsumerProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvsi_ConsumerProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvsi_SpecialtyPharmaceuticalSegmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvsi_SpecialtyPharmaceuticalSegmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cvsi_CommonStockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cvsi_CommonStockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_OwnershipAxis=cvsi_CannaVestEuropeGmbHMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_OwnershipAxis=cvsi_CannaVestEuropeGmbHMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355886090840">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 4,024<span></span>
</td>
<td class="nump">$ 9,107<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">501<span></span>
</td>
<td class="nump">501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash and restricted cash shown in the statements of cash flows</a></td>
<td class="nump">$ 4,525<span></span>
</td>
<td class="nump">$ 9,608<span></span>
</td>
<td class="nump">$ 12,935<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355891098184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue Product Sales by Channel (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales, net</a></td>
<td class="nump">$ 24,429<span></span>
</td>
<td class="nump">$ 53,696<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of product sales, net</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=cvsi_RetailFDMMember', window );">Retail - FDM</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales, net</a></td>
<td class="nump">$ 1,651<span></span>
</td>
<td class="nump">$ 2,229<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of product sales, net</a></td>
<td class="nump">6.80%<span></span>
</td>
<td class="nump">4.20%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=cvsi_RetailNaturalProductsAndOtherMember', window );">Retail - Natural products and other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales, net</a></td>
<td class="nump">$ 15,073<span></span>
</td>
<td class="nump">$ 41,534<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of product sales, net</a></td>
<td class="nump">61.70%<span></span>
</td>
<td class="nump">77.30%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=cvsi_ECommMember', window );">E-Comm</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Product sales, net</a></td>
<td class="nump">$ 7,705<span></span>
</td>
<td class="nump">$ 9,933<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">% of product sales, net</a></td>
<td class="nump">31.50%<span></span>
</td>
<td class="nump">18.50%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=cvsi_RetailFDMMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=cvsi_RetailFDMMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=cvsi_RetailNaturalProductsAndOtherMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=cvsi_RetailNaturalProductsAndOtherMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=cvsi_ECommMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=cvsi_ECommMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355898219560">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INVENTORY (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterials', window );">Raw materials</a></td>
<td class="nump">$ 4,923<span></span>
</td>
<td class="nump">$ 4,503<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcess', window );">Work in process</a></td>
<td class="nump">785<span></span>
</td>
<td class="nump">415<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">3,132<span></span>
</td>
<td class="nump">5,053<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Total gross inventory</a></td>
<td class="nump">8,840<span></span>
</td>
<td class="nump">9,971<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory write-down</a></td>
<td class="nump">300<span></span>
</td>
<td class="nump">200<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">Outside the United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryLineItems', window );"><strong>Inventory [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryGross', window );">Total gross inventory</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcess">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcess</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355892101048">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>PROPERTY &amp; EQUIPMENT (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 5,269<span></span>
</td>
<td class="nump">$ 5,170<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation</a></td>
<td class="num">(2,392)<span></span>
</td>
<td class="num">(1,555)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment,net</a></td>
<td class="nump">2,877<span></span>
</td>
<td class="nump">3,615<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">800<span></span>
</td>
<td class="nump">700<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office furniture and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 2,596<span></span>
</td>
<td class="nump">1,285<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office furniture and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment useful life</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember', window );">Office furniture and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Tenant improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 1,967<span></span>
</td>
<td class="nump">1,925<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sic_Z3821', window );">Laboratory and other equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 691<span></span>
</td>
<td class="nump">691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment useful life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 1,269<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_OfficeEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=sic_Z3821">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=sic_Z3821</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355892079368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS - Intangible Asset Schedule (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 3,907<span></span>
</td>
<td class="nump">$ 3,907<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">177<span></span>
</td>
<td class="nump">141<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">3,730<span></span>
</td>
<td class="nump">3,766<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember', window );">In-process research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">3,730<span></span>
</td>
<td class="nump">3,730<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">3,730<span></span>
</td>
<td class="nump">3,730<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember', window );">Trade names</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">100<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember', window );">Non-compete agreements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 77<span></span>
</td>
<td class="nump">$ 77<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="nump">77<span></span>
</td>
<td class="nump">61<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Useful Life (Years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_InProcessResearchAndDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_NoncompeteAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355887708904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INTANGIBLE ASSETS - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentForAmortization', window );">Amortization expense</a></td>
<td class="nump">$ 36,000<span></span>
</td>
<td class="nump">$ 35,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">Future amortization expense</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentForAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentForAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355898185384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>ACCRUED EXPENSES (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued payroll expenses</a></td>
<td class="nump">$ 8,324<span></span>
</td>
<td class="nump">$ 8,787<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">1,481<span></span>
</td>
<td class="nump">2,069<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses</a></td>
<td class="nump">9,805<span></span>
</td>
<td class="nump">10,856<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionAxis=cvsi_TaxLiabilityMember', window );">Tax liability</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Accrued payroll expenses</a></td>
<td class="nump">$ 6,200<span></span>
</td>
<td class="nump">$ 6,600<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionAxis=cvsi_TaxLiabilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionAxis=cvsi_TaxLiabilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355891494072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>DEBT - Schedule of Debt (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 3,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtCurrent', window );">Less: Current portion of debt</a></td>
<td class="num">(2,174)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Long-term portion of debt</a></td>
<td class="nump">1,453<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Note Payable, Other | PPP loan</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">2,906<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Insurance financing</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 721<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19,20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvsi_PayrollProtectionProgramLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvsi_PayrollProtectionProgramLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvsi_FirstInsuranceFundingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvsi_FirstInsuranceFundingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355891242904">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Principal Payments on Debt (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 2,174<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo', window );">2022</a></td>
<td class="nump">1,453<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Long-term debt, gross</a></td>
<td class="nump">$ 3,627<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04.(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24072-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355888475336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>DEBT - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Apr. 17, 2020</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember', window );">Note Payable, Other | PPP loan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt', window );">Proceeds from debt</a></td>
<td class="nump">$ 2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="nump">0.98%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Premium Finance Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5.15%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt periodic payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember', window );">Unsecured Debt | Insurance financing</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Debt interest rate (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Debt face value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentPeriodicPayment', window );">Debt periodic payment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnsecuredDebt', window );">Net carrying amount of debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentPeriodicPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the required periodic payments including both interest and principal payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentPeriodicPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfLongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfLongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnsecuredDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnsecuredDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_NotesPayableOtherPayablesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvsi_PayrollProtectionProgramLoanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvsi_PayrollProtectionProgramLoanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_UnsecuredDebtMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvsi_PremiumFinanceAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvsi_PremiumFinanceAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=cvsi_FirstInsuranceFundingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=cvsi_FirstInsuranceFundingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355902303928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCKHOLDERS EQUITY - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 08, 2020 </div>
<div>USD ($) </div>
<div>businessDay </div>
<div>tradingDay </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">190,000,000<span></span>
</td>
<td class="nump">190,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,664,000<span></span>
</td>
<td class="nump">99,416,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock - shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100,664,000<span></span>
</td>
<td class="nump">99,416,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=cvsi_CommonStockPurchaseAgreementMember', window );">SPA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction', window );">Value of shares | $</a></td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock', window );">Number of specified trading days between directions to purchase stock | tradingDay</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_SaleOfStockFairValueOfPutOption', window );">Fair value of put option (in USD per share) | $ / shares</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement', window );">Number of business days between issuance and settlement | businessDay</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Common stock sold (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds recognized | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices', window );">Shares issued as commitment fee (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">185,454<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Stock offering cost | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee', window );">Fair value of shares issued as commitment fee | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_SaleOfStockFairValueOfPutOption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale of Stock, Fair Value Of Put Option</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_SaleOfStockFairValueOfPutOption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Fair Value Of Shares Issued, Payment Of Commitment Fee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Maximum Value Of Shares Issued In Transaction</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Number Of Business Days Between Issuance And Settlement</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Number Of Specified Trading Days Between Directions To Purchase Stock</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesIssuedForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesIssuedForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cvsi_CommonStockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cvsi_CommonStockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355883701016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Narrative (Details)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">9 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Jan. 01, 2021 </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Sep. 30, 2019 </div>
<div>company</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 11, 2019 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized weighted average period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Aggregate intrinsic value, exercised in period | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="nump">$ 4.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility', window );">Number of peers included in calculation of expected volatility | company</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember', window );">Equity Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock option, maximum term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Unvested options granted (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,210,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25,225,000<span></span>
</td>
<td class="nump">28,105,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cvsi_StockOptionModificationMember', window );">Stock Option Modification</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.66<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Unvested options granted (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,130,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation cost | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=cvsi_OptionsOutsidePlanMember', window );">Options Outside the Amended 2013 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested stock options (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (USD per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.14<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Options outstanding (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Options vested (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,950,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of RSU's vested | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingIncomeLossMember', window );">Operating Income (Loss)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.9<span></span>
</td>
<td class="nump">15.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_TitleOfIndividualAxis=cvsi_FormerFoundersMember', window );">Former Founders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 9.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Equity Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Equity Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cvsi_Amended2013PlanMember', window );">Amended 2013 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Shares authorized under plan (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">34,976,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance', window );">Shares unissued and reserved for issuance (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,165,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent', window );">Annual increase in shares available for issuance as percent of total shares outstanding (percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan', window );">Annual increase to shares authorized for issuance under the Plan (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cvsi_Amended2013PlanMember', window );">Amended 2013 Plan | Equity Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Stock option, maximum term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cvsi_Amended2013PlanMember', window );">Amended 2013 Plan | Minimum | Equity Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cvsi_Amended2013PlanMember', window );">Amended 2013 Plan | Maximum | Equity Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=cvsi_Amended2013PlanMember', window );">Amended 2013 Plan | Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized', window );">Shares available for issuance under the Plan (shares)</a></td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation, Annual Increase to Shares Authorized for Issuance under the Plan</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation, Annual Increase to Shares Authorized for Issuance under the Plan as Percent of Common Stock Outstanding, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Number of Peers Included in Calculation of Expected Volatility</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common shares reserved for future issuance related to deferred compensation arrangements with individuals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of additional shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cvsi_StockOptionModificationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cvsi_StockOptionModificationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=cvsi_OptionsOutsidePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=cvsi_OptionsOutsidePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingIncomeLossMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_OperatingIncomeLossMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_TitleOfIndividualAxis=cvsi_FormerFoundersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_TitleOfIndividualAxis=cvsi_FormerFoundersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=cvsi_Amended2013PlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=cvsi_Amended2013PlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355898139880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Summary of Stock Options Activity (Details) - Equity Option - USD ($)<br> $ / shares in Units, shares in Thousands, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding beginning balance (shares)</a></td>
<td class="nump">28,105<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod', window );">Granted (shares)</a></td>
<td class="nump">6,210<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (shares)</a></td>
<td class="num">(612)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited (shares)</a></td>
<td class="num">(8,478)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Outstanding ending balance (shares)</a></td>
<td class="nump">25,225<span></span>
</td>
<td class="nump">28,105<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Exercisable (shares)</a></td>
<td class="nump">22,254<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Vested or expected to vest (shares)</a></td>
<td class="nump">25,225<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding beginning balance (USD per share)</a></td>
<td class="nump">$ 0.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (USD per share)</a></td>
<td class="nump">0.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (USD per share)</a></td>
<td class="nump">0.37<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Forfeited (USD per share)</a></td>
<td class="nump">0.91<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Outstanding ending balance (USD per share)</a></td>
<td class="nump">0.48<span></span>
</td>
<td class="nump">$ 0.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Exercisable (USD per share)</a></td>
<td class="nump">0.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Vested or expected to vest (USD per share)</a></td>
<td class="nump">$ 0.48<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Outstanding balance, weighted average remaining contract term (in years)</a></td>
<td class="text">5 years 8 months 12 days<span></span>
</td>
<td class="text">5 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Options exercisable, weighted average remaining contract term (in years)</a></td>
<td class="text">5 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1', window );">Options vested or expected to vest, weighted average remaining contract term (in years)</a></td>
<td class="text">5 years 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding beginning balance, aggregate intrinsic value</a></td>
<td class="nump">$ 12,335<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Outstanding ending balance, aggregate intrinsic value</a></td>
<td class="nump">2,186<span></span>
</td>
<td class="nump">$ 12,335<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Options exercisable, aggregate intrinsic value</a></td>
<td class="nump">2,010<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Options vested or expected to vest, aggregate intrinsic value</a></td>
<td class="nump">$ 2,186<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Net number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_StockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_StockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355886140024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>STOCK-BASED COMPENSATION - Assumptions Used to Estimate Fair Value (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="nump">132.90%<span></span>
</td>
<td class="nump">126.10%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-Free Interest Rate</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected Term (in years)</a></td>
<td class="text">5 years 3 months 29 days<span></span>
</td>
<td class="text">2 years 8 months 26 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend Rate</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair Value Per Share on Grant Date</a></td>
<td class="nump">$ 0.36<span></span>
</td>
<td class="nump">$ 1.92<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355891290648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>NET INCOME (LOSS) PER SHARE - Antidilutive Shares (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">25,225,000<span></span>
</td>
<td class="nump">28,105,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">20,225,000<span></span>
</td>
<td class="nump">18,105,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember', window );">Performance stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvsi_UnvestedStockOptionsMember', window );">Unvested Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive shares</a></td>
<td class="nump">8,000,000<span></span>
</td>
<td class="nump">8,000,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvsi_UnvestedStockOptionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=cvsi_UnvestedStockOptionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355895339032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>RELATED PARTIES - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2017</div></th>
<th class="th"><div>Jul. 31, 2016</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_AccruedPayrollTaxesCurrentEmployeePortion', window );">Employee portion of payroll taxes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Options vested (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,950,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvsi_FormerPresidentandCEOMember', window );">Former President and CEO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesCurrent', window );">Due from former President and CEO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">$ 0.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvsi_FormerPresidentandCEOMember', window );">Former President and CEO | Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedPayrollTaxesCurrent', window );">Payroll taxes payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvsi_FormerPresidentandCEOMember', window );">Former President and CEO | Prepaid Expenses and Other Current Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DueFromRelatedPartiesCurrent', window );">Due from former President and CEO</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForLoanAndLeaseLosses', window );">Impairment charge related to previously recorded receivable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvsi_FormerPresidentandCEOMember', window );">Former President and CEO | Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvsi_FormerPresidentandCEOMember', window );">Former President and CEO | Selling, General and Administrative Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_PayrollTaxExpense', window );">Payroll tax expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvsi_FormerPresidentandCEOMember', window );">Former President and CEO | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod', window );">Stock option exercise period extension</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares', window );">Options vested (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price of outstanding vested options (USD per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options issued (shares)</a></td>
<td class="nump">5,000,000<span></span>
</td>
<td class="nump">6,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Unvested stock options (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvsi_FormerPresidentandCEOMember', window );">Former President and CEO | Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested RSU's (shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,950,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvsi_FormerChiefOperatingOfficerMember', window );">Former Chief Operating Officer</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvsi_FormerChiefOperatingOfficerMember', window );">Former Chief Operating Officer | Accrued Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvsi_FormerChiefOperatingOfficerMember', window );">Former Chief Operating Officer | Other Noncurrent Liabilities</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent', window );">Accounts payable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvsi_FormerChiefOperatingOfficerMember', window );">Former Chief Operating Officer | Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Stock based compensation expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_AccruedPayrollTaxesCurrentEmployeePortion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Payroll Taxes, Current, Employee Portion</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_AccruedPayrollTaxesCurrentEmployeePortion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_PayrollTaxExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payroll Tax Expense</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_PayrollTaxExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Extension of Expiration Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount for accounts payable to related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.15(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedPayrollTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedPayrollTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DueFromRelatedPartiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DueFromRelatedPartiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForLoanAndLeaseLosses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to estimated loss from loan and lease transactions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.11)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11B<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=SL6953423-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForLoanAndLeaseLosses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options vested.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvsi_FormerPresidentandCEOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvsi_FormerPresidentandCEOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_AccruedLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherNoncurrentLiabilitiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvsi_FormerChiefOperatingOfficerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=cvsi_FormerChiefOperatingOfficerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355888070664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>COMMITMENTS AND CONTINGENCIES - Lawsuits (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2020 </div>
<div>lawsuit</div>
</th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_LitigationCaseAxis=cvsi_SmithComplaintMember', window );">Smith Complaint</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LossContingenciesLineItems', window );"><strong>Loss Contingencies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_NumberofDerivativeLawsuits', window );">Number of shareholder derivative suits filed</a></td>
<td class="nump">4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_NumberofDerivativeLawsuits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Derivative Lawsuits</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_NumberofDerivativeLawsuits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LossContingenciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LossContingenciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_LitigationCaseAxis=cvsi_SmithComplaintMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_LitigationCaseAxis=cvsi_SmithComplaintMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355894779448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>LEASES - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Jul. 27, 2020 </div>
<div>leaseTerminationAgreement</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">$ 3,057<span></span>
</td>
<td class="nump">$ 8,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liabilities for operating leases</a></td>
<td class="nump">4,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">1,000<span></span>
</td>
<td class="nump">$ 1,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease payments</a></td>
<td class="nump">1,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=cvsi_SanDiegoFacilityMember', window );">Terminated San Diego Facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_NumberOfLeaseTerminationAgreements', window );">Number of lease termination agreements | leaseTerminationAgreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use assets</a></td>
<td class="nump">4,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Lease liabilities for operating leases</a></td>
<td class="nump">5,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnTerminationOfLease', window );">Gain termination of lease</a></td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_NumberOfLeaseTerminationAgreements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of Lease Termination Agreements</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_NumberOfLeaseTerminationAgreements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnTerminationOfLease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on termination of lease before expiration of lease term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 40<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121604053&amp;loc=SL77918607-209975<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnTerminationOfLease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=cvsi_SanDiegoFacilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis=cvsi_SanDiegoFacilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355902596152">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Right-of-use Assets and Lease Liabilities (Details)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate</a></td>
<td class="nump">6.50%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term</a></td>
<td class="text">5 years 19 days<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355895049464">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>LEASES - Maturity of Lease Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths', window );">2021</a></td>
<td class="nump">$ 928<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo', window );">2022</a></td>
<td class="nump">925<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree', window );">2023</a></td>
<td class="nump">957<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour', window );">2024</a></td>
<td class="nump">986<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive', window );">2025</a></td>
<td class="nump">1,015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive', window );">Thereafter</a></td>
<td class="nump">85<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments due</a></td>
<td class="nump">4,896<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less imputed interest</a></td>
<td class="num">(749)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">4,147<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Current operating lease liabilities</a></td>
<td class="nump">680<span></span>
</td>
<td class="nump">$ 723<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Non-current operating lease liabilities</a></td>
<td class="nump">$ 3,467<span></span>
</td>
<td class="nump">$ 9,517<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355892150168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SEGMENT INFORMATION (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>segment</div>
</th>
<th class="th">
<div>Dec. 31, 2019 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Product sales, net</a></td>
<td class="nump">$ 24,429<span></span>
</td>
<td class="nump">$ 53,696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">11,009<span></span>
</td>
<td class="nump">35,088<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">2,943<span></span>
</td>
<td class="nump">5,877<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">30,658<span></span>
</td>
<td class="nump">46,451<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(22,592)<span></span>
</td>
<td class="num">(17,240)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,788<span></span>
</td>
<td class="nump">2,788<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvsi_ConsumerProductsMember', window );">Consumer Products Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Product sales, net</a></td>
<td class="nump">24,429<span></span>
</td>
<td class="nump">53,696<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">11,009<span></span>
</td>
<td class="nump">35,088<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">678<span></span>
</td>
<td class="nump">2,106<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">30,547<span></span>
</td>
<td class="nump">46,405<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(20,216)<span></span>
</td>
<td class="num">(13,423)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementBusinessSegmentsAxis=cvsi_SpecialtyPharmaceuticalsMember', window );">Specialty Pharmaceutical Segment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Revenues', window );">Product sales, net</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">2,265<span></span>
</td>
<td class="nump">3,771<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">111<span></span>
</td>
<td class="nump">46<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating loss</a></td>
<td class="num">(2,376)<span></span>
</td>
<td class="num">(3,817)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">2,800<span></span>
</td>
<td class="nump">2,800<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets</a></td>
<td class="nump">$ 3,700<span></span>
</td>
<td class="nump">$ 3,800<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvsi_ConsumerProductsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvsi_ConsumerProductsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementBusinessSegmentsAxis=cvsi_SpecialtyPharmaceuticalsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementBusinessSegmentsAxis=cvsi_SpecialtyPharmaceuticalsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355894768712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES INCOME TAXES - Components of Income Tax Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="num">(52)<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current tax expense (benefit)</a></td>
<td class="num">(52)<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(1)<span></span>
</td>
<td class="num">(640)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(264)<span></span>
</td>
<td class="num">(4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred tax benefit</a></td>
<td class="num">(265)<span></span>
</td>
<td class="num">(644)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">$ (317)<span></span>
</td>
<td class="num">$ (615)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355891905016">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Income Tax Provision (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Amount</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">Income tax benefit at federal statutory rate</a></td>
<td class="num">$ (4,746)<span></span>
</td>
<td class="num">$ (3,624)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State taxes, net of federal effect</a></td>
<td class="num">(1,391)<span></span>
</td>
<td class="num">(1,142)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther', window );">Other permanent differences</a></td>
<td class="nump">115<span></span>
</td>
<td class="nump">43<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">569<span></span>
</td>
<td class="num">(274)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation', window );">Non-deductible officer compensation (IRC 162(m))</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,242<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">R&amp;D tax credits</a></td>
<td class="num">(242)<span></span>
</td>
<td class="num">(320)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">769<span></span>
</td>
<td class="num">(241)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Increase in valuation allowance</a></td>
<td class="nump">4,609<span></span>
</td>
<td class="nump">3,701<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax benefit</a></td>
<td class="num">$ (317)<span></span>
</td>
<td class="num">$ (615)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract', window );"><strong>Percent of pretax income (loss)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Income tax benefit at federal statutory rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State taxes, net of federal effect</a></td>
<td class="nump">6.20%<span></span>
</td>
<td class="nump">6.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther', window );">Other permanent differences</a></td>
<td class="num">(0.50%)<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="num">(2.50%)<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent', window );">Non-deductible officer compensation (IRC 162(m))</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="num">(7.20%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">R&amp;D tax credits</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.90%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(3.60%)<span></span>
</td>
<td class="nump">1.40%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Increase in valuation allowance</a></td>
<td class="num">(20.40%)<span></span>
</td>
<td class="num">(21.50%)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations', window );">Income tax benefit</a></td>
<td class="nump">1.30%<span></span>
</td>
<td class="nump">3.60%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Reconciliation, Non-deductible Officer Compensation</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Reconciliation, Non-deductible Officer Compensation, Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355977260040">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>INCOME TAXES - Deferred Income Taxes (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxesAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 5,876<span></span>
</td>
<td class="nump">$ 2,627<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness', window );">Business credit carryforwards</a></td>
<td class="nump">918<span></span>
</td>
<td class="nump">620<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets', window );">Intangible assets</a></td>
<td class="nump">756<span></span>
</td>
<td class="nump">890<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock-based compensation</a></td>
<td class="nump">6,470<span></span>
</td>
<td class="nump">6,740<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInventory', window );">Change to inventory</a></td>
<td class="nump">61<span></span>
</td>
<td class="nump">268<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_DeferredTaxAssetOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="nump">1,126<span></span>
</td>
<td class="nump">2,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals', window );">Accruals and reserves</a></td>
<td class="nump">2,275<span></span>
</td>
<td class="nump">383<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">17,482<span></span>
</td>
<td class="nump">14,394<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_DeferredTaxLiabilityOperatingLeaseAssets', window );">Operating lease assets</a></td>
<td class="num">(830)<span></span>
</td>
<td class="num">(2,437)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment', window );">Operating lease assets</a></td>
<td class="num">(396)<span></span>
</td>
<td class="num">(390)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets', window );">CanX intangible assets</a></td>
<td class="num">(1,013)<span></span>
</td>
<td class="num">(1,054)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(29)<span></span>
</td>
<td class="num">(172)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(2,268)<span></span>
</td>
<td class="num">(4,053)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(15,371)<span></span>
</td>
<td class="num">(10,762)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilitiesNet', window );">Net deferred tax liabilities</a></td>
<td class="num">$ (157)<span></span>
</td>
<td class="num">$ (421)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_DeferredTaxAssetOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Asset, Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_DeferredTaxAssetOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_DeferredTaxLiabilityOperatingLeaseAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liability, Operating Lease Assets</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_DeferredTaxLiabilityOperatingLeaseAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(15)(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e31917-109318<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInventory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInventory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible general business tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355888315336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Valuation allowance (decrease) increase</a></td>
<td class="nump">$ 4.6<span></span>
</td>
<td class="nump">$ 3.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">21.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">R&amp;D credit carryforwards</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority | After 2017</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">14.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Domestic Tax Authority | Before 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">7.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction | California Franchise Tax Board</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">16.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">R&amp;D credit carryforwards</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State and Local Jurisdiction | States Other than California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforward</a></td>
<td class="nump">$ 3.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=cvsi_After2017Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=cvsi_After2017Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxPeriodAxis=cvsi_Before2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxPeriodAxis=cvsi_Before2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=us-gaap_CaliforniaFranchiseTaxBoardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityNameAxis=cvsi_StatesOtherThanCaliforniaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityNameAxis=cvsi_StatesOtherThanCaliforniaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355890221832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>INCOME TAXES - Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance as of January 1:</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increase in current year positions</a></td>
<td class="nump">47<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increase in prior year positions</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decrease in prior year positions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance as of December 31:</a></td>
<td class="nump">$ 166<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.20.4</span><table class="report" border="0" cellspacing="2" id="idm140355920657640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SUBSEQUENT EVENT (Details) - SPA - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 19, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Common stock sold (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Event</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Common stock sold (in shares)</a></td>
<td class="nump">5,941,816<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Proceeds recognized</a></td>
<td class="nump">$ 3.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_cvsi_SaleOfStockWeightedAveragePricePerShare', window );">Weighted average price per share</a></td>
<td class="nump">$ 0.53<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cvsi_SaleOfStockWeightedAveragePricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Weighted Average Price Per Share</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cvsi_SaleOfStockWeightedAveragePricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cvsi_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=cvsi_CommonStockPurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=cvsi_CommonStockPurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>76
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( .Z*<U('04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " #NBG-24I(10>X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M:L,P#(9?9?B>*$Y@92;UI:.G#@8K;.QF;+4UBV-C:R1]^R5>FS*V!]C1TN]/
MGT"M#D+[B,_1!XQD,=V-KNN3T&'-3D1! "1]0J=2.27ZJ7GPT2F:GO$(0>D/
M=42HJ^H>')(RBA3,P"(L1"9;HX6.J,C'"][H!1\^8Y=A1@-VZ+"G!+SDP.0\
M,9S'KH4;8(811I>^"V@68J[^B<T=8)?DF.R2&H:A')J<FW;@\/:T>\GK%K9/
MI'J-TZ]D!9T#KMEU\FNS>=QOF:RKFA=54_"'/5^)NA%\]3Z[_O"["3MO[,'^
M8^.KH&SAUUW(+U!+ P04    " #NBG-2F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M .Z*<U)%/73?1 8  %<8   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MC5G;<MLV$'U.OV)'R:3MC&7QHIL3VS.R9+=J8D=CY3)IIP\P"4D8DX *@);U
M]UV $BE[*) O%F][<+!8G,6NSS="/JH5I1J>TX2KB]9*Z_6'3D=%*YH2=2K6
ME..;A9 IT7@KEQVUEI3$UBA-.H'G]3LI8;QU>6Z?S>3EN<ATPCB=25!9FA*Y
MO:*)V%RT_-;^P3U;KK1YT+D\7Y,EG5/];3V3>-<I4&*64JZ8X"#IXJ(U\C],
MPJXQL%]\9W2C#J[!3.5!B$=S,XTO6IYA1!,::0-!\.>)CFF2&"3D\=\.M%6,
M:0P/K_?H-W;R.)D'HNA8)#]8K%<7K6$+8KH@6:+OQ>9/NIM0S^!%(E'V+VSR
M;[O=%D29TB+=&2.#E/'\ESSO''%@,/2.& 0[@^"5@7]LA'!G$#8UZ.X,K*L[
M^52L'R9$D\MS*38@S=>(9BZL,ZTU3I]QL^YS+?$M0SM].19/5$(;OLTG\-N[
MW^$=, ZW+$EP4=1Y1^,0YL-.M(.[RN&"(W!^ +>"ZY6":Q[3^"5 ![D5!(,]
MP:O B3BAT2F$_@D$7N!5$!J[S6^)/ 6_;\W]"O.)V_ROC./H7M7H+V83%NX.
M+5[H=/<_HP>E)8;\OP[(;@'9M9#=8PX2488;4</7[9I6K9C;W/?:GQPL>@6+
M7C,6(\XSDL ]70NIJ^BX<;3,J(-.OZ#3;T9G1B43L8E&P/U1Z9\:I%W\_?+F
M34T,# IN R?B.)/24+MA*D)/_:1$.OFYT=IM/VB'OH/7L. U;!A(DJ"N6UD^
MOHQNK 5)E&L=SPI.9TZ<:ZZ9WJ*K$@IW6?I 9147-X;G>>U>MS\8./CX7JF7
M7A-&]W3)S!Y&=]V1M'+=:H#&WV$>,<HCJDY@RJ-3%[T#.?>;T$,\(7'IB%G%
M$YAKC"T0$L8BXUIN\3>NYNQ&GUR[2 8ER: )R:_D&:8Q1AQ;L,@R=:QQ#>30
M:WMGW>[9H.MB6,JT'S9A.(IC216NS^X"/N-W\(57^\X-Z7O>P(,K(CE5,"9\
M:[:7(*X<Z9<YP'>K^&N^8W.'Z_U5;'@E5S?<G'"8,+H4+G)E:O#=FOZ:7!&-
M,RF>&&Z 2H9NS/'(1:U,$[Y;W5]3FPFE49/_9NOC6\2->!;XKP\:+[F5:<*O
MR1.6&1[FCU-Q PS[?1>1,B_X;C'_+$R>FJT$=XEP#4APYK4#O^<4X3(K^(W2
M H$?6#"T'SE&.<PI4<@PAJE2V1&*;M0[5[@'988(&F4( M]%@FJ+U93-7Y6,
M:J#<C,JD$#1)"K^J73IG?&GW8(8ZE)]%*JFY,7]2Y>)6YH*@42Z8<DUE7@2:
M@Q!Q,G,CUC K<T#0* ?8M4/!UBB'<EO)QXUS)WB;1!&6NIB.,3XK@N$EPU+U
M@T:J/T])DL!5IO"UJBS::G!J#MU!J?1!(Z6_3JE<FBC[ Q'T"O4K76/"JV3F
M!JP[1P:ET@=N79Z.;^YAE,5,8^(9:4U1Z.V1XR8ARTIF;KQ:9J7.!VZ9WJ_B
M"K7,Z2HW3"VA4N\#MU3O",VRAX1%Z!]!JK;A9(?2LRBFO_1TV<?ZZ*EJ[%+9
M@T;*CFY(<6WF6D2/>&!8$4S/\"73N&@\QLBJ; 3DR/T#/K[7[WN]P;!;32LL
M-3UT"_&^-E(')VO<R@^F$%A028\<8FI0QU1JPCBHO FF0"Q KRC(HKAX_W88
M^(./RK2R&&=6'M=2/&_!A"^UY=H" YHA,]/AV)??MY1:F4= Z\.52&(J%6@!
M#Q06J$ Q;!AN33/<G$:91&QT,7H7KI^C%>%+:A>!*=OA6V=29:;800 L?;(D
MWSM^=P1<:,!;U$B-9N ''L1DBU"+_!D%BJ#'9[;(R^"M*8.I:1H!EMS4G#+>
MO_7[WL=][^<$, B O7*_W+L?WR"W&9$:IM-I/AY38)J#8'H<KO(J+#-IV*B\
M&J/?)9*>(M]G^$0K]VL-%):E?L_WSOJNBB4L\VCHSGHCC(78QL,Q0:L!J-./
M\*#'Y4YX12-AU^'8]6!N\'%E=JJ!N_GI8E4FR[!AG^RP[W*<DQOL6"NH<]")
M-4G0=K051*;LSINRQ=.B:SZRO>).^7G><K\E)H<J2.@"3;W3 0JMS+O8^8T6
M:]O7?1!:B]1>KBC!;6X^P/<+(?3^Q@Q0_"_A\G]02P,$%     @ [HIS4OPQ
MW![X!0  /1@  !@   !X;"]W;W)K<VAE971S+W-H965T,BYX;6RMF5USVR@4
MAO\*X^GLMC-.+-!WZG@FC;/;SG2;3)WN7F,)VTPEH0**D_WU"[)CV0+A7.Q-
M+-F'PWL.'!X@TRWC/\6&$ F>RZ(2UZ.-E/759"*R#2FQN&0UJ=0O*\9++-4K
M7T]$S0G.VT9E,4&>%TU*3*O1;-I^]\!G4];(@E;D@0/1E"7F+Y](P;;7(SAZ
M_>([76^D_F(RF]9X319$_J@?N'J;'+SDM"25H*P"G*RN1S?PZM;W=8/6XF]*
MMN+H&>A0EHS]U"]?\NN1IQ61@F12N\#JXXG<DJ+0GI2.7WNGHT.?NN'Q\ZOW
M/]K@53!++,@M*_ZAN=Q<CY(1R,D*-X7\SK:?R3Z@4/O+6"':OV"[M_5&(&N$
M9.6^L5)0TFKWB9_WB3AJ (.!!FC? +VU@;]OT&9NLE/6AC7'$L^FG&T!U];*
MFWYH<].V5M'02@_C0G+U*U7MY.SV_MOB_NN7^<WCW1Q\NOEZ\^WV#BP^W]T]
M+L %^+&8@_?O/H!W@%;@<<,:@:M<3"=2]:S;3[)]+Y]VO:"!7N8DNP0^' /D
M(<_2_/;-S6%ZVGRBXCT$C0Y!H]:?/Q1TPSFI),!"$"FN'![]@T>_]1@,><1B
M U1N0*8?R*^&/N%"=6'-U<Y5V+K29?8T"SP43"=/QQDQC5+HQ0>C$Y7!067@
M5/F=",EI)LE.ITW;SD%TU&WHP9XTM\V)LO"@+'0JN\DRUJATJ94A(RIWRX*,
M046D36)H= \ABGH:32,$XX'T10>1D5/DE^I)#2GC+S95D=%AD@1>3Y5IE*;Q
M0.KB@ZK8J>J!DQK3')!GM;0+(MIIR.2&<)O,V,R+'Z.>3-,(>A$<T)D<="9.
MG8],XD(M:<>E9U.8F)U'2>3W))I6/O*C@0%.#Q+3,ZE4>.3R!?R&R_IC6\:U
M0I8<G(JIF<WD:);MI)I&?@1#NU+H=>NVY]1ZKY1B2:LU*(C"F".A>T<G KRP
MK])BE<1>.B#S""_P3,U(7*VIJF<QF,6]BQ.!L=^O':M5% T([%  D5/@GXSE
M6UH45F'('-\X2?K"SEB="NN( MU(N=<E[!I6WRP4'QI9LU@% 1H0UX$$NDFR
M*V:'.),1OA>AL*_.@A(4)0-E##N:P/!-@"\H7M*"2DJ<E(<= : ; 0=.U?A%
M0\H:N[G*P\A8%:Q6<"CR#@;030,ED#>DHX%5H+F^IXEGC(V- DDX5' =!J";
M Z]C4S/>;N39"K#>6O8Z;%;00G/ICQ)CVIM&,?('I'=X@&X^6*07K%I?2,)+
M=798VE<W"R1@W-_N6:P\NUS4(0*Y$7%*W*-:L,E$YOH/ ]_O[ZML9CY,!V8%
MZCB!W)SHX\PY!9 %!4'4KS"+51H.51@Z.CNX@3$?&&=D8@ &87_?8K$:&N>.
M%,A-BCE9$37&.9#X^4SB+#0P=@(6HP -;/Y01PSD)L8.9^<FH<F#?F5;3 )O
M:/IUP$#N\\>N5,ZILYP\T@ :0VPY>_AA,#3,'7N0FSVWK"RIU/O1W1X_8Y4N
M&%)E2B]X_XU) B#Z8%7N]*ROBJY$C3-R/:HY$80_D=$,V,[I_X.CT^@[L*'8
MB?2%9-G/#2MRPL7O[=:\/\5/'7<\0FX>J?/3OGR$[F*LT,Z!.KTW!+SS+CW/
M@Q\!],;J 8@-YOJ U<@-X_1?DG\$%7O]E@JAP=N>OAHIU+8W5Z-C'0T33L8L
M=YF<!MK1"YVAEYH_"EJ.*-/!,*'GC:,H:*-+TW$ (W?8:FNHZ3A7I_ERJ>K^
M]>ZGM=.W.&-UTA<U:2_Q"OM:91+1V-VZ;4YO<CIL^FYLWN0YU7A7"X(^6%_0
M"F2XIFJ!L%[FF$",0XCZBX+-S(N/M@&G8CMN^FYNJOU>4S8%UG<Z.5G1C%KA
MY)LLO(C\%/6O=FQV:K#] 6KZ'35]-S5W"ZPX6\1[N1:60@3[]Q06,Y3"8$CL
MT66>&Z@&#=II^V;QYM6=[>QC,;.=?29'=[OZ8OTOS->T$FJ;M%+MO,M8.>"[
MN^K=BV1U>]V[9%*RLGW<$*Q$:P/U^XHI4.Q?] WRX3\&L_\ 4$L#!!0    (
M .Z*<U)EN"M0V@(  *T)   8    >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL
MG99;;]HP%,>_BA7MH94Z<@$"5!") E4K=2TJ[?8P[<$D!V(UL3/;0+=//]M)
M,RBW  _$E_,_YW><X]C=%>-O(@:0Z#U-J.A9L939M6V+,(84BQK+@*J9&>,I
MEJK+Y[;(..#(B-+$]AS'MU-,J!5TS=B8!UVVD FA,.9(+-(4\S\WD+!5SW*M
MCX%G,H^E'K"#;H;G, 'YFHVYZMFEEXBD0 5A%'&8]:R^>SUP'2TP%M\)K,1:
M&^E4IHR]Z<Y]U+,<300)A%*[P.JQA $DB?:D.'X73JTRIA:NMS^\WYKD53)3
M+&# DA\DDG'/:ELH@AE>)/*9K>Z@2*BI_84L$>8?K7+;9LM"X4)(EA9B19 2
MFC_Q>[$0:P*WL4?@%0*OJJ!>".HFT9S,I#7$$@==SE:(:VOE33?,VABURH90
M_1HGDJM9HG0R&#P]3IX>[H?]E]$0W?0?^H^#$9K<C48O$W0QQARHC$&2$">7
MZ"OZ@FPD8C4JNK94T;4/.RPBW>21O#V1AA#64-V]0I[C.3OD@\IRM[,IMU7.
M9>)>F;AG_-7W^)M(+$'5HT1LAFX)Q30D.$%C)HBIKY_]J9!<5=FO \'J9;"Z
M"=;8$VRL:A,XAPBI%QJ^7:$,<[3$R0+0!:'H=3)$&?!\:2]W+6WNOF7<ZYVY
M#)R:XSANUUZN+^%1LPWZ1DG?.(T^+P&$%S)FG/Q5$Q?YT$[VW+F_!N4Z^>\3
M?07##?YFR=\\BY\(L3C"WMQ"^@Q]R&*#UB]I_;-HU3=82$PC0N<'D?VCR(<L
M-I!;)7+K(/* I:G:,H97?25.+>Y6M>(^:K;!WB[9VZ>PGU;:[>V*[>RN[2J6
M&_R=DK]S!G^%TN[LVFV^W]AFW[;L=!JNOQ?==?X?/LX9\%4KO7!>)84=IGMR
ML-?.4GV1^8;YG%"!$I@IJ5-KJ0W/\[M!WI$L,\?KE$EU6)MFK.Y3P+6!FI\Q
M)C\Z^L0N;VC!/U!+ P04    " #NBG-20OK,0(L$  #^#@  &    'AL+W=O
M<FMS:&5E=',O<VAE970T+GAM;*5776_B.A#]*Q;:AZVT+;%#0JA:I):R]R+U
M Q7V[L-J'PP9(-HDYMH&NO_^CI.0 '&BE>X+B</,\9FQ?<9S=Q#RE]H :/*1
MQ*FZ[VRTWMYVNVJY@82K&[&%%/]9"9EPC4.Y[JJM!!YF3DG<98[C=Q,>I9WA
M7?9M*H=W8J?C*(6I)&J7)%S^?H18'.X[M'/\\!ZM-]I\Z [OMGP-,]#?ME.)
MHVZ)$D8)I"H2*9&PNN\\T-L1'1B'S.*?" [JY)V84!9"_#*#27C?<0PCB&&I
M#03'QQY&$,<&"7G\6X!VRCF-X^G[$?UK%CP&L^ *1B+^'H5Z<]\).B2$%=_%
M^ET<_H8B(,_@+46LLE]R*&R=#EGNE!9)X8P,DBC-G_RC2,2) V,-#JQP8'_J
MX!8.;A9HSBP+ZXEK/KR3XD"DL48T\Y+E)O/&:*+4+.-,2_PW0C\]'+V]SMZ>
M)T\/\_$3F<WQ\3)^G<_(VU?R-AV_/\PG:$"NR;?9$_G\Z8JH#9>@2)22^4;L
M%$]#]85\.AO?=342,_#=94'B,2?!&DA01EY$JC>*C-,0PG. +D94AL6.83VR
M5L0G6-X0EWXAS&&.A=#HC]WIH(6.6V;9S?#<!KQ)NA0)D)GF&O ,:/+C8:&T
MQ#W\LP6]5Z+W,O1> _I4BG"WU$3Q&' U4M"V)<@QO S#'.[]D/5Z#*/;G^:E
M;N6Y_L OK<X(>B5!KY7@2"A-Q(JLA0@542(.;01S#/]D:NKVS.J=$;18!;X3
MV GZ)4&_E>!?4BA%ME*L(FON_/JDU'$N<U>W<CTG:*#6+ZGU6[?.VQ8DUU&Z
M)O"!VJU W;9LF:!$#5H#?@<%7"XW! \LJMX>Y7QK-J8M^* 6%AOTW(O8ZT9>
MT._;0Q^4) >M)&<H[ACX%[*&%),09V1YB"H8F<-C]-_&=U!?!L?W@@O"=:N>
MW_.HG3%U*CEU6CG/A4:BU:*-BT6SBJ)39^KZ#KU@:C'SF,L:]A4]47[:2K4B
M&>/NMQ*DM9FO&?,&[)*AQ8[V6<]IH,@JBJR5XB35@.5&D\]1IJ!7QT/0J'(%
MX"F5RV-J,;FF7@/52N&IVTKUV2C( O!B!20G2S3_:%AXUY97R\I;[#"OK(EL
M53!H>\68E 21<@H-JE> G$WOTOXE28N5WYC/JF30]IKQBE?8QGWIU:H4YH\%
MO4MJ%COJ^[1I7U;E@OJMHCSF,L6#H\@4))F9*U&;*--*ZVF_->COV:T34.7V
M>#;70'"9$KSL%K<NO(8KC2*8B2)>7J-EKM]1O#-.>$@*RRMKUOKUHS$8T$LE
MMYGU [])&:N*0]M+SG%!"<K.65RD*19SYS3&F94]I'S*X'2!G1M6TR>K&6TH
M3[2J3[2]0+UCX4QW*$;'&YB)8 9R'RV!_!A_:-/N+&(@SUBP?EH#:)]@IZ[7
MG&]O"_P72!8@;=?9_X^3IZ![TDDD(-=9@Z5PN7:ISF_?Y=>RB7O(6I>+[X^F
MN<LZE HF[PQ?N%Q'J2(QK!#2N>GC\91YLY4/M-AF_<I":.Q^LM<--J@@C0'^
MOQ)"'P=F@K+E'?X'4$L#!!0    ( .Z*<U(>6[K[200  .T0   8    >&PO
M=V]R:W-H965T<R]S:&5E=#4N>&ULQ5A=;Z,X%/TK%IJ'&6E2,-^,DDA-R&BJ
MF6FZ3;JK?73!2:P"SF#3M/]^;: D?"8=[6I? H9SK\^]U[X'9WR@Z1/;8<S!
M2QPE;*+L.-]_4546['",V!7=XT2\V= T1EP,TZW*]BE&86X41ZJN:;8:(Y(H
MTW'^["Z=CFG&(Y+@NQ2P+(Y1^CK#$3U,%*B\/;@GVQV7#]3I>(^V>(7YP_XN
M%2.U\A*2&">,T 2D>#-1KN&7!72E08[XD^ #.[D',I1'2I_DX":<*)IDA",<
M<.D"B<LSGN,HDIX$CU^E4Z6:4QJ>WK]Y_YH'+X)Y1 S/:?07"?ENHK@*"/$&
M91&_IX=ON S(DOX"&K'\%QQ*K*: (&.<QJ6Q8!"3I+BBES(1)P;0Z#'02P/]
M4@.C-# :!KK38V"6!F;3H"\&JS3(0U>+V//$^8BCZ3BE!Y!*M/ F;_+LY]8B
M7R21"V7%4_&6"#L^G2]O5\L?-_[U>N&#U5I<?BYNURNP_"I&R_GW;\L?_N)^
M!19_/-RL_P8C\+#RP<</GP#;H10S0!*PWM&,H21DG\&'VGBL<L%0SJ,&)9M9
MP4;O8;.F'$4=9O-ALSF-8['H5IP&3QW6_K#U=1@2N6A1!.X0"4<W"9BC/>EF
MLCCC*PBR.(L0QR'P\88$A->=J*(^59'TJDAZ[M7L\3K#6Y(D)-F*/1&A),#@
MH\AS48%/ '$Q57 %#/@9Z!ITN_)7^+=S_[)W/$\]TS.UL?K<0<NH:!GOI'4!
ME5GATSJA8F@0VA65@G ;Y=41?AMA6= PZZA%&S72+4UWNB,WJ\C-P<AO&,OR
M@.D&!,7B8W+Q@4U*8X!?<!H0EK\M'M.]7&#LM&Q=53);53)-Q^ZF:E54K?^"
M:E?EK!8]2X>-NEFM?#<0?I>7GH5H5S':@S'F&W\D]2*4,0H19:B0(<9H0/+=
M>"!\!S8T2T*<,H#C?41?A>!QP##G$9:WG4';[9UC&<V8SH!J03E54,YO!=5%
MTFGGU'*;&^8,J$;2K4BZ@R1OQ:=,1%EGYMS6?"-HVU!K[-"SL!HQKR+F#1);
M).&%_=+KVHE>NZ">"7NV(M2.8JN]A]4%3&:EQU,JN@=-I['O2EAMXS4R[7>X
M<C3':;;,#MA(Q&[T]$QX\JD!_X^N6<YZRM>&1@_9H^3"8<W]%_LF;*LO=*QF
M<89!]2B."@V');HWBKP/ OPK(_PU?T-XW@W/Y=IHY]KH8WE44_B;<MK#LC/)
M;?'4/:.9Y&%0G?Y18>&PQ+ZG4\.V_!FNV]23<Z@ZT:-,PF&='.K6L*UA(UW7
MW59W.(NKDSO*'1S6NXL[MOQ:Z%B9;7F#XK!L]_$Z*AP<EKC!GMW)959ZK#5C
MJ$.]V;,[8*V>W<8X%M2-9E7:L)%M>'ISR:@G)T7Y1\!/E(IO> 8BO!&&VI4C
M/*3%V;H8<+K/#X^/E(NC:'Z[PTCL2@D0[S>4\K>!/(]6_W!,_P%02P,$%
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MFVUCO6WLV78! 5UPX;1XO7*H5ZJH?;SH$T(F\=G@L6T'AQ@>C7#4B)T &S;
MAD%]+[._P$DAKJ5 DD-@I[Q,\X*A\HA8/56?TT1LT1JRAD 'P3+E1Y"+JD3F
MY:8.YESF3'P)&&O48!H%C77-(*.E>5+GB3)#R8Y7,O]'/W!9L-YNU#+-9$PZ
MYK-EQGCDMMVXP3D.XISQW0X00HRGOU NQ ', HD9I? \US9%:\9<@,<6&!Q%
M'<"VC.>H)PW<21#N4N'LJYR9*8A ),)KT8GU<CJ9X Y"6V@XG$S=(*<-R.G_
M HD2(;CR"7C^E$MP17Z #%0)Q';[@K]H:PLF9<%J9_ZPX)(AC#^ZU)L&;%OK
M9DM,AQ2[=<.12=;1&YZM FQ3YEHEOD8R>58QQ_+'9 5!I[SGJ!BZ7_YH*136
MY_C:-MP1(=..3@XICTOA%OW@H$;?5(H 7;)<[+E("J74.G^&4X(#8])-,=AV
M_VG7N1Q"/K#$@"5!L%=)!B7"2B+VK!S+&9K'+4[ 4=H%9PL1ZLDFV% /IF&2
MX&5?I]F"@?\'05([]*:3+DA;:(+''I"&R'"8R:[9FE45G"^X+G,?;VR]MT]&
M73IS28WBV //T!D>!N'=RBVKG*B&CG.U0-E"/J<S9(9'08:=;9-RPSI\J6-#
M<UN1)ZN\>),[L2$E'&:ERS2%# *[F[SBM(?-+U-LN9!#B/A<R/ 0#A/1O'R$
MC,:K%R<NFU7P.+("T);JXYCX$K1A'QRFG[N*[9,\>XV]^HBX\BDHYL'M(1$'
M\II-&F0ZM+*P+=6GD:\6(89;2)A;FG/?)R^:3'3EE*:5*DM>]7'!)C8M]$D\
M[C*B0PR/XHD'MB$0$B:0Q6MM&:HJG;!M@NB/J55&N<2@O/8X,3%<0D@PK.>+
MGS?+]S<*Q+  ";/ W:%*MRK_ Y.ROP_Y7M&_TP!V?N_C:#CN&L EAF.? 0P1
MD+=;FI.#RR&LQ7L.SI'Y7;A=8G[<AB%(N./Y.E]<+F;O/SB3Z$FX;;FK>,I8
M)M"ZXCM=9SBUMQL1,HU&7>5M*0\1$4,,)$P,]Y#:ZCH9/.L V0 R&LO\0$,-
MR!&E+=*/QQX.)X8?2)@?3@VI&JND3'4\I*V.RXG901[3+G<XA'RV-;Q!WN*-
M-F3VS*HTKT.X[@[Y7E7\[G"P^0"/AUW,MM#0QW;44 8-4T83PON*/^89.,/J
M!:KW$LS]=AA3FP\H&7<K*H>4+X2IX0SZ-F=D+*UTF0R91^GPJ=9$9<S'I- M
MH"+ "E)2E:>J;52_.Q5Q,,0PFG3=QB5&J8](J"$2&FY*9N\&_PFMV"8O2W4V
MX%DO+'%6NM1N3J:CJ%O:.:0PF=*A1YW6_"Q,7_]%'::*JX B-G/%0](-#8?4
MB;JG>AAZHW&0)I:'_;YNO:&I;89?JL]-"RX@<P;+=6KHB(8;EGDIF3(,4G6G
MTPJAGN1H EO$,X:AALUHF,WF)21;5G=Y?FP.,K/ V3)3'SK#973\_M,Q9Z*\
MJ7SMHF65E"+1MPWALS+$1-\@IE9I!BD3"E7YHCV[J=-4-DK^;R%.'>QE>;LM
MXQNY4<->-,Q>UEC*U.#WMS_JC@>BM]#3-\E;/]>3"O#@';"&;YA('1T/]!<6
M582F<J=3=\-P<9CAEI!^PJ?%GM.Z05>SMU+-V%KSN _*+E56U[?[T][0M(8?
M]<<\U-7&C@&=1?(.(9\!#%7&8:ILNVQ>0HSH4DIN*W[8;$]J*ZW[J\O6T\:Q
M<]@8VT0X)MWQG4/(IXMARCC,E+<G7EF[WG&2PE<R >G,.M&NJ[;&+4[=;%;L
MYC.'R#"./+P9&]Z,P[QY?QJ![2FP&A*KF?>6%YGF_E61;\SM2-M?0T/BV"9*
M2S=;9!1'GOP2MRZ_PJVBJ@D*)L1)81PHB6/[K@M;!8Q#B':1#EH7JSM6;?1]
MLT Z/]=7E,W3YD[[4M_D=IY?X2^S^F;:;%-?E']/*JC)!+C7&K:,/H\!4%7?
M/==?)-_KZ]L5EY+O],<M2^!LE0#\ON9P9L<OZ@7-_P"X^!=02P,$%     @
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MVC:-^WB]C7C'4+2\U2&X8.>'/M$*5YCQ4ZWCAF'C:*/<U$$;ZE1G0#W^MO=
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MC'_#H?.=4,:\-5;5QV":UUQV7_9X[,-)P#Q^(2 ]!J2>=Y?(LWS'+%LOM3J
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M2JBB +7]&-82&& O04'&[H.UI7UG/7L3ZP.Z 91'2@B!3$(>(Z493A9#BK9
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ME3^#'SH;SH=/;$C#AI1Q>T6,\HUT\NK2Z =A:#6DT06;RKL!KJ@H*%-G\+;
M/G<U_?KY]I_'-]?3MV_$[>>/=V\_3:^_OO_\Z?+$03JM.<F"I!LO*7U"4I**
MC[IR2RO>5KG*^P). *O%EC;8;M)G);Y162Q&223283I\1MZHM77$\D9/V;J4
M1AU3#'-Q)S=(+2>NC9'50O'UOZYGUAGDR;^?439NE8U9V?C_X-C_39*XMD+/
M!;RD5C-E6D]%PBV540+&BM$XNC@[C8;#H;!DO16R=DMMBO_ !RAI45A;RRI3
MHD;0#.T4M]_$-"L4'MI(O*\0@VNX!R$5LLK%%V6==+A)A\E(O/U1%VY#J^!
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MJPUR$17&C2$#[A5KA7Z0-^];'+]4(+LS3EL@,#WIF/YTP>PSS"@.?+X%\_2
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M0.T-Z'NIJ.R[B0\P_(4L_P502P,$%     @ [HIS4GME4D^P"0  '!H  !D
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MSQ-7')P?38\QX]=X"_@X;JE-:BYNL:R@C?" #D:%R P,[@(UUSU@RD:GC=4
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MIBWGMP@@5O!HDYJZ%$/:LX).-^)2,WM[Y$Y*7'UZCB\IUT6VFT0CW')6XX1
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M 1?S^%AB%$K'&_!];FUH7CC ]K?5];]02P,$%     @ [HIS4F7%][_]!
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MCK<R!5^NE$3_)@*\7QA3M3<DH/N$^?)_4$L#!!0    ( .Z*<U*9DQ5Y<P(
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M82L1[]0,@R)V@8@@0KI>%O/2X+X,[K:HUQVLA"J$CR(N2":@'IJ0W(UVJ-"
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M=1(^'6L493  !/^1-_@27\.. 4!E(5K1^2VH#>BX[=",-Y\!N.=+6"K"I8@
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M*>!9CH3S9I8>@PP"X@JL<,RQ_WE0JI/6]_2@/%Z#2:Y;VVP&9?F![P8)CM]
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M/GR#V>,?T\GT=@%G2[8J4)\/ D.!K7N0[H-<UT'B3X)$,=Q+87(-MR+#["U
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M^Z-^T*2%/4O.*Y2&*PD:BWEP$4^70^?O'9XYMF9/!E?)6JE7I]SF\R!R":'
MS#H&1L<;7J(0CHC2^+/E#/J0#K@O[]AO?.U4RYH9O%3BA>>VG ?C '(L6"/L
M2K7?<%O/R/%E2AC_A;;S39, LL9856W!E$'%97>R]VT?]@#CZ  @V0(2GW<7
MR&=YQ2Q;S+1J03MO8G."+]6C*3DNW4]YM)IN.>'LXO;^^?K^Z?OJ)YP\L;5
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M:^VH5X5E33\'--Z ]BNMW5[P ?K?S>(_4$L#!!0    ( .Z*<U*S0J*5^P(
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M(D<(!6;6(3!:7O &A7! 1.-WBQET*5W@[GZ+_MG73K4LF<$;)7[PW!;3X#*
M'%>L%O9!;;Y@6X\GF"EA_!,VC6__*H"L-E:5;3 Q*+EL5O;:ZK 3<!D="$C:
M@,3S;A)YE@MFV6RBU0:T\R8TM_&E^F@BQZ5[*8]6TRVG.#M;W,Z?X/2)+06:
MLTEH"=)=A%D;/F_"DP/A<0+W2MK"P*W,,?\;("0N':%D2VB>'$5<8'8._;@'
M291$1_#Z78%]C]<_B+>TL. F$\K4&N'G]=)831_#KR/@@PY\X,$'!\ ?J4?R
M6B"H%;A$^P0\BN!Z;FPJEN$TH*8RJ%\P:#@STZ!F6"Y1=Y+ AB[HMU*"&LK
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M@D977X8!Z&8\- >K*M^2.V6IP?VVH(F*VCG0_UPI>SRX -V,GOX%4$L#!!0
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MD?\C,%,!\OV"4K%9J 3U/Y/>7U!+ P04    " #OBG-2PNEA=[H"   :"
M&0   'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6RMEEUOFS 4AO^*A7;12FOY
MSD=%D-9DU2IM;97T0].T"Q=.@E6PF>V$]M_/!DII(*@7O0DV/N_KYQS;.$'!
M^)-( "1ZSE(J9D8B97YFFB)*(,/BE.5 U<B:\0Q+U>4;4^0<<%R*LM1T+&MD
M9IA0(PS*=S<\#-A6IH3"#4=BFV68OYQ#RHJ981NO+Y9DDTC]P@R#'&]@!?(N
MO^&J9S8N,<F "L(HXK">&=_LL[EM:4$9<4^@$*TVTJD\,O:D.Y?QS+ T$:00
M26V!U6,'<TA3[:0X_M6F1C.G%K;;K^X79?(JF4<L8,[2!Q++9&9,#!3#&F]3
MN63%#Z@3\K5?Q%)1_J*BBO5\ T5;(5E6BQ5!1FCUQ,]U(5H"VSL@<&J!\U&!
M6PO<,M&*K$QK@24. \X*Q'6T<M.-LC:E6F5#J%[&E>1JE"B=#"^O[K]?W5XO
M?Z.C!4A,4G&,3M#=:H&.OARC+XA0=)NPK< T%H$IU8Q:9T:U^WGE[AQP7T!T
MBES[*W(LQ^J1SS\LMZ?OY:;*LTG6:9)U2C_W4+)T!U0R_H+^_%1#Z%)")OX.
M&+N-L5L:>P>,E[A0BR*!$YSVEJF2^Z5<GZQ=Z$T=-S!W[6+T!/G66] [,J\A
M\P;)'M0ATHN8<Q:!Z&6K#$:M:<<3?P^M&^/9?C^9WY#Y@V07A!*U;V.T8:Q_
M;_F=25W;=?;(ND&^Y1\HVJA!&PVBW3*)4[3A3 A5NWK/]!&..I-/)IZU1]@-
MFD['=C_AN"$<#Q*^[>2"$PDG,2MH'^"X6T)KGZ\;X[1BWN%-&KS)(-[U5@H2
M Y()H#NJ &.TDNI\B(&S-FV\IY][B&WK[5MH?<ZZUS[MH[I?U9X0MU-6L_7A
MUK?F+\PWA J4PEJIK-.QDO/J(JHZDN7EM_R1274SE,U$7=[ =8 :7S,F7SOZ
M>FC^#H3_ 5!+ P04    " #OBG-2U[>G=>P#  "2$   &0   'AL+W=O<FMS
M:&5E=',O<VAE970T,"YX;6R]6-MNXS80_15"6!2[0#82J4BV4MO QG;1 $G7
MS:5%4?2!D48VL1+I):DX ?KQI2Z6Y)N\2).\Q*(T<^;P4'/LR6 EY#>U -#H
M*4VX&EH+K9?GMJW"!:14G8HE</,D%C*EVBSEW%9+"30JDM+$)H[CVREEW!H-
MBGLS.1J(3">,PTPBE:4IE<\7D(C5T,+6^L8-FR]T?L,>#99T#K>@[Y<S:59V
MC1*Q%+AB@B,)\=#Z@L_'Q,\3BH@_&*Q4ZQKE6WD0XEN^N(R&EI,S@@1"G4-0
M\_$(8TB2',GP^%Z!6G7-/+%]O4;_I=B\V<P#53 6R9\LTHNAU;=0!#'-$GTC
M5K]"M2$OQPM%HHJ_:%7&>KZ%PDQID5;)AD'*>/E)GRHA6@GX4 *I$LAVPMF!
M!+=*<(N-ELR*;4VHIJ.!%"LD\VB#EE\4VA399C>,Y\=XJZ5YRDR>'LUNOLZF
M-W=_H9]HNOP937^_OYQ=3W^[0Q\GH"E+U"?T&=W?3M#'#Y_0!\0XNEN(3%$>
MJ8&M#8$<Q@ZK8A=E,7*@&";H6G"]4&C*(X@V 6S#O*9/UO0O2"?B!,)3Y.(3
M1!SB["$T_N%T''30<6LUW0+//:2F-/TE]?,)FB64:V1D0M/O&5N:%U^COZ],
M.+K4D*I_.HJ=U<7.BF)G1XH556!=Y03-I5![#Z>$\PJXO+T?1Q[QS;8?VX+M
M"<(]IP[:8.K53+U.IE>@U+GIV#!+LX1JB$RC&=,)&<U;>1_5$L]OL?A,W(!L
M<=T3A3W/VT_6K\GZ+Y&5@]Y'U-^A0/J]WA;/W2#7QP=H]FJ:O4Z:DR,*]G9J
M]AUGB]=N3,\Y<-3]FE:_D];7.&8AH#B3G.E,PJ:*'6]]4!<(WK[%L-/8H_.Z
M35;AM1N(>(&_I7P5U98>D_Z!5P*WS!S_#_71O^B:<99F:9<TI"E&WN$D&FO%
M[@M. F4*XBQ!"8MA[W%T@[KH&:A4700;.\;=?GQ<?/IT3/S&4;'W#N(WGHA?
M8HI'Q>\&]8Z+W[@A[K;#.^"Y#"Q=2O$(.;E.W,;.</\==&[,#0>O;#?!CMW@
MP-_^ JJB-NPF( ?LAC3F2+K-\8H^"$FUD"5?H1<@?\CL2>-H!+^]_J3Q-$)>
M5_\*KZV_'^ M^:L@_T#0)M?&$,E;&.(1T.,]21I#)-V&.!9<:9F5\YJ9'$QK
MSB5LZ[@)WA@@>0<#)(T!DA?]*NQX,?S=QO2VWXL],>U?Y"57NS7=I2#GQ="K
M4"@RKLM)J;Y;#]9?BG%RZ_Z%&;C+\;B!*:?U:RKGC"N40&P@G=.>H23+ ;A<
M:+$L9L@'H<U$6EPN@$8@\P#S/!9"KQ=Y@?K?$*/_ %!+ P04    " #OBG-2
MGJ2==](#   E$   &0   'AL+W=O<FMS:&5E=',O<VAE970T,2YX;6R]6&UO
MVCH4_BM6M ^KM#:QP^L$2$"[7:2NJD:[JZNK?7"3 T1+;*[ME'6_?G:2)D""
MX4ZH7R!.SGG\G)-S'GP8;+CX(5< "OU,8B:'SDJI]4?7E<$*$BJO^!J8?K+@
M(J%*+\72E6L!-,R<DM@EGM=Q$QHQ9S3([MV+T8"G*HX8W LDTR2AXF4",=\,
M'>R\WO@:+5?*W'!'@S5=PAS4X_I>Z)5;HH11 DQ&G"$!BZ$SQA^GQ#<.F<6W
M"#9RZQJ94)XX_V$6LW#H>(81Q! H T'UUS-,(8X-DN;Q7P'JE'L:Q^WK5_1/
M6? ZF"<J8<KCOZ-0K89.ST$A+&@:JZ]\\Q<4 ;4-7L!CF7VB36'K.2A(I>))
MX:P9)!'+O^G/(A%;#KASP($4#F3?H77 P2\<LLRY.;,LK&NJZ&@@^ 8)8ZW1
MS$66F\Q;1Q,Q\QKG2NBGD?93H]G=P_CN\VQR>X/&\_G-PQQ=HAE3E"VCIQC0
M6$I=2G-=/&&JE^^O0=$HEA?:ZG%^C=Z_NT#O4,30PXJGDK)0#ERE61EL-R@8
M3'(&Y  #3- 7SM1*HAL60K@+X.IPRIC(:TP38D6\AN *^?@#(A[Q&@A-3W;'
M?0L=OTRQG^'Y!_ ^12Q2<'FKRS6LY5:B?V^U/9HI2.1WRVZM<K=6MEOKP&Z?
M!9<23:D0+Q%;HG'"4Z::WDH.T\Y@3+,_C_R^UQVXS]N9.F*TP[!=,FQ;&8Z#
M($W2F"J=#DU/J.@7-2W=1#)'ZFSMC[O['!ML6KB98J>DV+%2O--%?T(*.[6=
M_:[O[=%K,NITFOEU2WY=*[\9NUP+'H!^TP(D4!&LD.X^K5_/6IC76F:5I91Z
MY2Z]-RC<?KE;_SR%VS\EZT>,=AABKQ)+[VRE6T!M4]@G:379I;BEY_@<I5N@
M',GB,:M=CJ3B2*P<'P0- 3&:@+04#JX$%K^%PN)*8O&9-+; V=$FKY9DN]$N
MQTID\?E4%C=(:)UFW:AWB&6EL_@L0EN@M&V]5#<AA^A5,HOM.OLH89'&Z#9:
MZ+///UIGY44C/3M*&[T8UZ:3R)]X[L92B3GNV5/-V67 DS4H0'0I ,ROA!6Z
M4F[<?X/^(Y4,$[L,G]Q_!<YV4=2.#W:;78:5"A.["O^?[B-UD:V3K-MT#IQQ
M2"7#Q"[#)S9?@6)KO@83?."(0RI5)_XYFN\(BJ7Y_L0SC\7=&K@2$,ML#I4H
M,"G,YY3R;CGKCK,);^_^1,_ ^<1:P>0#]!<JEA&3*(:%AO2NNCJY(I])\X7B
MZVRL>^)*#XG9Y4K/\2",@7Z^X%R]+LP&Y3\#H]]02P,$%     @ [XIS4O[T
M2#A@ @  G04  !D   !X;"]W;W)K<VAE971S+W-H965T-#(N>&ULC511;]HP
M$/XK5K2'5MJ:D!"V51 I0-LAK555VNUAVH-)#F+5L9E](6R_?K83,LH*ZDML
MG^_[[KN+[X:U5,^Z $"R+;G0(Z] 7%_ZOLX***F^D&L0YF8I54G1'-7*UVL%
M-'>@DOMA$ S\DC+A)4-GNU?)4%;(F8![1715EE3]'@.7]<CK>3O# UL5: U^
M,ES3%<P!G];WRIS\CB5G)0C-I" *EB,O[5U.8NOO'+XQJ/7>GMA,%E(^V\,L
M'WF!%00<,K0,U"P;F #GELC(^-5R>EU("]S?[]BO7>XFEP75,)'\.\NQ&'F?
M/)+#DE8<'V3]!=I\G,!,<NV^I&Y\X\@C6:51EBW8*"B9:%:Z;>NP!^@-C@#"
M%A > OI' %$+B%RBC3*7UI0B389*UD19;\-F-ZXV#FVR8<+^Q3DJ<\L,#I/9
MW6-Z=S,;?[TBZ7Q^]3@G'\@=58K:ZI*S*2!E7)\;Z]-\2L[>G0]]-&$MV,_:
M$.,F1'@D1"\DMU)@H<F5R"%_2> ;O9WH<"=Z')YDG$)V0:+>>Q(&8?"*H,F;
MX;W/)^1$70TCQQ<=X;N1,J\9YX2*G,P$4K%B"PXDU1I0DRG3&9>Z4D!^I N-
MRCS=GR?"]KNP?1>V?R1L6DJ%[ ]U[0!;T]<:7OL[#4OL6&Q3;Y)H$ 2F;IO]
MDKWB%>][O9 8=Q+CDQ*O*[1ITS<JC?_3<!C?WWOI):B5&P":9+(2V+R?SMK-
MF-2UUH%];&9/,RK^T32#ZY:J%1.:<%@:RN#BH]&CFF'0'%"N73\M))KN=-O"
MS$]0UL'<+Z7$W<$&Z"9R\A=02P,$%     @ [XIS4C$[6;6( @  %@<  !D
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M1CVK;4&(*[*)Y8SMOF#AIZGYEBP6Y@F[8JYKP7(C)$L*L%*0T#1_D[<B#T<
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MJ9YK8R_&O]C_T6Y(W<!",7 ?%_?R$W&E-FX-KPM_50U[;RH!4P77=.R[2H;
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M8FFB50O:15LV9_A2/=J*X](U94O:GG*+HW3]L-@^;&$ OAT#50P:@[ P!LD
MDSFLT=8,:\YV7'#B:.#]"HEQ83XD(5D%CB?,NFS+8[;X2K859D,8CSY"',71
MO_#0"N_5Q[WZV/.-KZEWX@S\7NP,:=O@/S<XQSWGV'-.KG ^^49B#NP%M9U+
MR+G)5",)-".\5/-MOMEP&KV[H6O2ZYK\GRZ-[M)QN0?A>T2HJTOR;M-.X8!,
M&QA]@9P=S"6AX=EXN9OZ@^D]E\:F+2QE-/PT#4 ?I__HD*K]Q.T4V?GU9FD?
M#-0NP)X72M')<4/</T'I&U!+ P04    " #OBG-2^?Z!@.@"   _"0  &0
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M5#S1_1^DZ9!7UHMHRJM?L*]C76\$HAT7-&N2)4&6Y/4__M8,Q$$""@<24).
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MY%<*,!4@G\>4BM- +5!]]_C_ %!+ P04    " #OBG-2[#C2.T@$   F$@
M&0   'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6RU6%UOHS@4_2M6-+-*I&G
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M ==\3R/H+SY#X'"W(L41?#K[^+L6ZN8#<.WDTV0R?3J_V8^?V<0Y]%Z%S@^
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MS(-H>_7V#S,]?V$+]O\HXK]02P,$%     @ [XIS4I>*NQS     $P(   L
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MR*I19"U09"U09"U09"W^4]9G:Y=_'#\\\];4W2&?#?]VFKT!4$L! A0#%
M  @ [HIS4@=!36*!    L0   !               ( !     &1O8U!R;W!S
M+V%P<"YX;6Q02P$"% ,4    " #NBG-24I(10>X    K @  $0
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M=#(N>&UL4$L! A0#%     @ [HIS4F6X*U#: @  K0D  !@
M ("!M10  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( .Z*
M<U)"^LQ BP0  /X.   8              " @<47  !X;"]W;W)K<VAE971S
M+W-H965T-"YX;6Q02P$"% ,4    " #NBG-2'ENZ^TD$  #M$   &
M        @(&&'   >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%
M  @ [HIS4HEOP*;=!P  #2   !@              ("!!2$  'AL+W=O<FMS
M:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( .Z*<U)7>N?L900  .L)   8
M              " @1@I  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"
M% ,4    " #NBG-222;7^=8F  #;>   &               @(&S+0  >&PO
M=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ [HIS4F5G5\'( @
M3 8  !@              ("!OU0  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM
M;%!+ 0(4 Q0    ( .Z*<U*-PWW(-P,  /H&   9              " @;U7
M  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ [HIS4E'^
M8+;H @  HP8  !D              ("!*UL  'AL+W=O<FMS:&5E=',O<VAE
M970Q,2YX;6Q02P$"% ,4    " #NBG-2&"5J#J\"  #6!0  &0
M    @(%*7@  >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    (
M .Z*<U+F#>:]$PD  ,P6   9              " @3!A  !X;"]W;W)K<VAE
M971S+W-H965T,3,N>&UL4$L! A0#%     @ [HIS4H/NB[L)!@  S@X  !D
M             ("!>FH  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"
M% ,4    " #NBG-2[\&N@!T*  !8&@  &0              @(&Z<   >&PO
M=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( .Z*<U+!N"J*B0,
M )$(   9              " @0Y[  !X;"]W;W)K<VAE971S+W-H965T,38N
M>&UL4$L! A0#%     @ [HIS4GME4D^P"0  '!H  !D              ("!
MSGX  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " #NBG-2
MLV5!K$,+  !S'   &0              @(&UB   >&PO=V]R:W-H965T<R]S
M:&5E=#$X+GAM;%!+ 0(4 Q0    ( .Z*<U)63]:V@ 4  &<-   9
M      " @2^4  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%
M  @ [HIS4F7%][_]!   !PP  !D              ("!YID  'AL+W=O<FMS
M:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " #NBG-2 JO?J<(*  #.'
M&0              @($:GP  >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+
M 0(4 Q0    ( .Z*<U*9DQ5Y<P(  #(%   9              " @1.J  !X
M;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ [HIS4M:T+<%_
M'P  _V,  !D              ("!O:P  'AL+W=O<FMS:&5E=',O<VAE970R
M,RYX;6Q02P$"% ,4    " #NBG-2^@24N.D#  #<"   &0
M@(%SS   >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( .Z*
M<U*1/8,H? (  "\%   9              " @9/0  !X;"]W;W)K<VAE971S
M+W-H965T,C4N>&UL4$L! A0#%     @ [HIS4@-)O!,/ P  >@8  !D
M         ("!1M,  'AL+W=O<FMS:&5E=',O<VAE970R-BYX;6Q02P$"% ,4
M    " #NBG-2LT*BE?L"  "F!@  &0              @(&,U@  >&PO=V]R
M:W-H965T<R]S:&5E=#(W+GAM;%!+ 0(4 Q0    ( .Z*<U(=LL($P (  -H%
M   9              " @;[9  !X;"]W;W)K<VAE971S+W-H965T,C@N>&UL
M4$L! A0#%     @ [HIS4@8VGSRJ @  3 8  !D              ("!M=P
M 'AL+W=O<FMS:&5E=',O<VAE970R.2YX;6Q02P$"% ,4    " #NBG-2CL[W
MQ0,$  #1"   &0              @(&6WP  >&PO=V]R:W-H965T<R]S:&5E
M=#,P+GAM;%!+ 0(4 Q0    ( .Z*<U*N;4&DP (  *\%   9
M  " @=#C  !X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @
M[HIS4I@-\P8" P  'P<  !D              ("!Q^8  'AL+W=O<FMS:&5E
M=',O<VAE970S,BYX;6Q02P$"% ,4    " #NBG-2.V)?'$P#   Z!P  &0
M            @($ Z@  >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4
M Q0    ( .Z*<U(VFJF&ZP4  #H/   9              " @8/M  !X;"]W
M;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ [HIS4ATIZZHQ @
MAP0  !D              ("!I?,  'AL+W=O<FMS:&5E=',O<VAE970S-2YX
M;6Q02P$"% ,4    " #NBG-2-?X!W(\&  #Z'0  &0              @($-
M]@  >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( .Z*<U).
M'DB9L (  +L&   9              " @=/\  !X;"]W;W)K<VAE971S+W-H
M965T,S<N>&UL4$L! A0#%     @ [XIS4@GAH*9I P  I0P  !D
M     ("!NO\  'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( .^*<U(Q.UFUB (  !8'   9              "
M@0X1 0!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ [XIS
M4A77=BB9 @  7 <  !D              ("!S1,! 'AL+W=O<FMS:&5E=',O
M<VAE970T-"YX;6Q02P$"% ,4    " #OBG-2CI8?"AH"  "P!   &0
M        @(&=%@$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0
M   ( .^*<U(GNQD0.0,  $8+   9              " @>X8 0!X;"]W;W)K
M<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ [XIS4N\.12P[!   Z@\
M !D              ("!7AP! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q0
M2P$"% ,4    " #OBG-2(1A+P $'  "8)   &0              @('0( $
M>&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( .^*<U+CZP5_
MT 0  !@3   9              " @0@H 0!X;"]W;W)K<VAE971S+W-H965T
M-#DN>&UL4$L! A0#%     @ [XIS4C+$:5+_ @  >P@  !D
M ("!#RT! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4    " #O
MBG-28L3Z;^8"   A"@  &0              @(%%, $ >&PO=V]R:W-H965T
M<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( .^*<U*3?C8;[04  '<<   9
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M970U-BYX;6Q02P$"% ,4    " #OBG-2D"2.I7<$   H$@  &0
M    @('=1 $ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    (
M .^*<U(2%5#]Y0(   ,)   9              " @8M) 0!X;"]W;W)K<VAE
M971S+W-H965T-3@N>&UL4$L! A0#%     @ [XIS4NPXTCM(!   )A(  !D
M             ("!ITP! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q02P$"
M% ,4    " #OBG-28[[@[M4#  #E#0  &0              @($F40$ >&PO
M=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( .^*<U*C+QF]BP,
M #4-   9              " @3)5 0!X;"]W;W)K<VAE971S+W-H965T-C$N
M>&UL4$L! A0#%     @ [XIS4F+&P//G @  # @  !D              ("!
M]%@! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"% ,4    " #OBG-2
MT2\:Y<H"  #I!P  &0              @($27 $ >&PO=V]R:W-H965T<R]S
M:&5E=#8S+GAM;%!+ 0(4 Q0    ( .^*<U)).:GU4@(  %X,   -
M      "  1-? 0!X;"]S='EL97,N>&UL4$L! A0#%     @ [XIS4I>*NQS
M    $P(   L              ( !D&$! %]R96QS+RYR96QS4$L! A0#%
M  @ [XIS4A#!V4(N!0  4RD   \              ( !>6(! 'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    ( .^*<U(G9=6E# (  (0E   :
M  "  =1G 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M .^*<U+NU>T8Y@$  /4D   3              "  1AJ 0!;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@    !' $< :!,  "]L 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.20.4</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>136</ContextCount>
  <ElementCount>403</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>56</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>11</UnitCount>
  <MyReports>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOW</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOW</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - ORGANIZATION AND BUSINESS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/ORGANIZATIONANDBUSINESS</Role>
      <ShortName>ORGANIZATION AND BUSINESS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2109103 - Disclosure - INVENTORY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/INVENTORY</Role>
      <ShortName>INVENTORY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2112104 - Disclosure - PROPERTY &amp; EQUIPMENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/PROPERTYEQUIPMENT</Role>
      <ShortName>PROPERTY &amp; EQUIPMENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2115105 - Disclosure - INTANGIBLE ASSETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/INTANGIBLEASSETS</Role>
      <ShortName>INTANGIBLE ASSETS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2119106 - Disclosure - ACCRUED EXPENSES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/ACCRUEDEXPENSES</Role>
      <ShortName>ACCRUED EXPENSES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2122107 - Disclosure - DEBT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/DEBT</Role>
      <ShortName>DEBT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2127108 - Disclosure - STOCKHOLDERS EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/STOCKHOLDERSEQUITY</Role>
      <ShortName>STOCKHOLDERS EQUITY</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2129109 - Disclosure - STOCK-BASED COMPENSATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/STOCKBASEDCOMPENSATION</Role>
      <ShortName>STOCK-BASED COMPENSATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2134110 - Disclosure - NET INCOME (LOSS) PER SHARE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/NETINCOMELOSSPERSHARE</Role>
      <ShortName>NET INCOME (LOSS) PER SHARE</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2137111 - Disclosure - RELATED PARTIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/RELATEDPARTIES</Role>
      <ShortName>RELATED PARTIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2139112 - Disclosure - COMMITMENTS AND CONTINGENCIES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIES</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2141113 - Disclosure - LEASES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/LEASES</Role>
      <ShortName>LEASES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2146114 - Disclosure - SEGMENT INFORMATION</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/SEGMENTINFORMATION</Role>
      <ShortName>SEGMENT INFORMATION</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2149115 - Disclosure - INCOME TAXES</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/INCOMETAXES</Role>
      <ShortName>INCOME TAXES</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2156116 - Disclosure - SUBSEQUENT EVENT</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/SUBSEQUENTEVENT</Role>
      <ShortName>SUBSEQUENT EVENT</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2310302 - Disclosure - INVENTORY (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/INVENTORYTables</Role>
      <ShortName>INVENTORY (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cvsciences.com/role/INVENTORY</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2313303 - Disclosure - PROPERTY &amp; EQUIPMENT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/PROPERTYEQUIPMENTTables</Role>
      <ShortName>PROPERTY &amp; EQUIPMENT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cvsciences.com/role/PROPERTYEQUIPMENT</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2316304 - Disclosure - INTANGIBLE ASSETS (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/INTANGIBLEASSETSTables</Role>
      <ShortName>INTANGIBLE ASSETS (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cvsciences.com/role/INTANGIBLEASSETS</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2320305 - Disclosure - ACCRUED EXPENSES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/ACCRUEDEXPENSESTables</Role>
      <ShortName>ACCRUED EXPENSES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cvsciences.com/role/ACCRUEDEXPENSES</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2323306 - Disclosure - DEBT (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/DEBTTables</Role>
      <ShortName>DEBT (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cvsciences.com/role/DEBT</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2330307 - Disclosure - STOCK-BASED COMPENSATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/STOCKBASEDCOMPENSATIONTables</Role>
      <ShortName>STOCK-BASED COMPENSATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cvsciences.com/role/STOCKBASEDCOMPENSATION</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2335308 - Disclosure - NET INCOME (LOSS) PER SHARE (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/NETINCOMELOSSPERSHARETables</Role>
      <ShortName>NET INCOME (LOSS) PER SHARE (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cvsciences.com/role/NETINCOMELOSSPERSHARE</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2342309 - Disclosure - LEASES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/LEASESTables</Role>
      <ShortName>LEASES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cvsciences.com/role/LEASES</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2347310 - Disclosure - SEGMENT INFORMATION (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/SEGMENTINFORMATIONTables</Role>
      <ShortName>SEGMENT INFORMATION (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cvsciences.com/role/SEGMENTINFORMATION</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2350311 - Disclosure - INCOME TAXES (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/INCOMETAXESTables</Role>
      <ShortName>INCOME TAXES (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://cvsciences.com/role/INCOMETAXES</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - ORGANIZATION AND BUSINESS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/ORGANIZATIONANDBUSINESSDetails</Role>
      <ShortName>ORGANIZATION AND BUSINESS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cvsciences.com/role/ORGANIZATIONANDBUSINESS</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2408404 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue Product Sales by Channel (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails</Role>
      <ShortName>SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue Product Sales by Channel (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - INVENTORY (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/INVENTORYDetails</Role>
      <ShortName>INVENTORY (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cvsciences.com/role/INVENTORYTables</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2414406 - Disclosure - PROPERTY &amp; EQUIPMENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/PROPERTYEQUIPMENTDetails</Role>
      <ShortName>PROPERTY &amp; EQUIPMENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cvsciences.com/role/PROPERTYEQUIPMENTTables</ParentRole>
      <Position>40</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2417407 - Disclosure - INTANGIBLE ASSETS - Intangible Asset Schedule (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails</Role>
      <ShortName>INTANGIBLE ASSETS - Intangible Asset Schedule (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2418408 - Disclosure - INTANGIBLE ASSETS - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/INTANGIBLEASSETSNarrativeDetails</Role>
      <ShortName>INTANGIBLE ASSETS - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2421409 - Disclosure - ACCRUED EXPENSES (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/ACCRUEDEXPENSESDetails</Role>
      <ShortName>ACCRUED EXPENSES (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cvsciences.com/role/ACCRUEDEXPENSESTables</ParentRole>
      <Position>43</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2424410 - Disclosure - DEBT - Schedule of Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/DEBTScheduleofDebtDetails</Role>
      <ShortName>DEBT - Schedule of Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2425411 - Disclosure - Debt - Principal Payments on Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/DebtPrincipalPaymentsonDebtDetails</Role>
      <ShortName>Debt - Principal Payments on Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2426412 - Disclosure - DEBT - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/DEBTNarrativeDetails</Role>
      <ShortName>DEBT - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2428413 - Disclosure - STOCKHOLDERS EQUITY - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails</Role>
      <ShortName>STOCKHOLDERS EQUITY - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2431414 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2432415 - Disclosure - STOCK-BASED COMPENSATION - Summary of Stock Options Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Summary of Stock Options Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2433416 - Disclosure - STOCK-BASED COMPENSATION - Assumptions Used to Estimate Fair Value (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/STOCKBASEDCOMPENSATIONAssumptionsUsedtoEstimateFairValueDetails</Role>
      <ShortName>STOCK-BASED COMPENSATION - Assumptions Used to Estimate Fair Value (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2436417 - Disclosure - NET INCOME (LOSS) PER SHARE - Antidilutive Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/NETINCOMELOSSPERSHAREAntidilutiveSharesDetails</Role>
      <ShortName>NET INCOME (LOSS) PER SHARE - Antidilutive Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cvsciences.com/role/NETINCOMELOSSPERSHARETables</ParentRole>
      <Position>51</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2438418 - Disclosure - RELATED PARTIES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails</Role>
      <ShortName>RELATED PARTIES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2440419 - Disclosure - COMMITMENTS AND CONTINGENCIES - Lawsuits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIESLawsuitsDetails</Role>
      <ShortName>COMMITMENTS AND CONTINGENCIES - Lawsuits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2443420 - Disclosure - LEASES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/LEASESNarrativeDetails</Role>
      <ShortName>LEASES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2444421 - Disclosure - LEASES - Right-of-use Assets and Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/LEASESRightofuseAssetsandLeaseLiabilitiesDetails</Role>
      <ShortName>LEASES - Right-of-use Assets and Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2445422 - Disclosure - LEASES - Maturity of Lease Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails</Role>
      <ShortName>LEASES - Maturity of Lease Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2448423 - Disclosure - SEGMENT INFORMATION (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/SEGMENTINFORMATIONDetails</Role>
      <ShortName>SEGMENT INFORMATION (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cvsciences.com/role/SEGMENTINFORMATIONTables</ParentRole>
      <Position>57</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2451424 - Disclosure - INCOME TAXES INCOME TAXES - Components of Income Tax Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails</Role>
      <ShortName>INCOME TAXES INCOME TAXES - Components of Income Tax Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2452425 - Disclosure - INCOME TAXES - Income Tax Provision (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails</Role>
      <ShortName>INCOME TAXES - Income Tax Provision (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2453426 - Disclosure - INCOME TAXES - Deferred Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails</Role>
      <ShortName>INCOME TAXES - Deferred Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2454427 - Disclosure - INCOME TAXES - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/INCOMETAXESNarrativeDetails</Role>
      <ShortName>INCOME TAXES - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2455428 - Disclosure - INCOME TAXES - Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/INCOMETAXESUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>INCOME TAXES - Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="cvsi-20201231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2457429 - Disclosure - SUBSEQUENT EVENT (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://cvsciences.com/role/SUBSEQUENTEVENTDetails</Role>
      <ShortName>SUBSEQUENT EVENT (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://cvsciences.com/role/SUBSEQUENTEVENT</ParentRole>
      <Position>63</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="cvsi-20201231.htm">cvsi-20201231.htm</File>
    <File>a302certificationceoex3112.htm</File>
    <File>a302certificationcfoex3122.htm</File>
    <File>a906certificationceoex3212.htm</File>
    <File>a906certificationcfoex3222.htm</File>
    <File>consentex231202010kng.htm</File>
    <File>cvsi-20201231.xsd</File>
    <File>cvsi-20201231_cal.xml</File>
    <File>cvsi-20201231_def.xml</File>
    <File>cvsi-20201231_lab.xml</File>
    <File>cvsi-20201231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/sic/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>82
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "cvsi-20201231.htm": {
   "axisCustom": 0,
   "axisStandard": 28,
   "contextCount": 136,
   "dts": {
    "calculationLink": {
     "local": [
      "cvsi-20201231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "cvsi-20201231_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "cvsi-20201231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "cvsi-20201231_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "cvsi-20201231_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "cvsi-20201231.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 525,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 6,
    "http://xbrl.sec.gov/dei/2020-01-31": 4,
    "total": 10
   },
   "keyCustom": 31,
   "keyStandard": 372,
   "memberCustom": 24,
   "memberStandard": 31,
   "nsprefix": "cvsi",
   "nsuri": "http://cvsciences.com/20201231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://cvsciences.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2112104 - Disclosure - PROPERTY & EQUIPMENT",
     "role": "http://cvsciences.com/role/PROPERTYEQUIPMENT",
     "shortName": "PROPERTY & EQUIPMENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2115105 - Disclosure - INTANGIBLE ASSETS",
     "role": "http://cvsciences.com/role/INTANGIBLEASSETS",
     "shortName": "INTANGIBLE ASSETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2119106 - Disclosure - ACCRUED EXPENSES",
     "role": "http://cvsciences.com/role/ACCRUEDEXPENSES",
     "shortName": "ACCRUED EXPENSES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122107 - Disclosure - DEBT",
     "role": "http://cvsciences.com/role/DEBT",
     "shortName": "DEBT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2127108 - Disclosure - STOCKHOLDERS EQUITY",
     "role": "http://cvsciences.com/role/STOCKHOLDERSEQUITY",
     "shortName": "STOCKHOLDERS EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2129109 - Disclosure - STOCK-BASED COMPENSATION",
     "role": "http://cvsciences.com/role/STOCKBASEDCOMPENSATION",
     "shortName": "STOCK-BASED COMPENSATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2134110 - Disclosure - NET INCOME (LOSS) PER SHARE",
     "role": "http://cvsciences.com/role/NETINCOMELOSSPERSHARE",
     "shortName": "NET INCOME (LOSS) PER SHARE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2137111 - Disclosure - RELATED PARTIES",
     "role": "http://cvsciences.com/role/RELATEDPARTIES",
     "shortName": "RELATED PARTIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139112 - Disclosure - COMMITMENTS AND CONTINGENCIES",
     "role": "http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIES",
     "shortName": "COMMITMENTS AND CONTINGENCIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2141113 - Disclosure - LEASES",
     "role": "http://cvsciences.com/role/LEASES",
     "shortName": "LEASES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2146114 - Disclosure - SEGMENT INFORMATION",
     "role": "http://cvsciences.com/role/SEGMENTINFORMATION",
     "shortName": "SEGMENT INFORMATION",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2149115 - Disclosure - INCOME TAXES",
     "role": "http://cvsciences.com/role/INCOMETAXES",
     "shortName": "INCOME TAXES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2156116 - Disclosure - SUBSEQUENT EVENT",
     "role": "http://cvsciences.com/role/SUBSEQUENTEVENT",
     "shortName": "SUBSEQUENT EVENT",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "role": "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "role": "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2310302 - Disclosure - INVENTORY (Tables)",
     "role": "http://cvsciences.com/role/INVENTORYTables",
     "shortName": "INVENTORY (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2313303 - Disclosure - PROPERTY & EQUIPMENT (Tables)",
     "role": "http://cvsciences.com/role/PROPERTYEQUIPMENTTables",
     "shortName": "PROPERTY & EQUIPMENT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2316304 - Disclosure - INTANGIBLE ASSETS (Tables)",
     "role": "http://cvsciences.com/role/INTANGIBLEASSETSTables",
     "shortName": "INTANGIBLE ASSETS (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2320305 - Disclosure - ACCRUED EXPENSES (Tables)",
     "role": "http://cvsciences.com/role/ACCRUEDEXPENSESTables",
     "shortName": "ACCRUED EXPENSES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2323306 - Disclosure - DEBT (Tables)",
     "role": "http://cvsciences.com/role/DEBTTables",
     "shortName": "DEBT (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2330307 - Disclosure - STOCK-BASED COMPENSATION (Tables)",
     "role": "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONTables",
     "shortName": "STOCK-BASED COMPENSATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2335308 - Disclosure - NET INCOME (LOSS) PER SHARE (Tables)",
     "role": "http://cvsciences.com/role/NETINCOMELOSSPERSHARETables",
     "shortName": "NET INCOME (LOSS) PER SHARE (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2342309 - Disclosure - LEASES (Tables)",
     "role": "http://cvsciences.com/role/LEASESTables",
     "shortName": "LEASES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2347310 - Disclosure - SEGMENT INFORMATION (Tables)",
     "role": "http://cvsciences.com/role/SEGMENTINFORMATIONTables",
     "shortName": "SEGMENT INFORMATION (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2350311 - Disclosure - INCOME TAXES (Tables)",
     "role": "http://cvsciences.com/role/INCOMETAXESTables",
     "shortName": "INCOME TAXES (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - ORGANIZATION AND BUSINESS (Details)",
     "role": "http://cvsciences.com/role/ORGANIZATIONANDBUSINESSDetails",
     "shortName": "ORGANIZATION AND BUSINESS (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RestrictedCashAndCashEquivalents",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)",
     "role": "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:ConcentrationRiskCreditRisk",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:CashUninsuredAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)",
     "role": "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RestrictedCash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2408404 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue Product Sales by Channel (Details)",
     "role": "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Revenue Product Sales by Channel (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - INVENTORY (Details)",
     "role": "http://cvsciences.com/role/INVENTORYDetails",
     "shortName": "INVENTORY (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterials",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS",
     "role": "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414406 - Disclosure - PROPERTY & EQUIPMENT (Details)",
     "role": "http://cvsciences.com/role/PROPERTYEQUIPMENTDetails",
     "shortName": "PROPERTY & EQUIPMENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2417407 - Disclosure - INTANGIBLE ASSETS - Intangible Asset Schedule (Details)",
     "role": "http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails",
     "shortName": "INTANGIBLE ASSETS - Intangible Asset Schedule (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdjustmentForAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418408 - Disclosure - INTANGIBLE ASSETS - Narrative (Details)",
     "role": "http://cvsciences.com/role/INTANGIBLEASSETSNarrativeDetails",
     "shortName": "INTANGIBLE ASSETS - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AdjustmentForAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421409 - Disclosure - ACCRUED EXPENSES (Details)",
     "role": "http://cvsciences.com/role/ACCRUEDEXPENSESDetails",
     "shortName": "ACCRUED EXPENSES (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedSalariesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424410 - Disclosure - DEBT - Schedule of Debt (Details)",
     "role": "http://cvsciences.com/role/DEBTScheduleofDebtDetails",
     "shortName": "DEBT - Schedule of Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425411 - Disclosure - Debt - Principal Payments on Debt (Details)",
     "role": "http://cvsciences.com/role/DebtPrincipalPaymentsonDebtDetails",
     "shortName": "Debt - Principal Payments on Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i27feea483e57465a9526919db75d6d01_D20200417-20200417",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceOfLongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426412 - Disclosure - DEBT - Narrative (Details)",
     "role": "http://cvsciences.com/role/DEBTNarrativeDetails",
     "shortName": "DEBT - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i27feea483e57465a9526919db75d6d01_D20200417-20200417",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ProceedsFromIssuanceOfLongTermDebt",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2428413 - Disclosure - STOCKHOLDERS EQUITY - Narrative (Details)",
     "role": "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
     "shortName": "STOCKHOLDERS EQUITY - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i5ce71eb8f7d045f680a63998d5ebc762_D20201208-20201208",
      "decimals": "INF",
      "lang": "en-US",
      "name": "cvsi:SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock",
      "reportCount": 1,
      "unique": true,
      "unitRef": "tradingday",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431414 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details)",
     "role": "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
     "shortName": "STOCK-BASED COMPENSATION - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ibfbe4fc0a05542b79480de4c56feef6f_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2432415 - Disclosure - STOCK-BASED COMPENSATION - Summary of Stock Options Activity (Details)",
     "role": "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails",
     "shortName": "STOCK-BASED COMPENSATION - Summary of Stock Options Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i18b1bfee52e244df92d350109e304526_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i131f52df83994257bc0a0cfa19c3a287_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY",
     "role": "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONSOLIDATED STATEMENTS OF STOCKHOLDERS EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i131f52df83994257bc0a0cfa19c3a287_I20181231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2433416 - Disclosure - STOCK-BASED COMPENSATION - Assumptions Used to Estimate Fair Value (Details)",
     "role": "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONAssumptionsUsedtoEstimateFairValueDetails",
     "shortName": "STOCK-BASED COMPENSATION - Assumptions Used to Estimate Fair Value (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436417 - Disclosure - NET INCOME (LOSS) PER SHARE - Antidilutive Shares (Details)",
     "role": "http://cvsciences.com/role/NETINCOMELOSSPERSHAREAntidilutiveSharesDetails",
     "shortName": "NET INCOME (LOSS) PER SHARE - Antidilutive Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "cvsi:AccruedPayrollTaxesCurrentEmployeePortion",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438418 - Disclosure - RELATED PARTIES - Narrative (Details)",
     "role": "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails",
     "shortName": "RELATED PARTIES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "cvsi:AccruedPayrollTaxesCurrentEmployeePortion",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i5c0ab77805bb4407a83db8bc568155ac_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cvsi:NumberofDerivativeLawsuits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "lawsuit",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2440419 - Disclosure - COMMITMENTS AND CONTINGENCIES - Lawsuits (Details)",
     "role": "http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIESLawsuitsDetails",
     "shortName": "COMMITMENTS AND CONTINGENCIES - Lawsuits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i5c0ab77805bb4407a83db8bc568155ac_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "cvsi:NumberofDerivativeLawsuits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "lawsuit",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2443420 - Disclosure - LEASES - Narrative (Details)",
     "role": "http://cvsciences.com/role/LEASESNarrativeDetails",
     "shortName": "LEASES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:LeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2444421 - Disclosure - LEASES - Right-of-use Assets and Lease Liabilities (Details)",
     "role": "http://cvsciences.com/role/LEASESRightofuseAssetsandLeaseLiabilitiesDetails",
     "shortName": "LEASES - Right-of-use Assets and Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445422 - Disclosure - LEASES - Maturity of Lease Liabilities (Details)",
     "role": "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails",
     "shortName": "LEASES - Maturity of Lease Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2448423 - Disclosure - SEGMENT INFORMATION (Details)",
     "role": "http://cvsciences.com/role/SEGMENTINFORMATIONDetails",
     "shortName": "SEGMENT INFORMATION (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NumberOfReportableSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "segment",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451424 - Disclosure - INCOME TAXES INCOME TAXES - Components of Income Tax Expense (Details)",
     "role": "http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails",
     "shortName": "INCOME TAXES INCOME TAXES - Components of Income Tax Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452425 - Disclosure - INCOME TAXES - Income Tax Provision (Details)",
     "role": "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails",
     "shortName": "INCOME TAXES - Income Tax Provision (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOW",
     "role": "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOW",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453426 - Disclosure - INCOME TAXES - Deferred Income Taxes (Details)",
     "role": "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails",
     "shortName": "INCOME TAXES - Deferred Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i95335529356f4afbb8b76a88b727d1d2_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454427 - Disclosure - INCOME TAXES - Narrative (Details)",
     "role": "http://cvsciences.com/role/INCOMETAXESNarrativeDetails",
     "shortName": "INCOME TAXES - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ib68a40c3668644fc87db08988f699fec_I20191231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2455428 - Disclosure - INCOME TAXES - Unrecognized Tax Benefits (Details)",
     "role": "http://cvsciences.com/role/INCOMETAXESUnrecognizedTaxBenefitsDetails",
     "shortName": "INCOME TAXES - Unrecognized Tax Benefits (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ifc2c804db67543dd84291701c746b6fa_I20181231",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "i7e602472f0d2419187a53398197f884a_D20200101-20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457429 - Disclosure - SUBSEQUENT EVENT (Details)",
     "role": "http://cvsciences.com/role/SUBSEQUENTEVENTDetails",
     "shortName": "SUBSEQUENT EVENT (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ie5001f6661f94fcb9a78097ff24a3842_D20210101-20210319",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - ORGANIZATION AND BUSINESS",
     "role": "http://cvsciences.com/role/ORGANIZATIONANDBUSINESS",
     "shortName": "ORGANIZATION AND BUSINESS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "role": "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES",
     "shortName": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2109103 - Disclosure - INVENTORY",
     "role": "http://cvsciences.com/role/INVENTORY",
     "shortName": "INVENTORY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "cvsi-20201231.htm",
      "contextRef": "ia8871b9aac304a01bd29485de5d3c19e_D20200101-20201231",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 56,
   "tag": {
    "cvsi_AccountsReceivableThresholdforDeterminingDelinquentAccount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accounts Receivable, Threshold for Determining Delinquent Account",
        "label": "Accounts Receivable, Threshold for Determining Delinquent Account",
        "terseLabel": "Threshold for determining delinquent accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableThresholdforDeterminingDelinquentAccount",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvsi_AccruedPayrollTaxesCurrentEmployeePortion": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Payroll Taxes, Current, Employee Portion",
        "label": "Accrued Payroll Taxes, Current, Employee Portion",
        "terseLabel": "Employee portion of payroll taxes"
       }
      }
     },
     "localname": "AccruedPayrollTaxesCurrentEmployeePortion",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvsi_AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments to Additional Paid in Capital, Share-based Compensation, Employment Settlement",
        "label": "Adjustments to Additional Paid in Capital, Share-based Compensation, Employment Settlement",
        "terseLabel": "Stock-based compensation associated with founders employment settlements"
       }
      }
     },
     "localname": "AdjustmentstoAdditionalPaidinCapitalSharebasedCompensationEmploymentSettlement",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvsi_After2017Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "After 2017 [Member]",
        "label": "After 2017 [Member]",
        "terseLabel": "After 2017"
       }
      }
     },
     "localname": "After2017Member",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_Amended2013PlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name pertaining to equity-based compensation arrangements.",
        "label": "Amended 2013 Plan [Member] [Default Label]",
        "verboseLabel": "Amended 2013 Plan"
       }
      }
     },
     "localname": "Amended2013PlanMember",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_Before2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Before 2018 [Member]",
        "label": "Before 2018 [Member]",
        "terseLabel": "Before 2018"
       }
      }
     },
     "localname": "Before2018Member",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_CannaVestEuropeGmbHMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "CannaVest Europe, GmbH [Member]",
        "label": "CannaVest Europe, GmbH [Member]",
        "terseLabel": "CannaVest Europe, GmbH"
       }
      }
     },
     "localname": "CannaVestEuropeGmbHMember",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_CashlessExerciseOfStockOptions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cashless Exercise of Stock Options",
        "label": "Cashless Exercise of Stock Options",
        "terseLabel": "Cashless exercise of options"
       }
      }
     },
     "localname": "CashlessExerciseOfStockOptions",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvsi_CommonStockPurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock Purchase Agreement",
        "label": "Common Stock Purchase Agreement [Member]",
        "terseLabel": "Common Stock Purchase Agreement",
        "verboseLabel": "SPA"
       }
      }
     },
     "localname": "CommonStockPurchaseAgreementMember",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://cvsciences.com/role/SUBSEQUENTEVENTDetails",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_ConsumerProductsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specialty Pharmaceuticals [Member]",
        "label": "Consumer Products [Member]",
        "terseLabel": "Consumer Products Segment"
       }
      }
     },
     "localname": "ConsumerProductsMember",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/SEGMENTINFORMATIONDetails",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_DeferredTaxAssetOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Asset, Operating Lease Liabilities",
        "label": "Deferred Tax Asset, Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "DeferredTaxAssetOperatingLeaseLiabilities",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvsi_DeferredTaxLiabilityOperatingLeaseAssets": {
     "auth_ref": [],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Tax Liability, Operating Lease Assets",
        "label": "Deferred Tax Liability, Operating Lease Assets",
        "negatedLabel": "Operating lease assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilityOperatingLeaseAssets",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvsi_ECommMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "E-Comm",
        "label": "E-Comm [Member]",
        "terseLabel": "E-Comm"
       }
      }
     },
     "localname": "ECommMember",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation": {
     "auth_ref": [],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Reconciliation, Non-deductible Officer Compensation",
        "label": "Effective Income Tax Reconciliation, Non-deductible Officer Compensation",
        "terseLabel": "Non-deductible officer compensation (IRC 162(m))"
       }
      }
     },
     "localname": "EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensation",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvsi_EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent": {
     "auth_ref": [],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective Income Tax Reconciliation, Non-deductible Officer Compensation, Percent",
        "label": "Effective Income Tax Reconciliation, Non-deductible Officer Compensation, Percent",
        "terseLabel": "Non-deductible officer compensation (IRC 162(m))"
       }
      }
     },
     "localname": "EffectiveIncomeTaxReconciliationNondeductibleOfficerCompensationPercent",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvsi_FirstInsuranceFundingMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First Insurance Funding",
        "label": "First Insurance Funding [Member]",
        "terseLabel": "Insurance financing"
       }
      }
     },
     "localname": "FirstInsuranceFundingMember",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/DEBTNarrativeDetails",
      "http://cvsciences.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_FormerChiefOperatingOfficerMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Chief Operating Officer [Member]",
        "label": "Former Chief Operating Officer [Member]",
        "terseLabel": "Former Chief Operating Officer"
       }
      }
     },
     "localname": "FormerChiefOperatingOfficerMember",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_FormerFoundersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former Founders",
        "label": "Former Founders [Member]",
        "terseLabel": "Former Founders"
       }
      }
     },
     "localname": "FormerFoundersMember",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_FormerPresidentandCEOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former President and CEO [Member]",
        "label": "Former President and CEO [Member]",
        "terseLabel": "Former President and CEO"
       }
      }
     },
     "localname": "FormerPresidentandCEOMember",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_ImpairmentOfTaxReceivableForRSUSettlement": {
     "auth_ref": [],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Impairment Of Tax Receivable For RSU Settlement",
        "label": "Impairment Of Tax Receivable For RSU Settlement",
        "terseLabel": "Derecognition of tax receivable for founder RSU settlement (Note 11)"
       }
      }
     },
     "localname": "ImpairmentOfTaxReceivableForRSUSettlement",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvsi_NoncashLeaseExpense": {
     "auth_ref": [],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Lease Expense",
        "label": "Noncash Lease Expense",
        "terseLabel": "Non-cash lease expense"
       }
      }
     },
     "localname": "NoncashLeaseExpense",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvsi_NumberOfAdditionalSuppliers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Additional Suppliers",
        "label": "Number of Additional Suppliers",
        "terseLabel": "Number of additional suppliers"
       }
      }
     },
     "localname": "NumberOfAdditionalSuppliers",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvsi_NumberOfLeaseTerminationAgreements": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Lease Termination Agreements",
        "label": "Number of Lease Termination Agreements",
        "terseLabel": "Number of lease termination agreements"
       }
      }
     },
     "localname": "NumberOfLeaseTerminationAgreements",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvsi_NumberofDerivativeLawsuits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Derivative Lawsuits",
        "label": "Number of Derivative Lawsuits",
        "terseLabel": "Number of shareholder derivative suits filed"
       }
      }
     },
     "localname": "NumberofDerivativeLawsuits",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIESLawsuitsDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvsi_NumberofSuppliers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of Suppliers",
        "label": "Number of Suppliers",
        "terseLabel": "Number of suppliers"
       }
      }
     },
     "localname": "NumberofSuppliers",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvsi_OptionsOutsidePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Options Outside the Amended 2013 Plan [Member]",
        "label": "Options Outside the Amended 2013 Plan [Member]",
        "terseLabel": "Options Outside the Amended 2013 Plan"
       }
      }
     },
     "localname": "OptionsOutsidePlanMember",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_PayrollProtectionProgramLoanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payroll Protection Program Loan",
        "label": "Payroll Protection Program Loan [Member]",
        "terseLabel": "PPP loan"
       }
      }
     },
     "localname": "PayrollProtectionProgramLoanMember",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/DEBTNarrativeDetails",
      "http://cvsciences.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_PayrollTaxExpense": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payroll Tax Expense",
        "label": "Payroll Tax Expense",
        "terseLabel": "Payroll tax expense"
       }
      }
     },
     "localname": "PayrollTaxExpense",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvsi_PremiumFinanceAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Premium Finance Agreement [Member]",
        "terseLabel": "Premium Finance Agreement"
       }
      }
     },
     "localname": "PremiumFinanceAgreementMember",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_PurchaseOfInsuranceThroughIssuanceOfNotePayable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase of insurance through issuance of note payable",
        "label": "Purchase of insurance through issuance of note payable",
        "terseLabel": "Purchase of insurance through issuance of note payable (Note 7)"
       }
      }
     },
     "localname": "PurchaseOfInsuranceThroughIssuanceOfNotePayable",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvsi_RecognitionofEquityAwardandWithholdingObligationandReceivable": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recognition of Equity Award and Withholding Obligation and Receivable",
        "label": "Recognition of Equity Award and Withholding Obligation and Receivable",
        "terseLabel": "Recognition of founder RSU tax withholding obligation and receivable (Note 11)"
       }
      }
     },
     "localname": "RecognitionofEquityAwardandWithholdingObligationandReceivable",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvsi_RetailFDMMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retail - FDM",
        "label": "Retail - FDM [Member]",
        "terseLabel": "Retail - FDM"
       }
      }
     },
     "localname": "RetailFDMMember",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_RetailNaturalProductsAndOtherMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Retail - Natural Products And Other",
        "label": "Retail - Natural Products And Other [Member]",
        "terseLabel": "Retail - Natural products and other"
       }
      }
     },
     "localname": "RetailNaturalProductsAndOtherMember",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-of-Use Asset Foregone in Exchange for Reduction in Operating Lease Liability",
        "label": "Right-of-Use Asset Foregone in Exchange for Reduction in Operating Lease Liability",
        "negatedTerseLabel": "Derecognition of operating ROU asset related to operating lease termination"
       }
      }
     },
     "localname": "RightOfUseAssetForegoneInExchangeForReductionInOperatingLeaseLiability",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvsi_SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of Property and Equipment in Exchange for Prepaid Expenses and Other and Inventory",
        "label": "Sale of Property and Equipment in Exchange for Prepaid Expenses and Other and Inventory",
        "terseLabel": "Sale of property and equipment in exchange for note receivable (recorded in prepaid expense and other) and inventory"
       }
      }
     },
     "localname": "SaleOfPropertyAndEquipmentInExchangeForPrepaidExpensesAndOtherAndInventory",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvsi_SaleOfStockFairValueOfPutOption": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of Stock, Fair Value Of Put Option",
        "label": "Sale of Stock, Fair Value Of Put Option",
        "terseLabel": "Fair value of put option (in USD per share)"
       }
      }
     },
     "localname": "SaleOfStockFairValueOfPutOption",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cvsi_SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Fair Value Of Shares Issued, Payment Of Commitment Fee",
        "label": "Sale Of Stock, Fair Value Of Shares Issued, Payment Of Commitment Fee",
        "terseLabel": "Fair value of shares issued as commitment fee"
       }
      }
     },
     "localname": "SaleOfStockFairValueOfSharesIssuedPaymentOfCommitmentFee",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvsi_SaleOfStockMaximumValueOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Maximum Value Of Shares Issued In Transaction",
        "label": "Sale Of Stock, Maximum Value Of Shares Issued In Transaction",
        "terseLabel": "Value of shares"
       }
      }
     },
     "localname": "SaleOfStockMaximumValueOfSharesIssuedInTransaction",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvsi_SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Number Of Business Days Between Issuance And Settlement",
        "label": "Sale Of Stock, Number Of Business Days Between Issuance And Settlement",
        "terseLabel": "Number of business days between issuance and settlement"
       }
      }
     },
     "localname": "SaleOfStockNumberOfBusinessDaysBetweenIssuanceAndSettlement",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvsi_SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Number Of Specified Trading Days Between Directions To Purchase Stock",
        "label": "Sale Of Stock, Number Of Specified Trading Days Between Directions To Purchase Stock",
        "terseLabel": "Number of specified trading days between directions to purchase stock"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSpecifiedTradingDaysBetweenDirectionsToPurchaseStock",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvsi_SaleOfStockWeightedAveragePricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Weighted Average Price Per Share",
        "label": "Sale Of Stock, Weighted Average Price Per Share",
        "terseLabel": "Weighted average price per share"
       }
      }
     },
     "localname": "SaleOfStockWeightedAveragePricePerShare",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "cvsi_SanDiegoFacilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "San Diego Facility",
        "label": "San Diego Facility [Member]",
        "terseLabel": "Terminated San Diego Facility"
       }
      }
     },
     "localname": "SanDiegoFacilityMember",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation, Annual Increase to Shares Authorized for Issuance under the Plan",
        "label": "Share-based Compensation, Annual Increase to Shares Authorized for Issuance under the Plan",
        "terseLabel": "Annual increase to shares authorized for issuance under the Plan (shares)"
       }
      }
     },
     "localname": "SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlan",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvsi_SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation, Annual Increase to Shares Authorized for Issuance under the Plan as Percent of Common Stock Outstanding, Percent",
        "label": "Share-based Compensation, Annual Increase to Shares Authorized for Issuance under the Plan as Percent of Common Stock Outstanding, Percent",
        "terseLabel": "Annual increase in shares available for issuance as percent of total shares outstanding (percent)"
       }
      }
     },
     "localname": "SharebasedCompensationAnnualIncreasetoSharesAuthorizedforIssuanceunderthePlanasPercentofCommonStockOutstandingPercent",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Extension of Expiration Period",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Extension of Expiration Period",
        "terseLabel": "Stock option exercise period extension"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardExtensionofExpirationPeriod",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "cvsi_SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Peers Included in Calculation of Expected Volatility",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Peers Included in Calculation of Expected Volatility",
        "terseLabel": "Number of peers included in calculation of expected volatility"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofPeersIncludedinCalculationofExpectedVolatility",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "cvsi_SmithComplaintMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Smith Complaint [Member]",
        "label": "Smith Complaint [Member]",
        "terseLabel": "Smith Complaint"
       }
      }
     },
     "localname": "SmithComplaintMember",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIESLawsuitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_SpecialtyPharmaceuticalSegmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specialty Pharmaceutical Segment",
        "label": "Specialty Pharmaceutical Segment [Member]",
        "terseLabel": "Specialty Pharmaceutical Segment"
       }
      }
     },
     "localname": "SpecialtyPharmaceuticalSegmentMember",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_SpecialtyPharmaceuticalsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specialty Pharmaceuticals [Member]",
        "label": "Specialty Pharmaceuticals [Member]",
        "terseLabel": "Specialty Pharmaceutical Segment"
       }
      }
     },
     "localname": "SpecialtyPharmaceuticalsMember",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/SEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_StatesOtherThanCaliforniaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "States Other than California",
        "label": "States Other than California [Member]",
        "terseLabel": "States Other than California"
       }
      }
     },
     "localname": "StatesOtherThanCaliforniaMember",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_StockIssuedDuringPeriodSharesEquityCommitment": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued during Period, Shares, Equity Commitment",
        "label": "Stock Issued during Period, Shares, Equity Commitment",
        "terseLabel": "Issuance of common stock under equity commitment (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesEquityCommitment",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "cvsi_StockIssuedDuringPeriodValueEquityCommitment": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Issued during Period, Value, Equity Commitment",
        "label": "Stock Issued during Period, Value, Equity Commitment",
        "terseLabel": "Issuance of common stock under equity commitment"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueEquityCommitment",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "cvsi_StockOptionModificationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock Option Modification",
        "label": "Stock Option Modification [Member]",
        "terseLabel": "Stock Option Modification"
       }
      }
     },
     "localname": "StockOptionModificationMember",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_TaxLiabilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax Liability [Member]",
        "label": "Tax Liability [Member]",
        "terseLabel": "Tax liability"
       }
      }
     },
     "localname": "TaxLiabilityMember",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/ACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "cvsi_UnvestedStockOptionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unvested Stock Options",
        "label": "Unvested Stock Options [Member]",
        "terseLabel": "Unvested Stock Options"
       }
      }
     },
     "localname": "UnvestedStockOptionsMember",
     "nsuri": "http://cvsciences.com/20201231",
     "presentation": [
      "http://cvsciences.com/role/NETINCOMELOSSPERSHAREAntidilutiveSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r536",
      "r537",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report",
        "terseLabel": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity's Reporting Status Current"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r541"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float",
        "terseLabel": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers",
        "terseLabel": "Entity a Voluntary Filer"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer",
        "terseLabel": "Entity a Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r536",
      "r537",
      "r538"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag",
        "terseLabel": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "sic_Z3821": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "3821 Laboratory Apparatus and Furniture [Member]",
        "terseLabel": "Laboratory and other equipment"
       }
      }
     },
     "localname": "Z3821",
     "nsuri": "http://xbrl.sec.gov/sic/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/PROPERTYEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LitigationCaseAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Axis]",
        "terseLabel": "Litigation Case [Axis]"
       }
      }
     },
     "localname": "LitigationCaseAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIESLawsuitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_LitigationCaseTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Litigation Case [Domain]",
        "terseLabel": "Litigation Case [Domain]"
       }
      }
     },
     "localname": "LitigationCaseTypeDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIESLawsuitsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r294",
      "r295",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r501",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/PROPERTYEQUIPMENTDetails",
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r294",
      "r295",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r501",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/PROPERTYEQUIPMENTDetails",
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_OwnershipAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Axis]",
        "terseLabel": "Ownership [Axis]"
       }
      }
     },
     "localname": "OwnershipAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_OwnershipDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ownership [Domain]",
        "terseLabel": "Ownership [Domain]"
       }
      }
     },
     "localname": "OwnershipDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r175",
      "r274",
      "r276",
      "r451",
      "r500",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r175",
      "r274",
      "r276",
      "r451",
      "r500",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r284",
      "r294",
      "r295",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r501",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/PROPERTYEQUIPMENTDetails",
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r284",
      "r294",
      "r295",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r501",
      "r504"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/PROPERTYEQUIPMENTDetails",
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis": {
     "auth_ref": [
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of Property [Axis]",
        "terseLabel": "Name of Property [Axis]"
       }
      }
     },
     "localname": "RealEstateAndAccumulatedDepreciationDescriptionOfPropertyAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RealEstateAndAccumulatedDepreciationNameOfPropertyDomain": {
     "auth_ref": [
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name of Property [Domain]",
        "terseLabel": "Name of Property [Domain]"
       }
      }
     },
     "localname": "RealEstateAndAccumulatedDepreciationNameOfPropertyDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r176",
      "r177",
      "r274",
      "r277",
      "r503",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INVENTORYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r176",
      "r177",
      "r274",
      "r277",
      "r503",
      "r520",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532",
      "r533"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INVENTORYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualAxis": {
     "auth_ref": [
      "r181",
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Axis]",
        "terseLabel": "Title of Individual [Axis]"
       }
      }
     },
     "localname": "TitleOfIndividualAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_TitleOfIndividualWithRelationshipToEntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of Individual [Domain]",
        "terseLabel": "Title of Individual [Domain]"
       }
      }
     },
     "localname": "TitleOfIndividualWithRelationshipToEntityDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "terseLabel": "ACCRUED EXPENSES"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/ACCRUEDEXPENSES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r41"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableRelatedPartiesCurrentAndNoncurrent": {
     "auth_ref": [
      "r99",
      "r432",
      "r477",
      "r496"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount for accounts payable to related parties.",
        "label": "Accounts Payable, Related Parties",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableRelatedPartiesCurrentAndNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r4",
      "r26",
      "r182",
      "r183"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://cvsciences.com/role/ACCRUEDEXPENSESDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/ACCRUEDEXPENSESDetails",
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesMember": {
     "auth_ref": [
      "r44"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.",
        "label": "Accrued Liabilities [Member]",
        "terseLabel": "Accrued Liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccruedPayrollTaxesCurrent": {
     "auth_ref": [
      "r11",
      "r44"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for statutory payroll taxes incurred through that date and withheld from employees pertaining to services received from them, including entity's matching share of the employees FICA taxes and contributions to the state and federal unemployment insurance programs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Payroll Taxes, Current",
        "terseLabel": "Payroll taxes payable"
       }
      }
     },
     "localname": "AccruedPayrollTaxesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r44"
     ],
     "calculation": {
      "http://cvsciences.com/role/ACCRUEDEXPENSESDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Salaries, Current",
        "terseLabel": "Accrued payroll expenses"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/ACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r39",
      "r229"
     ],
     "calculation": {
      "http://cvsciences.com/role/PROPERTYEQUIPMENTDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Less: accumulated depreciation"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/PROPERTYEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r27",
      "r337"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r334",
      "r335",
      "r336"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentForAmortization": {
     "auth_ref": [
      "r80",
      "r222"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of recurring noncash expense charged against earnings in the period to allocate the cost of assets over their estimated remaining economic lives.",
        "label": "Amortization",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "AdjustmentForAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r296",
      "r298",
      "r340",
      "r341"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash flows used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for advertising cost.",
        "label": "Advertising Cost [Policy Text Block]",
        "terseLabel": "Advertising"
       }
      }
     },
     "localname": "AdvertisingCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AdvertisingExpense": {
     "auth_ref": [
      "r344"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.",
        "label": "Advertising Expense",
        "terseLabel": "Advertising costs"
       }
      }
     },
     "localname": "AdvertisingExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r298",
      "r326",
      "r339"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Stock based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails",
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "auth_ref": [
      "r186",
      "r198",
      "r199",
      "r201"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable.",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive shares"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/NETINCOMELOSSPERSHAREAntidilutiveSharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/NETINCOMELOSSPERSHAREAntidilutiveSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/NETINCOMELOSSPERSHAREAntidilutiveSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/NETINCOMELOSSPERSHAREAntidilutiveSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r94",
      "r157",
      "r164",
      "r171",
      "r191",
      "r392",
      "r394",
      "r404",
      "r472",
      "r489"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r7",
      "r9",
      "r56",
      "r94",
      "r191",
      "r392",
      "r394",
      "r404"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r299",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails",
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]",
        "terseLabel": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r397",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]",
        "terseLabel": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingImprovementsMember": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Addition, improvement, or renovation to a facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building Improvements [Member]",
        "terseLabel": "Tenant improvements"
       }
      }
     },
     "localname": "BuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/PROPERTYEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CaliforniaFranchiseTaxBoardMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government of the state of California.",
        "label": "California Franchise Tax Board [Member]",
        "terseLabel": "California Franchise Tax Board"
       }
      }
     },
     "localname": "CaliforniaFranchiseTaxBoardMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r85",
      "r86",
      "r87"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Purchase of property and equipment in accounts payable and accrued expenses"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r36",
      "r518",
      "r519"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r2",
      "r36",
      "r82"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Money market funds classified as cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r14",
      "r83",
      "r90"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r14",
      "r83",
      "r90",
      "r470"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r75",
      "r82",
      "r88"
     ],
     "calculation": {
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of year",
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of year",
        "totalLabel": "Total cash and restricted cash shown in the statements of cash flows"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r75",
      "r405"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r36"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashUninsuredAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash as of the balance sheet date that is not insured by the Federal Deposit Insurance Corporation.",
        "label": "Cash, Uninsured Amount",
        "terseLabel": "Cash in excess of FDIC limits"
       }
      }
     },
     "localname": "CashUninsuredAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r49",
      "r238",
      "r478",
      "r495"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 12)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsDisclosureTextBlock": {
     "auth_ref": [
      "r237"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant arrangements with third parties, which includes operating lease arrangements and arrangements in which the entity has agreed to expend funds to procure goods or services, or has agreed to commit resources to supply goods or services, and operating lease arrangements. Descriptions may include identification of the specific goods and services, period of time covered, minimum quantities and amounts, and cancellation rights.",
        "label": "Commitments Disclosure [Text Block]",
        "terseLabel": "COMMITMENTS AND CONTINGENCIES"
       }
      }
     },
     "localname": "CommitmentsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r103",
      "r104"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock - par value (in USD per share)",
        "verboseLabel": "Common stock par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock - shares authorized (shares)",
        "verboseLabel": "Common stock authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r24"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock - shares issued (shares)",
        "verboseLabel": "Common stock issued"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r24",
      "r254"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock - shares outstanding (shares)",
        "verboseLabel": "Common stock - shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common stock, par value $0.0001; 190,000 shares authorized; 100,664 and 99,416 shares issued and outstanding as of December 31, 2020 and 2019, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r89",
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "terseLabel": "Compensation and Benefits"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Income"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r138",
      "r139",
      "r179",
      "r402",
      "r403",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r134",
      "r486"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r138",
      "r139",
      "r179",
      "r402",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "% of product sales, net"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r138",
      "r139",
      "r179",
      "r402",
      "r403"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/PROPERTYEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r263",
      "r264",
      "r275"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "auth_ref": [
      "r274",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by sales channel for delivery of good or service in contract with customer.",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "terseLabel": "Contract with Customer, Sales Channel [Axis]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "auth_ref": [
      "r274",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary.",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "terseLabel": "Contract with Customer, Sales Channel [Domain]"
       }
      }
     },
     "localname": "ContractWithCustomerSalesChannelDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "auth_ref": [
      "r65",
      "r451"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.",
        "label": "Cost of Goods and Services Sold",
        "terseLabel": "Shipping and handling costs"
       }
      }
     },
     "localname": "CostOfGoodsAndServicesSold",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r66",
      "r94",
      "r191",
      "r404"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of goods sold"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "auth_ref": [
      "r95",
      "r371",
      "r381"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current federal tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current Federal Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "CurrentFederalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r95",
      "r371",
      "r381",
      "r383"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.",
        "label": "Current Income Tax Expense (Benefit)",
        "totalLabel": "Total current tax expense (benefit)"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Current:"
       }
      }
     },
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "auth_ref": [
      "r95",
      "r371",
      "r381"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Current State and Local Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "DEBT"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/DEBT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r18",
      "r19",
      "r20",
      "r473",
      "r475",
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/DEBTNarrativeDetails",
      "http://cvsciences.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r20",
      "r249",
      "r475",
      "r488"
     ],
     "calculation": {
      "http://cvsciences.com/role/DEBTScheduleofDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://cvsciences.com/role/DebtPrincipalPaymentsonDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "totalLabel": "Long-term debt, gross"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/DEBTScheduleofDebtDetails",
      "http://cvsciences.com/role/DebtPrincipalPaymentsonDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "auth_ref": [
      "r414",
      "r415"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face (par) amount of debt instrument at time of issuance.",
        "label": "Debt Instrument, Face Amount",
        "verboseLabel": "Debt face value"
       }
      }
     },
     "localname": "DebtInstrumentFaceAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "auth_ref": [
      "r46"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "terseLabel": "Debt interest rate (percent)"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/DEBTNarrativeDetails",
      "http://cvsciences.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/DEBTNarrativeDetails",
      "http://cvsciences.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentPeriodicPayment": {
     "auth_ref": [
      "r47",
      "r484"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the required periodic payments including both interest and principal payments.",
        "label": "Debt Instrument, Periodic Payment",
        "terseLabel": "Debt periodic payment"
       }
      }
     },
     "localname": "DebtInstrumentPeriodicPayment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r47",
      "r98",
      "r255",
      "r258",
      "r259",
      "r260",
      "r413",
      "r414",
      "r415",
      "r485"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/DEBTNarrativeDetails",
      "http://cvsciences.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common shares reserved for future issuance related to deferred compensation arrangements with individuals.",
        "label": "Deferred Compensation Arrangement with Individual, Common Stock Reserved for Future Issuance",
        "terseLabel": "Shares unissued and reserved for issuance (shares)"
       }
      }
     },
     "localname": "DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r95",
      "r372",
      "r381"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r80",
      "r95",
      "r372",
      "r381",
      "r382",
      "r383"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred Income Tax Expense (Benefit)",
        "totalLabel": "Total deferred tax benefit"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]",
        "terseLabel": "Deferred:"
       }
      }
     },
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "auth_ref": [
      "r21",
      "r22",
      "r361",
      "r474",
      "r487"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.",
        "label": "Deferred Tax Liabilities, Gross",
        "negatedTotalLabel": "Total deferred tax liabilities"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxLiabilitiesNet": {
     "auth_ref": [
      "r349",
      "r350"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.",
        "label": "Deferred Income Tax Liabilities, Net",
        "negatedTotalLabel": "Net deferred tax liabilities",
        "terseLabel": "Deferred tax liability"
       }
      }
     },
     "localname": "DeferredIncomeTaxLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredIncomeTaxesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Income Taxes and Other Assets [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "DeferredIncomeTaxesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r95",
      "r372",
      "r381"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred state and local tax expense (benefit) pertaining to income (loss) from continuing operations.",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "terseLabel": "State"
       }
      }
     },
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGoodwillAndIntangibleAssets": {
     "auth_ref": [],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Assets, Goodwill and Intangible Assets",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r362"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsInventory": {
     "auth_ref": [
      "r369",
      "r370"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from inventory.",
        "label": "Deferred Tax Assets, Inventory",
        "terseLabel": "Change to inventory"
       }
      }
     },
     "localname": "DeferredTaxAssetsInventory",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "auth_ref": [
      "r369",
      "r370"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness": {
     "auth_ref": [
      "r367",
      "r369",
      "r370"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible general business tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, General Business",
        "terseLabel": "Business credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsGeneralBusiness",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r367",
      "r369",
      "r370"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "R&amp;D credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r369",
      "r370"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "verboseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals": {
     "auth_ref": [
      "r369",
      "r370"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from reserves and accruals.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals",
        "terseLabel": "Accruals and reserves"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Deferred Tax Liabilities, Gross [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssets": {
     "auth_ref": [
      "r369",
      "r370"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets including goodwill.",
        "label": "Deferred Tax Liabilities, Goodwill and Intangible Assets",
        "negatedLabel": "CanX intangible assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "auth_ref": [
      "r369",
      "r370"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other.",
        "label": "Deferred Tax Liabilities, Other",
        "negatedLabel": "Other"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilitiesPropertyPlantAndEquipment": {
     "auth_ref": [
      "r369",
      "r370"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from property, plant, and equipment.",
        "label": "Deferred Tax Liabilities, Property, Plant and Equipment",
        "negatedLabel": "Operating lease assets"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESDeferredIncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Matching contribution to 401(k) plan"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r80",
      "r227"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/PROPERTYEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r80",
      "r152"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r274",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Revenue Product Sales by Channel"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r342"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "STOCK-BASED COMPENSATION"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Domestic Tax Authority"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DueFromRelatedPartiesCurrent": {
     "auth_ref": [
      "r5",
      "r15",
      "r25",
      "r96",
      "r432"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of receivables to be collected from related parties where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth, at the financial statement date. which are usually due within one year (or one business cycle).",
        "label": "Due from Related Parties, Current",
        "terseLabel": "Due from former President and CEO"
       }
      }
     },
     "localname": "DueFromRelatedPartiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "verboseLabel": "Earnings Per Share:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r121"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic and Diluted",
        "terseLabel": "Net loss per common share , basic and diluted (in USD per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r123",
      "r124",
      "r125",
      "r127"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "NET INCOME (LOSS) PER SHARE"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/NETINCOMELOSSPERSHARE"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperations": {
     "auth_ref": [
      "r352"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation, Percent",
        "totalLabel": "Income tax benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperations",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Percent [Abstract]",
        "terseLabel": "Percent of pretax income (loss)"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateContinuingOperationsTaxRateReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r352",
      "r384"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Income tax benefit at federal statutory rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r352",
      "r384"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "terseLabel": "Increase in valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther": {
     "auth_ref": [
      "r352",
      "r384"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent",
        "terseLabel": "Other permanent differences"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r352",
      "r384"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r352",
      "r384"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r352",
      "r384"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State taxes, net of federal effect"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r352",
      "r384"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_EffectiveIncomeTaxRateContinuingOperations",
       "weight": -1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "negatedTerseLabel": "R&amp;D tax credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r327"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized weighted average period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/NETINCOMELOSSPERSHAREAntidilutiveSharesDetails",
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r108",
      "r116",
      "r118",
      "r129",
      "r195",
      "r254",
      "r261",
      "r334",
      "r335",
      "r336",
      "r377",
      "r378",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r507",
      "r508",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r293",
      "r399",
      "r441",
      "r442",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r285",
      "r286",
      "r291",
      "r293",
      "r399",
      "r441"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290",
      "r291",
      "r293",
      "r441",
      "r442",
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueOfFinancialInstrumentsPolicy": {
     "auth_ref": [
      "r90",
      "r400",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.",
        "label": "Fair Value of Financial Instruments, Policy [Policy Text Block]",
        "terseLabel": "Fair Value of Financial Instruments"
       }
      }
     },
     "localname": "FairValueOfFinancialInstrumentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Useful Life (Years)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r221"
     ],
     "calculation": {
      "http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "terseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r223"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "Future amortization expense"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INTANGIBLEASSETSNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r216",
      "r217",
      "r221",
      "r224",
      "r452",
      "r456"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r221",
      "r456"
     ],
     "calculation": {
      "http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r216",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r221",
      "r452"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "terseLabel": "Intangibles, net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedTerseLabel": "Loss on disposal of fixed assets"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnTerminationOfLease": {
     "auth_ref": [
      "r416"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on termination of lease before expiration of lease term.",
        "label": "Gain (Loss) on Termination of Lease",
        "terseLabel": "Gain termination of lease"
       }
      }
     },
     "localname": "GainLossOnTerminationOfLease",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r209",
      "r211",
      "r471"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "terseLabel": "Goodwill",
        "verboseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://cvsciences.com/role/SEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": {
     "auth_ref": [
      "r90",
      "r218"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined.",
        "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r80",
      "r210",
      "r212",
      "r214"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "terseLabel": "Goodwill impairment charges"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r64",
      "r94",
      "r157",
      "r163",
      "r167",
      "r170",
      "r173",
      "r191",
      "r404"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      },
      "http://cvsciences.com/role/SEGMENTINFORMATIONDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "terseLabel": "Gross profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://cvsciences.com/role/SEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r90",
      "r226",
      "r233"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InProcessResearchAndDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "In process investigation of new knowledge useful in developing new product or service or new process or technique or improvement to existing product or process, and translation of knowledge into plan or design for new product or process or for improvement to existing product or process.",
        "label": "In Process Research and Development [Member]",
        "terseLabel": "In-process research and development"
       }
      }
     },
     "localname": "InProcessResearchAndDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r61",
      "r157",
      "r163",
      "r167",
      "r170",
      "r173",
      "r469",
      "r479",
      "r483",
      "r498"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r231"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails",
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails",
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]",
        "terseLabel": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]",
        "terseLabel": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameAxis": {
     "auth_ref": [
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by name of taxing authority.",
        "label": "Income Tax Authority, Name [Axis]",
        "terseLabel": "Income Tax Authority, Name [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Named agency, division or body that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority, Name [Domain]",
        "terseLabel": "Income Tax Authority, Name [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]",
        "terseLabel": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r353",
      "r359",
      "r366",
      "r379",
      "r385",
      "r387",
      "r388",
      "r389"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "INCOME TAXES"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r95",
      "r117",
      "r118",
      "r155",
      "r351",
      "r380",
      "r386",
      "r499"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      },
      "http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax benefit",
        "totalLabel": "Income tax benefit"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://cvsciences.com/role/INCOMETAXESINCOMETAXESComponentsofIncomeTaxExpenseDetails",
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Income Tax Rate Reconciliation, Amount [Abstract]",
        "terseLabel": "Amount"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r59",
      "r90",
      "r347",
      "r348",
      "r359",
      "r360",
      "r365",
      "r373",
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r352"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "terseLabel": "Increase in valuation allowance"
       }
      }
     },
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r352"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "terseLabel": "Income tax benefit at federal statutory rate"
       }
      }
     },
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseOther": {
     "auth_ref": [
      "r352"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount",
        "terseLabel": "Other permanent differences"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseOther",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "auth_ref": [
      "r352"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount",
        "verboseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "auth_ref": [
      "r352"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r352"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "terseLabel": "State taxes, net of federal effect"
       }
      }
     },
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r352"
     ],
     "calculation": {
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "negatedTerseLabel": "R&amp;D tax credits"
       }
      }
     },
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESIncomeTaxProvisionDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxesPaid": {
     "auth_ref": [
      "r77",
      "r84"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.",
        "label": "Income Taxes Paid",
        "terseLabel": "Income taxes paid"
       }
      }
     },
     "localname": "IncomeTaxesPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredIncomeTaxes": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the account that represents the temporary difference that results from Income or Loss that is recognized for accounting purposes but not for tax purposes and vice versa.",
        "label": "Increase (Decrease) in Deferred Income Taxes",
        "negatedLabel": "Deferred taxes"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Change in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r225"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all or part of the information related to intangible assets.",
        "label": "Intangible Assets Disclosure [Text Block]",
        "terseLabel": "INTANGIBLE ASSETS"
       }
      }
     },
     "localname": "IntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INTANGIBLEASSETS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r215",
      "r219"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestIncomeExpenseNet": {
     "auth_ref": [
      "r481"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net amount of operating interest income (expense).",
        "label": "Interest Income (Expense), Net",
        "negatedLabel": "Interest (income) expense, net"
       }
      }
     },
     "localname": "InterestIncomeExpenseNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r74",
      "r76",
      "r84"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Interest paid"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryCurrentTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about inventory expected to be sold or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Current [Table]",
        "terseLabel": "Inventory, Current [Table]"
       }
      }
     },
     "localname": "InventoryCurrentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INVENTORYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]",
        "terseLabel": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "INVENTORY"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INVENTORY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r32",
      "r205"
     ],
     "calculation": {
      "http://cvsciences.com/role/INVENTORYDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INVENTORYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryGross": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://cvsciences.com/role/INVENTORYDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount, as of the balance sheet date, of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Inventory, Gross",
        "totalLabel": "Total gross inventory"
       }
      }
     },
     "localname": "InventoryGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INVENTORYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Inventory [Line Items]",
        "terseLabel": "Inventory [Line Items]"
       }
      }
     },
     "localname": "InventoryLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INVENTORYDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r3",
      "r54"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r13",
      "r55",
      "r90",
      "r128",
      "r202",
      "r203",
      "r206"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "verboseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterials": {
     "auth_ref": [
      "r53"
     ],
     "calculation": {
      "http://cvsciences.com/role/INVENTORYDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of raw materials expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Raw Materials, Gross",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterials",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INVENTORYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r54",
      "r101",
      "r204"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Inventory write-down"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INVENTORYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcess": {
     "auth_ref": [
      "r52"
     ],
     "calculation": {
      "http://cvsciences.com/role/INVENTORYDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before valuation and LIFO reserves of merchandise or goods in the production process expected to be completed within one year or operating cycle, if longer.",
        "label": "Inventory, Work in Process, Gross",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcess",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INVENTORYDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "auth_ref": [
      "r80"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.",
        "label": "Issuance of Stock and Warrants for Services or Claims",
        "terseLabel": "Common stock issued for commitment fee"
       }
      }
     },
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r425",
      "r427"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "terseLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease Information"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]",
        "terseLabel": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Maturities of Lease Liabilities"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/LEASESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r426"
     ],
     "calculation": {
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments due"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive": {
     "auth_ref": [
      "r426"
     ],
     "calculation": {
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails_1": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due after fifth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due after Rolling Year Five",
        "verboseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterRollingYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive": {
     "auth_ref": [
      "r426"
     ],
     "calculation": {
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails_1": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fifth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Five",
        "verboseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour": {
     "auth_ref": [
      "r426"
     ],
     "calculation": {
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails_1": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in fourth rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four",
        "verboseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree": {
     "auth_ref": [
      "r426"
     ],
     "calculation": {
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails_1": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in third rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three",
        "verboseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo": {
     "auth_ref": [
      "r426"
     ],
     "calculation": {
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in second rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two",
        "verboseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths": {
     "auth_ref": [
      "r426"
     ],
     "calculation": {
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for operating lease, due in next rolling twelve months following latest statement of financial position date. For interim and annual periods when interim periods are reported on a rolling approach, from latest statement of financial position date.",
        "label": "Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months",
        "verboseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r426"
     ],
     "calculation": {
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "LEASES"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/LEASES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r43",
      "r94",
      "r165",
      "r191",
      "r393",
      "r394",
      "r395",
      "r404"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r31",
      "r94",
      "r191",
      "r404",
      "r476",
      "r493"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and stockholders' equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r45",
      "r94",
      "r191",
      "r393",
      "r394",
      "r395",
      "r404"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongTermDebtCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://cvsciences.com/role/DEBTScheduleofDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt, classified as current. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Current Maturities",
        "negatedTerseLabel": "Less: Current portion of debt"
       }
      }
     },
     "localname": "LongTermDebtCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": {
     "auth_ref": [
      "r100",
      "r247"
     ],
     "calculation": {
      "http://cvsciences.com/role/DebtPrincipalPaymentsonDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/DebtPrincipalPaymentsonDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": {
     "auth_ref": [
      "r100",
      "r247"
     ],
     "calculation": {
      "http://cvsciences.com/role/DebtPrincipalPaymentsonDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Long-Term Debt, Maturity, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/DebtPrincipalPaymentsonDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://cvsciences.com/role/DEBTScheduleofDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DebtInstrumentCarryingAmount",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Long-term portion of debt"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/DEBTNarrativeDetails",
      "http://cvsciences.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r47",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/DEBTNarrativeDetails",
      "http://cvsciences.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LossContingenciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Loss Contingencies [Line Items]",
        "terseLabel": "Loss Contingencies [Line Items]"
       }
      }
     },
     "localname": "LossContingenciesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIESLawsuitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LossContingenciesTable": {
     "auth_ref": [
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r245",
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses the specific components (such as the nature, name, and date) of the loss contingency and gives an estimate of the possible loss or range of loss, or states that a reasonable estimate cannot be made. Excludes environmental contingencies, warranties and unconditional purchase obligations.",
        "label": "Loss Contingencies [Table]",
        "terseLabel": "Loss Contingencies [Table]"
       }
      }
     },
     "localname": "LossContingenciesTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/COMMITMENTSANDCONTINGENCIESLawsuitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MinorityInterestOwnershipPercentageByParent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The parent entity's interest in net assets of the subsidiary, expressed as a percentage.",
        "label": "Noncontrolling Interest, Ownership Percentage by Parent",
        "terseLabel": "Ownership interest (percent)"
       }
      }
     },
     "localname": "MinorityInterestOwnershipPercentageByParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "FINANCING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r75"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "INVESTING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r75",
      "r78",
      "r81"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "OPERATING ACTIVITIES"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r57",
      "r58",
      "r62",
      "r81",
      "r94",
      "r107",
      "r112",
      "r113",
      "r114",
      "r115",
      "r117",
      "r118",
      "r120",
      "r157",
      "r163",
      "r167",
      "r170",
      "r173",
      "r191",
      "r404",
      "r480",
      "r497"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r106",
      "r107",
      "r108",
      "r109",
      "r110",
      "r111",
      "r114",
      "r126",
      "r192",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r330",
      "r331",
      "r332",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r375",
      "r376",
      "r377",
      "r378",
      "r453",
      "r454",
      "r455",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued and Newly Adopted Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonUsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Countries excluding the United States of America (US).",
        "label": "Non-US [Member]",
        "terseLabel": "Outside the United States"
       }
      }
     },
     "localname": "NonUsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INVENTORYDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NoncashInvestingAndFinancingItemsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Noncash Investing and Financing Items [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash transactions:"
       }
      }
     },
     "localname": "NoncashInvestingAndFinancingItemsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NoncompeteAgreementsMember": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.",
        "label": "Noncompete Agreements [Member]",
        "terseLabel": "Non-compete agreements"
       }
      }
     },
     "localname": "NoncompeteAgreementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NotesPayableCurrent": {
     "auth_ref": [
      "r42"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.",
        "label": "Notes Payable, Current",
        "terseLabel": "Current portion of long-term debt"
       }
      }
     },
     "localname": "NotesPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NotesPayableOtherPayablesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A written promise to pay a note to a third party.",
        "label": "Notes Payable, Other Payables [Member]",
        "terseLabel": "Note Payable, Other"
       }
      }
     },
     "localname": "NotesPayableOtherPayablesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/DEBTNarrativeDetails",
      "http://cvsciences.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/ORGANIZATIONANDBUSINESSDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r145"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OfficeEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.",
        "label": "Office Equipment [Member]",
        "terseLabel": "Office furniture and equipment"
       }
      }
     },
     "localname": "OfficeEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/PROPERTYEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total Operating Expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r157",
      "r163",
      "r167",
      "r170",
      "r173"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      },
      "http://cvsciences.com/role/SEGMENTINFORMATIONDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Operating loss"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://cvsciences.com/role/SEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLossMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing operating income (loss).",
        "label": "Operating Income (Loss) [Member]",
        "terseLabel": "Operating Income (Loss)"
       }
      }
     },
     "localname": "OperatingIncomeLossMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r418"
     ],
     "calculation": {
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "netLabel": "Lease liabilities for operating leases",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails",
      "http://cvsciences.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r418"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      },
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Current portion of operating lease liability",
        "verboseLabel": "Current operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r418"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Non-current operating lease liabilities",
        "verboseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://cvsciences.com/role/LEASESMaturityofLeaseLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r419",
      "r421"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating lease payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r417"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "netLabel": "Right-of-use assets",
        "terseLabel": "Operating lease assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://cvsciences.com/role/LEASESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r424",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/LEASESRightofuseAssetsandLeaseLiabilitiesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r423",
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted average remaining lease term"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/LEASESRightofuseAssetsandLeaseLiabilitiesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r367"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforward"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]",
        "terseLabel": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]",
        "terseLabel": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r102",
      "r119",
      "r143",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles.",
        "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]",
        "terseLabel": "ORGANIZATION AND BUSINESS"
       }
      }
     },
     "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/ORGANIZATIONANDBUSINESS"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r10",
      "r11",
      "r12",
      "r44"
     ],
     "calculation": {
      "http://cvsciences.com/role/ACCRUEDEXPENSESDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other accrued liabilities"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/ACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r40"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r48"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Member]",
        "terseLabel": "Other Noncurrent Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]",
        "terseLabel": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r73"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "terseLabel": "Stock offering cost"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r69"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PerformanceSharesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement awarded for meeting performance target.",
        "label": "Performance Shares [Member]",
        "terseLabel": "Performance stock options"
       }
      }
     },
     "localname": "PerformanceSharesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/NETINCOMELOSSPERSHAREAntidilutiveSharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r299",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in USD per share)",
        "verboseLabel": "Preferred stock par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (shares)",
        "verboseLabel": "Preferred stock authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (shares)",
        "verboseLabel": "Preferred stock issued"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r23"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (shares)",
        "verboseLabel": "Preferred stock outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETSParenthetical",
      "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r23"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "terseLabel": "Preferred stock, par value $0.0001; 10,000 shares authorized; no shares issued and outstanding"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r6",
      "r8",
      "r207",
      "r208"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses and other"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpensesAndOtherCurrentAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing prepaid expenses and other current assets.",
        "label": "Prepaid Expenses and Other Current Assets [Member]",
        "terseLabel": "Prepaid Expenses and Other Current Assets"
       }
      }
     },
     "localname": "PrepaidExpensesAndOtherCurrentAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r70"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of common stock"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfLongTermDebt": {
     "auth_ref": [
      "r71"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from a debt initially having maturity due after one year or beyond the operating cycle, if longer.",
        "label": "Proceeds from Issuance of Long-term Debt",
        "terseLabel": "Proceeds from debt"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfLongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r70",
      "r329"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromUnsecuredNotesPayable": {
     "auth_ref": [
      "r71"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from borrowings supported by a written promise to pay an obligation that is uncollateralized (where debt is not backed by the pledge of collateral).",
        "label": "Proceeds from Unsecured Notes Payable",
        "terseLabel": "Proceeds from debt"
       }
      }
     },
     "localname": "ProceedsFromUnsecuredNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]",
        "terseLabel": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r39",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/PROPERTYEQUIPMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r234",
      "r522",
      "r523",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "PROPERTY &amp; EQUIPMENT"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/PROPERTYEQUIPMENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r38",
      "r228"
     ],
     "calculation": {
      "http://cvsciences.com/role/PROPERTYEQUIPMENTDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/PROPERTYEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/PROPERTYEQUIPMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r16",
      "r17",
      "r230",
      "r494"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://cvsciences.com/role/PROPERTYEQUIPMENTDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property &amp; equipment, net",
        "totalLabel": "Property and equipment,net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://cvsciences.com/role/PROPERTYEQUIPMENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r37",
      "r90",
      "r230",
      "r522",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r16",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/PROPERTYEQUIPMENTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r16",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/PROPERTYEQUIPMENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property and equipment useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/PROPERTYEQUIPMENTDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r63",
      "r200"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Bad debt expense"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProvisionForLoanAndLeaseLosses": {
     "auth_ref": [
      "r79",
      "r184",
      "r482"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to estimated loss from loan and lease transactions.",
        "label": "Provision for Loan and Lease Losses",
        "terseLabel": "Impairment charge related to previously recorded receivable"
       }
      }
     },
     "localname": "ProvisionForLoanAndLeaseLosses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "auth_ref": [
      "r90",
      "r185",
      "r188",
      "r189",
      "r190"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.",
        "label": "Receivable [Policy Text Block]",
        "terseLabel": "Accounts Receivable"
       }
      }
     },
     "localname": "ReceivablesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]",
        "terseLabel": "Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]"
       }
      }
     },
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r292",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionAxis": {
     "auth_ref": [
      "r292",
      "r431",
      "r432",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party transaction.",
        "label": "Related Party Transaction [Axis]",
        "terseLabel": "Related Party Transaction [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/ACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionDomain": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Transaction between related party.",
        "label": "Related Party Transaction [Domain]",
        "terseLabel": "Related Party Transaction [Domain]"
       }
      }
     },
     "localname": "RelatedPartyTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/ACCRUEDEXPENSESDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/ACCRUEDEXPENSESDetails",
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r292",
      "r431",
      "r435",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r429",
      "r430",
      "r432",
      "r436",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "RELATED PARTIES"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RepaymentsOfNotesPayable": {
     "auth_ref": [
      "r72"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.",
        "label": "Repayments of Notes Payable",
        "negatedLabel": "Repayment of unsecured debt"
       }
      }
     },
     "localname": "RepaymentsOfNotesPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r345",
      "r534"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      },
      "http://cvsciences.com/role/SEGMENTINFORMATIONDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://cvsciences.com/role/SEGMENTINFORMATIONDetails",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r90",
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research &amp; Development Expense"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r88",
      "r470",
      "r491"
     ],
     "calculation": {
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofCashCashEquivalentsandRestrictedCashDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalents": {
     "auth_ref": [
      "r14",
      "r82",
      "r88",
      "r470",
      "r491"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash and Cash Equivalents",
        "terseLabel": "Restricted cash",
        "verboseLabel": "Restricted cash"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Restricted Stock Units (RSUs)"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails",
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r28",
      "r261",
      "r337",
      "r492",
      "r511",
      "r516"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r108",
      "r116",
      "r118",
      "r195",
      "r334",
      "r335",
      "r336",
      "r377",
      "r378",
      "r507",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r148",
      "r149",
      "r162",
      "r168",
      "r169",
      "r175",
      "r176",
      "r179",
      "r273",
      "r274",
      "r451"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Product sales, net"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESRevenueProductSalesbyChannelDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r91",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r283"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r60",
      "r94",
      "r148",
      "r149",
      "r162",
      "r168",
      "r169",
      "r175",
      "r176",
      "r179",
      "r191",
      "r404",
      "r483"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Product sales, net"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r422",
      "r427"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating ROU lease assets obtained in exchange for operating lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RoyaltyExpense": {
     "auth_ref": [
      "r67"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property.",
        "label": "Royalty Expense",
        "netLabel": "Stock-based compensation associated with founders employment settlements (Note 11)"
       }
      }
     },
     "localname": "RoyaltyExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Proceeds recognized"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://cvsciences.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://cvsciences.com/role/SUBSEQUENTEVENTDetails",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Common stock sold (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://cvsciences.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of accrued expenses"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/ACCRUEDEXPENSESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r123"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/NETINCOMELOSSPERSHAREAntidilutiveSharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of cash and cash equivalents.",
        "label": "Schedule of Cash and Cash Equivalents [Table Text Block]",
        "terseLabel": "Schedule of Cash, Cash Equivalents and Restricted Cash"
       }
      }
     },
     "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "auth_ref": [
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "terseLabel": "Reconciliation of income tax provision"
       }
      }
     },
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation.",
        "label": "Schedule of Debt [Table Text Block]",
        "terseLabel": "Schedule of Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of deferred tax assets"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r122"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Computation of Basic and Diluted Earnings per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/NETINCOMELOSSPERSHARETables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of effective income tax rate reconciliation"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r216",
      "r220",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r216",
      "r220"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of intangible assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INTANGIBLEASSETSTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r13",
      "r33",
      "r34",
      "r35"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INVENTORYTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": {
     "auth_ref": [
      "r247"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt.",
        "label": "Schedule of Maturities of Long-term Debt [Table Text Block]",
        "terseLabel": "Schedule of Principal Payments on Debt"
       }
      }
     },
     "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/DEBTTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r39",
      "r230"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/PROPERTYEQUIPMENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r97",
      "r433",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/ACCRUEDEXPENSESDetails",
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "auth_ref": [
      "r157",
      "r160",
      "r166",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table disclosing the profit or loss and total assets for each reportable segment of the entity. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": {
     "auth_ref": [
      "r157",
      "r160",
      "r166",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.",
        "label": "Schedule of Segment Reporting Information, by Segment [Table Text Block]",
        "terseLabel": "Schedule Of Segment Reporting Information"
       }
      }
     },
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SEGMENTINFORMATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r299",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r306",
      "r314",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Fair value assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r50",
      "r92",
      "r130",
      "r131",
      "r251",
      "r252",
      "r253",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r261"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "auth_ref": [
      "r358",
      "r374"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits.",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "terseLabel": "Schedule of Unrecognized Tax Benefits"
       }
      }
     },
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentDomain": {
     "auth_ref": [
      "r144",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r162",
      "r163",
      "r164",
      "r165",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r173",
      "r179",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity.",
        "label": "Segments [Domain]",
        "terseLabel": "Segments [Domain]"
       }
      }
     },
     "localname": "SegmentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SEGMENTINFORMATIONDetails",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SegmentReportingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Segment Reporting [Abstract]",
        "terseLabel": "Segment Reporting [Abstract]"
       }
      }
     },
     "localname": "SegmentReportingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "auth_ref": [
      "r144",
      "r146",
      "r147",
      "r157",
      "r161",
      "r167",
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r178",
      "r179",
      "r180"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.",
        "label": "Segment Reporting Disclosure [Text Block]",
        "terseLabel": "SEGMENT INFORMATION"
       }
      }
     },
     "localname": "SegmentReportingDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SEGMENTINFORMATION"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Segment Reporting Information [Line Items]",
        "terseLabel": "Segment Reporting Information [Line Items]"
       }
      }
     },
     "localname": "SegmentReportingInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r68"
     ],
     "calculation": {
      "http://cvsciences.com/role/SEGMENTINFORMATIONDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SEGMENTINFORMATIONDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, General and Administrative Expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r79"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "verboseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r300"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r313"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "terseLabel": "Vested RSU's (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r316"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "Fair value of RSU's vested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend Rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONAssumptionsUsedtoEstimateFairValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "verboseLabel": "Volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONAssumptionsUsedtoEstimateFairValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-Free Interest Rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONAssumptionsUsedtoEstimateFairValueDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized",
        "terseLabel": "Shares available for issuance under the Plan (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "auth_ref": [
      "r302"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized",
        "terseLabel": "Shares authorized under plan (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Exercisable (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Exercisable (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r316"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value, exercised in period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r312"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Forfeited (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Net number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Net of Forfeitures",
        "terseLabel": "Unvested options granted (shares)",
        "verboseLabel": "Granted (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Stock options issued (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Fair Value Per Share on Grant Date"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONAssumptionsUsedtoEstimateFairValueDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r328"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "periodEndLabel": "Outstanding ending balance, aggregate intrinsic value",
        "periodStartLabel": "Outstanding beginning balance, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r308",
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Outstanding ending balance (shares)",
        "periodStartLabel": "Outstanding beginning balance (shares)",
        "terseLabel": "Options outstanding (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Shares"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r307"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Outstanding ending balance (USD per share)",
        "periodStartLabel": "Outstanding beginning balance (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r319"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "terseLabel": "Options vested or expected to vest, aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Vested or expected to vest (USD per share)",
        "verboseLabel": "Weighted average exercise price of outstanding vested options (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails",
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number",
        "terseLabel": "Vested or expected to vest (shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r297",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails",
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (USD per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r90",
      "r299",
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Stock Based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Stock option, maximum term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r321",
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "verboseLabel": "Expected Term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONAssumptionsUsedtoEstimateFairValueDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r328"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value",
        "terseLabel": "Options exercisable, aggregate intrinsic value"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options exercisable, weighted average remaining contract term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares",
        "terseLabel": "Unvested stock options (shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails",
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Outstanding balance, weighted average remaining contract term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r319"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term",
        "terseLabel": "Options vested or expected to vest, weighted average remaining contract term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options vested.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares",
        "terseLabel": "Options vested (shares)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/RELATEDPARTIESNarrativeDetails",
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.",
        "label": "Shares, Outstanding",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShippingAndHandlingMember": {
     "auth_ref": [
      "r276"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Packing and transport of product.",
        "label": "Shipping and Handling [Member]",
        "terseLabel": "Shipping and Handling"
       }
      }
     },
     "localname": "ShippingAndHandlingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r102"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State and Local Jurisdiction"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementBusinessSegmentsAxis": {
     "auth_ref": [
      "r0",
      "r144",
      "r148",
      "r149",
      "r150",
      "r151",
      "r152",
      "r153",
      "r154",
      "r155",
      "r156",
      "r157",
      "r158",
      "r159",
      "r162",
      "r163",
      "r164",
      "r165",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r173",
      "r179",
      "r213",
      "r232",
      "r235",
      "r236",
      "r500"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by business segments.",
        "label": "Segments [Axis]",
        "terseLabel": "Segments [Axis]"
       }
      }
     },
     "localname": "StatementBusinessSegmentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SEGMENTINFORMATIONDetails",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r51",
      "r103",
      "r104",
      "r105",
      "r108",
      "r116",
      "r118",
      "r129",
      "r195",
      "r254",
      "r261",
      "r334",
      "r335",
      "r336",
      "r377",
      "r378",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r507",
      "r508",
      "r509"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r103",
      "r104",
      "r105",
      "r129",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.",
        "label": "Stock Issued During Period, Shares, Issued for Services",
        "terseLabel": "Shares issued as commitment fee (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesIssuedForServices",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r23",
      "r24",
      "r254",
      "r261",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (shares)",
        "verboseLabel": "Issuance of common stock from exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r51",
      "r254",
      "r261"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock from exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contracts conveying rights, but not obligations, to buy or sell a specific quantity of stock at a specified price during a specified period (an American option) or at a specified date (a European option).",
        "label": "Equity Option [Member]",
        "terseLabel": "Equity Option"
       }
      }
     },
     "localname": "StockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONSummaryofStockOptionsActivityDetails",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r24",
      "r29",
      "r30",
      "r94",
      "r187",
      "r191",
      "r404"
     ],
     "calculation": {
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS",
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders' equity"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Note [Abstract]"
       }
      }
     },
     "localname": "StockholdersEquityNoteAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r93",
      "r261",
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "STOCKHOLDERS EQUITY"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKHOLDERSEQUITY"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r412",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://cvsciences.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r412",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r412",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://cvsciences.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r412",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails",
      "http://cvsciences.com/role/SUBSEQUENTEVENTDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]",
        "terseLabel": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r438",
      "r440"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "SUBSEQUENT EVENT"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUBSEQUENTEVENT"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/STOCKHOLDERSEQUITYNarrativeDetails",
      "http://cvsciences.com/role/SUBSEQUENTEVENTDetails",
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental cash flow disclosures:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFCASHFLOW"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplierConcentrationRiskMember": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.",
        "label": "Supplier Concentration Risk [Member]",
        "terseLabel": "Supplier Concentration Risk"
       }
      }
     },
     "localname": "SupplierConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TaxPeriodAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information about the period subject to enacted tax laws.",
        "label": "Tax Period [Axis]",
        "terseLabel": "Tax Period [Axis]"
       }
      }
     },
     "localname": "TaxPeriodAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxPeriodDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identified tax period.",
        "label": "Tax Period [Domain]",
        "terseLabel": "Tax Period [Domain]"
       }
      }
     },
     "localname": "TaxPeriodDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TradeNamesMember": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights acquired through registration of a business name to gain or protect exclusive use thereof.",
        "label": "Trade Names [Member]",
        "terseLabel": "Trade names"
       }
      }
     },
     "localname": "TradeNamesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INTANGIBLEASSETSIntangibleAssetScheduleDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfRevenueExtensibleList": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates type of revenue from product and service. Includes, but is not limited to, revenue from contract with customer and other sources.",
        "label": "Revenue, Product and Service [Extensible List]",
        "terseLabel": "Revenue, Product and Service [Extensible List]"
       }
      }
     },
     "localname": "TypeOfRevenueExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r346",
      "r355"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Balance as of December 31:",
        "periodStartLabel": "Balance as of January 1:"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r356"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "terseLabel": "Decrease in prior year positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "auth_ref": [
      "r357"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "terseLabel": "Increase in current year positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "auth_ref": [
      "r356"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "terseLabel": "Increase in prior year positions"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESUnrecognizedTaxBenefitsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebt": {
     "auth_ref": [
      "r20",
      "r475",
      "r490"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).",
        "label": "Unsecured Debt",
        "verboseLabel": "Net carrying amount of debt"
       }
      }
     },
     "localname": "UnsecuredDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/DEBTNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnsecuredDebtMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt obligation not collateralized by pledge of, mortgage of or other lien on the entity's assets.",
        "label": "Unsecured Debt [Member]",
        "terseLabel": "Unsecured Debt"
       }
      }
     },
     "localname": "UnsecuredDebtMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/DEBTNarrativeDetails",
      "http://cvsciences.com/role/DEBTScheduleofDebtDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r132",
      "r133",
      "r135",
      "r136",
      "r140",
      "r141",
      "r142"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r364"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Valuation allowance (decrease) increase"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/INCOMETAXESNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "terseLabel": "Weighted average common shares outstanding, basic and diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://cvsciences.com/role/CONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 11
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-04.(a))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21728-107793"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "250",
   "URI": "http://asc.fasb.org/topic&trid=2122394"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=120380238&loc=d3e3842-109258"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8657-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8721-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(11))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(j)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8813-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "26",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8844-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "34",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8981-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "280",
   "URI": "http://asc.fasb.org/topic&trid=2134510"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4647-111522"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=SL6953423-111524"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5033-111524"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10149-111534"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=84159169&loc=d3e10178-111534"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=68074540&loc=d3e5879-108316"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.P.4(d))",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14394-108349"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14453-108349"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14472-108349"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12021-110248"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=121555522&loc=d3e12053-110248"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4534-113899"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11149-113907"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120383193&loc=d3e11178-113907"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(b)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=SL37586934-109318"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31917-109318"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e31931-109318"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32687-109319"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32705-109319"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32718-109319"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=SL6600010-109319"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32537-109319"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32857-109319"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32559-109319"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32621-109319"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32632-109319"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "217",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121610041&loc=d3e36027-109320"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330215-122817"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5263-128473"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "60",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13279-108611"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "40",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121604053&loc=SL77918607-209975"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19,20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "http://asc.fasb.org/topic&trid=2122774"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.15(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.10)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.11)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Subparagraph": "(c)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(15)(b)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.17)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r535": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r536": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r537": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r538": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r539": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r541": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2(a),(d))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6787-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18726-107790"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>83
<FILENAME>0001510964-21-000012-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001510964-21-000012-xbrl.zip
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M'SY,/%?_D".]P6@\/!OVNN/AY06Y/"-7H^%%;WC5/2=GPXLN7,+5Y1E(#$:
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M";.X[W)#4,,S/,_V0/520QJ.35FX1M(Y74I]/\ZC1.9YMV@B7PA$)#GNAZR
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M*+'Q<)A06HR&- B$$U!7!D%H$E?>,\0-__5-@%=%%,-_&8O)-SWF$B(<TS7
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M$0<E&JYNOL31-ZY/N/!P%=XS:!C:OA$*UP@8M6S#IV2%M]RN*>%>;%.NSV3
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M 7=LTP1 < ,&*L0AS/>LD#A\ S3)#R3^>PF"+_%8VS6AOK2!)*'C."3T*9[
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M/B]DBI).KW;S)2#"IL1V=&:%X+[;5J SW_%T*0/&@]#V'4M@IJCA&MI[EB7
M;?LLF>#"4,K$8]"]6F[+KO9C^K5<J=J'/SM9+[U.MC*U1)EJW'X1ML7LT+9T
MP_!=G8)DZ4'@>WI@A)0$Q'),K)G7!594-:ZV0K0Z0J1\O$[V,4NOP)_;1A26
M*DGT"S,]X@H\]9*;7*>^3W4_L(3.3,>W0I\3QP%)VJ^MAPC]%!+T,<U'+#Z+
MAMN(W)+EIVGBZC-W;,/7;<I!?KAEZYY%I$Y"CQL^<8C!C)UWODG,>]F6J^^%
MEPR'L;=A!F@=#5FLR1O)QWAV(ES&JL_YK]HOP(P:<N.OW]K<A%N9EK-E[N$T
MK-E"9ZZ-9"R'_3216J*"7+L8<(S'Z'MJ+),,)%K(3448M&UK,,@MIBP94UJ3
M+Z[OFA+ 0R>V+3"CQ=>9&W+0>8(YS'68=(.==Y[CK(=2UC=49%3)JH\(&-N@
M^++%IGYL? D]QR;"E;IMFI9. T/J'A%2=ZA!2&#;U#;HSCO3-W23V-^=!_:D
MN.3%.!]%X60;>%T54V8N:[K(*Y&9% ^G7)N_!--DZQH?+:255LFE2\/9G7=M
MP)O'>/5;U2_F:A9\I1Y&R;RKM[G<LO9L\VG[M9^W11Q\W!??7&[Z>[9AO4)G
M??OE=\)#9QWZM'W[+[V;:*F8V(M&1=DDR7A?XS'+\V<LN#VZ]W=MIR-CRMOI
M3@9!&O^2__HS3T:[S$-4K"&KK3:@(:[[$5R9J9'G;)R9*VNT6//HMS6;G#>U
ME^6-[<3\9!/S=8-E!>Q&\]EVX_F"W;A"X;U[EJ19;:."CJO:EKO:_U5F&=&&
M+-.N6#R6N&50R_LJD?#;0;W'C<AED*V9"$P5DEHPT7A?\DL-NGJI105UYC++
MHUQCVK6,8_TR2:^AGY+E8& +N)&/,03(<DW(,$J*Q/.C,9@+U+ ?V(P))-^;
M=Q).9?Y]WL()R#3*=?[/IB!=4M1%??SUM]^= ,W^@R3KEA1K*H*M90SFQ<J2
M65^X81+'HH;.+<? C=66[E$SU.W -J4=<$M0 WW(N]&/I;+J__[+M*W?OF/I
M8'U )DE'<.6_XPC5!VB-$/>M9FKC=_[4G=];A/FA"/,YC<?)B&5JIV^6_]S(
M0K_X 74XD42W;.;JE'-79R$3NA2NY](0)MRD6V1Y562Y[DNU+^(.O/Q"?M7Z
M8*<@I@B-Q?$46.81)Y#E ]#F]Y>7T 3<3<[5HWC6H%3Q F)JJK!3KOT"[87P
M_WP,+G+>3W&+7E5[8M1GH[M]OV;Y?5Q4+Y=C^!5,L$1HOYC%& ,I@1KCX )&
M@,^K1^$E[$79CCK#275"=9+E(\TW-,$F^=[K@T99R:HHZ0&=PFRG\4^.'?87
MCPK7L@Q7=Z4=8I*1KS.3F[H=.LP)K, B)-AY!_ILA<%C*4JNG:Z&AM]0Y$1$
M 3 91*,1P(^, 52R-,&(23S1Y)7,)EH3'70\$OU*:G4V8D7%D3O .FMCWI2;
M=Q:/Y#D>T8J@V]5[VB^OPU7DB7Q-'/='+6(]W 73,O>F;G2D-G,/<3/W:ZN7
M@E!3K2'S7W^ 3IAC(>2@4D7\U#KA\OJ+\-P0=Z?I+J>>3BUJZ[[I<3TP05<0
M87H&(0_J!.V?+,5NGFK8:H;7T PJ+AC#4*3&. ?-D.'YV@HS,"B8/'@5O/Q$
M?_!&/@"5 E_)*KL08&8 DS#910,<F@.K%:?M7#O/TNM1O[J]!_:X5'U304A5
MRDVE8_[OOSS3A&$^TD-UF_Q6/7;O@?+^;O7 H_V;/HA&>/GP(WVMOEF%28D9
MZ&;E5LS[$GO?70%_]5(23&_/)"]_]@HU]DSWY>OHF]8>=;P7;];:<^C3,ATV
MJ*S@AX=%[Y_MUWV)47Y/Q=6'4XVFE3B7/:07)5SM9R/9!@G=JY?'*0[G4VR!
MQL)YFDT>*I*C0L+[Y0-K:<D7>;^GO4^T<XAYOI^,5N^@WZZ?7[?-!CVK?XY:
M]4^3]N H;E^(RU:O=C?O%Y^EV(\SS!D^:1B=>LTZ[?4OVR?-ZW:]:9X='IMM
M$^X=8)7RJBC.*6U=M+Y8 9CYW+%TQS&%3DU+J'*-NLE]X4C<4^,SE>IXWYQZ
M<EW@=95>>], M_N8<;G\<;X<Z997G;Q )#7)[\<Y="Q?SWCSCT:D5E68?-*J
M?7$)LPQN4%TXW-:IQ8CN48/K+#0\@SB^!U2>D\]_?D#",](E_UEFY<K!0>-A
M]W$+!B\'!M44'ZH9WB\F> L*WP*%R3PH=#Y]\0D)F$N!$(P:8*7(0&<F_+2I
MXY" \]#SO:>=5_#=9Y,N.686?B4VA=MCGY@ @^LL:G4%C#C,A!FEVC@OXEHP
MU.)\J0?.*D@S]:UX@A^_CN#3\%DM@;&E:$U<1;DR"A.6<)1<,!6Q4B4^C">J
M"Y:)7,-2EY%X+&?3^H7]^F"(ZKEQY1?!#O,A#VY]F.792V]EPD)I&&)J/489
MV6@DL4HI$@AHA;5^H6_L7"WL_SO76)Z#B8,_*LK),)1J>24I-ZOC.Q&NNB1
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M*[%^8;_B8\3^1?R*Z( #F@>!U>0CU>+;: 2?XT_!W+Y,D%7&,$,X0*#!(*]
M:O^SUBUYJ@2KW>FM= #]G]R]?"WO7@'"E9<4=<JKXZI!_/9 PDS,?6L7&)T#
M&#&M#K;F-;(=:/MAJ? +*D= 29XF8%=&0D%;/@:1$!'+(FQ@Q"ZEXFJF7??3
M6"I4OY8 6W@M01:78$/(/ <* Y\HX-[5QDD,E]1$<#0*;D:%0KF.8'JB1$0(
MH_EW$7ZIY@(8!2>UH[KVH=/Y#R90S<I'KR0/?Y5C>_THUVH%GAPIF;X#)TB]
MP@R8F@HS(Z'DGCFM-.J7:K1D::T/+ +L<16EX_RK$+>+%]3KR,2@OY$'P=J
M[Y3OW7U-O315G(FH5!G 8SH&UB\AJVRRSZ[D?$\&3$AL[-ZG!L#M,"8>CP5P
M.MZ>_B@?A]^E!$FT@V:ZEX-/SZ)DWHQ2G\>7 JD)"1<5G =3TP6F#F12Z'&:
M7J)*F;TZE6D8=50H>Y1M?*C$SX]9=(5]F+.6/L!_S@M2'$DDR\P:\^UY:ZP@
MG>H=0@)J>F6D0>=D<I$6UAT8A:,2P<M/YBS$J<P")$/Q_T>ZCR]?1:(R%>$[
MB/):K]!EP/^H?(KO)PN&IR*,&G"4ETRG\ ,G]AZKP2-)"G9)E(_2#-6HX@C
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M-Z5?D658%D&:+V-;Y;Q$*H!:%7(I*TA*W@=A3L\G>UHST5IL@NFASFYUB(G
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MD\/AXQL*$D+R&!/.8Y2CRF >OO?6 ^SR=!UF&+C^X*UW\4_X)[(A_-G#SC3
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MN_-.>A@9Q[&MT(1/0MTRBV.!G&2":A.ETLDI@S-R X?V/49A<TLNL#MF5=2
MU/M">!_SGO69WB>/@[-*Q'OD7ZWX0)'YRU]Z&,,Z1'(HP_4-DA-C-$96%4E1
MP3SA(!UZ@U%\@XW%LDDNEAQN2807PQ2_B+YL:M5+/)/I31^@(9&&$HRE!;Y1
MM,9=9=]#/)R"A9A2Z(Z\/P$:4*"W&%47U:JI-K2M.V*I+9,Y)?%F+QPZQN R
MSV-^":Y5Z0HBB8);PI?:P8^<=:.ZH$)A@.?FYJ8Q&>5IK]N/PU&CASX<H C^
MW+N6+I0I_OS.QTY4R)W&=":@NRZP]'>.PL5PKB32N4-IB#QY2&W(KS9>R@H?
M<-LPG(CEA 4+"F44/NU^1_:BO ,T["06Z.\!.6/)MN90(/R^OO;I\.L:C+C4
M5<1I"43*\L"(=U;3?5U!=JTB[K^I0\2*Q\U5W:KH'B$U05=-4=?H, 6+<JH+
MU<F#$;N+A/M(-PV4J"3BD)<I"7<D5HX4R87KC$9/D@5LIYI ,1LAAD:!=XV9
M;ZSYL_C'Y*1(C<2%(6D8NINVFPF3VGGQ1Z6?(1B_ >.^%4JIR$D-!I.M%3,F
M49;D[-G%QP5D-G+S;C13.*>+(>F<%C$R#8K8B.N<<$:X<XPE,$*\9#&;:9*\
MA<M#KN=2V_&1N$WU)X),NI7S'6+0Z[8(MF.XY@NU8<Q9>%>&-I&H(P'C(NBU
M(6A)Z<,[-EM3^R*[N1X=+0T78NJ:;_L6*O.#,5V'7.[7#Z\0/,*4,RRWOZ!:
M*'_ELE[?^ZPPGV<RA)UZ 5H)<D2(VQ9)]S7X-YQ-!WJ%EWF6,R*[N54ELE&5
MC;&RVHIMX/H3V-Y#K(("R1#(AD$T#5QOV13"[3 )U!@_ZB)][DO*$7[BW!"%
M"67A=(,1>472H5+:!V!"-%C<9Y!Q?!/B0!4*5"6LI";E@79QGF)PGU0;!TT'
M=A$,5W$JUQ3!G?7:::4!97"FY8THI*EDZL(N<9_@;[) P<0*T?A1XCI90<[F
M*/1C%2]J8?*RLP+T(XOOHIN#$*<@;F_:&TD);1=+WQC-U7B8R V"7_A/#J()
MBU)D^((NPN5?B6)RX:E 6Q^SG#ENB6-W9FT@%=PI=U6/XM:@\:4H( 11UEO/
M0'5F1U.<].F ##$!2CS:!- )S&EC8]8V ULX N;JF7?9[ILX&!WY>$>]HDF>
MF9)_4@IU.UPS<$.^?K',?JF5P&KEJ: O:]KC?,8H8\1AYC JE6N#..\C_G)T
M!8<:'J_8/\O1>XH:$I\Y"3*]D=W<*G@$5,&(I_%%4ZD\9H3F4285-61'_B!8
M$+C6_G-A/)06'PC_$?N)O>/NAPH[0=0IQL0I['F.Z$T4H1QZ,4=Y,,.&:NQ[
M.2(S$&G,H%?QE/DC3D@=. @F=&(>@_A;K6/$:/XA=<)%RWN$U85E"R#H@Y&&
MEK_&/4B'<*ALP/8=$\A+6@@,BK)*;Z(,'W+7ZV@5RJ-D1I,%27FE*)VJ$%$D
M35I.($JH"941Y"(3Y:9@HAUMF.^3#J:LJ.D*_#Z/<ZEE2S67'>@LY%6T*B]9
M%Y4$^7)9JCDT4%X,X;'1M)!T34&>)"!L-ET4&^$+4%(:[Q<GL8G+!0,3$IC>
MT+K.-4D]*6!W'M->R(-AD(QB.(S^D@*/=KW?8H)I2*5V&(S:KX>ZD/BKZB-.
M1L"I(E)<S%B"DB.1NL!2= Z2@/;)*;@QR"DEL131)J-%8,,XZ204<&!&>8H]
M72XL"MMLU0%V"5-7<6)T.DHV@BT'Q$+\'B"MN@Y&.6=6"ZX%&RSR1TP0%H@:
M&K*7!I&>QFB0X'.\]U,@E0+SND_;4 P.1V,H%"?#_5TIU')KLTG7LRY$?<B(
MUD-4TK$9=LKV6+[B2&1N.NG'B:^;^=]RDKRYB%&GCA@MP5CJB!$IO(H\SH64
MFRJH3?(W!Q-"/>#DP;L@%@F8K/H%%(QP%!E35N3T630E(Y+\M)SXG"\/S,E&
M_C0"&B%E7> X[><K@,EIV"44TK"*E[\=<(I4.;5<(\W!#0M#7!+^0T"("9J;
M]&G^^8\R."T,O\='[" &>T, "'%*#I1Q$820TUQ-HD+I$___%#35;E#^CJ#Y
M,/Q7.DU)#]"<+!?+P[#T+ ]B!5758Y!7HQ&!_HRP-@9K;J?+/(VYR6:\3 1(
MD1DT2"?,EVKW&'FA,5 =7\46.+I8):2;G"21H,&-I@44#(&TV2[C")X8',']
M61S!.T$KM:E&7N5L6H4T";HTEKPV.[_L[#7]YF['AV^BT78F/F-\QV<RRTBY
M)K24TU!Z$@7>;T TXELYJ23AO A82>8BAM%QN; Y%7L22=E/U$0%&8<^G$^R
M2F=J^F+]17R*-J0N9N&5L")$_9B$"8?D6YOM]E)OH;F%%/?!.'7,: >YU2"N
M6HA31.>\ [VTQB[M>WD-6;H89.GJ[2PTA1474N9L7)NC:B)'E8<&\" >A3'Y
M+#'E*(R!&=&[%8H/]J:B&4 WB4'X\H%@7X' (;!_4V[-,4GROM161NCNI.%P
MQ&U&(^*,W920I]PD$B?S@P)UJ084=&IUYD\N06(L>?IOM5YQ[B*K'5H/PS+/
M9+ZO=1Y.''!!FDDX73Q:RHW5<>2= &B$'Z1BAQ+C,(:-4;,H53Z&: PB#AZ+
M_\E#0>7E.PIIN/A1_2YD9OA=  9+WCH:;QG"W@3PI(>"5"4,T>=%_0OG3E?&
M(JXF$SI@'$VTV/I:BXJCJQBE6L&YQ)&J&:0[T;;*]Q(\,95.S)R2-&#86Z"&
MA.F0Q"$E/:"OKB=9!&$4Q=>\/UU%I8I,:>'3.>=A>V.0(U3 !-\!PEQ)32&^
MB5N?S'.BV31P8U"%?67Q@0=83,HI696=3GQN52*@M=>P"?IR5CFI$R!D8*Y#
MHH0A_MT+!W3]4ZNQYXT95)YN_-.6_<'7<5H"+_ U*KLD6!:/)D:6T^<3O0J1
MZ);ZH)DCK8(;T+*X#PVSH\ $% ODEWEBM]M%#$*,O.PD=(J3EC*7F%?$&C+X
M2#-Y6NC%)0L!C\ K!F3DOCHV$\GF%;GM?5(7(]H-\B38VC;7Q2(V(<@&[RDQ
M NL4^S/]A"0+E#S0!7E QS[\" I3##/^K^JS8:(G --CK+(2MNN-P?0@@JA^
M%17*;\HJ(;KI/3"F1*0T:(T@8S&AJS"!?CQ&S!2>IR0B6RKHQ5!]AZY<D:8'
M(%LTK.ZTI*'1M>*#R4YQHEP)(<=*<:)V/776*"8)C)5BW14%"F5@.X4]3H1C
M5L)2?C7!-U'R'@&@+[=B<VM9&V6#9WIEC?$;F'(;]P3.%$>ZJ'1G H]'O2D?
M(5<QLH ^)>C@Y B.42Q=<[$(\E'JNJ&K>26DID.M/IG@&WI8!=[C,>C1T?OZ
ME.^+,TSB;IZ:7.=)HH;<\M5GGJ;28/8IN#V]*/\O*^2<ZB"P=XT4U\:<P#9A
M-L^(<]++3F4778(&I.':.);,?08R%FN"<6(^A26G:(29C ;?.[XXQ2V$KZ2"
MS6P8)OT-S&Z8PEG:Q1@ AN($1I4J2CE[SUD!LN&+BMHL=C4H'].4V[-@ :$$
M0>E5?5@4H,*4]G>&Q:6TR;.2-]R=>:(V[!P?."<@&-&^1"2=!^).F0DMP ZT
M74O3-QH0SH"K]C? HDU5V;J=?49_*%6F:A=S5%AB7\7L9AB0*&$4VP+#S$R_
M-/M;)F\$F?,](YA(I.$D<9\@;T=]K")?8=ED\:@R%_*!@M#HCH-%T^* 2[7+
MLCJ.)!,*W1:TTFC&7G/!,I$+4X%[RD)QI-[GKV><V8K#,M$%^XNIIP5Y,05^
M'DM!(HLPOR!]\&B*>SEJKH&.I@<I*Q=&& XE\! B+Y J#8-4T54V]!FN0:,Z
MZ[F2\IPGIA!"\AK160-S!HY1(Q&(R$@>,Y(5N7C4(IL+]@(YN- %9\4!(]50
M@K;E4A",2)H>"PE139RB:#F;V?]D>3O(@:E9^!KQ0G4>=:1<<_M6'2E?@K&\
MC4AYM=EX%%V'24P(O7!:?:7DV!7,)CR)"V;A)!X)D+L!1LNF$_8=#(/_PN&(
MN5Q*BB%UL:!Q/4NCD+^DA81R<O%DW$:V:/^9O'+'H:2Q<;2FBG8,5<BQ&B1
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MZ8"T>E[,PS E6"T!,Q??.+IL=9@;@3R)FN60IL,U:2P078&&]X&IB7/2=);
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M^<1,CH]H5 $KE3\7XGX08UV$3A+3N?Z.?L&A3%V'?-\,O<=PL'8VE]_!NMT
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M70CGMG#9,( QCW $7160IA+KYBO ?\*>\*O#R_>PM9=_\Y)=FF-#$YJFYI6
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M$OKS6@&5817C 4;D_P(,,N=J#R1,$$;>1"6#.('I]%0%\R$SP**' Q!&.@E
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MIIA03:Y/EGE1%F*02CM_M2&,V:&%9+#RV"MJ&W :<*Q.9"YP[2J);[)AZ4S
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MN)U$R3"D)E-#'#_9^G%TM8%%^;-+M)#?]][^XK#_M[6[Q>_6[MIR6#+5LO1
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MT+%(N9,LK8(=XB0_(ASLS(L;WB>Q+&Z4>3LCINHATYYQ!ZREL08/3C#KAI*
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MBX7 \V#(_(+-Y# 2NRW,5K%[P^4P+"O1RCB;X.]K3!.;%;!39P4LP5A>("M
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MKPFOV,(A-57_/&V_''<[D6. X0BM]3[2FX<6J7CB77]H8"FM\3[Z<M=L'ZH
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MEX(5BW_ R!$,PL %&IF"#<K#,J=52%DC5R6'&Q:/*&1S?;"YCBE!P-$0I9'
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M:,\#,,% 0*W"0'%% ;$2(66HD50O!+G+(%<OQ:*&\ZA;T4V ,CJO!&N@J)-
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MH(-:H<#CKDT:_):&[34M79=-?UGW^VSZ,YO^Q Y/E/):*@ Q254K=31]Q0B
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M'-#40P"=TM8:K0.E:QMP'<]RR[-^![L9C98=C68DC!F-G@Z-QC2048IYW#$
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M>)MO($^Y'5TM*^!4T) R@!BT@#(-@8RD BCIA4)2$2HB#64-*&^>L^6R LN
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M.)2EA1/7 9\:X11E!7+P%7(T.49L(M%@ UMP<5( PIB4L((_MQ%I<%@  &
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M$ZJE5C2.(I9D:^\C?SX>XY[\9O&U?E8,-?/*:^T%K_Y:/APZK*[E4U[+!@B
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M!YL7W8LC/\A]&6M.,E]FA"5*DUSZFK!,<^9+E?L\7'M/U^.(/FVSZ>?K)?U
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M0'[:*_:"W&LWKO@Q_/8%<9:%:/61S&6%5I^;64P;LK(HIXE(0A)17Q(624Z
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MQT,$1XGP0= FC,0Z#0E+E2:9C ,B=93&0,0\Y?DMC?,>T+YDIN70DS>X_OV
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M3C%HRR4Q5MT\S,_/02B:X*X6P\7;[#174!CQ>I6Z4'+#6\I@A!L%YVQLY/$
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M1\.^-Q[!*FS,0:OEL(?UF9PF)XJ1F/0!21MURSP$FTB&%P-D*\/)2#AV!@+
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M"Z-8,Z[S'/.D 3KG29!(*H.CW4<WJ:WA%)S-3G4TEZ;SV$/!LVLF%'WK?[V
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M7*29EC*(D[7WX3H-Y]LO/$PU62+SRNHB_PJKPNHB/]U%;J!$Q(5(6*))2I.
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MH:^*"$; :68.6(Y7;];>OOWX"?AJX]_O-YK;&]O7;KF7''"EEWCK(V_,WE@
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M=4$P?SF_'Q0.<<XZ+(W@3H#S0S560ED?O2.$7<[;7M_X<^<!.?VW/V9V6#H
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MGX!ZT[K>M*XWK4?(;:3>L*XWK)?%N+\P%#[&L:+82A/EL=EIPLAVOL7VU]B
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M1 ]DN="#&Z:*\&-E!>:9'LNAB=N5YYV0/RZTX/1E,,CQR9<F:GS9)=RDFW"
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MDW#@<FMW&:!C>V?K[?_]WZU_UC<^;A<;'SYM[NP^H$')K4]=&M_IGK%>L%O
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M]V M<82U2*#<+$56$8^BC0S<5H>I+>MXYEL27 BH3!S>@W5;YM^79%1&5JA
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MR01G_<JRP2D$R$G/][*_3JBJ%8>Y6^\ /))1O\A<-IN+OL<-O*N0=;_J?'0
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MR<?#9FMTS;__/G0GH;UU]+G=.&F<P7O \^#]CCX>;?W5;.T>O0/WZMUA8_V
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M@I>F/4&&NPR0Q*/PT1$IR(*2K19=K?6OLJ?HFU%7T\O"\;FT@1UU=BT.;;\
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M@>XEO;.'8>H3$>DE"]J^8F8TQ:[A]_=?P*<F&58:,0;*Q:WBP+.E1")2FN&
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M0T"[V.R>CY*8F^W1EN.$9]T+*?L\*<#8.L'<]]'D5^9BUS:T0P1,+D]Y=7)
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MF-U4Q6RB\7Q5Q:RJ8K::*F:W0^2SL!<N!]Q1HM(DYHR*/AM M93+D_=8J7D
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MU21M:_"R$]<A-F&,6&NU%XQ<\T&IJ6OH]=3)D1WJ8NP$AR6-=Q(*/_8FWVP
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M>V"O'2;P';Q@-H^]P8'=]S@9XI7R_&IAG-,3*^\U\LTY6>"/W_T/4$L#!!0
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M;J-MM,7?=3<2CQ_?U3*6$3=W">[\=9W)M3#^9=Q?R]W?0YAWL/^K!ZLC@#6
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M/KV11&3!A7(^I=3DO%5'W'TR?TVX^*+8HK*>Z]5#K@EZ?WP-^:::3M.<J0Y
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M/)U\'<X6UW=6R=NL'+=NBF8]^)6R,7LY0VF'!;>//4%U[T[&\^'X8CC^=)T
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M28I>$JDL0J.QY)NBR:>45395V246D.S?PF]!0_TVQ5OAT':%<SH#%S+SWO-
MJ NX"R;<2IWWCNAH$2ZC7"E1)\"P!M5SX$%[8J^P!ES"",<'Z=0/>NAP#6>H
M)#4Q4)4)-=D@*N>(C3H1126D!)1%6N4P?SF<Y\""%@2]\ASV/WZ9$PPZ1?]L
M-WOL]<G57]^^N_A[FSEC]\^LEBFV'/5<?IA@DANA=)0QE/H+ZZE3'%2P-EL>
M^<K\L&7XMY'UQ>6O)^=G_V>2[G=R_N;5AZNS\].KG5(B5SVJL60WPC@G4*]%
MDLIHGBF361D7I:$X-[05GC*C.QN@;4&.;\J,NQFV*,Z[)]:2ZE+$\TGHUD:9
MC.%61.E#\@E-S\AES R$CGF5<)=@WT;&5Q]^^^WD\A\7;Z_.?CT_>WOV^N3\
M^N3UZXL/Y]=GY[^^Q^GQ^NQT)^IN^.3&,M]E!'.R-QIA!\<TI4I:BWNUEB4X
M2VTRW@?;V7XL[>O@??^FBW^Z$^^W?,.>=+)\1/.KN,DY.FN]=DX*%X/R01OT
MS$(4-O"\H6Z6C:U]'4WB3A4U-'O^GO2S;#1SV@&=LW,F!6^I]*@4:F.R1HMH
M(N-9;:B=Q7&UKYMS/QCX4?<+--@_=GS3GO2U?H3SFG,B*\\2  69M;%66NYI
M5#YZX#YLJ+F%=S8]E/S]),;^N#<J:0&#?@^_C)/0S?!B\/J3[WV$L][#3W1[
ML8N*^W9:P*C7BD<@7 KTQ:DJIP4R$^."<NB*,6:KG*<W1M[4X_NMV^L/T+DY
MZXU@ ,/1Q>\]& P_=3^_AT%$&/XCO/HZK?[IY&@@")^)+T'Q$OTB#ET2(BWE
MCN<H:?0UA+0%QOW[AOOEWKP?64M]%>)-EPAOT(TC2*_]\--);_*?XEE_\3=%
M6IT$(4N@Z$ K"R4)V>!7B-1%;[SUG#D::M#K*6 OC5.M*JI&H!KA?.AU>\/Q
M -+);1%"I^3!.$\3R5YJA 2!!)<C0=,"T!$R'*%5"54O8GEI=&FJCA;K"29Y
M@N?C(JU^OAI__GS3Q=6PD[.,*>#K6=*.2#"&V.R >.95E$&$$,U3-MSR1[\4
M7;<@V+8S_:=H+O*W>/HW7.CM185$(PA+X/YF/7'64Y*D3R;E<KHBMU#XTI>\
M0-4W%W:+^?</EY_%/>JM[PXF^9)ONL.2=H-K4R<+E7PIC51)!B)%5,1*[I"\
M,AMGN?%UCK0V1OA2*%57=2WF]=\!1<E$@#1\BP+\T!M"+%O=>7\$P_?^ZR1I
MR#J3(&9&I Z92!\I6D.@B'(EK*$4RZK*"=F3R%X:I]I558NE =,:!J3X19XF
M ?@_NK?CVPG3\4>37-=I=<-9[WK@>T,?BYXZW$5J:2E=0..:R( <"#1[XAUC
MD0?NJ>(;[67;O_NE<&<?JJF0BE_6S8YC#J3D$C%PQ, X^F*E,  RCE8#C\Q6
MR< O+W\I_-A9X!72\^<VRY/1:S\8?,6Q3JM#@#HJ%1BBJ<6-4K)$ F1#F!#*
MVV ""%:+#JMAO42BM*2D10JY9@72TS$/+R$"XL,-\1IY,"RE"+D_> ,C&-QV
M2TK*&\"__]<8\<_^I),TDS+)1*),I4E 8L1S:@C5PK+D$BBV83'TSAA>"I'V
MJ:HE$;KFN84W-_W?2X_/MPBT/PZC/+Y9'$Y'>^F5U98D@U@EX%<A%:PI!2NM
MA&ASE23#C>"]%+)55-H2;K60ISP<7>1?^_TT1.=Q5BPYO,)9T7%.*..%*-5<
M&MU$X7#TN+JZ3*/+4GCJJN2LKX;TTCC4DG*6\*9QDYD"ZO?NS<W9[6??'4R*
MQ4JYI70N&H[N()INN!E3R0G:[0J_S8&"3$E368,SR^&\-+ZTH)0E7-DYLOSM
M".P+],90@@BO^[W1 !V^OW='GUZ/AZ/^+0Q._X@WXU*1>C(< OXO7?L_.IJ+
MJ"%FXJ-/I4P6O4'#&,D:? [91<FK;&8[8'UI+*NMSB44;!S7?E.T4CH$(-YN
M&!?UO+_QLQ8X,"C!T0%,8O&#KP\_-#N! \C6H&!(C+%$Y7,@5G!&F$<O-21O
MI:D2D&P&^Z41<X]*7L+1QG'Q2Q@"/K$$\=_@%+OI?YZ4R_U1>EI AZ,H4#21
MY BN' Q%XC4$@F: TXR5+BRI4C[':E0OC6'MJ6@)@5KHD_,%!J/N$,=]!TE(
MZI/5AIB0<;#&X];/=41BTR2- ^-#'9]P <I+HTI#92SA1^,0]R3V_FJ^4\[)
M8%!$4>3RZNNWC[SWD]9P)[_[09K\\S<8CN[[1+$.*"MQWTZ$\E1V=%UZ0DF%
M1+#1)'#9U3G_;7,0+XV3!R/ $C:WTUIGH>_3XF#"_&!P.G8'DP]/A](10L24
M$D*'K$N+32!!>T.T=M8':@RKL[6V-H(7R>.]JWX)B7<^/6@JQVES%94R+=>E
MD$191O1HMGHE':$B!,:#R.C:'U.>_5Z[&!V6HOM3[*%[) T'H\Y]HORDF8>"
M8(U4CCB.^X$,41)OM"5"9\L"-URY3=93?/ #2N)W\W1<>/.A>A[M4=G]-H3>
M8AKY(R"S4OY-H&S1!&D['ARBY5%#;2S3:0-15M8N:"%]V2T]T(AVG].DY'"0
M3"'YI++/>A.7\GBTNJ)Q43VE;B/!%I4Y.09_[7L]7RSYT_&@_QE^O0U_G77+
MR)Y2=$1#N>L$ER'G;!FG)RRK&#*34<2YX[X5"0DK7[$_,[6QU/NMBZQ"#=CK
M?J]4I4T-VLON\)^OOE[CGTZXBO8L35P:-&Q#*4^S0)S4FM#H.4>N9I/JE/"L
MQO1R=N>V%53ADI %: 78;*9L JUF$\,UV [3RK U/3[%CX9*J-+';C7$J(1C
M)8"IK$U$"E>*%JT@S(;(8HG_I#K9LOOFQQ.M#0]!CVUD7^/.JEG!T@+$V<Y(
M.<_644]PBRQM7Y5!UQD428E%KVBB7E;)G'T"U_X#9:WI<#X$UJ("*I@F]V5'
MK[[>?_E7A%L.S[Z^*T=GT]G!@C-!4R(LH 2R$208D8D(+D9-!5IL51J&;P;O
MY1DL%=368J7J LK?P)>"MMM'A6[W>.\VT@W UK1FMD)[&/NFAMI7,:N:SBKL
M<MN!9AJ4-N6RT%B\014""2J6@UZIN*5:\#H-78Z 8$\82$?'KVU459-79[W/
MX]%P(@%V%U.PP>1R!,5-I$1&RA&D+ GA'$SP@C%3=TM<Q+1_JZFB-E?QIJ$J
M:MP#/ [#;NKZP=<'U923B4)Y2")FB5M\AE)TRTF@Z&,$I404D6F6JF19KT3T
M\BRE=I13H8/# SCG_A:_?%!C.YLOFR"L:1$]#?% -U:TH]-YIM112 VG_FFD
M(5OF($?B:3D"R<Q-*DY*$PGG$Z-)JRHVSJ$H\]2E%H=BS#9Z:/T(Z=O="^_'
MN W[(9Q\',!DV;W;.77@*1I#LJ&E8Q65Q)?;HT"G; 4( 6&SED%/O^L ]]6U
MK)Y^/=FV:)64(S7<8=,XCBX&LU*TZ:DH"\PJ[0GW*90\0!QU3)PH6EH#!^.4
MMVV=!R\#\')LCU94T&)#GP=X'M8GWJ4N; "J[2R0E6CVGP_27%&+6F])RBTG
MB*P&1[TPWH$EV7G<!#DSY<C=$0 II4@^YKS)*< QJGY-TLB>-+^-<&L8BY^Z
MGS^7*K]>^JOO)?S8Q[MK5W#C"TYJHHPN[<70_O&E724#ZZ3)R257QSM=A6B_
M>2<M:6PAY;D-<=>(4MS=Z_9J/.SV8#B\FJ:3#F=F<'04F"4VE7M#!8-2 2H(
MS]E;KH+4NDH7XK6H7H[%T+Z26NSA=@]NBN7>%WX:3-7@Q$,T![XYL[FVYGG0
M6-0U=I)'H$!XJDS6A.K2$0R<)AX7->(\!R]9R+S2_=CU];[I#9F5U;Z-A-N/
M'?2&XUL8W&V2LSU,!ZJ3]HEP34W)A,!ABF!Q@0M@A J&TSD?<F6\8-GS#Q C
MV%WB_7;%U>*6/^WL^!EBU]^,OK[_Y >W/L)XU(W^9C;@.YO$9U0+LE.KG$LE
MM"26,T6<]M8%[YC<,/ZSR=N^6^VV+LH*B_.D;.Y;-IN1-"NAB:81P>CDB8O4
M$R%93C* ,JE*^/<1BI=GONVNA J-4I\L(AZNK2*>#*.72F..$CV]2_C88$Q5
MK;X*@SJ,\=B *]M6B^]+T56B%Q7&9HRQ4GE*<*Z7>M%28<)"(M;B#W#<"G25
MFHOOA[Q/6,!'SMUM]%N#L^54Z.)S&<C,-@"MH=A+) +"D S%%- S((QKF:5
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ME4*")W#MWXIL0WT+*;_MR;Z"&_FA-P0T;,LU6N&N;$%#C%3J3)#KC$A$1X(
M0ZBU(DD>9:P3/%F"Y5E0H*F,*ZP(CPVAR;)G8Q)9ND"XA53\VDPL@T"H9U+S
M(*2251:!12C/Q3IL*.3JON.#HH9-<-6T#E<!.XQ]V%1Q:WG04.K5%X,'^$*I
M(?>!$QYX+(M4)CYK3C+/"FA,-L<J0:7]LN$)&W%?9-A&V&V?0Z--@E*Y>3]
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M>,OG)@AKEH@]#?$PQ6(MZ71-'+]%A1R&.L'G[*VUA"46B9PD5V5+298NR:"
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M7R8O6(@'Y4*55MK3"-V*X?R]._ITUDO=+]TT]C</C*1+&,+@RR0!X>UX-![
MW<ESAQKM%=>&,%7:_ 1-T10/G$".N/0)0$.\"KE;'\F+(_=AN="VMS215%@0
M9J^'X,]Z<0#XJU%_?C[F_N ._1BW\<'H$[R_\3T_G#4P[^<' W\0RY[]NN,$
M^IA@* &/_Q0#%AV0Q(BF2G+( ;C>L [@$/!?#.6_$X:T6!S7_H@[G J9LPDD
MJZ!PZ\J:.)4<45X'%R773&YV.U*KL'YP>#\:K=!]O;%U=9+21-?^9L'. B5%
M*MD(05A#I(R&.&844<YF0SD.S50Y]Z\XIA?#]&/C1X66]#L/;?+/WV XNL\/
M9IV2W@F),Z)T+OF_)?V&,TZR]!ZR2"'8.GG^+0[B![GWQ8 6JQX?C65Q5UH8
M2Y@?R^D?G[O34HGI2#J9LS+]-#&J7#HL(1/GN",B:; @%+.B2G9.:R-XF3S>
MN^Y;K.J\&\C)S>0SD)8+%.'BE]#AG@+GN%,$W#309D(?UR=A"2C!E8HAYCJ+
M[6;P7AS]*FBM1N'G4T(:KI+2M.)Y^"M^<C0\FTV5OT/WXR<<\\D7&/B/</H'
M^IK=(;P?="-T1 Q!*"D)@,Q$VH#25"D0GC6 X($#5&E!N\<QOCB6'RM_:I2X
M[BKII2/M< W.B90(;B+EVKG2;,1+1F@.(:J8 Q-U$O1:'<8/PN^/!15*;D]O
M/]_TOP+,:C>7#^Z\W_N"5CU,#?SA=7\TB;K?_[[4^)WW1_^ T27$_L?>Q(T-
M&E+6V1 +6A$9P!.7A2#!I1B=8R'&5(/>U4;TXIA^'-RH42!<;6332?VV/YC]
MJ'R.=8QU61M0R-9<@IFL[%M.(H/!!"5M<JI*-=A^A_EC?AP/B]JLH6YKXWMP
M C6-@G:B%Q'GO2=4*DZD<HJX<C*KI5<A29VHJ1=2:7,D+X[ZA^5"C8+OIB.Z
M\U3N+;O)3#_KC0;=WK ;)U6I'1:I82:BR-'%QWW/2Q*$,,1P)H.0P,61I:YM
M,;@?<^#0C&FSWGW=D>ZW$885 =3IG.[G]P #'%Z\&2? N?[:W\3QS>0A_5SB
M7['4:_?+3VZZHZ\=BTN 8EX1$R9A5B1RR(81KQTMU[!;F>>FQW;'^+6 OQCJ
M'STK:I3P[WR,,)OG?YN8?X_3+CL9$J4Y.9S-OA0>)H6#"IIDRQ,X*F.N<RUC
MC<&\&/H?#2-J="?86::G_QKC-/UV6<]P<C/J]2??>S3<1[O<?3.@3HA9<&8U
M28J67F'E[DR@B9B8-369)IN/*T.@T7!?YE0Y;E95Z>?0<(6XCQK,+1)2BA2<
MH*6'-"52 .Z%AG+D-_>,JTS5?#_XX]@V5HSG94Z' _-B"=^;GR)_Z[&P\WG@
MM".#TCSF[#G!T> VJ,&3 ++<V.%%N44[<2<K=SMI-H)]]48Y-),/HO%C:;M2
M<I1+Y?>DT#_K$!!Q) EW%B*3L<0:BS/0:PZ&4D%=G8ZB#T <07.5?=)@OKW3
MKNJHT$+C#LNL#\ F:&IV6GD,YS!=5797SPH]-Y!M?8U;)D/DB1+ARJUC4G*"
M/YIDO"H6G'4N5KGW<!^:?J(92BU%;R/2MJOW3FXG5?2<,E%0W;?@2,**C!X%
M-:6Y2U;$RR11+3HJ&B"(M-G%3$L?OW^[N(G ^ZU*JT)I<>G1 _\:XWYS^@7_
MN<8_FS!4R" H1X:JDGP@-0O$*FV(DR$P )9HG5;@*_"\[#V\#255N,)O":S9
M'-D$6-4>:JN0':YU6F/]/<V)!L*OT2]M)<"<<3(8"02 XU10 G#CHT!PV\LI
MTHB_V]?:<N#N:/LCQ38RKT^&V=[G:7#"HI-M8VD$YF@@7D=!C%*!<QX=UU62
MOY:B.4# K1UMK>? #J)NT<P8#D:=R[)#3JAMP (SRA.A!)J].4KBO0^$19-M
M=C$ENDG>*S[T@:[QNWD]/WKKRS0==A=\BR7C]R!F)-P$QA9FP>8\:'^&/[WY
M-]# O X;B*_%M7P>#N!.1!UH EF$TFLZDF"0I0+]5X:4%(IODJ)X'%I<L5FW
MK\1MI-:R\GY#2=V.;V= ./AR[7LB/H=,I"EI(Y)9@M^%;'1BT6UR7K:1^AZ]
M>7\;;2/9]]L07,M;Z>RRYKOUP%EN&,LD1XN6(E><!"49P1W=*B-5-*RU[?31
MF[]##>XLN);GX'5W5$R";RVZ)@N+Y$@CD6C9X<L="VCS>^L\R4ZY)#/7WFY2
M_;F1)I<B>+E&4G.%M-AH9"F@TM+M$J99@,-/W<_7_=/>J#OZ.O,5-H':ME&U
M)<;]&UXM:'4=1RJHI/8Z\P1D .J51(Q<*X/^80E#,W $\2:6I!8\;A*3^7[8
ML\;@.RQYMM%$VP<Z;_N#6QB\[4_ZC0WO[)U@:$#C%K='AU:O"[CGVJ")RQ*B
MX%J8>6JL.,]9]O3]FA)5==%O4Y 5CGK.>K%_"Y.;X,K>^:[\09%T(7>T@3L?
M+*$R.;2K9+DAFR%2FZ3)@1LCJU3?K,'T,DV2MI55H6_4"FBS*;,)N)I'/VO1
M'>;XIS5=;L:1!HJH$/E?#S+H$!E3Z'I1ZM$30Z?.N:A)5((S$-;0.B< !V#)
M$\=!AR')-O*O0(X+7)=]:8DW1?FN/[S;*\O](C@L0Q ![KQ>:G3T2Y EH_L?
MP265JW0"78EH_\=#+6JN7T/L%4R4Z>9Y=Q(:N*#9VDBTX1S!H EFLV1$AFQC
M!)N]K;(X/$+QLLV0W152H=??[H+X-HQ>FDOGVF1,55-5*@SJ,&9. ZZTUCBM
M9477R(2H,3;KJ(=H&*$QIW+KF26E>2PQC)L@M#'.5&DH]?V0]PGKZ\BYNXU^
M:W!V<DO"I,QJ9B=(Z0235A,>8B"2J4Q<#I*D*)U,DJ'!6B=S9Q[)$9;)55?P
M/.,:::=%*V[: N$!FG[JYN[4:ITAH]9HE3P0F[A&6\09,NEL8ZQ(5BK-/)W+
M&5C5QF+=:UXP*5K60=L!Y@<]CKH)'J3!0V*)9ND)"ZQ$6B6:JRI;(I-7B6?O
M'7_RQL&U;WCIG&A%\A62R"]A.!IT2U^3"6L_H%:&EU<?9N"RU8F6Z@J0LMS#
MPSRQ00#Q62<A60C25C%LUJ)ZP51J7VLKTPVK7\)[-;Z]]8.O_?Q@N1R>Q%'W
M2SD :OOBTXW>5NDRU.U'.G_A;]"9"J8A I4T0A#<@@I">LNT$VK%!:D;O??@
MEZ9JH=%, D90@Z7+?'#$AX#?!@K9L21#J%*4V!SZH1O[/6A5>-F_N7G;'Y1?
M=I)/.:E@B0%5!)H\P1FO2/!>.8[+CI9'V;U[^7".<+5OE],5&UCNRHH:A8ZM
MM^5,@E%7*G.DR(S(F#.QEB62+!K0R4C**E6OO. 6K2U2K'K;UFWX<8A XW;-
M^!5HJ@(D J&4K,L@B!.6$HTF7;;4!4/K-)]I=1@_J'Y89M2H0BZV9;DH$]*;
M\>#^>K5I]Z>'AN==4]G4H;@-:FXSX3F58KB PG-:$FJ3#TK18!54X?+64'_P
MM;Z&C^F.U-E 4&H9NN66[F_3S#L:J*6>\"B!2&9<Z4B5B>/.2^89B[X.:=L?
MRP]6'P%'CNE^U)4V%.@<N4N."!I+K)IJ$I)&:PHBY19X"+Q.JX"Z-O;^13M;
M&DM"R-VM BD9* E$2 I')'>%M@[E&W30WABOV5$:= LC^8Y6D^-PT)MQX0A=
ME6F_VY->NFN1?MTO/UI<3KB@!M='B19!,0N,T,09DX@%*R4#D9TZS"V++0WP
MQU0X!N;4<'+:VX_672-9;)L\LVVTU#%8=.:$GX0O@B$^.T]8RD9+HY+BA\DI
M:GVH/V;-<;'I"!VR#4?<$2YRPWDF6I:",<4ML0(248)E*1B56AW[T<<SN<)W
M3U0]S,S:BF='E<2Z_<W&*4;F)R4O-J,+F "(]Y818VRRKA2_Z,,<S[[(F[&/
M=%H=B&^'L/2>&NK"W6EK1TN#3D9R3[@P <T(B68$+2=5)E$.B7L6#A-5;'68
M/R98[0E6CW6'L :?&NV2V.O:\=JHO=.:$3LY(G,)ORI]!)@1G ?-)3^0+]7R
M0'_,L]KSK";SCOM$8.TP Q>:!R:)*QU:I#":>&DR,0( (@I!YWJ7/^W;[SKH
MZ<%:-7"=M'/!$AU*2K$MN>26 HG44$#]>)N/_4SAF2QOQQ$HJL&;(URE5D21
M-QT]&$'!</0SG%)$@N<D&$L)TT:JP +3\2AG3;-A_YA,Q\NR"EV#FH[^)*4)
M/?S-F^ZPW&=63*"3,!P-?!QUI!()MWI'%,^.2,_1S(E2$J L*FXD=?HHDV/6
MCNK'##D81VIUKPA/#RYL;2I>0E$N_OQUOS<9ZMC?7,/@EG=RTHI*=*R-C)+(
M%#UQ/)343&YSX$$ K[>S['>LW]%D:9^M+5^E6IMJM4XD&@QY]2ZZ:LBL(S+-
M5FI>TNMPR(P;M%J3)DHIGZE5-*AZ!2#['>N/V?7]4*W6H42#(6]MNJZ6A)8V
M1A$3X<G&T@L/B*4H&#1BLXVELT&RQSCIVA/!C[GXW1/SN#-<SG!DW=ZP&__F
M;\;H.&:'6SAJ)<=<4M^"(4$R5)(-S(,SW.?CJH]^:D0_)M"QT>8(8WJK!V:C
M<M8HBO+E)5FZ%'U8F8EP'H>$F[&KTY-D3_/AH+;W8V!H]YC(E-2.!%7.=8++
MQ#DKB,\"/0QAO0M5VL#6&]*/Q>?HB'.(5J6-8[TG'S\.X*,?S8V\$WTV0CM%
M/-H<Q0S!U4DD0S2*@,<@6/;T&%>GG4?\8T)];[1;G&^F\7QKK5LRSRF8A!:+
M+3D=4DN!"T<6A"EG$IKVEL8ZF01MC:#%^>!O;H[WK. @&E\6N?RIR"^-_EQF
M,J2__#P:C.';#]%-A#]&IS<3)'_Y>0@?RQ?M-DI'$Q0M:Z4(.,MQLZ.)A R<
M"*W !3 JNRJWMSRS1NE;$6%MH_1M%')4Z?EKV@5N,J8?C=*W;Y2^%5?VT6QZ
M%T5_+R0.$(4WZ+93K02:*<(2IVPBQ:X2,G"?*G5^^6[(NU6C]*/C[C;ZW4NC
M]*A9EBYF L#0FD\VD^!S(A30,35>^@Q5MN;GVBA]*P4_V2A]&^VL[$E8O5'M
MR7 XOITZ:!]04J/^Z7#4O44?[*WO#B;N5^O=:C=_9:66M3N.>:YO+43E2UMK
M4 :DC]I)XX)#9X,+KCW-*_K6[C3Z;?1\?GI]=HYO/'UW<77U_O3RZJ\GEZ>[
M:&_Y@QKK9 -\<Y)VH" PIA,H+670#H!*PV+FG.7D:>=)I(WE-S'B=YH#ZQY7
M1Y;+L,Y)U&<;J'<J:L5E--PBBZU4DED1C+%NN40743>6ZTEOU$W=F_&H^P4F
MZ_6PP7*SY1OJ2'_#$<TI1#()/E)O%,U21.>5-B%'Q:.T7ONT7"&KW]4P O#P
MN1#' Q0-#$__B#=CA/P6=^.RZXY'DTWW(I_Z03FU'KZ'P03%MR",M*(<40LB
M1#FW3BP2;R,0913$P)GPJ4K+@K8&T#B4T@S'R6U_W!MU$D](C91)3AQ*R_M
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M$_AD(]_PLO *Z/:_VK?*K,?WA1]:>[7N>VQ<&3KM_C]++1UV,E@C$FZE$73
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M4$;>$30)+X,A=G([E562>.<3.M54:.NBEBEOI-V-7_F<M%Y'SHML<(TMY95
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MJ\%R./NJ"VI9]2W*^- E/\/!J/,.9?YQ8N.\]L-I(HV6AD9F$E&LI AS%M#
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M4IPJIW:]3BQO\L9JW"S6RN0N*3IQOCZ-$2E+0Y$<S@Q(FWEAB;*%.3C= S2
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MFDEQ/$H9".B^CU<J-6RID4814&ERL]FE/=VLK2NS6S/Z@&HZ0*,1L"H!JU/
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M%.<ZBY2 .-,4(B$1I!0S8R2D68325*?(*S_WW$!C8Y#=L+6. 7R'4+HM^A
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M7\\'M:A$F2#"HR0C F+&C1D8I390JLK-T5AHA/(LC;P.X"^/.38*KT6NW;P
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MU^ZWH^WFV&M!.LH4S7&,(<9,0D1$ BDQ!GV2JCQ-L:#87.15+SP,UL/4 S]
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M,E/WMF+BYZOCAX\%<%HMM%XM1V+TMW(^5DU+7X&EL4U$+7&0".$3,^!#.:$
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MQ#U_1#=2@FE55,JGI8H?Y.TT$Q[&8=AFKZS31N@;L,6UDKNI^-0'KAY50OK
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MO2=L9;Z3[2DL C;KLL+@IGXG2E#,-N&V:R1  \7.:[-S'!7P!/UYYC'H:?S
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MQ4P"FL&04:'_43IYQ"Y*F=O*Z/W1&?R_N?'<91SM:.QJ=$9FJ4J_FZ !:(Q
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MV'[@[=9V7N$<F96O1G) 4I$E.G[SB?J$3IQ*9(G!>1:1[8T#=Y!Y0;]]VYB
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ME$;I[=DI^&UZ?-I@T=KKT^IF'U5B3](]3"C,^F6U_:+U>)0;7B8XHU3$"59
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MZV^K_+P?R)>'7ZO^G\&F:M4<;-=G[2LTB?[(5PXQL#Y'NYL$IQZ\B;H7&8/
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M)"2*F2*9O0/H7,#<YKY6$1@=:X=/W8K7Q3MQ 40;E\YUT(SMPZFTJ[T-=UY
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M1GL3,6(4OZGZ,A_H7V;:?-$CN,FY"<DVOQ_:^,MJ@.P8;SS81R:]4\1+?,]
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MSD[FKW_BVS04_+C>*)EO7_0DN5\]RDV^%@N6D1@*:BK$2;,>0R&@0@\XXX)
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M?/38R2?R):,NS>*+UWG?/]S^T(_/__OP0-X0Q],?ZX5DD4E9ER"*S4%.&L:
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M6LFZV<\(>XV+6(RRRSB6]#;[BXO6MNXL+E\]-,#'%#K:>>HP4CR),@YXEB
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M.V+& ,V@ #"5"+!$)2 3J61,I%%,W)AG%#7GQEK[[V]IC&O@SSA#:<EV;SY
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MA<H4I9<$TBPCD&69X'$HPSAP*DKO5[RI$=?WQ4]9KJ1H?>K DQ%7__M=E7S
M-76)Y[$4@50)23&DJ4HARI2"&%5UBQ$+4JV;P-2M@LG;C>8X=4]^G=+P62Y6
M;S8D0Z]M'D-=:B6-*T:MIC;-ZV1L'Y>%DOEJ?2[,:?2@E^-#,J5@EST)_U1!
M+L?1]1W<<J*7*[8/5:]T;AP^/\Z7O]\OU+)XKJ5J0X)9@,,H"6(H1<(@$E1
M2E,!XTAD3 B%$L=(:[M^I[8J=\4&7,L-E!8<B+SD\V5IYKIC-2M;_!VV%WY1
M'6.;T0)J1 9&9M 1>IBP;#>@O.\[++H>?_]AC\?1?8C#ZSYSR9ICEGRQSA=/
M3:XT39%'DRUNYA(BE*$XE5#@*($(HP02&G$H".<X26,J=*=7IY5UEFMJ7-<<
MEM=NX])4:\B;C(!S]]2)OL;.C@??8$3>Y%+S6-+9=M@&*1GH%]?AD\VZBS:!
MO+.]\;1+0=N_^7ZT_;A\I?/5:^-\/(M"3&-NC@X(5A EB8*8APQ*CA!)%<,D
M368+N;+CWMW&K28LJ2=LV\6 MHT)EVJVCSM>(;0LEUQCK']>W?"HY7IA$I\
M^?PR7];[S%*N5O626H)WGTT\3A@Z<NX>\';4V0/0D9S::L':X 9_I'9<8Y_<
MM-?#J!1S7+M]ICCQE'NBA ^:6U:O'_.Y+.[T%_S)1/,DB*6<9A)210A$C"#S
M*8 4QUPJE<4B5;8I$HZT/S6[J1815#*"5DC[K C'$#P_=3W@,K3UX@2)4PJ$
M,XI?D?S@6*NCI3TXHU(WX<&YQ_HZMCP_FZ3T>MEJ;C5E$+.89 E,5" @$H)!
M2H,$\C3DL0HEC4.KZ)V3/4QM\M8"UN'DKDXK^^#9+;A703+PO.VB,<"M[TG5
M_;J6['<RLA/)"1T/W45./=AO,K=!@5_TB*ZZD8&?-L6VX@PS'$442B5"B&))
M(,$BAD)@&D0ABQ%/76;WY2ZG-MU;B?6VV<B\%U_;OQZ:!?AV[. 7TH'IP@.:
MSAQB#Y!/4K'H=526L4=AGW8<WG3CH;)8S9KX(Q-PW(0?E>^7SS1?S,*42!5E
M5:JD *( )Q S3F$6R% D44(S896WXVPO$V2;PW"L6E1+?CD/ZGE*\0;5\"SB
MCI(U;UBA<(8J]/L=FM#_VJ>(\QV,P@I6.K9$8/>P9QO$A+\U7]HL(9&B<0!5
MBBA$3$:0,<4@R5(L>)!Q)!,O1LBVSPGRPNEU\P88P1UYPF4 KC1$^L$Z,(=\
M6BZ>X*?\9U7Y>O%4A095=8\],DD/9$8Q03K=3L,&.<3!V@@Y\JIO)MK4A^>2
MAICS% J*&40JBB%1:0AQE"18$H:3P.J8TK[+/Q4/^2*>#=[7\DX?%-]V U15
M60=&<%!)/@H)[<,T#@=M>IT(!1V4MK=FH(,W^Q'0QWR1KV2U)-V;/"+5FE0M
M2>6OQ;(L9S0UU8Z9@$)J$PBE@FOF80FD$FLC2)$0Q4Z',9<ZG!KY5$*!.UH4
MKR9M_.WS<NU*.A<QMJ,<G\@-3#BUJ(VELQ6VMG4J[V0MKS^6L47&)\=<['-4
MAK%%8)]?K-_KD?3#>&T\+:JJ2TO5%$\Q_L)Z]3&QAZ:JBG'V8//\J?(_T#]_
MW.3VG"4$44J1WG4E*#$G,0PRE1A'WY"CC 5"95;><->+,C5&ZBA355>OO33
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MZA)\EH4I4\9^2G&F-Y@\#B&FIJA/E@4$*1:(*FCWR?1D1SJ^1+.:<YN0WZV
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MD'["]?V><6S\AQ1KDQ-3&S?KH@JS>%"?EHNG;[)X?B_9JDHGM9U%BDD<211
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M<80XE6$<XA3B4 B($LWP+%4AS'B22IY('(=.Y47MNW8B^Q$2%31Q]KT3%#B
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M?%J6'J]-W(#RFGG:KN=Q4U([H7&0J]KM[8&N24[2XS:5]D)\T5^^S_KKV)1
M5HE,8QEG,% FW74:IA"G(H,I)J%$H4RSP,V&'4#(R9%?)^M[KZK4@XRDIQN+
M@<=G:#)U&!K_UPE78#?J+4(?.:=U>7 %TLYW!M?TU2-%S'Y<;>/<N'CZ)+4
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MD%UL$'_'X^-_FY$3]!'#DOC(A\OE*3$2;*&/!PTV531'&<'K7, Z8ZQ&+OF
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MP@G,T:LF+?)^0->X9ZI-\#:D)CH UB?ZW-7]^.N:4[2L@P'?3BG4L"8Z3HX
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M3XR0(5L,=;Q9!I4-AY"]!A&,X%J:X-M4*FY#W+C&=WP(S1OKLP.,UB/R0!'
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M+O#NO7GLF>7/INWY$*+O!3.OYB=A.IN@D2I@,1"0)2 O@*)X5 H*PQRR)H?
M;..J/0TUY^\>!S=[:N\A#.P@RO&;6,YFX=]QN7I]6K-*?SN)?_L=:TN;20GT
M+I8C.8665H3WKLHE "\ZQ<)5DG<GB&_L7[GA%1WH?1>-S0<77P?QW+WBUA=G
MG^A/U^M"8J&85%F0&"DT]0[!JSH#( 4A:%T4FYNDV#Y"T\CC&YY]JQE:33TB
MKC)RL1[KY0(7)H%VCB)@Z07XY"1P%Q-/Q6N9VPRZW$S3N,[-8'K_$9YV5$('
M>%K/,9OBXAY+%P:9"5&<9P'*>?FJMN 8:LB9IZ!99D'Q%ICZ 5V=X6I7_3\T
M>'(@972 K:NZ_!=G5]_^C=BKZ6YG;VNRV_E*Y-';:!A(AR2Q8B5$*PO(Z%,R
M3)*3T>2Z83OR1IX<,]J>V4!Y/4'R=PS+T\6Y)._S=[&6N4%MK O@4O5&]7KH
M.\4WBN(=X>K\QC;3X9Y$Y;BFL 5,-B%Q<)WU!,C#V=?3U7(M,7X9#+EHBPD6
MA$T,5&*"F%(<0A9H8Y"<MVE1] A-G8!M>"1LPMR>:ND 81]/XW*:IV%Q=CXC
M;#T'8KTHF8A9IJ)H>RCKL2$"(B./.&HM*=#FAK=)XME(T<A3LD;;:X=140]8
MNR;_73BA;S\MPFP9UM,2+U9E+(Y[+ D"J\>%A7OPI1X?R>1#YBP;W6:D_0])
M&WL0^2 8N(NL814R^KGK_.1D/ENS<SEP[N#S M>+]-(ZFSK^V%HH=12RXDQ!
M<!$!32Y.HJ1P_XY1VW0 ^\-WC0R8@54[;R?GD2]MR);7B:U'BX^X^#9-Y^<_
MFD?N="VB"CF23T 1>TA9@&8NBA*MUV&;HI"M;FX>(F#D$7NC7/OMK8@^@%3'
MIEYPL+Q8:2Q(&SPZ*#Z0C1;<UJL0#XA**9E#*F6;8[*GH.D^%>/=#.VOV/LH
MV5/*/7A#7Z9?OYZ/=_M;F&7ZV.<+XZG(*$>O#&AK2#22]O7@R4YS=%[9DGWV
M;3SO312-#IU]M7VOXFP(T?> H<O!*Y>SHRXGI5RXALDSY Y<UIZ8X<1,"A)$
M*<$)'94Q32II'Z5JY&&=XT5Q@ZFJ!]R=TWYYTR\#T[888$8$$HLW$&CI@ \"
M@^*QB)*:X.PF%2.[V\-I]RYN=A;U^.'8;'E:>[%<V/ +$VLB,]F$#,(P6Z_
M2"PR.EI)$:W4T0IVQ[7>&((]]/R1<;"[MN;#BFYL[7_\BK73]NKL_9>P. D)
M3U?3%(XO!'2YW89"*J658'2I4\*<JI,E=*WJ=CX&S]66X?@V;QLWOV4@9 PN
MU@YVD_4LZ^O4"ZM8T=* 88F(-SF 3RR 5+QD%5';W.0(\!85(T^ 'LU+V5T5
M'>#HX482!XM%%=A:>B_.KC_S/IS5GZTYOF9[EFN;B7ID=K%2K;5.Z<" Q*I
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MI_-2<>6<AAA<!A&T+Q2$*YZ;C&;>@K9QX\MV>+I?US:LFGX.X[1/P\T'G]3
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M5)^VX@F8V'P/L:<&.O!'KWGY/:Q.%VM?Z*B\G<\^?\+%R0/\&8[%\'H$Y:T
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M@JK]%$SBF8ELR6?^">W656?8]7M>G+T\#LOSJ:T3YR7SQ7!(BE$@J5A=:S)
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M%^C:#E,G4!-HH8>N7ZG^=O;YS>M7'_[\^.;]Y[,O[SZ\OT_U#B_"'G_24*_
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M>D#?*6=>7FU/4I!IW0W.E!:@M-?@:XN 44''K$QFMMW=U9"<C+SO^<0CM\.
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M4 1>6*.D\1FJ.M]8<6PH#J?!#N#X;I;FW\FJ*!RJ<ONC_H,JWGK:>%&4$UF
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MY*PUDSI99T^F*V;#O<=U'/GZ M^3$#_-U\M@O_P;SW_@G_/9ZAM%F+[DS%$
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M*&!7DL>M&;5':E,5=I^UW/F_M]'0_%$T=,#;F?V_;-@LZ!!.CY ML< EQNS
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M#P._EDH;#).M.AK_FBTPS;_.IO^]%L#U-)IA^AM?^/!ANQUWX>0(O8^N+HC
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M8;8/^W<W#5;9[@N[.BX/ U$S.;>OKUW]HOXG4K3X?_T?_S]02P$"% ,4
M" #OBG-2FH">+H (  !I*0  '@              @ $     83,P,F-E<G1I
M9FEC871I;VYC96]E>#,Q,3(N:'1M4$L! A0#%     @ [XIS4IL!DRIX"
M72D  !X              ( !O @  &$S,#)C97)T:69I8V%T:6]N8V9O97@S
M,3(R+FAT;5!+ 0(4 Q0    ( .^*<U+(?.6O_00  %$6   >
M  "  7 1  !A.3 V8V5R=&EF:6-A=&EO;F-E;V5X,S(Q,BYH=&U02P$"% ,4
M    " #OBG-2=I.RB?<$  !%%@  '@              @ &I%@  83DP-F-E
M<G1I9FEC871I;VYC9F]E>#,R,C(N:'1M4$L! A0#%     @ [XIS4H;YY%[:
M @  )0D  !D              ( !W!L  &-O;G-E;G1E>#(S,3(P,C Q,&MN
M9RYH=&U02P$"% ,4    " #OBG-20*D(M*H< @!"610 $0
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M+3(P,C Q,C,Q7VQA8BYX;6Q02P$"% ,4    " #OBG-2/)L1+IN-  #X8P8
M%0              @ %SN0, 8W9S:2TR,#(P,3(S,5]P<F4N>&UL4$L%!@
0   +  L  0,  $%'!     $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>